Citrus Sinensis ID: 022413
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | 2.2.26 [Sep-21-2011] | |||||||
| P27450 | 419 | Probable serine/threonine | yes | no | 0.865 | 0.613 | 0.648 | 4e-98 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.717 | 0.516 | 0.676 | 9e-88 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.851 | 0.617 | 0.587 | 7e-87 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.754 | 0.575 | 0.641 | 4e-85 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.909 | 0.633 | 0.557 | 5e-83 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.861 | 0.648 | 0.532 | 2e-80 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.710 | 0.495 | 0.638 | 3e-80 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.680 | 0.412 | 0.674 | 3e-79 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.717 | 0.547 | 0.612 | 1e-78 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.861 | 0.519 | 0.561 | 2e-78 |
| >sp|P27450|CX32_ARATH Probable serine/threonine-protein kinase Cx32, chloroplastic OS=Arabidopsis thaliana GN=At4g35600 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 358 bits (918), Expect = 4e-98, Method: Compositional matrix adjust.
Identities = 179/276 (64%), Positives = 220/276 (79%), Gaps = 19/276 (6%)
Query: 14 SSSNNINANASSSSAGAYNKYGHTMEISATSSSAGK-SQFSQAISEAGVEEASPNGQILE 72
+++N+ N SS+ GA T+SS G+ SQFS IS + S +G++LE
Sbjct: 23 TTNNHSNGTEFSSTTGA-----------TTNSSVGQQSQFSD-ISTGII---SDSGKLLE 67
Query: 73 TPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
+P+LKV++FLDLK+ATKNFKPDS+LG+GGFG+VY+GWVD TLAPS+ G GM+VAIK+LN
Sbjct: 68 SPNLKVYNFLDLKTATKNFKPDSMLGQGGFGKVYRGWVDATTLAPSRVGSGMIVAIKRLN 127
Query: 133 PESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS 192
ES+QGF EW+SEVNFLG LSH NLVKLLGYC EDKELLLVYE+M +GSLE+HLFRRN
Sbjct: 128 SESVQGFAEWRSEVNFLGMLSHRNLVKLLGYCREDKELLLVYEFMPKGSLESHLFRRN-- 185
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252
P WD+R+KI IGAARGL FLH+ +++VIYRDFKASNILLD NY+AK+SDFGLAKLGP
Sbjct: 186 -DPFPWDLRIKIVIGAARGLAFLHSLQREVIYRDFKASNILLDSNYDAKLSDFGLAKLGP 244
Query: 253 AGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
A +SHVTTR+MGTYGYAAPEY+ATG+ Y+ S F
Sbjct: 245 ADEKSHVTTRIMGTYGYAAPEYMATGHLYVKSDVFA 280
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 9e-88, Method: Compositional matrix adjust.
Identities = 144/213 (67%), Positives = 180/213 (84%)
Query: 68 GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
G+IL++P+LK F+F +LK+AT+NF+PDS+LGEGGFG V+KGW+D++TL SK G G+V+A
Sbjct: 46 GEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIA 105
Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
+KKLN + QG +EW +EVN+LG+ SHPNLVKL+GYC ED+ LLVYE+M RGSLENHLF
Sbjct: 106 VKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLF 165
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
RR QPLSW +RLK+A+GAA+GL FLH +E VIYRDFK SNILLD YNAK+SDFGL
Sbjct: 166 RRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGL 225
Query: 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF 280
AK GP G +SHV+TR+MGTYGYAAPEY+ATG+
Sbjct: 226 AKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHL 258
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 7e-87, Method: Compositional matrix adjust.
Identities = 154/262 (58%), Positives = 199/262 (75%), Gaps = 9/262 (3%)
Query: 19 INANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKV 78
++A + S+GA KY + S G S ++ + E G+IL++P+LK
Sbjct: 5 LSAQVKAESSGASTKYD-----AKDIGSLGSKASSVSVRPSPRTE----GEILQSPNLKS 55
Query: 79 FSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG 138
FSF +LKSAT+NF+PDS+LGEGGFG V+KGW+D+K+L S+ G G+V+A+KKLN + QG
Sbjct: 56 FSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQG 115
Query: 139 FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
+EW +EVN+LG+ SH +LVKL+GYC ED+ LLVYE+M RGSLENHLFRR QPLSW
Sbjct: 116 HQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSW 175
Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH 258
+RLK+A+GAA+GL FLH+SE +VIYRDFK SNILLD YNAK+SDFGLAK GP G +SH
Sbjct: 176 KLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSH 235
Query: 259 VTTRVMGTYGYAAPEYVATGNF 280
V+TRVMGT+GYAAPEY+ATG+
Sbjct: 236 VSTRVMGTHGYAAPEYLATGHL 257
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 314 bits (805), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 145/226 (64%), Positives = 184/226 (81%), Gaps = 2/226 (0%)
Query: 68 GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
G+IL+ +LK FS +LKSAT+NF+PDS++GEGGFG V+KGW+D+ +LAPSK G G+V+A
Sbjct: 45 GEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIA 104
Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
+K+LN E QG EW +E+N+LG+L HPNLVKL+GYC E++ LLVYE+M RGSLENHLF
Sbjct: 105 VKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLF 164
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
RR QPLSW+ R+++A+GAARGL FLH ++ +VIYRDFKASNILLD NYNAK+SDFGL
Sbjct: 165 RRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGL 224
Query: 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSA--KFGNVI 291
A+ GP G SHV+TRVMGT GYAAPEY+ATG+ + S FG V+
Sbjct: 225 ARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVL 270
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 156/280 (55%), Positives = 205/280 (73%), Gaps = 10/280 (3%)
Query: 1 MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
MGNC S +SSS++ +AN++S S+ +K ++ S+ + S
Sbjct: 1 MGNCLDS-SAKVDSSSHSPHANSASLSSRVSSK-------TSRSTVPSSLSINSYSSVES 52
Query: 61 VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
+ G+IL +P+LK F+F +LK+AT+NF+PDSLLGEGGFG V+KGW+D TL SK
Sbjct: 53 LPTPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKP 112
Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
G G+VVA+KKL E QG +EW +EVN+LG+LSHPNLVKL+GYC E + LLVYE+M +G
Sbjct: 113 GSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKG 172
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240
SLENHLFRR QPL+W IR+K+AIGAA+GL FLH ++ +VIYRDFKA+NILLD +N+
Sbjct: 173 SLENHLFRRG--AQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNS 230
Query: 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF 280
K+SDFGLAK GP G ++HV+T+VMGT+GYAAPEYVATG
Sbjct: 231 KLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRL 270
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (764), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 149/280 (53%), Positives = 199/280 (71%), Gaps = 24/280 (8%)
Query: 1 MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
MG+CF S A +I N SS + YG ++ +SS+ +Q ++
Sbjct: 1 MGSCFSSRVKA------DIFHNGKSS-----DLYGLSLSSRKSSSTVAAAQKTE------ 43
Query: 61 VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
G+IL + +K F+F +LK AT+NF+PDS++GEGGFG V+KGW+D+ TL P+K
Sbjct: 44 -------GEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKP 96
Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
G G+V+A+KKLN E QG EW +E+N+LG+LSHPNLVKL+GYC ED+ LLVYE+MQ+G
Sbjct: 97 GTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKG 156
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240
SLENHLFRR +PL W +R+ +A+ AA+GL FLH+ KVIYRD KASNILLD +YNA
Sbjct: 157 SLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNA 216
Query: 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF 280
K+SDFGLA+ GP G S+V+TRVMGTYGYAAPEY+++G+
Sbjct: 217 KLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHL 256
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (764), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 136/213 (63%), Positives = 176/213 (82%), Gaps = 2/213 (0%)
Query: 68 GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
G+IL +P+LK F+F +LK+ATKNF+ D+LLGEGGFG V+KGW+D +L S+ G G+VVA
Sbjct: 63 GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122
Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
+K+L PE QG +EW +EVN+LG+LSHPNLV L+GYC E + LLVYE+M +GSLENHLF
Sbjct: 123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
RR QPL+W IR+K+A+GAA+GL FLH ++ +VIYRDFKA+NILLD ++NAK+SDFGL
Sbjct: 183 RR--GAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGL 240
Query: 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF 280
AK GP G +HV+T+V+GT+GYAAPEYVATG
Sbjct: 241 AKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRL 273
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 139/206 (67%), Positives = 166/206 (80%), Gaps = 4/206 (1%)
Query: 76 LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
LK FSF+DLK AT+NF+P+SLLGEGGFG V+KGWV++ AP K G G+ VA+K LNP+
Sbjct: 121 LKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG 180
Query: 136 MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
+QG +EW +E+N+LG L HPNLVKL+GYC ED + LLVYE+M RGSLENHLFRR+ P
Sbjct: 181 LQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LP 237
Query: 196 LSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
L W IR+KIA+GAA+GL FLH K VIYRDFK SNILLDG YNAK+SDFGLAK P
Sbjct: 238 LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDE 297
Query: 255 GESHVTTRVMGTYGYAAPEYVATGNF 280
G++HV+TRVMGTYGYAAPEYV TG+
Sbjct: 298 GKTHVSTRVMGTYGYAAPEYVMTGHL 323
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (749), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 131/214 (61%), Positives = 176/214 (82%), Gaps = 1/214 (0%)
Query: 68 GQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA 127
G+IL + +K FSF +LK AT+NF+ DS++GEGGFG V++GW+D+ TL P+K+ G+V+A
Sbjct: 38 GEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIA 97
Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
+K+LNP+ QG EW +E+N+LG+LSHPNLVKL+GYC ED++ LLVYE+M +GSLENHLF
Sbjct: 98 VKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLF 157
Query: 188 RR-NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246
N +PLSW +R+K+A+ AA+GL FLH+ KVIYRD KASNILLD ++NAK+SDFG
Sbjct: 158 ANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFG 217
Query: 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF 280
LA+ GP G +S+V+TRVMGT+GYAAPEYV+TG+
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHL 251
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (748), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 150/267 (56%), Positives = 188/267 (70%), Gaps = 11/267 (4%)
Query: 22 NASSSSAGAYNKYGHTMEISATSSSAGKS---QFSQAISEAGVEEASPNGQILE----TP 74
+ASSSS N TME + + + Q S + + E +S I E +
Sbjct: 66 DASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISS 125
Query: 75 DLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE 134
L+ F+F DLK +T+NF+P+SLLGEGGFG V+KGW+++ AP K G G+ VA+K LNP+
Sbjct: 126 HLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPD 185
Query: 135 SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
+QG +EW +E+NFLG L HPNLVKL+GYC ED + LLVYE+M RGSLENHLFRR+
Sbjct: 186 GLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---L 242
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253
PL W IR+KIA+GAA+GL FLH K VIYRDFK SNILLD +YNAK+SDFGLAK P
Sbjct: 243 PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPD 302
Query: 254 GGESHVTTRVMGTYGYAAPEYVATGNF 280
G++HV+TRVMGTYGYAAPEYV TG+
Sbjct: 303 EGKTHVSTRVMGTYGYAAPEYVMTGHL 329
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | ||||||
| 255561407 | 420 | serine/threonine-protein kinase cx32, pu | 0.959 | 0.678 | 0.744 | 1e-124 | |
| 359477083 | 310 | PREDICTED: probable serine/threonine-pro | 0.969 | 0.929 | 0.707 | 1e-114 | |
| 296088660 | 315 | unnamed protein product [Vitis vinifera] | 0.969 | 0.914 | 0.707 | 1e-114 | |
| 356529677 | 397 | PREDICTED: probable serine/threonine-pro | 0.932 | 0.697 | 0.697 | 1e-113 | |
| 224114471 | 337 | predicted protein [Populus trichocarpa] | 0.750 | 0.661 | 0.847 | 1e-113 | |
| 224084090 | 437 | predicted protein [Populus trichocarpa] | 0.966 | 0.656 | 0.707 | 1e-111 | |
| 357517679 | 408 | Serine/threonine protein kinase BIK1 [Me | 0.848 | 0.617 | 0.741 | 1e-110 | |
| 449456951 | 405 | PREDICTED: probable serine/threonine-pro | 0.952 | 0.698 | 0.677 | 1e-108 | |
| 449495183 | 405 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.952 | 0.698 | 0.680 | 1e-108 | |
| 242060210 | 436 | hypothetical protein SORBIDRAFT_04g00136 | 0.962 | 0.655 | 0.660 | 1e-107 |
| >gi|255561407|ref|XP_002521714.1| serine/threonine-protein kinase cx32, putative [Ricinus communis] gi|223539105|gb|EEF40701.1| serine/threonine-protein kinase cx32, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1157), Expect = e-124, Method: Compositional matrix adjust.
Identities = 218/293 (74%), Positives = 256/293 (87%), Gaps = 8/293 (2%)
Query: 1 MGNCFGSL-FVASNSSSN---NINANASSSSAG-AYNKYGHTMEISATSSSAGKSQFSQA 55
MGNCF S A+N+S++ IN SS+ +N TM+ SATSSSAGKSQFS A
Sbjct: 1 MGNCFVSFSHDATNNSTSAFSTINPTTPGSSSNITFNTT--TMDFSATSSSAGKSQFSAA 58
Query: 56 ISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTL 115
+SE ++A+PNGQILE P++K F+F DLKSATKNF+ D+LLGEGGFG+V+KGW+D+KT
Sbjct: 59 VSEMN-DDANPNGQILEVPNMKEFTFADLKSATKNFRADTLLGEGGFGKVFKGWIDEKTY 117
Query: 116 APSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYE 175
APSKTG+GMVVAIKKLN ESMQGF+EWQSEVNFLGRLSHPNLVKL+GYCWEDKELLLVYE
Sbjct: 118 APSKTGIGMVVAIKKLNSESMQGFQEWQSEVNFLGRLSHPNLVKLIGYCWEDKELLLVYE 177
Query: 176 YMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
+MQ+GSLENHLFR+NP+++PLSW++RLKIAIGAARGL FLHTS+KKVIYRDFKASNILLD
Sbjct: 178 FMQKGSLENHLFRKNPAVEPLSWELRLKIAIGAARGLAFLHTSDKKVIYRDFKASNILLD 237
Query: 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
GNYNAKISDFGLAKLGP+GG+SHVTTRVMGTYGYAAPEY+ATG+ Y+ S +G
Sbjct: 238 GNYNAKISDFGLAKLGPSGGDSHVTTRVMGTYGYAAPEYIATGHLYVKSDVYG 290
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477083|ref|XP_002280326.2| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 208/294 (70%), Positives = 238/294 (80%), Gaps = 6/294 (2%)
Query: 1 MGNCFGSLFVASNSS----SNNINANASS--SSAGAYNKYGHTMEISATSSSAGKSQFSQ 54
MGNC GS S S +N SS S +G + + +S TSSSAG + S
Sbjct: 1 MGNCCGSPSTEPTPSFPGTSTQVNEVPSSKFSVSGTSDNTSNDGGLSITSSSAGNGRLSA 60
Query: 55 AISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKT 114
A + +EA P GQIL TP+LK+FSF DLK+AT+NFK D++LG GGFG V+KG VD+KT
Sbjct: 61 APASESHDEAFPEGQILPTPNLKIFSFADLKTATRNFKSDNVLGIGGFGTVFKGSVDEKT 120
Query: 115 LAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174
LAP K G GMVVAIKKLNPES+QGF+EWQSEVNFLGRLSHPNLVKLLGYCW+DKELLLVY
Sbjct: 121 LAPCKAGTGMVVAIKKLNPESLQGFQEWQSEVNFLGRLSHPNLVKLLGYCWDDKELLLVY 180
Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
E+MQ+GSLENHLFRRNPSI+PLSW +RLKIAIGAARGL FLHTS+K+VIYRDFKASNILL
Sbjct: 181 EFMQKGSLENHLFRRNPSIEPLSWQLRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 240
Query: 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
DG YNAKISDFGLAKLGP+GGESHVTTRVMGTYGYAAPEY+ATG+ Y+ S +G
Sbjct: 241 DGEYNAKISDFGLAKLGPSGGESHVTTRVMGTYGYAAPEYIATGHLYVKSDVYG 294
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088660|emb|CBI37651.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 208/294 (70%), Positives = 238/294 (80%), Gaps = 6/294 (2%)
Query: 1 MGNCFGSLFVASNSS----SNNINANASS--SSAGAYNKYGHTMEISATSSSAGKSQFSQ 54
MGNC GS S S +N SS S +G + + +S TSSSAG + S
Sbjct: 1 MGNCCGSPSTEPTPSFPGTSTQVNEVPSSKFSVSGTSDNTSNDGGLSITSSSAGNGRLSA 60
Query: 55 AISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKT 114
A + +EA P GQIL TP+LK+FSF DLK+AT+NFK D++LG GGFG V+KG VD+KT
Sbjct: 61 APASESHDEAFPEGQILPTPNLKIFSFADLKTATRNFKSDNVLGIGGFGTVFKGSVDEKT 120
Query: 115 LAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174
LAP K G GMVVAIKKLNPES+QGF+EWQSEVNFLGRLSHPNLVKLLGYCW+DKELLLVY
Sbjct: 121 LAPCKAGTGMVVAIKKLNPESLQGFQEWQSEVNFLGRLSHPNLVKLLGYCWDDKELLLVY 180
Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
E+MQ+GSLENHLFRRNPSI+PLSW +RLKIAIGAARGL FLHTS+K+VIYRDFKASNILL
Sbjct: 181 EFMQKGSLENHLFRRNPSIEPLSWQLRLKIAIGAARGLAFLHTSDKQVIYRDFKASNILL 240
Query: 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
DG YNAKISDFGLAKLGP+GGESHVTTRVMGTYGYAAPEY+ATG+ Y+ S +G
Sbjct: 241 DGEYNAKISDFGLAKLGPSGGESHVTTRVMGTYGYAAPEYIATGHLYVKSDVYG 294
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529677|ref|XP_003533415.1| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1065), Expect = e-113, Method: Compositional matrix adjust.
Identities = 205/294 (69%), Positives = 240/294 (81%), Gaps = 17/294 (5%)
Query: 1 MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAIS--- 57
MG CF S+SS N + S+S + N + SAT+SSAGKSQFS+ S
Sbjct: 1 MGLCF------SSSSPNPPQQYSGSASTDSKN-----VGFSATTSSAGKSQFSEIASGSI 49
Query: 58 ---EAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKT 114
+ + SP+GQILE P+LKVFSF DLKSATK+FK D+LLGEGGFGRVYKGW+D+KT
Sbjct: 50 DSSQGSLPLPSPHGQILERPNLKVFSFGDLKSATKSFKSDTLLGEGGFGRVYKGWLDEKT 109
Query: 115 LAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174
L+P+K G GMVVAIKKLNP+S QGF+EWQSEVNFLGRLSHPNLVKLLGYCW+D ELLLVY
Sbjct: 110 LSPAKAGSGMVVAIKKLNPQSTQGFQEWQSEVNFLGRLSHPNLVKLLGYCWDDDELLLVY 169
Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
E++ +GSLENHLFRRNP+I+PLSW+ R KIAIGAARGL FLH SEK++IYRDFKASNILL
Sbjct: 170 EFLPKGSLENHLFRRNPNIEPLSWNTRFKIAIGAARGLAFLHASEKQIIYRDFKASNILL 229
Query: 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
D N+NAKISDFGLAKLGP+GG+SHVTTRVMGTYGYAAPEY+ATG+ Y+ S +G
Sbjct: 230 DVNFNAKISDFGLAKLGPSGGQSHVTTRVMGTYGYAAPEYIATGHLYVKSDVYG 283
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114471|ref|XP_002332362.1| predicted protein [Populus trichocarpa] gi|222874679|gb|EEF11810.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1060), Expect = e-113, Method: Compositional matrix adjust.
Identities = 189/223 (84%), Positives = 212/223 (95%)
Query: 66 PNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMV 125
PNGQILE+P+LK F+F DLKS TKNFK D+LLGEGGFG+VYKGW+D++T APSK+G GMV
Sbjct: 1 PNGQILESPNLKEFTFADLKSTTKNFKSDTLLGEGGFGKVYKGWIDERTYAPSKSGSGMV 60
Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH 185
VAIKKLNPES+QGF+EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYE+MQ+GSLENH
Sbjct: 61 VAIKKLNPESVQGFQEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEFMQKGSLENH 120
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245
LFR+NP+I+PLSWDIRLKIA+GAARGL FLHTS+KKVIYRDFKASNILLDGNYNAKISDF
Sbjct: 121 LFRKNPNIEPLSWDIRLKIAVGAARGLTFLHTSDKKVIYRDFKASNILLDGNYNAKISDF 180
Query: 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
GLAKLGP+GGESHVTTRVMGTYGYAAPEY+ATG+ Y+ S +G
Sbjct: 181 GLAKLGPSGGESHVTTRVMGTYGYAAPEYIATGHLYVKSDVYG 223
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224084090|ref|XP_002307210.1| predicted protein [Populus trichocarpa] gi|222856659|gb|EEE94206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1046), Expect = e-111, Method: Compositional matrix adjust.
Identities = 206/291 (70%), Positives = 234/291 (80%), Gaps = 4/291 (1%)
Query: 1 MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSS-AGKSQFSQAISEA 59
MGNC S F S S+ N N S+ T+++SATSSS +SQFS+A S
Sbjct: 1 MGNCLRSFFY-DPSPSSIANNNPSTPGTSNSTYSSTTIDVSATSSSIVCRSQFSEAASHD 59
Query: 60 GVEE--ASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAP 117
E ++ NGQILE+ +L+ F+F DLK ATKNFK D+LLGEGGFG+VYKGW+D KT AP
Sbjct: 60 EGNEVISNANGQILESSNLEEFTFSDLKRATKNFKSDTLLGEGGFGKVYKGWIDQKTYAP 119
Query: 118 SKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYM 177
SK+G GMVVAIKKLN SMQG EEWQSEVNFLGRLSHPNLVKLLG+CWEDKELLLVYE+M
Sbjct: 120 SKSGSGMVVAIKKLNSGSMQGLEEWQSEVNFLGRLSHPNLVKLLGFCWEDKELLLVYEFM 179
Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237
+GSLENHLFR +I+PLSWDIRLKIAIGAARGL FLH SEK+VIYRDFKASNILLDG
Sbjct: 180 PKGSLENHLFRSKRNIEPLSWDIRLKIAIGAARGLAFLHASEKQVIYRDFKASNILLDGK 239
Query: 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
YNAKISDFGLAKLGP+GGESHVTTRVMGTYGYAAPEY+ATG+ Y+ S +G
Sbjct: 240 YNAKISDFGLAKLGPSGGESHVTTRVMGTYGYAAPEYIATGHLYVKSDVYG 290
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357517679|ref|XP_003629128.1| Serine/threonine protein kinase BIK1 [Medicago truncatula] gi|355523150|gb|AET03604.1| Serine/threonine protein kinase BIK1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1039), Expect = e-110, Method: Compositional matrix adjust.
Identities = 192/259 (74%), Positives = 225/259 (86%), Gaps = 7/259 (2%)
Query: 37 TMEISATSSSAGKSQFSQAIS-------EAGVEEASPNGQILETPDLKVFSFLDLKSATK 89
T+ SAT+SSAG+SQFS+ S + + SPNGQILE P+LKVFSF++LK+ATK
Sbjct: 31 TVGFSATTSSAGRSQFSEVASGSIDDTTDGSLPFPSPNGQILERPNLKVFSFIELKAATK 90
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
+FK D+LLGEGGFG+VYKGW+D+KTL+P+K G GMVVAIKKLN ES QGF+EWQSEVNFL
Sbjct: 91 SFKSDTLLGEGGFGKVYKGWLDEKTLSPTKAGSGMVVAIKKLNSESTQGFQEWQSEVNFL 150
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
GRLSHPNLVKLLGYCW+D ELLLVYE+M +GSLENHLFRRNP+I+PLSW+ R+KIAIGAA
Sbjct: 151 GRLSHPNLVKLLGYCWDDDELLLVYEFMPKGSLENHLFRRNPNIEPLSWNTRIKIAIGAA 210
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGY 269
RGL FLH S +VIYRDFKASNILLDG+Y AKISDFGLAKLGP+GG+SHVTTRVMGTYGY
Sbjct: 211 RGLAFLHDSADQVIYRDFKASNILLDGSYIAKISDFGLAKLGPSGGQSHVTTRVMGTYGY 270
Query: 270 AAPEYVATGNFYLLSAKFG 288
AAPEY+ATG+ Y+ S +G
Sbjct: 271 AAPEYIATGHLYVKSDVYG 289
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456951|ref|XP_004146212.1| PREDICTED: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1021), Expect = e-108, Method: Compositional matrix adjust.
Identities = 195/288 (67%), Positives = 232/288 (80%), Gaps = 5/288 (1%)
Query: 1 MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
MGNC S S SN + A S+ G + +E S T+S+AG SQFS A S
Sbjct: 1 MGNCLTS----SAHHSNAVPCQAVFSTPGTSGNFSGIVESSGTNSTAGGSQFSAAGS-VD 55
Query: 61 VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
V E+ P+G+IL+ P+LK FSF +LK TKNF+P+SL+G+GGFG+VYKGWVDDKTLAPSK+
Sbjct: 56 VSESCPSGKILDQPNLKEFSFTELKLITKNFRPESLIGQGGFGKVYKGWVDDKTLAPSKS 115
Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
GMVVAIKKLN ES+QGF++WQ+EVNFLGRL+HPN+VKLLG+CWED ELLLVYE+M RG
Sbjct: 116 NSGMVVAIKKLNAESVQGFQDWQAEVNFLGRLNHPNVVKLLGFCWEDDELLLVYEFMPRG 175
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240
SLENHLF R SI+PLSW+ RLKIAIGAARGL FLH+SEK+VIYRDFKASNILLD NYN+
Sbjct: 176 SLENHLFGRRSSIEPLSWERRLKIAIGAARGLAFLHSSEKEVIYRDFKASNILLDLNYNS 235
Query: 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
KISDFGLA+LGP G ESHVTTR+MGTYGY APEYV+TG+ Y+ S +G
Sbjct: 236 KISDFGLARLGPTGEESHVTTRIMGTYGYVAPEYVSTGHLYVKSDVYG 283
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449495183|ref|XP_004159758.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase Cx32, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1019), Expect = e-108, Method: Compositional matrix adjust.
Identities = 196/288 (68%), Positives = 230/288 (79%), Gaps = 5/288 (1%)
Query: 1 MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
MGNC S S SN + A S+ G + +E S T+S+AG SQFS A S
Sbjct: 1 MGNCLTS----SAHHSNAVPCQAVFSTPGTSGNFSGIVESSGTNSTAGGSQFSAAGS-VD 55
Query: 61 VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
V E P+G+IL+ P+LK FSF +LK TKNF+P+SL+G+GGFG+VYKGWVDDKTLAPSK+
Sbjct: 56 VSEPYPSGKILDQPNLKEFSFTELKLITKNFRPESLIGQGGFGKVYKGWVDDKTLAPSKS 115
Query: 121 GLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
GMVVAIKKLN ES+QGF+EWQ+EVNFLGRL+HPNLVKLLG+CWED E LLVYE+M RG
Sbjct: 116 NSGMVVAIKKLNAESVQGFQEWQAEVNFLGRLNHPNLVKLLGFCWEDDEFLLVYEFMPRG 175
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240
SLENHLF R SI+PLSW+ RLKIAIGAARGL FLH+SEK+VIYRDFKASNILLD NYN+
Sbjct: 176 SLENHLFGRRSSIEPLSWERRLKIAIGAARGLAFLHSSEKEVIYRDFKASNILLDLNYNS 235
Query: 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
KISDFGLA+LGP G ESHVTTR+MGTYGY APEYV+TG+ Y+ S +G
Sbjct: 236 KISDFGLARLGPTGEESHVTTRIMGTYGYVAPEYVSTGHLYVKSDVYG 283
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242060210|ref|XP_002451394.1| hypothetical protein SORBIDRAFT_04g001360 [Sorghum bicolor] gi|241931225|gb|EES04370.1| hypothetical protein SORBIDRAFT_04g001360 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1014), Expect = e-107, Method: Compositional matrix adjust.
Identities = 193/292 (66%), Positives = 234/292 (80%), Gaps = 6/292 (2%)
Query: 1 MGN-CFGSLFVASNSSSNNINANASSSSAGAYNKYGHTM-EISATSSSAGKSQFSQAISE 58
MGN C G VA + ++ +S ++G+ T ++S+ SS S S++ S
Sbjct: 1 MGNICGGKDRVAEDFRPSSPGTTMTSKTSGSLTTSQSTTGKLSSVSSGFMASAGSRSTSG 60
Query: 59 AGVEEAS--PNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLA 116
V+E + P+GQILE P+L+ F+F++LK+ATKNF+PDS+LGEGGFGRVYKGWVD+KT+A
Sbjct: 61 GFVDEGAKYPDGQILEAPNLRTFTFMELKTATKNFRPDSVLGEGGFGRVYKGWVDEKTMA 120
Query: 117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
P++ G GMVVA+KKLN ESMQG+EEWQSE+NFLGRLSHPNLVKLLGYCWEDKELLLVYE+
Sbjct: 121 PTRNGTGMVVAVKKLNSESMQGYEEWQSEINFLGRLSHPNLVKLLGYCWEDKELLLVYEF 180
Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
M +GSLENHLFRR PLSW++RLKI+IGAARGL FLH SEK+VIYRDFKASNILLD
Sbjct: 181 MAKGSLENHLFRRG--CAPLSWELRLKISIGAARGLAFLHASEKQVIYRDFKASNILLDA 238
Query: 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
NYNAK+SDFGLAKLGP G SH+TTRVMGTYGYAAPEYVATG+ Y+ S +G
Sbjct: 239 NYNAKLSDFGLAKLGPTGSNSHITTRVMGTYGYAAPEYVATGHLYVKSDVYG 290
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 297 | ||||||
| TAIR|locus:2059642 | 414 | Kin3 "kinase 3" [Arabidopsis t | 0.828 | 0.594 | 0.674 | 4e-90 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.794 | 0.557 | 0.635 | 2e-81 | |
| TAIR|locus:2014614 | 484 | AT1G76360 [Arabidopsis thalian | 0.760 | 0.466 | 0.659 | 3.2e-81 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.868 | 0.663 | 0.575 | 1.8e-78 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.808 | 0.563 | 0.618 | 1.1e-76 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.804 | 0.605 | 0.579 | 9.3e-75 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.811 | 0.565 | 0.585 | 1.2e-74 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.824 | 0.594 | 0.583 | 1.9e-74 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.781 | 0.599 | 0.600 | 3.6e-73 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.676 | 0.410 | 0.678 | 7.5e-73 |
| TAIR|locus:2059642 Kin3 "kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 899 (321.5 bits), Expect = 4.0e-90, P = 4.0e-90
Identities = 168/249 (67%), Positives = 209/249 (83%)
Query: 41 SATSSSAGKSQFSQA-ISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGE 99
+ T +S G + S + S A E+A P+GQIL P+L++FS +L+++T+NF+ +++LGE
Sbjct: 36 TTTGTSRGSNISSNSGFSVASGEDAYPDGQILPIPNLRIFSLAELRASTRNFRSENVLGE 95
Query: 100 GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVK 159
GGFG+V+KGW++DKT P K G V+A+KKLN ES QGFEEWQ EVNFLGR+SHPNLVK
Sbjct: 96 GGFGKVFKGWLEDKT--PGKQSNGTVIAVKKLNAESFQGFEEWQCEVNFLGRVSHPNLVK 153
Query: 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE 219
LLGYC E +ELLLVYEYMQ+GSLENHLFR+ ++QPLSW+IRLKIAIGAA+GL FLH SE
Sbjct: 154 LLGYCLEGEELLLVYEYMQKGSLENHLFRKGSAVQPLSWEIRLKIAIGAAKGLAFLHASE 213
Query: 220 KKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN 279
K+VIYRDFKASNILLDG+YNAKISDFGLAKLGP+ +SH+TTRVMGT+GYAAPEYVATG+
Sbjct: 214 KQVIYRDFKASNILLDGSYNAKISDFGLAKLGPSASQSHITTRVMGTHGYAAPEYVATGH 273
Query: 280 FYLLSAKFG 288
Y+ S +G
Sbjct: 274 LYVKSDVYG 282
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
Identities = 150/236 (63%), Positives = 189/236 (80%)
Query: 44 SSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFG 103
SS A S S++ S + G+IL++P+LK F+F +LK+AT+NF+PDS+LGEGGFG
Sbjct: 33 SSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFG 92
Query: 104 RVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGY 163
V+KGW+D++TL SK G G+V+A+KKLN + QG +EW +EVN+LG+ SHPNLVKL+GY
Sbjct: 93 SVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGY 152
Query: 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVI 223
C ED+ LLVYE+M RGSLENHLFRR QPLSW +RLK+A+GAA+GL FLH +E VI
Sbjct: 153 CLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVI 212
Query: 224 YRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN 279
YRDFK SNILLD YNAK+SDFGLAK GP G +SHV+TR+MGTYGYAAPEY+ATG+
Sbjct: 213 YRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGH 268
|
|
| TAIR|locus:2014614 AT1G76360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 815 (292.0 bits), Expect = 3.2e-81, P = 3.2e-81
Identities = 151/229 (65%), Positives = 187/229 (81%)
Query: 60 GVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
G + P+G+I+ TP+LK+F+ ++LK+ATKNF+P+S++GEGGFG+V+KGWVD+KTLAPS+
Sbjct: 133 GRKAVPPSGKIV-TPNLKMFTLVELKTATKNFRPESVIGEGGFGQVFKGWVDEKTLAPSR 191
Query: 120 TGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQR 179
G+G+ VA+KK NP+S QG EWQ EV FLG+ HPNLVKLLGYCWE+ + LLVYEY+ +
Sbjct: 192 AGVGIPVAVKKSNPDSEQGLHEWQCEVRFLGKFHHPNLVKLLGYCWEENQFLLVYEYLPK 251
Query: 180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239
GSLENHLF + P WD RLKIAI AA+GL FLH SEK VIYRDFKASNILLD N++
Sbjct: 252 GSLENHLFSKGAEALP--WDTRLKIAIEAAQGLTFLHNSEKSVIYRDFKASNILLDSNFH 309
Query: 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288
AK+SDFGLAK GP G SHVTTRVMGT GYAAPEY+ATG+ Y+ S +G
Sbjct: 310 AKLSDFGLAKNGPINGFSHVTTRVMGTQGYAAPEYMATGHLYVRSDVYG 358
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 789 (282.8 bits), Expect = 1.8e-78, P = 1.8e-78
Identities = 153/266 (57%), Positives = 198/266 (74%)
Query: 34 YGHTMEISATSSSAGKSQFSQAISEAGVEEAS----PN--GQILETPDLKVFSFLDLKSA 87
+ + ++ SS+ S+F G AS P G+IL+ +LK FS +LKSA
Sbjct: 5 FSNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYMPRTEGEILQNANLKNFSLSELKSA 64
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
T+NF+PDS++GEGGFG V+KGW+D+ +LAPSK G G+V+A+K+LN E QG EW +E+N
Sbjct: 65 TRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEIN 124
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
+LG+L HPNLVKL+GYC E++ LLVYE+M RGSLENHLFRR QPLSW+ R+++A+G
Sbjct: 125 YLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALG 184
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
AARGL FLH ++ +VIYRDFKASNILLD NYNAK+SDFGLA+ GP G SHV+TRVMGT
Sbjct: 185 AARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQ 244
Query: 268 GYAAPEYVATGNFYLLSA--KFGNVI 291
GYAAPEY+ATG+ + S FG V+
Sbjct: 245 GYAAPEYLATGHLSVKSDVYSFGVVL 270
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 772 (276.8 bits), Expect = 1.1e-76, P = 1.1e-76
Identities = 154/249 (61%), Positives = 193/249 (77%)
Query: 41 SATSSSAGKSQFSQAISEAGVEEA-SPN--GQILETPDLKVFSFLDLKSATKNFKPDSLL 97
S TS S S S S + VE +P G+IL +P+LK F+F +LK+AT+NF+PDSLL
Sbjct: 31 SKTSRSTVPSSLS-INSYSSVESLPTPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLL 89
Query: 98 GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL 157
GEGGFG V+KGW+D TL SK G G+VVA+KKL E QG +EW +EVN+LG+LSHPNL
Sbjct: 90 GEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNL 149
Query: 158 VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT 217
VKL+GYC E + LLVYE+M +GSLENHLFRR QPL+W IR+K+AIGAA+GL FLH
Sbjct: 150 VKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGA--QPLTWAIRMKVAIGAAKGLTFLHD 207
Query: 218 SEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT 277
++ +VIYRDFKA+NILLD +N+K+SDFGLAK GP G ++HV+T+VMGT+GYAAPEYVAT
Sbjct: 208 AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVAT 267
Query: 278 GNFYLLSAK 286
G L+AK
Sbjct: 268 GR---LTAK 273
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 754 (270.5 bits), Expect = 9.3e-75, P = 9.3e-75
Identities = 142/245 (57%), Positives = 188/245 (76%)
Query: 35 GHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPD 94
G + ++ S S+ KS S ++ A E G+IL + +K F+F +LK AT+NF+PD
Sbjct: 17 GKSSDLYGLSLSSRKS--SSTVAAAQKTE----GEILSSTPVKSFTFNELKLATRNFRPD 70
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
S++GEGGFG V+KGW+D+ TL P+K G G+V+A+KKLN E QG EW +E+N+LG+LSH
Sbjct: 71 SVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSH 130
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
PNLVKL+GYC ED+ LLVYE+MQ+GSLENHLFRR +PL W +R+ +A+ AA+GL F
Sbjct: 131 PNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAF 190
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEY 274
LH+ KVIYRD KASNILLD +YNAK+SDFGLA+ GP G S+V+TRVMGTYGYAAPEY
Sbjct: 191 LHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEY 250
Query: 275 VATGN 279
+++G+
Sbjct: 251 MSSGH 255
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
Identities = 147/251 (58%), Positives = 190/251 (75%)
Query: 41 SATSSSAGKS-----QFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDS 95
S TS S G S +S S + G+IL +P+LK F+F +LK+ATKNF+ D+
Sbjct: 31 SKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTEGEILSSPNLKAFTFNELKNATKNFRQDN 90
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LLGEGGFG V+KGW+D +L S+ G G+VVA+K+L PE QG +EW +EVN+LG+LSHP
Sbjct: 91 LLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHP 150
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
NLV L+GYC E + LLVYE+M +GSLENHLFRR QPL+W IR+K+A+GAA+GL FL
Sbjct: 151 NLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGA--QPLTWAIRMKVAVGAAKGLTFL 208
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV 275
H ++ +VIYRDFKA+NILLD ++NAK+SDFGLAK GP G +HV+T+V+GT+GYAAPEYV
Sbjct: 209 HEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYV 268
Query: 276 ATGNFYLLSAK 286
ATG L+AK
Sbjct: 269 ATGR---LTAK 276
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
Identities = 147/252 (58%), Positives = 187/252 (74%)
Query: 43 TSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGF 102
+S + S ++ S A ++ G++L +P LK F+F +LK+AT+NF+PDS++GEGGF
Sbjct: 35 SSLTIQSSSYNDDTSVASLQTPRSEGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGF 94
Query: 103 GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLG 162
G VYKGW+D++TL+PSK G GMVVA+KKL E QG +W +EV+ LGRL H NLVKL+G
Sbjct: 95 GYVYKGWIDERTLSPSKPGSGMVVAVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIG 154
Query: 163 YCWEDKEL-LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK 221
YC + + LLVYEYM +GSLENHLFRR +P+ W R+K+AIGAARGL FLH E +
Sbjct: 155 YCSKGDHIRLLVYEYMPKGSLENHLFRRGA--EPIPWRTRIKVAIGAARGLAFLH--EAQ 210
Query: 222 VIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
VIYRDFKASNILLD +NAK+SDFGLAK+GP G +HV+T+VMGT GYAAPEYVATG
Sbjct: 211 VIYRDFKASNILLDSEFNAKLSDFGLAKVGPTGDRTHVSTQVMGTQGYAAPEYVATGRIT 270
Query: 282 LLSA--KFGNVI 291
S FG V+
Sbjct: 271 AKSDVYSFGVVL 282
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 739 (265.2 bits), Expect = 3.6e-73, P = 3.6e-73
Identities = 143/238 (60%), Positives = 183/238 (76%)
Query: 41 SATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEG 100
S T S + F+ + S + + S G++L +P LK F+F +LK+AT+NFKP+S++GEG
Sbjct: 36 SLTIPSYSNNSFTTS-SWSNLTPRS-EGELLPSPTLKAFTFNELKTATRNFKPNSMIGEG 93
Query: 101 GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKL 160
GFG VYKGW+ +++L+PSK G GMVVA+KKL E QG +EW +EV++LGRL H NLVKL
Sbjct: 94 GFGCVYKGWIGERSLSPSKPGSGMVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKL 153
Query: 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK 220
+GYC E ++ LLVYEYM +GSLENHLFRR +P+ W R+K+A AARGL FLH E
Sbjct: 154 IGYCLEGEKRLLVYEYMPKGSLENHLFRRGA--EPIPWKTRMKVAFSAARGLSFLH--EA 209
Query: 221 KVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG 278
KVIYRDFKASNILLD ++NAK+SDFGLAK GP G +HVTT+V+GT GYAAPEY+ATG
Sbjct: 210 KVIYRDFKASNILLDVDFNAKLSDFGLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATG 267
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 736 (264.1 bits), Expect = 7.5e-73, P = 7.5e-73
Identities = 139/205 (67%), Positives = 166/205 (80%)
Query: 76 LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
LK FSF+DLK AT+NF+P+SLLGEGGFG V+KGWV++ AP K G G+ VA+K LNP+
Sbjct: 121 LKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG 180
Query: 136 MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
+QG +EW +E+N+LG L HPNLVKL+GYC ED + LLVYE+M RGSLENHLFRR+ P
Sbjct: 181 LQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LP 237
Query: 196 LSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
L W IR+KIA+GAA+GL FLH K VIYRDFK SNILLDG YNAK+SDFGLAK P
Sbjct: 238 LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDE 297
Query: 255 GESHVTTRVMGTYGYAAPEYVATGN 279
G++HV+TRVMGTYGYAAPEYV TG+
Sbjct: 298 GKTHVSTRVMGTYGYAAPEYVMTGH 322
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P27450 | CX32_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6485 | 0.8653 | 0.6133 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 297 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-47
Identities = 71/179 (39%), Positives = 93/179 (51%), Gaps = 18/179 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHP 155
LGEGGFG VY D KT G VAIK + E EE E+ L +L+HP
Sbjct: 1 LGEGGFGTVYLAR-DKKT--------GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+VKL G ++ L LV EY + GSL++ L LS D L+I + GL +L
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYL 108
Query: 216 HTSEKKVIYRDFKASNILLD-GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
H +I+RD K NILLD N K++DFGL+KL + + ++GT Y APE
Sbjct: 109 H--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPE 163
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 5e-45
Identities = 64/160 (40%), Positives = 86/160 (53%), Gaps = 10/160 (6%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL 152
LGEG FG VYKG TL G + VA+K L ++ Q EE+ E + +L
Sbjct: 4 GKKLGEGAFGEVYKG-----TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
HPN+VKLLG C E++ L++V EYM G L ++L R + LS L A+ ARG+
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGM 116
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252
+L K I+RD A N L+ N KISDFGL++
Sbjct: 117 EYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-44
Identities = 76/194 (39%), Positives = 97/194 (50%), Gaps = 21/194 (10%)
Query: 91 FKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVN 147
++ LG G FG VYK G +VA+K L S + + + E+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT----------GKIVAVKILKKRSEKSKKDQTARREIR 50
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L RLSHPN+V+L+ + L LV EY + G L ++L R P LS D KIA+
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQ 106
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
RGL +LH +I+RD K NILLD N KI+DFGLAK S TT V GT
Sbjct: 107 ILRGLEYLH--SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-TTFV-GTP 162
Query: 268 GYAAPEYVATGNFY 281
Y APE + GN Y
Sbjct: 163 WYMAPEVLLGGNGY 176
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-44
Identities = 68/181 (37%), Positives = 91/181 (50%), Gaps = 18/181 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
LGEG FG VYKG L + VA+K L ++ Q EE+ E + +L HP
Sbjct: 7 LGEGAFGEVYKG-----KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+VKLLG C E++ L +V EYM+ G L ++L R+N LS L A+ ARG+ +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRP--KLSLSDLLSFALQIARGMEYL 118
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT---YGYAAP 272
K I+RD A N L+ N KISDFGL++ R G + AP
Sbjct: 119 E--SKNFIHRDLAARNCLVGENLVVKISDFGLSRD----LYDDDYYRKRGGKLPIRWMAP 172
Query: 273 E 273
E
Sbjct: 173 E 173
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 6e-43
Identities = 59/166 (35%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
LGEG FG VYKG TL G VA+K L + + EE+ E + + +LSHP
Sbjct: 7 LGEGAFGEVYKG-----TLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+V+LLG C + + L +V EYM G L + L R++ + L+ L++A+ A+G+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHG--EKLTLKDLLQMALQIAKGMEYL 118
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
K ++RD A N L+ N KISDFGL++
Sbjct: 119 E--SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG 162
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-42
Identities = 61/184 (33%), Positives = 92/184 (50%), Gaps = 19/184 (10%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFL 149
++ LGEG FG+VY D KT G +VAIK + + ++ E E+ L
Sbjct: 1 YEILEKLGEGSFGKVYLA-RDKKT--------GKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
+L HPN+V+L ++ +L LV EY + G L + L ++ + + R
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSE--DEAR-FYLRQIL 107
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGY 269
L +LH K +++RD K NILLD + + K++DFGLA+ +TT V GT Y
Sbjct: 108 SALEYLH--SKGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEY 162
Query: 270 AAPE 273
APE
Sbjct: 163 MAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-40
Identities = 71/217 (32%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
LGEG FG VYKG K G VA+K L ++ + +++ E + +L HP
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL-----FRRNPSIQPLSWDIRLKIAIGAAR 210
N+V+LLG C E++ L LV EYM+ G L ++L +P LS L AI A+
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT------RVM 264
G+ +L KK ++RD A N L+ + KISDFGL++ T R M
Sbjct: 117 GMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 265 GTYGYAAPEYVATGNFYLLSAK-----FGNVINVCMY 296
APE + G F ++K FG V ++
Sbjct: 175 ------APESLKDGIF---TSKSDVWSFG----VLLW 198
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 59/183 (32%), Positives = 90/183 (49%), Gaps = 17/183 (9%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
F+ +G+GGFG VYK +T G VAIK + ES + E+ +E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKAR-HKRT--------GKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
+ HPN+VK G + EL +V E+ GSL++ L + Q L+ + +
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLK 109
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
GL +LH +I+RD KA+NILL + K+ DFGL+ + ++GT +
Sbjct: 110 GLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWM 164
Query: 271 APE 273
APE
Sbjct: 165 APE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 54/163 (33%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHP 155
LGEG FG+V P G VA+K LN Q +++ E+ L L H
Sbjct: 12 LGEGHFGKVELC-----RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 156 NLVKLLGYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
N+VK G C + + L L+ EY+ GSL ++L R I + L + +G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI---NLKRLLLFSSQICKGMD 123
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
+L ++ I+RD A NIL++ KISDFGLAK+ P +
Sbjct: 124 YLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-30
Identities = 59/182 (32%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEVNFLGRLS 153
LLG G FG VY +D T G ++A+K L+ +S + E + E+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 154 HPNLVKLLGYCW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
HPN+V+ G E L + EY+ GSL + L ++ + IR K G
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEP--VIR-KYTRQILEG 113
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
L +LH +++RD K +NIL+D + K++DFG AK T V GT + A
Sbjct: 114 LAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 272 PE 273
PE
Sbjct: 172 PE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 60/181 (33%), Positives = 94/181 (51%), Gaps = 21/181 (11%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLS 153
L+G G FG VYKG ++ +T G VAIK+++ E + + + E++ L L
Sbjct: 7 LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
HPN+VK +G L ++ EY + GSL + + P + L ++ +GL
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLA 113
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA-KLGPAGGESHVTTRVMGTYGYAAP 272
+LH E+ VI+RD KA+NIL + K++DFG+A KL + V+GT + AP
Sbjct: 114 YLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAP 168
Query: 273 E 273
E
Sbjct: 169 E 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (261), Expect = 7e-26
Identities = 67/195 (34%), Positives = 93/195 (47%), Gaps = 24/195 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EV 146
+++ LGEG FG VY VA+K L + +E + E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL------------VALKVLAKKLESKSKEVERFLREI 48
Query: 147 NFLGRLSHP-NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L L+HP N+VKL + ++ L LV EY+ GSLE L ++ PLS L I
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFIL 107
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN-AKISDFGLAKLGPAGGES----HVT 260
L +LH K +I+RD K NILLD + K+ DFGLAKL P G + +
Sbjct: 108 AQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 261 TRVMGTYGYAAPEYV 275
+ +GT GY APE +
Sbjct: 166 STSVGTPGYMAPEVL 180
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 53/155 (34%), Positives = 80/155 (51%), Gaps = 16/155 (10%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LG G FG V++G W K VAIK L + + +++Q EV L RL H
Sbjct: 14 LGSGYFGEVWEGLW---KNRVR--------VAIKILKSDDLLKQQDFQKEVQALKRLRHK 62
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+L+ L C + + ++ E M++GSL F R+P Q L + +A A G+ +L
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
E+ I+RD A NIL+ + K++DFGLA+L
Sbjct: 121 E--EQNSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 20/157 (12%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRL 152
+ +G+G FG V G G VA+K L +S Q F +E + + L
Sbjct: 12 ATIGKGEFGDVMLG-----------DYRGQKVAVKCLKDDSTAAQAF---LAEASVMTTL 57
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
HPNLV+LLG + L +V EYM +GSL ++L R ++ ++ +L A+ G+
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGM 115
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+L EK ++RD A N+L+ + AK+SDFGLAK
Sbjct: 116 EYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 19/197 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
LGEG FG+VYKG + P++ VAIK L + +E++ E + L HP
Sbjct: 13 LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLK 203
N+V LLG C +++ +++EY+ G L L R +P L L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRV 263
IAI A G+ +L S ++RD A N L+ KISDFGL++ + V ++
Sbjct: 129 IAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 264 MGTYGYAAPEYVATGNF 280
+ + PE + G F
Sbjct: 187 LLPVRWMPPEAILYGKF 203
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 58/179 (32%), Positives = 83/179 (46%), Gaps = 39/179 (21%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMV-------VAIKKLNPE-SMQGFEEWQSEVNF 148
+G+G FGRV++ G++ VA+K L E S ++Q E
Sbjct: 13 IGQGAFGRVFQA-----------RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ-------------- 194
+ HPN+VKLLG C K + L++EYM G L L R+P Q
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 195 ----PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
PLS +L IA A G+ +L SE+K ++RD N L+ N KI+DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 1e-24
Identities = 65/184 (35%), Positives = 89/184 (48%), Gaps = 24/184 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
LG+G FG+V V K G + A+K L + + + E +E N L R++
Sbjct: 1 LGKGSFGKVLL--V-------RKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 154 HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARG 211
HP +VKL Y ++ +E L LV EY G L +HL + R A I A
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSE--ERARFYAAEIVLA-- 105
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
L +LH +IYRD K NILLD + + K++DFGLAK + G T GT Y A
Sbjct: 106 LEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLA 161
Query: 272 PEYV 275
PE +
Sbjct: 162 PEVL 165
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 8e-24
Identities = 63/163 (38%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRLSHP 155
LGEG FG+V D P+ G G +VA+K L E Q W+ E+N L L H
Sbjct: 12 LGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 156 NLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
N+VK G C E K L L+ EY+ GSL ++L + ++ L L A G+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMA 121
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
+LH+ + I+RD A N+LLD + KI DFGLAK P G E
Sbjct: 122 YLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-23
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 23/164 (14%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EV 146
++ LGEG +G VYK D KT G +VA+KK+ + E S E+
Sbjct: 1 YEKLEKLGEGTYGVVYKAR-DKKT--------GEIVALKKIRLD--NEEEGIPSTALREI 49
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK-IA 205
+ L L HPN+VKLL +++L LV+EY L+ +L +R + P +K I
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP----NLIKSIM 104
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
RGL + H+ ++++RD K NIL++ + K++DFGLA+
Sbjct: 105 YQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-23
Identities = 55/170 (32%), Positives = 88/170 (51%), Gaps = 25/170 (14%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSH 154
LG G FG VYKG W+ P + + VAIK L E+ + +E E + + H
Sbjct: 15 LGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-----SIQPLSWDIRLKIAIGAA 209
P++V+LLG C ++ L+ + M G L +++ RN S L+W +++ A
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQI------A 119
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259
+G+ +L EK++++RD A N+L+ + KI+DFGLAKL E
Sbjct: 120 KGMSYL--EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV-DEKEY 166
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-22
Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 17/187 (9%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE--EWQSEVN 147
++ +G+G FG+VY L K+ G + +K+++ +M E + +EV
Sbjct: 1 KYEIIKQIGKGSFGKVY--------LVRRKSD-GKLYVLKEIDLSNMSEKEREDALNEVK 51
Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L +L+HPN++K +E+K L +V EY G L + ++ +P + L +
Sbjct: 52 ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
L +LH +K+++RD K NI L N K+ DFG++K+ + V+GT
Sbjct: 111 QLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGT 166
Query: 267 YGYAAPE 273
Y +PE
Sbjct: 167 PYYLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 53/187 (28%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL--NPESMQGFEEWQSEVNFLGRL 152
++GEG +G V K G +VAIKK + + + EV L +L
Sbjct: 7 GVVGEGAYGVVLKCRNKAT---------GEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS------IQPLSWDIRLKIAI 206
H N+V L L LV+EY++R LE L +P ++ W +
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQL------ 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
+ + + H +I+RD K NIL+ + K+ DFG A+ A S +T V T
Sbjct: 110 --LQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 267 YGYAAPE 273
Y APE
Sbjct: 165 RWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-22
Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 39/203 (19%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFE---EWQSEVNFLG 150
LLG G FG VY+G D G A+K L + G E + + E+ L
Sbjct: 7 LLGSGSFGSVYEGLNLDD---------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS 57
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL---KIAIG 207
+L HPN+V+ LG E+ L + E + GSL L + +P+ IRL +I +G
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQILLG 114
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM--- 264
L +LH ++ ++RD K +NIL+D N K++DFG+AK V
Sbjct: 115 ----LEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKS 160
Query: 265 --GTYGYAAPEYVATGNFYLLSA 285
G+ + APE +A Y L+A
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAA 183
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V+ G + T VA+K L P +M E + E + +L H
Sbjct: 14 LGAGQFGEVWMGTWNGTT----------KVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDK 62
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LV+L C E++ + +V EYM +GSL + L ++ + L + +A A G+ +L
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+ I+RD A NIL+ N KI+DFGLA+L
Sbjct: 121 --SRNYIHRDLAARNILVGENLVCKIADFGLARL 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 8e-22
Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 23/192 (11%)
Query: 96 LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLS 153
LG+G FG V +G W + G + VA+K L + + +++ E + L
Sbjct: 2 KLGDGSFGVVRRGEWS-------TSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS--WDIRLKIAIGAARG 211
H NL++L G L++V E GSL + L + +S D ++IA G
Sbjct: 55 HENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NG 109
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT---RVMGTYG 268
+ +L + K+ I+RD A NILL + KI DFGL + P + +V +V +
Sbjct: 110 MRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFA 165
Query: 269 YAAPEYVATGNF 280
+ APE + T F
Sbjct: 166 WCAPESLRTRTF 177
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-21
Identities = 56/165 (33%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 97 LGEGGFGRVYKGWVD------DKTLAPSKTGLGMV-VAIKKLNP-ESMQGFEEWQSEVNF 148
LGEG FG V+ D +K A + V VA+K L P S E++ EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-------SIQPLSWDIR 201
L RLS PN+ +LLG C D L ++ EYM+ G L L + + + LS+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246
L +A A G+ +L ++RD N L+ NY KI+DFG
Sbjct: 133 LYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-21
Identities = 52/158 (32%), Positives = 81/158 (51%), Gaps = 22/158 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK----KLNPESMQGFEEWQSEVNFLGR 151
+G+G FG VYKG + T VA+K L P+ + F + E L +
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE----------VAVKTCRSTLPPDLKRKFLQ---EAEILKQ 48
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
HPN+VKL+G C + + + +V E + GSL L R + L+ L++++ AA G
Sbjct: 49 YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL--RKKKNR-LTVKKLLQMSLDAAAG 105
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ +L + K I+RD A N L+ N KISDFG+++
Sbjct: 106 MEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 51/156 (32%), Positives = 83/156 (53%), Gaps = 13/156 (8%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNFLGRLSH 154
++G+G FG VY G + D K A+K LN ++ E++ E + SH
Sbjct: 2 VIGKGHFGCVYHGTLIDS--DGQKIH----CAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55
Query: 155 PNLVKLLGYCWEDKEL-LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
PN++ LLG C + L+V YM+ G L N F R+ + P D+ + + A+G+
Sbjct: 56 PNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDL-IGFGLQVAKGME 112
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+L + KK ++RD A N +LD ++ K++DFGLA+
Sbjct: 113 YL--ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 2e-20
Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 44/193 (22%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQS--EVNFLGRLS 153
+GEG +G+VYK G +VA+KK+ E+ +GF + E+ L +L
Sbjct: 7 IGEGTYGQVYKA---------RNKKTGELVALKKIRMENEKEGFPI-TAIREIKLLQKLR 56
Query: 154 HPNLVKLLGYCWEDK--ELLLVYEYMQ---RGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
HPN+V+L + +V+EYM G L++ K
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV---------------KFTESQ 101
Query: 209 AR--------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ GL +LH +++RD K SNIL++ + K++DFGLA+ + T
Sbjct: 102 IKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 261 TRVMGTYGYAAPE 273
RV+ T Y PE
Sbjct: 160 NRVI-TLWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL 152
LGEG FG+V K + L VA+K L ++ + + SE+ + +
Sbjct: 17 GKPLGEGAFGQVVKA--EAVGLDNPNET--STVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 153 -SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI------- 204
H N++ LLG C ++ L +V EY G+L + L R P + S D
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 205 -----AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A ARG+ FL + KK I+RD A N+L+ ++ KI+DFGLA+
Sbjct: 133 DLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 28/196 (14%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGR 151
+ ++G G FG V +G + P K + VAIK L S + +E + +G+
Sbjct: 9 EKVIGGGEFGEVCRG----RLKLPGKKEI--DVAIKTLKAGS-SDKQRLDFLTEASIMGQ 61
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
HPN+++L G + + ++++ EYM+ GSL+ L R N + + + G A G
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-REND--GKFTVGQLVGMLRGIASG 118
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGESHVTTRVMGTYG-- 268
+ +L SE ++RD A NIL++ N K+SDFGL++ L + E+ TT+ G
Sbjct: 119 MKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTK-----GGK 169
Query: 269 ----YAAPEYVATGNF 280
+ APE +A F
Sbjct: 170 IPIRWTAPEAIAYRKF 185
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 24/195 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHP 155
LG G FG V KG K+G + VA+K L E + G +E+ E + + +L HP
Sbjct: 3 LGHGNFGSVVKGVYL------MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI-AIGAARGLGF 214
+V+L+G C + L+LV E G L +L ++ I LK A A G+ +
Sbjct: 57 CIVRLIGVCKGEP-LMLVMELAPLGPLLKYL-KKRREIP----VSDLKELAHQVAMGMAY 110
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGESHVTTRVMGTY--GYAA 271
L K ++RD A N+LL + AKISDFG+++ LG G + G + + A
Sbjct: 111 LE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYA 166
Query: 272 PEYVATGNFYLLSAK 286
PE + N+ S+K
Sbjct: 167 PECI---NYGKFSSK 178
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 59/188 (31%), Positives = 82/188 (43%), Gaps = 22/188 (11%)
Query: 97 LGEGGFGRVYKGW-VDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+G G FG+VY +D L M V ++ + +E E+ L L HP
Sbjct: 8 IGGGTFGKVYTAVNLDTGEL--------MAVKEIRIQDNDPKTIKEIADEMKVLELLKHP 59
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
NLVK G +++ + EY G+LE L + I IR+ + GL +L
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHV-IRV-YTLQLLEGLAYL 115
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAG---GESHVTTRVMGTYGYAA 271
H +++RD K +NI LD N K+ DFG A L GE + GT Y A
Sbjct: 116 H--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL--AGTPAYMA 171
Query: 272 PEYVATGN 279
PE V TG
Sbjct: 172 PE-VITGG 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-20
Identities = 56/186 (30%), Positives = 93/186 (50%), Gaps = 17/186 (9%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EVN 147
+FK LG+G +G VYK K L+ ++ A+K+++ SM E + E+
Sbjct: 1 DFKVLKKLGKGSYGSVYKV----KRLSDNQF-----YALKEVDLGSMSQKEREDAVNEIR 51
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L ++HPN++ + +L +V EY G L + +R + + +I I
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
RGL LH E+K+++RD K++NILL N KI D G++K+ + ++ +GT
Sbjct: 112 LLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTP 165
Query: 268 GYAAPE 273
Y APE
Sbjct: 166 HYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-20
Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNFLGRLSHP 155
LG+G FG VY+G K VAIK +N SM+ E+ +E + + +
Sbjct: 14 LGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR------NPSIQPLSWDIRLKIAIGAA 209
++V+LLG + L+V E M +G L+++L R NP + P + +++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
G+ +L KK ++RD A N ++ + KI DFG+ +
Sbjct: 130 DGMAYLA--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-20
Identities = 66/213 (30%), Positives = 93/213 (43%), Gaps = 40/213 (18%)
Query: 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK-LNPESMQGFE-EWQ 143
S ++++ LGEG FG VYK KT G VVA+KK L GF
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKA-RQIKT--------GRVVALKKILMHNEKDGFPITAL 55
Query: 144 SEVNFLGRLSHPNLVKLLGYCWED--------KELLLVYEYMQR---GSLENHLFRRNPS 192
E+ L +L HPN+V L+ E + +V YM G LEN + S
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL-- 250
I+ + G+ +LH E +++RD KA+NIL+D KI+DFGLA+
Sbjct: 116 ------QIKC-YMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 251 -------GPAGGESHVTTRVMGTYGYAAPEYVA 276
G GG + T ++ T Y PE +
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-20
Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 27/181 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNF 148
N LGEG FG+V K T VA+K L + + SE N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYT----TVAVKMLKENASSSELRDLLSEFNL 56
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--------------------FR 188
L +++HP+++KL G C +D LLL+ EY + GSL + L +
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
NP + L+ + A +RG+ +L +E K+++RD A N+L+ KISDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 249 K 249
+
Sbjct: 175 R 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 52/189 (27%), Positives = 81/189 (42%), Gaps = 23/189 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EVNFLGRLSH 154
+GEG +G VYK G +VAIKK+ + E+ L L+H
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH 57
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLEN--HLFRRNPSIQPLSWDIRLKIAIGAARGL 212
PN++KLL +L LV+E+M + L + + L + +GL
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGL 111
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
F H+ +++RD K N+L++ K++DFGLA+ G T + T Y AP
Sbjct: 112 AFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARS--FGSPVRPYTHYVVTRWYRAP 167
Query: 273 EYVATGNFY 281
E + Y
Sbjct: 168 ELLLGDKGY 176
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 66/210 (31%), Positives = 94/210 (44%), Gaps = 41/210 (19%)
Query: 84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEW 142
L T F+ ++GEG +G+VYK KT G +VAIK ++ E + EE
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIEDEE--EEI 49
Query: 143 QSEVNFLGRLS-HPNLVKLLG------YCWEDKELLLVYEYMQRGS---LENHLFRRNPS 192
+ E N L + S HPN+ G D +L LV E GS L L ++
Sbjct: 50 KEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-- 107
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252
+ L + I RGL +LH E KVI+RD K NILL N K+ DFG++
Sbjct: 108 -KRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVS---- 160
Query: 253 AGGESHVTTRVM------GTYGYAAPEYVA 276
+ + + + GT + APE +A
Sbjct: 161 ----AQLDSTLGRRNTFIGTPYWMAPEVIA 186
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 22/189 (11%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
++ LGEG + VYK D +T G +VAIKK+ + ++ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALR 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
E+ L L HPN++ LL + LV+E+M LE + + + SI DI+
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLE-KVIK-DKSIVLTPADIK-SY 107
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
+ RGL +LH +++RD K +N+L+ + K++DFGLA+ + +T +V+
Sbjct: 108 MLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVV 164
Query: 265 GTYGYAAPE 273
T Y APE
Sbjct: 165 -TRWYRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPS-------KTGLGMVVAIKKLNPE-SMQGFEEWQSEVNF 148
LGEG FG V+ V + P+ + G ++VA+K L P+ + ++ EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---- 195
L RL PN+++LLG C ++ L ++ EYM+ G L L N ++ P
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 196 --LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253
+S+ L +A+ A G+ +L S ++RD N L+ N KI+DFG+++ A
Sbjct: 133 PAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 254 GGESHVTTRVMGTYGYAAPEYVATGNF 280
G + R + + A E + G F
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKF 217
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHP 155
LGEG FG+V+ G + +VA+K L S ++++ E L H
Sbjct: 13 LGEGAFGKVFLG----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN-----------PSIQPLSWDIRLKI 204
N+VK G C E ++V+EYM+ G L N R + + L+ L+I
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A+ A G+ +L + + ++RD N L+ + KI DFG+++
Sbjct: 128 AVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 88 TKNFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSE 145
+ LLG G FG V+KG W+ P + + VAIK + + Q F+E
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRL 202
+ +G L H +V+LLG C L LV + GSL +H+ + S+ P L+W +++
Sbjct: 60 MLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR 262
A+G+ +L E ++++R+ A NILL + +I+DFG+A L + + +
Sbjct: 119 ------AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 263 VMGTYGYAAPEYVATGNF 280
+ A E + G +
Sbjct: 171 HKTPIKWMALESILFGRY 188
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 55/182 (30%), Positives = 91/182 (50%), Gaps = 21/182 (11%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLS 153
+LG+G G VYK T G + A+KK++ + ++ E+ L
Sbjct: 7 KVLGQGSSGVVYKV-RHKPT--------GKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI--QPLSWDIRLKIAIGAARG 211
P +VK G +++ E+ +V EYM GSL + L ++ I L+ IA +G
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLA-----YIARQILKG 111
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
L +LHT ++ +I+RD K SN+L++ KI+DFG++K+ + T +GT Y +
Sbjct: 112 LDYLHT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMS 168
Query: 272 PE 273
PE
Sbjct: 169 PE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 22/156 (14%)
Query: 97 LGEGGFGRVYKG-W--VDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
LG G FG V+ G W D VAIK + +M +++ E + +LS
Sbjct: 12 LGSGQFGVVHLGKWRGKID-------------VAIKMIREGAMSE-DDFIEEAKVMMKLS 57
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
HPNLV+L G C + + + +V EYM G L N+L R W L + +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEW--LLDMCSDVCEAME 114
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+L I+RD A N L+ + K+SDFGLA+
Sbjct: 115 YLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-19
Identities = 59/188 (31%), Positives = 93/188 (49%), Gaps = 28/188 (14%)
Query: 91 FKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
F LGEG +G VYK + G VVAIK + E +E E++ L
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKET----------GQVVAIKVVPVEE--DLQEIIKEISIL 52
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI--- 206
+ P +VK G +++ +L +V EY GS+ + + N + L+ + +IA
Sbjct: 53 KQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---KTLTEE---EIAAILY 106
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA-KLGPAGGESHVTTRVMG 265
+GL +LH+ K I+RD KA NILL+ AK++DFG++ +L + + V+G
Sbjct: 107 QTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIG 161
Query: 266 TYGYAAPE 273
T + APE
Sbjct: 162 TPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 22/174 (12%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
LG+G FG V D P + G VVA+KKL + + +++ E+ L L H
Sbjct: 10 QQLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64
Query: 155 PNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRR-----NPSIQPLSWDIRLKIAIG 207
N+VK G C+ + L LV EY+ GSL ++L + + + + I
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------- 117
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
+G+ +L K+ ++RD NIL++ KI DFGL K+ P E +
Sbjct: 118 -CKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE--EWQSEVNFLGRLSH 154
+G+G FG V+K K V A+K+++ M E E E L +L
Sbjct: 8 IGKGSFGVVFK--------VVRKAD-KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
+++ + +L +V EY + G L H + +PL D + I GL
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
LH+ KK+++RD K+ N+ LD N KI D G+AKL ++ ++GT Y +PE
Sbjct: 117 LHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-18
Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 27/191 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW--QSEVN 147
++ ++G G FG V+ L K +V+ IK++ E M E Q+E
Sbjct: 1 KYEKIRVVGRGAFGIVH--------LCRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQ 51
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP----LSWDIRLK 203
L LSHPN+++ EDK L++V EY G+L ++ +R S+ L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN-AKISDFGLAKLGPAGGESHVTTR 262
+A+ H K +++RD K NILLD + KI DFG++K+ +S T
Sbjct: 112 LALH--------HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT- 160
Query: 263 VMGTYGYAAPE 273
V+GT Y +PE
Sbjct: 161 VVGTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 2e-18
Identities = 61/192 (31%), Positives = 88/192 (45%), Gaps = 32/192 (16%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+GEG G VYK D T G VAIKK+ Q E +E+ + HPN
Sbjct: 27 IGEGASGEVYKA-TDRAT--------GKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA------R 210
+V EL +V EYM GSL + + +N +R+ A +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNF--------VRMNEPQIAYVCREVLQ 127
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHVTTRVMGTYGY 269
GL +LH+ + VI+RD K+ NILL + + K++DFG A+L + + V+GT +
Sbjct: 128 GLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYW 182
Query: 270 AAPEYVATGNFY 281
APE V Y
Sbjct: 183 MAPE-VIKRKDY 193
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVNFLGRLS 153
+LGEG FG V +G + + K VA+K KL+ + EE+ SE +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 154 HPNLVKLLGYCWEDKEL------LLVYEYMQRGSLENHLFRRNPSIQPLSWDIR--LKIA 205
HPN++KL+G C+E L +++ +M+ G L + L P ++ LK
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ A G+ +L S + I+RD A N +L + ++DFGL+K
Sbjct: 120 VDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 70/187 (37%), Positives = 89/187 (47%), Gaps = 34/187 (18%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRLS 153
+G G FG VY D +T VVAIKK++ Q E+WQ EV FL +L
Sbjct: 23 IGHGSFGAVYFAR-DVRT--------NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGS----LENHLFRRNPSIQPLSWDIRLKIAIGAA 209
HPN ++ G + LV EY GS LE H +PL I GA
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-------KPLQEVEIAAICHGAL 125
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL-GPAGGESHVTTRVMGTYG 268
+GL +LH+ E+ I+RD KA NILL K++DFG A L PA S V GT
Sbjct: 126 QGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFV-----GTPY 176
Query: 269 YAAPEYV 275
+ APE +
Sbjct: 177 WMAPEVI 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-18
Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 97 LGEGGFGRVYKGWVDD-----KTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLG 150
LGEG FG V+ + AP G ++VA+K L + + ++ E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN--------PSIQPLSWDIRL 202
RL +PN+++LLG C D L ++ EYM+ G L L +R +I +S L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR 262
+A+ A G+ +L + ++RD N L+ +Y KI+DFG+++ +G + R
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 263 VMGTYGYAAPEYVATGNF 280
+ + A E + G F
Sbjct: 191 AVLPIRWMAWESILLGKF 208
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-18
Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 22/186 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLSH 154
+G+G FG V K V K+ G ++ K+++ +M E+ Q SEVN L L H
Sbjct: 8 IGKGSFGTVRK--VRRKSD-------GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH 58
Query: 155 PNLVKLLGYCWE-DKE---LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
PN+V+ Y D+ L +V EY + G L + + + + + +I
Sbjct: 59 PNIVRY--YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 211 GLGFLHT---SEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
L H V++RD K +NI LD N N K+ DFGLAK+ G +S +GT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTP 174
Query: 268 GYAAPE 273
Y +PE
Sbjct: 175 YYMSPE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-18
Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 26/189 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG+G FG+VYK A K G+ A K + ES + E++ E++ L HPN
Sbjct: 13 LGDGAFGKVYK--------AQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-----RNPSIQPLSWDIRLKIAIGAARG 211
+V L + + +L ++ E+ G+L++ + P I+ + +
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQM--------LEA 115
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
L FLH KVI+RD KA NILL + + K++DFG++ + + T +GT + A
Sbjct: 116 LNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMA 171
Query: 272 PEYVATGNF 280
PE VA F
Sbjct: 172 PEVVACETF 180
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-18
Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 23/165 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL------G 150
LG G FG VY+G + + + VA+K L PES Q E +FL
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTL-PESCSE----QDESDFLMEALIMS 64
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-RNPSIQPLSWDIR--LKIAIG 207
+ +H N+V+L+G +E ++ E M G L++ L R +P S ++ L A
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDG---NYNAKISDFGLAK 249
A+G +L E I+RD A N LL AKI+DFG+A+
Sbjct: 125 VAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 8e-18
Identities = 55/161 (34%), Positives = 77/161 (47%), Gaps = 28/161 (17%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS-----EVNFLGR 151
LG+G FG VY + G +VAIKK+ + F W+ EV L +
Sbjct: 7 LGDGTFGSVYLARNKET---------GELVAIKKM----KKKFYSWEECMNLREVKSLRK 53
Query: 152 L-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
L HPN+VKL E+ EL V+EYM+ G+L + R +P S + I +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQ 110
Query: 211 GLGFLHTSEKKVIY--RDFKASNILLDGNYNAKISDFGLAK 249
GL +H K + RD K N+L+ G KI+DFGLA+
Sbjct: 111 GLAHIH----KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-18
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 18/155 (11%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+G G FG V+ G W++ + VAIK + +M E++ E + +LSHP
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTIREGAMSE-EDFIEEAQVMMKLSHP 59
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
LV+L G C E + LV+E+M+ G L ++L + S + L + + G+ +L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYL 116
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+S VI+RD A N L+ N K+SDFG+ +
Sbjct: 117 ESS--NVIHRDLAARNCLVGENQVVKVSDFGMTRF 149
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDD--KTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
N++ LLG+G FGRVY + D + LA + V +PE+ + + E+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQ------VPFDPDSPETKKEVNALECEIQ 56
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVY-EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L L H +V+ G C D E L ++ EYM GS+++ L + L+ + K
Sbjct: 57 LLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTR 111
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA-----GGESHVTT 261
G+ +LH++ +++RD K +NIL D N K+ DFG +K G VT
Sbjct: 112 QILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT- 168
Query: 262 RVMGTYGYAAPEYV 275
GT + +PE +
Sbjct: 169 ---GTPYWMSPEVI 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V++G ++ T VA+K L P +M +++ +E + +L HP
Sbjct: 14 LGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPK 62
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
L++L C ++ + +V E M+ GSL +L L I +A A G+ +L
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLE 120
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+ I+RD A N+L+ N K++DFGLA++
Sbjct: 121 --AQNYIHRDLAARNVLVGENNICKVADFGLARV 152
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 52/179 (29%), Positives = 77/179 (43%), Gaps = 18/179 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGF-EEWQSEVNFLGRLSH 154
+GEG G V+K D +T G VA+KK+ G + E+ L H
Sbjct: 8 IGEGAHGIVFKA-KDRET--------GETVALKKVALRRLEGGIPNQALREIKALQACQH 58
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
P +VKLL +LV EYM L L +PL +G+ +
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAY 114
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+H +++RD K +N+L+ + KI+DFGLA+L + +V T Y APE
Sbjct: 115 MH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 55/155 (35%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+G G +G VYK D T G +VAIK + E FE Q E++ L HPN
Sbjct: 11 IGSGTYGDVYKA-RDIAT--------GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 157 LVKLLG-YCWEDKELLLVYEYMQRGSLEN--HLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
+V G Y DK L +V EY GSL++ + R PLS + +GL
Sbjct: 62 IVAYFGSYLRRDK-LWIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLA 115
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
+LH E I+RD K +NILL + + K++DFG++
Sbjct: 116 YLH--ETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFL 149
F +G+G FG VYK +D +T VVAIK ++ E+ E+ Q E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
+ P + K G + +L ++ EY GS + L L I
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVL 108
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
GL +LH E+ I+RD KA+NILL + K++DFG++
Sbjct: 109 LGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 63/190 (33%), Positives = 91/190 (47%), Gaps = 28/190 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNF 148
+ K ++GEG FG+V K + K GL M AIK++ S ++ E+
Sbjct: 8 DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 149 LGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR------------NPSIQP 195
L +L HPN++ LLG C L L EY G+L + L + N +
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG 255
LS L A ARG+ +L S+K+ I+RD A NIL+ NY AKI+DFGL++ G
Sbjct: 121 LSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----G 173
Query: 256 ESHVTTRVMG 265
+ + MG
Sbjct: 174 QEVYVKKTMG 183
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 43/197 (21%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQS---EVNFLG 150
+ +GEG +G VYK G VA+KK+ P S +G S E+ L
Sbjct: 5 AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53
Query: 151 RL---SHPNLVKLLGYC--WEDKE---LLLVYEYMQRGSLENHLFRRNPS------IQPL 196
+L HPN+V+LL C L LV+E++ + L +L + I+ L
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDL 112
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
+ RG+ FLH+ ++++RD K NIL+ + KI+DFGLA++ E
Sbjct: 113 MRQL--------LRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFE 160
Query: 257 SHVTTRVMGTYGYAAPE 273
+T+ V+ T Y APE
Sbjct: 161 MALTSVVV-TLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 55/155 (35%), Positives = 82/155 (52%), Gaps = 18/155 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V+ G+ + T VAIK L SM E + +E N + +L HP
Sbjct: 14 LGAGQFGEVWMGYYNGHT----------KVAIKSLKQGSMSP-EAFLAEANLMKQLQHPR 62
Query: 157 LVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
LV+L Y +E + ++ EYM+ GSL + L + P L+ + + +A A G+ F+
Sbjct: 63 LVRL--YAVVTQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
K I+RD +A+NIL+ KI+DFGLA+L
Sbjct: 119 E--RKNYIHRDLRAANILVSETLCCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 51/154 (33%), Positives = 83/154 (53%), Gaps = 14/154 (9%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LLG+G FG V+KG + DKT KT K+ P+ ++ ++ SE L + HP
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKT-------CKEDLPQELK--IKFLSEARILKQYDHP 52
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+VKL+G C + + + +V E + G + L ++ ++ +K A+ AA G+ +L
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL---VKFALDAAAGMAYL 109
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ K I+RD A N L+ N KISDFG+++
Sbjct: 110 ES--KNCIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 61/199 (30%), Positives = 81/199 (40%), Gaps = 45/199 (22%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSE 145
+F+ LG G FGRV L K G A+K L+ ++ E +E
Sbjct: 1 DDFEFIKTLGTGSFGRV--------MLVRHKGS-GKYYALKILSKAKIVKLKQVEHVLNE 51
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L + HP LV L G +D L LV EY+ G L +HL + +
Sbjct: 52 KRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG------------RFP 99
Query: 206 IGAAR--------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES 257
AR L +LH+ ++YRD K N+LLD + KI+DFG AK
Sbjct: 100 EPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAK-------- 149
Query: 258 HVTTRVM---GTYGYAAPE 273
V R GT Y APE
Sbjct: 150 RVKGRTYTLCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LGEG FG+V+ + L+P+K M+VA+K L ++ +++Q E L L H +
Sbjct: 13 LGEGAFGKVF--LAECYNLSPTKDK--MLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI------QPLSWDIRLKIA----I 206
+VK G C + L++V+EYM+ G L L P QP L ++ I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ G ++ + + ++RD N L+ N KI DFG+++
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-17
Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LG G +G VY+G W + VA+K L ++M+ EE+ E + + HP
Sbjct: 14 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 62
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
NLV+LLG C + ++ E+M G+L ++L N + L +A + + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQISSAMEYL 120
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+K I+RD A N L+ N+ K++DFGL++L
Sbjct: 121 E--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-17
Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 21/188 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
LG+GGFG V A G + A KKL+ + + +G + +E L ++S
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 154 HPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
+V L Y +E K +L LV M G L+ H++ P + I I
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQII----C 106
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
G H +++++YRD K N+LLD + N +ISD GLA G + GT GY AP
Sbjct: 107 GLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAP 163
Query: 273 EYVATGNF 280
E + +
Sbjct: 164 EVLQGEVY 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-17
Identities = 56/155 (36%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-SH 154
LG G FG+V V+ SK+ M VA+K L P + E SE+ + L +H
Sbjct: 43 LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
N+V LLG C +L++ EY G L N L R+ S L+ + L + A+G+ F
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAF 156
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
L + K I+RD A N+LL KI DFGLA+
Sbjct: 157 L--ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 15/188 (7%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHP 155
+G G VY VAIK+++ E Q +E + EV + + +HP
Sbjct: 9 IGVGATAVVYAAICLPN---------NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+VK EL LV Y+ GSL + + + L I + +GL +L
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR--VMGTYGYAAPE 273
H++ + I+RD KA NILL + + KI+DFG++ GG+ R +GT + APE
Sbjct: 119 HSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 274 YVATGNFY 281
+ + Y
Sbjct: 177 VMEQVHGY 184
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 33/197 (16%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEVNFLG 150
++G G FG V++G + P + + VAIK L P G+ E Q SE + +G
Sbjct: 12 VIGAGEFGEVFRGILK----MPGRKE--VAVAIKTLKP----GYTEKQRQDFLSEASIMG 61
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
+ SH N+++L G + K +++ EYM+ G+L+ +L + +G R
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-------LVGMLR 114
Query: 211 GL--GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
G+ G + S+ ++RD A NIL++ N K+SDFGL+++ E TT + G
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGG 170
Query: 269 -----YAAPEYVATGNF 280
+ APE +A F
Sbjct: 171 KIPIRWTAPEAIAYRKF 187
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 58/185 (31%), Positives = 94/185 (50%), Gaps = 25/185 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
+GEG FG V +G G VA+K + + + Q F E E + +L H
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHK 59
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
NLV+LLG + L +V E M +G+L N L R ++ + L+ ++ A G+ +L
Sbjct: 60 NLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQ--LLQFSLDVAEGMEYL 116
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV 275
+ KK+++RD A NIL+ + AK+SDFGLA++G G + +++ + APE +
Sbjct: 117 ES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPEAL 169
Query: 276 ATGNF 280
F
Sbjct: 170 KHKKF 174
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-17
Identities = 51/165 (30%), Positives = 87/165 (52%), Gaps = 20/165 (12%)
Query: 91 FKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNF 148
FK +LG G FG VYKG W+ P + + VAIK+L S + +E E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKIA 205
+ + +P++ +LLG C + L+ + M G L +++ +I L+W +++
Sbjct: 63 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--- 118
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
A+G+ +L E+++++RD A N+L+ + KI+DFGLAKL
Sbjct: 119 ---AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-16
Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 45/200 (22%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS------ 144
++ +G G +G V VD +T G VAIKK++ F++
Sbjct: 2 YELLKPIGSGAYGVVCSA-VDKRT--------GRKVAIKKISNV----FDDLIDAKRILR 48
Query: 145 EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFR--RNPSIQPLS 197
E+ L L H N++ LL + ++ +V E M E L + ++P QPL+
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSP--QPLT 101
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES 257
D RGL +LH++ VI+RD K SNIL++ N + KI DFGLA+
Sbjct: 102 DDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPD 156
Query: 258 HVTTRVMGTYGYAAPEYVAT 277
+ T EYV T
Sbjct: 157 EDEKGFL-T------EYVVT 169
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-16
Identities = 52/153 (33%), Positives = 77/153 (50%), Gaps = 16/153 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V+ G K A K VAIK +N +M E++ E + +LSHP
Sbjct: 12 LGSGQFGVVHLG----KWRAQIK------VAIKAINEGAMSE-EDFIEEAKVMMKLSHPK 60
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LV+L G C + K L +V E+M+ G L N+L +R + D+ L + G+ +L
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLE 117
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ I+RD A N L+ K+SDFG+ +
Sbjct: 118 RN--SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 56/190 (29%), Positives = 97/190 (51%), Gaps = 26/190 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESM----QGFEEWQSEVNFL 149
+LG+G +G VY G + G ++A+K+ L+ ++ + +E+ Q EV+ L
Sbjct: 7 VLGKGAYGTVYCGLTNQ----------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
L H N+V+ LG C +D + + E++ GS+ + L R P +P+ +I G A
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK----LGPAGGESHVTTRVMG 265
+LH V++RD K +N++L N K+ DFG A+ +G G S++ + G
Sbjct: 117 ----YLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 266 TYGYAAPEYV 275
T + APE +
Sbjct: 171 TPYWMAPEVI 180
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EV 146
+F+ ++G+G FG+V + K T + A+K +N + ++ E
Sbjct: 1 HFELLRVIGKGAFGKV---CIVQK----RDTKK--MFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 147 NFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L L+HP LV L Y ++D+E + LV + + G L HL ++ + ++ I
Sbjct: 52 RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ---VKFWIC 107
Query: 206 -IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
I A L +LH K +I+RD K NILLD + I+DF +A +TT
Sbjct: 108 EIVLA--LEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTS 160
Query: 265 GTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296
GT GY APE + + + + + V Y
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWS--LGVTAY 190
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 56/196 (28%), Positives = 85/196 (43%), Gaps = 24/196 (12%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQSEVNFLG 150
S LGEG G V K K GM+ A+K + NP+ + + E+
Sbjct: 7 SRLGEGAGGSVTK--CRLK-------NTGMIFALKTITTDPNPDLQK---QILRELEINK 54
Query: 151 RLSHPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
P +VK G ++ + + EY + GSL++ + + + KIA
Sbjct: 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESV 114
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
+GL +LH +K+I+RD K SNILL K+ DFG++ G S T GT
Sbjct: 115 LKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVS--GEL-VNSLAGTFT-GTSF 168
Query: 269 YAAPEYVATGNFYLLS 284
Y APE + + + S
Sbjct: 169 YMAPERIQGKPYSITS 184
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 27/199 (13%)
Query: 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEV 146
K + ++G G FG V +G + P K + VAIK L G+ E Q SE
Sbjct: 7 KIEEVIGAGEFGEVCRG----RLKLPGKRE--IFVAIKTLK----SGYTEKQRRDFLSEA 56
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
+ +G+ HPN++ L G + + ++++ E+M+ G+L++ L + + I+L +
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV----IQL---V 109
Query: 207 GAARGL--GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
G RG+ G + SE ++RD A NIL++ N K+SDFGL++ T +
Sbjct: 110 GMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 265 G---TYGYAAPEYVATGNF 280
G + APE +A F
Sbjct: 170 GGKIPIRWTAPEAIAYRKF 188
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 53/160 (33%), Positives = 86/160 (53%), Gaps = 20/160 (12%)
Query: 96 LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS 153
+LG G FG VYKG WV P + + VAIK LN + + E+ E + +
Sbjct: 14 VLGSGAFGTVYKGIWV------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKIAIGAAR 210
HP+LV+LLG C + LV + M G L +++ +I L+W +++ A+
Sbjct: 68 HPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
G+ +L E+++++RD A N+L+ + KI+DFGLA+L
Sbjct: 121 GMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 35/204 (17%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----S 144
K + ++G G FG V G + P K + VAIK L G+ E Q S
Sbjct: 5 CIKIEKVIGAGEFGEVCSG----RLKLPGKREI--PVAIKTLK----AGYTEKQRRDFLS 54
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
E + +G+ HPN++ L G + K +++V EYM+ GSL+ L + + I+L
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV----IQL-- 108
Query: 205 AIGAARGL--GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR 262
+G RG+ G + S+ ++RD A NIL++ N K+SDFGL+++ E+ TTR
Sbjct: 109 -VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
Query: 263 VMGTYG------YAAPEYVATGNF 280
G + APE +A F
Sbjct: 168 -----GGKIPIRWTAPEAIAYRKF 186
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 21/198 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLSHP 155
LGE FG++YKG + + ++ +VAIK L + + Q + E+Q E + + L HP
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI-------------QPLSWDIRL 202
N+V LLG +++ + +++EY+ +G L L R+P L L
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR 262
IAI A G+ +L S +++D A NIL+ + KISD GL++ + V +
Sbjct: 128 HIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 263 VMGTYGYAAPEYVATGNF 280
+ + PE + G F
Sbjct: 186 SLLPIRWMPPEAIMYGKF 203
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 58/191 (30%), Positives = 91/191 (47%), Gaps = 28/191 (14%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVN 147
++ K + ++GEG FG+V + + K GL M AIK L S ++ E+
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMI-------KKDGLKMNAAIKMLKEFASENDHRDFAGELE 54
Query: 148 FLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL------------FRRNPSIQ 194
L +L HPN++ LLG C L + EY G+L + L + + +
Sbjct: 55 VLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS 114
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
L+ L+ A A G+ +L SEK+ I+RD A N+L+ N +KI+DFGL++
Sbjct: 115 TLTSQQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----- 167
Query: 255 GESHVTTRVMG 265
GE + MG
Sbjct: 168 GEEVYVKKTMG 178
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LGEG FG+V+ + L P + M+VA+K L S +++Q E L L H +
Sbjct: 13 LGEGAFGKVF--LAECHNLLPEQDK--MLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ-----------PLSWDIRLKIA 205
+V+ G C E + LL+V+EYM+ G L L P + L+ L IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A G+ +L + ++RD N L+ KI DFG+++
Sbjct: 129 SQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL--NPESMQGFEEWQSEVNFLGRLS 153
L+GEG +G V K + G +VAIKK + + + E+ L +L
Sbjct: 8 LVGEGSYGMVMKCKHKET---------GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
H NLV L+ K L LV+E++ L++ + P+ L K RG+
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPN--GLDESRVRKYLFQILRGIE 114
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
F H+ +I+RD K NIL+ + K+ DFG A+ A GE + T + T Y APE
Sbjct: 115 FCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPE 170
Query: 274 YVATGNFYLLSAKFGNVINV----CMY 296
+ + K+G +++ C+
Sbjct: 171 LL------VGDTKYGRAVDIWAVGCLV 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-16
Identities = 62/184 (33%), Positives = 88/184 (47%), Gaps = 28/184 (15%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNFLGRLSH 154
++GEG FG+V K + K GL M AIK++ S ++ E+ L +L H
Sbjct: 2 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 155 -PNLVKLLGYCWEDKELLLVYEYMQRGSLENHL------------FRRNPSIQPLSWDIR 201
PN++ LLG C L L EY G+L + L N + LS
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
L A ARG+ +L S+K+ I+RD A NIL+ NY AKI+DFGL++ G+
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVK 167
Query: 262 RVMG 265
+ MG
Sbjct: 168 KTMG 171
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-16
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 26/191 (13%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVN 147
++ +GEG FG++Y LA +K+ V IK+++ M + E + EV
Sbjct: 1 RYEIIKKIGEGSFGKIY--------LAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVI 51
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI----QPLSWDIRLK 203
L ++ HPN+V E+ L +V EY G L + R+ + Q LSW +++
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI- 110
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKISDFGLAKLGPAGGESHVTTR 262
LG H ++K+++RD K+ NI L N AK+ DFG+A+ E T
Sbjct: 111 -------SLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-- 161
Query: 263 VMGTYGYAAPE 273
+GT Y +PE
Sbjct: 162 CVGTPYYLSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 61/186 (32%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 100 GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEEWQSEVNFLGRLSHPN 156
G +GRV+ LA K G + AIK + M ++ +E + L + P
Sbjct: 4 GAYGRVF--------LA-KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 157 LVKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI-RLKIA-IGAARGLG 213
+VKL Y ++ K L LV EY+ G L L ++ L D+ R+ IA I A L
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLE---NVGSLDEDVARIYIAEIVLA--LE 107
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG------PAGGESHVTTRVMGTY 267
+LH +I+RD K NIL+D N + K++DFGL+K+G + R++GT
Sbjct: 108 YLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 268 GYAAPE 273
Y APE
Sbjct: 166 DYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-16
Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 23/191 (12%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN----------PESMQGFEEWQSE 145
LG G FG VYK K ++A+K++N E + + SE
Sbjct: 7 HLGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 146 VNFLG-RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
V + +L HPN+V+ E+ L +V + ++ L H Q + + I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
+ L +LH EK++++RD +NI+L + I+DFGLAK T V+
Sbjct: 119 FVQMVLALRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174
Query: 265 GTYGYAAPEYV 275
GT Y+ PE V
Sbjct: 175 GTILYSCPEIV 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 8e-16
Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 57/201 (28%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---------EVN 147
LG+G +G V+K +D +T VVA+KK+ F+ +++ E+
Sbjct: 15 LGKGAYGIVWKA-IDRRT--------KEVVALKKI-------FDAFRNATDAQRTFREIM 58
Query: 148 FLGRLS-HPNLVKLLGY--CWEDKELLLVYEYM--------QRGSLEN-HLFRRNPSIQP 195
FL L HPN+VKLL DK++ LV+EYM + LE+ H +R Q
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KRYIMYQL 116
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL---GP 252
L + L ++H+ VI+RD K SNILL+ + K++DFGLA+
Sbjct: 117 L-------------KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 253 AGGESHVTTRVMGTYGYAAPE 273
E+ V T + T Y APE
Sbjct: 162 ENPENPVLTDYVATRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-16
Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 26/198 (13%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQSEVN 147
NF+ +GEG +G VYK A +K G VVA+KK L+ E+ E++
Sbjct: 1 NFQKVEKIGEGTYGVVYK--------ARNKL-TGEVVALKKIRLDTETEGVPSTAIREIS 51
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL----SWDIRLK 203
L L+HPN+VKLL + +L LV+E++ + L+ + S PL S+ +L
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL- 109
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRV 263
+GL F H+ +V++RD K N+L++ K++DFGLA+ G T
Sbjct: 110 -----LQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHE 160
Query: 264 MGTYGYAAPEYVATGNFY 281
+ T Y APE + +Y
Sbjct: 161 VVTLWYRAPEILLGCKYY 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 97 LGEGGFGRVY-------KGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
LGEG FG V+ + ++D ++VA+K L ++ + ++ E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------- 201
+ RL PN+++LL C L ++ EYM+ G L L R P D+
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ +A A G+ +L S ++RD N L+ NY KI+DFG+++
Sbjct: 133 IFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 28/194 (14%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSH 154
LG G FG V+ G+ ++ T VA+K L P +M Q F E E N + L H
Sbjct: 14 LGAGQFGEVWMGYYNNST----------KVAVKTLKPGTMSVQAFLE---EANLMKTLQH 60
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAIGAARGL 212
LV+L +++ + ++ EYM +GSL + L + P D +IA G A
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA--- 117
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY--GYA 270
+ K I+RD +A+N+L+ + KI+DFGLA++ ++ T R + +
Sbjct: 118 ---YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWT 171
Query: 271 APEYVATGNFYLLS 284
APE + G+F + S
Sbjct: 172 APEAINFGSFTIKS 185
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
N + + LG G FG V+ K + G +V +K L + + E++ E++
Sbjct: 6 NLQEITTLGRGEFGEVFLA----KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI-----QPLSWDIRLK 203
+LSH N+V+LLG C E + ++ EY G L+ L PLS ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ A G+ L + + ++RD A N L+ K+S L+K
Sbjct: 122 LCTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 60/199 (30%), Positives = 83/199 (41%), Gaps = 45/199 (22%)
Query: 98 GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLSH 154
G G +GRVYK K K AIKK + Q QS E+ L L H
Sbjct: 9 GRGTYGRVYKAK--RKNGKDGK-----EYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 155 PNLVKLLGYCWE--DKELLLVYEYMQRGSLE---NHLFRRNPSIQP-----LSWDIRLKI 204
N+V L+ E DK + L+++Y + + H + SI P L W I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI---- 117
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA----KISDFGLAKL------GPAG 254
G+ +LH++ V++RD K +NIL+ G KI D GLA+L A
Sbjct: 118 ----LNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 255 GESHVTTRVMGTYGYAAPE 273
+ V+ T Y APE
Sbjct: 172 LD-----PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-15
Identities = 57/181 (31%), Positives = 83/181 (45%), Gaps = 21/181 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLS 153
LG+GGFG V V + G + A KKL+ + ++ G + E L +++
Sbjct: 1 LGKGGFGEVCAVQVKNT---------GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 154 HPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
P +V L Y +E K L LV M G L+ H++ ++ ++ I A
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIY----NVGERGLEMERVIHYSAQITC 106
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
G LH ++YRD K N+LLD N ++SD GLA G T+ GT GY AP
Sbjct: 107 GILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAP 163
Query: 273 E 273
E
Sbjct: 164 E 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 53/156 (33%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
LGEG FG+V D P G VA+K L PES + + E+ L L H
Sbjct: 12 LGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 156 NLVKLLGYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
N+VK G C ED + L+ E++ GSL+ +L R I + +LK A+ +G+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI---NLKQQLKYAVQICKGMD 123
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+L ++ ++RD A N+L++ + KI DFGL K
Sbjct: 124 YL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 26/185 (14%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
LG+GGFG V A G + A KKLN + + +G+E E L ++
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50
Query: 154 HPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLF---RRNPSIQ-PLSWDIRLKIAIGA 208
H + L Y ++ K +L LV M G L H++ NP P + +I
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQII--- 107
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
G H ++++IYRD K N+LLD + N +ISD GLA G T GT G
Sbjct: 108 ---SGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPG 162
Query: 269 YAAPE 273
+ APE
Sbjct: 163 FMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-15
Identities = 55/163 (33%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH 154
LG G FG VY+G D L P +G + VA+K L + Q +E+ E + + +H
Sbjct: 2 FLGSGAFGEVYEGTATD-ILGPG-SG-PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH 58
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-RNPSIQP--LSWDIRLKIAIGAARG 211
PN+VKLLG C ++ ++ E M+ G L ++L R P L+ L I + A+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 212 LGFLHTSEKKVIYRDFKASNILL-----DGNYNAKISDFGLAK 249
+L + I+RD A N L+ D + KI DFGLA+
Sbjct: 119 CVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 62/183 (33%), Positives = 86/183 (46%), Gaps = 25/183 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGRL 152
+G+G FG+V LA K G A+K L +++ +E + +E N L +
Sbjct: 3 IGKGSFGKVL--------LAKHKAD-GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI-AIGAAR 210
HP LV L Y ++ + L V +Y+ G L HL R +P R + A A
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIAS 107
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
LG+LH +IYRD K NILLD + ++DFGL K G S T+ GT Y
Sbjct: 108 ALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYL 163
Query: 271 APE 273
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSE 145
+FK ++GEG F V +K +K AIK L+ + + + E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAK--EKE--TNKE-----YAIKILDKRQLIKEKKVKYVKIE 51
Query: 146 VNFLGRLS-HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
L RL+ HP ++KL Y ++D+E L V EY G L ++ R+ S L
Sbjct: 52 KEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI-RKYGS---LDEKCTRF 106
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
A L +LH+ K +I+RD K NILLD + + KI+DFG AK+
Sbjct: 107 YAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKV 151
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 24/193 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQG--FEEWQ 143
+ LG G F Y G ++A+K++ N S Q E +
Sbjct: 1 EWLKGQQLGTGAFSSCY---------QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALR 51
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
E+ + RL+HP+++++LG ED L E+M GS+ + L + + +
Sbjct: 52 KEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIIN 107
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKISDFGLA-KLGPAG-GESHVT 260
RGL +LH E ++I+RD K +N+L+D +I+DFG A +L G G
Sbjct: 108 YTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165
Query: 261 TRVMGTYGYAAPE 273
+++GT + APE
Sbjct: 166 GQLLGTIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-15
Identities = 68/209 (32%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 71 LETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK 130
L+ P++ F + K F +G G FG VY D +T VVAIKK
Sbjct: 9 LKDPEIAELFFKE--DPEKLFTDLREIGHGSFGAVYFAR-DVRT--------NEVVAIKK 57
Query: 131 LNPESMQGFEEWQ---SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
++ Q E+WQ EV FL R+ HPN ++ G + LV EY GS + L
Sbjct: 58 MSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE 116
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
+Q + I GA +GL +LH+ +I+RD KA NILL K++DFG
Sbjct: 117 VHKKPLQEVEI---AAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGS 171
Query: 248 AKL-GPAGGESHVTTRVMGTYGYAAPEYV 275
A + PA +GT + APE +
Sbjct: 172 ASIASPANS-------FVGTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 61/183 (33%), Positives = 85/183 (46%), Gaps = 26/183 (14%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRLS 153
+G G FG VY + + VVA+KK++ Q E+WQ EV FL +L
Sbjct: 29 IGHGSFGAVYFA---------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
HPN ++ G ++ LV EY GS + L +Q + I GA +GL
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEI---AAITHGALQGLA 135
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA-KLGPAGGESHVTTRVMGTYGYAAP 272
+LH+ I+RD KA NILL K++DFG A K PA +GT + AP
Sbjct: 136 YLHSHNM--IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-------FVGTPYWMAP 186
Query: 273 EYV 275
E +
Sbjct: 187 EVI 189
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-15
Identities = 63/187 (33%), Positives = 93/187 (49%), Gaps = 25/187 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-- 153
+LG+G FG+V LA K G + A+K L + + ++ + + L+
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 154 --HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
HP L +L C++ K+ L V EY+ G L H+ R +P + +I +G
Sbjct: 53 GKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG--- 108
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTYGY 269
L FLH E+ +IYRD K N+LLD + KI+DFG+ K G GG VTT GT Y
Sbjct: 109 -LQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDY 162
Query: 270 AAPEYVA 276
APE ++
Sbjct: 163 IAPEILS 169
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 24/196 (12%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFL 149
++ L+G G +G VY+G T G VVA+K +N ++ + Q EV L
Sbjct: 3 YQRLELIGRGAYGAVYRG-KHVPT--------GRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 150 GRLSH---PNLVKLLGYCW-EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
+L PN+ K G + + L ++ EY + GS+ L + P + I ++
Sbjct: 54 SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVL 111
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
+ L ++H VI+RD KA+NIL+ N K+ DFG+A L S +T V G
Sbjct: 112 VA----LKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFV-G 163
Query: 266 TYGYAAPEYVATGNFY 281
T + APE + G +Y
Sbjct: 164 TPYWMAPEVITEGKYY 179
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-15
Identities = 56/196 (28%), Positives = 81/196 (41%), Gaps = 53/196 (27%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----------EV 146
+GEG +G V+K ++ G +VAIKK F E + E+
Sbjct: 9 IGEGSYGVVFK--CRNRET-------GQIVAIKK--------FVESEDDPVIKKIALREI 51
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP------SIQPLSWDI 200
L +L HPNLV L+ ++L LV+EY L + +NP I+ + W
Sbjct: 52 RMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQT 109
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGE--S 257
+ + F H I+RD K NIL+ K+ DFG A+ L G +
Sbjct: 110 --------LQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 258 HVTTRVMGTYGYAAPE 273
+V TR Y APE
Sbjct: 160 YVATR-----WYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-15
Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LGEG FG+V+ + L P + + +VA+K L S +++ E L L H +
Sbjct: 13 LGEGAFGKVF--LAECYNLCPEQDKI--LVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI---------QPLSWDIRLKIAIG 207
+VK G C E L++V+EYM+ G L L P L+ L IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A G+ +L + + ++RD N L+ N KI DFG+++
Sbjct: 129 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-15
Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 25/192 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFEEWQ--------SE 145
L+G+G +GRVY LA + T G ++A+K+ L + Q SE
Sbjct: 8 LIGKGTYGRVY--------LALNVTT-GEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
+ L L H N+V+ LG+ ++ L + EY+ GS+ + L + L ++
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
GL +LH+ K +++RD KA N+L+D + KISDFG++K ++ + G
Sbjct: 119 ----EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 266 TYGYAAPEYVAT 277
+ + APE + +
Sbjct: 173 SVFWMAPEVIHS 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-15
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 29/194 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PE--SMQGFEEWQSEV 146
+ + +G G FGRV+ L + A+K + PE ++ + +E
Sbjct: 2 DLERIKTVGTGTFGRVH--------LVRDRIS-EHYYALKVMAIPEVIRLKQEQHVHNEK 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKI 204
L +SHP +++L + + L ++ EY+ G L ++L R + L + +
Sbjct: 53 RVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC 112
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
A+ +LH+ K+++YRD K NILLD + K++DFG AK + T +
Sbjct: 113 ALE------YLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTL 158
Query: 265 -GTYGYAAPEYVAT 277
GT Y APE + +
Sbjct: 159 CGTPEYLAPEVIQS 172
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-15
Identities = 58/181 (32%), Positives = 92/181 (50%), Gaps = 21/181 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
+GEG +G VYKG + KT G +VA+KK+ ES + E S E++ L L
Sbjct: 8 IGEGTYGVVYKG-RNKKT--------GQIVAMKKIRLESEE--EGVPSTAIREISLLKEL 56
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
HPN+V L ++ L L++E++ L+ +L P Q + ++ +G+
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGI 114
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
F H+ ++V++RD K N+L+D K++DFGLA+ G V T + T Y AP
Sbjct: 115 LFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAP 170
Query: 273 E 273
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 24/159 (15%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
+GEG +G VYK A K G +VA+KK+ E+ E S E++ L L
Sbjct: 7 IGEGTYGVVYK--------ARDKLT-GEIVALKKIRLETED--EGVPSTAIREISLLKEL 55
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL--KIAIGAAR 210
+HPN+V+LL + +L LV+E+ L+ L + S D L +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
G+ + H+ +V++RD K N+L+D K++DFGLA+
Sbjct: 111 GIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-15
Identities = 56/163 (34%), Positives = 84/163 (51%), Gaps = 20/163 (12%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVN 147
K K +G+G FG V G D + G VA+K + N + Q F +E +
Sbjct: 6 KELKLLQTIGKGEFGDVMLG--DYR---------GNKVAVKCIKNDATAQAF---LAEAS 51
Query: 148 FLGRLSHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
+ +L H NLV+LLG E+K L +V EYM +GSL ++L R S+ L D LK ++
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSL 109
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ +L + ++RD A N+L+ + AK+SDFGL K
Sbjct: 110 DVCEAMEYLEAN--NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 25/200 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHP 155
LGE FG+VYKG + + VAIK L ++ EE++ E RL HP
Sbjct: 13 LGEDRFGKVYKGHL----FGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP---------------SIQPLSWDI 200
N+V LLG +++ L +++ Y L L R+P +++P +
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF-- 126
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ I A G+ FL S V+++D N+L+ N KISD GL + A +
Sbjct: 127 -VHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 261 TRVMGTYGYAAPEYVATGNF 280
+ + +PE + G F
Sbjct: 184 GNSLLPIRWMSPEAIMYGKF 203
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 56/182 (30%), Positives = 94/182 (51%), Gaps = 22/182 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG+G FG+VYK A +K G++ A K ++ +S + E++ E++ L HPN
Sbjct: 13 LGDGAFGKVYK--------AQNKE-TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-RNPSIQPLSWDIRLKIAIGAARGLGFL 215
+VKLL + + L ++ E+ G+++ + P +P IR+ + L +L
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEP---QIRV-VCKQTLEALNYL 119
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR--VMGTYGYAAPE 273
H E K+I+RD KA NIL + + K++DFG++ A + R +GT + APE
Sbjct: 120 H--ENKIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPE 173
Query: 274 YV 275
V
Sbjct: 174 VV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 28/159 (17%)
Query: 97 LGEGGFGRV----YKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL 152
LG G FG V ++G D VAIK + SM +E+ E + +L
Sbjct: 12 LGTGQFGVVKYGKWRGQYD--------------VAIKMIKEGSMSE-DEFIEEAKVMMKL 56
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIAIGAAR 210
SH LV+L G C + + + +V EYM G L N+L + L L++
Sbjct: 57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCE 111
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
G+ +L + K+ I+RD A N L+D K+SDFGL++
Sbjct: 112 GMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG+G FG+VYK A +K G + A K + +S + E++ E+ L +HP
Sbjct: 20 LGDGAFGKVYK--------AKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
+VKLLG + D +L ++ E+ G+++ + + + + + + A L +LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA---LQYLH 127
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR--VMGTYGYAAPEY 274
+ K+I+RD KA N+LL + + K++DFG++ A + R +GT + APE
Sbjct: 128 S--MKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 275 V 275
V
Sbjct: 182 V 182
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 50/164 (30%), Positives = 70/164 (42%), Gaps = 20/164 (12%)
Query: 123 GMVVAIKKL---NPESMQGFEEWQSEVNFLGRLSHPNLVKLL--GYCWEDKELLLVYEYM 177
G VAIK L PE ++ E RL HPN+V LL G L V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--- 234
+L L P RL + + A + +++RD K NI++
Sbjct: 62 PGRTLREVL--AADGALPAGETGRLMLQVLDA----LACAHNQGIVHRDLKPQNIMVSQT 115
Query: 235 DGNYNAKISDFGLAKLGPAGGESHV-----TTRVMGTYGYAAPE 273
+AK+ DFG+ L P ++ V TT V+GT Y APE
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-H 154
LGEG FG+V + + + S+ + VA+K L + + + SE+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
N++ LLG C ++ L ++ EY +G+L L R P ++DI +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A ARG+ +L + ++ I+RD A N+L+ + KI+DFGLA+
Sbjct: 138 SCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 26/193 (13%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVN 147
++ S +GEG +G V T G+ VAIKK++P Q F + E+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSA-THKPT--------GVKVAIKKISPFEHQTFCQRTLREIK 55
Query: 148 FLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
L R H N++ +L + ++ +V E M E L++ + Q LS D
Sbjct: 56 ILRRFKHENIIGILDIIRPPSFE-SFNDVYIVQELM-----ETDLYKLIKT-QHLSNDHI 108
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG-PAGGESHVT 260
RGL ++H++ V++RD K SN+LL+ N + KI DFGLA++ P +
Sbjct: 109 QYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166
Query: 261 TRVMGTYGYAAPE 273
T + T Y APE
Sbjct: 167 TEYVATRWYRAPE 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-14
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 18/178 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G G V K V + TG M V +L ++ E++ L + + P
Sbjct: 9 LGAGNSGVVSK--VLHR-----PTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPY 60
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
+V G + + ++ + EYM GSL+ L + I KIA+ +GL +LH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLA-KLGPAGGESHVTTRVMGTYGYAAPE 273
+ K+I+RD K SNIL++ K+ DFG++ +L + ++ V GT Y APE
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 57/181 (31%), Positives = 86/181 (47%), Gaps = 10/181 (5%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
+LG+GG+G+V++ V T A + M V K + + ++E N L + H
Sbjct: 2 KVLGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
P +V L+ +L L+ EY+ G L HL R ++ + +I++ L
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEH 115
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEY 274
LH + +IYRD K NILLD + K++DFGL K G VT GT Y APE
Sbjct: 116 LHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEI 171
Query: 275 V 275
+
Sbjct: 172 L 172
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-14
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 31/199 (15%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSEV 146
N++ LLG+G FGRVY + D TG + V + +PES + +E + E+
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDAD-------TGRELAVKQVQFDPESPETSKEVNALECEI 55
Query: 147 NFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
L L H +V+ G C D + L + E+M GS+++ L S L+ ++ K
Sbjct: 56 QLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRK 110
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK------LGPAGGES 257
G+ +LH++ +++RD K +NIL D N K+ DFG +K L G +S
Sbjct: 111 YTRQILEGVSYLHSN--MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168
Query: 258 HVTTRVMGTYGYAAPEYVA 276
V GT + +PE ++
Sbjct: 169 -----VTGTPYWMSPEVIS 182
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLS-H 154
LGEG FG+V + + K + VA+K L ++ + + SE+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
N++ LLG C +D L ++ EY +G+L +L R P S+DI +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
ARG+ +L + +K I+RD A N+L+ N KI+DFGLA+
Sbjct: 141 SCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 60/188 (31%), Positives = 90/188 (47%), Gaps = 35/188 (18%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
+GEG +G VYK D T +A+KK+ E Q E S E++ L +
Sbjct: 10 IGEGTYGVVYKA-RDRVT--------NETIALKKIRLE--QEDEGVPSTAIREISLLKEM 58
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL-----FRRNPS-IQPLSWDIRLKIAI 206
H N+V+L +K L LV+EY+ L+ H+ F +NP I+ + I
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI------ 111
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA-KISDFGLAKLGPAGGESHVTTRVMG 265
RG+ + H+ +V++RD K N+L+D NA K++DFGLA+ G T +
Sbjct: 112 --LRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVV 165
Query: 266 TYGYAAPE 273
T Y APE
Sbjct: 166 TLWYRAPE 173
|
Length = 294 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 58/187 (31%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS 153
LG G FGRV +A K G G AIK L M+ + E + L LS
Sbjct: 26 LGTGSFGRV--------RIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR--RNPSIQPLSWDIRLKIAIGAARG 211
HP +V ++ ++ + + E++ G L HL + R P+ + L +A
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA------ 130
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM---GTYG 268
+LH K +IYRD K N+LLD + K++DFG AK V R GT
Sbjct: 131 FEYLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCGTPE 180
Query: 269 YAAPEYV 275
Y APE +
Sbjct: 181 YLAPEVI 187
|
Length = 329 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 18/167 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRL-SH 154
LGEG FG+V + L K VA+K L ++ + + SE+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR---------NPSIQP---LSWDIRL 202
N++ LLG C +D L ++ EY +G+L +L R NP+ P LS+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A ARG+ +L + KK I+RD A N+L+ + KI+DFGLA+
Sbjct: 144 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SH 154
LGEG FG+V + + K + VA+K L ++ + + SE+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI------------RL 202
N++ LLG C +D L ++ EY +G+L +L R P S+D +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A ARG+ +L + +K I+RD A N+L+ + KI+DFGLA+
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 61/192 (31%), Positives = 88/192 (45%), Gaps = 23/192 (11%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEV 146
+F +LG+G FG+V LA K G + AIK L + + E E
Sbjct: 1 DFNFLMVLGKGSFGKV--------MLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 147 NFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L P + L C++ + L V EY+ G L H+ + +P + +I+
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM- 264
+G L FLH + +IYRD K N++LD + KI+DFG+ K G VTTR
Sbjct: 112 VG----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFC 162
Query: 265 GTYGYAAPEYVA 276
GT Y APE +A
Sbjct: 163 GTPDYIAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-14
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LGEG FG V +G L + L + V K+ + E++ SE + HPN
Sbjct: 7 LGEGEFGSVMEG-----QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 157 LVKLLGYCWEDKEL------LLVYEYMQRGSLENHLFRRNPSIQP--LSWDIRLKIAIGA 208
+++L+G C + E +++ +M+ G L + L P L + +K
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A G+ +L S K I+RD A N +L+ N N ++DFGL+K
Sbjct: 122 ASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-14
Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 19/180 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
+G+G FG V+KG +D++T VVAIK ++ E + E+ Q E+ L + P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+ K G +D +L ++ EY+ GS + L P PL I +GL +L
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYL 117
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV 275
H SEKK I+RD KA+N+LL + K++DFG+A G +GT + APE +
Sbjct: 118 H-SEKK-IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 65/221 (29%), Positives = 90/221 (40%), Gaps = 57/221 (25%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SE 145
+F+ ++G G FG V+ V DK G V A+K L M + +E
Sbjct: 1 DDFEVIKVIGRGAFGEVW--LVRDKDT-------GQVYAMKVLRKSDMIKRNQIAHVRAE 51
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
+ L P +VKL Y ++D+E L LV EYM G L N L R++ + P R I
Sbjct: 52 RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEET-ARFYI 107
Query: 205 -----AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES-- 257
A+ + LGF+H RD K NIL+D + + K++DFGL K +
Sbjct: 108 AELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
Query: 258 --------------------HVTTRVM-----GTYGYAAPE 273
H RV GT Y APE
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 61/183 (33%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRLS 153
+G G FG VY + + S+ VVAIKK++ Q E+WQ EV FL +L
Sbjct: 23 IGHGSFGAVYFA----RDVRNSE-----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
HPN ++ G + LV EY GS + L +Q + + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEI---AAVTHGALQGLA 129
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL-GPAGGESHVTTRVMGTYGYAAP 272
+LH+ +I+RD KA NILL K+ DFG A + PA +GT + AP
Sbjct: 130 YLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAP 180
Query: 273 EYV 275
E +
Sbjct: 181 EVI 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 59/189 (31%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVN 147
F+ +LG+GGFG V A G + A KKL + ++ G +E
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L +++ +V L Y +E K+ L LV M G L+ H++ ++ +D +
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY----NMGNPGFDEERAVFY 107
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
A G ++++YRD K NILLD + +ISD GLA P G + RV GT
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRV-GT 164
Query: 267 YGYAAPEYV 275
GY APE V
Sbjct: 165 VGYMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 20/162 (12%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-------FEEWQSEVN 147
+L+G G FG VY G + +G M V +L S + E+
Sbjct: 6 ALIGSGSFGSVYLG-------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIA 58
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L L H N+V+ LG + L + EY+ GS+ L + L + +I
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-- 116
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+GL +LH + +I+RD K +NIL+D KISDFG++K
Sbjct: 117 --KGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 53/185 (28%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+GEG G V +A K+ G VA+KK++ Q E +EV + HPN
Sbjct: 27 IGEGSTGIV--------CIATDKST-GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLEN---HLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
+V++ EL +V E+++ G+L + H I + + + L
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLAVLKALS 129
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR--VMGTYGYAA 271
FLH + VI+RD K+ +ILL + K+SDFG A V R ++GT + A
Sbjct: 130 FLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC----AQVSKEVPRRKSLVGTPYWMA 183
Query: 272 PEYVA 276
PE ++
Sbjct: 184 PEVIS 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-SEVNF 148
NFK LGEG + VYKG ++T G +VA+K+++ ++ +G E++
Sbjct: 1 NFKQLEKLGEGTYATVYKG--------RNRTT-GEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRN-PSIQPLSWDIRLKI 204
+ L H N+V+L + +L+LV+EYM + ++ H R S+ +L
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+G+ F H E +V++RD K N+L++ K++DFGLA+
Sbjct: 110 ----LKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LG+G F +YKG L G + V +K L + + + + +LSH
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+LVKL G C D E ++V EY++ G L+ L R + L W +L +A A L +L
Sbjct: 62 HLVKLYGVCVRD-ENIMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 216 HTSEKKVIYRDFKASNILL-----DGNYN--AKISDFGLA 248
+KK+++ + NIL+ + Y K+SD G+
Sbjct: 118 E--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-13
Identities = 50/158 (31%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NP-ESMQGFEEWQSEVNFLGR 151
+G G FG+V G SK V +K+L P E + +E Q
Sbjct: 3 IGNGWFGKVLLGEAHRGM---SKAR----VVVKELRASATPDEQLLFLQEVQP----YRE 51
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR-RNPSIQPLSWDIRLKIAIGAAR 210
L+HPN+++ LG C E LLV E+ G L+N+L R Q D+ ++A A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
GL +LH ++ I+ D N L + + KI D+GLA
Sbjct: 112 GLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
++ K + LG G FG V+ + T VA+K + P SM E + +E N
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGSMS-VEAFLAEANV 54
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ L H LVKL ++ + ++ E+M +GSL + L S QPL I I
Sbjct: 55 MKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI-- 111
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY- 267
A G+ F+ ++ I+RD +A+NIL+ + KI+DFGLA++ ++ T R +
Sbjct: 112 AEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFP 166
Query: 268 -GYAAPEYVATGNFYLLS 284
+ APE + G+F + S
Sbjct: 167 IKWTAPEAINFGSFTIKS 184
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 59/180 (32%), Positives = 91/180 (50%), Gaps = 19/180 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
+G+G FG V+KG +D++T VVAIK ++ E + E+ Q E+ L + P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+ K G + +L ++ EY+ GS + L R P LK + +GL +L
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGP-FDEFQIATMLKEIL---KGLDYL 117
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV 275
H SEKK I+RD KA+N+LL + K++DFG+A G +GT + APE +
Sbjct: 118 H-SEKK-IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---S 144
NFK + +G+G F VYK G VVA+KK+ M + Q
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKVQIFEMMDAKARQDCLK 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLE---NHLFRRNPSI-QPLSWDI 200
E++ L +L HPN++K L E+ EL +V E G L H ++ I + W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGESHV 259
+++ L +H K++++RD K +N+ + K+ D GL + +H
Sbjct: 112 FVQL----CSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH- 164
Query: 260 TTRVMGTYGYAAPEYV 275
++GT Y +PE +
Sbjct: 165 --SLVGTPYYMSPERI 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 36/200 (18%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ----- 143
+ ++ + +GEG +G+V+K + L K G G VA+K++ +Q EE
Sbjct: 1 QQYECVAEIGEGAYGKVFKA----RDL---KNG-GRFVALKRVR---VQTGEEGMPLSTI 49
Query: 144 SEVNFLGRLS---HPNLVKLLGYCW---EDKE--LLLVYEYMQRGSLENHLFRR-NPSIQ 194
EV L L HPN+V+L C D+E L LV+E++ + L +L + P +
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108
Query: 195 PLSW-DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253
+ D+ ++ RGL FLH+ +V++RD K NIL+ + K++DFGLA++
Sbjct: 109 TETIKDMMFQLL----RGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 162
Query: 254 GGESHVTTRVMGTYGYAAPE 273
T V+ T Y APE
Sbjct: 163 ---QMALTSVVVTLWYRAPE 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 60/187 (32%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGR 151
+LG+G FG+V + + G + AIK L + + E E L
Sbjct: 6 MVLGKGSFGKV---------MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
P + L C++ + L V EY+ G L H+ + +P + +IAIG
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG--- 113
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTYGY 269
L FLH+ K +IYRD K N++LD + KI+DFG+ K GG TTR GT Y
Sbjct: 114 -LFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPDY 167
Query: 270 AAPEYVA 276
APE +A
Sbjct: 168 IAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 61/184 (33%), Positives = 81/184 (44%), Gaps = 26/184 (14%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
LLG+G FG+V L K G A+K L E + +E +E L
Sbjct: 2 LLGKGTFGKV--------ILVREKAT-GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA--A 209
HP L L Y ++ + L V EY G L HL R + R + GA
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARF-YGAEIV 105
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGY 269
LG+LH V+YRD K N++LD + + KI+DFGL K G + G + GT Y
Sbjct: 106 SALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 161
Query: 270 AAPE 273
APE
Sbjct: 162 LAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 64/201 (31%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN--- 147
F+ ++LG G FG+V LA K G + AIK L + +E +S +
Sbjct: 1 FRCLAVLGRGHFGKV--------LLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 148 -FL--GRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRR---NPSIQPLSWDI 200
F HP LV L C++ ++ + V EY G L H+ P + +
Sbjct: 52 IFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACV 110
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
L GL +LH E K++YRD K N+LLD KI+DFGL K G G+ T
Sbjct: 111 VL--------GLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--T 158
Query: 261 TRVMGTYGYAAPEYVATGNFY 281
+ GT + APE V T Y
Sbjct: 159 STFCGTPEFLAPE-VLTETSY 178
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-13
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 21/190 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V+ G + T VA+K L P +M E + E + +L H
Sbjct: 14 LGNGQFGEVWMGTWNGNT----------KVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDK 62
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LV+L E + + +V EYM +GSL + F ++ + L + +A A G+ ++
Sbjct: 63 LVQLYAVVSE-EPIYIVTEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY--GYAAPEY 274
I+RD +++NIL+ KI+DFGLA+L ++ T R + + APE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEA 174
Query: 275 VATGNFYLLS 284
G F + S
Sbjct: 175 ALYGRFTIKS 184
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 19/180 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
+G+G FG VYKG +D++T VVAIK ++ E + E+ Q E+ L + P
Sbjct: 12 IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+ + G + +L ++ EY+ GS + L P PL I +GL +L
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYL 117
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV 275
H SE+K I+RD KA+N+LL + K++DFG+A G +GT + APE +
Sbjct: 118 H-SERK-IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-13
Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 13/160 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
LG+G FG VY+G +T VAIK +N SM+ E+ +E + + +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETR----VAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
++V+LLG + + L++ E M RG L+++L NP P S +++A A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
G+ +L+ + K ++RD A N ++ ++ KI DFG+ +
Sbjct: 130 DGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-13
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 36/195 (18%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFE-EWQSEVNFLGRL 152
+GEG +G+VYK D T G +VA+KK+ ++ +GF E+ L +L
Sbjct: 13 GQIGEGTYGQVYKA-RDKDT--------GELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 153 SHPNLVKLLGYCWEDKELL----------LVYEYMQR---GSLENHLFRRNPS-IQPLSW 198
+H N+V L + ++ L LV+EYM G LE+ L + I+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH 258
+ GL + H +K ++RD K SNILL+ K++DFGLA+L +
Sbjct: 124 QL--------LEGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 259 VTTRVMGTYGYAAPE 273
T +V+ T Y PE
Sbjct: 174 YTNKVI-TLWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-13
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 21/194 (10%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSEV 146
N++ LLG+G FGRVY + D TG + + +PES + +E + E+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD-------TGRELAAKQVQFDPESPETSKEVSALECEI 55
Query: 147 NFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
L L H +V+ G C D K L + EYM GS+++ L + L+ + K
Sbjct: 56 QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRK 110
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR- 262
G+ +LH++ +++RD K +NIL D N K+ DFG +K S R
Sbjct: 111 YTRQILEGMSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 263 VMGTYGYAAPEYVA 276
V GT + +PE ++
Sbjct: 169 VTGTPYWMSPEVIS 182
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-13
Identities = 59/192 (30%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG+G FG V+ G + T VAIK L P +M E + E + +L H
Sbjct: 14 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 62
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ--PLSWDIRLKIAIGAARGLGF 214
LV+L E+ + +V EYM +GSL + L P D+ +IA G A
Sbjct: 63 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA----- 116
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY--GYAAP 272
+ ++RD +A+NIL+ N K++DFGLA+L ++ T R + + AP
Sbjct: 117 -YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAP 172
Query: 273 EYVATGNFYLLS 284
E G F + S
Sbjct: 173 EAALYGRFTIKS 184
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 26/140 (18%)
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
E+ L ++HPN+VK + E+ ++ E+M GSLE + ++ I
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI---- 177
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
G+ +LH + +++RD K SN+L++ N KI+DFG+ S + + M
Sbjct: 178 ----LSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGV---------SRILAQTM 222
Query: 265 -------GTYGYAAPEYVAT 277
GT Y +PE + T
Sbjct: 223 DPCNSSVGTIAYMSPERINT 242
|
Length = 353 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 20/193 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRLSHP 155
LG G FG V KG + + VAIK L E+ + +E E + +L +P
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+V+++G C E + L+LV E G L L + I +S + L + +G
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEI-TVSNVVELMHQVS----MGMK 109
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY--GYAAPE 273
+ K ++RD A N+LL + AKISDFGL+K +S+ R G + + APE
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPE 168
Query: 274 YVATGNFYLLSAK 286
+ NF S++
Sbjct: 169 CI---NFRKFSSR 178
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
++ + D LG+G FG V+ G + T VAIK L P +M E + E
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTT----------KVAIKTLKPGTMMP-EAFLQEAQI 54
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ +L H LV L E+ + +V E+M +GSL + F + + L + +A
Sbjct: 55 MKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQI 111
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY- 267
A G+ ++ I+RD +A+NIL+ N KI+DFGLA+L ++ T R +
Sbjct: 112 ADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFP 166
Query: 268 -GYAAPEYVATGNFYLLS 284
+ APE G F + S
Sbjct: 167 IKWTAPEAALYGRFTIKS 184
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVN 147
F+ +LG+GGFG V A G + A KKL + ++ G +E
Sbjct: 2 FRQYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L +++ +V L Y +E K+ L LV M G L+ H++ + ++ +
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA----GFEEGRAVFY 107
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
A G +++++YRD K NILLD + + +ISD GLA P G + RV GT
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GT 164
Query: 267 YGYAAPEYV 275
GY APE V
Sbjct: 165 VGYMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 62/190 (32%), Positives = 88/190 (46%), Gaps = 23/190 (12%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVN 147
F+ +LG+GGFG V A G + A KKL + ++ G +E
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRR-NPSIQPLSWDIRLKIA 205
L +++ +V L Y +E K+ L LV M G L+ H++ NP +D + I
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FDEQRAIF 106
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
A G ++++YRD K NILLD + +ISD GLA P G V RV G
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRV-G 163
Query: 266 TYGYAAPEYV 275
T GY APE +
Sbjct: 164 TVGYMAPEVI 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 23/184 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP-ESMQGFEEWQSEVNFLGRLSHP 155
LG+G FG VY D K +A + + + + +LNP E++Q +E Q L +L HP
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHP 62
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRN----PSIQPLSWDIRLKIAIGAA 209
+VK E ++ EY + L+ L + Q W I+L +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGY 269
G+ ++H ++++++RD KA NI L N KI DFG+++L G + T GT Y
Sbjct: 118 -GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYY 171
Query: 270 AAPE 273
+PE
Sbjct: 172 MSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 22/161 (13%)
Query: 96 LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLS 153
+LG G FG VYKG W P + + VAIK L S + +E E + +
Sbjct: 14 VLGSGAFGTVYKGIW------IPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP----SIQPLSWDIRLKIAIGAA 209
P + +LLG C + LV + M G L +++ R N S L+W +++ A
Sbjct: 68 SPYVCRLLGICLTST-VQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQI------A 119
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+G+ +L E ++++RD A N+L+ + KI+DFGLA+L
Sbjct: 120 KGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 59/195 (30%), Positives = 87/195 (44%), Gaps = 53/195 (27%)
Query: 99 EGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFE-EWQSEVNFLGRLSHPN 156
EG +G VY+ D KT G +VA+KKL E +GF E+N L +L HPN
Sbjct: 15 EGTYGVVYRA-RDKKT--------GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 157 LVKLLGYCWEDKELL---------LVYEYMQ---RGSLENHLFRRNPS------IQPLSW 198
+V + KE++ +V EY++ + +E S +Q LS
Sbjct: 66 IVTV-------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS- 117
Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH 258
G+ LH + +++RD K SN+LL+ KI DFGLA+ G
Sbjct: 118 ------------GVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLK 161
Query: 259 VTTRVMGTYGYAAPE 273
T+++ T Y APE
Sbjct: 162 PYTQLVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 24/197 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTG--LGMVVAIKKLNPESM----QGFEEWQ 143
NF+ +LG G +G+V+ L G G + A+K L ++ + E +
Sbjct: 1 NFELLRVLGTGAYGKVF--------LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR 52
Query: 144 SEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
+E L + P LV L D +L L+ +Y+ G L HL++R + ++R+
Sbjct: 53 TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRV 109
Query: 203 KIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
IA I A L LH + +IYRD K NILLD + ++DFGL+K A E
Sbjct: 110 YIAEIVLA--LDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA-EEEERAY 164
Query: 262 RVMGTYGYAAPEYVATG 278
GT Y APE + G
Sbjct: 165 SFCGTIEYMAPEVIRGG 181
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGR 151
+GEG FG VY+G + S + VA+K + E++ E + +
Sbjct: 10 LGRCIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
HP++VKL+G + + +V E G L ++L S+ S + + +
Sbjct: 64 FDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASL---ILYSYQLSTA 119
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
L +L + K+ ++RD A N+L+ K+ DFGL++
Sbjct: 120 LAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 55/183 (30%), Positives = 82/183 (44%), Gaps = 24/183 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVNFLGRLSH 154
++GEG FGR L A+K++ P+S E+ + E L ++ H
Sbjct: 7 VVGEGSFGR---------ALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP----LSWDIRLKIAIGAAR 210
PN+V D L +V EY G L + + + P L W +++
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM-------- 109
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
LG H EK+V++RD K+ NI L N K+ DFG A+L + G ++ T V GT Y
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYACTYV-GTPYYV 167
Query: 271 APE 273
PE
Sbjct: 168 PPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 62/184 (33%), Positives = 88/184 (47%), Gaps = 25/184 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGR 151
++G+G FG+V LA K+ G A+K L +++ +E +E N L
Sbjct: 2 VIGKGSFGKVL--------LAKRKSD-GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI-AIGAA 209
L HP LV L Y ++ E L V +Y+ G L HL R ++P R + A A
Sbjct: 53 LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVA 106
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGY 269
+G+LH+ +IYRD K NILLD + ++DFGL K G T+ GT Y
Sbjct: 107 SAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCGTPEY 162
Query: 270 AAPE 273
APE
Sbjct: 163 LAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 27/191 (14%)
Query: 97 LGEGGFGRVYKGWVD-DKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+G G FG V+ G + D T K+ + L P+ F + E L + SHP
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKS------CRETLPPDLKAKFLQ---EARILKQYSHP 53
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+V+L+G C + + + +V E +Q G L P L +++ AA G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYL 110
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK------LGPAGGESHVTTRVMGTYGY 269
+ K I+RD A N L+ KISDFG+++ GG + + +
Sbjct: 111 ES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK------W 162
Query: 270 AAPEYVATGNF 280
APE + G +
Sbjct: 163 TAPEALNYGRY 173
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 53/205 (25%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EV 146
F+ + +GEG +G VY+ D + G +VA+KK+ ++ + S E+
Sbjct: 7 TEFEKLNRIGEGTYGIVYRA-RDTTS--------GEIVALKKVRMDNERDGIPISSLREI 57
Query: 147 NFLGRLSHPNLVKLL---------------GYCWEDKELLLVYEYMQRGSLENHLFRRNP 191
L L HPN+V+L YC +D LL + M
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT------------ 103
Query: 192 SIQPLSWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
P S + ++K + + RGL +LH E +I+RD K SN+LL KI+DFGLA+
Sbjct: 104 ---PFS-ESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157
Query: 251 --GPAGGESHVTTRVMGTYGYAAPE 273
PA +T +V+ T Y APE
Sbjct: 158 YGLPAK---PMTPKVV-TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-12
Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 41/167 (24%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
+GEG +G V+K + +T +VA+K++ + E S E+ L L
Sbjct: 8 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDD--EGVPSSALREICLLKEL 56
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQ----------RGSLENHLFRRNPSIQPLSWDIRL 202
H N+V+L DK+L LV+EY G ++ + + S+ +L
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK--------SFMFQL 108
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+GL F H V++RD K N+L++ N K++DFGLA+
Sbjct: 109 ------LKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 60/185 (32%), Positives = 87/185 (47%), Gaps = 23/185 (12%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGR 151
++G+G FG+V LA K G A+K L + + +E + +E N L
Sbjct: 2 VIGKGSFGKVL--------LAKRKLD-GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA-AR 210
+ HP LV L ++L V +++ G L HL R +P R + A
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIAS 107
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
LG+LH+ ++YRD K NILLD + ++DFGL K G A +S TT GT Y
Sbjct: 108 ALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYL 163
Query: 271 APEYV 275
APE +
Sbjct: 164 APEVI 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 46/203 (22%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
+KP +G G +G V +D ++ G VAIKK+ F+
Sbjct: 6 RYKPIENIGSGAYGVVCSA-IDTRS--------GKKVAIKKIP----HAFDVPTLAKRTL 52
Query: 145 -EVNFLGRLSHPNLVKLLGYCW----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
E+ L H N++ + + K++ +V + M E+ L S QPL+ +
Sbjct: 53 RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEE 107
Query: 200 -IR------LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252
IR L RGL ++H++ VI+RD K SN+L++ + +I DFG+A+
Sbjct: 108 HIRYFLYQLL-------RGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158
Query: 253 AGGESH--VTTRVMGTYGYAAPE 273
+ H T + T Y APE
Sbjct: 159 SSPTEHKYFMTEYVATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS 153
+LG+G FG V + + S+ G VA+K L + S EE+ E +
Sbjct: 6 MLGKGEFGSVREAQLK------SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 154 HPNLVKLLGYCWEDKEL------LLVYEYMQRGSLENHLFRRNPSIQP--LSWDIRLKIA 205
HPN++KL+G + +++ +M+ G L L +P L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
I A G+ +L S K I+RD A N +L+ N ++DFGL+K
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSEV 146
N++ LLG G FG VY + D TG + V +P+S + +E + E+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDAD-------TGRELAVKQVPFDPDSQETSKEVNALECEI 55
Query: 147 NFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
L L H +V+ G C D K+L + EYM GS+++ L + L+ ++ +
Sbjct: 56 QLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRR 110
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+G+ +LH++ +++RD K +NIL D N K+ DFG +K
Sbjct: 111 YTRQILQGVSYLHSN--MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 61/183 (33%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLG-R 151
+LG+G FG+V + G V AIK L + + + +E L
Sbjct: 2 VLGKGSFGKV---------MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
HP L L C++ K+ L V EY+ G L + R +P S R A
Sbjct: 53 AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS---RF-YAAEVTL 107
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
L FLH VIYRD K NILLD + K++DFG+ K G G TT GT Y
Sbjct: 108 ALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYI 163
Query: 271 APE 273
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 27/193 (13%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFE-EWQSEVNF 148
++P + +G G +G VYK G VA+K + + G EV
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHS---------GHFVALKSVRVQTNEDGLPLSTVREVAL 52
Query: 149 LGRLS---HPNLVKLLGYCWE---DKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
L RL HPN+V+L+ C D+E + LV+E++ + L +L + P P I
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE-TI 110
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ + RGL FLH + +++RD K NIL+ K++DFGLA++
Sbjct: 111 K-DLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMAL 164
Query: 261 TRVMGTYGYAAPE 273
T V+ T Y APE
Sbjct: 165 TPVVVTLWYRAPE 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 60/191 (31%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVN 147
F+ +LG+GGFG V A G + A K+L + ++ G +E
Sbjct: 2 FRQYRVLGKGGFGEV---------CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRR-NPSIQPLSWDIRLKIA 205
L +++ +V L Y +E K+ L LV M G L+ H++ NP + +
Sbjct: 53 ILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE------EERAL 105
Query: 206 IGAARGL-GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
AA L G + +YRD K NILLD + +ISD GLA P G + RV
Sbjct: 106 FYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV- 162
Query: 265 GTYGYAAPEYV 275
GT GY APE +
Sbjct: 163 GTVGYMAPEVL 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 25/183 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE--EWQSEVNFLGRLSH 154
+GEG FG+ L SK G IK++N M E E + EV L + H
Sbjct: 8 IGEGSFGKAI--------LVKSKED-GKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN----PSIQPLSWDIRLKIAIGAAR 210
PN+V+ E+ L +V +Y + G L + + P Q L W +++ +A+
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--- 115
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
H ++K+++RD K+ NI L + K+ DFG+A++ + E T +GT Y
Sbjct: 116 -----HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYL 168
Query: 271 APE 273
+PE
Sbjct: 169 SPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 26/196 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQSEVNFLGRL 152
LG G FG V KG K KT VA+K L N +++ +E E N + +L
Sbjct: 3 LGSGNFGTVKKGMY--KMKKSEKT-----VAVKILKNDNNDPALK--DELLREANVMQQL 53
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
+P +V+++G C E + +LV E + G L N ++N + + + +
Sbjct: 54 DNPYIVRMIGIC-EAESWMLVMELAELGPL-NKFLQKNKHVT-----EKNITELVHQVSM 106
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY--GYA 270
G + E ++RD A N+LL + AKISDFGL+K E++ + G + +
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWY 165
Query: 271 APEYVATGNFYLLSAK 286
APE + N+Y S+K
Sbjct: 166 APECM---NYYKFSSK 178
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 31/187 (16%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLG-R 151
+LG+G FG+V LA K G + A+K L + + E +E L
Sbjct: 2 VLGKGSFGKV--------MLARLKES-GRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHL--FRR--NPSIQPLSWDIRLKIAI 206
+HP L +L C++ + L V E++ G L H+ RR + + +I
Sbjct: 53 RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI------ 105
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
L FLH +K +IYRD K N+LLD + K++DFG+ K G G++ T+ GT
Sbjct: 106 --TSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGT 159
Query: 267 YGYAAPE 273
Y APE
Sbjct: 160 PDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 60/194 (30%), Positives = 88/194 (45%), Gaps = 25/194 (12%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
F+ ++G G +G+VYKG G + AIK ++ + EE + E+N L
Sbjct: 18 FELVEVVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLK 67
Query: 151 RLSH-PNLVKLLGY------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
+ SH N+ G D +L LV E+ GS+ + + +N L D
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAY 125
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHVTTR 262
I RGL LH KVI+RD K N+LL N K+ DFG+ A+L G +
Sbjct: 126 ICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--- 180
Query: 263 VMGTYGYAAPEYVA 276
+GT + APE +A
Sbjct: 181 FIGTPYWMAPEVIA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 32/186 (17%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+G+G G VY G VAIK++N + E +E+ + HPN
Sbjct: 27 IGQGASGTVYTA---------IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA------R 210
+V L EL +V EY+ GSL + + + + AA +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQ 126
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHVTTRVMGTYGY 269
L FLH+++ VI+RD K+ NILL + + K++DFG A++ P E + ++GT +
Sbjct: 127 ALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYW 181
Query: 270 AAPEYV 275
APE V
Sbjct: 182 MAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 24/193 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---S 144
NF+ + +G G F VY+ +D K VA+KK+ M + Q
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKP-----------VALKKVQIFEMMDAKARQDCVK 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRL 202
E++ L +L+HPN++K L ED EL +V E G L + F++ + P +
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR 262
+ + +A H ++V++RD K +N+ + K+ D GL + + ++
Sbjct: 112 FVQLCSA----VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHS 165
Query: 263 VMGTYGYAAPEYV 275
++GT Y +PE +
Sbjct: 166 LVGTPYYMSPERI 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 44/123 (35%), Positives = 62/123 (50%), Gaps = 12/123 (9%)
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAAR 210
S+P LV L L LV EY+ G L H+ R+ P + + IA
Sbjct: 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----- 108
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
L FLH E+ +IYRD K N+LLD + + K++D+G+ K G G++ T+ GT Y
Sbjct: 109 -LNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYI 163
Query: 271 APE 273
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 26/172 (15%)
Query: 69 QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVA- 127
Q ++ K + D+ S+ K ++++ G G YKG K G+ VV
Sbjct: 673 QFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKG-------KSIKNGMQFVVKE 722
Query: 128 IKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
I +N SE+ +G+L HPN+VKL+G C +K L++EY++ +L L
Sbjct: 723 INDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL- 774
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-EKKVIYRDFKASNILLDGNY 238
RN LSW+ R KIAIG A+ L FLH V+ + I++DG
Sbjct: 775 -RN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820
|
Length = 968 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW 142
L T ++ +G+G +G+VYK V +K G + A+K L+P S EE
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYK--VTNKKD-------GSLAAVKILDPISDVD-EEI 65
Query: 143 QSEVNFLGRLS-HPNLVKLLGYCWE-DK----ELLLVYEYMQRGS---LENHLFRRNPSI 193
++E N L L HPN+VK G ++ DK +L LV E GS L L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG--- 122
Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGP 252
Q L + I GA GL LH + ++I+RD K +NILL K+ DFG+ A+L
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNN--RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 253 AGGESHVTTRVMGTYGYAAPEYVATGNFY 281
+ + +GT + APE +A Y
Sbjct: 181 TRLRRNTS---VGTPFWMAPEVIACEQQY 206
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-11
Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 39/196 (19%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+LG+G +G VY + L+ +AIK++ + + E+ L H
Sbjct: 15 VLGKGTYGIVYAA----RDLSTQVR-----IAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL-------FRRNPSIQPLSWDIRLKIAIGA 208
N+V+ LG E+ + E + GSL L +I + I
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI-------- 117
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNA--KISDFG----LAKLGPAGGESHVTTR 262
GL +LH + ++++RD K N+L++ Y+ KISDFG LA + P T
Sbjct: 118 LEGLKYLH--DNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP------CTET 168
Query: 263 VMGTYGYAAPEYVATG 278
GT Y APE + G
Sbjct: 169 FTGTLQYMAPEVIDKG 184
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 61/186 (32%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL 152
+LG+G FG+V LA K G + AIK L + + E E L
Sbjct: 7 VLGKGSFGKV--------MLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
P + L C++ + L V EY+ G L + + +P + +IAIG
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTYGYA 270
L FLH+ K +IYRD K N++LD + KI+DFG+ K G VTT+ GT Y
Sbjct: 114 LFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYI 168
Query: 271 APEYVA 276
APE +A
Sbjct: 169 APEIIA 174
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 5e-11
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 25/201 (12%)
Query: 84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ 143
L+ F+ L+G G +G+VYKG G + AIK ++ + EE +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTGDEE-EEIK 50
Query: 144 SEVNFLGRLSH-PNLVKLLGYCWE------DKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
E+N L + SH N+ G + D +L LV E+ GS+ + + +N L
Sbjct: 51 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTL 108
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGG 255
+ I RGL LH + KVI+RD K N+LL N K+ DFG+ A+L G
Sbjct: 109 KEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 166
Query: 256 ESHVTTRVMGTYGYAAPEYVA 276
+ +GT + APE +A
Sbjct: 167 RRNT---FIGTPYWMAPEVIA 184
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 60/188 (31%), Positives = 80/188 (42%), Gaps = 19/188 (10%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
LLG+G FG+V + + G A+K L E + +E +E L
Sbjct: 2 LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
HP L L L V EY G L HL R + S D L
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSAL 108
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
+LH SEK V+YRD K N++LD + + KI+DFGL K G G + T GT Y AP
Sbjct: 109 DYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 165
Query: 273 EYVATGNF 280
E + ++
Sbjct: 166 EVLEDNDY 173
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE 141
L ++ ++F+ +G G +G VYK G + AIK + E + F
Sbjct: 2 LSRRNPQEDFELIQRIGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAV 52
Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLEN--HLFRRNPSIQPLSWD 199
Q E+ + H N+V G +L + E+ GSL++ H+ PLS
Sbjct: 53 VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV------TGPLSES 106
Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259
++ +GL +LH+ K ++RD K +NILL N + K++DFG++ A + +
Sbjct: 107 QIAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVS----AQITATI 160
Query: 260 TTR--VMGTYGYAAPEYVA 276
R +GT + APE A
Sbjct: 161 AKRKSFIGTPYWMAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 31/187 (16%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+G G +G VYK G + A+K + E F Q E+ + H N
Sbjct: 17 VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLEN--HLFRRNPSIQPLSWDIRLKIAI---GAARG 211
+V G ++L + EY GSL++ H+ PLS L+IA +G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHV------TGPLS---ELQIAYVCRETLQG 118
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR--VMGTYGY 269
L +LH+ K ++RD K +NILL N + K++DFG+A A + + R +GT +
Sbjct: 119 LAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVA----AKITATIAKRKSFIGTPYW 172
Query: 270 AAPEYVA 276
APE A
Sbjct: 173 MAPEVAA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 6e-11
Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 77 KVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM 136
K+ + + + K + +G+G G V+ G VAIK++N +
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTA---------IDVATGQEVAIKQINLQKQ 57
Query: 137 QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
E +E+ + L +PN+V L EL +V EY+ GSL + + +
Sbjct: 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGG 255
+ R + L FLH ++ VI+RD K+ N+LL + + K++DFG A++ P
Sbjct: 118 AAVCR-----ECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--- 167
Query: 256 ESHVTTRVMGTYGYAAPEYV 275
E + ++GT + APE V
Sbjct: 168 EQSKRSTMVGTPYWMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 67/206 (32%), Positives = 94/206 (45%), Gaps = 38/206 (18%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-- 153
+LG+G FG+V+ LA K G AIK L + + ++ + + LS
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 154 --HPNLVKLLGYC-WEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
HP L L YC ++ KE L V EY+ G L H+ + P + +I G
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK---LGPAGGESHVTTRVMGT 266
L FLH+ K ++YRD K NILLD + + KI+DFG+ K LG A T GT
Sbjct: 109 --LQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-----TCTFCGT 159
Query: 267 YGYAAPEYVATGNFYLLSAKFGNVIN 292
Y APE LL K+ ++
Sbjct: 160 PDYIAPE-------ILLGQKYNTSVD 178
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 46/160 (28%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
LG+G FG VY+G D ++T VA+K +N S++ E+ +E + + +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETR----VAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
++V+LLG + + L+V E M G L+++L NP P + +++A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
G+ +L+ KK ++RD A N ++ ++ KI DFG+ +
Sbjct: 130 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 22/189 (11%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
LLG+G FG+V + + G A+K L E + +E +E L
Sbjct: 2 LLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
HP L L Y ++ + L V EY G L HL R + + +
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSA 107
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
L +LH+ + V+YRD K N++LD + + KI+DFGL K G + G + T GT Y A
Sbjct: 108 LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163
Query: 272 PEYVATGNF 280
PE + ++
Sbjct: 164 PEVLEDNDY 172
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 21/188 (11%)
Query: 90 NFKPDSLLGEGGFGR--VYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSE 145
++ P +LG+G FG +Y+ +T +V K++N + + + +E
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-----------RTEDDSLVVWKEVNLTRLSEKERRDALNE 49
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
+ L L HPN++ + +D LL+ EY G+L + + R+ + +
Sbjct: 50 IVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ 109
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
I +A + ++H + +++RD K NI L K+ DFG++K+ G E + V+G
Sbjct: 110 IVSA--VSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVG 163
Query: 266 TYGYAAPE 273
T Y +PE
Sbjct: 164 TPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 54/177 (30%), Positives = 75/177 (42%), Gaps = 30/177 (16%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-----EWQ 143
K+FK LLG+G GRV+ V K G G + A+K L+ + M +
Sbjct: 1 KHFKKIKLLGKGDVGRVF--LVRLK-------GTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP----SIQPLSWD 199
E+ L L HP L L + L LV +Y G L L +R P S +
Sbjct: 52 QEI--LATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEE----V 104
Query: 200 IRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG 255
R A + A L +LH ++YRD K NILL + + +SDF L+K
Sbjct: 105 ARFYAAEVLLA--LEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 14/137 (10%)
Query: 141 EW-QSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN--PSIQPL 196
+W Q+E + + S HP LV L + L V EY+ G L H+ R+ P
Sbjct: 40 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR 99
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
+ + +A L +LH E+ +IYRD K N+LLD + K++D+G+ K G G+
Sbjct: 100 FYSAEISLA------LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151
Query: 257 SHVTTRVMGTYGYAAPE 273
+ T+ GT Y APE
Sbjct: 152 T--TSTFCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 23/203 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEW-QSEVNFLGRLS 153
LG GGFGRV V K A+K + + G +E SE L +
Sbjct: 1 LGVGGFGRVEL--VKVK-------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN 51
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
HP +VKL + K + ++ EY G L L R + R IA
Sbjct: 52 HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIA-CVVLAFE 107
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+LH + +IYRD K N+LLD N K+ DFG AK +G ++ GT Y APE
Sbjct: 108 YLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPE 162
Query: 274 YVATGNFYLLSAKFGNVINVCMY 296
+ Y S + ++ + +Y
Sbjct: 163 -IILNKGYDFSVDYWSL-GILLY 183
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 57/195 (29%), Positives = 82/195 (42%), Gaps = 46/195 (23%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---------E 145
S +G G +G+V T G VAIKKL+ +QS E
Sbjct: 21 SPVGSGAYGQVCSA---------FDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRE 64
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKEL------LLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
+ L + H N++ LL L LV M L N++ + Q LS D
Sbjct: 65 LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DL-NNIVKC----QKLSDD 118
Query: 200 -IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH 258
I+ + RGL ++H++ +I+RD K SNI ++ + KI DFGLA+ +
Sbjct: 119 HIQF-LVYQILRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175
Query: 259 VTTRVMGTYGYAAPE 273
V TR Y APE
Sbjct: 176 VATR-----WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 27/167 (16%)
Query: 96 LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----SEVNFL 149
LL EG FGR++ G +D+K P K V +K E Q E L
Sbjct: 13 LLQEGTFGRIFYGILIDEK---PGKEEEVFVKTVK-------DHASEIQVTLLLQESCLL 62
Query: 150 GRLSHPNLVKLLGYCWEDKELLLV-YEYMQRGSLENHLFRRNPSIQPLSWDIRLK----- 203
LSH N++ +L C ED E V Y YM G+L+ LF + + + L
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLV 120
Query: 204 -IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+AI A G+ +LH ++ VI++D A N ++D KI+D L++
Sbjct: 121 HMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 41/123 (33%), Positives = 61/123 (49%), Gaps = 12/123 (9%)
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF--RRNPSIQPLSWDIRLKIAIGAAR 210
+HP LV L + L V E++ G L H+ R+ P + + +A
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----- 108
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
L FLH E+ +IYRD K N+LLD + K++D+G+ K G G++ T+ GT Y
Sbjct: 109 -LNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYI 163
Query: 271 APE 273
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 24/166 (14%)
Query: 123 GMVVAIKKL-NPESMQGF-EEWQSEVNFLGRLSHPNLVKLLG-YCWEDKELLLVYEYMQR 179
G VAIKK+ P S + E+ L L H N++ L + +++ V E +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-- 92
Query: 180 GSLENHLFRRNPS----IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235
G+ + L P IQ + I RGL ++H++ V++RD K SNIL++
Sbjct: 93 GTDLHRLLTSRPLEKQFIQYFLYQI--------LRGLKYVHSA--GVVHRDLKPSNILIN 142
Query: 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
N + KI DFGLA++ + +T V Y Y APE + T Y
Sbjct: 143 ENCDLKICDFGLARI----QDPQMTGYVSTRY-YRAPEIMLTWQKY 183
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 49/155 (31%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVNFLGRLSH 154
LGEG + VYKG SK G +VA+K +L E F + E + L L H
Sbjct: 13 LGEGSYATVYKGR--------SKL-TGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKH 62
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
N+V L K L LV+EY+ L+ ++ + ++RL RGL +
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH--NVRL-FLFQLLRGLAY 118
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
H +++V++RD K N+L+ K++DFGLA+
Sbjct: 119 CH--QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 58/189 (30%), Positives = 84/189 (44%), Gaps = 22/189 (11%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRL 152
LLG+G FG+V + + G A+K L E + +E +E L
Sbjct: 2 LLGKGTFGKV---------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
HP L L Y ++ K+ L V EY+ G L HL R + S D
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSA 107
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
L +LH+ K++YRD K N++LD + + KI+DFGL K G + T GT Y A
Sbjct: 108 LDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLA 163
Query: 272 PEYVATGNF 280
PE + ++
Sbjct: 164 PEVLEDNDY 172
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 37/194 (19%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKK--LNPESMQGFE-EWQSEVNFLGRLS 153
+G+G FG V+K K KT +VA+KK + E +GF E+ L L
Sbjct: 20 IGQGTFGEVFK--ARHK-----KTK--QIVALKKVLMENEK-EGFPITALREIKILQLLK 69
Query: 154 HPNLVKLLGYCWEDK--------ELLLVYEYMQR---GSLENHLFRRNPSIQPLSWDIRL 202
H N+V L+ C LV+E+ + G L N + S +I+
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS------EIK- 122
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK---LGPAGGESHV 259
K+ GL ++H + K+++RD KA+NIL+ + K++DFGLA+ L +
Sbjct: 123 KVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 260 TTRVMGTYGYAAPE 273
T RV+ T Y PE
Sbjct: 181 TNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 43/198 (21%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQSEVNFLGR 151
+G G FG V K PS T ++A+K++ + + + +++ + R
Sbjct: 11 EIGRGAFGTVNKML-----HKPSGT----IMAVKRIRSTVDEKEQKRL---LMDLDVVMR 58
Query: 152 LSH-PNLVKLLGY------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQP--LSWDIRL 202
S P +VK G CW EL+ + SL+ ++ + + +I
Sbjct: 59 SSDCPYIVKFYGALFREGDCWICMELMDI-------SLDK-FYKYVYEVLKSVIPEEILG 110
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG---ESHV 259
KIA+ + L +L E K+I+RD K SNILLD N N K+ DFG++ G +S
Sbjct: 111 KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGIS------GQLVDSIA 163
Query: 260 TTRVMGTYGYAAPEYVAT 277
TR G Y APE +
Sbjct: 164 KTRDAGCRPYMAPERIDP 181
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 20/184 (10%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTG--LGMVVAIKKLNPESMQGFEEWQS--EVNFLGR 151
+LG+G FG+V+ L TG G + A+K L +++ + ++ E + L
Sbjct: 3 VLGQGSFGKVF--------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE 54
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
++HP +VKL + +L L+ ++++ G L R + + D++ +A A
Sbjct: 55 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLA-ELALA 110
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
L LH+ +IYRD K NILLD + K++DFGL+K E GT Y A
Sbjct: 111 LDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKK-AYSFCGTVEYMA 166
Query: 272 PEYV 275
PE V
Sbjct: 167 PEVV 170
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 26/199 (13%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP--ESMQGFEEWQSEVNF 148
+K ++G+G +G V +D T G VAIKK+N E + E+
Sbjct: 2 YKIQEVIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 149 LGRLSHPNLVKLLGYCW-----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
L L HP++V++ E K++ +V+E M+ S + + + N + P L
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHHQFFLY 110
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT-TR 262
+ R L ++HT+ V +RD K NIL + + KI DFGLA++ + + T
Sbjct: 111 QLL---RALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 263 VMGTYGYAAPEYVATGNFY 281
+ T Y APE G+F+
Sbjct: 166 YVATRWYRAPELC--GSFF 182
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 49/183 (26%), Positives = 88/183 (48%), Gaps = 14/183 (7%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG+G +G VYK + TG+ M + +L + + F + E++ L + P
Sbjct: 9 LGKGNYGSVYK-------VLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPY 60
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
+V G + + + + EYM GSL+ L+ + + + D+ +I +GL FL
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL- 118
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA 276
E +I+RD K +N+L++GN K+ DFG++ + + +G Y APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIK 174
Query: 277 TGN 279
+G
Sbjct: 175 SGG 177
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVN 147
+F+ S LG G G V K V K PS G+++A K ++ E + E+
Sbjct: 5 DDFERISELGAGNGGVVTK--VQHK---PS----GLIMARKLIHLEIKPAIRNQIIRELQ 55
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIA 205
L + P +V G + D E+ + E+M GSL+ L +R P +I K++
Sbjct: 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE------EILGKVS 109
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA-KLGPAGGESHVTTRVM 264
I RGL +L + ++++RD K SNIL++ K+ DFG++ +L + S V TR
Sbjct: 110 IAVLRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-- 166
Query: 265 GTYGYAAPE 273
Y +PE
Sbjct: 167 ---SYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-10
Identities = 35/128 (27%), Positives = 66/128 (51%), Gaps = 13/128 (10%)
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
P +V G + + + E+M GSL+ ++++ P+ +I KIA+ GL +
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKK---GGPIPVEILGKIAVAVVEGLTY 118
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE--SHVTTRVMGTYGYAAP 272
L+ + ++++RD K SNIL++ K+ DFG++ GE + + +GT Y +P
Sbjct: 119 LY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS------GELINSIADTFVGTSTYMSP 171
Query: 273 EYVATGNF 280
E + G +
Sbjct: 172 ERIQGGKY 179
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 33/200 (16%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL 152
++G GGFG VY K G + A+K L+ + + QG +E L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 153 SHPN--LVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
S + + + Y + + L + + M G L HL + + ++R A
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---EMRF---YAAE 105
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA----KLGPAGGESHVTTRVMG 265
LG H + V+YRD K +NILLD + + +ISD GLA K P H + +G
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VG 157
Query: 266 TYGYAAPEYVATGNFYLLSA 285
T+GY APE + G Y SA
Sbjct: 158 THGYMAPEVLQKGVAYDSSA 177
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 22/192 (11%)
Query: 90 NFKPDSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SE 145
NF+ + +G G F VY+ + D G+ VA+KK+ + + E
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLD----------GVPVALKKVQIFDLMDAKARADCIKE 52
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLK 203
++ L +L+HPN++K ED EL +V E G L + F++ + P +
Sbjct: 53 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRV 263
+ + +A H ++V++RD K +N+ + K+ D GL + ++ +
Sbjct: 113 VQLCSA----LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSL 166
Query: 264 MGTYGYAAPEYV 275
+GT Y +PE +
Sbjct: 167 VGTPYYMSPERI 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 65/194 (33%), Positives = 84/194 (43%), Gaps = 45/194 (23%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR---- 151
+LG+G FG+V LA K G AIK L + + E+ E + R
Sbjct: 2 VLGKGSFGKVM--------LAELK-GTNEFFAIKALKKDVV--LEDDDVECTMVERRVLA 50
Query: 152 --LSHPNLVKLLGYC-WEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
HP L L +C ++ KE L V EY+ G L H IQ +
Sbjct: 51 LAWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFH-------IQS-----SGRFDEA 96
Query: 208 AAR--------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259
AR GL FLH K +IYRD K N+LLD + + KI+DFG+ K GE
Sbjct: 97 RARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN-MNGEGKA 153
Query: 260 TTRVMGTYGYAAPE 273
+T GT Y APE
Sbjct: 154 ST-FCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 53/187 (28%), Positives = 82/187 (43%), Gaps = 46/187 (24%)
Query: 126 VAIKKLNPESMQGFEEWQS------EVNFLGRLSHPNLVKLLGYCWED----------KE 169
VAIKK+ F+ E+ L L H N++ + +D +
Sbjct: 33 VAIKKIA----NAFDNRIDAKRTLREIKLLRHLDHENVIAI-----KDIMPPPHREAFND 83
Query: 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKA 229
+ +VYE M + L + S Q LS D RGL ++H++ V++RD K
Sbjct: 84 VYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKP 136
Query: 230 SNILLDGNYNAKISDFGLAKLGPAGGE---SHVTTRVMGTYGYAAPEYVATGNFYLLSAK 286
SN+LL+ N + KI DFGLA+ G+ +V TR Y APE + L ++
Sbjct: 137 SNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR-----WYRAPELL------LNCSE 185
Query: 287 FGNVINV 293
+ I+V
Sbjct: 186 YTTAIDV 192
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL 152
++G GGFG VY K G + A+K L+ + + QG +E L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 153 SH---PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
S P +V + +L + + M G L HL + + ++R
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK---EMRF---YATE 105
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGY 269
LG H + V+YRD K +NILLD + + +ISD GLA + + H + +GT+GY
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGY 161
Query: 270 AAPEYVATGNFYLLSAKF 287
APE + G Y SA +
Sbjct: 162 MAPEVLQKGTAYDSSADW 179
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 69 QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
+ILE K+ S + + K + +G+G G VY +D T G VAI
Sbjct: 3 EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTA-IDIAT--------GQEVAI 49
Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
K++N + E +E+ + +PN+V L EL +V EY+ GSL + +
Sbjct: 50 KQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 109
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL- 247
++ R + L FLH+++ VI+RD K+ NILL + + K++DFG
Sbjct: 110 TCMDEGQIAAVCR-----ECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 162
Query: 248 AKLGPAGGESHVTTRVMGTYGYAAPEYV 275
A++ P E + ++GT + APE V
Sbjct: 163 AQITP---EQSKRSTMVGTPYWMAPEVV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 39/128 (30%), Positives = 58/128 (45%), Gaps = 12/128 (9%)
Query: 123 GMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
+VA+KK+N + S + + Q E+ +L HPN++ + D EL +V M G
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAI---GAARGLGFLHTSEKKVIYRDFKASNILLDGN 237
S E+ L P P L IA L ++H K I+R KAS+ILL G+
Sbjct: 85 SCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGD 137
Query: 238 YNAKISDF 245
+S
Sbjct: 138 GKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 38/197 (19%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVN 147
+PD +G G FG V+ V D P G VA+KK+ P Q + E+
Sbjct: 2 VEPDRPIGYGAFGVVWS--VTD----PRD---GKRVALKKM-PNVFQNLVSCKRVFRELK 51
Query: 148 FLGRLSHPNLVKLLGY-------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD- 199
L H N++ L +E E+ +V E MQ + L + S QPLS D
Sbjct: 52 MLCFFKHDNVLSALDILQPPHIDPFE--EIYVVTELMQ-----SDLHKIIVSPQPLSSDH 104
Query: 200 IRL---KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
+++ +I RGL +LH++ +++RD K N+L++ N KI DFGLA++
Sbjct: 105 VKVFLYQIL----RGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158
Query: 257 SHVTTRVMGTYGYAAPE 273
H+T V+ Y Y APE
Sbjct: 159 KHMTQEVVTQY-YRAPE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 43/127 (33%), Positives = 62/127 (48%), Gaps = 16/127 (12%)
Query: 152 LSH--PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
SH P +VK GY D ++ + E M + + L +R P+ DI K+ +
Sbjct: 69 KSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKR--IQGPIPEDILGKMTVAIV 124
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG---ESHVTTRVMGT 266
+ L +L + VI+RD K SNILLD + N K+ DFG++ G +S TR G
Sbjct: 125 KALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGIS------GRLVDSKAKTRSAGC 177
Query: 267 YGYAAPE 273
Y APE
Sbjct: 178 AAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 55/183 (30%), Positives = 78/183 (42%), Gaps = 23/183 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVNFLGRLS 153
+G+G FG+VY+ K + A+K L+ + + +E E N L R
Sbjct: 1 IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51
Query: 154 H---PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
P +V L D +L LV +YM G L HL + + R K I A
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYI-AEL 105
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
L H + ++YRD K NILLD + + DFGL+K ++ T GT Y
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 271 APE 273
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 45/201 (22%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN- 147
K+F+ + +G+GG+G+V+ LA K G +VA+K++ + +EV
Sbjct: 1 KDFQILTQVGQGGYGQVF--------LA-KKKDTGEIVALKRMKKSLLF----KLNEVRH 47
Query: 148 ------FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWD- 199
L LVKLL Y ++D E L L EY+ G L LS D
Sbjct: 48 VLTERDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGV----LSEDH 102
Query: 200 -----IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
+ A+ A LG++H RD K N L+D + + K++DFGL+K
Sbjct: 103 ARFYMAEMFEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVTY 154
Query: 255 GESHVTTRVMGTYGYAAPEYV 275
S V+G+ Y APE +
Sbjct: 155 ANS-----VVGSPDYMAPEVL 170
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 16/140 (11%)
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRL 202
E+ L + P +V G + D E+ + E+M GSL+ L R P +I
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE------NILG 102
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA-KLGPAGGESHVTT 261
KI+I RGL +L + K+++RD K SNIL++ K+ DFG++ +L + S V T
Sbjct: 103 KISIAVLRGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT 161
Query: 262 RVMGTYGYAAPEYVATGNFY 281
R Y +PE + G Y
Sbjct: 162 R-----SYMSPERL-QGTHY 175
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 22/197 (11%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTG--LGMVVAIKKLNPESM----QGFEEWQ 143
NF+ +LG G +G+V+ L +G G + A+K L ++ + E +
Sbjct: 1 NFELLKVLGTGAYGKVF--------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR 52
Query: 144 SEVNFLGRLSHPNLVKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
+E L + + L Y ++ D +L L+ +Y+ G L HL +R + +
Sbjct: 53 TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EV 107
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR 262
+I G L H + +IYRD K NILLD N + ++DFGL+K E
Sbjct: 108 QIYSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYS 165
Query: 263 VMGTYGYAAPEYVATGN 279
GT Y AP+ V G+
Sbjct: 166 FCGTIEYMAPDIVRGGD 182
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 58/189 (30%), Positives = 84/189 (44%), Gaps = 26/189 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HP 155
+G+G +G+V+K V +K G A+K L+P EE ++E N L LS HP
Sbjct: 26 IGKGTYGKVFK--VLNKKN-------GSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 156 NLVKLLG-YCWEDK----ELLLVYEYMQRGS---LENHLFRRNPSIQPLSWDIRLKIAIG 207
N+VK G Y +D +L LV E GS L +R ++ L A+
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL- 134
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
+G H K I+RD K +NILL K+ DFG++ +GT
Sbjct: 135 ----MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTP 188
Query: 268 GYAAPEYVA 276
+ APE +A
Sbjct: 189 FWMAPEVIA 197
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 16/154 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLSHP 155
LGEG + VYKG SK +V A+K++ E +G EV+ L L H
Sbjct: 14 LGEGTYATVYKG--------RSKLTDNLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+V L +K L LV+EY+ + L+ +L SI + + L RGL +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL---FQLLRGLNYC 120
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
H +KV++RD K N+L++ K++DFGLA+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 9/155 (5%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
+G G FG+V G V+ P++ V +K+L S+Q ++ E L H
Sbjct: 3 IGNGWFGKVILGEVNSG-YTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
NL++ LG C E LLV E+ G L+ +L R + ++ D + LG L
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLL 114
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
H + I+ D N LL + KI D+GL+
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 58/184 (31%), Positives = 85/184 (46%), Gaps = 25/184 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEVN-FLGR 151
++G+G FG+V LA K A+K L +++ +E + SE N L
Sbjct: 2 VIGKGSFGKVL--------LARHKAE-EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 52
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
+ HP LV L +L V +Y+ G L HL R ++P + +IA
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SA 108
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK--LGPAGGESHVTTRVMGTYGY 269
LG+LH+ ++YRD K NILLD + ++DFGL K + G T+ GT Y
Sbjct: 109 LGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEY 162
Query: 270 AAPE 273
APE
Sbjct: 163 LAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 28/185 (15%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE--WQSEVNFLGRLSH 154
+G+G +G V +L +T G IKKLN + E + E L +L H
Sbjct: 8 VGKGSYGEV--------SLVRHRT-DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH 58
Query: 155 PNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRN----PSIQPLSWDIRLKIAIGA 208
PN+V WE D L +V + + G L + L + P Q + W +++ +A
Sbjct: 59 PNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA--- 114
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
L +LH EK +++RD K N+ L K+ D G+A++ + + + ++GT
Sbjct: 115 ---LQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 269 YAAPE 273
Y +PE
Sbjct: 168 YMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 27/179 (15%)
Query: 100 GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRLSHP 155
G FG VY LA ++ G AIK L M + + + + P
Sbjct: 7 GAFGSVY--------LAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP 57
Query: 156 NLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
+ KL Y ++ K+ L LV EY+ G + + ++ L D + G+
Sbjct: 58 YVAKLY-YSFQSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVED 112
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
LH ++ +I+RD K N+L+D + K++DFGL++ G + +GT Y APE
Sbjct: 113 LH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 3e-09
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 69 QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
+ILE K+ S + + K + +G+G G VY +D T G VAI
Sbjct: 4 EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAI 50
Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
+++N + E +E+ + +PN+V L EL +V EY+ GSL + +
Sbjct: 51 RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL- 247
++ R + L FLH+++ VI+RD K+ NILL + + K++DFG
Sbjct: 111 TCMDEGQIAAVCR-----ECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 248 AKLGPAGGESHVTTRVMGTYGYAAPEYV 275
A++ P E + ++GT + APE V
Sbjct: 164 AQITP---EQSKRSTMVGTPYWMAPEVV 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-09
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----NPESMQGFEEWQS 144
K+ K + +LG G FG + +G + PSK L VAI L + + +GF +
Sbjct: 5 KSIKIERILGTGRFGELCRGCLK----LPSKREL--PVAIHTLRAGCSDKQRRGF---LA 55
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
E LG+ H N+V+L G +++V EYM G+L++ L + L + +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGM 112
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
G A G+ +L SE +++ A +L++ + KIS F + T +
Sbjct: 113 LPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMS 167
Query: 265 GTYG--YAAPEYVATGNF 280
G +AAPE + +F
Sbjct: 168 GKSPVLWAAPEAIQYHHF 185
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 22/188 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G G VYK + ++ L + V + E + + SE+ L + P
Sbjct: 9 LGHGNGGTVYKAYH-----LLTRRILAVKVIPLDITVELQK---QIMSELEILYKCDSPY 60
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
++ G + + + + E+M GSL+ ++R+ P + +IA+ +GL +L
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLD--VYRKIPE------HVLGRIAVAVVKGLTYLW 112
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA 276
+ K+++RD K SN+L++ K+ DFG++ + + +GT Y APE ++
Sbjct: 113 SL--KILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERIS 166
Query: 277 TGNFYLLS 284
+ + S
Sbjct: 167 GEQYGIHS 174
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 16/154 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLSHP 155
LGEG + V+KG SK +V A+K++ E +G EV+ L L H
Sbjct: 14 LGEGTYATVFKG--------RSKLTENLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+V L DK L LV+EY+ + L+ ++ + + I L + RGL +
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYC 120
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
H +KV++RD K N+L++ K++DFGLA+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 59/187 (31%), Positives = 79/187 (42%), Gaps = 36/187 (19%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
LG G FGRV LA K VAIK+ + + + SE L ++
Sbjct: 38 LGTGSFGRV--------ILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG----AA 209
HP V L G ++ L LV E++ G L RRN R +G A
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNK---------RFPNDVGCFYAAQ 139
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR---VMGT 266
L F + ++YRD K N+LLD + K++DFG AK+ V TR + GT
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGT 191
Query: 267 YGYAAPE 273
Y APE
Sbjct: 192 PEYIAPE 198
|
Length = 340 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 15/162 (9%)
Query: 97 LGEGGFGRVYKG----WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL 152
LG+G F +++KG D L ++ V +K L+ E + + + +L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTE------VLLKVLDKSHRNYSESFFEAASMMSQL 56
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
SH +LV G C E ++V EY++ GSL+ +L ++N ++ +SW +L++A A L
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW--KLEVAKQLAWAL 113
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
FL +K + + + A N+LL + K + KL G
Sbjct: 114 HFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 18/155 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNFLGRLSHP 155
LGEG + V+KG SK +VA+K++ E +G EV+ L L H
Sbjct: 13 LGEGTYATVFKG--------RSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI-GAARGLGF 214
N+V L ++ L LV+EY L++ L + + L +KI + RGL +
Sbjct: 64 NIVTLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
H ++K+++RD K N+L++ K++DFGLA+
Sbjct: 119 CH--KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 39/183 (21%)
Query: 86 SATKNFKP-DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
S ++ + + LGEG +G+V K + T G +VAIKK+ +
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAY---------DTLTGKIVAIKKVKIIEISNDVTKDR 55
Query: 145 --------------EVNFLGRLSHPNLVKLLG-YCWEDKELLLVYEYMQ---RGSLENHL 186
E+ + + H N++ L+ Y D + LV + M + ++ +
Sbjct: 56 QLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-INLVMDIMASDLKKVVDRKI 114
Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246
++ + I GL LH ++RD +NI ++ KI+DFG
Sbjct: 115 RLTESQVKCILLQI--------LNGLNVLHKW--YFMHRDLSPANIFINSKGICKIADFG 164
Query: 247 LAK 249
LA+
Sbjct: 165 LAR 167
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 30/186 (16%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--SEVNFLGRLSH 154
LG G +G V DK G ++A+K++ ++ E+ + +++ R
Sbjct: 9 LGRGAYGVV------DKMRHVPT---GTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVD 58
Query: 155 -PNLVKLLGYCWEDKELLLVYEYMQRGSLEN---HLFRRNPSIQPLSWDIRLKIAIGAAR 210
P V G + + ++ + E M SL+ ++ + +I DI KIA+ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPE---DILGKIAVSIVK 114
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG---ESHVTTRVMGTY 267
L +LH S+ VI+RD K SN+L++ N K+ DFG++ G +S T G
Sbjct: 115 ALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS------GYLVDSVAKTIDAGCK 167
Query: 268 GYAAPE 273
Y APE
Sbjct: 168 PYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 18/155 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLSH 154
LGEG + VYKG S+ G +VA+K ++ ++ +G F + E + L L H
Sbjct: 13 LGEGSYATVYKGI--------SRIN-GQLVALKVISMKTEEGVPFTAIR-EASLLKGLKH 62
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
N+V L + L V+EYM L ++ + + P +++RL RGL +
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP--YNVRL-FMFQLLRGLAY 118
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+H + +++RD K N+L+ K++DFGLA+
Sbjct: 119 IH--GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 36/173 (20%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ----- 143
+F+ ++G G FG V L K G + A+KKL M E+ Q
Sbjct: 1 DDFESIKVIGRGAFGEV--------RLVQKKDT-GHIYAMKKLRKSEM--LEKEQVAHVR 49
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDI-R 201
+E + L +P +VKL Y ++D+ L L+ EY+ G + L +++ + + R
Sbjct: 50 AERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDT----FTEEETR 104
Query: 202 LKI-----AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
I AI + LG++H RD K N+LLD + K+SDFGL
Sbjct: 105 FYIAETILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 21/150 (14%)
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHL-----FRRNPSIQPLSWDIRLKIAI 206
L HPN+++ LG C E LLV+EY + G L+++L RRN + L ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMAC 106
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG-GESHVTT--RV 263
A G+ +H + ++ D N L + K+ D+G +GP+ E ++ T
Sbjct: 107 EIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDK 161
Query: 264 MGTYGYAAPEYVATGNFYLLSA---KFGNV 290
+ APE V + L++A K NV
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNV 191
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 52/188 (27%), Positives = 84/188 (44%), Gaps = 12/188 (6%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGL-GMVVAIKKLNPESMQGFEEWQSEVNF 148
NF+ +LG G +G+V+ + K L M V K + + E ++E N
Sbjct: 1 NFELLKVLGTGAYGKVF---LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV 57
Query: 149 LGRLSHPNLVKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L + + L Y ++ + +L L+ +Y+ G + HL++R S D ++ G
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSED-EVRFYSG 112
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
L H + ++YRD K NILLD + ++DFGL+K E T GT
Sbjct: 113 EII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTYSFCGTI 170
Query: 268 GYAAPEYV 275
Y APE +
Sbjct: 171 EYMAPEII 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 20/179 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVNFLGRLSH 154
LGEG + VYKG SK G +VA+K +L E F + E + L L H
Sbjct: 13 LGEGSYATVYKG--------KSKVN-GKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKH 62
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
N+V L + L LV+EY+ L ++ + + P + + L RGL +
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFL---FQLLRGLSY 118
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+H ++ +++RD K N+L+ K++DFGLA+ SH + + T Y P+
Sbjct: 119 IH--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 123 GMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL 182
G VA+KK++ Q E +EV + H N+V + EL +V E+++ G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 183 ENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242
+ + + + ++ + + R L +LH + VI+RD K+ +ILL + K+
Sbjct: 107 TDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKL 159
Query: 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA 276
SDFG E ++GT + APE ++
Sbjct: 160 SDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVIS 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 18/180 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+GEG G V +A K+ G +VA+KK++ Q E +EV + H N
Sbjct: 28 IGEGSTGIV--------CIATVKSS-GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
+V++ EL +V E+++ G+L + + + + ++ + + + L LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH 133
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA 276
+ VI+RD K+ +ILL + K+SDFG E ++GT + APE ++
Sbjct: 134 A--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELIS 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 34/204 (16%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSE 145
K+F SL+G G FG V V +K G + A+K + + E ++ E
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKAT-------GDIYAMKVMKKSVLLAQETVSFFEEE 51
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDI---- 200
+ L + P + +L Y ++DK+ L LV EY G L + L R D+
Sbjct: 52 RDILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFY 107
Query: 201 --RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH 258
L +AI + +G++H RD K N+L+D + K++DFG A A
Sbjct: 108 LAELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSAARLTANK--M 157
Query: 259 VTTRV-MGTYGYAAPEYVATGNFY 281
V +++ +GT Y APE + T N
Sbjct: 158 VNSKLPVGTPDYIAPEVLTTMNGD 181
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 60/186 (32%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLG-R 151
+LG+G FG+V LA K G G A+K L + + E E L
Sbjct: 2 VLGKGSFGKVL--------LAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52
Query: 152 LSHPNLVKLLGYC-WEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
+P L L YC ++ KE L V E++ G L H+ + +D+ A
Sbjct: 53 WENPFLTHL--YCTFQTKEHLFFVMEFLNGGDLMFHIQDKG------RFDLYRATFYAAE 104
Query: 210 R--GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
GL FLH+ K +IYRD K N++LD + + KI+DFG+ K G++ +T GT
Sbjct: 105 IVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN-VFGDNRAST-FCGTP 160
Query: 268 GYAAPE 273
Y APE
Sbjct: 161 DYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 21/186 (11%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE-EWQSEVNF 148
+F+ S LG G G V+K V K PS G+++A K ++ E + E+
Sbjct: 6 DFEKISELGAGNGGVVFK--VSHK---PS----GLIMARKLIHLEIKPAIRNQIIRELQV 56
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
L + P +V G + D E+ + E+M GSL+ L + + I K++I
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAV 112
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA-KLGPAGGESHVTTRVMGTY 267
+GL +L + K+++RD K SNIL++ K+ DFG++ +L + S V TR
Sbjct: 113 IKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR----- 166
Query: 268 GYAAPE 273
Y +PE
Sbjct: 167 SYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 30/199 (15%)
Query: 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE- 141
L+ ++F ++G G FG V V K+ SK V A+K L+ M +
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKS---SKQ----VYAMKLLSKFEMIKRSDS 87
Query: 142 ---WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
W+ E + + + +V+L +DK L +V EYM G L N + N I P W
Sbjct: 88 AFFWE-ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDI-PEKW 143
Query: 199 DI----RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
+ +A+ A +GF+H RD K N+LLD + + K++DFG A
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195
Query: 255 GESHVTTRVMGTYGYAAPE 273
G T V GT Y +PE
Sbjct: 196 GMVRCDTAV-GTPDYISPE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 9/110 (8%)
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELL----LVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
E+ L R+ N++K+ G+ + + L L+ EY RG L L + + LS+
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKT 123
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+L +AI +GL L+ K Y++ + + L+ NY KI GL K+
Sbjct: 124 KLDMAIDCCKGLYNLYKYTNKP-YKNLTSVSFLVTENYKLKIICHGLEKI 172
|
Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW 142
DL S + +P LG G G V+ VD VA+KK+ Q +
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKHA 49
Query: 143 QSEVNFLGRLSHPNLVKL--------------LGYCWEDKELLLVYEYMQRGSLENHLFR 188
E+ + RL H N+VK+ +G E + +V EYM E L
Sbjct: 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDL-A 103
Query: 189 RNPSIQPLSWD-IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDFG 246
PLS + RL RGL ++H++ V++RD K +N+ ++ + KI DFG
Sbjct: 104 NVLEQGPLSEEHARL-FMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFG 160
Query: 247 LAK-LGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
LA+ + P + + T Y +P + + N Y
Sbjct: 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+GEG G V +A K G VA+K ++ Q E +EV + H N
Sbjct: 29 IGEGSTGIV--------CIAREKHS-GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL---KIAI---GAAR 210
+V++ +EL ++ E++Q G+L + + RL +IA +
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTD-----------IVSQTRLNEEQIATVCESVLQ 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR--VMGTYG 268
L +LH+ + VI+RD K+ +ILL + K+SDFG A V R ++GT
Sbjct: 129 ALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFC----AQISKDVPKRKSLVGTPY 182
Query: 269 YAAPEYVA 276
+ APE ++
Sbjct: 183 WMAPEVIS 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL--NPESMQGFEEWQSEVNF 148
F+ ++GEG +G V K + +VAIKK + E+ + E E+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETK---------EIVAIKKFKDSEENEEVKETTLRELKM 53
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
L L N+V+L +L LV+EY+++ LE L P+ P +R I
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-KVRSYI-YQL 109
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
+ + + H ++ +++RD K N+L+ N K+ DFG A+ G ++ T V T
Sbjct: 110 IKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRW 166
Query: 269 YAAPEYVATGNFYLLSAKFGNVINV 293
Y +PE LL A +G +++
Sbjct: 167 YRSPE-------LLLGAPYGKAVDM 184
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 16/178 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+G+G FG+V + D + + I+K + S +E L +++ P
Sbjct: 1 IGKGSFGKVMQVRKRDTQ------RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPF 54
Query: 157 LVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+V L + ++ E L LV ++ G L +HL R +D+ A
Sbjct: 55 IVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREG------RFDLSRARFYTAELLCALE 107
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+ + VIYRD K NILLD + + DFGL KL + T GT Y APE
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 57/202 (28%), Positives = 83/202 (41%), Gaps = 38/202 (18%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGRL 152
+GEG +G+VYK DK G +VA+KK E + E E++ L L
Sbjct: 9 IGEGTYGKVYKA--RDKNT-------GKLVALKKTRLEMDE--EGIPPTALREISLLQML 57
Query: 153 SH-PNLVKLLGYCWEDKE-------LLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRL 202
S +V+LL E E L LV+EY+ L+ + R P +PL
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPG-RPLPAKTIK 113
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA-KISDFGLAKLG--PAGGESHV 259
+G+ H + V++RD K N+L+D KI+D GL + P +H
Sbjct: 114 SFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 260 TTRVMGTYGYAAPEYVATGNFY 281
T Y APE + Y
Sbjct: 172 IV----TLWYRAPEVLLGSTHY 189
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 48/208 (23%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
+S K++K +++G G FG VY+ D + VAIKK+ +Q +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEK---------VAIKKV----LQDPQYKNR 108
Query: 145 EVNFLGRLSHPNLVKLLGYCW------EDKELLL----------VYEYMQRGSLENHLFR 188
E+ + L+H N++ L Y + +K + L V++YM+ + NH
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL- 167
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKISDFGL 247
P + +L R L ++H+ K + +RD K N+L+D N + K+ DFG
Sbjct: 168 --PLFLVKLYSYQL------CRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217
Query: 248 AK--LGPAGGESHVTTRVMGTYGYAAPE 273
AK L S++ +R Y APE
Sbjct: 218 AKNLLAGQRSVSYICSRF-----YRAPE 240
|
Length = 440 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 16/147 (10%)
Query: 113 KTLAPSKTGLGMV------VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLL-GYCW 165
+L P G V KK+ +++ G + E++ L +SH ++ L+ Y W
Sbjct: 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW 157
Query: 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225
+ +++ +Y + LF PL + + I L +LH + +I+R
Sbjct: 158 KSTVCMVMPKY------KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH--GRGIIHR 209
Query: 226 DFKASNILLDGNYNAKISDFGLA-KLG 251
D K NI LD NA + DFG A KL
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAACKLD 236
|
Length = 392 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 50/171 (29%), Positives = 75/171 (43%), Gaps = 36/171 (21%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ-----S 144
+F ++G+G FG V K G + A+K L M F++ Q +
Sbjct: 2 DFHTVKVIGKGAFGEVR---------LVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKA 50
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSWDI-RL 202
E + L P +V L Y ++D + L L+ E++ G L L + S D+ R
Sbjct: 51 ERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRF 105
Query: 203 KIA-----IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
+A I A LGF+H RD K NIL+D + K+SDFGL+
Sbjct: 106 YMAECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 37/203 (18%)
Query: 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGF-E 140
++ ++ K +G G +G V +D +T G VAIKKL P + F +
Sbjct: 12 EVPDRYRDLKQ---VGSGAYGTVCSA-LDRRT--------GAKVAIKKLYRPFQSELFAK 59
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKEL------LLVYEYM--QRGSLENHLFRRNPS 192
E+ L + H N++ LL D L LV +M G L H
Sbjct: 60 RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR 119
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252
IQ L + + +GL ++H + +I+RD K N+ ++ + KI DFGLA+
Sbjct: 120 IQFLVYQM--------LKGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169
Query: 253 AGGESHVTTRVMGTYGYAAPEYV 275
+ +V TR Y APE +
Sbjct: 170 SEMTGYVVTR-----WYRAPEVI 187
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 33/193 (17%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP--ESMQGFEEWQSEV 146
+N P +G G +G V + D KT G+ VA+KKL+ +S+ + E+
Sbjct: 20 QNLSP---VGSGAYGSVCAAF-DTKT--------GLRVAVKKLSRPFQSIIHAKRTYREL 67
Query: 147 NFLGRLSHPNLVKLLGY------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
L + H N++ LL E ++ LV M G+ N++ + Q L+ D
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK----CQKLTDDH 121
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ RGL ++H+++ +I+RD K SN+ ++ + KI DFGLA+ +V
Sbjct: 122 VQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 179
Query: 261 TRVMGTYGYAAPE 273
TR Y APE
Sbjct: 180 TR-----WYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN-PSIQPLSWDI 200
W+ E + + + P +V+L +DK L +V EYM G L N + + P +
Sbjct: 91 WE-ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA 149
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ +A+ A +G +H RD K N+LLD + + K++DFG G
Sbjct: 150 EVVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 261 TRVMGTYGYAAPEYVAT 277
T V GT Y +PE + +
Sbjct: 202 TAV-GTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 24/163 (14%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVN 147
F +G G FG V L K + A+K L + ++E +
Sbjct: 3 FVKIKTIGIGAFGEV--------CLV-RKVDTNALYAMKTLRKADVLMRNQAAHVKAERD 53
Query: 148 FLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLS--WDIRLKI 204
L + +VKL Y ++DK+ L V +Y+ G + + L R + L+ + L
Sbjct: 54 ILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC 112
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
AI + +GF+H RD K NIL+D + + K++DFGL
Sbjct: 113 AIESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 69/216 (31%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE--WQSEVNFLGRL- 152
+LG G FG+V V+ K VA+K L E E SE+ L +
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLK-EGATASEHKALMSELKILIHIG 68
Query: 153 SHPNLVKLLGYCWE-DKELLLVYEYMQRGSLENH-------------------------- 185
+H N+V LLG C + + L+++ E+ + G+L N
Sbjct: 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMV 128
Query: 186 ----LFRRNPSIQ----------------------------PLSWDIRLKIAIGAARGLG 213
+ RR + Q PL+ + + + ARG+
Sbjct: 129 EQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME 188
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
FL + +K I+RD A NILL N KI DFGLA+
Sbjct: 189 FL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE- 141
DL+ ++++ ++G G FG V L K+ V A+K L+ M +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEV--------QLVRHKS-TRKVYAMKLLSKFEMIKRSDS 87
Query: 142 ---WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN-PSIQPLS 197
W+ E + + + P +V+L +D+ L +V EYM G L N + + P
Sbjct: 88 AFFWE-ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 146
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES 257
+ + +A+ A +GF+H RD K N+LLD + + K++DFG G
Sbjct: 147 YTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 258 HVTTRVMGTYGYAAPEYVAT 277
T V GT Y +PE + +
Sbjct: 199 RCDTAV-GTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 57/210 (27%), Positives = 79/210 (37%), Gaps = 43/210 (20%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEW 142
K K + +LG G G V L + G A+K ++ E M
Sbjct: 28 KEQAKKYWISRVLGSGATGTV---------LCAKRVSDGEPFAVKVVDMEGMSEADKNRA 78
Query: 143 QSEVNFLGRLSHPNLVKLLGYCWED------------KELLLVYEYMQRGSLENHLFRRN 190
Q+EV L ++VK C ED + LV +Y G L + R
Sbjct: 79 QAEVCCLLNCDFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA 134
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFL-------HTSEKKVIYRDFKASNILLDGNYNAKIS 243
+ + R A GL F+ H K +I+RD K++NILL N K+
Sbjct: 135 KTNRTF----REHEA-----GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185
Query: 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
DFG +K+ A V GT Y APE
Sbjct: 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
|
Length = 496 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 35/190 (18%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQ-SEVNFLGRLS 153
+G G +G V +D +T G VAIKKL+ P + F + E+ L +
Sbjct: 22 QVGSGAYGSVCSA-IDKRT--------GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ 72
Query: 154 HPNLVKLL--------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
H N++ LL G ++D L++ Y + H + +Q L + +
Sbjct: 73 HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED-KVQYLVYQM----- 126
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
GL ++H++ +I+RD K N+ ++ + KI DFGLA+ A +V TR
Sbjct: 127 ---LCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 178
Query: 266 TYGYAAPEYV 275
Y APE +
Sbjct: 179 --WYRAPEVI 186
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSE 145
++F+ ++G G FG V K G V A+K L M E+ ++E
Sbjct: 1 EDFESLKVIGRGAFGEVR---------LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAE 51
Query: 146 VNFLGRLSHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLS--WDIRL 202
+ L +VK+ Y ++DK L L+ E++ G + L +++ + + +
Sbjct: 52 RDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAET 110
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
+AI + LGF+H RD K N+LLD + K+SDFGL
Sbjct: 111 VLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK---LGPAGGESHVTTRVMGT 266
GL ++H++ V++RD K N+L++ + KI DFGLA+ P +T V T
Sbjct: 116 CGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-AT 172
Query: 267 YGYAAPE 273
Y APE
Sbjct: 173 RWYRAPE 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-06
Identities = 22/41 (53%), Positives = 27/41 (65%), Gaps = 2/41 (4%)
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
ARG+ FL + +K I+RD A NILL N KI DFGLA+
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 27/191 (14%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EVNFLGRLS- 153
+GEG F V K KT G AIK + + + E+ + E+ L RLS
Sbjct: 7 IGEGTFSEVLKA-QSRKT--------GKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSP 56
Query: 154 HPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
HPN+++L+ ++ K L LV+E M E R+ +PL +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK----RPLPEKRVKSYMYQLLKS 112
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT-TRVMGTYGYA 270
L +H + +RD K NIL+ + K++DFG + G S T + T Y
Sbjct: 113 LDHMH--RNGIFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTRWYR 165
Query: 271 APEYVATGNFY 281
APE + T +Y
Sbjct: 166 APECLLTDGYY 176
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE---WQSEV 146
+F+ ++G G FG V K G + A+K L M E+ ++E
Sbjct: 2 DFESLKVIGRGAFGEVR---------LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAER 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLS--WDIRLK 203
+ L +VK+ Y ++DK L L+ E++ G + L +++ + + +
Sbjct: 53 DILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
+AI A LGF+H RD K N+LLD + K+SDFGL
Sbjct: 112 LAIDAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 20/155 (12%)
Query: 97 LGEGGFGRV-YKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LG G FG V VD L KT ++K + + ++E + L +
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKT-------LRKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 156 NLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGL 212
+VKL Y ++DK+ L V +Y+ G + + L R P + + L +AI + +
Sbjct: 62 WVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
GF+H RD K NIL+D + + K++DFGL
Sbjct: 121 GFIH--------RDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 24/59 (40%), Positives = 32/59 (54%), Gaps = 2/59 (3%)
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
PL D L+ + A+G+ FL + K I+RD A N+LL AKI DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 14/118 (11%)
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
E L ++HP+++++ +V + L +L +R+ +PL D L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRS---RPLPIDQALII 162
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK--------LGPAG 254
GL +LH +++I+RD K NI ++ I D G A+ LG AG
Sbjct: 163 EKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG 218
|
Length = 357 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 97 LGEGGFGRVYKG---WVDDKTLAPSKTGLGMVVAIKKLNPE----SMQGFEEWQSEVNFL 149
LG G ++Y G + DD + V +K L+P S+ FE + +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFET----ASMM 58
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
++SH ++V L G C D E ++V E+++ G L+ LF S L+ + K+A A
Sbjct: 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKS-DVLTTPWKFKVAKQLA 115
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL-----DGNYNA--KISDFGL 247
L +L +K +++ + NILL DG K+SD G+
Sbjct: 116 SALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 26/65 (40%), Positives = 38/65 (58%), Gaps = 5/65 (7%)
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
G+ LH++ +I+RD K SNI++ + KI DFGLA+ AG +T V+ Y Y
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YR 184
Query: 271 APEYV 275
APE +
Sbjct: 185 APEVI 189
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 35/98 (35%), Positives = 47/98 (47%), Gaps = 6/98 (6%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SH 154
LG G FG+V V+ K+ M VA+K L P + + E SE+ L L +H
Sbjct: 43 LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS 192
N+V LLG C L++ EY G L N L R+ S
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDS 136
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP--ESMQGFEEWQSEV 146
+N P +G G +G V + T L VA+KKL+ +S+ E+
Sbjct: 18 QNLTP---VGSGAYGSVCSAY---------DTRLRQKVAVKKLSRPFQSLIHARRTYREL 65
Query: 147 NFLGRLSHPNLVKLL-----GYCWED-KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
L + H N++ LL E+ E+ LV M G+ N++ + Q LS +
Sbjct: 66 RLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVK----CQKLSDEH 119
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ RGL ++H++ +I+RD K SN+ ++ + +I DFGLA+ +V
Sbjct: 120 VQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVA 177
Query: 261 TRVMGTYGYAAPE 273
TR Y APE
Sbjct: 178 TR-----WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 24/63 (38%), Positives = 33/63 (52%), Gaps = 3/63 (4%)
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
G H +I+RD K SNI++ + KI DFGLA+ G S + T + T Y AP
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 187
Query: 273 EYV 275
E +
Sbjct: 188 EVI 190
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL-S 153
+LG G FG+V +G S++ M VA+K L P + ++ SE+ + L
Sbjct: 44 ILGSGAFGKVVEG----TAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGP 99
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
H N+V LLG C + + ++ EY G L N+L + +
Sbjct: 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 21/41 (51%), Positives = 27/41 (65%), Gaps = 2/41 (4%)
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A+G+ FL + +K I+RD A NILL N KI DFGLA+
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 24/157 (15%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS 153
LG G FG V LA K + A+K L + + ++E + L
Sbjct: 9 LGIGAFGEV--------CLA-RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD 59
Query: 154 HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLS--WDIRLKIAIGAAR 210
+ +V+L Y ++DK+ L V +Y+ G + + L R + L+ + L A+ +
Sbjct: 60 NEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH 118
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
+GF+H RD K NIL+D + + K++DFGL
Sbjct: 119 KMGFIH--------RDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 32/170 (18%)
Query: 127 AIKKLNPESM-------QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQR 179
A+KK+N +++ Q F E + L +P +V + + L +V EY++
Sbjct: 30 AMKKINKQNLILRNQIQQVF----VERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85
Query: 180 GSLENHLFRRNPSIQPLSWDI-RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238
G L +I L D+ R+ A L +LH +++RD K N+L+
Sbjct: 86 GDCATLL----KNIGALPVDMARMYFA-ETVLALEYLHNY--GIVHRDLKPDNLLITSMG 138
Query: 239 NAKISDFGLAKLGPAG-------GESHVTTR------VMGTYGYAAPEYV 275
+ K++DFGL+K+G G TR V GT Y APE +
Sbjct: 139 HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 24/63 (38%), Positives = 33/63 (52%), Gaps = 3/63 (4%)
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
G H +I+RD K SNI++ + KI DFGLA+ G S + T + T Y AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 194
Query: 273 EYV 275
E +
Sbjct: 195 EVI 197
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 38/142 (26%), Positives = 62/142 (43%), Gaps = 26/142 (18%)
Query: 145 EVNFLGRLSHPNLVKLLGY-------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
E L RLSHP ++ LL C L++ +Y R L +L R ++PL
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC------LVLPKY--RSDLYTYLGAR---LRPLG 258
Query: 198 WDIRLKIAIGAARGLG---FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
++ A + L ++H + +I+RD K N+L++G + + DFG A
Sbjct: 259 ---LAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 255 GESHVTTRVMGTYGYAAPEYVA 276
+ + GT APE +A
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLA 335
|
Length = 461 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 22/165 (13%)
Query: 120 TGLGMVVAIKKL-NPESMQGF-EEWQSEVNFLGRLSHPNLVKLLGY------CWEDKELL 171
T LG+ VA+KKL P Q + E+ L ++H N++ LL E +++
Sbjct: 43 TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102
Query: 172 LVYEYMQRGSLEN-HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230
LV E M + H+ + + L + + G+ LH++ +I+RD K S
Sbjct: 103 LVMELMDANLCQVIHMELDHERMSYLLYQMLC--------GIKHLHSA--GIIHRDLKPS 152
Query: 231 NILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV 275
NI++ + KI DFGLA+ A +T V+ Y Y APE +
Sbjct: 153 NIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPEVI 194
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 25/94 (26%), Positives = 44/94 (46%), Gaps = 10/94 (10%)
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIAIGAARGL 212
PN+V L Y + + LV ++ + G L +H+ F P W + +A+ A
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246
LH + ++ RD +NILLD + +++ F
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 38/204 (18%)
Query: 97 LGEGGFGRVYKG----WVDDKTLAPSK---TGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
+G G +G VYK DD+ A + TG+ M E+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----------------REIALL 52
Query: 150 GRLSHPNLVKL--LGYCWEDKELLLVYEYMQRGSLENHLFRR----NPSIQPLSWDIRLK 203
L HPN++ L + D+++ L+++Y + F R N L +
Sbjct: 53 RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN----YNAKISDFGLAKL--GPAGGES 257
+ G+ +LH + V++RD K +NIL+ G KI+D G A+L P +
Sbjct: 113 LLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 258 HVTTRVMGTYGYAAPEYVATGNFY 281
+ V+ T+ Y APE + Y
Sbjct: 171 DLDPVVV-TFWYRAPELLLGARHY 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 20/41 (48%), Positives = 25/41 (60%), Gaps = 2/41 (4%)
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A+G+ FL + K I+RD A NILL KI DFGLA+
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 11/107 (10%)
Query: 144 SEVNFLGRLSHPNLVKLLG-YCWEDKELLLVYEYMQRGSLENHLF-RRNPSIQPLSWDIR 201
+E + L ++HP++++L G + + L++ Y + L +L +RN +I DI
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAI----CDI- 184
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
L I R + +LH E ++I+RD KA NI ++ + + DFG A
Sbjct: 185 LAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 16/107 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLG-----MVVAIKKLNPESMQGFEE-WQ 143
N + LG G FG+V + + GLG + VA+K L + E
Sbjct: 39 NLQFGKTLGAGAFGKVVEA---------TAFGLGKEDNVLRVAVKMLKASAHTDEREALM 89
Query: 144 SEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR 189
SE+ L L H N+V LLG C +L++ EY G L N L ++
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 4/132 (3%)
Query: 143 QSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS-WDIR 201
+SE++ L H +VK D +LLL+ EY G L + +R P +++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
L + L +H+ +K+++RD K++NI L K+ DFG +K V +
Sbjct: 173 L-LFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 262 RVMGTYGYAAPE 273
GT Y APE
Sbjct: 230 SFCGTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 50/210 (23%)
Query: 97 LGEGGFGRVYKG----WVDDKTLAPSK---TGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
+G G +G VYK D+K A + TG+ M E+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----------------REIALL 52
Query: 150 GRLSHPNLVKL--LGYCWEDKELLLVYEYMQ----------RGSLENHLFRRNPSIQPLS 197
L HPN++ L + D+++ L+++Y + R S N + P P S
Sbjct: 53 RELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPMQLPRS 108
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN----YNAKISDFGLAKL--G 251
L I G+ +LH + V++RD K +NIL+ G KI+D G A+L
Sbjct: 109 MVKSLLYQI--LDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 252 PAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
P + + V+ T+ Y APE + Y
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHY 193
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 18/114 (15%)
Query: 143 QSEVNFLGRLSHPNLVKLLGYCWEDKELLL--VYEYM--QRGSLENHLFRRNPSIQ---- 194
++E+ LGRL+H N++K+ +E+L YM Q+ + + F + +
Sbjct: 211 ENEILALGRLNHENILKI-------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
PL R I + ++H +KK+I+RD K NI L+ + + DFG A
Sbjct: 264 PLLKQTR-AIMKQLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRLS-H 154
LG G FGRV V+ S + M VA+K L + ++ SE+ + L H
Sbjct: 45 LGSGAFGRV----VEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
N+V LLG C + + ++ EY + G L ++L R
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNF 148
KP S G FG+VY G K + A+K + M + Q+E +
Sbjct: 10 KPIS---RGAFGKVYLGR---------KKNNSKLYAVKVVKKADMINKNMVHQVQAERDA 57
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLEN--HLFRRNPSIQPLSWDIRLKIAI 206
L P +V L + LV EY+ G +++ H++ ++ +K
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY------FDEEMAVKYIS 111
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
A L +LH +I+RD K N+L+ + K++DFGL+K+
Sbjct: 112 EVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 48/206 (23%), Positives = 80/206 (38%), Gaps = 41/206 (19%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE----EWQSEVNFLGR 151
L+G+GG G VY + D VA+KK+ E + + E
Sbjct: 9 LIGKGGMGEVYLAY--DPVC-------SRRVALKKIR-EDLSENPLLKKRFLREAKIAAD 58
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA--- 208
L HP +V + C + + Y++ +L+ L + + LS ++ K ++GA
Sbjct: 59 LIHPGIVPVYSICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 209 -----ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA-------------KL 250
+ ++H+ K V++RD K NILL I D+G A +
Sbjct: 118 IFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 251 GPAGGESHVTT---RVMGTYGYAAPE 273
T +++GT Y APE
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 56/298 (18%)
Query: 7 SLFVASNSSSNNINANASSSSAGA-YNKYGHTMEISATSSSAGKSQFSQAISEAGVEEAS 65
S A S S A+S+ +G + G AT++ + + + V A
Sbjct: 47 STNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTYAL 106
Query: 66 PNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMV 125
PN Q E V D+ +T+ FK SLLGEG FG+V + W D+ K
Sbjct: 107 PN-QSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAW--DR-----KRKEYCA 158
Query: 126 VAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK-ELLLVYEYMQRGSLEN 184
V I + P+ + + + E+ F+ ++ + D+ L+ + Y Q +
Sbjct: 159 VKIVRNVPKYTR---DAKIEIQFMEKVRQADP--------ADRFPLMKIQRYFQNET--G 205
Query: 185 HLFRRNPSIQP--LSWDIR---------LKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233
H+ P P L W ++ +I L + HT E +++ D K NIL
Sbjct: 206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENIL 264
Query: 234 LDGNYNA----------------KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV 275
++ + +I D LG E H T ++ T Y +PE V
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICD-----LGGCCDERHSRTAIVSTRHYRSPEVV 317
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.55 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.25 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.08 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.95 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.91 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.71 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.69 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.6 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.59 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.55 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.44 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.39 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.22 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.06 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.06 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.98 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.94 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.71 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.67 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.61 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.43 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.36 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.29 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.28 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.26 | |
| PLN02236 | 344 | choline kinase | 97.26 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.02 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.02 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.96 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.86 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.75 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.73 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.58 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.51 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.46 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.4 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.2 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.83 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.53 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=354.90 Aligned_cols=192 Identities=31% Similarity=0.445 Sum_probs=174.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..+|.+.+.||.|+||+||+|+++.+ +..||||.+... ..+.++.+..|+.+|+.++|||||+++++++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~---------~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKS---------GTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccC---------CceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 56899999999999999999998876 788999999876 4455677889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC------Cc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN------YN 239 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~------~~ 239 (297)
.++.+|+|||||.||+|.++|+.+ +.+++..++.++.||+.||++|| +++||||||||.||||+.. -.
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCce
Confidence 999999999999999999999987 56999999999999999999999 6999999999999999764 46
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+|+.+... ....+.||+|-|||||++...+|+.|+|+||+|+|||+|+
T Consensus 154 LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l 208 (429)
T KOG0595|consen 154 LKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCL 208 (429)
T ss_pred EEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHH
Confidence 899999999987643 2456789999999999999999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=339.67 Aligned_cols=193 Identities=31% Similarity=0.460 Sum_probs=174.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|+++++||+|+||+||+++.+++ ++.+|+|.+++... ...+....|..||.+++||+||+++-.|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt---------~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDT---------GKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEccc---------CceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 56899999999999999999876643 89999999987632 3457788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
++...+|+|+||+.||+|..+|++. ..+++..++.++.+|+.||.||| +.|||||||||+|||||.+|+++|+|
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEec
Confidence 9999999999999999999999876 66999999999999999999999 59999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++..... ...+.++|||+.|||||++.+..|+..+|.||||+++|+||
T Consensus 169 FgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML 219 (357)
T KOG0598|consen 169 FGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEML 219 (357)
T ss_pred cccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHh
Confidence 9999864332 23456689999999999999999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=331.99 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=173.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEe-EE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLG-YC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~-~~ 164 (297)
..+|++.++||+|.||+||++....+ |..+|.|.+.-. +.+..+.+..|+.+|++|+|||||++++ .+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~---------g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLD---------GKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccC---------cchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 45789999999999999999977654 788999998744 3445577889999999999999999999 45
Q ss_pred EcCCe-eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhc--CCCCceeccCCCCcEEEcCCCceE
Q 022413 165 WEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT--SEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 165 ~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~--~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
.++++ ++||||||.+|+|.++|+..+...+.+++..+++++.|++.||..||+ .+.-|+||||||.||+|+.+|.+|
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence 55555 999999999999999998777767889999999999999999999996 334599999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhc
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
|.|||+++.+.. ......+.+|||.||+||.+.+.+|+++||||||||++|+|
T Consensus 169 LGDfGL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEM 221 (375)
T KOG0591|consen 169 LGDFGLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEM 221 (375)
T ss_pred eccchhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 999999998754 22345668999999999999999999999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=346.87 Aligned_cols=192 Identities=32% Similarity=0.457 Sum_probs=175.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.+|..+++||+|+|+.||++...+. |..||+|++.+. +....+++.+|++|.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~t---------ge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDT---------GEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCC---------CcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 5799999999999999999977543 889999999874 3345578899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|||+|+|+.++|..++.++ .+++|.+++.+..||+.||.||| +.+|+|||||..|+||+++.+|||+||
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEeccc
Confidence 999999999999999999999866 67999999999999999999999 489999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||..+...+. ...+.||||.|+|||++.....++.+||||+||+||.||
T Consensus 163 GLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL 212 (592)
T KOG0575|consen 163 GLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLL 212 (592)
T ss_pred ceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhh
Confidence 99998765433 445689999999999999888999999999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=329.33 Aligned_cols=191 Identities=27% Similarity=0.414 Sum_probs=172.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..+.+.++.||+|..|+||++.++.+ ++.+|+|.+... +....+.+.+|+++++..+||+||.+|+.|..
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t---------~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPT---------GKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCC---------CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34566788999999999999988865 889999999544 44455788999999999999999999999999
Q ss_pred CC-eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 167 DK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 167 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+. .++|+||||++|+|.+++... +.+++...-.|+.+|++||.|||. +++||||||||+||||+..|+||||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccc
Confidence 99 599999999999999999876 569999999999999999999995 489999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhc
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
|.++.+... ...++.||..|||||.+.+..|+.++||||||+.++||
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLEL 270 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHH
Confidence 999876433 55678999999999999999999999999999999987
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=332.03 Aligned_cols=193 Identities=28% Similarity=0.407 Sum_probs=166.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-------hHHHHHHHHHHhcCCCCCCccc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-------GFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
..+.|.+.+.||.|+||.|-+|+.+.+ |..||||++++.... .....++|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~t---------gk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKT---------GKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEccc---------CcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 456789999999999999999976654 899999999865321 2234679999999999999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC--
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-- 237 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~-- 237 (297)
++++|..++..|+||||++||+|.+.+..+ ..+.+..-..+++|++.|+.||| +.||+||||||+|||+..+
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSNDAE 314 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccCCc
Confidence 999999999999999999999999999877 55778888999999999999999 5999999999999999765
Q ss_pred -CceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcc---cccchhhhhhhhhcC
Q 022413 238 -YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYL---LSAKFGNVINVCMYL 297 (297)
Q Consensus 238 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslGv~l~~ll 297 (297)
..+||+|||+|+... +.....++||||.|.|||++.+..+.. +.|+|||||+||-+|
T Consensus 315 ~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcL 375 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCL 375 (475)
T ss_pred ceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEe
Confidence 789999999999753 334567789999999999998765433 679999999999765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=316.10 Aligned_cols=190 Identities=32% Similarity=0.411 Sum_probs=174.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++++.||.|+||+|.+++.+.. |..+|+|.+++.. .++.+...+|..+|+.+.||+++++++.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~---------g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~ 113 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHS---------GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF 113 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccC---------CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence 46799999999999999999977764 8899999998764 34557788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+.+|+||||++||.|..++++. +++++..++.++.||+.||+|||+ .+|++|||||+|||||++|.+||+|
T Consensus 114 ~d~~~lymvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitD 187 (355)
T KOG0616|consen 114 KDNSNLYMVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITD 187 (355)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEe
Confidence 9999999999999999999999887 679999999999999999999994 9999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|+.+.. .+.+.||||.|+|||++....|..++|.|+|||++|+||
T Consensus 188 FGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMl 235 (355)
T KOG0616|consen 188 FGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEML 235 (355)
T ss_pred ccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHH
Confidence 999997532 367789999999999999999999999999999999996
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=330.74 Aligned_cols=210 Identities=55% Similarity=0.924 Sum_probs=182.4
Q ss_pred CCcccCHHHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCC
Q 022413 75 DLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154 (297)
Q Consensus 75 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h 154 (297)
....|++.++...+++|.....||+|+||.||+|...+ +..||||++.....+...+|.+|+.++.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 56779999999999999999999999999999998886 56799998877654313559999999999999
Q ss_pred CCcccEEeEEEcCC-eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhc-CCCCceeccCCCCcE
Q 022413 155 PNLVKLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT-SEKKVIYRDFKASNI 232 (297)
Q Consensus 155 ~nIv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-~~~~ivH~Dlkp~Ni 232 (297)
||+|+|+|||.+.+ +.+||+||+++|+|.++|+..... +++|..+++|+.++|+||+|||. ....||||||||+||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 99999999999998 599999999999999999876432 78999999999999999999996 223699999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++++||+|||+|+..+.. .........||.+|+|||++..+..+.++|||||||+|++|+
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI 272 (361)
T ss_pred eECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence 9999999999999999765431 111111117999999999999999999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=330.50 Aligned_cols=198 Identities=28% Similarity=0.347 Sum_probs=175.2
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCC-CCCCcccE
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRL-SHPNLVKL 160 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~ 160 (297)
.....+|.+++.||+|+|++|++|...+. ++.||||++.+. ..+..+.+.+|-.+|.+| .||.|++|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t---------~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKAT---------GKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCC---------CceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 44567999999999999999999976654 889999999865 223345677899999999 69999999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
+..|+|+..+|+|+||+++|+|.++|.+. +.+++..++.++.+|+.||+||| .+|||||||||+|||||+++++
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhi 213 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHI 213 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcE
Confidence 99999999999999999999999999887 67999999999999999999999 5999999999999999999999
Q ss_pred EEccccccccCCCCCCc-----------ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGES-----------HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||.|+.+...... .....++||..|++||++.....++.+|+|+||||||-||
T Consensus 214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQml 281 (604)
T KOG0592|consen 214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQML 281 (604)
T ss_pred EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHh
Confidence 99999999987643211 1125589999999999999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=322.45 Aligned_cols=191 Identities=35% Similarity=0.556 Sum_probs=164.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcE-EEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMV-VAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~-vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
+..+.+.||.|+||+||+|.++. .. ||+|++..... ...+.|.+|+.+|.+++|||||+|+|++.+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g-----------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRG-----------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCC-----------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34445669999999999999984 44 99999986532 225689999999999999999999999999
Q ss_pred CC-eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC-ceeccCCCCcEEEcCCC-ceEEc
Q 022413 167 DK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK-VIYRDFKASNILLDGNY-NAKIS 243 (297)
Q Consensus 167 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-ivH~Dlkp~Nill~~~~-~~kl~ 243 (297)
.. .+.+||||+++|+|.++++.. ....+++..++.++.||++||.|||+ .+ ||||||||+|||++.++ ++|||
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEEC
Confidence 87 799999999999999999874 22679999999999999999999995 77 99999999999999997 99999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceec--ccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA--TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...... .......||+.|||||++. ...|+.++||||||++||+|+
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~ 240 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL 240 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH
Confidence 999998654321 1223367999999999999 558999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=325.10 Aligned_cols=194 Identities=29% Similarity=0.443 Sum_probs=170.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc----ch-hhHHHHHHHHHHhcCCC-CCCcccE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE----SM-QGFEEWQSEVNFLGRLS-HPNLVKL 160 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~~ 160 (297)
..++|.+++.||+|+||+|++|.+..+ +..||+|++++. .. ...+.+.+|+.++++++ ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t---------~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLT---------GEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccC---------CCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 456899999999999999999987765 688999987764 22 22356678999999999 9999999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC-Cc
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YN 239 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~-~~ 239 (297)
++++.....+|+||||+.||+|.+++... .++.+..+..++.|++.|++|||+ +||+||||||+|||++.+ +.
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCC
Confidence 99999999999999999999999999884 568899999999999999999994 999999999999999999 99
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccC-Cc-ccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FY-LLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslGv~l~~ll 297 (297)
+||+|||++.... .......+.+||+.|+|||++.+.. |+ .++|||||||+||.|+
T Consensus 160 ~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 160 LKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred EEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 9999999998764 2223456689999999999999877 76 5799999999999885
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=320.75 Aligned_cols=196 Identities=25% Similarity=0.322 Sum_probs=171.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
..++|+++++||+|+||.||+|+-++ +|..+|+|++++... .+++.+..|-.+|...++|.||++|-.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred CcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 35689999999999999999996554 499999999987643 455778899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
|++...+||||||++||++..+|... ..+++..++.++.+++.|++-|| +.|+|||||||+|+|||..|++||.
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeec
Confidence 99999999999999999999999876 67999999999999999999999 6999999999999999999999999
Q ss_pred cccccccCCCC-----------------------CC-----cce-----------------eeccCCcccccCcceeccc
Q 022413 244 DFGLAKLGPAG-----------------------GE-----SHV-----------------TTRVMGTYGYAAPEYVATG 278 (297)
Q Consensus 244 Dfg~a~~~~~~-----------------------~~-----~~~-----------------~~~~~gt~~y~aPE~~~~~ 278 (297)
||||+.-+... .. ... ....+|||.|||||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 99998532210 00 000 1135799999999999999
Q ss_pred CCcccccchhhhhhhhhcC
Q 022413 279 NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 279 ~~~~~sDvwslGv~l~~ll 297 (297)
.|....|.||||||+||||
T Consensus 364 gY~~~cDwWSLG~ImyEmL 382 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEML 382 (550)
T ss_pred CCCccccHHHHHHHHHHHH
Confidence 9999999999999999997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=324.64 Aligned_cols=191 Identities=31% Similarity=0.405 Sum_probs=172.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|.+.+.||+|+||.||||+.+ .+.+.||+|.+++.. .++.+.+.+|++|++.++||||+.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK---------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK---------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeecccc---------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 47888999999999999999544 448899999998764 3456778999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
..++|+|+||+.| +|..+|... ..++++.++.|+.+++.||.||| +.+|+|||+||.|||++..+.+|+||||
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhh
Confidence 9999999999977 999999876 66999999999999999999999 4999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|+.... .....+...|||.|||||++.+..|+..+|+|||||++|+|+
T Consensus 146 ~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~ 194 (808)
T KOG0597|consen 146 LARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELY 194 (808)
T ss_pred hhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHh
Confidence 9996544 334567789999999999999999999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=300.84 Aligned_cols=192 Identities=28% Similarity=0.350 Sum_probs=165.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
+.|+.+.++|+|+||+||+|+++++ |+.||||++.... +.-.+-.++|+.+|++|+|||+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~T---------gqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDT---------GQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCc---------ccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 3688889999999999999977765 9999999986542 3333456899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
...+++|.|||+. ++.+-|.... ..++...+..+++|++.|+.||| ..++|||||||+||||+..|.+||||||
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccch
Confidence 9999999999976 5555555442 45889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+|+.+...+ ...+..+.|.+|+|||.+.+ ..|....|||++||++.+|+
T Consensus 147 FAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~ 196 (396)
T KOG0593|consen 147 FARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELL 196 (396)
T ss_pred hhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHh
Confidence 999876433 34556778999999999998 67888999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=315.05 Aligned_cols=195 Identities=28% Similarity=0.368 Sum_probs=168.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..+.|+.++.||+|+||.||+|++..+ |..||+|++..+. .....-..+|+.||++|+||||++|.+..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~t---------gkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLET---------GKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeeccc---------CcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 345788999999999999999977665 8999999987654 33445567999999999999999999999
Q ss_pred EcC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 165 WED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 165 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
.+. ..+|+|+|||+. +|.-++.... ..+++.++..++.||+.||.||| .+||+|||||.+|||||.+|.+||
T Consensus 186 t~~~~~siYlVFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred EecCCceEEEEEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEe
Confidence 887 689999999966 8888886543 56999999999999999999999 599999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+|||||+++....... .+..+-|.+|+|||++.|. .|+.+.|+||.||||.||+
T Consensus 260 aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~ 314 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF 314 (560)
T ss_pred ccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH
Confidence 9999999876544332 3445679999999999985 5889999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=325.59 Aligned_cols=193 Identities=31% Similarity=0.433 Sum_probs=172.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCC-CCCcccEEe
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS-HPNLVKLLG 162 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~~~~ 162 (297)
..++|.++++||+|.||+|+++....+ ++.+|||.+++.. ..+++....|..|+.... ||+++.++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~---------~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGT---------NEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCC---------CcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence 457899999999999999999987765 7899999998863 345677888999988886 999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
.|+..+++|+||||+.||++..+.+. ..+++..++.++++|+.||+||| ++||||||||.+|||+|.+|.+||
T Consensus 437 ~fQT~~~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 437 CFQTKEHLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred ccccCCeEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcEEe
Confidence 99999999999999999995444432 45999999999999999999999 699999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++.....+ ..+.++||||.|||||++.+..|+.+.|.|||||+||+||
T Consensus 510 ADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML 562 (694)
T KOG0694|consen 510 ADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML 562 (694)
T ss_pred cccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH
Confidence 9999999754333 3567899999999999999999999999999999999997
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=313.91 Aligned_cols=195 Identities=32% Similarity=0.427 Sum_probs=165.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
....+++.+.||+|.||.||.|.++.. ..||+|.+...... .+.|.+|+++|++|+|+|||++++++..
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 344566778999999999999999863 35899988765332 2678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+..+||||||++.|+|.++|.... ...+.....+.++.|||.||+||++ +++|||||.++||||+++..+||+|||
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccc
Confidence 889999999999999999998732 2568888999999999999999994 999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|+...+.. ........-..-|.|||.+..++|+.+||||||||+||||+
T Consensus 349 LAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~f 398 (468)
T KOG0197|consen 349 LARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELF 398 (468)
T ss_pred cccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHh
Confidence 999543322 21222222356799999999999999999999999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=304.46 Aligned_cols=193 Identities=25% Similarity=0.395 Sum_probs=172.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
...+|++.+.||+|.||+|-+|..... |+.||||.+.+.. .++.-.+.+|++||..|+||||+++|++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~s---------gR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV 121 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKS---------GREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV 121 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccC---------CcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence 345899999999999999999866543 8999999998764 3455678899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
|+..+.+.|||||..+|.|.+|+..+ +.+++.++++|++||..|+.||| ++++||||||.+|||+|+++.+||+
T Consensus 122 FENkdKIvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIA 195 (668)
T KOG0611|consen 122 FENKDKIVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIA 195 (668)
T ss_pred hcCCceEEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeee
Confidence 99999999999999999999999987 67999999999999999999999 6999999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCc-ccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY-LLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~~ll 297 (297)
|||++..+... ...+++||+|-|.+||++.+..|. +..|-|||||+||.|.
T Consensus 196 DFGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLV 247 (668)
T KOG0611|consen 196 DFGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLV 247 (668)
T ss_pred ccchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHh
Confidence 99999876432 245679999999999999887775 4689999999999873
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=283.66 Aligned_cols=192 Identities=29% Similarity=0.383 Sum_probs=166.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-h-HHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-G-FEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.+|...+.||+|.||.||+|++..+ |+.||||++...... . .....+|+..|+.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t---------~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTET---------GKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCC---------CcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 4688889999999999999987654 899999999866432 1 2456899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
...+.+|+||++. +|+..|+... ..++...+..++.+++.||+||| .+.|+||||||.|+||+.+|.+||+|||
T Consensus 73 ~~~l~lVfEfm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 73 KSNLSLVFEFMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred CCceEEEEEeccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeeccc
Confidence 9999999999955 9999998764 66889999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+|+.+...... .+..+-|..|+|||.+.|. .|....|+||.|||+.|||
T Consensus 147 LAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 147 LARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred chhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH
Confidence 99987554332 2223679999999999885 5888999999999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=293.79 Aligned_cols=197 Identities=26% Similarity=0.312 Sum_probs=170.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.+.|++++.||.|.-|+||++..... +..+|+|+++++.. +...+.+.|-+||+.++||.++.||..|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t---------~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGT---------NCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCC---------CceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 34688889999999999999987764 57899999998643 4456788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
+.++..|+|||||+||+|..+.+++.. ..+++..++.++.+|+.||+||| ..|||+|||||+||||.++|++.|.|
T Consensus 147 et~~~~cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLsD 222 (459)
T KOG0610|consen 147 ETDKYSCLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLSD 222 (459)
T ss_pred eccceeEEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEeee
Confidence 999999999999999999999876643 66999999999999999999999 59999999999999999999999999
Q ss_pred ccccccCCCC--------------------------------C-Cc---------------------ceeeccCCccccc
Q 022413 245 FGLAKLGPAG--------------------------------G-ES---------------------HVTTRVMGTYGYA 270 (297)
Q Consensus 245 fg~a~~~~~~--------------------------------~-~~---------------------~~~~~~~gt~~y~ 270 (297)
|.|+..+... . .. .....++||-+|+
T Consensus 223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl 302 (459)
T KOG0610|consen 223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL 302 (459)
T ss_pred ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence 9987543210 0 00 1123467999999
Q ss_pred CcceecccCCcccccchhhhhhhhhcC
Q 022413 271 APEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 271 aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++.|..-+.+.|.|.|||++||||
T Consensus 303 APEvI~G~GHgsAVDWWtfGIflYEmL 329 (459)
T KOG0610|consen 303 APEVIRGEGHGSAVDWWTFGIFLYEML 329 (459)
T ss_pred cceeeecCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999997
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=310.26 Aligned_cols=192 Identities=29% Similarity=0.358 Sum_probs=167.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCC-CCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 164 (297)
..++|.+++.||.|+||.||+|+..++ +..||||++++.-. ...-.-++|+..|++|. ||||+++.+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~---------~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi 78 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKET---------GELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI 78 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCC---------CceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence 456899999999999999999977665 78899999876532 21123369999999999 99999999999
Q ss_pred EcCC-eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 165 WEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 165 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
.+.+ .+|+||||| ..+|.+++..+. ..+++..++.|+.||+.||+|+| ++|+.|||+||+|||+.....+||+
T Consensus 79 ~d~~~~L~fVfE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 79 RDNDRILYFVFEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred hccCceEeeeHHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEec
Confidence 9998 999999999 559999998874 77999999999999999999999 6999999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhc
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~l 296 (297)
|||+||...... -.+..+.|.+|+|||++.. +.|+.+.|+|++|||++|+
T Consensus 153 DFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl 203 (538)
T KOG0661|consen 153 DFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAEL 203 (538)
T ss_pred ccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHH
Confidence 999999764322 3456788999999999876 5677889999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=312.63 Aligned_cols=192 Identities=27% Similarity=0.347 Sum_probs=173.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
...|...+.||+|+.|.||.|..... +..||||.++.......+-+.+|+.+|+..+|+|||.+++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~---------~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIST---------KQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccC---------CceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 44688889999999999999865544 778999999887766667789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+|+||||++||+|.+.+... .+++.++..|+++++.||+||| ..||+|||||.+|||++.+|.+||+|||+
T Consensus 343 deLWVVMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeee
Confidence 9999999999999999998764 4899999999999999999999 59999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|..+..... ...+..|||+|||||++....|.++.||||||++++||+
T Consensus 416 caqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMv 463 (550)
T KOG0578|consen 416 CAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMV 463 (550)
T ss_pred eeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHh
Confidence 987765433 456688999999999999999999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=298.15 Aligned_cols=196 Identities=33% Similarity=0.459 Sum_probs=165.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|...+.||+|+||.||++...++ |...|+|.+...+....+.+.+|+.+|++|+|||||++++.....
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~---------g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKT---------GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCC---------CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 34688889999999999999987754 778999998776433367789999999999999999999974444
Q ss_pred C--eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEEcc
Q 022413 168 K--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISD 244 (297)
Q Consensus 168 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl~D 244 (297)
. .++++|||+++|+|.+++.+.. ..+++..++.+.+||+.||+||| ++|||||||||+|||++. ++.+||+|
T Consensus 87 ~~~~~~i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 87 ENDEYNIFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred cCeeeEeeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEecc
Confidence 3 6999999999999999998764 25999999999999999999999 599999999999999999 79999999
Q ss_pred ccccccCCC-CCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPA-GGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
||+++.... .........+.||+.|||||++.++. ...++|||||||++.+|+
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~ 216 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML 216 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEecc
Confidence 999986553 11122234578999999999999633 334899999999999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=315.33 Aligned_cols=191 Identities=28% Similarity=0.369 Sum_probs=170.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.-|++++.||.|+-|.|-+|++..+ |+..|||++.+.. ......+.+|+.||+.+.||||+++|++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~T---------GqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAET---------GQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhhcccc---------cceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 4588999999999999999977764 9999999998762 123467789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
...++|+|+||++||.|++++..+ +++++.++.++++||+.|+.||| ..+|+||||||+|+|||..+.+||+||
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeecc
Confidence 999999999999999999999987 67999999999999999999999 489999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcc-cccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYL-LSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslGv~l~~ll 297 (297)
|+|.+-.. ...-.+-||.|.|.|||++.|.+|.- ++||||+|||||.||
T Consensus 157 GMAsLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALL 206 (786)
T KOG0588|consen 157 GMASLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALL 206 (786)
T ss_pred ceeecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHH
Confidence 99986332 22345679999999999999999874 799999999999986
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=292.18 Aligned_cols=196 Identities=26% Similarity=0.317 Sum_probs=168.2
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh--hHHHHHHHHHHhcCCCCCCcccEEe
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLG 162 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~ 162 (297)
.+..++|+.+..|++|+||.||+|++..+ ++.||+|+++.+... ..-.-++|+.+|.+++|||||.+-+
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t---------~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkE 142 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKT---------DEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKE 142 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCc---------ceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEE
Confidence 33466899999999999999999976654 889999999865432 1123479999999999999999999
Q ss_pred EEEcC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 163 YCWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 163 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
+.... +.+|+|||||+. +|..++.... +++...++..+..|++.|++||| +..|+||||||+|+|+...|.+
T Consensus 143 VVvG~~~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~l 216 (419)
T KOG0663|consen 143 VVVGSNMDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGIL 216 (419)
T ss_pred EEeccccceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcE
Confidence 88754 679999999965 9999998775 67999999999999999999999 6999999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
||+|||+||.+.... ...+..+-|.+|+|||.+.+.+ |++..|+||+|||+.+||
T Consensus 217 KiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l 272 (419)
T KOG0663|consen 217 KIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELL 272 (419)
T ss_pred EecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHH
Confidence 999999999876542 2345566799999999999855 888999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.54 Aligned_cols=197 Identities=30% Similarity=0.454 Sum_probs=162.4
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh--------------hHHHHHHHHHHhc
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--------------GFEEWQSEVNFLG 150 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~~~~E~~~l~ 150 (297)
....++|++++.||+|.||.|-+|+...+ +..||||++.+.... ..++..+|+.||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~---------~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVD---------GKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCC---------CcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 44568999999999999999999987765 889999999754221 1357889999999
Q ss_pred CCCCCCcccEEeEEEcC--CeeEEEEEecCCCCHHHHHhhcCCCCCC-CCHHHHHHHHHHHHHHhcchhcCCCCceeccC
Q 022413 151 RLSHPNLVKLLGYCWED--KELLLVYEYMQRGSLENHLFRRNPSIQP-LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF 227 (297)
Q Consensus 151 ~l~h~nIv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dl 227 (297)
+++|||||+|+++..+. +.+|||+|||..|.+...- ...+ +.+.++++++++++.||+|||. +|||||||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDI 236 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDI 236 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHh--cCeecccc
Confidence 99999999999998876 5799999999988774432 1233 8999999999999999999995 99999999
Q ss_pred CCCcEEEcCCCceEEccccccccCCCC---CCcceeeccCCcccccCcceecccC---C-cccccchhhhhhhhhcC
Q 022413 228 KASNILLDGNYNAKISDFGLAKLGPAG---GESHVTTRVMGTYGYAAPEYVATGN---F-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 228 kp~Nill~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~sDvwslGv~l~~ll 297 (297)
||+|+||+++|++||+|||.+.....+ +.........|||.|+|||...++. + ..+-||||+||+||+||
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll 313 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL 313 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence 999999999999999999998755322 1122233468999999999998743 2 24679999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=307.81 Aligned_cols=198 Identities=26% Similarity=0.443 Sum_probs=169.5
Q ss_pred HHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCccc
Q 022413 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 82 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
.++.....+..+.+.||.|.||+||+|.|..+ ||||++.-.. .+..+.|.+|+..+++.+|.||+-
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL 452 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD------------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL 452 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc------------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence 34444556778889999999999999999876 9999987653 346789999999999999999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
|.|++..+.. .||+.+|+|-+|+.+|+..+ ..++....+.|+.||++|+.|||. ++|||||||..|||+++++.
T Consensus 453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred eehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCc
Confidence 9999988776 99999999999999998765 669999999999999999999995 99999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc---cCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT---GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~~ll 297 (297)
|||.|||++..-.............|...|||||++.. .+|++.|||||||+++||||
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl 587 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL 587 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH
Confidence 99999999865332222222333457888999999974 46899999999999999996
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.34 Aligned_cols=194 Identities=23% Similarity=0.321 Sum_probs=167.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||+||+|..... ++.||+|++.... ......+.+|+.++.+++||||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDT---------GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCC---------CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 3789999999999999999977654 7889999987542 223456788999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+...+|+||||++||+|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||||+.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeec
Confidence 999999999999999999999765 45899999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCc---------------------------------ceeeccCCcccccCcceecccCCcccccchhhhhh
Q 022413 246 GLAKLGPAGGES---------------------------------HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVIN 292 (297)
Q Consensus 246 g~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~ 292 (297)
|+++.+...... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 998754321100 00123579999999999999999999999999999
Q ss_pred hhhcC
Q 022413 293 VCMYL 297 (297)
Q Consensus 293 l~~ll 297 (297)
+|+|+
T Consensus 226 l~ell 230 (363)
T cd05628 226 MYEML 230 (363)
T ss_pred HHHHH
Confidence 99985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=295.68 Aligned_cols=197 Identities=27% Similarity=0.388 Sum_probs=172.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.++||.|.-++||+|+.... +..||||+++.++. ...+.+.+|+..|+.++||||++++..|.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~---------~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPT---------NEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeeccc---------CCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 356899999999999999999987654 78899999987654 34588899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.+..+|+||+||.+|++.+++...-+ ..+++..+..|.++++.||.||| ++|.||||||+.||||+.+|.|||+||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEcCc
Confidence 99999999999999999999987654 44899999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcce-e-eccCCcccccCcceecc--cCCcccccchhhhhhhhhc
Q 022413 246 GLAKLGPAGGESHV-T-TRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 246 g~a~~~~~~~~~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~l 296 (297)
|.+..+...+.... . ..+.|||+|||||++.. ..|++|+||||||++.+||
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~EL 225 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACEL 225 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHH
Confidence 98765555442221 2 56789999999999543 5799999999999999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=307.70 Aligned_cols=193 Identities=23% Similarity=0.277 Sum_probs=165.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.|++++.||+|+||+||+|....+ ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~---------~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDT---------HALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 588899999999999999987654 7889999987542 2344678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+||| ..||+||||||+||||+.++.+||+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCc
Confidence 99999999999999999999765 45888999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCc---------------------------------------------ceeeccCCcccccCcceecccCCc
Q 022413 247 LAKLGPAGGES---------------------------------------------HVTTRVMGTYGYAAPEYVATGNFY 281 (297)
Q Consensus 247 ~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 281 (297)
+++.+...... ......+||+.|+|||++.+..++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 97643210000 001235799999999999988899
Q ss_pred ccccchhhhhhhhhcC
Q 022413 282 LLSAKFGNVINVCMYL 297 (297)
Q Consensus 282 ~~sDvwslGv~l~~ll 297 (297)
.++|||||||++|+|+
T Consensus 227 ~~~DiwSlG~il~ell 242 (381)
T cd05626 227 QLCDWWSVGVILFEML 242 (381)
T ss_pred CccceeehhhHHHHHH
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=307.24 Aligned_cols=194 Identities=24% Similarity=0.304 Sum_probs=165.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|.+.+.||+|+||+||++....+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDT---------GKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCC---------CCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 3688999999999999999977654 7889999986532 233467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999999765 45889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCc---------------------------------------------ceeeccCCcccccCcceecccCC
Q 022413 246 GLAKLGPAGGES---------------------------------------------HVTTRVMGTYGYAAPEYVATGNF 280 (297)
Q Consensus 246 g~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 280 (297)
|+++........ ......+||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 998633210000 00012469999999999998899
Q ss_pred cccccchhhhhhhhhcC
Q 022413 281 YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 281 ~~~sDvwslGv~l~~ll 297 (297)
+.++|||||||++|+|+
T Consensus 226 ~~~~DiwSlGvil~ell 242 (377)
T cd05629 226 GQECDWWSLGAIMFECL 242 (377)
T ss_pred CCceeeEecchhhhhhh
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=306.13 Aligned_cols=194 Identities=24% Similarity=0.336 Sum_probs=167.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||+||+|....+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDT---------GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 4789999999999999999987654 7789999987542 233456788999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeec
Confidence 999999999999999999999765 45899999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcc------------------------------------eeeccCCcccccCcceecccCCcccccchhh
Q 022413 246 GLAKLGPAGGESH------------------------------------VTTRVMGTYGYAAPEYVATGNFYLLSAKFGN 289 (297)
Q Consensus 246 g~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl 289 (297)
|+++.+....... .....+||+.|+|||++.+..++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9987543211000 0112469999999999998999999999999
Q ss_pred hhhhhhcC
Q 022413 290 VINVCMYL 297 (297)
Q Consensus 290 Gv~l~~ll 297 (297)
||++|+|+
T Consensus 226 G~il~el~ 233 (364)
T cd05599 226 GVIMYEML 233 (364)
T ss_pred hhHHHHhh
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=304.37 Aligned_cols=195 Identities=26% Similarity=0.353 Sum_probs=172.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|..++++|+|+||.+++++++.+ +..+++|.+..... ...+...+|+.++++++|||||.+.+.|.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~---------~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~ 73 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSD---------DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE 73 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccC---------CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh
Confidence 35799999999999999999877665 56799999876533 23346789999999999999999999999
Q ss_pred cCCe-eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 166 EDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 166 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
+++. ++|||+||+||+|.+.|.+++ ...++++.+..++.|++.|+.||| +..|+|||||+.|||++.++.|||.|
T Consensus 74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 74 EDGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred cCCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecc
Confidence 9988 999999999999999998775 355899999999999999999999 69999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|+.+.... ....+..|||.||+||++.+.+|..++|+|||||++|+|.
T Consensus 150 fGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 150 FGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred hhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 99999875432 2455678999999999999999999999999999999984
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=301.23 Aligned_cols=190 Identities=28% Similarity=0.413 Sum_probs=167.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 87 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGT---------GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF 87 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCC---------CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45799999999999999999987654 7889999986542 23346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+++..|+||||+++++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||||+.++.+||+|
T Consensus 88 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kl~D 161 (329)
T PTZ00263 88 QDENRVYFLLEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVKVTD 161 (329)
T ss_pred EcCCEEEEEEcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999999765 45788999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++..... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 162 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 209 (329)
T PTZ00263 162 FGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209 (329)
T ss_pred ccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence 9999865322 22357999999999999988999999999999999985
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=306.00 Aligned_cols=193 Identities=23% Similarity=0.286 Sum_probs=165.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.|+++++||+|+||+||+|..... +..+|+|.+.... ......+.+|+.++++++||||+++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~---------~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDT---------KALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCC---------CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 588899999999999999987654 7789999987543 2334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+.+|+||||+++|+|.+++.+. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECC
Confidence 99999999999999999999765 45788999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCC---------------------------------------------cceeeccCCcccccCcceecccCCc
Q 022413 247 LAKLGPAGGE---------------------------------------------SHVTTRVMGTYGYAAPEYVATGNFY 281 (297)
Q Consensus 247 ~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 281 (297)
+++.+..... .......+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 9753211000 0001235799999999999999999
Q ss_pred ccccchhhhhhhhhcC
Q 022413 282 LLSAKFGNVINVCMYL 297 (297)
Q Consensus 282 ~~sDvwslGv~l~~ll 297 (297)
.++|||||||++|+|+
T Consensus 227 ~~~DiwSlGvil~ell 242 (382)
T cd05625 227 QLCDWWSVGVILYEML 242 (382)
T ss_pred CeeeEEechHHHHHHH
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=306.19 Aligned_cols=194 Identities=23% Similarity=0.279 Sum_probs=165.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++++.||+|+||.||+|..... ++.||+|.+..... .....+.+|+.+|++++||||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDT---------NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCC---------CCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 3689999999999999999987654 78899999875422 23456789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+++.+|+||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999999765 45788999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCC-----------------------------------------cceeeccCCcccccCcceecccCCcccc
Q 022413 246 GLAKLGPAGGE-----------------------------------------SHVTTRVMGTYGYAAPEYVATGNFYLLS 284 (297)
Q Consensus 246 g~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~s 284 (297)
|++..+..... .......+||+.|+|||++.+..++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 99753211000 0001235799999999999998999999
Q ss_pred cchhhhhhhhhcC
Q 022413 285 AKFGNVINVCMYL 297 (297)
Q Consensus 285 DvwslGv~l~~ll 297 (297)
|||||||++|+|+
T Consensus 226 DiwSlGvilyell 238 (376)
T cd05598 226 DWWSVGVILYEML 238 (376)
T ss_pred eeeeccceeeehh
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=297.11 Aligned_cols=189 Identities=27% Similarity=0.330 Sum_probs=166.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||+|....+ ++.||+|.+.... .+..+.+.+|+.++++++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRIS---------EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCC---------CCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 3689999999999999999987654 7889999986532 233466889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEec
Confidence 999999999999999999999765 45889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++..... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~ 192 (291)
T cd05612 146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192 (291)
T ss_pred CcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 999865321 22357999999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=297.75 Aligned_cols=186 Identities=31% Similarity=0.396 Sum_probs=162.1
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 171 (297)
++||+|+||.||+|....+ ++.||+|.+.... ......+.+|+.++++++||||+++++++...+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKAT---------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 4699999999999987654 7889999987542 233456789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+||||+++++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||||+.++.+||+|||+++..
T Consensus 72 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 72 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 999999999999998765 45889999999999999999999 589999999999999999999999999998753
Q ss_pred CCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 252 PAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 252 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 189 (323)
T cd05571 146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189 (323)
T ss_pred ccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhh
Confidence 2221 1233467999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.89 Aligned_cols=189 Identities=28% Similarity=0.361 Sum_probs=167.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||+|.+... ++.||+|.+.... ......+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDT---------GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCC---------CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 3689999999999999999987654 7789999987542 233466789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999999765 45889999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++.... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 192 (333)
T cd05600 146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL 192 (333)
T ss_pred cCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhh
Confidence 99975432 233457999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=275.99 Aligned_cols=194 Identities=28% Similarity=0.421 Sum_probs=171.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
..++|++++.||+|.||.||+|+.+.. +..||+|++.+... +-...+.+|++|-..|+||||+++|++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks---------~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKS---------LFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred chhhccccccccCCccccEeEeeeccC---------CcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 356899999999999999999987765 78899999876532 222567899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
|.+....|+++||..+|+|...|..... ..+++.....+..|++.||.||| .++|+||||||+|+|++.++.+||+
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiA 166 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIA 166 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeecc
Confidence 9999999999999999999999984432 45888888999999999999999 6999999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||.+...+ .....+.|||..|.+||++.+...+...|+|++|+++|++|
T Consensus 167 dfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 167 DFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred CCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 999987543 22456689999999999999999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.45 Aligned_cols=205 Identities=27% Similarity=0.355 Sum_probs=165.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.++||+|+||.||+|.+... .+...+..||+|.+.... ....+.+.+|+.++..+ +||||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 356899999999999999999975321 112236679999987543 23346788999999999 799999999988
Q ss_pred EcCC-eeEEEEEecCCCCHHHHHhhcCCC---------------------------------------------------
Q 022413 165 WEDK-ELLLVYEYMQRGSLENHLFRRNPS--------------------------------------------------- 192 (297)
Q Consensus 165 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------- 192 (297)
...+ .++++|||+++|+|.+++......
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7654 689999999999999999753210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCC
Q 022413 193 -------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265 (297)
Q Consensus 193 -------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 265 (297)
..++++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++...............+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 134778889999999999999999 58999999999999999999999999999986533221111223346
Q ss_pred cccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 266 TYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 266 t~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.|+|||++.+..++.++|||||||++|+|+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~ 270 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHH
Confidence 78899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.40 Aligned_cols=191 Identities=28% Similarity=0.343 Sum_probs=166.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+.... +..||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNED--------FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCC--------CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 457999999999999999999765431 3579999886432 23346778999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+.+|+||||+++|+|.+++... ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEec
Confidence 9999999999999999999999765 45889999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++.... ......||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 175 FG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 222 (340)
T PTZ00426 175 FGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222 (340)
T ss_pred CCCCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHh
Confidence 999986432 123457999999999999888999999999999999985
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=285.24 Aligned_cols=195 Identities=27% Similarity=0.341 Sum_probs=165.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh--hHHHHHHHHHHhcCCCCCC-cccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPN-LVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~ 165 (297)
..|...++||+|+||+||+|+...+ |..||+|++.....+ ......+|+.+|+.|+|+| |+.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~---------g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRT---------GKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecC---------CCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 3567778899999999999987765 789999998765332 2245679999999999999 999999999
Q ss_pred cCC------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
..+ .+++|+||+ ..+|..++....+....++...++.+++||+.||+||| +++|+||||||.||||+++|.
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSGV 158 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCCc
Confidence 877 899999999 55999999876543345777899999999999999999 499999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+|+....... ..+...+|..|+|||++.+. .|+...|+||+|||+++|+
T Consensus 159 lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~ 215 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMF 215 (323)
T ss_pred EeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHH
Confidence 99999999986543222 23445789999999999986 5788899999999999984
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.70 Aligned_cols=194 Identities=23% Similarity=0.334 Sum_probs=166.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||+||++..... +..||+|.+.... ......+.+|+.++..++||||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDT---------GHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3688999999999999999987654 7889999987532 233467788999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||++||+|.+++.+. ..+++..+..++.|++.||+||| +.||+||||||+||||+.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~Df 145 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDF 145 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999999765 45889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCC---------------------------------cceeeccCCcccccCcceecccCCcccccchhhhhh
Q 022413 246 GLAKLGPAGGE---------------------------------SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVIN 292 (297)
Q Consensus 246 g~a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~ 292 (297)
|+++.+..... .......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 225 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence 99875422100 000123579999999999999999999999999999
Q ss_pred hhhcC
Q 022413 293 VCMYL 297 (297)
Q Consensus 293 l~~ll 297 (297)
+|+|+
T Consensus 226 lyel~ 230 (360)
T cd05627 226 MYEML 230 (360)
T ss_pred eeecc
Confidence 99986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=289.84 Aligned_cols=189 Identities=28% Similarity=0.365 Sum_probs=159.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC--
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED-- 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 167 (297)
.|.-.+++|.|+||.||+|...+. +..||||++-++..- -.+|+++|+.++|||||++.-+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~---------~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRET---------EEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCC---------CceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 577789999999999999988765 678999998765432 25799999999999999999888743
Q ss_pred ---CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC-CceEEc
Q 022413 168 ---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKIS 243 (297)
Q Consensus 168 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~-~~~kl~ 243 (297)
-.+.+||||++. +|.+.++........++...++-+.+||++||+||| ..||+||||||.|+|+|.+ |.+|||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEEec
Confidence 256789999965 999999854333366788888889999999999999 4999999999999999976 999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
|||.|+.+..+... .+...|..|+|||.+.+. .|+.+.||||.||++.|||
T Consensus 169 DFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl 220 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELL 220 (364)
T ss_pred cCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHh
Confidence 99999988665442 334568999999999985 5888999999999999986
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=294.22 Aligned_cols=186 Identities=29% Similarity=0.384 Sum_probs=161.2
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 171 (297)
+.||+|+||.||++....+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKAT---------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 4699999999999987654 7889999987542 234456778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+||||+++++|..++... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++..
T Consensus 72 lv~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 72 FVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 999999999999888765 45889999999999999999999 589999999999999999999999999998753
Q ss_pred CCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 252 PAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 252 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 189 (323)
T cd05595 146 ISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189 (323)
T ss_pred cCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHH
Confidence 2211 1223457999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=293.55 Aligned_cols=186 Identities=30% Similarity=0.385 Sum_probs=161.7
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 171 (297)
+.||+|+||.||++....+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKAS---------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 4699999999999987654 7889999987542 234467789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+||||+++++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 72 lv~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 999999999999988765 45889999999999999999999 589999999999999999999999999998753
Q ss_pred CCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 252 PAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 252 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 189 (328)
T cd05593 146 ITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189 (328)
T ss_pred CCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHh
Confidence 2211 1223457999999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.70 Aligned_cols=208 Identities=27% Similarity=0.436 Sum_probs=168.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCC-------ccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCccc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTL-------APSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-------~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
.++|++.+.||+|+||.||+|.+....- ...+...+..||+|.+.... ......+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999998754310 01123345689999987653 333467899999999999999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCcee
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNP---------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY 224 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH 224 (297)
+++++.+.+..++||||+++++|.+++..... ....+++..++.++.||+.||.||| +.||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCccc
Confidence 99999999999999999999999999865321 1134677889999999999999999 589999
Q ss_pred ccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 225 RDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 225 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|+|+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999998653322212222345678899999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=287.67 Aligned_cols=192 Identities=29% Similarity=0.403 Sum_probs=165.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.|+..+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.++++++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRAT---------GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecC---------CceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 377889999999999999987654 78899999875432 223467889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg 147 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLG 147 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865322 35889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 195 (285)
T cd05631 148 LAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI 195 (285)
T ss_pred CcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHH
Confidence 998653321 223457899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=292.85 Aligned_cols=187 Identities=31% Similarity=0.392 Sum_probs=161.0
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 171 (297)
+.||+|+||.||++..... +..||+|.+.... ......+..|+.+++.++||||+++++++...+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKAT---------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 4699999999999977654 7889999987542 233456778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+ ..||+||||||+|||++.++.+||+|||+++..
T Consensus 72 lv~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 72 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999999988765 458999999999999999999994 379999999999999999999999999998753
Q ss_pred CCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 252 PAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 252 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (325)
T cd05594 147 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 190 (325)
T ss_pred CCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeec
Confidence 2221 1223457999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=300.16 Aligned_cols=194 Identities=23% Similarity=0.261 Sum_probs=165.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
..++|++.+.||+|+||.||++.+... ++.+|+|.+.+.. ......+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSS---------QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 346899999999999999999987654 7789999986432 2233567899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+++.+|+||||+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999998653 3788899999999999999999 5899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccC----CcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN----FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~~ll 297 (297)
|||++........ ......+||+.|+|||++.+.. ++.++|+|||||++|+|+
T Consensus 185 DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell 241 (370)
T cd05621 185 DFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241 (370)
T ss_pred ecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence 9999986543221 1223567999999999997543 778999999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=307.85 Aligned_cols=198 Identities=21% Similarity=0.203 Sum_probs=170.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
.|.+.+.||+|+||.||+|....+. +..|++|.+..........+.+|+.+++.++||||+++++++...+.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~--------~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDP--------KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCC--------CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 4899999999999999999765431 45688888766555555677889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
+|+||||+++|+|.+++........++++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 99999999999999988754333456889999999999999999999 5899999999999999999999999999998
Q ss_pred cCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..............+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 265 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHH
Confidence 654332222334567999999999999989999999999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=291.53 Aligned_cols=184 Identities=27% Similarity=0.334 Sum_probs=160.6
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
||+|+||.||+|....+ ++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~---------~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRDT---------QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 69999999999987654 778999998653 223446778999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 72 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 72 LAFINGGELFHHLQRE----GRFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred EcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 9999999999999765 45889999999999999999999 59999999999999999999999999999975432
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.. .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 187 (312)
T cd05585 146 DD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187 (312)
T ss_pred CC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHH
Confidence 21 2234467999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=283.23 Aligned_cols=194 Identities=28% Similarity=0.347 Sum_probs=167.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCC--cchhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP--ESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
...|...+.||+|+||.|..+.+..+ |..||+|++.. ...-..++..+|+.+|+.++|+||+.+.+++.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t---------~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRT---------GEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCC---------CCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 44677789999999999999977765 78899999973 34455688899999999999999999999987
Q ss_pred c-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 166 E-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 166 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
. -+.+|+|+|+| +.+|.+.|+.+ ..++...+..+++|+++||+|+|| .+|+||||||.|+|++.+..+
T Consensus 92 p~~~~~f~DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred cccccccceeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCCE
Confidence 6 25799999999 66999999876 458999999999999999999995 999999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
||||||+|+...........+...-|.+|+|||++.. ..|+...||||.|||+.+||
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL 222 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML 222 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH
Confidence 9999999997654322233356678999999999875 56888999999999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.97 Aligned_cols=192 Identities=27% Similarity=0.368 Sum_probs=171.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh---hHHHHHHHHHHhcCCC-CCCcccEEe
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLS-HPNLVKLLG 162 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~~~~ 162 (297)
....|++.+.||+|.||.||++....+ |..+|+|.+.+.... ....+.+|+.+|+++. ||||+.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~t---------g~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKST---------GKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCC---------CceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 456799999999999999999977664 888999999876543 3467899999999999 999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC----CC
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG----NY 238 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~----~~ 238 (297)
+|++...+++|||++.||.|.+.+... . +++..+..++.|++.+++||| ..||+||||||+|+|+.. ++
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~----~-~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK----H-YSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc----c-CCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCCCC
Confidence 999999999999999999999999876 2 899999999999999999999 599999999999999954 35
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+|++|||++..... .......+|||+|+|||++....|+...|+||+||++|.||
T Consensus 177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL 232 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILL 232 (382)
T ss_pred cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHh
Confidence 799999999987654 23456789999999999999899999999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.45 Aligned_cols=196 Identities=22% Similarity=0.254 Sum_probs=166.6
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEE
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
....++|++.+.||+|+||.||++.+... ++.+|+|.+.... ......+.+|+.+++.++||||++++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~---------~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKST---------RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCC---------CcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 33457899999999999999999987754 7789999986432 22335577899999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+.+.+.+.+|+||||+++++|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999998653 3788889999999999999999 59999999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccC----CcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN----FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 183 L~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell 241 (371)
T cd05622 183 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241 (371)
T ss_pred EEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHH
Confidence 999999986543221 1223467999999999987543 778999999999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=296.31 Aligned_cols=194 Identities=27% Similarity=0.359 Sum_probs=168.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|.+.+.||+|+||+||+|....+ ++.||+|++.... ......+..|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDT---------GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCC---------CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 3689999999999999999987754 7889999987542 133467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++++|.+++... ..+++..++.++.||+.||+||| ..||+||||||+||||+.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecC
Confidence 999999999999999999999865 45889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCC---------------------------CcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGG---------------------------ESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 224 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhc
Confidence 9997654322 001123456999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=294.49 Aligned_cols=192 Identities=28% Similarity=0.370 Sum_probs=171.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..|...+.||+|+||.||+|.+... ++.||+|+++.+. ...++.+++|+.+|.+++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t---------~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKT---------KKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeeccc---------cceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 4577789999999999999988765 7889999998764 34568899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
..+|++||||.||++.+.+... ..+.+..+..|+++++.||.|||+ .+.+|||||+.|||+..+|.+||+|||.
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecce
Confidence 9999999999999999999865 334778888899999999999994 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+..+..... ...+++|||.|||||++....|+.++||||||++.|+|.
T Consensus 158 a~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla 205 (467)
T KOG0201|consen 158 AGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELA 205 (467)
T ss_pred eeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHh
Confidence 987655432 336789999999999999889999999999999999984
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=289.77 Aligned_cols=191 Identities=30% Similarity=0.362 Sum_probs=163.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCC-CCcccEEeEEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSH-PNLVKLLGYCW 165 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~ 165 (297)
+|++.+.||+|+||.||+|..... ++.||+|.+.+.. ....+.+..|..++..+.| ++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGT---------DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 588899999999999999987654 6789999987542 2344677889999999976 56888999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeec
Confidence 999999999999999999998765 45889999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 146 GMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred CcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHH
Confidence 99875322211 233467999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=291.66 Aligned_cols=194 Identities=24% Similarity=0.298 Sum_probs=166.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|.+.+.||+|+||+||++..... +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKAT---------GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 4689999999999999999977654 78899999875422 23456789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccC
Confidence 9999999999999999999997653 45899999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceec------ccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVA------TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGv~l~~ll 297 (297)
|++......... ......||+.|+|||++. ...++.++|||||||++|+|+
T Consensus 147 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 203 (330)
T cd05601 147 GSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203 (330)
T ss_pred CCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec
Confidence 999865433221 223457899999999987 456778999999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.13 Aligned_cols=194 Identities=22% Similarity=0.251 Sum_probs=165.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||+++.... ++.||+|.+.... ......+.+|..++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHT---------ERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4789999999999999999987654 7789999987532 223355778999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..|+||||++||+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEec
Confidence 9999999999999999999997643 45888999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~ll 297 (297)
|+++....... .......||+.|+|||++.+ +.++.++|+|||||++|+|+
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell 202 (331)
T cd05624 147 GSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202 (331)
T ss_pred cceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhh
Confidence 99976543221 12233579999999999875 46788999999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=289.29 Aligned_cols=192 Identities=26% Similarity=0.364 Sum_probs=168.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||++.+... +..+|+|.+.... ....+++.+|++++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPS---------GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCC---------CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 46899999999999999999987654 7789999987653 2344678999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence 99999999999999999999765 458899999999999999999995 3579999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++..... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 150 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 196 (331)
T cd06649 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196 (331)
T ss_pred cccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 98755322 223457899999999999989999999999999999984
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=290.31 Aligned_cols=194 Identities=23% Similarity=0.274 Sum_probs=164.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||+||++..... +..||+|.+.+.. ....+.+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNT---------GQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCC---------CCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 4789999999999999999987654 7789999987532 223356788999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++++|.+++.+.. ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999999997542 45889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~ll 297 (297)
|++........ .......||+.|+|||++.. ..++.++|||||||++|+|+
T Consensus 147 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (331)
T cd05597 147 GSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202 (331)
T ss_pred CceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh
Confidence 99875433221 11223469999999999873 45778999999999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=289.23 Aligned_cols=191 Identities=29% Similarity=0.331 Sum_probs=163.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
+|.+.+.||+|+||.||+|..... +..||+|.+.+.. ....+.+..|..++..+ +|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGT---------DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 588899999999999999987654 6789999987542 22334567788888777 4899999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccC
Confidence 999999999999999999998765 45889999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 G~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 195 (323)
T cd05616 146 GMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195 (323)
T ss_pred CCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHH
Confidence 9987533211 1233467999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=295.57 Aligned_cols=193 Identities=23% Similarity=0.252 Sum_probs=164.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||++..... +..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSS---------KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 46799999999999999999987654 7889999986532 22334577899999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+++.+|+||||+++|+|.+++... .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999999999998653 3788889999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceeccc----CCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG----NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGv~l~~ll 297 (297)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell 241 (370)
T cd05596 186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241 (370)
T ss_pred ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH
Confidence 999976533221 122345799999999998753 3788999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=287.92 Aligned_cols=190 Identities=29% Similarity=0.388 Sum_probs=161.0
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc----hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
++.||+|+||.||+++.... ...++.||+|.+.... ......+..|+.+|+.++||||+++++++..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTG------ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEccc------CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 36799999999999976432 1237889999987532 2233567789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.|+||||+++++|.+++... ..+.+..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 75 LYLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred EEEEEeCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 99999999999999999765 45788889999999999999999 5999999999999999999999999999987
Q ss_pred cCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 149 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 194 (323)
T cd05584 149 ESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDML 194 (323)
T ss_pred ecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHh
Confidence 532221 1233457999999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=288.87 Aligned_cols=186 Identities=26% Similarity=0.400 Sum_probs=160.9
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||.||+|.+..+ +..||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---------~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKT---------RRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 4699999999999987654 7789999987542 23345678899999998 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 9999999999999988765 45899999999999999999999 58999999999999999999999999999874
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 190 (329)
T cd05588 146 GIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred cccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHH
Confidence 32211 1233467999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=308.83 Aligned_cols=204 Identities=29% Similarity=0.437 Sum_probs=171.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
+.+.+..+.||+|+||+||+|....- ........||||.++..... ..++|++|+++|..|+|||||+|+|++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 45677789999999999999976542 12223568999999876544 67899999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCC----------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPS----------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
++.+++|+|||..|||.++|..+.+. ..+++..+.+.||.||+.||+||- ++.+|||||..+|+||.+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNCLVGE 638 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhceecc
Confidence 99999999999999999999755432 234889999999999999999999 488999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...|||+|||++|..=..+..+....-.-...||+||.|..++|+++|||||+||+|||++
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIF 699 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIF 699 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhh
Confidence 9999999999998643333222222223467899999999999999999999999999975
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=287.44 Aligned_cols=186 Identities=29% Similarity=0.382 Sum_probs=157.7
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcC-CCCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGR-LSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||.||+|.+..+ +..||+|.+.... ....+.+..|..++.. .+||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGT---------NEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 4699999999999987654 7789999987542 2233455667777765 4799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||++|++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~gg~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSS----GRFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 9999999999999998765 45889999999999999999999 59999999999999999999999999999975
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 190 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHH
Confidence 43221 2234467999999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=289.00 Aligned_cols=195 Identities=28% Similarity=0.345 Sum_probs=164.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc----hhhHHHHHHHHHHhcCCC-CCCcccEEeEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRLS-HPNLVKLLGYC 164 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 164 (297)
+|++.+.||+|+||.||++..... ..++..||+|.+.+.. ....+.+..|+.+++.+. ||||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG------HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 488899999999999999876431 1237889999986532 223356788999999995 99999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
...+.+++||||+++++|.+++..+ ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEee
Confidence 9999999999999999999999765 45889999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
||+++....... .......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 149 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 201 (332)
T cd05614 149 FGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201 (332)
T ss_pred CcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhh
Confidence 999976433221 1223467999999999998654 788999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=288.29 Aligned_cols=189 Identities=31% Similarity=0.426 Sum_probs=160.4
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHh---cCCCCCCcccEEeEE
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFL---GRLSHPNLVKLLGYC 164 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~~~~~~ 164 (297)
|++.+.||+|+||.||+|.+..+ +..||+|.+.+.. ....+.+.+|+.++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKT---------GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 67789999999999999987654 7889999987542 22335566666554 567899999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
...+..|+||||+++++|..++.. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCc
Confidence 999999999999999999988754 34899999999999999999999 59999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... .......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 145 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 195 (324)
T cd05589 145 FGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195 (324)
T ss_pred ccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH
Confidence 99987532211 1234467999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=288.98 Aligned_cols=194 Identities=22% Similarity=0.261 Sum_probs=164.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.++||+|+||.||++..... ++.+|+|.+.+.. ......+..|+.++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNA---------DKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCC---------CCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 3688999999999999999987654 6789999986532 222345788999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++|+|.+++.+.. ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~Df 146 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADF 146 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997643 45889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
|++........ .......||+.|+|||++. ...++.++|||||||++|+|+
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell 202 (332)
T cd05623 147 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202 (332)
T ss_pred chheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh
Confidence 99875432221 1223457999999999986 346888999999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=288.12 Aligned_cols=186 Identities=26% Similarity=0.414 Sum_probs=160.2
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||+||+|....+ ++.+|+|.+.+. .....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKT---------ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCC---------CCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 4699999999999987654 778999998754 223345677899888776 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
++||||+++++|..++... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~E~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 9999999999999888765 45899999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (329)
T cd05618 146 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred ccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHh
Confidence 32211 1233467999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=287.30 Aligned_cols=186 Identities=30% Similarity=0.405 Sum_probs=157.4
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHH-HhcCCCCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVN-FLGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
+.||+|+||+||+|.+..+ ++.||+|.+..... .....+..|.. +++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKAD---------GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 4699999999999987654 78899999875421 22244455544 56789999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|..++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 9999999999999998765 45889999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.... ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell 190 (323)
T cd05575 146 GIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190 (323)
T ss_pred cccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhh
Confidence 3221 11233457999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.88 Aligned_cols=191 Identities=21% Similarity=0.232 Sum_probs=163.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|.+.+.||+|+||.||++...+. ..+..|++|.+.... ...+|+.++++++||||+++++++...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 45799999999999999999875432 226779999876542 346799999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...+++||++. ++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|||+
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCcc
Confidence 99999999994 6898888543 56899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...............||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 281 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 97654432222233467999999999999999999999999999999984
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=287.12 Aligned_cols=186 Identities=30% Similarity=0.377 Sum_probs=159.5
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||.||+|..... ++.||+|.+.... ....+.+..|.+++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGT---------DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECCC---------CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 4699999999999987654 7789999987542 23345667888888866 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|..++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 9999999999999998765 45889999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 190 (321)
T cd05591 146 GILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM 190 (321)
T ss_pred cccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHh
Confidence 33221 1233457999999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=283.12 Aligned_cols=193 Identities=24% Similarity=0.338 Sum_probs=162.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|....+ +..||+|.+..... .....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLT---------ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCC---------CCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 35799999999999999999977654 77899999875432 223567799999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++..++||||+++ +|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG 148 (288)
T cd07871 75 ERCLTLVFEYLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFG 148 (288)
T ss_pred CCeEEEEEeCCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCc
Confidence 9999999999975 9999887543 34788899999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~ 198 (288)
T cd07871 149 LARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA 198 (288)
T ss_pred ceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHH
Confidence 9875432211 1233468999999999875 56888999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=294.04 Aligned_cols=187 Identities=21% Similarity=0.222 Sum_probs=161.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.+.||+|+||.||+|.+... ++.||+|.... ..+.+|+.++++++||||+++++++...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~---------~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKT---------CEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCC---------CCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 45799999999999999999987654 78899996532 3467899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++|||++ +++|..++... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|||+
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG~ 228 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGA 228 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCCc
Confidence 9999999999 46898888664 45789999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 229 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 277 (391)
T PHA03212 229 ACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277 (391)
T ss_pred cccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 97532211 11223467999999999999989999999999999999985
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=286.81 Aligned_cols=186 Identities=28% Similarity=0.405 Sum_probs=159.8
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||+||+|....+ +..||+|.+.+.. ....+.+..|..++..+ +||||+++++++...+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKES---------GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCC---------CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 4699999999999987654 7789999987542 23345677888888876 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred EEEEcCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 9999999999999998765 45889999999999999999999 59999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (320)
T cd05590 146 GIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190 (320)
T ss_pred cCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHh
Confidence 32221 1234467999999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=286.19 Aligned_cols=186 Identities=30% Similarity=0.391 Sum_probs=156.9
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHH-HhcCCCCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVN-FLGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||.||+|.+..+ +..||+|.+.... ......+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSD---------GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 4699999999999987654 7889999986542 122344555554 67889999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|...+... ..+++..+..++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999999999888754 45788899999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.... ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (321)
T cd05603 146 GVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190 (321)
T ss_pred CCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhh
Confidence 3221 11234467999999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=287.37 Aligned_cols=186 Identities=30% Similarity=0.385 Sum_probs=157.5
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHH-HhcCCCCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVN-FLGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||+||+|....+ +..+|+|.+.... ......+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLD---------GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 4699999999999987654 7889999986542 223345555554 57789999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|..++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 9999999999999988765 45889999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 190 (325)
T cd05604 146 GIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190 (325)
T ss_pred CCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhh
Confidence 32211 1233467999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=293.40 Aligned_cols=196 Identities=30% Similarity=0.429 Sum_probs=164.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.+..+.++||+|+||.||+|.+...... ....||+|..... ....+.++.+|+++|++++|||||++||+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3555678999999999999987753210 0122899988752 3456789999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.+..+++|||+|.||+|.++|.... ..++..+...++.+.+.||+||| ..+++||||..+|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEeCcc
Confidence 9999999999999999999998764 35889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceee-ccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTT-RVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++.... ..... ...-...|+|||.+..+.|++++|||||||++||.+
T Consensus 307 GLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 307 GLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred ccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 99875321 01111 112357899999999999999999999999999874
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.28 Aligned_cols=190 Identities=23% Similarity=0.345 Sum_probs=155.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC------CCCcccE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS------HPNLVKL 160 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~~ 160 (297)
..++|++.++||+|+||+||+|.+... +..||+|+++.... ....+..|+.+++.++ |++|+++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~---------~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKR---------KEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCC---------CeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 457899999999999999999987654 77899999864322 2234456777766664 4568899
Q ss_pred EeEEEcC-CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-
Q 022413 161 LGYCWED-KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY- 238 (297)
Q Consensus 161 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~- 238 (297)
++++..+ ..+++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ +.|||||||||+|||++.++
T Consensus 197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred EEEEEcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecCCc
Confidence 9988765 5789999988 78999988765 458999999999999999999995 36999999999999998765
Q ss_pred ---------------ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 ---------------NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ---------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 49999999876421 1233467999999999999999999999999999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=283.95 Aligned_cols=193 Identities=24% Similarity=0.342 Sum_probs=162.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|....+ +..||+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVN---------GKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCC---------CCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 46899999999999999999987653 77899999875432 223456789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
....++||||+. ++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg 148 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFG 148 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCC
Confidence 999999999995 68888886543 45788899999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 198 (303)
T cd07869 149 LARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198 (303)
T ss_pred cceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence 987543221 12233568999999999875 45788899999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=274.81 Aligned_cols=193 Identities=24% Similarity=0.349 Sum_probs=169.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..+.|++.++||+|+|+.||++.+.. +|+.+|+|+++... ....+++.+|+.|.+.|+||||+++++.+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 35678889999999999999975554 38889999987543 33568889999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CCceE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NYNAK 241 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~~~k 241 (297)
.+....|+|.|++.|++|..-|..+ ..+++..+-+.+.||+.||.||| .++|||||+||+|+|+.. ..-+|
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCcee
Confidence 9999999999999999998887766 55889999999999999999999 599999999999999954 45599
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+|..+.. ......+.|||+|||||++...+|+..+|||+.||+||.||
T Consensus 154 L~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 154 LADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred ecccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 999999998762 23456788999999999999999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.69 Aligned_cols=192 Identities=26% Similarity=0.369 Sum_probs=167.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||++.+..+ +..+|+|.+.... ......+.+|++++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~---------~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPS---------GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCC---------CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 46899999999999999999977654 7789999887542 2334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCC
Confidence 99999999999999999999765 457889999999999999999995 3579999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... ......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 196 (333)
T cd06650 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196 (333)
T ss_pred cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 98754321 123356899999999999888999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=292.39 Aligned_cols=205 Identities=30% Similarity=0.366 Sum_probs=166.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+... .+...+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 355799999999999999999975321 112236689999987543 23446788999999999 799999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCC-----------------------------------------------------
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNP----------------------------------------------------- 191 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 191 (297)
.+.+..++||||+++|+|.+++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999999965321
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 192 ------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 192 ------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 0124788889999999999999999 58999999999999999999999999999986543
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...........++..|+|||++.+..++.++|||||||++|+|+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ell 310 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHH
Confidence 22211122234567899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.83 Aligned_cols=186 Identities=28% Similarity=0.356 Sum_probs=156.0
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHH-HHhcCCCCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEV-NFLGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~-~~l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
+.||+|+||+||+|++..+ +..||+|.+..... .....+..|. .+++.++||||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAE---------EKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 4699999999999987654 67899999865321 2223344444 456789999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|.+++... ..+.+..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999999999999764 45788888999999999999999 59999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (325)
T cd05602 146 NIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190 (325)
T ss_pred cccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHh
Confidence 32211 1234467999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.23 Aligned_cols=186 Identities=27% Similarity=0.412 Sum_probs=161.0
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||+||+|..... ++.+|+|.+.... ....+.+.+|+.++.++ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKN---------DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 4699999999999987654 7789999987642 23345678899999888 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|..++... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 9999999999999988765 45899999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 190 (327)
T cd05617 146 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190 (327)
T ss_pred ccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHH
Confidence 32211 1234567999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=286.31 Aligned_cols=191 Identities=28% Similarity=0.346 Sum_probs=163.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCC-CCCcccEEeEEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW 165 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 165 (297)
+|...++||+|+||.||+|....+ +..||+|.+.... ....+.+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGT---------DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 477789999999999999987654 7889999987542 223456778888988886 678889999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+.+|+||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEecc
Confidence 999999999999999999998765 45899999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... .......||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 146 GMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred ccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHH
Confidence 9987532221 1233456999999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=279.79 Aligned_cols=188 Identities=29% Similarity=0.424 Sum_probs=161.2
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
||+|+||+||++.+..+ ++.+|+|.+..... ...+.+..|+.+++.++||||+++++++......++|
T Consensus 1 lg~G~~g~Vy~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRAT---------GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEccC---------CcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 68999999999977654 77899999875422 2335677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++.........+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 9999999999888654333356899999999999999999999 58999999999999999999999999999976543
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 191 (280)
T cd05608 150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191 (280)
T ss_pred CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence 221 223457899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.70 Aligned_cols=186 Identities=28% Similarity=0.389 Sum_probs=158.7
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 170 (297)
++||+|+||.||+|.+..+ +..||+|.+.... ......+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGK---------GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 4699999999999987654 7889999987542 12335566788887754 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred EEEECCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 9999999999999998765 45888999999999999999999 58999999999999999999999999999874
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~ 190 (316)
T cd05620 146 NVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190 (316)
T ss_pred cccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHH
Confidence 32221 1234567999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=285.70 Aligned_cols=188 Identities=24% Similarity=0.364 Sum_probs=156.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+|++.+.||+|+||.||+|.+..+ ++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPT---------GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCC---------CCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 4677889999999999999987654 77899999865432 3346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+++||||+++++|.+. ....+..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred CeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 999999999999998643 22566778899999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~ll 297 (297)
++...... .......||+.|+|||++.. ...+.++|||||||++|+|+
T Consensus 215 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~ 267 (353)
T PLN00034 215 SRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY 267 (353)
T ss_pred ceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHH
Confidence 98653221 11234579999999998853 22346899999999999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=282.00 Aligned_cols=193 Identities=23% Similarity=0.281 Sum_probs=163.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|+||.||+|.+..+ +..+|+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKET---------KEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCC---------CcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 4689999999999999999987654 7789999886542 2234667899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..|+||||++++.+..+.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 99999999999887665544322 45888999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~ 195 (287)
T cd07848 146 FARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELS 195 (287)
T ss_pred Cccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHH
Confidence 9986543221 1223456899999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=302.34 Aligned_cols=200 Identities=25% Similarity=0.250 Sum_probs=170.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|.+.+.||+|+||+||+|....+ ++.||+|.+... .......+.+|+.++..++|+||+++++.+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~---------g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSD---------GEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCC---------CCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 356899999999999999999977654 788999998654 234456788999999999999999998877
Q ss_pred EcCC--------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 165 WEDK--------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 165 ~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
...+ .+++||||+++|+|.+++..+......+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANILLCS 178 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEeC
Confidence 5432 378999999999999999765544467899999999999999999999 589999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLl 239 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999998654332222334567999999999999999999999999999999985
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=291.66 Aligned_cols=205 Identities=30% Similarity=0.372 Sum_probs=166.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|++.... +...+..||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLG----KEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCC----cccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 3557999999999999999999864321 12235679999987543 33346788999999999 799999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCC-----------------------------------------------------
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNP----------------------------------------------------- 191 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 191 (297)
...+..++||||+++|+|.+++.....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999999864321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcc
Q 022413 192 -------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH 258 (297)
Q Consensus 192 -------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 258 (297)
...++++..++.++.||+.||+||| +.||+||||||+|||+++++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 1134778889999999999999999 5899999999999999999999999999997654322211
Q ss_pred eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 259 VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 259 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
......+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ell 308 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence 122234567899999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=282.72 Aligned_cols=186 Identities=30% Similarity=0.401 Sum_probs=158.2
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcC-CCCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGR-LSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~ 170 (297)
+.||+|+||+||+|.+... +..||+|.+.... ......+..|..++.. ++||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGT---------NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 4699999999999987654 7789999987542 1233456677888876 4899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 9999999999999999765 45888999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 190 (316)
T cd05619 146 NMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190 (316)
T ss_pred CCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHH
Confidence 32211 1233457999999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=289.62 Aligned_cols=205 Identities=28% Similarity=0.361 Sum_probs=167.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCC-CCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 164 (297)
..++|+++++||+|+||.||+|.+... .+...+..||+|.+..... ...+.+.+|+.+++++. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 356899999999999999999986432 1122245799999975432 33467899999999996 99999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCC-----------------------------------------------------
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNP----------------------------------------------------- 191 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 191 (297)
.+.+..|+||||+++|+|.+++.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999999865321
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 192 ---------------------------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 192 ---------------------------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
....+++..++.++.|++.||+||| ..+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHhE
Confidence 0124778888999999999999999 58999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 333 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999998653322211222345678899999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.20 Aligned_cols=192 Identities=25% Similarity=0.360 Sum_probs=160.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|+||.||+|....+ +..||+|.+... ......++.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHT---------GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCC---------CCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 588899999999999999987654 788999988643 223345688999999999999999999988643
Q ss_pred -----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 168 -----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 168 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
..+|+||||+ +++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEE
Confidence 2589999999 56899988765 45889999999999999999999 589999999999999999999999
Q ss_pred ccccccccCCCCCC-cceeeccCCcccccCcceecc--cCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGE-SHVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~ 202 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHH
Confidence 99999975432211 111234578999999999875 67889999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=283.61 Aligned_cols=189 Identities=26% Similarity=0.342 Sum_probs=161.5
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLL 172 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 172 (297)
+.||+|+||.||++..... ...+..+|+|++..... .....+..|++++++++||||+++++++.+++.+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITG------PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEecc------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 6799999999999865321 12378899999875432 233566789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC
Q 022413 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 173 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
||||+++++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 76 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 99999999999998764 45899999999999999999999 5899999999999999999999999999987643
Q ss_pred CCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 253 AGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 253 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 150 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 192 (318)
T cd05582 150 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192 (318)
T ss_pred CCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeec
Confidence 321 1233467999999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=286.93 Aligned_cols=193 Identities=26% Similarity=0.347 Sum_probs=172.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
....|.+.+.||+|.|++|.+|++..+ +..||+|.+++... ...+.+.+|+++|+.|+|||||+++.+.
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t---------~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILT---------GTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCC---------CceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 456899999999999999999988765 78899999987643 3445688999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
..+..+|+||||+.+|.+++++..+ ....+..+..++.|+.+|++||| .+.|||||||++||||+.+..+||+|
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeec
Confidence 9999999999999999999999887 44566888999999999999999 59999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCc-ccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY-LLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~~ll 297 (297)
||++..+.... ...++||++.|.|||++.+.+|. +..|+||||++||.|+
T Consensus 199 fgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV 249 (596)
T KOG0586|consen 199 FGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALV 249 (596)
T ss_pred cccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeee
Confidence 99998876433 45678999999999999988765 5799999999999874
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=298.54 Aligned_cols=193 Identities=24% Similarity=0.416 Sum_probs=171.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+-|.|+..||.|+||+||+|..++. +...|.|.+.......++++.-|++||..++||+||++++.|..+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket---------~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e 101 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKET---------KLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE 101 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccc---------hhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence 34578889999999999999977654 666788998888888889999999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+|+++|||.||-+..++..-. .++.+..+..+++|++.||.|||+ ..|||||||..|||++.+|.++|+|||.
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecCcEeeecccc
Confidence 99999999999999988887654 679999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhc
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~l 296 (297)
+..... .......+.|||+|||||++. ..+|+.++||||||++|++|
T Consensus 177 SAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM 228 (1187)
T KOG0579|consen 177 SAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM 228 (1187)
T ss_pred cccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence 865432 223456789999999999975 46799999999999999987
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=292.78 Aligned_cols=188 Identities=27% Similarity=0.344 Sum_probs=164.5
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-C-----CCcccEEeE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H-----PNLVKLLGY 163 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~ 163 (297)
+|.+.++||+|+||.|-+|++..+ ++.||||+++.... .....+.|+.+|..|+ | -|||+++++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T---------~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKT---------GEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEecccccceeEEEEecCC---------CcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 688999999999999999988765 88999999987643 3355678999999997 4 489999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC--CCceE
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG--NYNAK 241 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~--~~~~k 241 (297)
|...+++|||.|.+ ..+|.++|..++. ..++...++.|+.||+.||.+|| +.+|||+|||||||||.+ ...+|
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCcee
Confidence 99999999999999 6699999987765 45889999999999999999999 699999999999999964 45799
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||.+..... .....+.+..|+|||++.|.+|+.+.||||||||+.||+
T Consensus 332 VIDFGSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~ 382 (586)
T KOG0667|consen 332 VIDFGSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELF 382 (586)
T ss_pred EEecccccccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHh
Confidence 999999986422 223567899999999999999999999999999999985
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=281.77 Aligned_cols=186 Identities=31% Similarity=0.418 Sum_probs=159.8
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 170 (297)
+.||+|+||+||+|.+..+ +..||+|.+.+.. ......+..|..+++.+ +||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGT---------DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCC---------CCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 4699999999999987654 6789999987542 23345667899999888 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 9999999999999988765 45899999999999999999999 58999999999999999999999999999874
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~ 190 (318)
T cd05570 146 GILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190 (318)
T ss_pred cCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHh
Confidence 32211 1223457899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=284.11 Aligned_cols=197 Identities=28% Similarity=0.460 Sum_probs=171.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh-HHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++...++++||+|.||+|.++.... +..||+|.+++..... ..+|.+|+++|.+|+||||+.++++|.
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 34567889999999999999998775 5789999999876544 478999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.++.+++++||++.|+|.+++..+.... +.......|+.||+.||+||.+ .++|||||.++|+|+++++++||+||
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCc
Confidence 9999999999999999999998875322 3445556799999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++-+-.+...+......-...|||||.+..++|+.+||||+|||++||++
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~ 733 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVF 733 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHH
Confidence 9998654444444444555678999999999999999999999999999974
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=274.04 Aligned_cols=193 Identities=30% Similarity=0.380 Sum_probs=171.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|..+++||+|.||+|.+++-+ .+++.+|+|+++++. ......-+.|-++|+..+||.+..+--.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEK---------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREK---------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeec---------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 467889999999999999998544 458999999998763 23445667899999999999999998889
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
+..+++++||||..||.|.-+|.+. +.+++...+.+..+|+.||.|||+ ++||+||||.+|+|+|.+|++||+|
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeee
Confidence 9999999999999999999998765 668999999999999999999995 9999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++.-... .....++||||.|+|||++....|..+.|.|.+||++|+||
T Consensus 312 FGLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm 362 (516)
T KOG0690|consen 312 FGLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM 362 (516)
T ss_pred cccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH
Confidence 9999864332 23466799999999999999999999999999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.56 Aligned_cols=204 Identities=30% Similarity=0.422 Sum_probs=170.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
....++.+.||+|+||.||.|...+..-.. ....||+|.+.+. +.+...+|++|..+|+.++|||||+++|++.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 345667789999999999999887642110 0346999999875 55677899999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPS---IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
....+|++|||+||+|..+|++..+. ...++....+.++.||++|+.||+ ++++|||||..+|+||+....+||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccCcEEEc
Confidence 99999999999999999999865332 355788999999999999999999 5999999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+|+..-............-...|||||.+..+.|+.+||||||||+|||+|
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence 999999433322222222223346799999999999999999999999999986
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.00 Aligned_cols=187 Identities=32% Similarity=0.420 Sum_probs=164.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..|.-++.||.|+||-||.|++..+ ...||||++.-.. .+..+++..|+..|+++.|||++.+-++|.
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n---------~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL 96 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRN---------SEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL 96 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCc---------cceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence 3466778999999999999987654 7889999987543 344577889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.+...|+||||| -|+-.+++.-.+ .++-+.++..|+.+.+.||+|||+ .+.||||||.-|||+.+.|.|||+||
T Consensus 97 re~TaWLVMEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDF 170 (948)
T KOG0577|consen 97 REHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADF 170 (948)
T ss_pred ccchHHHHHHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccc
Confidence 999999999999 668888887665 568889999999999999999996 88999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhc
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~l 296 (297)
|.|.+... .++++|||+|||||++. .+.|+-+.||||||+++++|
T Consensus 171 GSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIEL 218 (948)
T KOG0577|consen 171 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 218 (948)
T ss_pred cchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhh
Confidence 99987543 35689999999999986 47899999999999999886
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=275.90 Aligned_cols=192 Identities=30% Similarity=0.409 Sum_probs=164.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.|++.++||+|+||+||++....+ ++.||+|.+..... .....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRAT---------GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCC---------CceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 478889999999999999977643 77899999865422 223456789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++.+++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865422 45889999999999999999999 4899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...... ......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~ 195 (285)
T cd05605 148 LAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI 195 (285)
T ss_pred CceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHH
Confidence 987653221 123357899999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.12 Aligned_cols=198 Identities=25% Similarity=0.306 Sum_probs=164.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeE-EE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGY-CW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~-~~ 165 (297)
..++++.+.|.+|+|+.||+|..... +..||+|++-..+....+.+.+|+++|++|. |+|||.+++. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~---------~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKG---------GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCC---------CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 45678889999999999999988764 4789999988778888889999999999998 9999999993 32
Q ss_pred c------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 E------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
. .-+++|+||||.||.|-+++..+.. ..|++.++++|++|+++|+++||.....|||||||-|||||..++.
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 2 1368999999999999999987654 3499999999999999999999986667999999999999999999
Q ss_pred eEEccccccccCCCCCCcce-------eeccCCcccccCcceec---ccCCcccccchhhhhhhhhc
Q 022413 240 AKISDFGLAKLGPAGGESHV-------TTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~l 296 (297)
.||||||.|.-......... .-...-|+.|+|||++- +...++|+|||+|||+||.|
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 99999999864322211100 00123589999999974 56788999999999999986
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=292.87 Aligned_cols=189 Identities=23% Similarity=0.243 Sum_probs=162.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|.+.+.||+|+||.||+|.+... ++.||+|.... ..+.+|+++|++++||||+++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~---------~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDY---------PQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCC---------CCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 44799999999999999999987654 67899996432 3456899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++|||++ .++|.+++.... ..+++..++.|+.||+.||.||| ..|||||||||+||||+.++.+||+|||+
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCC
Confidence 9999999999 468988886543 45899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...............||+.|+|||++.+..++.++|||||||+||+|+
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~ 356 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHH
Confidence 98654322222223467999999999999999999999999999999973
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.23 Aligned_cols=200 Identities=24% Similarity=0.265 Sum_probs=174.8
Q ss_pred HHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcc
Q 022413 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLV 158 (297)
Q Consensus 82 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv 158 (297)
.+++....+|.++++||+|+||.|.++++... +..||+|++.+.. .....-|..|-.+|..-+.+=|+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t---------~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKST---------EKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeecc---------ccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence 34555667999999999999999999877654 8899999998732 23335688999999999999999
Q ss_pred cEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 159 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
+++-.|++++++|+||||++||+|..++.+. .++++..++.++.+|+.||.-|| +.|+|||||||+|||||..|
T Consensus 139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred HHHHHhcCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccC
Confidence 9999999999999999999999999999876 46999999999999999999999 59999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~ll 297 (297)
++||+|||.|-.+...+.- .....+|||.|++||++.. +.|....|.||+||++|+||
T Consensus 213 HikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl 275 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEML 275 (1317)
T ss_pred cEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHH
Confidence 9999999999777654432 3456789999999999963 56888999999999999996
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=289.46 Aligned_cols=177 Identities=27% Similarity=0.429 Sum_probs=158.8
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
++-||.|+.|.||+|+.+ ++.||||+++..+ ..++.-|++|+||||+.|.++|.....++||
T Consensus 129 LeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 355899999999999887 5679999886433 3477889999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
||||..|-|.+.|+.. ++++......+..+|+.|++|||. +.|||||||.-||||..+..|||+|||.++....
T Consensus 191 MEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999876 567888899999999999999995 7899999999999999999999999999987644
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
. .....++||..|||||++.+...+.|.|||||||+||+||
T Consensus 265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmL 305 (904)
T KOG4721|consen 265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEML 305 (904)
T ss_pred h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHH
Confidence 2 3456789999999999999999999999999999999997
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=282.43 Aligned_cols=186 Identities=23% Similarity=0.275 Sum_probs=160.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.+.||+|+||.||+|..... +..||+|..... ....|+.++++++||||+++++++...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~ 129 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQ---------PDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSG 129 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCC---------CceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeC
Confidence 45799999999999999999987654 677999975432 235699999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+ .++|.+++.... ..+++..++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 130 ~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 130 AITCMVLPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred CeeEEEEEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCcc
Confidence 9999999999 458888886543 45899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++..... .......||+.|+|||++.+..++.++|||||||++|+||
T Consensus 204 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell 250 (357)
T PHA03209 204 AQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250 (357)
T ss_pred ccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHH
Confidence 8753221 1223456899999999999999999999999999999985
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.19 Aligned_cols=198 Identities=24% Similarity=0.336 Sum_probs=165.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+.... ..+..||+|.++... ......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPS------KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCC------CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 357899999999999999999765321 226789999987653 2334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+|++|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCc
Confidence 999999999999999999987643 45889999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+........ .......++..|+|||++.+..++.++|||||||++|+||
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 202 (266)
T cd05064 153 RLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202 (266)
T ss_pred ccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHh
Confidence 8764322111 1111233567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.14 Aligned_cols=193 Identities=27% Similarity=0.382 Sum_probs=157.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCC---CCCCcccEEeE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLLGY 163 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~ 163 (297)
++|++.+.||+|+||+||+|.+.... +..||+|.+..... .....+.+|+.+++.+ +||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCC--------CeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 37999999999999999999875321 67899998764321 1223456677776655 69999999998
Q ss_pred EEc-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 164 CWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 164 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
+.. ...+++||||+. ++|.+++..... ..+++..++.++.|++.||+||| +.||+||||||+|||++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG 147 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCC
Confidence 852 356899999995 599999875432 34789999999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 148 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 203 (290)
T cd07862 148 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203 (290)
T ss_pred CEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHH
Confidence 9999999999765432 1233456899999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=274.12 Aligned_cols=205 Identities=25% Similarity=0.360 Sum_probs=167.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+... .+...+..||+|.+.... .....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 356799999999999999999987542 122336779999986543 233457889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPS------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
+....++||||+++++|.+++...... ...+++..+..++.|++.||+||| +.+++||||||+|||+++++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCCC
Confidence 999999999999999999999754321 234677889999999999999999 589999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 9999999987543322111112234578899999999888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.85 Aligned_cols=199 Identities=26% Similarity=0.386 Sum_probs=164.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..+|++.+.||+|+||.||+|.+.... ......||+|.+.... ....+++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCC-----CccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 357999999999999999999875431 1113458999987543 3345678899999999999999999998876
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
. ..++++||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEcccc
Confidence 4 5789999999999999997653 45788899999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...............++..|+|||++.+..++.++|||||||++|+|+
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~ 205 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence 998764332222222233467899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=282.58 Aligned_cols=193 Identities=22% Similarity=0.312 Sum_probs=170.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhH--HHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF--EEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..-|.+.+.||+|-|+.|-+|++.-. |..||||++++.+.... ..+.+|+.-|+.++|||||++|++..
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFT---------GekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFT---------GEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcc---------cceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 34588889999999999999876654 89999999998765433 46789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc-CCCceEEcc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-GNYNAKISD 244 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~-~~~~~kl~D 244 (297)
.+..+|||+|+=++|+|++||-++. ..+.+..+.++++||+.|+.||| +..+|||||||+|+++- .-|-|||.|
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeee
Confidence 9999999999999999999998876 56999999999999999999999 69999999999999875 468999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcc-cccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYL-LSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslGv~l~~ll 297 (297)
||++..+..+. ..++.||...|-|||++.+..|+. +.||||||||||+|.
T Consensus 163 FGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLV 213 (864)
T KOG4717|consen 163 FGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLV 213 (864)
T ss_pred ccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHH
Confidence 99998776543 356679999999999999999885 679999999999873
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=291.90 Aligned_cols=191 Identities=25% Similarity=0.353 Sum_probs=156.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.+.||+|+||.||+|..... ++.||+|++.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~---------~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDT---------SEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCC---------CCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 45799999999999999999987654 7789999886433 2335799999999999999999887532
Q ss_pred --------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-
Q 022413 168 --------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY- 238 (297)
Q Consensus 168 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~- 238 (297)
..+++||||+++ +|.+++.........+++..++.++.||+.||+||| +.+|+||||||+||||+.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCCC
Confidence 247799999965 787777643333366899999999999999999999 58999999999999998664
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 209 ~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 265 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265 (440)
T ss_pred ceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 79999999998654322 22345789999999998764 6889999999999999985
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.09 Aligned_cols=191 Identities=30% Similarity=0.445 Sum_probs=164.0
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC--
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED-- 167 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 167 (297)
|...+.||+|+||.||+|+++.. |+.||||.++... ....+++.+|+++|++|+|||||+++++-++.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnket---------G~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKET---------GRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeeeccccc---------ccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 45567899999999999977664 9999999998753 34567889999999999999999999876543
Q ss_pred ----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc--CCC--c
Q 022413 168 ----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GNY--N 239 (297)
Q Consensus 168 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~--~~~--~ 239 (297)
....+|||||.||+|...|.+-... ..+++.+++.++.++..||.||| ++|||||||||.||++- ++| .
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceE
Confidence 3578999999999999999864433 45999999999999999999999 79999999999999983 334 4
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhc
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~l 296 (297)
.||+|||.|+.++++. ...++.||+.|.+||++.. +.|+...|.|||||++|+.
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~c 217 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYEC 217 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHH
Confidence 7999999999876643 5778899999999999985 7788889999999999985
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=273.08 Aligned_cols=203 Identities=29% Similarity=0.450 Sum_probs=168.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||+|+||.||+|...... .......+++|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPN----ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCC----CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 47899999999999999999876431 11224679999987543 23346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
...+++|||+++++|.+++...... ...+++..++.++.|++.||.||| +.+++||||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEc
Confidence 9999999999999999999764321 145788899999999999999999 58999999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~ 220 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF 220 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHH
Confidence 99999999999997643322222233345688999999999889999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=281.20 Aligned_cols=184 Identities=29% Similarity=0.370 Sum_probs=153.8
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCC---CCCCcccEEeEEEcCCee
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL---SHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~ 170 (297)
||+|+||+||+|..... +..||+|.+..... .....+..|..++..+ .||||+++++++.+.+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDT---------RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECCC---------CCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 69999999999987654 78899999865322 2233445666666655 699999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|+||||+++++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred EEEEcCCCCChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 9999999999999998764 45889999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
..... ......+||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell 191 (330)
T cd05586 146 NLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191 (330)
T ss_pred CCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec
Confidence 32221 123346799999999998764 4788999999999999986
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=272.62 Aligned_cols=204 Identities=26% Similarity=0.390 Sum_probs=169.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|.+.+.||+|+||+||++..... .....+..+++|.+..........+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 45799999999999999999975331 11223567899998766555567889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCC---------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNP---------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
+..+++|||+++++|.+++..... ....+++..++.++.|++.||+||| +.|++||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCC
Confidence 999999999999999999975431 1234899999999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...............+++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~ 216 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999997543322111122334577899999999888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=302.39 Aligned_cols=198 Identities=23% Similarity=0.284 Sum_probs=165.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.++||+|+||.||+|.+... ++.||+|++.... ....+++.+|+.++++++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~t---------g~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVC---------SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCC---------CcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 5799999999999999999987654 7889999987542 223467899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNP-------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
+.+..|++|||++|++|.+++..... .....++..++.++.||+.||+||| +.||+||||||+|||++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCC
Confidence 99999999999999999999864211 1133566778899999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCC----------------cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGE----------------SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELL 225 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence 999999999976521100 00112356999999999999999999999999999999985
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=271.85 Aligned_cols=204 Identities=25% Similarity=0.392 Sum_probs=168.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|.+.+.||+|+||.||+|.+.+. .....+..||+|.+...... ..+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 35688899999999999999976542 11123577999998765433 44688999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNP----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
....+++|||+++++|.+++..... ....+++..+..++.|++.||+||| +.|++||||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGY 157 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcC
Confidence 9999999999999999999976432 2244788899999999999999999 589999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~ 218 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF 218 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHH
Confidence 9999999999987543222111122334678899999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.20 Aligned_cols=204 Identities=27% Similarity=0.368 Sum_probs=165.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
.++|++.++||+|+||.||+|..... ....+++.||+|++.... ....+.+..|+.+++++ +||||+++++++.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred HHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 45799999999999999999975432 122236789999987542 23345678899999999 7999999999886
Q ss_pred cC-CeeEEEEEecCCCCHHHHHhhcCCC----------------------------------------------------
Q 022413 166 ED-KELLLVYEYMQRGSLENHLFRRNPS---------------------------------------------------- 192 (297)
Q Consensus 166 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------------------------- 192 (297)
.. ..++++|||+++++|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 5789999999999999998643210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcc
Q 022413 193 -----IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267 (297)
Q Consensus 193 -----~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 267 (297)
...+++..+..++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+++.+.............++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 135789999999999999999999 5899999999999999999999999999998654322222222345677
Q ss_pred cccCcceecccCCcccccchhhhhhhhhcC
Q 022413 268 GYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 268 ~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.|+|||++.+..++.++|||||||++|+|+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~ 269 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIF 269 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHH
Confidence 899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=263.07 Aligned_cols=195 Identities=28% Similarity=0.412 Sum_probs=167.8
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--------hhhHHHHHHHHHHhcCCC-CC
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--------MQGFEEWQSEVNFLGRLS-HP 155 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~-h~ 155 (297)
...-..|...+.||+|..+.|-++.++.. +..+|+|++.... ....+.-.+|+.||+++. ||
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t---------~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP 83 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKET---------GKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHP 83 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhccc---------ccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCC
Confidence 33456788999999999999988766654 7788999886421 122345568999999996 99
Q ss_pred CcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 156 nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
+|+++.++++.+..+++|.|.|+.|.|.++|... ..++++..+.|++|++.|+.|||. +.||||||||+|||++
T Consensus 84 ~II~l~D~yes~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 84 YIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLD 157 (411)
T ss_pred cEEEeeeeccCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeec
Confidence 9999999999999999999999999999999876 568999999999999999999994 8999999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc------cCCcccccchhhhhhhhhcC
Q 022413 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~~ll 297 (297)
++.++||.|||++..+..+.+ ....||||+|+|||.+.- ..|+...|+|++|||+|.||
T Consensus 158 dn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred cccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence 999999999999998876543 456799999999999863 34677899999999999886
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=271.95 Aligned_cols=182 Identities=21% Similarity=0.332 Sum_probs=156.7
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh---HHHHHHHHHHhcCCCCCCcccEEeEEEc----C
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEEWQSEVNFLGRLSHPNLVKLLGYCWE----D 167 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~ 167 (297)
..|++|++|.||+|.+. ++.||+|.+....... .+.+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 67999999999999874 6789999987653322 4677899999999999999999999877 3
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
..+++||||+++|+|.+++... ..+++.....++.|++.||.|||. ..+++||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 5789999999999999999765 457888999999999999999995 35899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecc--cCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~ll 297 (297)
++.+... .....|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 170 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 170 EKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred Hhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 9864322 123468899999999976 67899999999999999985
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=282.57 Aligned_cols=191 Identities=28% Similarity=0.366 Sum_probs=160.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|+||.||++....+ +..||+|.+... .....+++.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRD---------GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCC---------CCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 478899999999999999976543 788999998653 223446788999999999999999999999887
Q ss_pred C-----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 168 K-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 168 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
+ ..|+||||+. ++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL 144 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKI 144 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEe
Confidence 6 7999999995 5888887654 45899999999999999999999 589999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++....... .......+++.|+|||++.+. .++.++|||||||++|+|+
T Consensus 145 ~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 199 (372)
T cd07853 145 CDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199 (372)
T ss_pred ccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHH
Confidence 99999986433211 122334678999999998874 4788999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=280.68 Aligned_cols=190 Identities=25% Similarity=0.293 Sum_probs=159.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||++..... +..||+|.+... ......++.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVL---------GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCC---------CceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 357899999999999999999976654 788999998653 223346778999999999999999999998
Q ss_pred EcCC------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 165 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
.... .+|+||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~ 160 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 160 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCC
Confidence 6543 57999999965 67766643 3788889999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 161 ~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 216 (359)
T cd07876 161 TLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216 (359)
T ss_pred CEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHH
Confidence 9999999999754221 1223356899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=270.67 Aligned_cols=202 Identities=28% Similarity=0.426 Sum_probs=166.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||+|+||+||+|.+... ....+..+++|.+.... .+....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLP-----GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecC-----CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 4688899999999999999976321 11236789999987543 33446788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNP-------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
...|++|||+++++|.+++..... ....+++..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEE
Confidence 999999999999999999864321 1234788899999999999999999 5899999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|+
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 220 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence 999999999999998654332222223344677899999998888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=269.29 Aligned_cols=185 Identities=29% Similarity=0.425 Sum_probs=157.6
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
||+|+||.||++..... +..+|+|.+..... .....+..|++++++++||||+++++++......++|
T Consensus 1 lg~G~~g~Vy~~~~~~~---------~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKNT---------GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEccC---------CcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 69999999999977654 78899999865322 1223456799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||++|++|.+++..... ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.++|+|||++.....
T Consensus 72 ~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred EecCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 999999999988865432 34788899999999999999999 59999999999999999999999999999876533
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.. ......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 148 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~ 188 (277)
T cd05607 148 GK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188 (277)
T ss_pred Cc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHH
Confidence 21 223356899999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=270.98 Aligned_cols=203 Identities=27% Similarity=0.412 Sum_probs=169.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
.+|.+.+.||+|+||.||+|.+... .....+..+++|.+........+.+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4688899999999999999976432 111235678999987766555577899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
..++||||+++++|.+++..... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEcc
Confidence 99999999999999999976432 1234789999999999999999999 599999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 219 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999997543322212223345678899999999889999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=273.15 Aligned_cols=189 Identities=30% Similarity=0.405 Sum_probs=169.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
-|.++++||+|+||.||+|.+++. |..+|||.+..+. +++++..|+.||.+.+.|++|++|+.++....
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~Es---------G~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRES---------GHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhcc---------CcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 366778999999999999988775 9999999987653 45788999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
+|+|||||.-|++.+.++-++ .++.+.++..++.+.+.||+||| ...-+|||||.-|||++.+|..||+|||.|.
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccccc
Confidence 999999999999999998765 67999999999999999999999 5888999999999999999999999999997
Q ss_pred cCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhc
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
.+.+. -...++..|||.|||||++..-.|..++|+||||++..+|
T Consensus 178 QLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEM 222 (502)
T KOG0574|consen 178 QLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEM 222 (502)
T ss_pred hhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhh
Confidence 66442 2234567899999999999999999999999999998886
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=270.46 Aligned_cols=208 Identities=29% Similarity=0.407 Sum_probs=171.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCc-------cccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCccc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLA-------PSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
.++|++.+.||+|+||.||+|........ ..+...+..||+|.+.... ....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 45799999999999999999987653211 1233345679999987653 334567889999999999999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
+++++..++..+++|||+++++|.+++..... ....+++..++.++.|++.||+||| +.+|+||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhce
Confidence 99999999999999999999999999976531 1125889999999999999999999 58999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++.++.++|+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 226 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHH
Confidence 99999999999999987654332222233445678999999998888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=272.28 Aligned_cols=191 Identities=26% Similarity=0.364 Sum_probs=166.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||+|+||.||++.+... +..+++|.+.... ......+.+|++++++++||||+++++.+.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~---------~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPS---------GLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCC---------CeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 3689999999999999999977654 6789999887542 23345688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCC
Confidence 9999999999999999999765 458899999999999999999995 36899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+...... ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 147 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~ 192 (308)
T cd06615 147 SGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA 192 (308)
T ss_pred ccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHH
Confidence 8754322 123457899999999998888999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=266.41 Aligned_cols=193 Identities=28% Similarity=0.375 Sum_probs=165.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|....+ +..+|+|++..........+.+|+.++++++||||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~---------~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHT---------GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCC---------CeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 45799999999999999999987654 778999998765444456778999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999999998754 45889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ......|++.|+|||.+. ...++.++|+|||||++|+|+
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 153 AAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred ceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 986532211 123356889999999885 345778999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=268.67 Aligned_cols=193 Identities=28% Similarity=0.387 Sum_probs=166.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|....+ +..+++|.+..........+.+|+.+++.++||||+++++.+...
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNT---------GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCC---------CcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 35788899999999999999977654 678999998766544556778999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..|++|||+++++|.+++... ..+++..++.++.|++.||+||| +.|++|+||||+||+++.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGV 152 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECccee
Confidence 9999999999999999998765 45889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......|++.|+|||++. ...++.++|+|||||++|+|+
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~ 203 (267)
T cd06645 153 SAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred eeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh
Confidence 87543221 1223457899999999874 456888999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=264.12 Aligned_cols=189 Identities=26% Similarity=0.375 Sum_probs=157.7
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
+.||+|+||.||+|....+ +..+|+|.+.... ......+.+|++++++++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~---------~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRAD---------NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEecC---------CceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 4689999999999987654 7789999876543 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 72 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 72 MELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred EeeccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCccccc
Confidence 99999999999987543 35789999999999999999999 58999999999999999999999999999875432
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
............+..|+|||.+.++.++.++||||||+++|+|+
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~ 190 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF 190 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 11110011112345799999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=268.27 Aligned_cols=198 Identities=28% Similarity=0.382 Sum_probs=162.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||+|+||+||+|.+..+.. .....+++|.+.... .....++..|+.+++++.||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGD-----SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCC-----ceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 478889999999999999998754310 012247888876442 233467788999999999999999999875 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++++||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+++||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCcc
Confidence 56789999999999999997643 45889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...............++..|+|||++.++.++.++||||||+++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~ 205 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 98654332222223345778899999999889999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=269.16 Aligned_cols=192 Identities=29% Similarity=0.405 Sum_probs=164.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.|++.++||+|+||.||++.+... ++.+|+|.+..... .....+.+|+.++++++|+||+++++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRAT---------GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCC---------CceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 367789999999999999987764 78899998865422 223456789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLG 147 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999998865422 35889999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 195 (285)
T cd05630 148 LAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195 (285)
T ss_pred ceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHH
Confidence 987543221 122346899999999999989999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=271.94 Aligned_cols=207 Identities=26% Similarity=0.355 Sum_probs=168.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
...+|.+.+.||+|+||.||+|.+..... .....+..+++|.+.... ....+++.+|+.+++.+ +||||+++++++
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 35678999999999999999997543110 111225679999887542 34456788999999999 799999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
......+++|||+++++|.+++...... ...+++..++.++.||+.||+||| +.||+||||||+||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Ni 168 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARNV 168 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccceE
Confidence 9999999999999999999999865321 234778889999999999999999 58999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 233 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 233 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999998654332222222234567899999998888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=264.51 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=166.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+.... .....|++|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPG------KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCC------CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 357899999999999999999876421 124579999987543 3334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..+++|||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccc
Confidence 999999999999999999997643 35889999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...............+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~ 202 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202 (266)
T ss_pred hhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHH
Confidence 998764221111122233467899999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=270.36 Aligned_cols=205 Identities=28% Similarity=0.363 Sum_probs=168.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||++...... .......+++|.+.... .+...++.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLD----NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCC----CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4567999999999999999999876431 11224679999887542 23446688999999999 799999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRN------------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
...+.++++|||+++++|.+++..+. .....+++..++.++.|++.||+||| +.+|+||||||+||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~Ni 163 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARNV 163 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceeeE
Confidence 99999999999999999999997542 22356889999999999999999999 58999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 228 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHh
Confidence 99999999999999998654332211122233567899999998889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=270.13 Aligned_cols=208 Identities=27% Similarity=0.440 Sum_probs=167.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCC-----ccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTL-----APSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
.++|++.+.||+|+||.||++....... ..........||+|.+.... ......+.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999987654210 01122234568999987652 33346788999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCC--------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNP--------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++||||||+|||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhEE
Confidence 999999999999999999999999865321 1123678889999999999999999 589999999999999
Q ss_pred EcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.++.+||+|||+++...............+++.|+|||++.++.++.++|+|||||++|+|+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~ 225 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHH
Confidence 9999999999999997654322211122234577899999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=290.01 Aligned_cols=206 Identities=19% Similarity=0.239 Sum_probs=155.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccc------cCCCCcE----EEEEecCCcchhhHHHHHHHHHHhcCCCCCC
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPS------KTGLGMV----VAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~------~~~~~~~----vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n 156 (297)
..++|++++.||+|+||+||+|.++....... ....+.. ++.|.+.. .......+.+|+.+|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999999987654210000 0000011 11121111 1123356789999999999999
Q ss_pred cccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 157 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
|+++++++.+.+..|+++|++ +++|.+++..... .........++.|+.||+.||+||| +.|||||||||+||||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIFLN 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEC
Confidence 999999999999999999999 4578777754321 1122345677889999999999999 58999999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|+||
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 362 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999986543221 1223457999999999999999999999999999999985
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=268.16 Aligned_cols=191 Identities=30% Similarity=0.407 Sum_probs=164.0
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
|+..++||+|+||+||+|.+..+ ++.+|+|.+..... .....+.+|+++++.++|+||+++++.+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRAT---------GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCC---------CcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 66778999999999999987654 77899999865432 2234567899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..+++|||+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCc
Confidence 999999999999999988865422 35899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 149 ~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 195 (285)
T cd05632 149 AVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI 195 (285)
T ss_pred ceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHH
Confidence 87543221 123356899999999999889999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.26 Aligned_cols=204 Identities=25% Similarity=0.361 Sum_probs=168.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|...... ....+..+++|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccC----CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 457999999999999999999876431 11235779999987553 2334578899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPS------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
....++||||+++++|.+++...... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCCE
Confidence 99999999999999999999754321 234678899999999999999999 5999999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...............++..|+|||++.+..++.++||||||+++|+|+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 215 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhh
Confidence 999999987543322111222345678999999999888999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=270.01 Aligned_cols=203 Identities=27% Similarity=0.373 Sum_probs=166.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+|++.+.||+|+||.||+|.+.... ....+..||+|.+..... ...+.+.+|+.++..++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTA----PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCC----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 35777889999999999999875421 112357899999875532 2346688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
...++++||+++++|.+++..... ....+++..++.++.|++.||+||| +.||+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEec
Confidence 999999999999999999863211 1234788889999999999999999 58999999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++.+||+|||+++...............+++.|+|||++.++.++.++||||||+++|+|+
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 220 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 99999999999988654332222223345678999999998889999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=273.06 Aligned_cols=192 Identities=26% Similarity=0.348 Sum_probs=161.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|.+.+.||+|+||.||+|..... +..+|+|.+..... .....+.+|+.++++++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLT---------ENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCC---------CCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 5799999999999999999977653 67899999875432 2234567899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++ +|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcccc
Confidence 999999999965 8888886543 44788899999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 199 (309)
T cd07872 151 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA 199 (309)
T ss_pred ceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 875432211 1223467899999999875 45788999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=263.45 Aligned_cols=194 Identities=28% Similarity=0.415 Sum_probs=165.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-----hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-----MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
++|++.+.||+|++|.||+|..... +..+++|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~---------~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDT---------GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCC---------CcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 4689999999999999999976643 7789999876432 2234578899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+++..++++||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999998765 45788999999999999999999 5999999999999999999999999
Q ss_pred cccccccCCCCCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++......... ......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 201 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHH
Confidence 999987643321111 112346788999999999988999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=275.59 Aligned_cols=193 Identities=30% Similarity=0.418 Sum_probs=170.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh---hHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
+.|..-++||+|+||.||-+....+ |..+|.|.+.+...+ .-...++|-.||.+++.++||.+--.|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraT---------GKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRAT---------GKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred cceeeeEEEecccccceeEEEEecc---------hhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 5688889999999999998877654 889999988764322 2245678999999999999999988899
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
..+.+++||..|.||+|.-+|.+... ..+++..++.++.+|+.||++|| +.+||+|||||+|||+|+.|+++|.|+
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEeecc
Confidence 99999999999999999999987654 56999999999999999999999 699999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|..+..... ....+||.+|||||++.+..|+...|.|||||+||+|+
T Consensus 332 GLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi 380 (591)
T KOG0986|consen 332 GLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMI 380 (591)
T ss_pred ceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHH
Confidence 99987765432 23347999999999999999999999999999999996
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=266.78 Aligned_cols=204 Identities=27% Similarity=0.389 Sum_probs=168.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|+..++||+|+||.||++..... .....+..+++|.+..........+.+|+++++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 45788899999999999999865431 12223667999998766655567889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPS-----------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
...+++|||+++++|.+++....+. ...+++..++.++.|++.||+||| +.+++||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcC
Confidence 9999999999999999999764321 124788999999999999999999 599999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 218 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 9999999999987543221111122234578899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=278.93 Aligned_cols=190 Identities=24% Similarity=0.268 Sum_probs=160.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||++..... ++.+|+|.+... ......++.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVL---------DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCC---------CceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 457899999999999999999976543 778999998754 223346778999999999999999999988
Q ss_pred EcC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 165 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
... ...|+||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.||+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~ 156 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 156 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCC
Confidence 654 357999999965 67777643 3788889999999999999999 59999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 157 ~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 212 (355)
T cd07874 157 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212 (355)
T ss_pred CEEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999864322 1223457899999999999989999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=267.77 Aligned_cols=204 Identities=25% Similarity=0.346 Sum_probs=165.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|...+. .....+..||+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 56899999999999999999976542 111225679999887543 2333567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCC------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNP------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
.+..++||||+++|+|.+++..... .....++..+..++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999975422 1234567788899999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...............++..|+|||.+.++.++.++|+|||||++|+|+
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~ 215 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 215 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHH
Confidence 999999988543322211122234567899999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.18 Aligned_cols=196 Identities=22% Similarity=0.336 Sum_probs=167.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLD---------RKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCC---------CCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 4799999999999999999987654 678999987542 2333457889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..++++||+++++|.+++.........+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999998754433355788999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++........ ......|++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 99876533211 122346889999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=271.41 Aligned_cols=206 Identities=28% Similarity=0.347 Sum_probs=166.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
.++|.+.+.||+|+||.||++.+..... ........+|+|.+.... ......+..|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 4579999999999999999997653210 111124579999987643 33446788899999999 6999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
..+..|+||||+++++|.+++..+.+ ....+++..++.++.|++.||+||| +.|++||||||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nil 172 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL 172 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheE
Confidence 99999999999999999999976532 1235788999999999999999999 589999999999999
Q ss_pred EcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 236 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999987553221111112223457899999999888999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=255.70 Aligned_cols=202 Identities=27% Similarity=0.299 Sum_probs=169.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+|+.||++..-. ++..+|+|++.-...++.+..++|++..++++|||+++++++...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 45789999999999999999986443 378899999987777777889999999999999999999887654
Q ss_pred CC-----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 167 DK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 167 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+. ..|++++|...|+|.+.+....-....+++..++.|+.+|++||++||.....+.||||||.|||+.+.+.++
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence 43 5999999999999999999877777789999999999999999999995333499999999999999999999
Q ss_pred EccccccccCCCCCCc-------ceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES-------HVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
|.|||.++..+..-.. +....-..|..|+|||.+. +...+.++|||||||+||+||
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m 235 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM 235 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH
Confidence 9999998765432111 1112234689999999885 345678999999999999985
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=278.57 Aligned_cols=190 Identities=23% Similarity=0.262 Sum_probs=160.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||++..... ++.||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAIL---------ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCC---------CcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 356899999999999999999976654 678999998753 223346778999999999999999999987
Q ss_pred EcC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 165 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
... ...|+||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~ 163 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 163 (364)
T ss_pred cccccccccCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCC
Confidence 643 357999999965 78777743 3778889999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 164 ~~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 219 (364)
T cd07875 164 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219 (364)
T ss_pred cEEEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHH
Confidence 9999999999864322 1223457899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=266.39 Aligned_cols=194 Identities=26% Similarity=0.405 Sum_probs=166.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+.|++.+.||.|+||.||+|..... +..+++|.+........+.+.+|+.+++.++||||+++++.+..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKET---------GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCC---------CceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 35799999999999999999987654 678999998877666667888999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++||||+++++|..++.+.. ..+++..+..++.|++.+|+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999988876543 45889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
+...... ........+++.|+|||++. ...++.++|+|||||++|+|+
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~ 209 (292)
T cd06644 157 SAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 209 (292)
T ss_pred ceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh
Confidence 8753221 11223456889999999985 345778999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=268.40 Aligned_cols=208 Identities=25% Similarity=0.413 Sum_probs=166.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCc-------cccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCccc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLA-------PSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
.++|++.+.||+|+||.||++........ ......+..+|+|.+.... ....+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 35799999999999999999865431100 0122235579999987543 334467889999999999999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS-------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
+++++...+..+++|||+++++|.+++...... ...+++..+..++.|++.||+||| +.+++||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChheE
Confidence 999999999999999999999999999764321 124678889999999999999999 58999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++.++|+|||+++.+.............+++.|+|||+..++.++.++|+|||||++|+|+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~ 226 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHH
Confidence 99999999999999997653322111122234467899999988889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=298.87 Aligned_cols=199 Identities=21% Similarity=0.277 Sum_probs=164.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++++.||+|+||+||+|.+... +..+|+|.+... .......+..|+.++++|+||||++++++|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~t---------g~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRT---------QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCC---------CeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 456899999999999999999987654 778999988654 223446788999999999999999999988
Q ss_pred EcC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCC-----CCceeccCCCCcEEEcC-
Q 022413 165 WED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE-----KKVIYRDFKASNILLDG- 236 (297)
Q Consensus 165 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-----~~ivH~Dlkp~Nill~~- 236 (297)
.+. ..+||||||+++++|.++|.........+++..++.|+.||+.||+|||... .+||||||||+||||+.
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 654 5799999999999999999764433356899999999999999999999521 45999999999999964
Q ss_pred ----------------CCceEEccccccccCCCCCCcceeeccCCcccccCcceecc--cCCcccccchhhhhhhhhcC
Q 022413 237 ----------------NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~ll 297 (297)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+||+|+
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 3458999999998653321 2234579999999999864 45788999999999999985
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=263.44 Aligned_cols=192 Identities=28% Similarity=0.392 Sum_probs=161.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|++.+.||+|+||.||++.+.+ +..+|+|.+..... ....+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 468889999999999999997654 34689998765432 2357888999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCc
Confidence 9999999999999999987543 34788999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~ 195 (256)
T cd05114 148 RYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred cccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHH
Confidence 76432211 1112223566899999999888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=265.31 Aligned_cols=191 Identities=27% Similarity=0.446 Sum_probs=164.4
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCee
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
|++.+.||+|+||.||+|..... +..+++|.+........+.+.+|+++++.++||||+++++++..++..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKET---------GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCC---------CeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 67788999999999999987654 678899998766656667888999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
++||||+++++|..++.... ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999998876532 45899999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......+++.|+|||++. +..++.++|+|||||++|+|+
T Consensus 153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 153 NTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred ccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 43221 1223456899999999984 455788999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.41 Aligned_cols=188 Identities=27% Similarity=0.435 Sum_probs=160.3
Q ss_pred CCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCC----cchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP----ESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 92 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+...+||+|+|-+||+|.+... |..||=-.++. ......++|..|+.+|+.|+||||+++|++|.+.
T Consensus 43 k~~evLGrGafKtVYka~De~~---------giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEE---------GIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ehhhhcccccceeeeecccccc---------chhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 4457899999999999988766 44444222211 2345568999999999999999999999999987
Q ss_pred Ce--eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEEcc
Q 022413 168 KE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISD 244 (297)
Q Consensus 168 ~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl~D 244 (297)
.. +.+|+|++..|+|..|+.+. +......+..|++||+.||.|||++...|||||||.+||||+. -|.|||.|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 65 99999999999999999887 5688889999999999999999998899999999999999986 49999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+..... ......|||.|||||++. ..|+...||||||+|+++|.
T Consensus 190 LGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv 237 (632)
T KOG0584|consen 190 LGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV 237 (632)
T ss_pred hhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH
Confidence 9999876432 223478999999999887 89999999999999999984
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.89 Aligned_cols=189 Identities=31% Similarity=0.419 Sum_probs=166.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||++.+... ++.+|+|.+.... ....+.+.+|++++++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGS---------GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 4688999999999999999987654 7789999886532 233467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.||+|+||+|+|||++.++.+||+||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999999999765 45889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++..... .....|++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 192 (290)
T cd05580 146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML 192 (290)
T ss_pred CCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHH
Confidence 998865332 23456899999999998888899999999999999985
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=264.91 Aligned_cols=199 Identities=31% Similarity=0.474 Sum_probs=165.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+.|++.+.||+|+||.||++.+... ....+..|++|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccC-----CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 3578899999999999999976431 22337789999987553 33446789999999999999999999998875
Q ss_pred --CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 168 --KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 168 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
...++||||++|++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCC
Confidence 56899999999999999986542 34789999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++........ .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ell 206 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhh
Confidence 999865432211 1122345677899999999888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=265.39 Aligned_cols=199 Identities=29% Similarity=0.441 Sum_probs=164.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC-
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED- 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~- 167 (297)
++|++.+.||+|+||.||++.... .....+..|++|.+........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 478899999999999999997542 12233778999998876666667889999999999999999999987543
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 168 -KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 168 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
..+++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCc
Confidence 46899999999999999997543 34789999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCccee-eccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVT-TRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++........... ....++..|+|||++.+..++.++|+|||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 205 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 205 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHh
Confidence 99865433221111 1122345699999999888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=267.04 Aligned_cols=202 Identities=27% Similarity=0.344 Sum_probs=165.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
+|++.+.||+|+||.||+|..... ........+++|.+.... ......+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 478889999999999999976532 111224578898887543 334467889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCC
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNP--------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK 228 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlk 228 (297)
..+++|||+.+++|.+++..... ....+++..++.++.|++.||.||| +.+|+|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhh
Confidence 99999999999999999864321 1245788999999999999999999 5999999999
Q ss_pred CCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 229 ASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 229 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|+
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~ 223 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHH
Confidence 999999999999999999997643322211122334577899999998888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=274.75 Aligned_cols=185 Identities=25% Similarity=0.382 Sum_probs=160.3
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 171 (297)
.++||.|.||+||-|+++.. |+.||||++++... +.-..+.+|+.||.+++||.||.+...|+..+.++
T Consensus 569 devLGSGQFG~VYgg~hRkt---------GrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKT---------GRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecceeccc---------CceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 47899999999999988765 99999999987532 23356789999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CCceEEcccccc
Q 022413 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NYNAKISDFGLA 248 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a 248 (297)
+|||-+ .|++.+.|..... ..+++.....++.||+.||.||| .++|||+||||+|||+.. --++||||||+|
T Consensus 640 VVMEKl-~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEehhh-cchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccce
Confidence 999999 5577777765543 56899999999999999999999 699999999999999964 457999999999
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhh
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCM 295 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ 295 (297)
++... ........|||.|+|||++.+..|...=|+||.|||+|-
T Consensus 715 RiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYV 758 (888)
T KOG4236|consen 715 RIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYV 758 (888)
T ss_pred eecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEE
Confidence 97643 334556789999999999999999999999999999984
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=276.04 Aligned_cols=189 Identities=25% Similarity=0.320 Sum_probs=159.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||+||+|..... +..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRL---------RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCC---------CCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 356899999999999999999977654 7789999987542 22345677899999999999999999987
Q ss_pred EcC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 165 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
... ...|++++++ +++|.+++.. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDC 155 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECCCC
Confidence 643 3579999988 7899888754 34899999999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 210 (343)
T cd07878 156 ELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210 (343)
T ss_pred CEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH
Confidence 999999999986432 1234578999999999977 56888999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=277.80 Aligned_cols=205 Identities=26% Similarity=0.352 Sum_probs=166.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCC-CCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 164 (297)
..++|.+.+.||+|+||.||+|.+.... ....+..||+|++..... ...+.+.+|+.+|.++. ||||+++++++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 3457889999999999999999876421 112356799999975432 23457889999999998 99999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCC-----------------------------------------------------
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNP----------------------------------------------------- 191 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 191 (297)
...+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975321
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCC
Q 022413 192 -----------------------------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230 (297)
Q Consensus 192 -----------------------------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~ 230 (297)
....+++..++.++.|++.||+||| +.+|+||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcc
Confidence 1124667788899999999999999 589999999999
Q ss_pred cEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 231 NILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 231 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l 335 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence 9999999999999999997643221111122345678999999999888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=267.33 Aligned_cols=191 Identities=28% Similarity=0.415 Sum_probs=156.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCC---CCCCcccEEeEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLLGYC 164 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~ 164 (297)
+|++.+.||+|+||+||+|.+..+ ++.||+|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHS---------GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCC---------CcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 488899999999999999987654 78899998875321 1123455677777665 699999999988
Q ss_pred Ec-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 165 WE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 165 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
.. ....+++|||+.+ +|.+++..... ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQ 146 (288)
T ss_pred ccccCCCCceEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCC
Confidence 64 2458999999964 89888875432 34889999999999999999999 589999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 147 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 201 (288)
T cd07863 147 VKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201 (288)
T ss_pred EEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHH
Confidence 9999999998653221 123356899999999999889999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=261.84 Aligned_cols=188 Identities=24% Similarity=0.329 Sum_probs=160.5
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 173 (297)
+.||+|+|+.|--++.-. ++..+|||++++.....+.++.+|++++.+.+ |+||++++++|+++..+|||
T Consensus 84 e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 679999999998775443 48889999999886666789999999999997 99999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---ceEEcccccccc
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY---NAKISDFGLAKL 250 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~ 250 (297)
||-+.||.|...|+++ ..+++.++..+..+|+.||.||| .+||.||||||+|||-.... -+|||||.+..-
T Consensus 155 fEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 9999999999999987 56999999999999999999999 69999999999999996544 479999998754
Q ss_pred CCCCC-----CcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGG-----ESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......+.+|+..|||||++. -..|+.+.|.||||||||-||
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL 285 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML 285 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHH
Confidence 32221 112234578999999999874 245778899999999999986
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=264.79 Aligned_cols=186 Identities=23% Similarity=0.393 Sum_probs=161.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.++||+|+||.||+|.+... +..+|+|.+... .....+.+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLT---------RRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCC---------CcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 3688899999999999999976643 778999988654 233346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|..+ ..+++..+..++.|++.||+||| +.||+|+||||+|||++.++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 72 NRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGV 141 (279)
T ss_pred CEEEEEEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 999999999999998654 23678888999999999999999 59999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+...... ......||+.|+|||++.+..++.++|+||||+++|+|+
T Consensus 142 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 187 (279)
T cd06619 142 STQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELA 187 (279)
T ss_pred ceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHH
Confidence 8754322 223457899999999999889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=262.57 Aligned_cols=194 Identities=26% Similarity=0.393 Sum_probs=163.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|++|.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 4578999999999999999997654 45699999876543 236788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..+++|||+++++|.+++.... ...+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcce
Confidence 99999999999999999997643 245889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ........+..|+|||++.+..++.++|+||||+++|+|+
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 198 (261)
T cd05068 150 ARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198 (261)
T ss_pred EEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHH
Confidence 986542211 1111122345799999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=262.90 Aligned_cols=192 Identities=28% Similarity=0.359 Sum_probs=162.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468889999999999999997654 34589998875433 2367889999999999999999999999989
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..+++|||+.+++|.+++.... ..+++..++.++.|++.||+||| +.|++|+||||+|||++.++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 9999999999999999997643 35889999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~ 195 (256)
T cd05113 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY 195 (256)
T ss_pred eecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHh
Confidence 76533221 1112233567899999998888999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=262.45 Aligned_cols=192 Identities=28% Similarity=0.370 Sum_probs=161.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
.+|++.+.||+|+||.||++.+.. +..+++|.+..... ....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 358889999999999999997653 44689998865432 2256788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccc
Confidence 9999999999999999997643 35889999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~ 195 (256)
T cd05059 148 RYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred eecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHh
Confidence 75432211 1111122345799999999889999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=265.33 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=162.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|.+..+. ......||+|.+.... ......+.+|+.+++.+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDG-----ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCC-----CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 457899999999999999999865431 0113358999886543 3334678899999999999999999998875
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
...++++||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCC
Confidence 45789999999999999997643 45889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~ 205 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELM 205 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 998664322211112223567899999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=265.28 Aligned_cols=204 Identities=26% Similarity=0.352 Sum_probs=164.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|.+.+.||+|+||.||+|.+.... ....+..|++|.+.... ......+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRD----GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCC----CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 457999999999999999999876521 01136789999887543 2333568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---ce
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPS---IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY---NA 240 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~---~~ 240 (297)
....++||||+++++|.+++...... ...+++..++.++.||+.||+||| +.+++||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCCcce
Confidence 99999999999999999999765321 135889999999999999999999 58999999999999998654 59
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++................++.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 999999998653221111111223456899999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=269.70 Aligned_cols=192 Identities=23% Similarity=0.308 Sum_probs=153.3
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc--CCeeE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE--DKELL 171 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~ 171 (297)
.++||+|+||+||+|...+. ..++.+|+|.+..... ...+.+|+.++++++||||+++++++.. ....|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 46899999999999986532 1267899999875432 2456789999999999999999999865 35689
Q ss_pred EEEEecCCCCHHHHHhhcCC-----CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE----cCCCceEE
Q 022413 172 LVYEYMQRGSLENHLFRRNP-----SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGNYNAKI 242 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill----~~~~~~kl 242 (297)
++|||+. ++|.+++..... ....+++..+..++.||+.||+||| +.||+||||||+|||+ +..+.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 9999994 588888753321 1235889999999999999999999 5899999999999999 45688999
Q ss_pred ccccccccCCCCCCc-ceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 210 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH
Confidence 999999865432211 122345789999999999874 5788999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=272.94 Aligned_cols=204 Identities=27% Similarity=0.334 Sum_probs=163.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+... .....++.||+|.+.... ......+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 45799999999999999999975431 122347789999987543 23346788999999999 5899999999886
Q ss_pred cC-CeeEEEEEecCCCCHHHHHhhcCCC----------------------------------------------------
Q 022413 166 ED-KELLLVYEYMQRGSLENHLFRRNPS---------------------------------------------------- 192 (297)
Q Consensus 166 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------------------------- 192 (297)
.. ...+++|||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 4689999999999999998753210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceee
Q 022413 193 -----------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261 (297)
Q Consensus 193 -----------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 261 (297)
...+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 123677888999999999999999 5999999999999999999999999999997653322111122
Q ss_pred ccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 262 RVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 262 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 275 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 234567899999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.81 Aligned_cols=194 Identities=26% Similarity=0.436 Sum_probs=164.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.++||+|+||.||+|...+ +..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4579999999999999999997654 45689998765433 346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..+++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCcc
Confidence 999999999999999999975432 45788889999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......++..|+|||++.+..++.++|||||||++|+|+
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 198 (261)
T cd05072 150 ARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198 (261)
T ss_pred ceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHH
Confidence 986543221 1112234567899999999888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=259.98 Aligned_cols=193 Identities=27% Similarity=0.372 Sum_probs=167.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|.+.+.||+|++|.||+|....+ +..|++|.+... .......+.+|++++++++||||+++++++.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKAD---------KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCC---------CcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 477889999999999999987654 778999988643 234457788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++.... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~ 147 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGV 147 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEccccc
Confidence 99999999999999999997642 245888999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 195 (256)
T cd08529 148 AKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC 195 (256)
T ss_pred ceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 886543221 223356889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=267.11 Aligned_cols=193 Identities=25% Similarity=0.325 Sum_probs=167.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
...+|++.+.||+|+||.||+|..... +..+++|.+........+.+.+|+.+++.+.||||+++++.+..
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~ 88 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVAT---------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCC---------CcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 346899999999999999999976543 77899999876655555778899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
....++||||+++++|.+++.. ..+++..+..++.|++.||+||| ..||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg 161 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECccc
Confidence 9999999999999999999864 34788899999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......|++.|+|||.+.+..++.++|||||||++|+|+
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~ 210 (296)
T cd06654 162 FCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210 (296)
T ss_pred cchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHH
Confidence 987543221 1122346899999999999888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=265.00 Aligned_cols=190 Identities=35% Similarity=0.492 Sum_probs=164.7
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhH--HHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF--EEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
|++.+.||+|+||+||++....+ +..+|+|.+........ ....+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKN---------GQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTT---------TEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECCC---------CeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 56789999999999999988765 77899999987654322 23456999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..+++|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccccccccccccc----cccccccccccccccccccccccc--ccccccccccccccccccccccccccccc
Confidence 999999999999999999844 568999999999999999999995 89999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceec-ccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVA-TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .........+++.|+|||++. +..++.++|+||||+++|+|+
T Consensus 146 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 193 (260)
T PF00069_consen 146 VKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELL 193 (260)
T ss_dssp EESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHH
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccc
Confidence 75311 122344567899999999998 788999999999999999984
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=263.21 Aligned_cols=194 Identities=30% Similarity=0.452 Sum_probs=167.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.+.||.|+||.||+|.+.. +..+++|.+..........+..|+.+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 4578999999999999999998765 566999998877665567788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++..... ..+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999999976432 45788999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ ......++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~ 198 (261)
T cd05148 151 ARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198 (261)
T ss_pred hhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 976543221 112334577899999998888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=261.34 Aligned_cols=194 Identities=27% Similarity=0.393 Sum_probs=162.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-----hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-----MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
.+|++.+.||+|+||.||+|...++ +..|++|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~---------~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADT---------GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCC---------CcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 4789999999999999999987654 7789999875321 2334678899999999999999999998
Q ss_pred EEcC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 164 CWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 164 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+.+. ..++++|||+++++|.+++... ..+++..++.++.|++.||+||| +.+|+|+||||+|||++.++.+|
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEE
Confidence 8764 5688999999999999998765 34788889999999999999999 58999999999999999999999
Q ss_pred EccccccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++........ .......|+..|+|||++.+..++.++||||||+++|+|+
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 203 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence 9999998754321111 1122346889999999999888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=261.54 Aligned_cols=199 Identities=26% Similarity=0.409 Sum_probs=162.2
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
|.+.+.||+|+||.||+|....+. ..+..+|+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD------GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC------CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 567899999999999999875431 124679999887542 334567889999999999999999999887655
Q ss_pred e------eEEEEEecCCCCHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 169 E------LLLVYEYMQRGSLENHLFRRNP--SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 169 ~------~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
. .+++|||+++++|..++..... ....+++..+..++.|++.||.||| +.+++||||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeE
Confidence 4 7999999999999999864321 2245889999999999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...............++..|+|||++.+..++.++||||||+++|+|+
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~ 209 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHH
Confidence 999999998654332211122233567899999998888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=263.06 Aligned_cols=194 Identities=26% Similarity=0.296 Sum_probs=154.5
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
+.||+|+||.||+|..... .....+++|.+..... .....+.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 3589999999999965432 1145688898765432 3345678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC
Q 022413 174 YEYMQRGSLENHLFRRNPS-IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
|||+++++|.+++...... ....++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence 9999999999999765422 233567788899999999999999 5899999999999999999999999999987533
Q ss_pred CCCCcceeeccCCcccccCcceecc-------cCCcccccchhhhhhhhhcC
Q 022413 253 AGGESHVTTRVMGTYGYAAPEYVAT-------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 253 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~~ll 297 (297)
............+++.|+|||++.. ..++.++|||||||++|+|+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHH
Confidence 2211111223345778999998743 35678999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=262.14 Aligned_cols=195 Identities=27% Similarity=0.416 Sum_probs=165.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|.+.+.||+|+||.||+|.+.+. +..+++|.+.... .....+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~---------~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecC---------CceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 34688889999999999999987654 6779999887543 2346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.++++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+|||+++++.+||+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCcc
Confidence 999999999999999999875432 45788999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ .......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 199 (263)
T cd05052 151 SRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 199 (263)
T ss_pred cccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 976543211 1111223467899999999899999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=265.57 Aligned_cols=194 Identities=27% Similarity=0.416 Sum_probs=167.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||.|+||.||++.+..+ +..+++|.+........+.+.+|+.++++++||||+++++.+..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKET---------GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCC---------CcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 35799999999999999999987653 678999998776666667889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...|+||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCcc
Confidence 99999999999999999987643 45899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......+++.|+|||++. +..++.++|+||||+++|+|+
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~ 202 (280)
T cd06611 150 SAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202 (280)
T ss_pred chhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence 87543221 1223456899999999975 344677999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=260.86 Aligned_cols=196 Identities=24% Similarity=0.363 Sum_probs=168.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||+|....+ +..+++|.+... .....+.+.+|++++++++|+||+++++.+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLD---------GRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCC---------CCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 5799999999999999999987643 778999987642 2233467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..+++|||+++++|.+++.........+++..++.++.+++.||.||| +.||+||||||+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecc
Confidence 999999999999999999998764444456889999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++....... ......+++.|+|||.+.+..++.++|+|||||++|+|+
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 99875433211 123346889999999999888999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=266.69 Aligned_cols=203 Identities=30% Similarity=0.381 Sum_probs=167.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|.+.+.||+|+||.||++..... .....+..+|+|.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 356799999999999999999975321 112236679999887653 23346788999999999 799999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
...+..+++|||+++++|.+++..... ..+++..+..++.|++.||+||| +.+|+|+||||+|||++.++.+||+|
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeEEECC
Confidence 999999999999999999999975432 33789999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~ 237 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHH
Confidence 99997654322111122234678899999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=259.98 Aligned_cols=194 Identities=29% Similarity=0.383 Sum_probs=168.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|..... +..+++|.+........+.+.+|++++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIAT---------GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCC---------CCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 35789999999999999999987653 567999998766555667889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+|++|||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 147 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGV 147 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECcccc
Confidence 99999999999999999987642 45889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceeccc---CCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATG---NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......++..|+|||++.+. .++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 148 SAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred chhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 87643321 122335688999999999876 7889999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=258.83 Aligned_cols=193 Identities=26% Similarity=0.342 Sum_probs=165.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
+|++.+.||+|+||.||++....+ +..+++|.+... .....+.+.+|+.+++.++||||+++++.+.+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNS---------DQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCC---------CceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 578899999999999999976654 778999988643 2334567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
.+|++|||+++++|.+++..... ..+++..++.++.|++.||.||| +.+|+|+||||+||++++++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCcc
Confidence 99999999999999998865322 45788999999999999999999 599999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~ 194 (255)
T cd08219 148 RLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC 194 (255)
T ss_pred eeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehh
Confidence 76533221 223456899999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=263.12 Aligned_cols=196 Identities=23% Similarity=0.355 Sum_probs=167.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||++....+ +..+++|.+... ......++.+|+.+++.++||||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~---------~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLD---------GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCC---------CceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 4688899999999999999987654 678999987643 2233467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..+++|||+++++|.+++.........+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999998754333356899999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++........ ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 200 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence 99876533221 123356899999999998888999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=266.50 Aligned_cols=193 Identities=26% Similarity=0.324 Sum_probs=167.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||.|+||.||++..... +..||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 87 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIAT---------GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 87 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCC---------CCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 356899999999999999999986544 77899999876554455678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.+ ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Dfg 160 (297)
T cd06656 88 GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFG 160 (297)
T ss_pred CCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcCc
Confidence 9999999999999999999865 34788899999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++........ ......+++.|+|||.+.+..++.++|+|||||++|+|+
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~ 209 (297)
T cd06656 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209 (297)
T ss_pred cceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9875433211 123346889999999999888999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=260.63 Aligned_cols=193 Identities=21% Similarity=0.292 Sum_probs=154.5
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEE
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 174 (297)
.||+|+||.||+|...... ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 5899999999998654321 13346777766543 334578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCC
Q 022413 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254 (297)
Q Consensus 175 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 254 (297)
||+++++|.+++.+........++..++.++.||+.||+||| +.+++||||||+|||++.++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence 999999999999865433345677788899999999999999 589999999999999999999999999998642221
Q ss_pred CCcceeeccCCcccccCcceecc-------cCCcccccchhhhhhhhhcC
Q 022413 255 GESHVTTRVMGTYGYAAPEYVAT-------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 255 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~~ll 297 (297)
..........+++.|+|||++.. ..++.++||||||+++|+|+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence 11112234567899999998753 24567899999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=260.69 Aligned_cols=194 Identities=25% Similarity=0.288 Sum_probs=155.9
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
+.||+|+||.||+|.+... ..+..+++|.+.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCC-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 3689999999999976542 125578999887543 23335788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC
Q 022413 174 YEYMQRGSLENHLFRRNPS-IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
|||+++++|.+++...... ....++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999999754321 234567788899999999999999 5899999999999999999999999999987543
Q ss_pred CCCCcceeeccCCcccccCcceeccc-------CCcccccchhhhhhhhhcC
Q 022413 253 AGGESHVTTRVMGTYGYAAPEYVATG-------NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 253 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslGv~l~~ll 297 (297)
............+++.|+|||++.+. .++.++|+||||+++|+|+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHH
Confidence 22211112234578899999998642 3578999999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=259.99 Aligned_cols=192 Identities=23% Similarity=0.320 Sum_probs=156.6
Q ss_pred ceecccCceEEEEEEECCCCCc---cccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLA---PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~---~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 171 (297)
+.||+|+||.||+|.+..+... .........+++|.+..........+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986542111 0111234568999887665555567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc-------eEEcc
Q 022413 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN-------AKISD 244 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~-------~kl~D 244 (297)
++|||+++++|..++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999988886543 45889999999999999999999 599999999999999987654 89999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceec-ccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~~ll 297 (297)
||++..... .....++..|+|||++. +..++.++|||||||++|+|+
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~ 203 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC 203 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHH
Confidence 999865422 12345788999999887 466888999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=267.50 Aligned_cols=207 Identities=26% Similarity=0.367 Sum_probs=165.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
...+|.+.+.||+|+||.||++...... .........+|+|.+.... ......+..|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGID--KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccC--CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 3457899999999999999999764311 0111235678999887543 33456788999999999 599999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
.+.+..+++|||+++++|.+++..... ....+++..+..++.|++.||.||| +.||+||||||+||
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Ni 165 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNV 165 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeE
Confidence 999999999999999999999976432 1235788899999999999999999 58999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 230 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHH
Confidence 99999999999999998654321111111223456799999998888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=261.51 Aligned_cols=198 Identities=26% Similarity=0.428 Sum_probs=163.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+|++.+.||+|+||.||+|....+. ..+..|++|.+... .......+..|+.+++.++||||+++++++.++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCC------CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 45888999999999999999876531 11346999998764 334457889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.|++||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCcc
Confidence 99999999999999999987643 45788999999999999999999 59999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccC---CcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVM---GTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++............... .+..|+|||++.+..++.++||||||+++|+|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l 205 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHh
Confidence 87654322111111111 245799999999899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=266.15 Aligned_cols=192 Identities=26% Similarity=0.340 Sum_probs=167.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.+.||.|++|.||+|..... ++.|++|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVAT---------GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCC---------CcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 45799999999999999999976544 788999988765555557788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++|+||+++++|.+++.. ..+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg~ 161 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGF 161 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence 999999999999999998864 34789999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ ......+++.|+|||.+.+..++.++|+|||||++|+|+
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~ll 209 (296)
T cd06655 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209 (296)
T ss_pred chhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHH
Confidence 875433211 123346889999999999888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=268.02 Aligned_cols=194 Identities=30% Similarity=0.371 Sum_probs=167.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCC-CCCcccEEe
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLS-HPNLVKLLG 162 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~ 162 (297)
...+|..+.+||+|+||+|.+|..+ ++.+.+|||+++++.. .+.+--..|-++|.... -|.+++++.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerk---------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred eecccceEEEeccCccceeeeeccc---------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 4567899999999999999998444 4477899999987632 23334456777777664 789999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
.|+..+++|+||||+.||+|--.|++- ..+-+..+..++.+|+-||-+|| ++||++||||.+|||+|.+|++||
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEe
Confidence 999999999999999999999998876 55777788899999999999999 599999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++.....+. .+.++||||.|+|||++...+|....|.||+||+||+||
T Consensus 492 ~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEml 544 (683)
T KOG0696|consen 492 ADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 544 (683)
T ss_pred eecccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHH
Confidence 99999987655433 456799999999999999999999999999999999996
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=260.64 Aligned_cols=198 Identities=25% Similarity=0.373 Sum_probs=159.2
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC-
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED- 167 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~- 167 (297)
|.+.+.||+|+||.||+|.+.... ....+|+|.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 356789999999999999876531 1235899988654 234457788999999999999999999987532
Q ss_pred -----CeeEEEEEecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 168 -----KELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 168 -----~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
...+++|||+++++|.+++.... .....+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCE
Confidence 25789999999999999885322 12245789999999999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~ 208 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIA 208 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHH
Confidence 999999998654322211122234577899999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=260.10 Aligned_cols=198 Identities=28% Similarity=0.414 Sum_probs=164.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+|++.+.||+|+||.||+|.+.... .....+|+|.++... ....+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPG------KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCC------CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 46889999999999999999765321 114578999987543 23346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999999999999999997643 35788999999999999999999 59999999999999999999999999999
Q ss_pred cccCCCCCCcce-eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHV-TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.......... .....++..|+|||++.+..++.++|+||||+++|+++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell 203 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHh
Confidence 986543221111 11122356899999999889999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=252.02 Aligned_cols=192 Identities=24% Similarity=0.374 Sum_probs=162.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCC-CCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 165 (297)
.++.+++..||.|+.|.||++.++.. |..+|||.+... ..+..++++..+.++..-+ .|+||+.+++|.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~---------~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRST---------GHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEccc---------ceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 34566678899999999999988865 889999999876 3455678888888877765 999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.+..+++.||.| ..-+..++..-. .++++..+-++...++.||.||.. ++||+|||+||+|||+|+.|.+|||||
T Consensus 162 ~n~dV~IcMelM-s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 162 TNTDVFICMELM-STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred eCchHHHHHHHH-HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecc
Confidence 999999999998 445666665443 568999999999999999999996 789999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc---cCCcccccchhhhhhhhhc
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT---GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~~l 296 (297)
|++-++.+.. ..+.-.|.+.|||||.+.- .+|+..+||||||+.|++|
T Consensus 237 GIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveL 287 (391)
T KOG0983|consen 237 GISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVEL 287 (391)
T ss_pred cccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhh
Confidence 9997765432 3344579999999999864 4688899999999999987
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=266.33 Aligned_cols=198 Identities=30% Similarity=0.418 Sum_probs=161.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+. ....+++|.+.... ......+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 457899999999999999999876431 12356787766432 23346788999999999 7999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
+.+..|+||||+++++|.+++..... ....+++..++.++.|++.||+||| +.||+||||||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nil 156 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNIL 156 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEE
Confidence 99999999999999999999975432 1135789999999999999999999 599999999999999
Q ss_pred EcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|+
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 217 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217 (303)
T ss_pred ecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHH
Confidence 9999999999999986421110 111123466799999998888899999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=269.62 Aligned_cols=206 Identities=27% Similarity=0.357 Sum_probs=165.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
..+|++.+.||+|+||.||+|.+.... .........+|+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGID--KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccC--CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 457999999999999999999764321 0111224568999887542 33456788999999999 7999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
..+..+++|||+++++|.+++....+ ....+++..++.++.|++.||.||| +.||+||||||+|||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil 166 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARNVL 166 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEE
Confidence 99999999999999999999976432 1235788899999999999999999 599999999999999
Q ss_pred EcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 230 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 230 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHH
Confidence 9999999999999997653322111122223456799999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=261.97 Aligned_cols=190 Identities=21% Similarity=0.292 Sum_probs=154.3
Q ss_pred eecccCceEEEEEEECCCCC---------------ccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccE
Q 022413 96 LLGEGGFGRVYKGWVDDKTL---------------APSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKL 160 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~---------------~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 160 (297)
.||+|+||.||+|.+..+.. ...+......|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997542210 011223345789999876655545678899999999999999999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC--
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-- 238 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-- 238 (297)
++++.+....++||||+++++|..++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999886532 45788999999999999999999 58999999999999997643
Q ss_pred -----ceEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhc
Q 022413 239 -----NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 239 -----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~l 296 (297)
.+|++|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 3899999987643211 12357888999998875 5688999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=261.37 Aligned_cols=195 Identities=35% Similarity=0.485 Sum_probs=160.5
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC--
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED-- 167 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 167 (297)
|++.+.||+|+||+||++.+.. .....+..||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4889999999999999876542 1123377899999876532 3346788999999999999999999987654
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
..++++|||+++++|.+++... .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeeccc
Confidence 4689999999999999999753 3899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++......... ......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~ 204 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence 98654322111 111223566799999998888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=263.53 Aligned_cols=196 Identities=36% Similarity=0.541 Sum_probs=160.2
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeE
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELL 171 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 171 (297)
+.+.||.|.||.||+|.+.. .....+..|+||.+.... .+..+.+.+|++++++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 45789999999999998883 112236789999996543 334688999999999999999999999999888899
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+||||+++|+|.++|..... ..+++..+..|+.||+.||.|||+ .+++|+||+++|||+++++.+||+|||+++..
T Consensus 78 lv~e~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc
Confidence 99999999999999987622 558999999999999999999995 89999999999999999999999999999865
Q ss_pred CCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 252 PAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 252 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.............+...|+|||.+.+..++.++||||||+++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~ 199 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEIL 199 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222222222334678899999999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=263.35 Aligned_cols=197 Identities=28% Similarity=0.396 Sum_probs=160.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCC-CCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 166 (297)
++|++.++||+|+||.||+|...++. ....+++|.+... .....+.+.+|+.++.++ +||||+++++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 57899999999999999999876531 1234688877643 233446788999999999 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
.+..+++|||+++++|.+++..... ....+++..++.++.|++.||+||| +.||+||||||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEE
Confidence 9999999999999999999975431 1134788999999999999999999 5999999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|+|+
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 999999999999986422110 111112345799999998888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.61 Aligned_cols=193 Identities=24% Similarity=0.307 Sum_probs=166.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
-|..++.||-|+||+|.++.-.++ ...+|+|.+.+.+. ........|-+||...+++-||+||-.|++
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT---------~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDT---------RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred ceEEEeeecccccceeEEEeecch---------hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 477788999999999999865543 56799999887643 344567789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+.+|+||+|++||++-.+|.+. +-|.+..++.++.++..|+++.| +.|+|||||||+|||||.+|++||.|||
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeeecc
Confidence 99999999999999999999877 66899999999999999999999 6999999999999999999999999999
Q ss_pred ccccCCCCCCc--------c--------------------------------eeeccCCcccccCcceecccCCcccccc
Q 022413 247 LAKLGPAGGES--------H--------------------------------VTTRVMGTYGYAAPEYVATGNFYLLSAK 286 (297)
Q Consensus 247 ~a~~~~~~~~~--------~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv 286 (297)
||.-+.+.-.+ . .....+||+.|+|||++....|+...|.
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 99643321000 0 0113569999999999999999999999
Q ss_pred hhhhhhhhhcC
Q 022413 287 FGNVINVCMYL 297 (297)
Q Consensus 287 wslGv~l~~ll 297 (297)
||.|||||+||
T Consensus 855 ws~gvil~em~ 865 (1034)
T KOG0608|consen 855 WSVGVILYEML 865 (1034)
T ss_pred hHhhHHHHHHh
Confidence 99999999996
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=260.30 Aligned_cols=199 Identities=26% Similarity=0.390 Sum_probs=164.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..+|++.+.||+|+||.||+|.+..+. ......+++|.+..... .....+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEG-----EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCC-----CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 357889999999999999999875431 11134689998876543 344678899999999999999999999887
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
...+++|||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCc
Confidence 78999999999999999997653 34889999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...............++..|+|||.+....++.++|+||||+++|+|+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~ 205 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHh
Confidence 998765332211112223457899999998888999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=258.42 Aligned_cols=193 Identities=27% Similarity=0.422 Sum_probs=163.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---------hhHHHHHHHHHHhcCCCCCCcccE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---------QGFEEWQSEVNFLGRLSHPNLVKL 160 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~~ 160 (297)
+|.+.+.||+|++|.||+|..... +..+++|.+..... +..+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASS---------GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecCC---------CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 478889999999999999986543 67799998764321 123567899999999999999999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
++++.+.+..+++|||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~ 145 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGI 145 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCE
Confidence 99999999999999999999999999765 45788899999999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCC----cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGE----SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++....... ........|++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~ 206 (267)
T cd06628 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206 (267)
T ss_pred EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh
Confidence 9999999886542211 01112345889999999999888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=265.05 Aligned_cols=193 Identities=25% Similarity=0.346 Sum_probs=161.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|..... +..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLT---------DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCC---------CcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 45799999999999999999977653 6789999986543 2223467789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++..++||||++ ++|.+++.... ..+++..+..++.|++.||+||| ..+|+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg 149 (301)
T cd07873 76 EKSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFG 149 (301)
T ss_pred CCeEEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCc
Confidence 999999999996 58998887543 45788999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
++........ ......+++.|+|||++.+. .++.++|||||||++|+|+
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 199 (301)
T cd07873 150 LARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199 (301)
T ss_pred chhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHH
Confidence 9875432211 12234578999999998754 4778999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=256.78 Aligned_cols=193 Identities=24% Similarity=0.352 Sum_probs=166.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.++||.|+||.||.+....+ +..+++|.+... .....+++.+|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTED---------DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCC---------CcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 588899999999999999876654 778999987654 234456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.++++|||+++++|.+++.... ...+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcc
Confidence 99999999999999999997653 245789999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ ......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~ 195 (256)
T cd08221 148 SKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195 (256)
T ss_pred eEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence 876543221 233456899999999999888999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=257.35 Aligned_cols=194 Identities=27% Similarity=0.400 Sum_probs=163.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-----hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-----MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
.+|+..+.||+|+||.||+|..... +..+++|.+.... .+....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDT---------GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCC---------CcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 4789999999999999999977654 7789999876431 2334578899999999999999999998
Q ss_pred EEcC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 164 CWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 164 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+.+. ..+++++||+++++|.+++... ..+++...+.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEE
Confidence 8763 6789999999999999999765 34788899999999999999999 58999999999999999999999
Q ss_pred EccccccccCCCCCC-cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGE-SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|+
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 999999876432111 11122345889999999999888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=263.71 Aligned_cols=194 Identities=24% Similarity=0.347 Sum_probs=164.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||++..... ++.|++|.+.... ......+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~---------~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKET---------RQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCC---------CcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 3688999999999999999987654 6789999887543 233457789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.++.+++||||++|++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~df 145 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDF 145 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeC
Confidence 999999999999999999999765 45888999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCC-------------cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGE-------------SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++....... ........++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~ 210 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHH
Confidence 99864211100 00112245788999999999888999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=262.64 Aligned_cols=200 Identities=28% Similarity=0.332 Sum_probs=164.2
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEe
Q 022413 84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLG 162 (297)
Q Consensus 84 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 162 (297)
+....++|++.+.||+|+||.||++..... +..+++|.+..... ....+.+|+.+++.+ +||||+++++
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~---------~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKN---------GSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCC---------CceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 344677999999999999999999977654 67899998765322 225677899999999 6999999999
Q ss_pred EEE-----cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 163 YCW-----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 163 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
++. ..+..++||||+++++|.+++.........+++..+..++.|++.||.||| ..+|+||||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEECCC
Confidence 874 345799999999999999988654333356888999999999999999999 5899999999999999999
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++...... .......|++.|+|||++.. ..++.++|||||||++|+|+
T Consensus 161 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~ 223 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223 (286)
T ss_pred CCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh
Confidence 999999999987653321 12233468999999999853 45788999999999999984
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.01 Aligned_cols=193 Identities=28% Similarity=0.406 Sum_probs=160.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.+.||+|+||.||+|.+.+ ...|++|.+..... ..+.+.+|++++++++||||+++++.+. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 3569999999999999999997654 23589999876433 2357889999999999999999999774 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCc
Confidence 568999999999999999975421 34788999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ell 197 (262)
T cd05071 149 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 197 (262)
T ss_pred eeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence 976543221 1112234567899999998889999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.67 Aligned_cols=202 Identities=24% Similarity=0.345 Sum_probs=167.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+|++.+.||+|+||+||+|...... .......+++|.+...... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIE----EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCC----cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 57899999999999999999876431 1233567999988765433 456789999999999999999999999998
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCC-----CCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSI-----QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
...++||||+++++|.+++....... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEEE
Confidence 99999999999999999997653211 25899999999999999999999 589999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... ........+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 159 ~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 212 (275)
T cd05046 159 SLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212 (275)
T ss_pred cccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 9999986432211 11122334677899999998888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=255.58 Aligned_cols=195 Identities=34% Similarity=0.481 Sum_probs=165.3
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
+.||+|+||.||+|...... ..+..+++|.+...... ..+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 46999999999999876531 22567999998765433 357888999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 174 YEYMQRGSLENHLFRRNPS-----IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
|||+++++|.+++...... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999999875221 256899999999999999999999 599999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
................+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHH
Confidence 8765432212233456788999999999888999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=273.07 Aligned_cols=199 Identities=26% Similarity=0.397 Sum_probs=170.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.+....+.++||+|.||.||+|.+.+.. ++....||||..+.+ .....+.|+.|..+|+.++||||++++|++.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3445666789999999999999987642 333567999999874 5566789999999999999999999999998
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+. ..|||||+++.|.|..+|+.++ ..++......++.||+.||+|||+ ..+|||||..+|||+.....+||+||
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeeccc
Confidence 75 6899999999999999998876 558888889999999999999996 88999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++.+.+....... ...-..-|||||.+.-..|+.+||||-|||++|+.|
T Consensus 536 GLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl 586 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEIL 586 (974)
T ss_pred chhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHH
Confidence 999988765543322 223356799999999999999999999999999875
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.94 Aligned_cols=194 Identities=26% Similarity=0.447 Sum_probs=163.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||+|+||.||++.+... +..+|+|.+... .......+.+|+.++++++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~---------~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPT---------GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCC---------CcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 3688999999999999999987654 778999988654 233346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|..++..... ...+++..+..++.|++.||.|||. +.+|+||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999999999998875321 2358999999999999999999994 36999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccC------CcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGN------FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGv~l~~ll 297 (297)
+...... ......+++.|+|||++.+.. ++.++|+|||||++|+|+
T Consensus 150 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~ 201 (286)
T cd06622 150 SGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA 201 (286)
T ss_pred cccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence 8754321 123346888999999986543 478999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=257.36 Aligned_cols=192 Identities=29% Similarity=0.460 Sum_probs=163.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc------hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES------MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
+|++.+.||.|+||.||+|.... +..+|+|.+.... .+....+.+|++++++++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~----------~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQ----------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEcC----------CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 58889999999999999997543 6789999876432 2233568899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+..+++|||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+|+|+||+|+||+++.++.+||+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEec
Confidence 99999999999999999999999765 45788999999999999999999 5899999999999999999999999
Q ss_pred cccccccCCCCC----CcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGG----ESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++....... .........|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 202 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA 202 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHH
Confidence 999987542211 111122356899999999999888999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.60 Aligned_cols=204 Identities=28% Similarity=0.417 Sum_probs=165.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|..... .....+..+|+|.+.... ......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 46799999999999999999976431 111236689999987553 3334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCC------------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCC
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNP------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK 228 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlk 228 (297)
.+..+++|||+++++|.+++..... ....+++..++.++.|++.||.||| +.+++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~ 157 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLA 157 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeeccccc
Confidence 9999999999999999999975321 1124678889999999999999999 5899999999
Q ss_pred CCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 229 ASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 229 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||++.++.+||+|||+++................++.|+|||++.+..++.++|||||||++|+|+
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHH
Confidence 999999999999999999987543221111122223467799999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=260.50 Aligned_cols=195 Identities=29% Similarity=0.389 Sum_probs=162.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
....|++.+.||+|+||.||+|..... ++.+|+|.+..... ....+..|+.+++++ +||||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~---------~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKT---------GQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCC---------CcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 355788899999999999999977654 77899999865432 335678899999998 6999999999987
Q ss_pred cC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 ED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
.. ...|++|||+.+++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+||++++++.
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~ 149 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAE 149 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCC
Confidence 53 468999999999999999876422 45889999999999999999999 589999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||++....... .......|++.|+|||++. +..++.++|||||||++|+|+
T Consensus 150 ~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~ 210 (272)
T cd06637 150 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210 (272)
T ss_pred EEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999987643321 1223457899999999986 345788999999999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=255.77 Aligned_cols=189 Identities=28% Similarity=0.367 Sum_probs=154.9
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEE
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 174 (297)
.||+|+||.||+|.+... ..+..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecC-------CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 389999999999976532 1155699999876533 33467889999999999999999999875 45789999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCC
Q 022413 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254 (297)
Q Consensus 175 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 254 (297)
||+++++|.+++.... ..+++..++.++.|++.||+||| +.|++||||||+|||++.++.+||+|||+++.....
T Consensus 74 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 74 EMASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EeCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999999999987543 45889999999999999999999 589999999999999999999999999999755332
Q ss_pred CCcce-eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 255 GESHV-TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 255 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .....+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192 (257)
T ss_pred ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence 21111 11122357899999998888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=242.37 Aligned_cols=195 Identities=25% Similarity=0.316 Sum_probs=160.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
.++...+..||+|++|.|-+-++.. .|...|+|.+.... .+..++.++|+.+..+. .+|++|+||+...
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 3445556789999999987765554 38999999987653 34457788899876665 5999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
++...|+.||.+ ..+|..+-.+--.....+++...-+|+..+..||.|||+ +..|+|||+||+||||+.+|++|+|||
T Consensus 116 regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEccc
Confidence 999999999999 558877766544455779999999999999999999998 799999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc----cCCcccccchhhhhhhhhc
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT----GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGv~l~~l 296 (297)
|.+-.+.++- ..+...|...|||||.+.. ..|+.+|||||||+.+++|
T Consensus 194 GIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiEl 245 (282)
T KOG0984|consen 194 GISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEM 245 (282)
T ss_pred ccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhh
Confidence 9987654321 2233568999999998853 4688999999999999987
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=264.41 Aligned_cols=196 Identities=29% Similarity=0.356 Sum_probs=166.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh---hHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||+|..... +..+|+|.+...... ..+.+..|+++++.++||||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGT---------GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCC---------CcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 3688899999999999999977653 778999998765322 4467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..|++|||+.+++|.+++.... ...+++..+..++.|++.||+||| ..|++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~df 147 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDF 147 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeec
Confidence 9999999999999999999987532 245889999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCc---------------------------ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGES---------------------------HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++......... .......||..|+|||++.+..++.++||||||+++|+|+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~ 226 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh
Confidence 998654321100 0112346889999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.90 Aligned_cols=193 Identities=24% Similarity=0.324 Sum_probs=163.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc-
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE- 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 166 (297)
+|++.+.||+|++|.||++....+ ++.+++|.+.... ....+.+.+|++++++++|||++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTD---------GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCC---------CcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 488999999999999999987654 6789999986542 2344678899999999999999999998764
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
...++++|||+++++|.+++..... ..+++..+..++.+++.||+||| +.|++||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEeccc
Confidence 4468999999999999999976422 45889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......+++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08223 148 IARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196 (257)
T ss_pred ceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHH
Confidence 987653321 1223456899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=258.94 Aligned_cols=191 Identities=28% Similarity=0.359 Sum_probs=167.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||.|++|.||+|....+ +..+++|.+.... ......+.+|+.+++.++||||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRT---------NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCC---------CeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 3688899999999999999987654 7889999987553 33446788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++|+||+++++|.+++... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999998753 5889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... .......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 145 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~ 192 (274)
T cd06609 145 SGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELA 192 (274)
T ss_pred ceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 98654321 1223456889999999999988999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=255.58 Aligned_cols=192 Identities=27% Similarity=0.410 Sum_probs=162.4
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
++||+|++|.||+|.+.... .....+|+|.+..... ...+.+.+|+.++++++||||+++++++.+ ...+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 46899999999999876421 1134689999987765 556789999999999999999999999988 899999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred EEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999999999987542 45889999999999999999999 58999999999999999999999999999986543
Q ss_pred CCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~ 194 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF 194 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHH
Confidence 22111 112345678999999998889999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=257.89 Aligned_cols=194 Identities=25% Similarity=0.392 Sum_probs=173.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCC-CCCcccEEe
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLS-HPNLVKLLG 162 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~~~~ 162 (297)
..++|.++++||+|+|++|-++++..+ .+.+|+|+++++ +.++++..+.|-.+..+.. ||.+|.++.
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t---------~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKT---------DQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ccccceeeeeecCcchhhhhheehccc---------ceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence 356899999999999999999876654 788999999875 3345677888999988875 999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
.|+.+..+++|.||++||+|...++++ +.++++.++.+..+|+.||.||| ++|||+||||.+|+|||..|++||
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikl 392 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKL 392 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceee
Confidence 999999999999999999999888876 66999999999999999999999 699999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.|+|+++..... ...+.++||||.|+|||++.+..|.+..|.|+|||++++||
T Consensus 393 tdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm 445 (593)
T KOG0695|consen 393 TDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 445 (593)
T ss_pred cccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH
Confidence 999999865433 33567899999999999999999999999999999999996
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=256.93 Aligned_cols=193 Identities=27% Similarity=0.415 Sum_probs=161.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.... +..+++|.+..... ..+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 4579999999999999999997654 45689998876543 2357889999999999999999999875 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...+++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCcee
Confidence 568999999999999999975422 45789999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+......... ......++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHH
Confidence 9765432211 112233566899999998888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=257.38 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=164.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|+..+.||+|+||.||+|....+. .....+++|.+.... ....+.+..|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPG------RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCC------CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 357888999999999999999876431 113479999987652 3345678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCc
Confidence 999999999999999999987543 45888999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcce-eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHV-TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++........... ......++.|+|||++.+..++.++|||||||++|+|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell 204 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence 9876543221111 11122345799999999888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=253.55 Aligned_cols=187 Identities=30% Similarity=0.437 Sum_probs=157.0
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
++||.|+||.||+|...+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~----------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD----------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEecC----------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 468999999999997543 56799999876533 2335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++.... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++.....
T Consensus 71 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 71 MELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred EECCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence 99999999999986543 34789999999999999999999 58999999999999999999999999999875432
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
... .......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 146 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~ 188 (250)
T cd05085 146 GIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF 188 (250)
T ss_pred ccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHh
Confidence 211 1111223467899999999889999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=263.90 Aligned_cols=192 Identities=23% Similarity=0.313 Sum_probs=152.8
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc--CCeeE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE--DKELL 171 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~ 171 (297)
..+||+|+||+||+|...+. ..+..+|+|.+...... ..+.+|+.++++++||||+++++++.. ....+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred ceEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCCc--HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 36799999999999986542 12577999988754322 456789999999999999999998854 46789
Q ss_pred EEEEecCCCCHHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE----cCCCceEE
Q 022413 172 LVYEYMQRGSLENHLFRRN-----PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGNYNAKI 242 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill----~~~~~~kl 242 (297)
+||||+. ++|.+++.... .....+++..++.++.||+.||+||| +.+|+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 9999985 58888775321 11235788999999999999999999 5899999999999999 45679999
Q ss_pred ccccccccCCCCCCc-ceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~ 210 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHH
Confidence 999999865432211 112345689999999998764 5788999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=263.28 Aligned_cols=199 Identities=27% Similarity=0.416 Sum_probs=162.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..+|+..+.||+|+||.||+|.+..... .....+|+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGE-----TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCC-----cceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 4578889999999999999998764311 1123579998875432 333467899999999999999999998875
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
. ..++++||+++|+|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEcccc
Confidence 4 5779999999999999987643 35788999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...............++..|+|||++.+..++.++||||||+++|+|+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~ 205 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHH
Confidence 998654322211222334577899999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.90 Aligned_cols=192 Identities=24% Similarity=0.357 Sum_probs=166.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||++..... +..+|+|.+.... ....+.+.+|+++++.++||||+++++.+..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~---------~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPT---------GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCC---------CcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 35788899999999999999987654 7789999876542 3344678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+.+++||||+++++|.+++... ..+++..+..++.+++.||.|||. ..+++||||||+||+++.++.++|+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCC
Confidence 99999999999999999988764 458899999999999999999995 3689999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... ......|+..|+|||++.+..++.++|+|||||++|+|+
T Consensus 150 l~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 196 (284)
T cd06620 150 VSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196 (284)
T ss_pred cccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHH
Confidence 98654221 122356899999999998889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=259.97 Aligned_cols=193 Identities=27% Similarity=0.351 Sum_probs=160.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|++|.||+|..... +..|++|.+.... ......+.+|+.++++++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKT---------GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECCC---------CcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 478889999999999999987654 7789999886542 22335678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..|+||||++ ++|.+++..... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999997 589888865332 245889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......+++.|+|||++.+. .++.++||||||+++|+|+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~ 196 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHH
Confidence 87543221 112234578999999988654 4788999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=256.57 Aligned_cols=202 Identities=25% Similarity=0.330 Sum_probs=162.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-h-HHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-G-FEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~-~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
...|+..+.||+|.||.||+|.-.+.. ......+|+|+++.++.. . -....+|+.+++.++||||+.+..++.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n-----~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTN-----DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCC-----cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 457999999999999999999544321 000347899998765321 1 145678999999999999999999988
Q ss_pred c-CCeeEEEEEecCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC----Cc
Q 022413 166 E-DKELLLVYEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN----YN 239 (297)
Q Consensus 166 ~-~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~----~~ 239 (297)
. +..+|+++||.+. +|...|+-+.. ....++...+..|++||+.|+.|||+ +-|+||||||.|||+..+ |.
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCe
Confidence 7 7899999999966 89998874322 23568899999999999999999994 889999999999999776 99
Q ss_pred eEEccccccccCCCCCCcc-eeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESH-VTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
|||+|||+++.+...-... .....+-|..|+|||.+.|.+ |+.+.|||++|||+.|||
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL 234 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL 234 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence 9999999999875432211 223355699999999999865 778899999999999986
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=259.54 Aligned_cols=204 Identities=25% Similarity=0.308 Sum_probs=167.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+.... ...+..|++|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3568999999999999999999876521 112567899988754 3344567889999999999999999999877
Q ss_pred c-CCeeEEEEEecCCCCHHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 166 E-DKELLLVYEYMQRGSLENHLFRRNPS----IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 166 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
. ....++++||+++++|.+++...... ...+++..++.++.|++.||+||| +.+++||||||+||++++++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCcE
Confidence 6 46789999999999999999764322 145889999999999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++.+.............++..|+|||++.+..++.++||||||+++|+++
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~ 213 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHh
Confidence 999999998653322111122234677899999999888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.48 Aligned_cols=197 Identities=30% Similarity=0.411 Sum_probs=163.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
-..+|+.+++||+|+||.||+++..-+ |+.||||+|.... .+...++.+|+.+|.+|+|||||+++..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlD---------Gr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWV 547 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLD---------GREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWV 547 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeeccc---------chhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhh
Confidence 456899999999999999999988766 8999999997653 334467889999999999999999998876
Q ss_pred c-------------------------------------------------------------------------------
Q 022413 166 E------------------------------------------------------------------------------- 166 (297)
Q Consensus 166 ~------------------------------------------------------------------------------- 166 (297)
+
T Consensus 548 Es~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg 627 (1351)
T KOG1035|consen 548 ESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDG 627 (1351)
T ss_pred ccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccc
Confidence 4
Q ss_pred --------------------------------C--------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHH
Q 022413 167 --------------------------------D--------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206 (297)
Q Consensus 167 --------------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 206 (297)
+ ..+||.||||+..+|.+++.++... -.....+++++
T Consensus 628 ~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFr 704 (1351)
T KOG1035|consen 628 RNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFR 704 (1351)
T ss_pred cccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHH
Confidence 1 2379999999998888887765421 14678889999
Q ss_pred HHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC----C------------CCCcceeeccCCccccc
Q 022413 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP----A------------GGESHVTTRVMGTYGYA 270 (297)
Q Consensus 207 ~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~gt~~y~ 270 (297)
+|+.||.|+| +.|||||||||.||++++++.|||.|||+|+... . .......+..+||.-|+
T Consensus 705 eIlEGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 705 EILEGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 9999999999 6999999999999999999999999999998621 0 11112345678999999
Q ss_pred Ccceeccc---CCcccccchhhhhhhhhcC
Q 022413 271 APEYVATG---NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 271 aPE~~~~~---~~~~~sDvwslGv~l~~ll 297 (297)
|||++.+. +|+.|.|+||||||+|||+
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~ 812 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEML 812 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHh
Confidence 99999865 4999999999999999996
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=264.70 Aligned_cols=192 Identities=20% Similarity=0.239 Sum_probs=157.5
Q ss_pred CCceeccc--CceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 93 PDSLLGEG--GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 93 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++++||+| +|++||++....+ +..||+|.++... ....+.+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPT---------GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeeccc---------CcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 46789999 6889999977654 8889999987642 233356778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+++++|.+++..+.. ..+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++++||+.+
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchh
Confidence 99999999999999999975432 34889999999999999999999 589999999999999999999999999865
Q ss_pred ccCCCCCCc-----ceeeccCCcccccCcceecc--cCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGES-----HVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~ll 297 (297)
......+.. .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 204 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 204 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHH
Confidence 433211110 01112346788999999976 45889999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=254.59 Aligned_cols=192 Identities=30% Similarity=0.411 Sum_probs=167.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|..... +..+++|.+..... .+.+.+|++++++++||||+++++.+.+.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~---------~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 70 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKET---------GQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN 70 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCC---------CcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence 35799999999999999999987754 67899999875533 57889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...|+++||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+||+|||+
T Consensus 71 ~~~~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 71 TDLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred CcEEEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEccccc
Confidence 99999999999999999997543 55899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ ......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~ 193 (256)
T cd06612 146 SGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMA 193 (256)
T ss_pred chhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHH
Confidence 876543221 223345889999999999888999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=255.41 Aligned_cols=188 Identities=30% Similarity=0.407 Sum_probs=159.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEE-c
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW-E 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~ 166 (297)
.++|++.+.||+|+||.||++... +..+++|.+..... .+.+.+|+.++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 457899999999999999998654 55689998865432 357889999999999999999999765 4
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
....+++|||+++++|.+++..... ..+++..++.++.|++.||+||| ..|++||||||+||+++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg 147 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFG 147 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCc
Confidence 4678999999999999999976432 34788999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++..... .....++..|+|||++.+..++.++||||||+++|+|+
T Consensus 148 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~ 193 (256)
T cd05082 148 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193 (256)
T ss_pred cceecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHH
Confidence 98754321 12234567899999998888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=258.75 Aligned_cols=192 Identities=26% Similarity=0.323 Sum_probs=164.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|+||.||+|.+... +..|++|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRET---------GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCC---------CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 588899999999999999987654 7789999987543 23346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeee
Confidence 9999999999 999999987543 55899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+........ .......|+..|+|||++.+. .++.++||||||+++|+|+
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 195 (286)
T cd07832 146 ARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL 195 (286)
T ss_pred cccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHH
Confidence 986543321 112334689999999998754 4688999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=258.84 Aligned_cols=192 Identities=27% Similarity=0.362 Sum_probs=162.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|+||.||+|....+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRET---------GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCC---------CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 3688999999999999999987654 7789999876432 1223567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
....++||||++++.|..++... ..+++..++.++.|++.||+||| +.+++||||||+||++++++.+||+|||
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccc
Confidence 99999999999998887776543 45899999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
++........ ......++..|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~ 195 (286)
T cd07847 146 FARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195 (286)
T ss_pred cceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHH
Confidence 9986543321 1223457889999999876 45788999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.64 Aligned_cols=190 Identities=24% Similarity=0.311 Sum_probs=156.2
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVY 174 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 174 (297)
+.||+|+||.||+|....... ........+++|.+........+.+..|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 468999999999997754210 001123458888887655555577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc--------eEEcccc
Q 022413 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN--------AKISDFG 246 (297)
Q Consensus 175 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~--------~kl~Dfg 246 (297)
||+++|+|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999997653 35788999999999999999999 599999999999999987765 6999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
++..... .....+++.|+|||++.+. .++.++||||||+++|+|+
T Consensus 154 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~ 199 (258)
T cd05078 154 ISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF 199 (258)
T ss_pred cccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH
Confidence 8865322 2234678999999999864 4788999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=254.34 Aligned_cols=189 Identities=32% Similarity=0.472 Sum_probs=164.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||.|+||.||+|... ++.|++|.+..... ..+++.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 457899999999999999999754 56799999876654 457789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++..... ..+++..+..++.|++.||.||| ..+++||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEccccc
Confidence 999999999999999999976532 35899999999999999999999 59999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... ....++..|+|||++.++.++.++|+||||+++|+|+
T Consensus 149 ~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~ 193 (256)
T cd05039 149 AKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193 (256)
T ss_pred cccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHH
Confidence 98653211 1223466899999998888999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=255.78 Aligned_cols=194 Identities=30% Similarity=0.452 Sum_probs=164.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|...+ +..+++|.+..... ..+++.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 5689999999999999999998654 45689998876443 236788999999999999999999999998
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...+++|||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred CceEEEEeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECcccc
Confidence 999999999999999999976431 35889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~ 198 (261)
T cd05034 150 ARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198 (261)
T ss_pred ceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHH
Confidence 876542111 1111223457899999999888999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=256.17 Aligned_cols=193 Identities=25% Similarity=0.430 Sum_probs=163.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc------hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES------MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
+|+..+.||+|++|.||++....+ +..+++|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~---------~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKT---------GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcCC---------CcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 478889999999999999976543 7789999886432 1234678899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-ceEE
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKI 242 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-~~kl 242 (297)
+.+.+..++||||+++++|.+++... .++++..+..++.|++.||.||| +.|++|+||||+||+++.++ .+||
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEE
Confidence 99999999999999999999999765 45889999999999999999999 58999999999999998775 5999
Q ss_pred ccccccccCCCCCC--cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGE--SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||++........ ........|+..|+|||++.+..++.++|+||||+++|+|+
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 202 (268)
T cd06630 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202 (268)
T ss_pred cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH
Confidence 99999876543211 11122346889999999998888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=255.76 Aligned_cols=194 Identities=25% Similarity=0.329 Sum_probs=162.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+.+.....||+|+||.||+|.+..+ +..|++|.+........+.+.+|+.++++++|+||+++++++..+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~---------~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLST---------QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCC---------CcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence 44455557899999999999977654 678999998776655667889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEEcc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPL--SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISD 244 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl~D 244 (297)
+..++++||+++++|.+++.... ..+ ++..+..++.|++.||+||| ..+|+||||||+||+++. ++.+||+|
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEec
Confidence 99999999999999999997642 234 77888899999999999999 589999999999999986 67999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccC--CcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN--FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~~ll 297 (297)
||++........ ......|++.|+|||++.+.. ++.++|+||||+++|+|+
T Consensus 153 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~ 205 (268)
T cd06624 153 FGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA 205 (268)
T ss_pred chhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHH
Confidence 999875432211 122345889999999987643 778999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=260.11 Aligned_cols=193 Identities=26% Similarity=0.355 Sum_probs=160.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|++|.||+|....+ +..|++|.+..... .....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLT---------GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCC---------CcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec
Confidence 35799999999999999999986643 67899999865432 122456789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg 148 (291)
T cd07844 75 KKTLTLVFEYLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFG 148 (291)
T ss_pred CCeEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECccc
Confidence 9999999999975 9999887643 35789999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~ 198 (291)
T cd07844 149 LARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA 198 (291)
T ss_pred cccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHH
Confidence 9875322111 1122346889999999875 45788999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.80 Aligned_cols=191 Identities=25% Similarity=0.315 Sum_probs=163.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
+.|.....||+|+||.||++..... +..||+|.+........+.+.+|+.+++.++||||+++++.+...+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHT---------GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD 92 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCC---------CCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence 3455567799999999999976543 6789999987655555577889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+++++|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcch
Confidence 99999999999999998854 34788999999999999999999 489999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
....... .......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 166 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~ 212 (292)
T cd06658 166 AQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212 (292)
T ss_pred hhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 7543221 1122346899999999998888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=255.95 Aligned_cols=193 Identities=25% Similarity=0.376 Sum_probs=162.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch----------hhHHHHHHHHHHhcCCCCCCccc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----------QGFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
+|.+.+.||.|+||.||+|....+ +..+|+|.+..... ...+.+..|+.++++++||||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~---------~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTT---------GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecCC---------CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 478889999999999999976543 77899998753211 12346778999999999999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
+++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~ 146 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGI 146 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCe
Confidence 999999999999999999999999999765 45888999999999999999999 589999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccC--CcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN--FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~~ll 297 (297)
++|+|||+++...............|+..|+|||++.... ++.++|+||||+++|+|+
T Consensus 147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~ 206 (272)
T cd06629 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206 (272)
T ss_pred EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence 9999999987643321111223456889999999987654 788999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=252.50 Aligned_cols=188 Identities=29% Similarity=0.423 Sum_probs=158.0
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
++||.|+||.||++...+ +..|++|.+...... ....+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 468999999999997654 567999988765433 446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++.... ..+++..+..++.+++.||+||| +.+++||||||+|||++.++.+||+|||++.....
T Consensus 71 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 145 (251)
T cd05041 71 MELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEG 145 (251)
T ss_pred EEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence 99999999999987543 35788899999999999999999 58999999999999999999999999999976432
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...........++..|+|||++.++.++.++|+||||+++|+|+
T Consensus 146 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~ 189 (251)
T cd05041 146 GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF 189 (251)
T ss_pred CcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHH
Confidence 21111111223356799999999889999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=254.71 Aligned_cols=193 Identities=31% Similarity=0.455 Sum_probs=162.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.++||+|+||.||+|...+ +..+|+|.+...... ...+.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~----------~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG----------HTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC----------CceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 4679999999999999999997543 567999998765432 367889999999999999999999864 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..+++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.|++||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 148 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGL 148 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCcc
Confidence 678999999999999999865432 45788999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ .......++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~ 197 (260)
T cd05067 149 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197 (260)
T ss_pred eeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHH
Confidence 976542211 1112234567899999999888999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.82 Aligned_cols=191 Identities=24% Similarity=0.334 Sum_probs=160.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|+||.||+|.+... |..+++|.+..... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~---------g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRET---------HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCC---------CcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 488889999999999999987654 77899998865321 2234677899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++++||++ ++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccch
Confidence 99999999996 58888876543 45899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
++....... ......+++.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 194 (284)
T cd07839 146 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 194 (284)
T ss_pred hhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHH
Confidence 875433211 122345789999999987644 688999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=259.26 Aligned_cols=202 Identities=30% Similarity=0.355 Sum_probs=165.3
Q ss_pred HHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccE
Q 022413 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKL 160 (297)
Q Consensus 82 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~ 160 (297)
.++....++|.+.+.||+|+||.||++....+ +..+|+|.+..... ....+.+|+.+++++ +||||+++
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~---------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~ 84 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKD---------GSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKF 84 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCC---------CCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEE
Confidence 34444577899999999999999999987654 77899998865432 235677899999999 79999999
Q ss_pred EeEEEcC-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 161 LGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 161 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
++++... ...++||||+++++|.+++.........+++..++.++.|++.||+||| +.+++||||||+||+++
T Consensus 85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~ 162 (291)
T cd06639 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLT 162 (291)
T ss_pred EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEc
Confidence 9998754 3689999999999999988753333356889999999999999999999 58999999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeccCCcccccCcceeccc-----CCcccccchhhhhhhhhcC
Q 022413 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-----NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGv~l~~ll 297 (297)
.++.+||+|||++........ ......|++.|+|||++... .++.++|+|||||++|+|+
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 999999999999876543221 12234688999999998643 3678999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=253.73 Aligned_cols=192 Identities=28% Similarity=0.430 Sum_probs=155.4
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEE-cCCeeEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW-EDKELLL 172 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-~~~~~~l 172 (297)
+.||+|+||.||+|.+.+.. .....+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCC------CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 46899999999999865321 12567999988643 3344567889999999999999999999776 4556899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC
Q 022413 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 173 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
+|||+.+++|.+++.... ....+..++.++.|++.||+||| +.+++||||||+|||+++++.+||+|||+++...
T Consensus 75 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999997543 33567788899999999999999 5899999999999999999999999999987543
Q ss_pred CCCCc--ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 253 AGGES--HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 253 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 196 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 196 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHH
Confidence 22110 1112234577899999998889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=253.40 Aligned_cols=190 Identities=28% Similarity=0.438 Sum_probs=163.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-----hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-----MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
+|+..+.||+|+||+||+|....+ +..|++|.+.... .+..+.+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDD---------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcCC---------CcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 477889999999999999987644 6789999875432 23446788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.....+++++||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+|+||+|+||+++.++.+||+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d 145 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLAD 145 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999999999999765 44788999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
||++....... ......|++.|+|||.+.... ++.++|+||||+++|+|+
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~ 196 (258)
T cd06632 146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA 196 (258)
T ss_pred Cccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHH
Confidence 99987643322 123456899999999988766 889999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=253.79 Aligned_cols=194 Identities=26% Similarity=0.409 Sum_probs=163.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-----chhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
.+|.+.+.||+|+||.||+|....+ +..+++|.+... ..+....+.+|+.++++++||||+++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADT---------GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCC---------CCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 4689999999999999999976643 778999987432 22344678899999999999999999999
Q ss_pred EEcC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 164 CWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 164 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+.+. ..+++++||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEE
Confidence 8764 4689999999999999998765 34788899999999999999999 58999999999999999999999
Q ss_pred EccccccccCCCCCC-cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGE-SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++....... ........++..|+|||++.+..++.++|+|||||++|+|+
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 203 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence 999999976432111 11123356899999999999888999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=255.49 Aligned_cols=197 Identities=23% Similarity=0.309 Sum_probs=162.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|.+.+.||+|+||.||+|.+.... .....+++|...... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 346888999999999999999865421 113468999887654 4455688999999999999999999998875
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
...++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+|||++.++.+||+|||
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCc
Confidence 56789999999999999997643 35889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... .......+++.|+|||.+....++.++||||||+++|+|+
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 202 (270)
T cd05056 153 LSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202 (270)
T ss_pred eeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence 9876543211 1112223456899999998888999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=253.03 Aligned_cols=188 Identities=28% Similarity=0.343 Sum_probs=155.0
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
.||+|+||.||+|.+... .++..+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 589999999999976432 126789999986543 234467889999999999999999999875 4567999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||.|||++.++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 74 MELAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 9999999999999754 45889999999999999999999 58999999999999999999999999999976543
Q ss_pred CCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence 22111 111223457899999998888999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=253.88 Aligned_cols=190 Identities=26% Similarity=0.383 Sum_probs=155.3
Q ss_pred ceecccCceEEEEEEECCCC-CccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKT-LAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~-~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
+.||+|+||.||+|.+.... ...........+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999886531 00111122345788876654432 4788899999999999999999999988 788999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-------ceEEcccc
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-------NAKISDFG 246 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-------~~kl~Dfg 246 (297)
|||+++++|.+++.... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999997653 25888999999999999999999 59999999999999999887 79999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceeccc--CCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATG--NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~~ll 297 (297)
++..... .....++..|+|||++.+. .++.++|+||||+++|+|+
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 9875432 1223567889999999876 7888999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=258.12 Aligned_cols=193 Identities=24% Similarity=0.320 Sum_probs=160.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|....+ +..+++|.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRIN---------GQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCC---------CcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 46799999999999999999987654 67899999865432 222456789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++..|+||||+. ++|.+++.... ..+.+..+..++.|++.||.||| ..+|+|+||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEeccc
Confidence 999999999995 68877775432 34678888899999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+++...... .......+++.|+|||++.+. .++.++|||||||++|+|+
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 198 (291)
T cd07870 149 LARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198 (291)
T ss_pred cccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence 987543221 112334578999999998764 5788999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=252.07 Aligned_cols=197 Identities=34% Similarity=0.489 Sum_probs=164.9
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
+++.+.||.|+||.||++.+.... ...+..+|+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLS-----GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCC-----CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 457789999999999999877531 012478999999765433 45788999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.+++|||+++++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+++
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCce
Confidence 9999999999999999976531 12899999999999999999999 5899999999999999999999999999997
Q ss_pred cCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 152 ~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~ 198 (258)
T smart00219 152 DLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198 (258)
T ss_pred ecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHH
Confidence 654331111 11223678999999998888999999999999999874
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=256.65 Aligned_cols=190 Identities=27% Similarity=0.370 Sum_probs=166.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
+|++.+.||.|+||.||+|..... +..+++|.+.... ....+.+.+|++++++++||||+++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDT---------KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccC---------CcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 488899999999999999977643 7789999987543 2345788899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
....++|+||+.+++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeecc
Confidence 99999999999999999999765 45889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ......|+..|+|||++.+..++.++|+||||+++|+|+
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 193 (258)
T cd05578 146 IATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL 193 (258)
T ss_pred cccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHH
Confidence 987654322 223456889999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=259.40 Aligned_cols=190 Identities=28% Similarity=0.400 Sum_probs=163.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
.|+..+.||+|+||.||+|.+... +..||+|.+.... ....+.+.+|+.++++++||||+++++.+...+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRT---------KEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCC---------CeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 466778899999999999987654 6789999887543 334467889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+++++|.+++.. ..+.+..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999999998854 34788999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
....... .......|+..|+|||++.+..++.++||||||+++|+|+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 195 (277)
T cd06642 149 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELA 195 (277)
T ss_pred ccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHH
Confidence 7654321 1223346889999999999888999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=256.85 Aligned_cols=195 Identities=24% Similarity=0.327 Sum_probs=158.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHH-hcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNF-LGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|+||.||++.+..+ +..||+|.+..... ....++..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPT---------GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCC---------CcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 4688999999999999999987654 78899999875422 222445556665 666789999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..|++|||++ ++|.+++.........+++..++.++.|++.||+|||+ ..+++||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999996 68888886543333568999999999999999999994 2399999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc----cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGv~l~~ll 297 (297)
+++...... ......|+..|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 150 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~ 201 (283)
T cd06617 150 ISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA 201 (283)
T ss_pred ccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHH
Confidence 987643211 1223468899999998865 44678999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=261.14 Aligned_cols=198 Identities=25% Similarity=0.312 Sum_probs=161.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
+|.+.+.||+|+||.||+|..... ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 478889999999999999987651 127889999988632 2333567889999999999999999999998
Q ss_pred C--CeeEEEEEecCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC----CCc
Q 022413 167 D--KELLLVYEYMQRGSLENHLFRRNPS-IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG----NYN 239 (297)
Q Consensus 167 ~--~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~----~~~ 239 (297)
. ..+++||||+++ +|.+++...... ...+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccce
Confidence 8 889999999964 787777543322 236889999999999999999999 589999999999999999 999
Q ss_pred eEEccccccccCCCCCC-cceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGE-SHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++....... ........+++.|+|||++.+. .++.++||||||+++|+|+
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 210 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999986543222 1122334678999999988764 5788999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=261.93 Aligned_cols=190 Identities=24% Similarity=0.287 Sum_probs=162.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
.|.....||+|+||.||++....+ +..|++|.+........+.+.+|+.+++.++||||+++++.+..++.
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHS---------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCC---------CCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 344456799999999999977643 67899999876544445678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.+++|||+++++|.+++.. ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 93 ~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred EEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHh
Confidence 9999999999999987754 34789999999999999999999 5899999999999999999999999999987
Q ss_pred cCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...... .......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 211 (297)
T cd06659 166 QISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211 (297)
T ss_pred hccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 543321 1223356899999999999888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=255.75 Aligned_cols=197 Identities=30% Similarity=0.385 Sum_probs=164.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
.+++|++.+.||+|++|.||+|..... ++.+++|.+..... ..+.+.+|+.+++++ .||||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKT---------GQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCC---------CcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 457899999999999999999987643 67899998876543 236788999999999 6999999999997
Q ss_pred cCC------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
... .+++||||+++++|.+++.........+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAE 151 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCe
Confidence 644 489999999999999998764433356899999999999999999999 589999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||++....... .......|++.|+|||++.. ..++.++||||||+++|+|+
T Consensus 152 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 152 VKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred EEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 9999999987543321 12233568999999998864 34678899999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=256.57 Aligned_cols=198 Identities=28% Similarity=0.380 Sum_probs=159.8
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
+.||+|+||.||+|.+.+.. .....+..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 36899999999999876421 011224678999876543 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-----ceEEccc
Q 022413 174 YEYMQRGSLENHLFRRNP---SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-----NAKISDF 245 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Df 245 (297)
|||+++++|.+++..... ....+++..++.++.|++.||+||| +.+++|+||||+||+++.++ .+||+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999999999975422 1234788999999999999999999 58999999999999999877 8999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...............++..|+|||++.++.++.++||||||+++|+|+
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 9987553322211122234578899999999999999999999999999974
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=253.71 Aligned_cols=192 Identities=29% Similarity=0.417 Sum_probs=159.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|.+.+.||+|++|.||+|.+.. +..+++|.+..... ..+.+.+|+.++++++||||+++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 468899999999999999997654 33589998765432 2367889999999999999999998875 46
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.||| +.|++|+||||+||++++++.++|+|||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccc
Confidence 78999999999999999976432 34788999999999999999999 589999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~ 197 (260)
T cd05069 150 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197 (260)
T ss_pred eEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHH
Confidence 76533221 1112234567899999998888999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=252.66 Aligned_cols=197 Identities=28% Similarity=0.384 Sum_probs=167.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||.|+||+||+|....+ +..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPN---------NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCC---------CcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 4789999999999999999976653 6789999986543 23457789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..+++|||+++++|.+++....+ ...+++..+..++.|++.||+||| +.|++||||||+||++++++.+||+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccch
Confidence 999999999999999999976432 135889999999999999999999 59999999999999999999999999999
Q ss_pred cccCCCCCCc--ceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGES--HVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+..+...... .......|++.|+|||++... .++.++|+|||||++|+|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence 8765443221 122334689999999998876 7889999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=258.15 Aligned_cols=192 Identities=27% Similarity=0.333 Sum_probs=166.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|.+.+.||.|+||.||++....+ +..+++|.+........+.+.+|+.+++.++||||+++++.+...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVAT---------GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCC---------CCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 46899999999999999999976543 677999998765544457788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..|+|+||+++++|.+++.+. .+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~ 161 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGF 161 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999999999998653 3788899999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ ......|++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll 209 (293)
T cd06647 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209 (293)
T ss_pred eeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 875443221 223346889999999998888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=258.99 Aligned_cols=191 Identities=27% Similarity=0.350 Sum_probs=161.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-----hHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-----GFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
+|++.+.||+|+||.||+|....+ +..|++|.+...... ....+..|++++++++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKET---------GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCC---------CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 478889999999999999987654 778999998755322 234567899999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.||+|+||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~d 145 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLAD 145 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEcc
Confidence 9999999999999 889999997642 35899999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
||+++....... ......+++.|+|||.+.+ ..++.++|+|||||++|+|+
T Consensus 146 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~ 197 (298)
T cd07841 146 FGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL 197 (298)
T ss_pred ceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999986543221 1223356889999998865 45788999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=254.54 Aligned_cols=199 Identities=30% Similarity=0.419 Sum_probs=165.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEc-
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWE- 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 166 (297)
++|++.+.||+|+||.||+|.+.... ...+..+|+|.+...... ..+.+.+|+.+++.+.||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 46788899999999999999875421 223778999998765443 45788999999999999999999999887
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 167 -DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 167 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
....+++|||+++++|.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence 568999999999999999997653 35889999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcce-eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHV-TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++........... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~ 206 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheee
Confidence 99987643221111 11223456799999998889999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=263.91 Aligned_cols=194 Identities=21% Similarity=0.253 Sum_probs=163.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCC--cchhhHHHHHHHHHHhcCCC-CCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP--ESMQGFEEWQSEVNFLGRLS-HPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~ 163 (297)
....|++++.||+|+.+.||++...+ .+.+|+|++.. .+.+.+.-+.+|+.+|.+|+ |.+|+++++|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 34579999999999999999986654 34577776543 35566788999999999997 9999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
-..++.+|+||||= ..+|..+|.+... ..+...++.+..|++.|+.++| +.||||.||||.|+|+- +|.+||+
T Consensus 429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLlV-kG~LKLI 501 (677)
T KOG0596|consen 429 EVTDGYLYMVMECG-DIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLLV-KGRLKLI 501 (677)
T ss_pred eccCceEEEEeecc-cccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEEE-eeeEEee
Confidence 99999999999975 5699999987642 2333378889999999999999 69999999999999986 5899999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccC-----------CcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-----------FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwslGv~l~~ll 297 (297)
|||.|........+-.....+||+.||+||.+.... ...+|||||||||||.|+
T Consensus 502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 999998777666666667789999999999986543 347899999999999985
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.64 Aligned_cols=197 Identities=25% Similarity=0.352 Sum_probs=166.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc-
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE- 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 166 (297)
+|++.+.||.|+||.||++....+ +..+++|.+... .....+++..|+.++++++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSD---------GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCC---------CCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 488899999999999999977654 778999988643 23344678899999999999999999998764
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC---CCCceeccCCCCcEEEcCCCceEE
Q 022413 167 -DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS---EKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 167 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~---~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
....+++|||+++++|.+++.........+++..++.++.|++.||+|||.. +.+++|+||||+||++++++.+||
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 3568999999999999999976544446789999999999999999999932 378999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||++........ ......+++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 152 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~ 204 (265)
T cd08217 152 GDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC 204 (265)
T ss_pred ecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHH
Confidence 99999986543221 123456899999999999888999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=252.45 Aligned_cols=192 Identities=27% Similarity=0.419 Sum_probs=161.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
.+|++.+.||+|+||.||++.+.. +..+++|.+...... ...+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 468888999999999999997653 456899988754332 256889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..+++|||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999999987543 35788999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......++..|+|||++.++.++.++||||||+++|+|+
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~ 195 (256)
T cd05112 148 RFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF 195 (256)
T ss_pred eecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHH
Confidence 75432211 1112233567899999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=250.74 Aligned_cols=192 Identities=28% Similarity=0.368 Sum_probs=164.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|+||.||++..... +..+++|.+.... ......+.+|+.+++.++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKAD---------QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCC---------CcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 588899999999999999977653 7789999886542 23456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC-CceEEcccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKISDFG 246 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg 246 (297)
+..++||||+++++|.+++..... ..+++..+..++.+++.+|+||| +.+++|+||||+||+++.+ +.+||+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCC
Confidence 999999999999999999976431 44789999999999999999999 5899999999999999854 568999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ......|++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~ 195 (256)
T cd08220 148 ISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195 (256)
T ss_pred CceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHH
Confidence 998654322 122346889999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.17 Aligned_cols=191 Identities=27% Similarity=0.376 Sum_probs=165.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..|+..+.||.|+||.||+|.+... +..+|+|.+.... ......+.+|+.+++++.||||+++++.+.+.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRT---------QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccC---------CEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3577889999999999999987654 6789999887543 34457788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEccccc
Confidence 999999999999999999864 34788899999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......++..|+|||++.+..++.++|+|||||++|+|+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~ 195 (277)
T cd06640 148 AGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELA 195 (277)
T ss_pred ceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHH
Confidence 87653321 1223346788999999999888999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=273.41 Aligned_cols=191 Identities=28% Similarity=0.298 Sum_probs=171.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.+++++..||-|+||.|=++..+.. ...+|+|.+++. +.++.+.+..|-.||...+.|+||++|..|.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred hhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 4677788899999999999877754 224788887654 4455578889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+...+|++||-|-||.|...|..+ +.++...++.++..++.|++||| .+|||+|||||+|+|++.+|-+||.||
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceEEeeh
Confidence 999999999999999999999887 67899999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+.+..+. .+.++||||.|+|||++.+...+.+.|.|+||+++|+||
T Consensus 565 GFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL 613 (732)
T KOG0614|consen 565 GFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELL 613 (732)
T ss_pred hhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHH
Confidence 9999875543 578899999999999999999999999999999999986
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=250.88 Aligned_cols=190 Identities=32% Similarity=0.454 Sum_probs=156.6
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
+.||+|+||.||+|.+.... ..+..+++|.+..... ...+.+.+|+.+++.+.||||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999765431 1246799999886543 34467889999999999999999999765 4578999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++... ..+++..+..++.|++.||+||| ..+++||||||+|||++.++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 74 MELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred EEeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence 9999999999999765 35889999999999999999999 58999999999999999999999999999986543
Q ss_pred CCCcce-eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHV-TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...... .....++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 192 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHH
Confidence 221111 11112346799999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.19 Aligned_cols=191 Identities=31% Similarity=0.434 Sum_probs=155.5
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCeeEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKELLL 172 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 172 (297)
++||+|+||.||+|...++. ....+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 36899999999999876531 1235788887753 233446788999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 173 VYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 173 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
+|||+++++|.+++..... ....+++..++.++.|++.||+||| +.|++||||||+|||+++++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeE
Confidence 9999999999999975431 1134788999999999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||++....... .......++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~ 205 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHH
Confidence 999999986322110 111123356799999998888999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=277.62 Aligned_cols=197 Identities=28% Similarity=0.452 Sum_probs=169.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
....+.++||.|.||+|++|+.+... .....||||.++.... +...+|+.|+.||.+++||||++|.++....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pg------kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPG------KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCCC------CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 34567789999999999999877542 1256899999987643 4557899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
..+.||+|||++|+|..+|+.+. ..+...+..-+++.|+.|++||- +.++|||||..+|||++.+...|++|||+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEeccccc
Confidence 99999999999999999998876 44888888899999999999998 79999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCC--cccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMG--TYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|.+.+.... ..++.-| ...|.|||.+..++|+.+|||||+|++|||.|
T Consensus 778 SRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVm 828 (996)
T KOG0196|consen 778 SRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 828 (996)
T ss_pred eeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEec
Confidence 9987554321 2222222 46899999999999999999999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=248.40 Aligned_cols=190 Identities=24% Similarity=0.278 Sum_probs=159.5
Q ss_pred hhcCCCCC-ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEE
Q 022413 87 ATKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 164 (297)
.+++|.+. ++||-|-.|+|-.+.++.+ ++.+|+|++... .+..+|+++--... |||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T---------~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRT---------QEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccc---------hhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 45677765 6799999999998876654 788999988644 23356777765554 99999999998
Q ss_pred Ec----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc---CC
Q 022413 165 WE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GN 237 (297)
Q Consensus 165 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~---~~ 237 (297)
+. ...+.+|||.++||.|+..++.+.. ..+++.++-.|+.||+.|+.|||+ .+|.||||||+|+|.. .+
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCC
Confidence 64 3579999999999999999987753 679999999999999999999995 8999999999999995 36
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..+||+|||+|+.-... ....+.|-||+|.|||++...+|+...|+|||||++|-||
T Consensus 201 a~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlL 257 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_pred cceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhh
Confidence 77999999999864332 2345678899999999999899999999999999999886
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=251.63 Aligned_cols=193 Identities=27% Similarity=0.417 Sum_probs=161.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.+.||+|+||.||++.+.. +..+++|.+..... ..+.+.+|+.++++++|+||+++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 4679999999999999999997554 44589998875432 34678899999999999999999999887
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...+++|||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCcc
Confidence 788999999999999999976432 45788889999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ .......++..|+|||++....++.++|+|||||++|+|+
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 197 (260)
T cd05073 149 ARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 197 (260)
T ss_pred eeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHH
Confidence 876543221 1112234567899999999888999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=252.57 Aligned_cols=186 Identities=31% Similarity=0.471 Sum_probs=157.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|++.+.||+|+||.||++... +..+++|.+..... .+.+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYT-----------GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEecccC-----------CCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 56899999999999999998543 56689998865432 35788999999999999999999988764
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~ 147 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLA 147 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCccc
Confidence 57999999999999999976432 35788999999999999999999 599999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+..... ......+..|+|||++.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 148 RVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred eecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 754321 11223457899999999889999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=272.25 Aligned_cols=185 Identities=28% Similarity=0.387 Sum_probs=164.0
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEEE
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYE 175 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 175 (297)
+||+|.||+||.|++.++ ...+|||.+...+.+..+-+..|+.+-++|+|.|||+++|.+.+.+++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~t---------qvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDT---------QVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeeccccc---------eeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 799999999999987765 56799999988777777888999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEEccccccccCC
Q 022413 176 YMQRGSLENHLFRRNPSIQPL--SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDFGLAKLGP 252 (297)
Q Consensus 176 ~~~~~~L~~~l~~~~~~~~~~--~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~ 252 (297)
-++||+|.++|.... +++ .+...-.+.+||+.||.||| +..|||||||-+|+||+. .|.+||.|||.++++.
T Consensus 653 qVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred cCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 999999999998765 445 67788889999999999999 799999999999999975 7999999999998753
Q ss_pred CCCCcceeeccCCcccccCcceeccc--CCcccccchhhhhhhhhc
Q 022413 253 AGGESHVTTRVMGTYGYAAPEYVATG--NFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 253 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~~l 296 (297)
- ...-+.++.||..|||||++..+ .|..++|||||||++.+|
T Consensus 728 g--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEM 771 (1226)
T KOG4279|consen 728 G--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEM 771 (1226)
T ss_pred c--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEee
Confidence 2 33456678999999999999764 488899999999999887
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=250.87 Aligned_cols=192 Identities=26% Similarity=0.401 Sum_probs=168.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||+|++|.||+|..... +..+++|.+..... .....+.+|+.++.+++||||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~---------~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPT---------GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCC---------CcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 3688899999999999999987754 77899999876643 3457789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCC-CCceeccCCCCcEEEcCCCceEEcccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+..+++|||+++++|.+++... ..+++..++.++.|++.||+||| + .+++||||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~ 145 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFG 145 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999765 55899999999999999999999 6 999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++........ ......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 194 (264)
T cd06623 146 ISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA 194 (264)
T ss_pred cceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHH
Confidence 9876543221 122346789999999999988999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=256.99 Aligned_cols=193 Identities=27% Similarity=0.309 Sum_probs=163.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|+||.||+|.+..+ +..|++|.+.... ....+.+.+|++++++++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKAT---------GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCC---------CcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 3688999999999999999987654 6789999887542 2334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..+++|||++++.+..++... ..+++..+..++.||+.||+||| +.+++||||+|+||++++++.+||+|||
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g 145 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFG 145 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeee
Confidence 99999999999886666555433 44889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
++........ .......++..|+|||++.+. .++.++|+||||+++|+|+
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 146 FARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred cccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHH
Confidence 9886544322 122345678999999999888 7889999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.08 Aligned_cols=193 Identities=25% Similarity=0.344 Sum_probs=165.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|+||.||++....+ ++.+++|.+... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKED---------GKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCC---------CCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 588899999999999999977654 778999988643 223346788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+|||++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~ 147 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGI 147 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999999999999999875422 34788999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ ......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~ 195 (256)
T cd08218 148 ARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195 (256)
T ss_pred eeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHH
Confidence 876433211 122345889999999999888999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.64 Aligned_cols=191 Identities=28% Similarity=0.410 Sum_probs=161.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcC--CCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR--LSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~ 165 (297)
....++.++||+|.||.||+|... ++.||||++..... +.|+.|-.|.+. +.|+||++|++.-.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhc
Confidence 345667789999999999999877 46799999975543 667888888776 46999999998776
Q ss_pred cCC----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhc-------CCCCceeccCCCCcEEE
Q 022413 166 EDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT-------SEKKVIYRDFKASNILL 234 (297)
Q Consensus 166 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-------~~~~ivH~Dlkp~Nill 234 (297)
... +++||++|.+.|+|.++|..+ .++|....+|+..+++||+|||. ++..|+|||||..||||
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv 349 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV 349 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence 655 899999999999999999875 38999999999999999999996 34679999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccC-Cc-----ccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FY-----LLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwslGv~l~~ll 297 (297)
..|++..|+|||||.++............+||..|||||++.+.. +. .+.||||+|.+||||+
T Consensus 350 K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 350 KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999998887654444445578999999999998632 22 2579999999999974
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=255.22 Aligned_cols=197 Identities=29% Similarity=0.386 Sum_probs=162.7
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeE
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGY 163 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 163 (297)
....+.|++.+.||.|+||.||+|.+... +..+|+|.+..... ....+..|+.+++++ +||||++++++
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKT---------GQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCC---------CcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 33457899999999999999999987654 67899998865432 235678899999998 69999999999
Q ss_pred EEc------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 164 CWE------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 164 ~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
+.. .+..|++|||+++++|.+++..... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCC
Confidence 853 4578999999999999999875432 34778889999999999999999 5899999999999999999
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
+.++|+|||++....... .......|++.|+|||++. +..++.++|+|||||++|+|+
T Consensus 158 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~ 220 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220 (282)
T ss_pred CCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH
Confidence 999999999987543211 1223456899999999986 356788999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=250.54 Aligned_cols=193 Identities=27% Similarity=0.387 Sum_probs=165.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|+||.||+|....+ +..+++|.+..... ...+.+..|+.++++++|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDT---------GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCC---------CcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 588899999999999999987654 67899999876543 3567889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++|+||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGC 145 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999998764 34788899999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcce--eeccCCcccccCcceecccC---CcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHV--TTRVMGTYGYAAPEYVATGN---FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~~ll 297 (297)
+........... .....+++.|+|||++.+.. ++.++||||||+++|+|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~ 200 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHH
Confidence 876543322111 12346789999999998766 888999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=258.18 Aligned_cols=192 Identities=29% Similarity=0.362 Sum_probs=161.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|+||.||+|.+... +..+|+|.+..... ...+.+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKET---------GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCC---------CCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 3688899999999999999987654 67899998765422 223567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++..++||||+++++|..+.... ..+++..++.++.|++.||+||| +.+++|+||+|+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeee
Confidence 99999999999998888776543 34889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......++..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 195 (286)
T cd07846 146 FARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195 (286)
T ss_pred eeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHH
Confidence 987653322 12233567899999999875 44778899999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.07 Aligned_cols=194 Identities=26% Similarity=0.333 Sum_probs=164.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|+..+.||.|++|.||++..... +..+|+|.+..... ....++.+|++++++++||||+++++++.+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNT---------GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCC---------CeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 3678889999999999999987653 77899998875432 3446788999999999999999999988654
Q ss_pred --CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 168 --KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 168 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+++||||+++++|.+++.........+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeec
Confidence 4789999999999999988654333456889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++....... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 150 g~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (287)
T cd06621 150 GVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA 197 (287)
T ss_pred cccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 9987543211 12345788999999999899999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=254.22 Aligned_cols=192 Identities=26% Similarity=0.377 Sum_probs=166.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|+..+.||+|+||.||++.+... +..+++|.+.... ......+.+|++++++++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPT---------GKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCC---------CcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 3678889999999999999987654 7789999887653 33446788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++++||+++++|.+++.... ..+++..+..++.|++.||+|||+ ..+++|+||||+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999997653 458889999999999999999993 28999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .....++..|+|||++.+..++.++||||||+++|+|+
T Consensus 148 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 193 (265)
T cd06605 148 SGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELA 193 (265)
T ss_pred chhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 86542211 11256889999999999889999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=252.14 Aligned_cols=190 Identities=29% Similarity=0.393 Sum_probs=163.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
-|++.+.||+|+||.||+|....+ +..+|+|.+.... ......+.+|+.++++++||||+++++.+...+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRT---------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCC---------CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 477889999999999999977654 6789999876543 234467889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+++++|.+++.. ..+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeecccc
Confidence 99999999999999999864 34789999999999999999999 599999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
....... .......++..|+|||.+.+..++.++|+|||||++|+|+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 195 (277)
T cd06641 149 GQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 195 (277)
T ss_pred eecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 7653321 1223356889999999998888999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=251.57 Aligned_cols=199 Identities=25% Similarity=0.378 Sum_probs=160.1
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
|.+.+.||+|+||.||+|.+... ..++..+|+|.+... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE------DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc------CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 66788999999999999986542 123678999988654 2334567889999999999999999999886542
Q ss_pred ------eeEEEEEecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 169 ------ELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 169 ------~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
..++++||+.+++|.+++.... .....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCE
Confidence 3478899999999998875322 11234788899999999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...............+++.|++||.+.+..++.++||||||+++|+|+
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~ 209 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHh
Confidence 999999998654322111222234567899999998888999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=251.32 Aligned_cols=196 Identities=26% Similarity=0.379 Sum_probs=163.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc----------chhhHHHHHHHHHHhcC-CCCCCcc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE----------SMQGFEEWQSEVNFLGR-LSHPNLV 158 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nIv 158 (297)
+|++.+.||+|+||.||+|.+... .+..+++|.+... ......++..|+.++.+ ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 478889999999999999987652 1567999987532 12233556788888865 7899999
Q ss_pred cEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 159 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
++++++.+.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||. ..+++|+||||+|||++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCC
Confidence 99999999999999999999999999986533333568999999999999999999994 37899999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||++....... ......|+..|+|||++.+..++.++|+||||+++|+|+
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~ 207 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC 207 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH
Confidence 99999999997654322 223456899999999999888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=252.71 Aligned_cols=183 Identities=29% Similarity=0.359 Sum_probs=149.6
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHH---hcCCCCCCcccEEeEEEcCCe
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNF---LGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~---l~~l~h~nIv~~~~~~~~~~~ 169 (297)
+||+|+||.||++....+ +..+|+|.+..... .....+.+|..+ +...+||||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADT---------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECCC---------CcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 489999999999977654 77899998865321 111223344433 334579999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.++||||+++++|.+++... ..+++..+..++.|++.||+||| ..+|+||||||+|||++.++.++|+|||++.
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 99999999999999998765 45899999999999999999999 5899999999999999999999999999987
Q ss_pred cCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
..... ......|++.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 146 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 190 (279)
T cd05633 146 DFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190 (279)
T ss_pred ecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHH
Confidence 54322 1223468999999999864 56888999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=252.06 Aligned_cols=185 Identities=30% Similarity=0.400 Sum_probs=158.0
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
||+|+||+||+|....+ ++.+++|.+.... ......+..|+.++++++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKAT---------GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcCC---------CcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 68999999999976654 7789999886532 12234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++..... ..+++..++.++.|++.||.||| ..|++||||+|+||+++.++.+||+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred EecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 999999999999976532 35889999999999999999999 58999999999999999999999999999875432
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
. .......++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 148 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~ 188 (277)
T cd05577 148 G---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188 (277)
T ss_pred C---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHh
Confidence 1 1122345788999999998888999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=230.62 Aligned_cols=190 Identities=25% Similarity=0.354 Sum_probs=161.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|...++||+|.||+||+|+..+. ++.||+|.+..++. --....++|+-+++.+.|.|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t---------~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRET---------HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCc---------cceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 466678999999999999976654 88999999875432 2235678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+-+|.||| ..+|..+....+ ..++...++.++.|+++||.|+|+ .++.||||||.|+||+.+|++||+|||+
T Consensus 74 kkltlvfe~c-dqdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfgl 147 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGL 147 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccch
Confidence 9999999999 559999988765 568899999999999999999995 8899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccC-Ccccccchhhhhhhhhc
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMY 296 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~l 296 (297)
++-+..... -.....-|..|++|.++.+.+ |++.-|+||-|||+.++
T Consensus 148 arafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifael 195 (292)
T KOG0662|consen 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195 (292)
T ss_pred hhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHH
Confidence 986543221 122234689999999999877 66778999999999875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=251.91 Aligned_cols=190 Identities=25% Similarity=0.328 Sum_probs=163.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
.|...+.||+|++|.||++..... +..+++|.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKST---------GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCC---------CCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 455567999999999999976543 67899998865554445678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.++++||+++++|.+++.. ..+++..+..++.|++.||+||| +.|++||||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccch
Confidence 9999999999999999876 23788899999999999999999 5899999999999999999999999999887
Q ss_pred cCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
....... ......|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell 209 (285)
T cd06648 164 QVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209 (285)
T ss_pred hhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence 5432211 123356899999999998888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=254.05 Aligned_cols=195 Identities=25% Similarity=0.300 Sum_probs=159.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCC-CCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLS-HPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 165 (297)
++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~---------~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNT---------GKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCC---------CcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 3688999999999999999987654 77899998765422 22356788999999996 699999999988
Q ss_pred cCCe-----eEEEEEecCCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CC
Q 022413 166 EDKE-----LLLVYEYMQRGSLENHLFRRNPS-IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NY 238 (297)
Q Consensus 166 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~ 238 (297)
..+. .|++|||+++ +|.+++...... ...+++..++.++.||+.||.||| +.+|+||||||+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCC
Confidence 7665 8999999975 898888754322 345899999999999999999999 589999999999999998 89
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++....... ......+++.|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 149 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 206 (295)
T cd07837 149 LLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206 (295)
T ss_pred eEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHH
Confidence 999999999875432211 1122356889999998865 45788999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=251.53 Aligned_cols=190 Identities=28% Similarity=0.424 Sum_probs=162.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCC---CCCcccEEeEEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCW 165 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~ 165 (297)
.|++.+.||.|+||.||+|.+..+ +..+++|.+... .......+.+|+.++++++ ||||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPT---------GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCC---------CcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 477889999999999999987654 778999988754 2334467888999999986 999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+....+++|||+++++|.+++... .+++..++.++.|++.||.||| +.||+|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccC
Confidence 999999999999999999988643 4889999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
|++....... .......|++.|+|||.+.++ .++.++|+|||||++|+|+
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll 196 (277)
T cd06917 146 GVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196 (277)
T ss_pred CceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence 9997654432 122345689999999998754 4688999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=264.68 Aligned_cols=189 Identities=25% Similarity=0.312 Sum_probs=162.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch----hh----HHHHHHHHHHhcCCC---CCCc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QG----FEEWQSEVNFLGRLS---HPNL 157 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~----~~~~~~E~~~l~~l~---h~nI 157 (297)
.+|..++.+|+|+||.|++|.+++. ...|++|.+.++.. +. +-.+-.|++||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n---------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKEN---------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeeeccc---------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 4699999999999999999998875 56799999876532 11 112347999999997 9999
Q ss_pred ccEEeEEEcCCeeEEEEEec-CCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 158 VKLLGYCWEDKELLLVYEYM-QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 158 v~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
++++++|++++.+||+||-. +|.+|.++|..+ ..+++.++..|++||+.|+++|| +.||||||||-+|+.++.
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVDS 705 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEec
Confidence 99999999999999999987 566999999766 66999999999999999999999 699999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCccc-ccchhhhhhhhhc
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLL-SAKFGNVINVCMY 296 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslGv~l~~l 296 (297)
+|-+||+|||.+.... +.....+.||..|.|||++.|.+|--+ -|||+||++||..
T Consensus 706 ~g~~klidfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillyti 762 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTI 762 (772)
T ss_pred CCeEEEeeccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEE
Confidence 9999999999987542 223566889999999999998887654 5999999999964
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=261.05 Aligned_cols=190 Identities=24% Similarity=0.282 Sum_probs=160.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|....+ +..||+|.+... ......++.+|+.++++++||||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVT---------GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCC---------CCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 357899999999999999999977654 778999998643 233345677899999999999999999988
Q ss_pred EcC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 165 WED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 165 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
... ...|+||||+. ++|.+.+... +++..+..++.|++.||+||| ..||+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~ 155 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDC 155 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCC
Confidence 644 35799999995 5888887542 788889999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 156 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 211 (353)
T cd07850 156 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211 (353)
T ss_pred CEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH
Confidence 99999999998653321 122346789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=249.03 Aligned_cols=183 Identities=31% Similarity=0.366 Sum_probs=159.3
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
||.|++|.||+|..... +..+++|.+..... ...+.+.+|+.+++.++||||+++++.+.++...+++
T Consensus 1 lg~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKSK---------NRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECCC---------CcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 68999999999987653 77899999875432 3346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||+++....
T Consensus 72 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 72 MEYCLGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred EecCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 9999999999999765 34888999999999999999999 59999999999999999999999999999986543
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.. ......+++.|++||++.+..++.++|+||||+++|+|+
T Consensus 146 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~ 186 (262)
T cd05572 146 GQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELL 186 (262)
T ss_pred cc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHH
Confidence 21 123346899999999998888999999999999999874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=250.62 Aligned_cols=183 Identities=29% Similarity=0.380 Sum_probs=150.3
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh---hHHHHHHH---HHHhcCCCCCCcccEEeEEEcCCe
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSE---VNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E---~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
+||+|+||.||+|..... ++.||+|.+...... ....+..| +.+++...||+|+++++++.+.+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADT---------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEecC---------CCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 489999999999976653 778999988654211 11122333 334555679999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.++||||++|++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 99999999999999988654 45899999999999999999999 5899999999999999999999999999987
Q ss_pred cCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
..... ......|+..|+|||++.++ .++.++|+||+||++|+|+
T Consensus 146 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~ 190 (278)
T cd05606 146 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190 (278)
T ss_pred ccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHH
Confidence 54322 12234689999999999754 6889999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=250.47 Aligned_cols=193 Identities=25% Similarity=0.342 Sum_probs=155.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 167 (297)
+.+-+..||.|+||+|++-.++.. |+..|||.+.... .+..++++.|.+...+- +.||||++||..+.+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~s---------g~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPS---------GKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCcc---------CcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 344456799999999999766654 8999999998653 35567888888876555 599999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhh-cCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 168 KELLLVYEYMQRGSLENHLFR-RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+..|+.||+| ..+|..+... .......+++...-+|....+.||.||-. +..|||||+||+|||++..|.+||||||
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeeccc
Confidence 9999999999 4466544321 11112558899999999999999999997 7899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc--cCCcccccchhhhhhhhhc
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~l 296 (297)
.+-.+..+ ...+.-.|...|||||.+.. ..|+.+|||||||++|||+
T Consensus 214 IcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~Ev 262 (361)
T KOG1006|consen 214 ICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEV 262 (361)
T ss_pred chHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeee
Confidence 98765432 22344579999999999974 3488999999999999985
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=251.40 Aligned_cols=194 Identities=28% Similarity=0.340 Sum_probs=168.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..+.|++.+.||.|++|.||+|.+... +..+++|.+..... ..+.+.+|+++++.++|+||+++++.+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRAT---------GKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccC---------CcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 456789999999999999999987753 67799999876544 44678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..|+++||+++++|.+++.... ..+++..+..++.|++.||+||| ..|++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccc
Confidence 999999999999999999998753 36899999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++........ ......+++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~ 210 (286)
T cd06614 162 FAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210 (286)
T ss_pred hhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHH
Confidence 9865433211 123345789999999998888999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=244.30 Aligned_cols=191 Identities=31% Similarity=0.431 Sum_probs=168.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
+|.+.+.||+|++|.||++....+ +..+++|.+........+.+.+|+.++++++||||+++++.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRT---------GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCC---------CcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 477889999999999999987653 67899999887655555788999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.++++||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeeccccc
Confidence 999999999999999987653 45899999999999999999999 5999999999999999999999999999987
Q ss_pred cCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
....... .....++..|+|||++.+..++.++|+||||+++|+|+
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~ 191 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHH
Confidence 6543221 23456889999999998888899999999999999885
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=254.34 Aligned_cols=193 Identities=26% Similarity=0.336 Sum_probs=161.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||.|+||.||+|.+..+ +..+++|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 74 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKT---------GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCC---------CcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEE
Confidence 35799999999999999999987654 67899998865432 22235678999999999999999999988
Q ss_pred cC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 166 ED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 166 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
.. +..|+||||+++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 75 GSNLDKIYMVMEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred ecCCCcEEEEehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEe
Confidence 77 899999999964 9999887643 35899999999999999999999 5899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
|||++........ ......+++.|+|||.+.+.. ++.++|+||||+++|+|+
T Consensus 149 d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 201 (293)
T cd07843 149 DFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201 (293)
T ss_pred ecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHH
Confidence 9999886543211 122345788999999987644 688999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=269.65 Aligned_cols=195 Identities=30% Similarity=0.412 Sum_probs=167.2
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYC 164 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 164 (297)
...+-|++.++||.|.+|.||++...+. ++..|+|+.+.....+ +++..|..+|+.+. |||++.++++|
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~---------~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKT---------GQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeec---------CceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3456799999999999999999977664 7778888887654332 66778888999885 99999999998
Q ss_pred Ec-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 165 WE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 165 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
.. ++++|||||||.||+.-+++.... ...+.|..+..|++.++.||.+|| ...++|||||-.|||++.++.
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCc
Confidence 74 468999999999999999998765 477999999999999999999999 588999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhc
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~l 296 (297)
|||+|||++..+.... ....+..|||.|||||++.- ..|+..+|+||||++.++|
T Consensus 162 VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEl 221 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEM 221 (953)
T ss_pred EEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehh
Confidence 9999999998765432 34566789999999999974 3467789999999998876
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=248.46 Aligned_cols=189 Identities=23% Similarity=0.251 Sum_probs=156.3
Q ss_pred HHHHhhcCCCCCcee--cccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCccc
Q 022413 83 DLKSATKNFKPDSLL--GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVK 159 (297)
Q Consensus 83 ~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~ 159 (297)
+.....++|.+.+.+ |.|+||.||++..... +..+++|.+........ |+.....+ +||||++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~---------~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~ 73 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPT---------QKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIK 73 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCC---------CcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEE
Confidence 334455677887776 9999999999976654 77899999865432211 22222222 6999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY- 238 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~- 238 (297)
+++.+...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.|++||||||+||+++.++
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~ 147 (267)
T PHA03390 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKD 147 (267)
T ss_pred EEEEEecCCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCCCC
Confidence 999999999999999999999999999765 36899999999999999999999 58999999999999999988
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.++|+|||+++..... ....+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 148 ~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 200 (267)
T PHA03390 148 RIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200 (267)
T ss_pred eEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999998754321 2246899999999999888999999999999999984
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=251.23 Aligned_cols=195 Identities=28% Similarity=0.347 Sum_probs=161.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch----hhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
+|++.+.||+|+||.||++..... ...|..||+|.+..... ...+.+.+|+.+++++ +|+||+++++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~------~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSG------HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccC------CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 478889999999999999876431 12378899999875321 2336678899999999 499999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
..+...++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||+++++.+||+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEee
Confidence 9999999999999999999999765 45788899999999999999999 59999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceeccc--CCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG--NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~~ll 297 (297)
||+++....... .......|+..|+|||.+.+. .++.++||||||+++|+|+
T Consensus 149 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll 202 (290)
T cd05613 149 FGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202 (290)
T ss_pred Cccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHh
Confidence 999876533211 122345689999999998753 4678899999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=254.16 Aligned_cols=189 Identities=32% Similarity=0.418 Sum_probs=160.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.+.|++.+.||+|+||+||+|..... +..|++|.+.... ....+++.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 84 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRT---------NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCC---------CcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45699999999999999999987653 7789999886432 23346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..++||||+. ++|.+++.... ..+++..+..++.|++.||.||| ..+|+||||+|+||+++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL~d 158 (307)
T cd06607 85 LREHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKLAD 158 (307)
T ss_pred EeCCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEEee
Confidence 99999999999996 57777775433 45889999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
||++...... ....+++.|+|||++. ...++.++||||||+++|+|+
T Consensus 159 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~ 208 (307)
T cd06607 159 FGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208 (307)
T ss_pred cCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHH
Confidence 9998754321 2346788999999885 356888999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=252.34 Aligned_cols=192 Identities=27% Similarity=0.379 Sum_probs=160.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||.|++|.||+|....+ +..|++|.+.... ......+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLT---------GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCC---------CCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 478899999999999999987654 7789999886542 22335688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+. ++|.+++..... ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999995 589888865422 45889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
++....... ......+++.|+|||++.+.. ++.++||||||+++|+|+
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~ 195 (284)
T cd07860 147 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195 (284)
T ss_pred hhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHH
Confidence 875432211 122335788999999987654 578899999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=245.44 Aligned_cols=195 Identities=26% Similarity=0.406 Sum_probs=169.1
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|.+.+.||.|+||.||++.+..+ +..+++|.+..... .....+.+|+++++.++|||++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSD---------GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCC---------CcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 578889999999999999987653 67899999876533 4456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++++||+++++|.+++.........+++..+..++.+++.||.||| +.|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999999999999875433466899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......|++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 197 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELC 197 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHH
Confidence 87654322 1223356899999999998888999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=253.13 Aligned_cols=189 Identities=25% Similarity=0.315 Sum_probs=162.0
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCee
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
|....+||+|+||.||++....+ +..+++|.+..........+.+|+.+++.++|+||+++++.+...+..
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSS---------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 92 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCC---------CeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence 33346799999999999987654 788999998655544556788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
+++|||+++++|.+++.. ..+++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 93 WVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred EEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEccccccee
Confidence 999999999999998754 34788999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 166 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~ 210 (292)
T cd06657 166 VSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210 (292)
T ss_pred ccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 43221 1223356899999999998888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=258.95 Aligned_cols=193 Identities=28% Similarity=0.381 Sum_probs=159.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....++.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPT---------GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCC---------CCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 46899999999999999999987654 7789999986532 2334667889999999999999999998765
Q ss_pred CC-----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 167 DK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 167 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
.. ..|+++||+. ++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEE
Confidence 43 5899999995 488887754 34899999999999999999999 58999999999999999999999
Q ss_pred EccccccccCCCCCCc-ceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++........ .......|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999998765332211 11223568999999998765 46888999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=254.32 Aligned_cols=194 Identities=29% Similarity=0.363 Sum_probs=160.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh--hHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+|+.++++++|+||+++++++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTS---------GEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVV 75 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCC---------CcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEE
Confidence 356899999999999999999987654 788999988644221 123456899999999999999999998
Q ss_pred EcC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 165 WED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 165 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
... +..++||||+. ++|.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 76 VGKHLDSIFLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred ecCCCCeEEEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEE
Confidence 765 56899999996 48988887543 45889999999999999999999 589999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 150 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 203 (309)
T cd07845 150 ADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203 (309)
T ss_pred CccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHH
Confidence 99999986543221 1122345788999999875 45788999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=251.75 Aligned_cols=197 Identities=20% Similarity=0.177 Sum_probs=148.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhH-----------HHHHHHHHHhcCCCCCC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-----------EEWQSEVNFLGRLSHPN 156 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~n 156 (297)
.++|++.++||+|+||+||+|.+..+.. .+..+++|.......... .....+...+..+.|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 4689999999999999999998765311 133466665432221100 11223445566788999
Q ss_pred cccEEeEEEcCC----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 157 LVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 157 Iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
|+++++.+.... ..++++|++ ..++.+.+... ...++..++.++.|++.||+||| +.+|+||||||+||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiKp~Ni 157 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIKPENI 157 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHE
Confidence 999999766543 357788887 44677766543 33567888999999999999999 58999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999865432211 1122346999999999999999999999999999999985
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=250.42 Aligned_cols=193 Identities=25% Similarity=0.383 Sum_probs=161.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
+|++.+.||.|++|.||+|....+ +..||+|.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTT---------GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCC---------CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 588899999999999999987654 77899998875432 23456778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+++ +|.+++..... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 99999999975 89888865432 245899999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+....... ......+++.|++||++.+. .++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~ 195 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 75432211 12234578899999988654 5688999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=253.11 Aligned_cols=196 Identities=26% Similarity=0.344 Sum_probs=159.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|....+ +..||+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKT---------KQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 80 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCC---------CcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEE
Confidence 456799999999999999999987654 78899998764322 2223556899999999999999999998
Q ss_pred EcCC--------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 165 WEDK--------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 165 ~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
.... ..++||||+. ++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~ 154 (310)
T cd07865 81 RTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITK 154 (310)
T ss_pred ecccccccCCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECC
Confidence 7654 4599999995 58888876542 35889999999999999999999 589999999999999999
Q ss_pred CCceEEccccccccCCCCCCc--ceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGES--HVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||++......... .......++..|+|||++.+. .++.++|+||||+++|+|+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~ 218 (310)
T cd07865 155 DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218 (310)
T ss_pred CCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence 999999999999765432211 112234578899999988764 3678999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=246.82 Aligned_cols=193 Identities=26% Similarity=0.388 Sum_probs=163.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|.+.+.||.|+||.||++....+ +..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSD---------SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCC---------CceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 478889999999999999987764 6789999986542 22345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-ceEEcccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKISDFG 246 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg 246 (297)
...++++||+++++|.+++..... ..+++..+..++.|++.||.||| ..+++|+||||+||++++++ .+||+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~ 147 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFG 147 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccc
Confidence 999999999999999999976432 34789999999999999999999 58999999999999998875 56999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+........ ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08225 148 IARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC 196 (257)
T ss_pred cchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9876543221 222346899999999998888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=243.70 Aligned_cols=193 Identities=28% Similarity=0.402 Sum_probs=167.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|.+.+.||+|++|.||+|....+ +..+++|.+..... ...+.+.+|+.++++++||||+++++.+.+.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDT---------GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCC---------CcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 477889999999999999987754 77899999876542 4457888999999999999999999999988
Q ss_pred --CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 168 --KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 168 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
...++++||+++++|.+++... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccc
Confidence 8999999999999999999765 36899999999999999999999 599999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|.+................++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9987654432211123356889999999998888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=264.69 Aligned_cols=199 Identities=26% Similarity=0.399 Sum_probs=168.9
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEe
Q 022413 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLG 162 (297)
Q Consensus 83 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~ 162 (297)
.+...+.+.....+||-|.||.||.|+|+.- ...||||.++.+ ...+++|+.|..+|+.++|||+|++++
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 3444455666778999999999999998864 556999998654 345689999999999999999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
+|..+..+|||+|||..|+|.+||++.+. ..++....++++.||..|+.||. .+++|||||..+|+|+.++..+|+
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEe
Confidence 99999999999999999999999987654 44677788899999999999999 699999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhc
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
+||||++++.-.... ......-..-|.|||-+....|+.+||||+|||+||++
T Consensus 407 ADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEI 459 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 459 (1157)
T ss_pred eccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHH
Confidence 999999987432211 11122235679999999999999999999999999985
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=247.36 Aligned_cols=186 Identities=28% Similarity=0.413 Sum_probs=159.8
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
||.|+||.||++..... +..+++|.+..... ...+.+.+|+.++++++||||+++++.+......|++
T Consensus 1 lg~g~~~~vy~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKST---------GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECCC---------CCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 68999999999987654 77899999876533 3456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++.+. ..+++..+..++.||+.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 72 MEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 9999999999999765 35899999999999999999999 59999999999999999999999999999875433
Q ss_pred CCC------cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGE------SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
... ........+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~ 195 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL 195 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence 211 01223356788999999998888999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=242.57 Aligned_cols=191 Identities=31% Similarity=0.465 Sum_probs=166.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|++|.||++..... +..+++|.+..... ...+.+.+|++++++++|||++++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLET---------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCC---------CcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 478899999999999999977654 67899999876643 4557889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..+++|||+++++|.+++... ..+++..+..++.|++.||.||| +.||+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEecccc
Confidence 9999999999999999998765 45899999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+........ ......++..|+|||.+.+..++.++|+|+||+++|+|+
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~ 193 (254)
T cd06627 146 ATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELL 193 (254)
T ss_pred ceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHH
Confidence 986543322 123356889999999998888889999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=251.42 Aligned_cols=195 Identities=27% Similarity=0.360 Sum_probs=158.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCC-CCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 166 (297)
++|...+.||+|+||.||++.+... +..+|+|.+.... ......+.+|+.++.++. ||||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPS---------GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCC---------CCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 3566778899999999999987654 7889999987543 234467889999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhc-CCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRR-NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
++..+++|||+. +++.++.... ......+++..+..++.|++.||+|||+ +.+|+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 75 EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeec
Confidence 999999999985 4665543211 1112558999999999999999999995 469999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceeccc---CCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG---NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... ......|++.|+|||++.+. .++.++|||||||++|+|+
T Consensus 153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 204 (288)
T cd06616 153 GISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA 204 (288)
T ss_pred chhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHH
Confidence 9987543221 12334688999999999876 6889999999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=251.18 Aligned_cols=187 Identities=31% Similarity=0.419 Sum_probs=158.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.|...+.||+|+||.||++..... +..+++|.+.... ......+.+|++++++++|||++++++++.+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRT---------NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCC---------CcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 477889999999999999987654 6789999886432 2334578899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+.| +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.+||+|||
T Consensus 97 ~~~~~lv~e~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg 170 (317)
T cd06635 97 EHTAWLVMEYCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFG 170 (317)
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCC
Confidence 9999999999965 7877776443 45889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
++..... .....|++.|+|||++. ++.++.++|||||||++|+|+
T Consensus 171 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~ 218 (317)
T cd06635 171 SASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218 (317)
T ss_pred CccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHH
Confidence 9875432 22346889999999974 456888999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=249.61 Aligned_cols=193 Identities=24% Similarity=0.331 Sum_probs=158.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|.+|.||+|....+ +..|++|.+..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVT---------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCC---------CcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 4788999999999999999987654 77899998865422 223567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEEccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDF 245 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df 245 (297)
.+..|+||||++ ++|.+++..... ..+++..+..++.||+.||+||| +.+++||||||+||+++. ++.+||+||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEccc
Confidence 999999999995 588888765432 23578888899999999999999 589999999999999985 567999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
|++....... .......+++.|+|||++.+. .++.++||||||+++|+|+
T Consensus 148 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~ 198 (294)
T PLN00009 148 GLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198 (294)
T ss_pred ccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9997543221 112234578899999988764 5788999999999999985
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=244.39 Aligned_cols=182 Identities=26% Similarity=0.327 Sum_probs=153.1
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHH-hcCCCCCCcccEEeEEEcCCee
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNF-LGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
+.||+|+||.||+|..... ++.||+|.+..... .....+..|..+ ....+||||+++++++...+..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRST---------GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCC---------CCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 5689999999999977654 67899999875432 222334455444 4455899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|++|||+++++|.+++... ..+++..+..++.|++.||.||| ..+++||||+|+||++++++.+||+|||+++.
T Consensus 73 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 9999999999999999765 45889999999999999999999 58999999999999999999999999999875
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
... .....+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~ 187 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL 187 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHH
Confidence 322 22346889999999998888899999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=245.89 Aligned_cols=193 Identities=28% Similarity=0.373 Sum_probs=166.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||+|+||.||++....+ +..+++|.+.... .....++.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSD---------NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCC---------CCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 478889999999999999976654 6789999987542 23346778899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...++||||+++++|.+++.........+++..++.++.|++.||+||| +.|++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 9999999999999999998774433456889999999999999999999 58999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+...... ......+++.|++||.+.+..++.++|+||||+++|+|+
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~ 195 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH
Confidence 9765433 122345789999999999888999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=255.69 Aligned_cols=194 Identities=30% Similarity=0.382 Sum_probs=159.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCC-CCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRL-SHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 163 (297)
..++|++.+.||+|+||.||+|.+... +..+++|.+... .......+.+|+.+++++ +||||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRT---------KEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCC---------CeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 456899999999999999999987643 678999987543 223345677899999999 99999999998
Q ss_pred EEcC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 164 CWED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 164 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+... ...|+||||++ ++|.+++... .+++..+..++.|++.||+||| +.||+||||||+|||++.++.+|
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~k 147 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVK 147 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEE
Confidence 8654 36899999996 5998888653 4778888999999999999999 58999999999999999999999
Q ss_pred EccccccccCCCCCCc---ceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES---HVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++........ .......|++.|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~ 207 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML 207 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHH
Confidence 9999999765433211 12234568999999998865 45788999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=286.21 Aligned_cols=195 Identities=28% Similarity=0.351 Sum_probs=165.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.-+|+....||.|.||.||-|...++ |...|+|.+...+ .+....+.+|+.++..++|||+|++|++-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~t---------GellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDT---------GELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCc---------cchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence 44788889999999999999987765 8889999876543 344567789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..+|.||||++|+|.+++... +..++.....+..|++.|++||| +.|||||||||+||+++.+|.+|+.||
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeecc
Confidence 999999999999999999999765 44677777888899999999999 699999999999999999999999999
Q ss_pred cccccCCCCCC--cceeeccCCcccccCcceecccC---CcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGE--SHVTTRVMGTYGYAAPEYVATGN---FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~~ll 297 (297)
|.|..+..... ........|||.|||||++.+.+ -..+.|||||||++.+|.
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA 1435 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee
Confidence 99987644321 11223568999999999998744 335789999999999984
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=246.66 Aligned_cols=190 Identities=23% Similarity=0.302 Sum_probs=160.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCC--C----CcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH--P----NLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~----nIv~~~ 161 (297)
.++|.+...+|+|.||.|-++++++. +..||+|+++.-.. ..+....|+++|.++.+ | -++++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~---------~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRET---------KEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCC---------CceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 67899999999999999999987764 67899999875432 23556779999999942 2 378888
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc------
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD------ 235 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~------ 235 (297)
++|...++.+||.|.+ |-++.++|..+.. .+++...++.+++|++.+++||| +.+++|-||||+|||+-
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccceEE
Confidence 9999999999999998 8899999987543 67889999999999999999999 69999999999999992
Q ss_pred --------------CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 236 --------------GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 --------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
....+||+|||.|+... ......+.|..|+|||++.+-.|+.++||||+||||+||.
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 13358999999998532 2234567899999999999999999999999999999873
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=256.31 Aligned_cols=194 Identities=24% Similarity=0.332 Sum_probs=160.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||.|+||.||+|....+ +..|++|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRS---------GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCC---------CCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 36899999999999999999976654 7789999987542 234467788999999999999999999876
Q ss_pred c----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 166 E----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 166 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
. ...+++||||+. ++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~k 147 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELR 147 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEE
Confidence 3 356899999995 5898888654 44899999999999999999999 58999999999999999999999
Q ss_pred EccccccccCCCCCCc--ceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES--HVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||++......... .......|+..|+|||++.+ ..++.++||||||+++|+|+
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH
Confidence 9999998764332211 11234578999999999865 45788999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=249.24 Aligned_cols=194 Identities=28% Similarity=0.351 Sum_probs=166.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCC-CCCcccEEeEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS-HPNLVKLLGYC 164 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 164 (297)
++|.+.+.||.|+||.||+|....+ +..+++|.+.... ....+.+.+|..+++++. ||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKET---------NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCC---------CCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 4788999999999999999987654 7889999987532 223366789999999999 99999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
...+..+++|||+++++|.+++... ..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecC
Confidence 9999999999999999999999765 46899999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCC------------------cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGE------------------SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||++........ ........++..|+|||++.+..++.++|+||||+++++|+
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~ 216 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence 999875433211 01223356789999999998888999999999999999874
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=255.10 Aligned_cols=192 Identities=27% Similarity=0.371 Sum_probs=160.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|.+.+.||+|+||+||+|....+ +..||+|.+... .......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSET---------NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCC---------CCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 45799999999999999999976653 788999988753 2223456778999999999999999999886
Q ss_pred cC-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 166 ED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 166 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
.. ...|+++||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~ 147 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDL 147 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCE
Confidence 54 34899999995 6898888654 45899999999999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...... .......++..|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 148 kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 203 (337)
T cd07858 148 KICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203 (337)
T ss_pred EECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence 999999998654322 12233467899999998865 46889999999999999985
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=264.65 Aligned_cols=198 Identities=26% Similarity=0.401 Sum_probs=167.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+..+.++||+|.||.|++|.|.... +.-..||||.+...... ...+|++|+.+|.+|+|||+++||++..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~ps------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPS------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCC------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 34556789999999999999887532 22457999999876543 56899999999999999999999999887
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
....+|+|+++.|+|.+.|++. ....|.......++.||+.||.||.+ +++|||||..+|+|+.....||||||||
T Consensus 183 qp~mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccc
Confidence 6789999999999999999872 22557788899999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeec-cCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTR-VMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+-+..+........ ..-...|+|||.+...+|+.+||||++||+|||||
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMF 309 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMF 309 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhh
Confidence 997765443332222 12345799999999999999999999999999996
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=245.75 Aligned_cols=188 Identities=27% Similarity=0.309 Sum_probs=155.0
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCC-CCCcccEEeEEEcC-
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWED- 167 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~- 167 (297)
|++.+.||+|+||.||+|....+ +..+|+|.+..... .......+|+.+++++. ||||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~---------~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKT---------GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcCC---------CcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 67788999999999999987654 67899998875421 12234457899999986 99999999999988
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 168 -KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 168 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+.+++||||++ ++|.+.+.... ..+++..+..++.|++.||+||| +.+++||||||+||+++. +.+||+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEecc
Confidence 89999999996 58888886543 45889999999999999999999 589999999999999999 999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... .....+++.|+|||++.. ..++.++|+|||||++|+|+
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~ 193 (282)
T cd07831 145 SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193 (282)
T ss_pred cccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHH
Confidence 9976533221 223457899999997654 45788999999999999984
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=246.94 Aligned_cols=191 Identities=26% Similarity=0.356 Sum_probs=159.7
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
|++.+.||.|++|.||+|.+..+ +..|++|.+.... ......+.+|++++++++||||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLT---------GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCC---------CCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 67789999999999999987654 7789999886543 222356788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..+++|||++ ++|.+++..... ..+++..++.++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~ 146 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLA 146 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence 9999999995 689999876432 35889999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+....... ......+++.|+|||++.+. .++.++|+||||+++|+|+
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 194 (283)
T cd07835 147 RAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194 (283)
T ss_pred cccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHH
Confidence 75432211 11223568899999988764 4688999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=246.23 Aligned_cols=191 Identities=26% Similarity=0.335 Sum_probs=160.4
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC-
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED- 167 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~- 167 (297)
|++.+.||.|+||.||+|..... +..+++|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKT---------GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCC---------CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 66788999999999999987754 6789999987653 23335678899999999999999999999988
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 168 -KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 168 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+..++||||+++ +|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++++++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEcccc
Confidence 899999999965 8988886542 45889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
++........ .......++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 196 (287)
T cd07840 146 LARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196 (287)
T ss_pred ceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence 9986543321 11223456888999998765 45788999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=253.70 Aligned_cols=193 Identities=25% Similarity=0.338 Sum_probs=160.0
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccE
Q 022413 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKL 160 (297)
Q Consensus 83 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~ 160 (297)
++....++|.+.+.||+|+||.||+|....+ +..||+|++.... ....+.+.+|+.++++++||||+++
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKT---------GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCC---------CeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence 3444678999999999999999999976543 7789999987542 2234567889999999999999999
Q ss_pred EeEEEcC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 161 LGYCWED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 161 ~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
++++... ...+++++++ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll 153 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAV 153 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEE
Confidence 9988643 3478888877 7899888754 34889999999999999999999 5899999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+.++.+||+|||+++.... ......+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 154 ~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 154 NEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred cCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence 9999999999999875422 1233467899999999876 46788999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=248.18 Aligned_cols=195 Identities=28% Similarity=0.342 Sum_probs=159.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|....+ +..|++|.+..... .....+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDT---------GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCC---------CcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence 456899999999999999999987654 67899999865422 2234667899999999999999999998
Q ss_pred EcCC----------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 165 WEDK----------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 165 ~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
.+.. .+++|+||+++ ++.+.+.... ..+++..++.++.|++.||+||| +.+|+||||||+||++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili 149 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILL 149 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence 7655 79999999976 7777776542 45899999999999999999999 5899999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
++++.+||+|||++........ .......+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~ 212 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212 (302)
T ss_pred CCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHH
Confidence 9999999999999986543221 11122346788999998864 35788999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=246.71 Aligned_cols=187 Identities=31% Similarity=0.418 Sum_probs=157.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.|...+.||+|+||+||+|..... +..+++|.+.... ....+.+.+|+++++.++|||++++++++.+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~---------~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHT---------NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCC---------CcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 477778899999999999976543 7789999886432 2334567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
....|+||||+. ++|.+++.... ..+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 93 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred CCEEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecC
Confidence 999999999995 57888776543 45889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
++.... ......|+..|+|||++. ...++.++|||||||++|+|+
T Consensus 167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~ 214 (313)
T cd06633 167 SASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214 (313)
T ss_pred CCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHH
Confidence 986432 122356889999999984 356888999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=253.13 Aligned_cols=189 Identities=25% Similarity=0.315 Sum_probs=159.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||++....+ +..||+|.+.... ......+.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRT---------GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCC---------CcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 456899999999999999999976654 7789999886432 22335678999999999999999999998
Q ss_pred EcCC------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 165 WEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 165 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
.... .+++||||+ +++|.+++.. ..+++..++.++.|++.||+||| +.||+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~ 155 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDC 155 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCC
Confidence 7653 468999999 7799888764 34889999999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||++...... .....+++.|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 156 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~ 210 (343)
T cd07880 156 ELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210 (343)
T ss_pred CEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999864321 223467899999999876 45788999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=246.34 Aligned_cols=195 Identities=28% Similarity=0.349 Sum_probs=161.6
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc----hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
+|++.+.||+|++|.||++...... ..+..+|+|.+.... ....+.+.+|+.++.++ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH------DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc------cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 4778899999999999998754321 126779999886432 22335678999999999 599999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
......++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEE
Confidence 9999999999999999999998764 45888999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccC--CcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN--FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~~ll 297 (297)
||+++...... ........|++.|+|||.+.+.. .+.++|+||||+++|+|+
T Consensus 149 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~ 202 (288)
T cd05583 149 FGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202 (288)
T ss_pred Ccccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH
Confidence 99987643321 11122356899999999987665 778999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=248.18 Aligned_cols=194 Identities=27% Similarity=0.418 Sum_probs=159.6
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcC--CCCCCcccEE
Q 022413 84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR--LSHPNLVKLL 161 (297)
Q Consensus 84 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~ 161 (297)
.+...++.++.+.||+|.||+||+|.|+ |..||||++...+. +.|.+|.+|... |+|+||+.|+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhh
Confidence 3445667888999999999999999998 67799999986654 567788888876 5899999998
Q ss_pred eEEEcC----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhc------CCCCceeccCCCCc
Q 022413 162 GYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT------SEKKVIYRDFKASN 231 (297)
Q Consensus 162 ~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~------~~~~ivH~Dlkp~N 231 (297)
+.-... .++|||++|.+.|+|.|+|.+. .++....++++..++.||++||. .+..|.|||||..|
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 865433 3799999999999999999874 48889999999999999999995 24569999999999
Q ss_pred EEEcCCCceEEccccccccCCCCC-C-cceeeccCCcccccCcceecccC----C--cccccchhhhhhhhhc
Q 022413 232 ILLDGNYNAKISDFGLAKLGPAGG-E-SHVTTRVMGTYGYAAPEYVATGN----F--YLLSAKFGNVINVCMY 296 (297)
Q Consensus 232 ill~~~~~~kl~Dfg~a~~~~~~~-~-~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwslGv~l~~l 296 (297)
||+..++.-.|+|+|||-+..... . .-..+..+||..|||||++...- | ...+||||||.++||+
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 999999999999999997664432 1 12234568999999999986421 1 2358999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=251.99 Aligned_cols=192 Identities=28% Similarity=0.359 Sum_probs=162.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+|++.+.||.|++|.||+|..... +..+++|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRT---------GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCC---------CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 588899999999999999987653 7789999887643 33446788999999999999999999998887
Q ss_pred C-----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 168 K-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 168 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
+ .+|++|||++ ++|.+++... ..+++..++.++.|++.||+||| ..||+||||||+|||++.++.++|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L 144 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKI 144 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEE
Confidence 5 7999999996 5898888654 36899999999999999999999 589999999999999999999999
Q ss_pred ccccccccCCCCCCc-ceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+|||++......... .......+++.|+|||++.+. .++.++|+||||+++|+|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~ 201 (330)
T cd07834 145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201 (330)
T ss_pred cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHH
Confidence 999999865443210 112334678999999999887 7889999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=250.51 Aligned_cols=194 Identities=24% Similarity=0.308 Sum_probs=157.8
Q ss_pred hcCCC-CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh--------------HHHHHHHHHHhcCC
Q 022413 88 TKNFK-PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--------------FEEWQSEVNFLGRL 152 (297)
Q Consensus 88 ~~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l 152 (297)
.++|. +.+.||.|+||+||+|..... +..||+|.+....... ...+.+|+++++.+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 77 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLT---------GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCC---------CCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence 34565 457899999999999986643 7789999886432211 12467899999999
Q ss_pred CCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 153 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
+||||+++++++...+..+++|||+. ++|.+++... ..+++.....++.|++.||+||| +.||+|+||||+||
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~ni 150 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANI 150 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHe
Confidence 99999999999999999999999996 5899988654 45889999999999999999999 58999999999999
Q ss_pred EEcCCCceEEccccccccCCCCC------------CcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGG------------ESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+++.++.+||+|||+++...... .........+++.|+|||++.+. .++.++|+||||+++|+|+
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999987654110 00111223468899999998764 4688999999999999985
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=249.35 Aligned_cols=190 Identities=23% Similarity=0.312 Sum_probs=153.6
Q ss_pred ceeccc--CceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCee
Q 022413 95 SLLGEG--GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 95 ~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
..||+| +||+||++.+... ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPT---------GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcCC---------CcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 356666 9999999977654 7889999987543 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
++||||+.+++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++||+.+..
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999999999999999876532 34888999999999999999999 58999999999999999999999999986543
Q ss_pred CCCCCCcc-----eeeccCCcccccCcceeccc--CCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESH-----VTTRVMGTYGYAAPEYVATG--NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~~ll 297 (297)
........ ......++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~ 204 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 22211100 01112346679999999764 4778999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=249.74 Aligned_cols=195 Identities=28% Similarity=0.360 Sum_probs=157.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh--hHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ +..+++|.+...... ....+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKT---------GRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCC---------CcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 56899999999999999999987654 678999987543221 2245678999999999999999999876
Q ss_pred cCC--------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 166 EDK--------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 166 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
+.. .+++||||+.+ +|...+.... ..+++..+..++.|++.||+||| ..||+||||||+|||++++
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~ 151 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQ 151 (311)
T ss_pred cccccccccCceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence 543 47999999954 7777776432 45899999999999999999999 5899999999999999999
Q ss_pred CceEEccccccccCCCCCCc---------ceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGES---------HVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++........ .......+++.|+|||++.+. .++.++||||||+++|+|+
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 221 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHH
Confidence 99999999999754332111 111234578889999988654 4788999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=245.04 Aligned_cols=193 Identities=26% Similarity=0.407 Sum_probs=158.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCC-CCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+... +..+|+|.+.... ......+..|+.++.++. ||||+++++++.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKT---------GHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCC---------CeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 46789999999999999999987754 6789999987543 223355667887776665 999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+....|++|||+. ++|.+++.... ..+++..+..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+||
T Consensus 85 ~~~~~~~v~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 85 TDSDVFICMELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred cCCeEEEEeeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECcc
Confidence 9999999999984 57777776533 468899999999999999999995 369999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccC----CcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN----FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~~ll 297 (297)
|++....... ......+++.|+|||++.+.. ++.++|+||||+++|+|+
T Consensus 160 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~ 212 (296)
T cd06618 160 GISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212 (296)
T ss_pred ccchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH
Confidence 9987643221 122335788999999987654 788999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=242.56 Aligned_cols=194 Identities=24% Similarity=0.310 Sum_probs=157.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCC---c--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP---E--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~---~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
+|.+.+.||+|+||+||++.+... +..+++|.+.. . .......+..|+.++++++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA---------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC---------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 588899999999999999976643 22344444332 1 122234567899999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+....++||||+++++|.+++.........+++..++.++.|++.||.||| +.|++|+||||+||+++. +.+||+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecc
Confidence 9999999999999999999998764433466899999999999999999999 589999999999999975 5699999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++....... ......|++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 999876533221 223456889999999998888899999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=249.32 Aligned_cols=189 Identities=28% Similarity=0.336 Sum_probs=158.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|....+ +..+|+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 78 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLT---------GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF 78 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCC---------CCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence 467899999999999999999976654 7789999876432 22336678899999999999999999998
Q ss_pred Ec-CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 165 WE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 165 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
.. ....+++|||+ +++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 79 ~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 79 ISPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred ecCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCEEeC
Confidence 76 45789999998 6689888764 34778888899999999999999 5899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++..... .....+++.|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 151 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 151 DFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred ccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 99998753221 123457889999999876 56888999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=244.51 Aligned_cols=190 Identities=27% Similarity=0.357 Sum_probs=161.4
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
|++.+.||.|++|.||+|....+ +..+++|.+..... .....+.+|+.++++++||||+++++++.+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLT---------GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCCC---------CcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 56788999999999999987654 77899998875532 23467788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++++||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||.+
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeee
Confidence 99999999965 8888887643 46889999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|+
T Consensus 146 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~ 193 (283)
T cd05118 146 RSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELL 193 (283)
T ss_pred EecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 7654332 112234578899999998876 7889999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=252.02 Aligned_cols=193 Identities=25% Similarity=0.325 Sum_probs=157.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|.+.+.||.|+||.||+|..... +..|++|.+........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~---------~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDC---------DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCC---------CcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 46899999999999999999977654 788999998766555557788999999999999999999776543
Q ss_pred --------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 168 --------------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 168 --------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+||+
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nil 146 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVF 146 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEE
Confidence 35899999996 589888754 34889999999999999999999 589999999999999
Q ss_pred EcC-CCceEEccccccccCCCCCCc-ceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 234 LDG-NYNAKISDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~-~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
++. ++.+||+|||+++........ .......++..|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence 974 567899999999765322111 11122357889999998754 45778999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=249.64 Aligned_cols=198 Identities=26% Similarity=0.316 Sum_probs=164.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-------hHHHHHHHHHHhcCCCCCCccc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-------GFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
..++|.++.+||+|+|+.||+|++... .+.||+|+....+.+ ..+...+|-.|-+.|+||.||+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~E---------qRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTE---------QRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccch---------hheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 345788899999999999999976653 678999986543221 1245668999999999999999
Q ss_pred EEeEEEc-CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc---
Q 022413 160 LLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--- 235 (297)
Q Consensus 160 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~--- 235 (297)
+|++|.- .+.++-|+|||+|.+|..||..+ ..+++.+++.|+.||+.||.||..-...|||-||||.|||+-
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 9999874 46799999999999999999877 568999999999999999999996567899999999999994
Q ss_pred CCCceEEccccccccCCCCCCcc-----eeeccCCcccccCcceeccc----CCcccccchhhhhhhhhcC
Q 022413 236 GNYNAKISDFGLAKLGPAGGESH-----VTTRVMGTYGYAAPEYVATG----NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGv~l~~ll 297 (297)
..|.+||.|||+++++....... .+....||.+|++||.+--+ +.+.+.||||+|||+|-.|
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl 678 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL 678 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh
Confidence 35889999999999887654331 23456799999999998643 4667899999999999654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=245.56 Aligned_cols=188 Identities=32% Similarity=0.422 Sum_probs=158.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
+.|...+.||+|+||.||+|..... +..+++|.+... .....+++.+|+.+++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRN---------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCC---------CcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 4577788999999999999987653 678999987642 2233457789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.....++||||+. ++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECCc
Confidence 9999999999996 58888776443 45788999999999999999999 589999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
|++..... .....+++.|+|||++. ...++.++|||||||++|+|+
T Consensus 160 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 208 (308)
T cd06634 160 GSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208 (308)
T ss_pred ccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHH
Confidence 99875432 12346889999999975 356788999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=241.07 Aligned_cols=190 Identities=28% Similarity=0.398 Sum_probs=157.1
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCC---CCCCcccEEeEEE
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLLGYCW 165 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~ 165 (297)
|++.+.||+|+||.||+|.+... +..+|+|.+..... .....+.+|+.+++++ .||||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNT---------GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECCC---------CCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 67788999999999999987653 67899999874322 1224556787777665 5999999999999
Q ss_pred cCCe-----eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 166 EDKE-----LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 166 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
..+. .+++|||+.+ +|.+++..... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eccCCCCceeEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCE
Confidence 8776 9999999964 89988876432 35889999999999999999999 5899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||++....... ......+++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 147 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~ 200 (287)
T cd07838 147 KIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200 (287)
T ss_pred EEeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHH
Confidence 999999987654322 122335788999999999989999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=249.84 Aligned_cols=187 Identities=27% Similarity=0.336 Sum_probs=155.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|.+.+.||+|+||.||+|....+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRT---------GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCC---------CcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 46899999999999999999977543 7789999886532 222356789999999999999999999987
Q ss_pred cCC------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
... .+++|+||+. .+|..++. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~ 155 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCE 155 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCC
Confidence 543 4699999995 47766652 24788999999999999999999 589999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 156 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred EEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence 999999998754321 223467889999999876 45888999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=236.71 Aligned_cols=173 Identities=19% Similarity=0.154 Sum_probs=147.0
Q ss_pred cCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEEEecCC
Q 022413 100 GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQR 179 (297)
Q Consensus 100 G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 179 (297)
|.+|.||++++..+ ++.+|+|.+..... +.+|...+....||||+++++++.+.+..+++|||+++
T Consensus 4 g~~~~v~~~~~~~~---------~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTRT---------QQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEccC---------CcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 88999999987654 78899999876532 23345555566799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcce
Q 022413 180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259 (297)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 259 (297)
++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 70 ~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 70 GKLWSHISKF----LNIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred CCHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 9999998765 34889999999999999999999 599999999999999999999999999987654321
Q ss_pred eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 260 TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 260 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.....++..|+|||++.+..++.++|+||+|+++|+|+
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 176 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELL 176 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHH
Confidence 22345677899999998888999999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=245.88 Aligned_cols=191 Identities=23% Similarity=0.252 Sum_probs=152.5
Q ss_pred CCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 92 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
.+.+.+|.|+++.||++ ..+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 5 ~i~~~~~~~~~v~~~~~--~~~---------~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (314)
T cd08216 5 LIGKCFEDLMIVHLAKH--KPT---------NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE 73 (314)
T ss_pred hhhHhhcCCceEEEEEe--cCC---------CCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence 34444555555444443 332 778999998754 33455788999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.+++|||+++++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+.
T Consensus 74 ~~~~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~ 149 (314)
T cd08216 74 LYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSV 149 (314)
T ss_pred EEEEEeccCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCccce
Confidence 9999999999999999976432 34788899999999999999999 5899999999999999999999999999886
Q ss_pred cCCCCCC-----cceeeccCCcccccCcceecc--cCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGE-----SHVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~ll 297 (297)
.+..... ........++..|+|||++.. ..++.++|+|||||++|+|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~ 204 (314)
T cd08216 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204 (314)
T ss_pred eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHH
Confidence 5432211 111223457788999999875 35788999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=248.08 Aligned_cols=194 Identities=24% Similarity=0.270 Sum_probs=155.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCC-CCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 166 (297)
+|++.+.||+|+||.||++..... ..+..+|+|.+.... ....+.+.+|+.+++++. ||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 478889999999999999987642 115679999886432 222456788999999995 9999999987543
Q ss_pred C----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 167 D----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 167 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
. ...|+++||+. ++|.+++... ..+++..++.++.||+.||+||| ..||+||||||+|||++.++.+||
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEe
Confidence 2 45788999985 6899988654 45889999999999999999999 589999999999999999999999
Q ss_pred ccccccccCCCCCCc--ceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGES--HVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++........ .......||+.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~ 204 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999765432111 11233568999999998765 46888999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=278.38 Aligned_cols=184 Identities=31% Similarity=0.491 Sum_probs=155.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
....|....+||+|+||.||+|....+ +..||+|.+...... ...|++++++++||||+++++++.+
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~---------~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKN---------GMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCC---------CcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 345688889999999999999987544 778999998654322 1346889999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC-CCCceeccCCCCcEEEcCCCceEEccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-EKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
++..|+||||+++|+|.+++.. +++..+..|+.|++.||+|||.. ..+|+||||||+||+++.++..++. |
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 9999999999999999999952 78899999999999999999952 4699999999999999999888875 6
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|....... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 827 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~ 872 (968)
T PLN00113 827 SLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872 (968)
T ss_pred cccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHH
Confidence 65543211 12236889999999999999999999999999999985
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=241.01 Aligned_cols=190 Identities=31% Similarity=0.400 Sum_probs=159.0
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDK 168 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~ 168 (297)
|++.+.||+|++|+||+|..... ++.|++|.+..... .......+|+..+++++ ||||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~---------~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKET---------GELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCC---------CcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 67789999999999999987654 67899998865422 12234467999999999 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+ +++|.+++.... ...+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeecccc
Confidence 999999999 789999887653 135789999999999999999999 589999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .....++..|+|||++.. ..++.++|+||||+++++|+
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~ 193 (283)
T cd07830 147 REIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY 193 (283)
T ss_pred eeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHH
Confidence 76533211 223457889999998854 45788999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=256.47 Aligned_cols=186 Identities=24% Similarity=0.271 Sum_probs=158.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
....|.+...+|.|+|+.|-.+.+..+ ++..++|++.+.. ....+|+.++... +||||+++++++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t---------~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPT---------DQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeeeecccc---------ccchhheeccccc----cccccccchhhhhcCCCcceeecceec
Confidence 356788899999999999998876654 6778999998762 2235577666666 4999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE-cCCCceEEcc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL-DGNYNAKISD 244 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill-~~~~~~kl~D 244 (297)
+..+.|+|||++.|+.|.+.+.... .....+.+|+++|+.|+.||| ++|||||||||+|||+ ++.++++|+|
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEE
Confidence 9999999999999999888886542 223677889999999999999 5999999999999999 6899999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||.++..... ..+.+-|..|.|||++....|++++|+||||++||+||
T Consensus 460 FG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML 507 (612)
T KOG0603|consen 460 FGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEML 507 (612)
T ss_pred echhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHH
Confidence 9999876543 33456789999999999999999999999999999997
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=235.49 Aligned_cols=184 Identities=33% Similarity=0.434 Sum_probs=159.4
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
||+|+||.||++..... +..+++|.+..... .....+..|+.++++++||||+++++.+..++..+++
T Consensus 1 lg~G~~~~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKDT---------GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECCC---------CcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 68999999999987653 67899998876532 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 72 LEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 9999999999999765 35889999999999999999999 59999999999999999999999999999876533
Q ss_pred CCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 254 GGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 254 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.. .......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 146 ~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~ 187 (250)
T cd05123 146 EG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML 187 (250)
T ss_pred CC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 21 1233456889999999998888899999999999999875
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=240.47 Aligned_cols=190 Identities=30% Similarity=0.418 Sum_probs=161.3
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
|++.+.||+|.+|.||+|..... +..+++|.+.... ....+.+..|+.++++++|+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKT---------GEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCC---------CcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 56678899999999999977654 7789999987653 233466788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||++ ++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||+|+||++++++.+||+|||++
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCcc
Confidence 9999999997 59999998653 35889999999999999999999 589999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+....... ......++..|+|||.+.+. .++.++||||||+++|+|+
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 193 (282)
T cd07829 146 RAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193 (282)
T ss_pred cccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHH
Confidence 76543221 12233467889999998876 7889999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=239.95 Aligned_cols=191 Identities=28% Similarity=0.346 Sum_probs=156.8
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+.+..+.||-|+||.||.+.+..+ |+.|++|++..-.. ..-+++.+|+.+|..++|.|++..+++.+-.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRd---------grrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp 124 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRS---------GKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA 124 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCC---------ccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence 456678999999999998766654 88899998865322 2336788999999999999999999887654
Q ss_pred C-----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 168 K-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 168 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
. ++|+++|++. .+|..+|..- +.++.+.+.-+.+||++||+|||+ .+|.||||||.|+|++.+..+||
T Consensus 125 h~dfFqEiYV~TELmQ-SDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKI 197 (449)
T KOG0664|consen 125 NPSFFQELYVLTELMQ-SDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKI 197 (449)
T ss_pred CchHHHHHHHHHHHHH-hhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEe
Confidence 2 5788899884 4888887654 668888999999999999999995 99999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
||||+++.-...... ..+...-|.+|+|||++.|. .|+.+.||||.|||+.+||
T Consensus 198 CDFGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELL 252 (449)
T KOG0664|consen 198 CDFGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELL 252 (449)
T ss_pred cccccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHH
Confidence 999999864332222 22333468999999999985 5888999999999999986
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=261.64 Aligned_cols=197 Identities=28% Similarity=0.383 Sum_probs=168.5
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
..+..++||.|+||+||+|.|-.. .......||+|++... ..+...+++.|+-+|.+++|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pe-----ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPE-----GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecC-----CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 345568999999999999987643 2333567999987654 3445578999999999999999999999998765
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
+-||++|+++|.|.++++.++ ..+.....+.|..||+.||.||| ++++|||||..+|||+.+-..+||.|||++
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchh
Confidence 889999999999999998765 56778899999999999999999 799999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.+.............-.+.|||=|.+....|+.+|||||+||++||+|
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElm 894 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELM 894 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHH
Confidence 9887655443333334467899999999999999999999999999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=248.11 Aligned_cols=189 Identities=28% Similarity=0.344 Sum_probs=159.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|++|.||+|..... +..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKT---------GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCC---------CcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 356899999999999999999987654 678999988653 223345677899999999999999999988
Q ss_pred EcCCe------eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 165 WEDKE------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 165 ~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
...+. .++|+||+ +++|.+++.. ..+++..+..++.|++.||+||| +.||+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~ 155 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDC 155 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCC
Confidence 76554 89999999 6799998865 34899999999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 156 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell 210 (343)
T cd07851 156 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210 (343)
T ss_pred CEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHH
Confidence 9999999999764321 233467889999999865 36788999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=247.64 Aligned_cols=208 Identities=19% Similarity=0.199 Sum_probs=149.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCC-------ccccCCCCcEEEEEecCCcchhhHHH--------------HHHH
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTL-------APSKTGLGMVVAIKKLNPESMQGFEE--------------WQSE 145 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-------~~~~~~~~~~vaiK~~~~~~~~~~~~--------------~~~E 145 (297)
..++|++.++||+|+||+||+|....... .......++.||+|.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 46789999999999999999997533210 01122336789999986543222222 3346
Q ss_pred HHHhcCCCCCCc-----ccEEeEEEc--------CCeeEEEEEecCCCCHHHHHhhcCC--------------------C
Q 022413 146 VNFLGRLSHPNL-----VKLLGYCWE--------DKELLLVYEYMQRGSLENHLFRRNP--------------------S 192 (297)
Q Consensus 146 ~~~l~~l~h~nI-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~ 192 (297)
+.++.+++|.++ +++++++.. .+..|+||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 667776643 3568999999999999999874321 0
Q ss_pred CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCc
Q 022413 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272 (297)
Q Consensus 193 ~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 272 (297)
...+++..++.++.|++.+|.||| ..+|+||||||+|||++.++.+||+|||+++....... .......+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 123467788999999999999999 58999999999999999999999999999975433211 111122358999999
Q ss_pred ceecccCC--------------------c--ccccchhhhhhhhhcC
Q 022413 273 EYVATGNF--------------------Y--LLSAKFGNVINVCMYL 297 (297)
Q Consensus 273 E~~~~~~~--------------------~--~~sDvwslGv~l~~ll 297 (297)
|++..... . .+.|+||+||++|+|+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~ 426 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMC 426 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHH
Confidence 99864321 1 2469999999999985
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=254.79 Aligned_cols=205 Identities=30% Similarity=0.397 Sum_probs=166.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCC-CCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 165 (297)
.++..+.+.||+|.||.|++|......... ......||+|.++.. ...+.+.+..|+.+|+.+. ||||+.+++++.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 345567779999999999999766432111 122567999998754 3345678899999999996 999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcC---C-------CC--CCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRN---P-------SI--QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~---~-------~~--~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
....+++|+||+..|+|.+++...+ . .. ..++....+.++.||+.|++||+ +..+|||||..+|||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAARNVL 450 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhhhEE
Confidence 9999999999999999999998765 0 11 13888999999999999999999 488999999999999
Q ss_pred EcCCCceEEccccccccCCCCCCcceeeccCC--cccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMG--TYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.++..+||+|||+|+.......... ..-.| ...|||||.+....|+.+|||||+||+||+++
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF 515 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh
Confidence 99999999999999996544322211 11122 23499999999999999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=251.48 Aligned_cols=199 Identities=22% Similarity=0.202 Sum_probs=139.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeE---
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGY--- 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~--- 163 (297)
..++|++.++||+|+||.||+|.+..+.. ..+..||+|++...... +.+..| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45789999999999999999998875421 22678999987643321 111111 1222222233222221
Q ss_pred ---EEcCCeeEEEEEecCCCCHHHHHhhcCCC----------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCcee
Q 022413 164 ---CWEDKELLLVYEYMQRGSLENHLFRRNPS----------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY 224 (297)
Q Consensus 164 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH 224 (297)
.......++||||+.+++|.+++...... ........+..++.||+.||+||| +.+|+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 23456899999999999999998754210 011123456689999999999999 589999
Q ss_pred ccCCCCcEEEcC-CCceEEccccccccCCCCCCcceeeccCCcccccCcceeccc----------------------CCc
Q 022413 225 RDFKASNILLDG-NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG----------------------NFY 281 (297)
Q Consensus 225 ~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 281 (297)
|||||+|||++. ++.+||+|||+++.+.... ........+++.|+|||++... .++
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999986 5899999999998654322 1223456789999999976432 233
Q ss_pred ccccchhhhhhhhhcC
Q 022413 282 LLSAKFGNVINVCMYL 297 (297)
Q Consensus 282 ~~sDvwslGv~l~~ll 297 (297)
.++|||||||+||+|+
T Consensus 358 ~k~DVwSlGviL~el~ 373 (566)
T PLN03225 358 DRFDIYSAGLIFLQMA 373 (566)
T ss_pred CCcccHHHHHHHHHHH
Confidence 4569999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=252.13 Aligned_cols=188 Identities=23% Similarity=0.298 Sum_probs=157.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|.+.++||+|+||+||+|++... ++.||+|++.... ......+..|+.+++.++||||+++++++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---------~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 73 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNN---------SKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCC---------CcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence 46799999999999999999987754 7789999987542 23346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
...+.+|+||||+.+++|.+++... ..+++..++.|+.||+.||+||| ..+||||||||+||||+.++.+||+|
T Consensus 74 ~~~~~~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~D 147 (669)
T cd05610 74 QSANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTD 147 (669)
T ss_pred EECCEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEe
Confidence 9999999999999999999999765 45788999999999999999999 48999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccC-Ccccccchhhhhh
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVIN 292 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~ 292 (297)
||+++...... .......+|+.|++||...... -...+++|++|+-
T Consensus 148 FGls~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 148 FGLSKVTLNRE--LNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN 194 (669)
T ss_pred CCCCccccCCc--ccccccccCccccCccccccCCCCceeeeeeecCcC
Confidence 99998653321 1233467899999999765433 3346788888853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=215.95 Aligned_cols=192 Identities=31% Similarity=0.411 Sum_probs=164.1
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
|.+.+.||.|++|.||++...+. +..+++|.+...... ..+.+.+|++.+++++|+|++++++++...+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~---------~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGT---------GELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCC---------CcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 56778999999999999987753 677999999876544 56788899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.++++||+++++|.+++..... .+++..+..++.+++.++.||| +.+++|+||+|.||+++.++.++|+|||++.
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 9999999999999999986531 1788999999999999999999 5899999999999999999999999999988
Q ss_pred cCCCCCCcceeeccCCcccccCccee-cccCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYV-ATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGv~l~~ll 297 (297)
....... .......++..|++||.+ ....++.++|+|+||+++++|+
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~ 194 (225)
T smart00221 147 FIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELL 194 (225)
T ss_pred EecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH
Confidence 6543320 012334678899999998 6677888999999999999874
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=226.77 Aligned_cols=195 Identities=26% Similarity=0.358 Sum_probs=157.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
...|+...+||+|.||+||+|+.... ++.||+|++.-+ +.-.-....+|+.+|..|.|+|++.+++.|.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~---------~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNT---------GKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCc---------cchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 45677788999999999999866553 777888876432 2222245689999999999999999988875
Q ss_pred c--------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 166 E--------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 166 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
. ...+|+|+.+|+. +|.-+|.... ..++..++.+++.+++.||.|+| +..|+|||+||+|+||+.+
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~d 160 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKD 160 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCC
Confidence 3 2359999999965 8988887654 56888999999999999999999 5889999999999999999
Q ss_pred CceEEccccccccCCCCCCc--ceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGES--HVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|.+||+|||+++.+....+. ...+..+-|..|++||.+.+ ..|+++-|+|+-|||+.+|.
T Consensus 161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw 223 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW 223 (376)
T ss_pred ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH
Confidence 99999999999765433221 12233455999999999987 45888999999999999873
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=225.99 Aligned_cols=133 Identities=24% Similarity=0.343 Sum_probs=114.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-----C---CCccc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-----H---PNLVK 159 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~ 159 (297)
..+|.+.++||-|-|++||+|++... .+.||+|+.+..... .+....|+.+|++++ | ..||+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~---------~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQN---------KRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccC---------CeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 36899999999999999999988765 688999998766443 256688999999884 2 36999
Q ss_pred EEeEEEcC----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 160 LLGYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 160 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
|++.|... .++++|+|++ |.+|..+|..... +.++...+++|++||+.||.|||. +.||||-||||+|||+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLL 221 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeee
Confidence 99999754 5899999999 8899999987654 558889999999999999999998 8999999999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=245.12 Aligned_cols=190 Identities=29% Similarity=0.372 Sum_probs=153.3
Q ss_pred CCCCceecccCceE-EEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCC
Q 022413 91 FKPDSLLGEGGFGR-VYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDK 168 (297)
Q Consensus 91 y~~~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~ 168 (297)
|.-.+++|.|+-|+ ||+|.+. ++.||||.+-.+.. ...++|+..|+.-+ |||||++|+.-.++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44457789998875 8999887 67899998865543 44578999999886 999999999888999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-----CCceEEc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-----NYNAKIS 243 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-----~~~~kl~ 243 (297)
++||++|.| ..+|.+++...............+.+..|++.||++||+ .+||||||||.||||.. ..+++|.
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEec
Confidence 999999999 569999998741111111114456788999999999995 99999999999999965 2568999
Q ss_pred cccccccCCCCCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++++..+..+. ......||-+|+|||++.....+.+.|+|||||++|+.|
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvl 708 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVL 708 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEe
Confidence 999999886654322 234567999999999999988888999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=244.69 Aligned_cols=193 Identities=28% Similarity=0.405 Sum_probs=168.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|.++..+|.|+||.||++++... +...|+|.++.+...++.-+++|+-+++..+||||+.+++.+..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s---------~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRS---------GELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CccchhheeeecCCcccchhhhccccc---------CchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh
Confidence 456899999999999999999976554 78899999988776677788899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+.+|++||||.||+|.+.-+-. .++.+.++..++++.+.||+|||+ .|-+|||||-.|||+++.|.+|++|||
T Consensus 84 ~dklwicMEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvklaDfg 157 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKLADFG 157 (829)
T ss_pred hcCcEEEEEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceeecccC
Confidence 99999999999999999987655 678999999999999999999994 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhc
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~l 296 (297)
.+..+... ......+.|||+|||||+-. .+.|...+|+|++|+...+|
T Consensus 158 vsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 158 VSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred chhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 98654332 12344578999999999864 46788999999999887664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=212.29 Aligned_cols=187 Identities=19% Similarity=0.302 Sum_probs=154.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 165 (297)
..++|++.+++|+|.+++||.|+...+ ...++||++++-.. +.+.+|+.||..|. ||||++++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~---------~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITN---------NEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCC---------CceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 356899999999999999999975543 56789999987654 56788999999998 999999999998
Q ss_pred cC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEE
Q 022413 166 ED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKI 242 (297)
Q Consensus 166 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl 242 (297)
++ ....++.||+.+.+...+. +.++...++.++.+++.||.|||| .||.|||+||.|++||. ...++|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred CccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeechhhceeee
Confidence 76 4688999999887776654 347778888999999999999995 99999999999999986 567999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+|+|+|..+..+... +-...+..|--||.+-. ..|+..=|+|||||++..|+
T Consensus 175 IDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi 227 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 227 (338)
T ss_pred eecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHH
Confidence 999999887654332 22345678899999876 44667779999999998874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=214.14 Aligned_cols=179 Identities=34% Similarity=0.469 Sum_probs=155.9
Q ss_pred CceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh-HHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEEEecCC
Q 022413 101 GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQR 179 (297)
Q Consensus 101 ~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 179 (297)
+||.||+|....+ +..+++|.+....... .+.+.+|++.+++++|+||+++++.+......++++||+++
T Consensus 1 ~~g~v~~~~~~~~---------~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKT---------GKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCC---------CcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 5899999987653 6789999988665433 57889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcce
Q 022413 180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259 (297)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 259 (297)
++|.+++.... .+++..+..++.+++.++.||| +.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 72 ~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 72 GDLFDLLKKRG----RLSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred CCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 99999987652 2788999999999999999999 5899999999999999999999999999998654321 2
Q ss_pred eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 260 TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 260 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.....++..|++||.+.+..++.++|+|+||+++|+|+
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~ 180 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELL 180 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 23456889999999998888999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=222.66 Aligned_cols=167 Identities=20% Similarity=0.179 Sum_probs=129.7
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-----chhhHHHHHHHHHHhcCCCCCCccc-
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQSEVNFLGRLSHPNLVK- 159 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~- 159 (297)
....+|.+.+.||+|+||+||+|.+.... ++.+|+|++... .....+.+.+|+++|++++|+||++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~--------~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDP--------GTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCC--------CeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 34678999999999999999999876422 667899986533 1223466899999999999999985
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccC-CCCcEEEcCCC
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF-KASNILLDGNY 238 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dl-kp~Nill~~~~ 238 (297)
+++ .+..|+||||++|++|.. +.. .. ...++.+++.||.||| +.||+|||| ||+|||++.++
T Consensus 87 l~~----~~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~~~ 149 (365)
T PRK09188 87 LLA----TGKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGPDG 149 (365)
T ss_pred EEE----cCCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcCCC
Confidence 443 246899999999999963 211 11 1357889999999999 599999999 99999999999
Q ss_pred ceEEccccccccCCCCCCcce------eeccCCcccccCcceecc
Q 022413 239 NAKISDFGLAKLGPAGGESHV------TTRVMGTYGYAAPEYVAT 277 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 277 (297)
.+||+|||+|+.+...+.... .....+++.|+|||.+.-
T Consensus 150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999999987654332111 135678999999999864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-31 Score=216.70 Aligned_cols=188 Identities=26% Similarity=0.304 Sum_probs=154.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..+|.-++.+|.|.- .|--+.+ .-.++.||+|++... .....++..+|..++..+.|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D---------~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFD---------QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEecch---------hhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 457888889999887 4544432 223778999987543 2233467789999999999999999999886
Q ss_pred cC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 ED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
-. ...|+||||+ ..+|.+.+... ++-.....|+.|++.|++|||+ .||+||||||+||++..++.
T Consensus 86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred ccccHHHHHhHHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhh
Confidence 43 4689999999 55999988733 7778889999999999999995 99999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+|+.-.. ....+....|..|.|||++.+..+....||||+||++.+|+
T Consensus 157 lKi~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 157 LKILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELI 211 (369)
T ss_pred eeeccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHh
Confidence 99999999985322 22344567899999999999999999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=218.72 Aligned_cols=210 Identities=21% Similarity=0.244 Sum_probs=168.6
Q ss_pred HHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccE
Q 022413 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKL 160 (297)
Q Consensus 82 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~ 160 (297)
.++.....+++...++.+|.||.||+|+|.+.+ .....+.|.+|.++.. ++-+...++.|.-.+..+.|||+.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEd----t~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREED----TYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccC----CcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 344445667888899999999999999887632 2222456777877654 44456788999999999999999999
Q ss_pred EeEEEcC-CeeEEEEEecCCCCHHHHHhhcCC----CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 161 LGYCWED-KELLLVYEYMQRGSLENHLFRRNP----SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 161 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
.++..+. ...++++.+...|+|..++...+. ..+.++..+...++.|++.|++||| +.||||.||..+|.+||
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCVID 430 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcceeh
Confidence 9997654 678999999999999999984322 2245667788889999999999999 59999999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+..++||+|=.++|.+-..+.......--....||+||.+.+..|+.+||||||||+||||+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELm 492 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELM 492 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHH
Confidence 99999999999998765544332222222356799999999999999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=209.13 Aligned_cols=189 Identities=21% Similarity=0.285 Sum_probs=152.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeE-E
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGY-C 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~-~ 164 (297)
..+.|.+.+.||+|.||.+-++.++.. ...+++|.+..... .+++|.+|...--.|. |.||+.-|++ |
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s---------~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQS---------KTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCC---------ceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 356799999999999999999987764 67799998876543 3478999998877775 9999998887 5
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc--CCCceEE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GNYNAKI 242 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~--~~~~~kl 242 (297)
+..+.+++++||++.|+|..-+... .+.+.....++.|++.|+.|||+ .++||||||.+||||- +..++||
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred hcCceEEEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEe
Confidence 5668899999999999999887653 37788889999999999999995 8999999999999993 3468999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceeccc---C--CcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG---N--FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~--~~~~sDvwslGv~l~~ll 297 (297)
||||+.+..... .....-+..|.+||++... . ..+.+|+|.||+++|..|
T Consensus 165 cDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl 219 (378)
T KOG1345|consen 165 CDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL 219 (378)
T ss_pred eecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence 999998764322 1222346789999987642 2 346789999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=200.38 Aligned_cols=184 Identities=38% Similarity=0.542 Sum_probs=157.4
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYE 175 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 175 (297)
||+|.+|.||++..... +..+++|.+...... ..+.+.+|+..++.+.|++|+++++++......++++|
T Consensus 1 l~~g~~~~v~~~~~~~~---------~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKT---------GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCC---------CcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 68999999999987653 678999998876442 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEEccccccccCCCC
Q 022413 176 YMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDFGLAKLGPAG 254 (297)
Q Consensus 176 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~ 254 (297)
|+++++|.+++.... ..+++..+..++.+++.++++|| +.+++|+||+|.||+++. ++.++|+|||.+......
T Consensus 72 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 72 YCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred cCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 999899999987642 35788999999999999999999 589999999999999999 899999999998765432
Q ss_pred CCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhc
Q 022413 255 GESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 255 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~l 296 (297)
.. ......+...|++||.+... .++.++|+|+||+++++|
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 21 12334578899999999876 788899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=222.37 Aligned_cols=191 Identities=20% Similarity=0.228 Sum_probs=158.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC------CCCcccEEe
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS------HPNLVKLLG 162 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~~ 162 (297)
.+|.+....|+|-|++|-+|.+... |..||||+|....... +.=+.|++||++|. --|+++++.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r---------~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQAR---------GQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCC---------CCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 4677888889999999999876653 7789999998764332 45578999999995 347999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAK 241 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~k 241 (297)
.|...+++|||+|-+ ..+|.+.|...... ..+....+..++.|++.||..|- ..||+|.||||+|||+++ ...+|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEeccCcceee
Confidence 999999999999998 66999999876543 44778889999999999999999 699999999999999987 46789
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||||.|.....+. .+.+.-+..|.|||++.|-.|+..-|+||.||+||+|.
T Consensus 578 LCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElY 629 (752)
T KOG0670|consen 578 LCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELY 629 (752)
T ss_pred eccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEee
Confidence 99999987654322 12233456799999999999999999999999999973
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=211.12 Aligned_cols=195 Identities=24% Similarity=0.298 Sum_probs=159.5
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYC 164 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 164 (297)
...+.|.+..+||+|.|++||++..... ....+.||+|.+.....- .++.+|+++|..+. +.||+++.+.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhh
Confidence 3456799999999999999999976652 123778999999876543 67899999999997 99999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEEc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKIS 243 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl~ 243 (297)
..+++..+||||++.....++... ++...+..+++.++.||.++| ..|||||||||.|+|.+. -+.-.|+
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCceEE
Confidence 999999999999999998888753 667888999999999999999 599999999999999975 5778999
Q ss_pred cccccccCC-----------------C-CCCc------------------------ceeeccCCcccccCcceecc-cCC
Q 022413 244 DFGLAKLGP-----------------A-GGES------------------------HVTTRVMGTYGYAAPEYVAT-GNF 280 (297)
Q Consensus 244 Dfg~a~~~~-----------------~-~~~~------------------------~~~~~~~gt~~y~aPE~~~~-~~~ 280 (297)
|||+|.... . .+.. .......||++|+|||++.. ...
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999996211 0 0000 00112469999999999875 457
Q ss_pred cccccchhhhhhhhhcC
Q 022413 281 YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 281 ~~~sDvwslGv~l~~ll 297 (297)
+++.||||.|||++.+|
T Consensus 256 ttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLL 272 (418)
T ss_pred CCccceeeccceeehhh
Confidence 78999999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=203.54 Aligned_cols=195 Identities=24% Similarity=0.193 Sum_probs=158.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCC----CCcccEEeEE-
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH----PNLVKLLGYC- 164 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~~~~~~- 164 (297)
+|++.+.||+|+||.||++...... ...+|+|............+..|+.++..+.. +++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 7999999999999999999876531 34688888765433222256778888888873 6899999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC-----Cc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-----YN 239 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~-----~~ 239 (297)
..+...|+||+.+ |.+|.++..... ...++..+++.|+.|++.+|.+|| +.|++||||||+|+++... ..
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccce
Confidence 5778899999988 999999876543 366999999999999999999999 5999999999999999864 46
Q ss_pred eEEccccccccCC--CCCCc------ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGP--AGGES------HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~--~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.|.|||+++... ..... .....+.||..|+++.+..+...+.+.|+|||+.++.+|+
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~ 231 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELL 231 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHh
Confidence 9999999998332 11110 0123456999999999999999999999999999998874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-27 Score=227.89 Aligned_cols=141 Identities=15% Similarity=0.130 Sum_probs=107.4
Q ss_pred CCCC-CCcccEEeEE-------EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCc
Q 022413 151 RLSH-PNLVKLLGYC-------WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKV 222 (297)
Q Consensus 151 ~l~h-~nIv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~i 222 (297)
.++| +||..+++++ .+...+++++||+ +++|.++|.... ..+++..++.++.||+.||+||| ++||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAH--SQGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHH--hCCe
Confidence 3445 5777787776 2334678889987 669999997532 55899999999999999999999 5999
Q ss_pred eeccCCCCcEEEcC-------------------CCceEEccccccccCCCCCC--------------cceeeccCCcccc
Q 022413 223 IYRDFKASNILLDG-------------------NYNAKISDFGLAKLGPAGGE--------------SHVTTRVMGTYGY 269 (297)
Q Consensus 223 vH~Dlkp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y 269 (297)
+||||||+||||+. ++.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666666653211000 0001124589999
Q ss_pred cCcceecccCCcccccchhhhhhhhhcC
Q 022413 270 AAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 270 ~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||||++.+..++.++|||||||+||+||
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl 209 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELF 209 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHh
Confidence 9999999999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=187.80 Aligned_cols=170 Identities=12% Similarity=0.103 Sum_probs=131.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh---HHH------HHHHHHHhcCCCCCCc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEE------WQSEVNFLGRLSHPNL 157 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~------~~~E~~~l~~l~h~nI 157 (297)
..++|++.++||.|+||.||+.... +..+|+|.+.+..... ..+ +.+|+..+.++.||+|
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~-----------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI 97 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD-----------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL 97 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC-----------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC
Confidence 4678999999999999999985432 4469999997653322 222 5789999999999999
Q ss_pred ccEEeEEEcC--------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCC
Q 022413 158 VKLLGYCWED--------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKA 229 (297)
Q Consensus 158 v~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp 229 (297)
..+.+++... ...+++|||++|.+|.++.. +++ ....+++.+|..|| +.|++|||+||
T Consensus 98 ~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH--~~gi~H~Dikp 163 (232)
T PRK10359 98 ASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH--QHGMVSGDPHK 163 (232)
T ss_pred CcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH--HcCCccCCCCh
Confidence 9999987644 35899999999999988731 222 24568899999999 59999999999
Q ss_pred CcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhc
Q 022413 230 SNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 230 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
+||+++.++ ++|+|||..+....... . ..++....|..++|+|+|||.+..+
T Consensus 164 ~Nili~~~g-i~liDfg~~~~~~e~~a---~-----------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 164 GNFIVSKNG-LRIIDLSGKRCTAQRKA---K-----------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred HHEEEeCCC-EEEEECCCcccccchhh---H-----------HHHHHHhHhcccccccceeEeehHH
Confidence 999999888 99999998765421110 0 1144455677789999999988653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=187.28 Aligned_cols=192 Identities=22% Similarity=0.208 Sum_probs=160.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~ 167 (297)
-.|+++++||+|+||+++.|...- +++.||||.-...... -.+..|-...+.|. .++|..+|-+..++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecccccc---------cCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 479999999999999999996543 3789999986544322 34556788888876 79999999888888
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-----CCceEE
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-----NYNAKI 242 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-----~~~~kl 242 (297)
.+-.||||++ |.+|+++..-+. +.++.+++..||.|++.-++|+| ++.+|+|||||+|+||.. ...+.|
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi 170 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIHI 170 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEEE
Confidence 8999999999 999999987654 66999999999999999999999 589999999999999964 345899
Q ss_pred ccccccccCCCCCCcc-----eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESH-----VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+|+.+.+..... ......||..||+=-...+...+...|+-|||-++++.|
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence 9999999876654321 123467999999999999999999999999999887754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=181.91 Aligned_cols=193 Identities=21% Similarity=0.195 Sum_probs=161.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 165 (297)
....|.++++||.|+||.+|+|..... |..||||.-...... -.+..|..+.+.|+ ...|+.+..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~---------ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITS---------GEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccC---------CceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhcc
Confidence 456899999999999999999977654 889999987654322 34577999999998 578888888899
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc---CCCceEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GNYNAKI 242 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~---~~~~~kl 242 (297)
+...-.+||+++ |.+|++++.-.. +.++..+++-++-|++.-++|+| .+++|||||||+|+|.. ....+.|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEE
Confidence 999999999999 999999987554 56899999999999999999999 59999999999999995 3567999
Q ss_pred ccccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhc
Q 022413 243 SDFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
+|||+++.+.+.... .......||..|.+--...+...+...|+-|+|.+|.++
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYf 214 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYF 214 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeee
Confidence 999999887554321 123446799999998888888888899999999998764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-25 Score=179.57 Aligned_cols=138 Identities=17% Similarity=0.171 Sum_probs=106.6
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh--h------------------------HHHHHHHHH
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--G------------------------FEEWQSEVN 147 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~E~~ 147 (297)
...||+|+||.||+|... + |+.||+|+++..... . ......|+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~---------g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA-N---------GEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC-C---------CCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 468999999999999765 2 788999998654211 0 012245999
Q ss_pred HhcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcch-hcCCCCceecc
Q 022413 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL-HTSEKKVIYRD 226 (297)
Q Consensus 148 ~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yL-H~~~~~ivH~D 226 (297)
++.++.++++.....+.. ...++||||++|+++...+... ..+++..+..++.|++.+|.|| | ..||+|||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrD 143 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQ--DCRLVHAD 143 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCC
Confidence 999998877644433322 2348999999887776553332 4588899999999999999999 6 48999999
Q ss_pred CCCCcEEEcCCCceEEcccccccc
Q 022413 227 FKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 227 lkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
|||+|||++ ++.++|+|||++..
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CCHHHEEEE-CCcEEEEEcccccc
Confidence 999999998 57899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=187.85 Aligned_cols=191 Identities=36% Similarity=0.498 Sum_probs=158.3
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh---hHHHHHHHHHHhcCCCCC-CcccEEeEEEc
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ---GFEEWQSEVNFLGRLSHP-NLVKLLGYCWE 166 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~ 166 (297)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 667889999999999999766 34788888765332 357889999999999988 79999999988
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-ceEEccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKISDF 245 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-~~kl~Df 245 (297)
....+++++|+.++++.+++...... ..+.......+..|++.++.|+| +.+++|||+||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEecc
Confidence 77889999999999999776654211 25888999999999999999999 58899999999999999988 7999999
Q ss_pred cccccCCCCCCcc----eeeccCCcccccCcceecc---cCCcccccchhhhhhhhhc
Q 022413 246 GLAKLGPAGGESH----VTTRVMGTYGYAAPEYVAT---GNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 246 g~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~~l 296 (297)
|+++......... ......||..|+|||.+.+ ..+....|+|++|++++.+
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~ 204 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHH
Confidence 9998554332211 2355689999999999987 5788899999999888764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=173.34 Aligned_cols=142 Identities=18% Similarity=0.160 Sum_probs=110.1
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh--h------------------------HHHHHHHH
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--G------------------------FEEWQSEV 146 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~E~ 146 (297)
+.+.||+|++|.||+|... + |+.||+|.++..... . ...+..|.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~---------g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 70 (190)
T cd05145 1 INGCISTGKEANVYHARTG-D---------GEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF 70 (190)
T ss_pred CCceeecCCCcEEEEEEcC-C---------CCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence 3578999999999999765 2 788999998754210 0 12345789
Q ss_pred HHhcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceecc
Q 022413 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRD 226 (297)
Q Consensus 147 ~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~D 226 (297)
..+.++.|++|.....+.... .++||||++|+++....... ..++...+..++.|++.++.+||+ +.||+|||
T Consensus 71 ~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrD 143 (190)
T cd05145 71 RNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGD 143 (190)
T ss_pred HHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCC
Confidence 999999999886555444332 48999999887654432222 346788899999999999999994 38999999
Q ss_pred CCCCcEEEcCCCceEEccccccccCC
Q 022413 227 FKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 227 lkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
|||+|||++ ++.++|+|||+++...
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999 8999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=166.18 Aligned_cols=137 Identities=16% Similarity=0.185 Sum_probs=105.2
Q ss_pred CCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-----CCCCcccEEeEEEc
Q 022413 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-----SHPNLVKLLGYCWE 166 (297)
Q Consensus 92 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~ 166 (297)
.-.++||+|+||.||. +..+ +.. +||++........+.+.+|+.+++.+ .||||+++++++++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~---------~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPED---------AQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEE--CCCC---------cCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 3457899999999995 3332 333 68887765444457789999999999 57999999999988
Q ss_pred CC---e-eEEEEEe--cCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh-cchhcCCCCceeccCCCCcEEEcC---
Q 022413 167 DK---E-LLLVYEY--MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL-GFLHTSEKKVIYRDFKASNILLDG--- 236 (297)
Q Consensus 167 ~~---~-~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al-~yLH~~~~~ivH~Dlkp~Nill~~--- 236 (297)
.. . +.+|||| +.+++|.+++.+. .+++. ..++.+++.++ +||| +.+||||||||+|||++.
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~ 143 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISE 143 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCC
Confidence 73 4 3478999 5579999999653 25544 35677888787 9999 599999999999999974
Q ss_pred -CCceEEccccccc
Q 022413 237 -NYNAKISDFGLAK 249 (297)
Q Consensus 237 -~~~~kl~Dfg~a~ 249 (297)
++.++|+||+.++
T Consensus 144 ~~~~~~LiDg~G~~ 157 (210)
T PRK10345 144 SEVIPVVCDNIGES 157 (210)
T ss_pred CCCcEEEEECCCCc
Confidence 3489999954443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=200.10 Aligned_cols=190 Identities=22% Similarity=0.233 Sum_probs=153.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC---CCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~ 165 (297)
..|.|.+.||+|+||+||+|...+ |+.||+|.-.+...+.+- .=.+++.+|+ -+-|+.+.....
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHc
Confidence 467788899999999999997664 788999998887665431 1222333443 355667777777
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc-------CCC
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-------GNY 238 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~-------~~~ 238 (297)
-.+.-++|+||.+.|+|.+++... ..+++..++.+..|++.-++.|| ..+|||+||||+|+||. ...
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred cCCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCCccc
Confidence 778889999999999999999844 56899999999999999999999 69999999999999993 234
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
-++|+|||.+..+..-.........++|-.+-++|+..|+.|++..|.|+|+.+++.||
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL 897 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVML 897 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHH
Confidence 58999999986543322333566678899999999999999999999999999999886
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-24 Score=197.01 Aligned_cols=194 Identities=25% Similarity=0.255 Sum_probs=149.0
Q ss_pred CCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEec-CCcchhh-HHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 92 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~-~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
....++|.|++|.|+....... .+......+++| . ....... ...+..|+.+-..|.|||++..+..+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~----~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSD----LKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCC----Cccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 4567899999997776544332 111112223333 1 1122211 1236778888889999999888888877776
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
.+-.||||++ +|..++... ..+....+..++.|++.|++||| ..||.||||||+|+++..+|.+||+|||.+.
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred chhhhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeecCcce
Confidence 6667999999 999999765 34777888899999999999999 5999999999999999999999999999997
Q ss_pred cCCCCCCc--ceeeccCCcccccCcceecccCCcc-cccchhhhhhhhhcC
Q 022413 250 LGPAGGES--HVTTRVMGTYGYAAPEYVATGNFYL-LSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslGv~l~~ll 297 (297)
......+. .....++|+.+|+|||++.+..|.+ ..||||.|++++.|.
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~ 519 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI 519 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe
Confidence 65544433 4456688999999999999999987 579999999999874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=162.48 Aligned_cols=176 Identities=19% Similarity=0.119 Sum_probs=127.3
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh----hHHHHHHHHHHhcCCC-CCCcccEEeEEEcC
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ----GFEEWQSEVNFLGRLS-HPNLVKLLGYCWED 167 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~ 167 (297)
+...|++|.||+||++... +..++.+.+...... ....+.+|+++|++|. |++|++++++
T Consensus 6 ~~~~l~~~~f~~v~~~~~~-----------~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---- 70 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGG-----------ERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---- 70 (218)
T ss_pred cceeecCCCcceEEEeecC-----------CceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----
Confidence 4578999999999976432 556776766544321 1135789999999996 5889999886
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccC-CCCcEEEcCCCceEEcccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF-KASNILLDGNYNAKISDFG 246 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg 246 (297)
+..+++|||+.|.+|.+.+.. ....++.|++.+|.++| +.||+|||| ||+|||++.++.++|+|||
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG 137 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQ 137 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECC
Confidence 457999999999988654311 11346789999999999 599999999 7999999999999999999
Q ss_pred ccccCCCCCCc----ce-------eeccCCcccccCcceeccc-CCc-ccccchhhhhhhhhc
Q 022413 247 LAKLGPAGGES----HV-------TTRVMGTYGYAAPEYVATG-NFY-LLSAKFGNVINVCMY 296 (297)
Q Consensus 247 ~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslGv~l~~l 296 (297)
++......... .. ..-...++.|++|+.-.-- ..+ ...+.++.|.-+|.+
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~ 200 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRF 200 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHH
Confidence 99865443310 00 0112368888888765432 333 355777888888865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=164.89 Aligned_cols=144 Identities=16% Similarity=0.133 Sum_probs=110.3
Q ss_pred hcCCCCCceecccCceEEEEEE-ECCCCCccccCCCCcEEEEEecCCcchh------------------------hHHHH
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGW-VDDKTLAPSKTGLGMVVAIKKLNPESMQ------------------------GFEEW 142 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~ 142 (297)
...|.+.+.||+|+||.||+|. ...+ |+.||+|.+...... ....+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~---------g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGS---------GKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA 97 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCC---------CcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence 3458899999999999999997 3322 788999988643210 11235
Q ss_pred HHHHHHhcCCCCC--CcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCC
Q 022413 143 QSEVNFLGRLSHP--NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK 220 (297)
Q Consensus 143 ~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~ 220 (297)
.+|+.++.++.+. .+++++++ ...++||||++|.+|....... ..+....+..++.|++.+|++|| ..
T Consensus 98 ~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH--~~ 167 (237)
T smart00090 98 EKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLY--KE 167 (237)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHH--hc
Confidence 6899999999753 34444442 2458999999998887654332 23555667889999999999999 58
Q ss_pred C-ceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 221 K-VIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 221 ~-ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
| |+||||||+||+++ ++.++|+|||.+...
T Consensus 168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 8 99999999999999 889999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-23 Score=187.23 Aligned_cols=182 Identities=26% Similarity=0.323 Sum_probs=147.8
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEE
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLL 172 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~l 172 (297)
++|+|+||.|+++.--. ....+..+|+|...+... ........|..++...+ ||.+++++-.++.+..+++
T Consensus 1 vlg~g~~gkvfLvrk~~------g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAG------GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhc------cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 37899999999763221 112266788888765421 11124456888888888 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC
Q 022413 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 173 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
+++|+.||+|...+... ..+++.....+..+++.+++++| +.+|+|||+|++||+++.+|++++.|||+++...
T Consensus 75 ~ld~~rgg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKE----VMFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhhhcccchhhhccccC----CchHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhH
Confidence 99999999998888765 55777888888899999999999 6999999999999999999999999999998654
Q ss_pred CCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 253 AGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 253 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.... .|||..|||||++. ....++|.||+|+++|+||
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~fell 185 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELL 185 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHh
Confidence 3221 28999999999997 4556889999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.6e-22 Score=158.53 Aligned_cols=98 Identities=22% Similarity=0.198 Sum_probs=85.4
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcce
Q 022413 180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259 (297)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 259 (297)
|+|.+++..+. ..+++..++.|+.|++.||+|||+ .+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeeccc-----
Confidence 68999997643 459999999999999999999995 54 999999999999999 9998764321
Q ss_pred eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 260 TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 260 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 98 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL 98 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence 125899999999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=157.91 Aligned_cols=135 Identities=23% Similarity=0.340 Sum_probs=112.4
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
+.||+|++|.||+|.+. +..+++|....... ....++.+|+.++..+.|++|+....++.+
T Consensus 2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 57999999999999764 45688887553221 112457789999999999998888777777
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
....+++|||++|++|.+++.... . .+..++.+++.+|.+|| ..+++|||++|.|||++ ++.++|+|||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECC
Confidence 888999999999999999986531 1 77889999999999999 58999999999999999 7899999999
Q ss_pred ccccC
Q 022413 247 LAKLG 251 (297)
Q Consensus 247 ~a~~~ 251 (297)
+++..
T Consensus 140 ~a~~~ 144 (211)
T PRK14879 140 LAEFS 144 (211)
T ss_pred cccCC
Confidence 98753
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.9e-21 Score=176.45 Aligned_cols=138 Identities=21% Similarity=0.263 Sum_probs=111.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEec-CCc-------chhhHHHHHHHHHHhcCCCCCCccc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPE-------SMQGFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
...|...++||+|+||+||+|.+... .+++|+. .+. .....+++.+|+++++.++|++|+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 400 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence 34567789999999999999877643 1233321 111 1112356889999999999999998
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
...+..+....++||||++|++|.+++. ....++.+++.+|.||| +.+++||||||+|||+ .++.
T Consensus 401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred eEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECCc
Confidence 8888877778899999999999998875 24568899999999999 5999999999999999 6789
Q ss_pred eEEccccccccC
Q 022413 240 AKISDFGLAKLG 251 (297)
Q Consensus 240 ~kl~Dfg~a~~~ 251 (297)
++|+|||+++..
T Consensus 466 ~~liDFGla~~~ 477 (535)
T PRK09605 466 LYLIDFGLGKYS 477 (535)
T ss_pred EEEEeCcccccC
Confidence 999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=154.10 Aligned_cols=131 Identities=24% Similarity=0.346 Sum_probs=105.5
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------hhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+||+|+||.||+|.+. +..+++|....... ....++.+|+.++..+.|+++....-++...
T Consensus 1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 4899999999999754 45688887543211 1235677899999999988766665566667
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..+++|||++|++|.+++.... . .++.+++.+|.+|| ..|++|+|++|.||+++ ++.++++|||+
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN-----D------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH-----H------HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCC
Confidence 77899999999999998875431 0 68899999999999 59999999999999999 89999999999
Q ss_pred cccC
Q 022413 248 AKLG 251 (297)
Q Consensus 248 a~~~ 251 (297)
++..
T Consensus 136 a~~~ 139 (199)
T TIGR03724 136 GKYS 139 (199)
T ss_pred CcCC
Confidence 8764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-22 Score=175.82 Aligned_cols=123 Identities=25% Similarity=0.338 Sum_probs=104.1
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
.+||.|++|...+|.++|..+... ...++...+.++.|++.|++| ++.+|||+||.||++..+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999755433 446778889999999999999 67999999999999999999999999998
Q ss_pred ccCCCCC----CcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGG----ESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
....... .....+...||..||+||++.+..|+.++|||+||++|++|+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~ 456 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELL 456 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHH
Confidence 7554332 111234567999999999999999999999999999999985
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.2e-20 Score=148.66 Aligned_cols=136 Identities=19% Similarity=0.077 Sum_probs=105.5
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch----------------------hhHHHHHHHHH
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----------------------QGFEEWQSEVN 147 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~E~~ 147 (297)
.|.+.+.||+|+||.||++...+ |+.+|+|.+..... ........|..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~----------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPD----------GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCC----------CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 48888999999999999987542 77899998654220 00123567899
Q ss_pred HhcCCCCC--CcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceec
Q 022413 148 FLGRLSHP--NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225 (297)
Q Consensus 148 ~l~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~ 225 (297)
++..+.|+ .++..++ ....+++|||++|++|.+.... .....++.+++.++.++| +.||+||
T Consensus 86 ~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh--~~gi~H~ 149 (198)
T cd05144 86 ALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAY--KHGIIHG 149 (198)
T ss_pred HHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHH--HCCCCcC
Confidence 99998877 4444443 2456899999999998765421 234568889999999999 5999999
Q ss_pred cCCCCcEEEcCCCceEEccccccccC
Q 022413 226 DFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 226 Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
||||+||++++++.++|+|||++...
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccC
Confidence 99999999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-21 Score=156.78 Aligned_cols=183 Identities=22% Similarity=0.310 Sum_probs=143.9
Q ss_pred CCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCe
Q 022413 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE 169 (297)
Q Consensus 92 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 169 (297)
.+.-+|.+...|+.|+|+|... .++.|++.... ...-++|..|.-.|+.+.||||+.+++.+..+..
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3445688888999999998854 36667665432 2233678899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc--cccc
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS--DFGL 247 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~--Dfg~ 247 (297)
+.++..|++.|+|+..++.... ...+..++..++.++++|++|||+.+.-|..--|....++||++.+.+|. |--+
T Consensus 262 lv~isq~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred ceEeeeeccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence 9999999999999999986532 44677889999999999999999865556666899999999999887764 3222
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCc---ccccchhhhhhhhhc
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY---LLSAKFGNVINVCMY 296 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwslGv~l~~l 296 (297)
+- ......-.|.||+||.+...+-+ .++|+|||++++|+|
T Consensus 340 sf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel 382 (448)
T KOG0195|consen 340 SF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWEL 382 (448)
T ss_pred ee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHh
Confidence 11 11122357899999999865533 468999999999987
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=135.31 Aligned_cols=134 Identities=25% Similarity=0.167 Sum_probs=110.5
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCC--CCcccEEeEEEcCCee
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH--PNLVKLLGYCWEDKEL 170 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~ 170 (297)
+.+.||.|.++.||++.... ..+++|....... ...+..|+.+++.+.| .++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-----------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-----------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEecC-----------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 45789999999999987653 4589998866543 3567889999999986 5899999988888899
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC-CCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-EKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
+++|||++++.+..+ +......++.+++.+|++||.. ..+++|+||+|+||++++.+.++++|||.++
T Consensus 69 ~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 69 YLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred EEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 999999988776543 3455667889999999999942 1479999999999999999999999999987
Q ss_pred c
Q 022413 250 L 250 (297)
Q Consensus 250 ~ 250 (297)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 5
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=147.36 Aligned_cols=190 Identities=18% Similarity=0.239 Sum_probs=120.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCC----------CC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSH----------PN 156 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~n 156 (297)
.+...+.||.|+++.||.+.+.++ ++.+|+|+.... .....+.+.+|......+.+ -.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t---------~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVET---------GEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTT---------TEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEEEEccC---------CceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 455678999999999999988765 889999986432 22344666666655544322 12
Q ss_pred cccEEeEEEc---------C---C-----eeEEEEEecCCCCHHHHHh---hcCCCCCCCCHHHHHHHHHHHHHHhcchh
Q 022413 157 LVKLLGYCWE---------D---K-----ELLLVYEYMQRGSLENHLF---RRNPSIQPLSWDIRLKIAIGAARGLGFLH 216 (297)
Q Consensus 157 Iv~~~~~~~~---------~---~-----~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~i~~al~yLH 216 (297)
++..++.... . . ..+++|+-+ -++|.+++. ........+....++.+..|+++.+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 2323333221 1 1 246788877 558887754 22221122334455677799999999999
Q ss_pred cCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc--------cCCcccccchh
Q 022413 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT--------GNFYLLSAKFG 288 (297)
Q Consensus 217 ~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvws 288 (297)
+ .|+||+||+|+|++++++|.++|.||+....... .......+..|.+||.... ..++.+.|.|+
T Consensus 163 ~--~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 163 S--YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp H--TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred h--cceEecccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 5 9999999999999999999999999998765321 1111334678999997643 24778899999
Q ss_pred hhhhhhhc
Q 022413 289 NVINVCMY 296 (297)
Q Consensus 289 lGv~l~~l 296 (297)
||+++|.|
T Consensus 236 LG~~ly~l 243 (288)
T PF14531_consen 236 LGITLYSL 243 (288)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999976
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.2e-18 Score=141.91 Aligned_cols=135 Identities=19% Similarity=0.182 Sum_probs=100.3
Q ss_pred ceec-ccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-------------hhhHHHHHHHHHHhcCCCCCCc--c
Q 022413 95 SLLG-EGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-------------MQGFEEWQSEVNFLGRLSHPNL--V 158 (297)
Q Consensus 95 ~~lg-~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v 158 (297)
..|| .|+.|+||++... +..+++|.+.... .....++.+|+.++.+|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4566 6777888877554 4457887664311 1223567889999999998775 6
Q ss_pred cEEeEEEcCC----eeEEEEEecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 159 KLLGYCWEDK----ELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 159 ~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
..+++..... ..++||||++| .+|.+++... .+++. .+.+++.+|.+|| +.||+||||||+|||
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NIL 174 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNIL 174 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEE
Confidence 6776644332 23599999997 6898887542 34443 3568899999999 599999999999999
Q ss_pred EcCCCceEEccccccccC
Q 022413 234 LDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~ 251 (297)
++.++.++|+|||.++..
T Consensus 175 v~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 175 LDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EcCCCCEEEEECCCcccC
Confidence 999899999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=138.44 Aligned_cols=136 Identities=21% Similarity=0.174 Sum_probs=96.2
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh--hHHH----------------------HHHHHHHh
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEE----------------------WQSEVNFL 149 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~E~~~l 149 (297)
.+.||+|+||.||+|.... ++.||+|.+...... .... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~----------~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDGD----------GEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECCC----------CCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 5689999999999997652 678999987653211 1111 13566666
Q ss_pred cCCCCC--CcccEEeEEEcCCeeEEEEEecCCCCHHHH-HhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceecc
Q 022413 150 GRLSHP--NLVKLLGYCWEDKELLLVYEYMQRGSLENH-LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRD 226 (297)
Q Consensus 150 ~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~D 226 (297)
..+.+. .+.+.++. ...+++|||++++.+... +.... . ......++.+++.++.++|. +.+|+|||
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~-~~~ivH~D 140 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYR-EAGLVHGD 140 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhh-ccCcCcCC
Confidence 666533 34445443 246899999998544321 11110 1 15567899999999999994 38999999
Q ss_pred CCCCcEEEcCCCceEEccccccccC
Q 022413 227 FKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 227 lkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
|||+||+++ ++.++|+|||.+...
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccc
Confidence 999999999 999999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-19 Score=168.85 Aligned_cols=160 Identities=25% Similarity=0.380 Sum_probs=113.6
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
....+|..+++|-.|+||.||++++... .+.+|+| ++++.. +++- ++.....|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~t---------rqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKET---------RQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeecccc---------ccchhhc-ccccch-----hhhc--cccccCCccee-------
Confidence 3457899999999999999999877754 4567774 333221 1111 33333444444
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
|+=...+... .+++.. ++.+++||| ..||+|||+||+|++|+.-|++|+.||
T Consensus 136 --------------gDc~tllk~~----g~lPvd--------mvla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDf 187 (1205)
T KOG0606|consen 136 --------------GDCATLLKNI----GPLPVD--------MVLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDF 187 (1205)
T ss_pred --------------chhhhhcccC----CCCcch--------hhHHhHhhc--cCCeecCCCCCCcceeeecccccccch
Confidence 3434444332 233322 267899999 599999999999999999999999999
Q ss_pred cccccCCCC--CC-----------cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAG--GE-----------SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~--~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+.++..-. .. .......+|||.|+|||++....|....|.|++|+|+|+.|
T Consensus 188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFL 252 (1205)
T KOG0606|consen 188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 252 (1205)
T ss_pred hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHh
Confidence 998752110 00 01123468999999999999999999999999999999875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-19 Score=171.02 Aligned_cols=189 Identities=21% Similarity=0.208 Sum_probs=141.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch----hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
+|...+.||.+.|=+|.+|++++ |. |++|++-+.+. ....+.+.|++ ...++|||.+++.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 56778899999999999998775 44 78888765442 22233345555 56668999999988877
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
...-.|+|=+|.. -+|.|.|..+ .-+...+.+-|+.|++.||.-+| +.||+|+|||.+||||+...-+.|+||
T Consensus 92 t~kAAylvRqyvk-hnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVK-HNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred hhHHHHHHHHHHh-hhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhcc
Confidence 7788899999984 4899988764 44667788889999999999999 699999999999999999999999999
Q ss_pred cccccC--CCCCCc---ceeeccCCcccccCcceecccC-----------CcccccchhhhhhhhhcC
Q 022413 246 GLAKLG--PAGGES---HVTTRVMGTYGYAAPEYVATGN-----------FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~--~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwslGv~l~~ll 297 (297)
..-+.. +..... ....+-..-..|+|||.+-.+. -+++=||||+||+++|||
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 765431 111111 1111222345799999875421 345669999999999985
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.8e-18 Score=146.58 Aligned_cols=137 Identities=23% Similarity=0.296 Sum_probs=102.2
Q ss_pred CCCCcccEEeEEEc---------------------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 022413 153 SHPNLVKLLGYCWE---------------------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205 (297)
Q Consensus 153 ~h~nIv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 205 (297)
+|||||++.++|.+ ...+|+||.-++ .+|.+++-.+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHHH
Confidence 59999999998875 235899999884 59999997653 4556777789
Q ss_pred HHHHHHhcchhcCCCCceeccCCCCcEEEc--CC--CceEEccccccccCCCCCC----cceeeccCCcccccCcceecc
Q 022413 206 IGAARGLGFLHTSEKKVIYRDFKASNILLD--GN--YNAKISDFGLAKLGPAGGE----SHVTTRVMGTYGYAAPEYVAT 277 (297)
Q Consensus 206 ~~i~~al~yLH~~~~~ivH~Dlkp~Nill~--~~--~~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~ 277 (297)
.|+++|+.||| ++||.|||||.+||||. +| -.+.|+|||.+--....+- ....-..-|...-||||+...
T Consensus 348 aQlLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 348 AQLLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 69999999999999993 33 3478899998742111110 001112346778899998754
Q ss_pred cC------CcccccchhhhhhhhhcC
Q 022413 278 GN------FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 278 ~~------~~~~sDvwslGv~l~~ll 297 (297)
.+ -+.++|.|+.|.+-||.|
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIf 451 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIF 451 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHh
Confidence 22 235899999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.2e-19 Score=164.09 Aligned_cols=196 Identities=25% Similarity=0.267 Sum_probs=156.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCC-CCCcccEEeEEEc
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE 166 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 166 (297)
.|.+.+.||+|+|+.|-......+ ....+|.|.+.... ....+....|..+-+.+. |+|++++++...+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 577778899999999977654332 14557777765442 233355566888888887 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHh-hcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-ceEEcc
Q 022413 167 DKELLLVYEYMQRGSLENHLF-RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKISD 244 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-~~kl~D 244 (297)
....++.++|..|+++.+.+. ... ...+...+..++.|+..++.|+|. +.++.|||+||+|.+++..+ .+++.|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred CcccccccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCC
Confidence 999999999999999998883 321 245566777889999999999995 48999999999999999999 999999
Q ss_pred ccccccCCC-CCCcceeeccCC-cccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPA-GGESHVTTRVMG-TYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
||+|..+.. .+........+| ++.|+|||...+.. .....|+||+|+++..|+
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~ 224 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML 224 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc
Confidence 999987766 555455556788 99999999998743 445789999999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-17 Score=149.14 Aligned_cols=145 Identities=27% Similarity=0.386 Sum_probs=118.0
Q ss_pred hcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCC
Q 022413 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK 228 (297)
Q Consensus 149 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlk 228 (297)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.... ..+++.....+.++|+.||+|||.... ..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeec
Confidence 567899999999999999999999999999999999998743 668899999999999999999997433 3999999
Q ss_pred CCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccC-------CcccccchhhhhhhhhcC
Q 022413 229 ASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-------FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 229 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwslGv~l~~ll 297 (297)
..|.+++..+.+||.|||+.................-..-|.|||.+.+.. .+.+.|+||+|+++++++
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999987653211111111112345699999998642 355789999999999874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=137.62 Aligned_cols=141 Identities=21% Similarity=0.221 Sum_probs=96.4
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhH----------------------------------
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF---------------------------------- 139 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------- 139 (297)
.+.||.|++|.||+|...+ |+.||||+..+...+..
T Consensus 122 ~~plasaSigQVh~A~l~~----------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVD----------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEecC----------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 3679999999999998764 78899999876522110
Q ss_pred ------HHHHHHHHHhcCC----CCCCcccEEeEEE-cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 022413 140 ------EEWQSEVNFLGRL----SHPNLVKLLGYCW-EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208 (297)
Q Consensus 140 ------~~~~~E~~~l~~l----~h~nIv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i 208 (297)
-++.+|...+.++ .|.+-+.+-.++. .....++||||++|++|.++..... ...+ ...++.++
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~ 265 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENL 265 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHH
Confidence 0133455555544 2222223222222 2345799999999999988765321 1122 23455555
Q ss_pred HH-HhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC
Q 022413 209 AR-GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 209 ~~-al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
+. .+..+| ..|++|+|++|.||+++.++.++|+|||++..+.
T Consensus 266 ~~~~l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 266 ARSFLNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 55 367788 5899999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-15 Score=139.99 Aligned_cols=145 Identities=16% Similarity=0.161 Sum_probs=95.5
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh-------------------------------
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG------------------------------- 138 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------- 138 (297)
.|.. +.||.|++|.||+|+..++ |+.||||++++...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~---------G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v 190 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDN---------GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV 190 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCC---------CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence 4666 7899999999999988753 7889999997652110
Q ss_pred ---HHH------HHHHHHHhcCCC----CCCcccEEeEEEc-CCeeEEEEEecCCCCHHHHH--hhcCCCCCCCCHHHHH
Q 022413 139 ---FEE------WQSEVNFLGRLS----HPNLVKLLGYCWE-DKELLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRL 202 (297)
Q Consensus 139 ---~~~------~~~E~~~l~~l~----h~nIv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~ 202 (297)
.+. +.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.++- .........+.+..+.
T Consensus 191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~ 270 (537)
T PRK04750 191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE 270 (537)
T ss_pred HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence 011 223443333332 3333333333332 34568999999999997753 2221111124444455
Q ss_pred HHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC----ceEEccccccccCCC
Q 022413 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY----NAKISDFGLAKLGPA 253 (297)
Q Consensus 203 ~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~a~~~~~ 253 (297)
.++.|++ +.|++|+|+||.||+++.++ +++++|||++..+..
T Consensus 271 ~~~~Qif---------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF---------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH---------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5555554 37899999999999999888 999999999876643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-14 Score=128.57 Aligned_cols=193 Identities=22% Similarity=0.192 Sum_probs=149.1
Q ss_pred cCCCCCceecc--cCceEEEEEEECCCCCccccCCCCcEEEEEecC--CcchhhHHHHHHHHHHhcCCC-CCCcccEEeE
Q 022413 89 KNFKPDSLLGE--GGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN--PESMQGFEEWQSEVNFLGRLS-HPNLVKLLGY 163 (297)
Q Consensus 89 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~ 163 (297)
..|.+.+.+|. |.+|.||.+.... ...+..+|+|.-+ ........+-.+|+...+.++ |+|.++.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 45777889999 9999999876521 2236778888733 222233344467888888887 9999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHH----HhcchhcCCCCceeccCCCCcEEEcCC-C
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILLDGN-Y 238 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~----al~yLH~~~~~ivH~Dlkp~Nill~~~-~ 238 (297)
+...+..|+-+|++ +.+|..+..... ..++....+.+..+... ||.++|+ ..++|-|+||+||+...+ .
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccc
Confidence 99999999999999 678888876543 33667778888888888 9999995 899999999999999999 8
Q ss_pred ceEEccccccccCCCCCCcce---eeccCCcccccCcceecccCCcccccchhhhhhhhh
Q 022413 239 NAKISDFGLAKLGPAGGESHV---TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCM 295 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ 295 (297)
..++.|||+...+....-... .....|..-|++||.. ++-++.++|+|+||.+..+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILE 319 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHh
Confidence 889999999887655432111 1223577889999976 4778889999999998764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-14 Score=113.85 Aligned_cols=128 Identities=17% Similarity=0.127 Sum_probs=93.6
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCc-ccEEeEEEcCCeeEE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLL 172 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~l 172 (297)
.+.|+.|.++.||++... +..+++|........ ...+..|+.+++.+.+.++ ++++... ....++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 457888999999998654 556999987654321 1345789999998875554 4455433 334689
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC-----ceeccCCCCcEEEcCCCceEEccccc
Q 022413 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK-----VIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 173 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
||||++|.++... . . ....++.+++.+|+.||. .+ ++|+|++|.||+++ ++.++++||+.
T Consensus 69 v~e~i~G~~l~~~---~------~---~~~~~~~~l~~~l~~LH~--~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 69 ITEFIEGSELLTE---D------F---SDPENLEKIAKLLKKLHS--SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred EEEecCCCccccc---c------c---cCHHHHHHHHHHHHHHhC--CCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 9999999877543 0 0 112356788999999995 55 59999999999999 67899999999
Q ss_pred ccc
Q 022413 248 AKL 250 (297)
Q Consensus 248 a~~ 250 (297)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.5e-13 Score=109.15 Aligned_cols=143 Identities=13% Similarity=0.087 Sum_probs=98.0
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-------------ch---------hhHHH----HHHHHH
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-------------SM---------QGFEE----WQSEVN 147 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-------------~~---------~~~~~----~~~E~~ 147 (297)
...||.|.=+.||.|...+.. ..+..+..+|+|+.+.. +. ...+. ..+|..
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 357899999999999754310 00112567899975421 00 00112 238999
Q ss_pred HhcCCC--CCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcch-hcCCCCcee
Q 022413 148 FLGRLS--HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL-HTSEKKVIY 224 (297)
Q Consensus 148 ~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yL-H~~~~~ivH 224 (297)
.|+++. .-++++++++ ...++||||+.+..+....... ..++......+..+++.+|..| | +.||||
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H--~~glVH 148 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYK--ECNLVH 148 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHH--hCCeec
Confidence 999986 3567777764 4668999999765442221111 2244556677889999999998 7 589999
Q ss_pred ccCCCCcEEEcCCCceEEcccccccc
Q 022413 225 RDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 225 ~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
+||++.|||++ ++.+.|+|||-+..
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCcee
Confidence 99999999997 47899999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=124.02 Aligned_cols=161 Identities=16% Similarity=0.146 Sum_probs=119.9
Q ss_pred CcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHH
Q 022413 123 GMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202 (297)
Q Consensus 123 ~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 202 (297)
+..|.+...+...........+-++.|+.++||||+++++.++.++.+|+|+|-+. .|..++.+. ....+.
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~~v~ 107 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKEEVC 107 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHHHHH
Confidence 55566666655443333456678889999999999999999999999999999874 577777653 355666
Q ss_pred HHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcc
Q 022413 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYL 282 (297)
Q Consensus 203 ~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 282 (297)
..+.||+.||.|||. +.+++|++|..+-|+|+..|+.||.+|.++........ ......---.|..|+.+....++
T Consensus 108 ~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~~s- 183 (690)
T KOG1243|consen 108 LGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSEWS- 183 (690)
T ss_pred HHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccccc-
Confidence 778999999999985 79999999999999999999999999998764322111 00111122346677765444343
Q ss_pred cccchhhhhhhhhcC
Q 022413 283 LSAKFGNVINVCMYL 297 (297)
Q Consensus 283 ~sDvwslGv~l~~ll 297 (297)
.|.|.||+++++++
T Consensus 184 -~D~~~Lg~li~el~ 197 (690)
T KOG1243|consen 184 -IDSWGLGCLIEELF 197 (690)
T ss_pred -hhhhhHHHHHHHHh
Confidence 39999999999875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=8e-14 Score=116.92 Aligned_cols=150 Identities=23% Similarity=0.254 Sum_probs=116.3
Q ss_pred HHhcCCCCCCcccEEeEEEcC-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC
Q 022413 147 NFLGRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK 221 (297)
Q Consensus 147 ~~l~~l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ 221 (297)
.-+-++.|.||++++.||.+. .+..+++||+..|+|..+|++.......+......+|+.||+.||.|||++...
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 345556799999999999764 358999999999999999998766667788888899999999999999998899
Q ss_pred ceeccCCCCcEEEcCCCceEEccccccccCCCC--CCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhc
Q 022413 222 VIYRDFKASNILLDGNYNAKISDFGLAKLGPAG--GESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 222 ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
|+|+++..+-|++..+|-+|+.--......... ..........+-++|.|||.=...+-+.++|||++|.+..+|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 999999999999999999997522111111000 000111223467899999987777788899999999877665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.4e-13 Score=105.11 Aligned_cols=131 Identities=23% Similarity=0.312 Sum_probs=97.5
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEec-CCc--ch-----hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPE--SM-----QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~-~~~--~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..+++|+=+.+|.+.+. |..+++|.- .+. .+ -...+..+|+.++.++.--.|...+=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 35778999999988554 334555542 221 11 112566789999999876566555556677
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+...|+|||++|..|.+.+... ...++..+-.-+.-|| +.||||+||.++||++..++ +.++|||
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEECC
Confidence 88889999999999998888654 1345666677777899 69999999999999998665 9999999
Q ss_pred cccc
Q 022413 247 LAKL 250 (297)
Q Consensus 247 ~a~~ 250 (297)
++..
T Consensus 137 Lg~~ 140 (204)
T COG3642 137 LGEF 140 (204)
T ss_pred cccc
Confidence 9975
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.2e-12 Score=104.98 Aligned_cols=141 Identities=22% Similarity=0.288 Sum_probs=103.3
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCC--CCcccEEeEEEcC---C
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH--PNLVKLLGYCWED---K 168 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~---~ 168 (297)
+.|+.|..+.||++...+ |..+++|....... .....+..|..+++.+.+ .++++++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 568899999999986543 45689998765432 123567889999999975 4567787776653 2
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC------------------------------
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------------------------------ 218 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------------------------------ 218 (297)
..++||||++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 67899999999887665421 1245555666667777777777631
Q ss_pred ------------------------CCCceeccCCCCcEEEcC--CCceEEcccccccc
Q 022413 219 ------------------------EKKVIYRDFKASNILLDG--NYNAKISDFGLAKL 250 (297)
Q Consensus 219 ------------------------~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~ 250 (297)
...++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 67789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-11 Score=96.60 Aligned_cols=143 Identities=18% Similarity=0.217 Sum_probs=104.3
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-------c-hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-------S-MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-------~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.+.++-+|+-+.|+++.+. |+...||.-... + .-...+..+|+.+|.++.--.|.-..=++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 5678889999999998776 566667643211 1 11235778999999998755655555567
Q ss_pred EcCCeeEEEEEecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---ce
Q 022413 165 WEDKELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY---NA 240 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~---~~ 240 (297)
.+...-.|.|||++| .++.+++...... .........++.+|-..+.-|| ..+|+|+||..+||++..++ .+
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~ 155 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITP 155 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCce
Confidence 777788899999977 4788888764321 1222222678888889999999 69999999999999996543 35
Q ss_pred EEcccccccc
Q 022413 241 KISDFGLAKL 250 (297)
Q Consensus 241 kl~Dfg~a~~ 250 (297)
.++|||++..
T Consensus 156 ~lIdfgls~~ 165 (229)
T KOG3087|consen 156 ILIDFGLSSV 165 (229)
T ss_pred EEEeecchhc
Confidence 8999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=118.33 Aligned_cols=191 Identities=20% Similarity=0.116 Sum_probs=141.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHH--HHHHHHHHhcCCC-CCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFE--EWQSEVNFLGRLS-HPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~-h~nIv~~~~~ 163 (297)
...+|..+..||.|.|+.|+....+.. .+..|++|.+......... .-..|+.+...+. |.+++..+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~--------~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPE--------GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCC--------CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 345788889999999999998754421 2667888877654332222 2246666666665 8999999888
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC-CceEE
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKI 242 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~-~~~kl 242 (297)
|....+.|+-.|||+++++...+.-. ..+++...+.+..|++.++.++| +..++|+|+||+||++..+ +.-++
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhhhc
Confidence 98888899999999999887766322 45788888999999999999999 5999999999999999876 78899
Q ss_pred ccccccccCCCCCCcceeeccCCccccc--CcceecccCCcccccchhhhhhhhhc
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYA--APEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
.|||....+.... ....++..++ +|+......+-.+.|+++||..+.+.
T Consensus 409 ~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~ 459 (524)
T KOG0601|consen 409 GDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEA 459 (524)
T ss_pred cccccccccceec-----ccccccccccccchhhcccccccccccccccccccccc
Confidence 9999886432211 1122333444 55555556677899999999776653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=2e-10 Score=97.36 Aligned_cols=124 Identities=15% Similarity=0.112 Sum_probs=90.1
Q ss_pred CcEEEEEecCCcchh-hH----------HHHHHHHHHhcCCCCC--CcccEEeEEEc-----CCeeEEEEEecCCC-CHH
Q 022413 123 GMVVAIKKLNPESMQ-GF----------EEWQSEVNFLGRLSHP--NLVKLLGYCWE-----DKELLLVYEYMQRG-SLE 183 (297)
Q Consensus 123 ~~~vaiK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~--nIv~~~~~~~~-----~~~~~lv~e~~~~~-~L~ 183 (297)
|+.+.+|........ .. ..+.+|...+.+|..- ..++++.+.+. ....+||||++++. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 567888866433211 01 1467898888888533 33444555543 23588999999886 798
Q ss_pred HHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-------CCceEEcccccccc
Q 022413 184 NHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-------NYNAKISDFGLAKL 250 (297)
Q Consensus 184 ~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-------~~~~kl~Dfg~a~~ 250 (297)
+++..... ...+......++.+++..+.-|| +.||+|+||++.|||++. +..+.|+||+.+..
T Consensus 125 ~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 125 DYCADWAT--NPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 88854211 33556677889999999999999 699999999999999975 47899999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-10 Score=92.78 Aligned_cols=98 Identities=26% Similarity=0.215 Sum_probs=64.7
Q ss_pred HHHHHHHHHhcCCCCC--CcccEEeEEEcCCeeEEEEEecC--CCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcc-
Q 022413 140 EEWQSEVNFLGRLSHP--NLVKLLGYCWEDKELLLVYEYMQ--RGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF- 214 (297)
Q Consensus 140 ~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~y- 214 (297)
.+..+|...|.++..- ++++++++. ..++||||++ |..+..+.... ++......++.+++..+..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHH
Confidence 4567899999999854 577777543 3479999998 65554433321 1123345566777775555
Q ss_pred hhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 215 LH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
+| ..||||+||.+.|||++++ .+.|+|||-+..
T Consensus 123 ~~--~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 123 LH--KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp HH--CTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred HH--hcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 56 6999999999999999987 999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.7e-12 Score=121.09 Aligned_cols=195 Identities=19% Similarity=0.177 Sum_probs=136.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.+.+.+.+.+-.|+++.++.+.- ...|...++|...... ..+.+....+-.++-.-++|.++...-.+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~p---------a~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~ 873 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASP---------AGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF 873 (1205)
T ss_pred CccceecccccCCCCcccccCCc---------cccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC
Confidence 45677777888899998886532 2234444444433221 11222333343344444567777665555
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
......+++++|+.+++|...++.. ...+...++.....+..+++|||+ ..++|||++|.|+|+..++..++.|
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~ 947 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTD 947 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCc
Confidence 5667899999999999999998765 345556666677788999999995 5589999999999999999999999
Q ss_pred ccccccCCCC----CC-------------------------cceeeccCCcccccCcceecccCCcccccchhhhhhhhh
Q 022413 245 FGLAKLGPAG----GE-------------------------SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCM 295 (297)
Q Consensus 245 fg~a~~~~~~----~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ 295 (297)
||+....... +. ........||+.|.+||.+.+......+|.|+.|+++++
T Consensus 948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence 9844321110 00 011223568999999999999999999999999999998
Q ss_pred cC
Q 022413 296 YL 297 (297)
Q Consensus 296 ll 297 (297)
.|
T Consensus 1028 ~l 1029 (1205)
T KOG0606|consen 1028 VL 1029 (1205)
T ss_pred hh
Confidence 65
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.3e-10 Score=91.69 Aligned_cols=134 Identities=18% Similarity=0.098 Sum_probs=93.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch----------------------hhHHHHHHHHH
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----------------------QGFEEWQSEVN 147 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~E~~ 147 (297)
-+.++..||.|.=+.||.|...+ |..+|+|.-..... -.....++|.+
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~----------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPK----------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHhhccccccCccceEEEEECCC----------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 35677899999999999998764 77899997542110 01234568999
Q ss_pred HhcCCCCC--CcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceec
Q 022413 148 FLGRLSHP--NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225 (297)
Q Consensus 148 ~l~~l~h~--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~ 225 (297)
+|.+|... .+++.++ .+...+||||++|..|...-. +....-.++..|+.-+.-+- +.||||+
T Consensus 162 ~L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~--~~GiVHG 226 (304)
T COG0478 162 ALQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAY--RRGIVHG 226 (304)
T ss_pred HHHHhhhcCCCCCCccc----cccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHH--HcCcccc
Confidence 99999744 6777765 356789999999976654321 11122223333333333322 2899999
Q ss_pred cCCCCcEEEcCCCceEEcccccc
Q 022413 226 DFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 226 Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
|+.+=|||++++|.+.++||-=+
T Consensus 227 DlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 227 DLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred CCchheEEEecCCCEEEEeCccc
Confidence 99999999999999999999544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.4e-09 Score=86.82 Aligned_cols=106 Identities=21% Similarity=0.187 Sum_probs=83.4
Q ss_pred HHHHHHHHHhcCCC--CCCcccEEeEEEcC----CeeEEEEEecCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHh
Q 022413 140 EEWQSEVNFLGRLS--HPNLVKLLGYCWED----KELLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212 (297)
Q Consensus 140 ~~~~~E~~~l~~l~--h~nIv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al 212 (297)
.+..+|...+..|. .-.+++.+++.+.. ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 46678888887775 33455666666553 2468999999884 7999887642 155567788999999999
Q ss_pred cchhcCCCCceeccCCCCcEEEcCCC---ceEEccccccccC
Q 022413 213 GFLHTSEKKVIYRDFKASNILLDGNY---NAKISDFGLAKLG 251 (297)
Q Consensus 213 ~yLH~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~~ 251 (297)
+-|| +.||+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 132 ~~lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 69999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.1e-09 Score=95.91 Aligned_cols=138 Identities=21% Similarity=0.273 Sum_probs=107.2
Q ss_pred eEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc----CCeeEEEEEecC
Q 022413 103 GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE----DKELLLVYEYMQ 178 (297)
Q Consensus 103 g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~e~~~ 178 (297)
.+.|+++..-+ |..|++|+++....+.......-++.++++.|+|||+|.++|.. +..+++|++|++
T Consensus 290 ~Ttyk~~s~~D---------G~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 290 ITTYKATSNVD---------GNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred ceeEeeeeccC---------CceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 56788877655 88899999954433322333456788999999999999998873 357999999997
Q ss_pred C-CCHHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 179 R-GSLENHLFRRNP-----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 179 ~-~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+ ++|.++.....+ .....++...+.++.|+..||.++|+ .|+.-+-|.|.+||++++.+++|...|
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C~ 438 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGCG 438 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEeccc
Confidence 6 478777653322 12457789999999999999999995 788889999999999999999988777
Q ss_pred ccccC
Q 022413 247 LAKLG 251 (297)
Q Consensus 247 ~a~~~ 251 (297)
....+
T Consensus 439 i~Dvl 443 (655)
T KOG3741|consen 439 IMDVL 443 (655)
T ss_pred ceeee
Confidence 65543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.2e-10 Score=109.80 Aligned_cols=87 Identities=14% Similarity=0.054 Sum_probs=64.1
Q ss_pred HHhcchhcCCCCceeccCCCC-cEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchh
Q 022413 210 RGLGFLHTSEKKVIYRDFKAS-NILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFG 288 (297)
Q Consensus 210 ~al~yLH~~~~~ivH~Dlkp~-Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvws 288 (297)
.+..|.|.. ..-.+++.+|. |++++....+++.|||.++...............||+.|+|||++.+..++.++||||
T Consensus 487 ~~~~~~~~~-~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwS 565 (669)
T cd05610 487 SGSQSGSYP-AITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWA 565 (669)
T ss_pred cccccCCCc-ccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHH
Confidence 344555531 33345666666 6677777778999999987655443322334568999999999999999999999999
Q ss_pred hhhhhhhcC
Q 022413 289 NVINVCMYL 297 (297)
Q Consensus 289 lGv~l~~ll 297 (297)
|||+||+|+
T Consensus 566 lG~il~Ell 574 (669)
T cd05610 566 LGVCLFEFL 574 (669)
T ss_pred HHHHHHHHH
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.2e-08 Score=80.89 Aligned_cols=138 Identities=17% Similarity=0.127 Sum_probs=99.2
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc------hhhHHHHHHHHHHhcCCCC--CCcccEEeEEE-c-
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES------MQGFEEWQSEVNFLGRLSH--PNLVKLLGYCW-E- 166 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~-~- 166 (297)
-|+|+-+.|++-... |..+-+|.-.... +-....|.+|+..+.+|.. -.++++. ++. .
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k 93 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK 93 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence 456888889886554 3346777653110 2233678899999999863 3355554 232 1
Q ss_pred ---CCeeEEEEEecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc--e
Q 022413 167 ---DKELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN--A 240 (297)
Q Consensus 167 ---~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~--~ 240 (297)
.-+.+||+|-+.| .+|.+++.... ..+.+......+..+++..+.-|| +.|+.|+|+.+.|||++.++. +
T Consensus 94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 94 IEGEWRALLVTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred cCCceEEEEEEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeE
Confidence 1358999998854 48888875532 134577777899999999999999 699999999999999986666 9
Q ss_pred EEcccccccc
Q 022413 241 KISDFGLAKL 250 (297)
Q Consensus 241 kl~Dfg~a~~ 250 (297)
+++||.-++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999987764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.2e-08 Score=93.70 Aligned_cols=139 Identities=14% Similarity=0.152 Sum_probs=90.0
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhH----------------------------------H
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF----------------------------------E 140 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------~ 140 (297)
..|+.++-|.||+|+..+ |+.||||+..+.-...+ +
T Consensus 131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 678999999999998876 88999999876422110 0
Q ss_pred ------HHHHHHHHhcCCC-----CCCcccEEeE-EEcCCeeEEEEEecCCCCHHHHHhhcCCC--CCCCCHHHHHHHHH
Q 022413 141 ------EWQSEVNFLGRLS-----HPNLVKLLGY-CWEDKELLLVYEYMQRGSLENHLFRRNPS--IQPLSWDIRLKIAI 206 (297)
Q Consensus 141 ------~~~~E~~~l~~l~-----h~nIv~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~ 206 (297)
++.+|..-+.++. .|+| .+=.+ +.....-.++|||++|..+.+...-.... ...+.......++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~ 279 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLR 279 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 1223444444442 2332 22222 33346679999999999888874322211 01122223333333
Q ss_pred HHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCC
Q 022413 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253 (297)
Q Consensus 207 ~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 253 (297)
|+. ..|++|.|..|-||+++.+|++-+.|||+...+..
T Consensus 280 q~~---------~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLL---------RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHH---------hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 332 26899999999999999999999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.3e-10 Score=101.41 Aligned_cols=173 Identities=17% Similarity=0.084 Sum_probs=121.3
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCC-cccEEeEEEcCCe
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGYCWEDKE 169 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~ 169 (297)
+.....++++++++++|.+.... .....+.+... ....-++++|.+++||| .+..++-+..++.
T Consensus 244 s~~fh~fvK~altknpKkRptae----------klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAE----------KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChh----------hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 44445678899999998644321 11224444332 23345888999999999 7777777777789
Q ss_pred eEEEEEecCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 170 LLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 170 ~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
.++.++++.++ +...... .....+.......+.+.-.++++|+|+ -.-+||| ||+..+ +..|..||+..
T Consensus 309 ~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~--~~~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHS--SYKVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred cchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccc--ccccCcc----cccccc-cccccccccCC
Confidence 99999999876 2222111 111234444555667778889999995 3358998 776654 78999999998
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhh
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVI 291 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv 291 (297)
..+.... ......+|+.|+|||+.....+....|+|++|+
T Consensus 379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~ 418 (829)
T KOG0576|consen 379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAV 418 (829)
T ss_pred cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCc
Confidence 7665432 345678999999999999999999999999996
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-07 Score=78.01 Aligned_cols=139 Identities=17% Similarity=0.161 Sum_probs=84.8
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCC--CcccEEeEEEcCCeeEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP--NLVKLLGYCWEDKELLL 172 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~~~~~l 172 (297)
..||.|..+.||+.. +..+++|....... .....+|.++++.+..- .+.+++++....+...+
T Consensus 7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-------------CCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 568999999999831 33467888765432 24568899999888633 35777888877788899
Q ss_pred EEEecCCCC-HH--------------HHH-------hhcCCCCCCCCHHHHHHHHH----------HHHH-Hhcchh--c
Q 022413 173 VYEYMQRGS-LE--------------NHL-------FRRNPSIQPLSWDIRLKIAI----------GAAR-GLGFLH--T 217 (297)
Q Consensus 173 v~e~~~~~~-L~--------------~~l-------~~~~~~~~~~~~~~~~~i~~----------~i~~-al~yLH--~ 217 (297)
|||+++|.+ +. ..+ +.-......+.... ..+.. ++.. ...+|. .
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~ 150 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVP 150 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence 999999863 11 111 11000011111000 00000 0000 111111 1
Q ss_pred CCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 218 SEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 218 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
....++|+|+.|.||++++++ +.|+||+.+..
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 234678999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.4e-07 Score=75.28 Aligned_cols=138 Identities=15% Similarity=0.128 Sum_probs=87.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHH---------HHHHHHhcCCCC---
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---------QSEVNFLGRLSH--- 154 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~E~~~l~~l~h--- 154 (297)
...+|.+.+++-......|.+-..+ +..+++|..........+.| .+++..+.++..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-----------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~ 97 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-----------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF 97 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-----------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence 4567888888877766667664443 66789998776543221221 233333333322
Q ss_pred CCcccEEeEEEc-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCC
Q 022413 155 PNLVKLLGYCWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKA 229 (297)
Q Consensus 155 ~nIv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp 229 (297)
..+..++-+.+. ....+++|||++|..|.++.. +++ .++..+..++.-|| +.|++|+|..|
T Consensus 98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH--~~G~~HGD~hp 163 (229)
T PF06176_consen 98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH--KHGFYHGDPHP 163 (229)
T ss_pred cccccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH--HcCCccCCCCc
Confidence 222232222222 245678999999988866532 222 24455667788999 59999999999
Q ss_pred CcEEEcCCCceEEcccccccc
Q 022413 230 SNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 230 ~Nill~~~~~~kl~Dfg~a~~ 250 (297)
.|++++++ .++++||+..+.
T Consensus 164 gNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 164 GNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred CcEEEECC-cEEEEECccccc
Confidence 99999854 499999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.7e-07 Score=82.11 Aligned_cols=185 Identities=17% Similarity=0.194 Sum_probs=118.4
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEE------
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW------ 165 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~------ 165 (297)
..+.||+|+-+.+|-.--. +. .+.|+...-....... .+..|... .||-+-.-+.|-.
T Consensus 15 ~gr~LgqGgea~ly~l~e~-----------~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-----------RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred CCccccCCccceeeecchh-----------hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 4678999999999853111 11 2446655433221111 22233333 4665433121111
Q ss_pred -cCCeeEEEEEecCCCC-HHHHHh--hcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 166 -EDKELLLVYEYMQRGS-LENHLF--RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 166 -~~~~~~lv~e~~~~~~-L~~~l~--~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
....+-++|+.++|.. +..++. .+.......+|...+.+++.++.+.+-|| +.|.+-+|++++|+|+.+++.+.
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceEE
Confidence 1233778898887752 233332 11222244679999999999999999999 68899999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
|.|=..-... . .........|.+.|.+||... +..-+...|-|.|||++|+||
T Consensus 158 LVdsDsfqi~-~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL 215 (637)
T COG4248 158 LVDSDSFQIN-A--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLL 215 (637)
T ss_pred EEcccceeec-c--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHH
Confidence 9974322221 2 222344567999999999765 233456789999999999986
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.5e-09 Score=95.30 Aligned_cols=90 Identities=21% Similarity=0.265 Sum_probs=69.9
Q ss_pred HHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCC------cce-eeccCCcccccCcceeccc
Q 022413 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE------SHV-TTRVMGTYGYAAPEYVATG 278 (297)
Q Consensus 206 ~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~-~~~~~gt~~y~aPE~~~~~ 278 (297)
.+++.||.|+|. ..++||++|.|++|.++..+.+||+.|+++........ +.. ..-......|.|||++.+.
T Consensus 106 ~~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 345589999997 68999999999999999999999999998754322111 000 0111245689999999988
Q ss_pred CCcccccchhhhhhhhhc
Q 022413 279 NFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 279 ~~~~~sDvwslGv~l~~l 296 (297)
.-+.++|+|||||++|.+
T Consensus 185 ~~~~~sd~fSlG~li~~i 202 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTI 202 (700)
T ss_pred cccccccceeeeeEEEEE
Confidence 888999999999999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.1e-07 Score=71.58 Aligned_cols=130 Identities=18% Similarity=0.148 Sum_probs=90.7
Q ss_pred CCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCc-ccEEeEEEcCCee
Q 022413 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKEL 170 (297)
Q Consensus 92 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~ 170 (297)
...+.|++|.+|.||++.+. +..+|+|+-..+.+. ..+..|+++|..+.-.++ .++|.+.. .
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~----~ 87 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE----D 87 (201)
T ss_pred hhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech----h
Confidence 34578999999999999877 457899987766554 678889999999875554 34554433 2
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCC-CCcEEEcCCCceEEccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK-ASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlk-p~Nill~~~~~~kl~Dfg~a~ 249 (297)
++.|||+.|..|.+.-.. .+...... ++..---|- ..||-|..|. |...+|..++.+.|+||.-|+
T Consensus 88 ~i~me~i~G~~L~~~~~~-------~~rk~l~~----vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG-------GDRKHLLR----VLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhc-------ccHHHHHH----HHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 455999999888766532 12222222 333322233 4788888887 777777777799999999988
Q ss_pred cC
Q 022413 250 LG 251 (297)
Q Consensus 250 ~~ 251 (297)
+.
T Consensus 155 ~k 156 (201)
T COG2112 155 FK 156 (201)
T ss_pred hc
Confidence 54
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.59 E-value=6.9e-07 Score=75.11 Aligned_cols=140 Identities=17% Similarity=0.077 Sum_probs=83.3
Q ss_pred ecccCc-eEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEEEE
Q 022413 97 LGEGGF-GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVY 174 (297)
Q Consensus 97 lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~ 174 (297)
|..|.. ..||+.... +..+.+|...... ...+.+|+++++.+. +--+++++++....+..++||
T Consensus 6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 444555 778986432 3357888776543 234567888888875 455777888777667789999
Q ss_pred EecCCCCHHHHH-------------------hhcCCCCCCCCHH--HHHHH-----------------------HHHHHH
Q 022413 175 EYMQRGSLENHL-------------------FRRNPSIQPLSWD--IRLKI-----------------------AIGAAR 210 (297)
Q Consensus 175 e~~~~~~L~~~l-------------------~~~~~~~~~~~~~--~~~~i-----------------------~~~i~~ 210 (297)
|+++|.+|.... +.......++... ..... ..++..
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 999998765431 1100000011100 00000 111111
Q ss_pred Hhcchh--cCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 211 GLGFLH--TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 211 al~yLH--~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
.|.-.. .....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 111100 0135689999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.2e-07 Score=74.95 Aligned_cols=144 Identities=24% Similarity=0.246 Sum_probs=83.0
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCC--CcccEEeEEEc---CC
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP--NLVKLLGYCWE---DK 168 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~---~~ 168 (297)
++.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++..... ..
T Consensus 2 i~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 3578899999999986553 36899987665 3346677888888888632 35677764433 23
Q ss_pred eeEEEEEecCCCCHHH----------------HHh---hcCCCCCCCCHHHH--H----HH---------------HHHH
Q 022413 169 ELLLVYEYMQRGSLEN----------------HLF---RRNPSIQPLSWDIR--L----KI---------------AIGA 208 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~----------------~l~---~~~~~~~~~~~~~~--~----~i---------------~~~i 208 (297)
..+++|++++|..+.. .+. ........+..... . .+ ...+
T Consensus 69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL 148 (239)
T ss_dssp EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence 5799999999987777 111 11001011111100 0 00 0011
Q ss_pred HH-Hhcchhc-----CCCCceeccCCCCcEEEc-CCCceEEcccccccc
Q 022413 209 AR-GLGFLHT-----SEKKVIYRDFKASNILLD-GNYNAKISDFGLAKL 250 (297)
Q Consensus 209 ~~-al~yLH~-----~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~ 250 (297)
.. .++.++. ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 11 2223331 246799999999999999 667778999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9.7e-07 Score=72.64 Aligned_cols=151 Identities=21% Similarity=0.162 Sum_probs=94.2
Q ss_pred HHHHHHhhcCCCCCceec---ccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh-------------------
Q 022413 81 FLDLKSATKNFKPDSLLG---EGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG------------------- 138 (297)
Q Consensus 81 ~~~~~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------- 138 (297)
...+....++..+....| .|.-+.||+|...+ +..+|+|+........
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~----------~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~ 106 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGD----------GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN 106 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC----------CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence 334444555666655554 56667799986533 6779999875321100
Q ss_pred -----HHHHHHHHHHhcCCC--CCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 022413 139 -----FEEWQSEVNFLGRLS--HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211 (297)
Q Consensus 139 -----~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~a 211 (297)
......|..-|+++. +-.+++.+.+. ...|||||+....+ -...-. ...+...+...+..++++.
T Consensus 107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~---pAP~Lk-Dv~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL---PAPRLK-DVPLELEEAEGLYEDVVEY 178 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC---CCCCcc-cCCcCchhHHHHHHHHHHH
Confidence 012346777777774 44555555543 45899999954311 011000 0122222566666777777
Q ss_pred hcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 212 l~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+.-|-. ..++||+||..=|||+. ++.+.++|||=|...
T Consensus 179 ~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 179 MRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHH-hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 777664 58999999999999999 899999999977543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.6e-06 Score=83.84 Aligned_cols=81 Identities=19% Similarity=0.244 Sum_probs=55.5
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCC-CCCc--ccEEeEEEcC--
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLS-HPNL--VKLLGYCWED-- 167 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~-- 167 (297)
.+.++.|.+..+|+....... ....+++|+..... ......+.+|..+|+.+. |++| ++++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 466788999999987554320 01346777765432 122346789999999996 6664 7778777664
Q ss_pred -CeeEEEEEecCCCC
Q 022413 168 -KELLLVYEYMQRGS 181 (297)
Q Consensus 168 -~~~~lv~e~~~~~~ 181 (297)
+..|+||||++|..
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 46899999998864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.8e-06 Score=79.26 Aligned_cols=137 Identities=18% Similarity=0.178 Sum_probs=86.3
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh-------------------------------HH---
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-------------------------------FE--- 140 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~--- 140 (297)
+.||.-+.|.||+|+.++ |..||||+-++.-.+. .+
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 679999999999998776 7889999977643211 01
Q ss_pred ---HHHHHHHHhcC----CCCCC------cccEEeEEEcCCeeEEEEEecCCCCHHHH--HhhcCCCCCCCCHHHHHHHH
Q 022413 141 ---EWQSEVNFLGR----LSHPN------LVKLLGYCWEDKELLLVYEYMQRGSLENH--LFRRNPSIQPLSWDIRLKIA 205 (297)
Q Consensus 141 ---~~~~E~~~l~~----l~h~n------Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~i~ 205 (297)
+|.+|.+-..+ +.|-+ |+++|-.+ .....|+|||++|..+.+. |.+. .++...+..-+
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-----gi~~~~i~~~l 309 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-----GISPHDILNKL 309 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-----CCCHHHHHHHH
Confidence 12234333332 23444 44443322 2457999999999866554 3333 24444333332
Q ss_pred HHHHHHhcchhcCCCCceeccCCCCcEEEc----CCCceEEccccccccCC
Q 022413 206 IGAARGLGFLHTSEKKVIYRDFKASNILLD----GNYNAKISDFGLAKLGP 252 (297)
Q Consensus 206 ~~i~~al~yLH~~~~~ivH~Dlkp~Nill~----~~~~~kl~Dfg~a~~~~ 252 (297)
.+...-+- ++ .|++|+|-.|-||++. .++++.+.|||+.....
T Consensus 310 ~~~~~~qI-f~---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 310 VEAYLEQI-FK---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHHHH-Hh---cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 22221111 22 6799999999999998 36889999999987643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.6e-06 Score=71.22 Aligned_cols=32 Identities=19% Similarity=0.280 Sum_probs=27.2
Q ss_pred CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
..+++|+|+.+.|||++++...-|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 45699999999999998766667999998865
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.3e-06 Score=70.29 Aligned_cols=103 Identities=24% Similarity=0.253 Sum_probs=78.1
Q ss_pred HHHHHHhcCCCC-CCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCC-C
Q 022413 143 QSEVNFLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE-K 220 (297)
Q Consensus 143 ~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~ 220 (297)
..|..+|+.+++ +++++++|+|-. +++.||...+++...-.... .....+|..+.+|+.+++..+.+|+... .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~-~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLS-QFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccc-cccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 458888888985 699999999833 67899998766643210000 0023689999999999999999998422 3
Q ss_pred CceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 221 KVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 221 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
.+.-.|++|+|+-+++++++|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 366689999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=64.96 Aligned_cols=125 Identities=26% Similarity=0.371 Sum_probs=87.0
Q ss_pred cCCCCCceecccCc-eEEEEEEECCCCCccccCCCCcEEEEEecC---Ccch------------------hhHHHHHHHH
Q 022413 89 KNFKPDSLLGEGGF-GRVYKGWVDDKTLAPSKTGLGMVVAIKKLN---PESM------------------QGFEEWQSEV 146 (297)
Q Consensus 89 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~---~~~~------------------~~~~~~~~E~ 146 (297)
.+++.++.||.|.- |.||++... |+.+|+|... .... ....-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 68889999999999 999999877 6689999921 1100 1123577888
Q ss_pred HHhcCCC---CCCc--ccEEeEEEcC------------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHH
Q 022413 147 NFLGRLS---HPNL--VKLLGYCWED------------------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203 (297)
Q Consensus 147 ~~l~~l~---h~nI--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 203 (297)
+...+|+ +.++ +++++|..-. ....||-||++... .+...
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~---- 168 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR---- 168 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----
Confidence 8888775 4456 8999987432 12356666665432 12222
Q ss_pred HHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 204 i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
-+.+|.+-|.-+| ..||+=+|+++.|.. .-||+|||.+
T Consensus 169 ~~~~~~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence 2355666677899 599999999999986 4588999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.8e-05 Score=62.16 Aligned_cols=132 Identities=20% Similarity=0.324 Sum_probs=87.7
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc----------------hhhHHHHHHHHHHhcCCC----
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----------------MQGFEEWQSEVNFLGRLS---- 153 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 153 (297)
..+||+|+.=.||.- .++ ....||+..+.. ....+...+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H--P~d----------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDD----------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC--CCC----------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 457999999999963 221 225777766554 111244556666555554
Q ss_pred --CCCcccEEeEEEcCCeeEEEEEecCC------CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceec
Q 022413 154 --HPNLVKLLGYCWEDKELLLVYEYMQR------GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225 (297)
Q Consensus 154 --h~nIv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~ 225 (297)
+.+|.+++|+.+...-.-+|+|.+.. .+|.+++... .++. .....+.+. .+||- +.+|+.+
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f---~~~l~--~~~Iv~~ 142 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEF---KRYLL--DHHIVIR 142 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHH---HHHHH--HcCCeec
Confidence 88999999999999888999998753 3588888543 2544 333333333 44555 4779999
Q ss_pred cCCCCcEEEcCC--C--ceEEcc-cccc
Q 022413 226 DFKASNILLDGN--Y--NAKISD-FGLA 248 (297)
Q Consensus 226 Dlkp~Nill~~~--~--~~kl~D-fg~a 248 (297)
||+|.||++... + .+.|+| ||-.
T Consensus 143 dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 143 DLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 999999999532 2 577777 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=7e-05 Score=64.87 Aligned_cols=76 Identities=14% Similarity=0.058 Sum_probs=53.7
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCC---CCcccEEeEEEcC---
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH---PNLVKLLGYCWED--- 167 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~--- 167 (297)
.+.||.|..+.||+....+ + .+.+|..+... ....+..|...|+.|.- ..++++++++...
T Consensus 19 ~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ----------G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eeecCCccceeEEEEEcCC----------C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 4679999999999864332 2 35666643311 12567889999988852 4688888877543
Q ss_pred CeeEEEEEecCCCCH
Q 022413 168 KELLLVYEYMQRGSL 182 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L 182 (297)
+..++|||+++|.++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 668999999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00012 Score=61.16 Aligned_cols=33 Identities=18% Similarity=0.248 Sum_probs=28.7
Q ss_pred CCCceeccCCCCcEEEcC-CCceEEccccccccC
Q 022413 219 EKKVIYRDFKASNILLDG-NYNAKISDFGLAKLG 251 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~ 251 (297)
..+++|+|+.+.|||+++ ++.+.|+||..|...
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 357999999999999998 578999999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00026 Score=63.44 Aligned_cols=77 Identities=17% Similarity=0.206 Sum_probs=53.9
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-------hhhHHHHHHHHHHhcCCC---CCCcccEEeE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-------MQGFEEWQSEVNFLGRLS---HPNLVKLLGY 163 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~nIv~~~~~ 163 (297)
.+.||.|.+..||++...+. ++.++||.-.+.. +-..++...|.+.|+.+. ..++++++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~g---------~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEG---------GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCCC---------CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 35789999999999876541 2468999854221 123466778888888763 3467788765
Q ss_pred EEcCCeeEEEEEecCCCC
Q 022413 164 CWEDKELLLVYEYMQRGS 181 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~ 181 (297)
++...++||||+++..
T Consensus 102 --D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 --DEELAVTVMEDLSDHK 117 (401)
T ss_pred --CCCCCEEEEecCCCcc
Confidence 4566899999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00039 Score=60.84 Aligned_cols=32 Identities=28% Similarity=0.356 Sum_probs=27.5
Q ss_pred CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
..++||+|+.|.|||++++...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 36899999999999999776668999998864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00011 Score=63.64 Aligned_cols=143 Identities=17% Similarity=0.115 Sum_probs=80.9
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCC--CcccEEeE------EE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP--NLVKLLGY------CW 165 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~------~~ 165 (297)
.+.|..|....+|+.... +..+++|..... ....+..|+.++..|.+. .+++++.. ..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 455667777889986543 234788887652 224556678877777532 24444431 22
Q ss_pred cCCeeEEEEEecCCCCHHH-----------HH---hhc----CCC---CCCCCHHHHH----------HHHHHHHHHhcc
Q 022413 166 EDKELLLVYEYMQRGSLEN-----------HL---FRR----NPS---IQPLSWDIRL----------KIAIGAARGLGF 214 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~-----------~l---~~~----~~~---~~~~~~~~~~----------~i~~~i~~al~y 214 (297)
..+..++|++|++|..+.. .+ +.. ... .....+.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999999876421 11 100 000 0001111100 001112222333
Q ss_pred hhc-----CCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 215 LHT-----SEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 215 LH~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
+.. ...+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 321 136799999999999999987788999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00017 Score=61.05 Aligned_cols=139 Identities=18% Similarity=0.105 Sum_probs=75.8
Q ss_pred ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCc-ccEEeEEEcCCeeEEEEE
Q 022413 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLLVYE 175 (297)
Q Consensus 97 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e 175 (297)
+..|-...+|+.... +..+++|..........-...+|..+++.+....+ ++++... + -++|||
T Consensus 4 ~~~G~tn~~y~~~~~-----------~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEHP-----------GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEeC-----------CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence 445777788986422 44678887654322210134678888888864333 4444432 2 378999
Q ss_pred ecCCCCHHH--------------HH---hhcCCCCCCCCHHH-HHHHH------------HHHHHHhcchh---cCCCCc
Q 022413 176 YMQRGSLEN--------------HL---FRRNPSIQPLSWDI-RLKIA------------IGAARGLGFLH---TSEKKV 222 (297)
Q Consensus 176 ~~~~~~L~~--------------~l---~~~~~~~~~~~~~~-~~~i~------------~~i~~al~yLH---~~~~~i 222 (297)
|++|..+.. .+ +.......+++... ...+. .++...+.-.. .....+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 999866432 11 11111111222111 11111 11111111110 012468
Q ss_pred eeccCCCCcEEEcCCCceEEccccccccC
Q 022413 223 IYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 223 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+|+|+.|.||++++++ +.|+||..+...
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence 9999999999999877 789999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00049 Score=59.96 Aligned_cols=144 Identities=19% Similarity=0.149 Sum_probs=79.0
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCC--CcccEEeE------EE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP--NLVKLLGY------CW 165 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~------~~ 165 (297)
.+.++.|....+|+....+ + .+++|+...... ...+..|..++..|... .+++++.. ..
T Consensus 27 i~~~~~G~~n~~y~v~t~~----------~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDV----------G-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ccccCCccccceEEEEeCC----------C-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 4567777778899865332 3 477887654321 13445566666666422 23444331 12
Q ss_pred cCCeeEEEEEecCCCCHH-----------HHH---hhcCCC---C--C---CCCHHHHH------------HHHHHHHHH
Q 022413 166 EDKELLLVYEYMQRGSLE-----------NHL---FRRNPS---I--Q---PLSWDIRL------------KIAIGAARG 211 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~-----------~~l---~~~~~~---~--~---~~~~~~~~------------~i~~~i~~a 211 (297)
..+..+++++|++|..+. ..+ +..... . . ...|.... .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 245678999999885431 111 110000 0 0 00111100 001112233
Q ss_pred hcchhc-----CCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 212 LGFLHT-----SEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 212 l~yLH~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
++++.. ...+++|+|+.+.||++++++.+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 444431 247899999999999999888778999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=2.4e-05 Score=66.96 Aligned_cols=132 Identities=15% Similarity=0.083 Sum_probs=88.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-------------------h---hHHHHHHHHH
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-------------------Q---GFEEWQSEVN 147 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------------~---~~~~~~~E~~ 147 (297)
-+.++..||-|.-+-||.+.+.+ |...++|....... + ..-...+|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 46778899999999999987665 66677775432100 0 0123457888
Q ss_pred HhcCCC-CCC-cccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceec
Q 022413 148 FLGRLS-HPN-LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225 (297)
Q Consensus 148 ~l~~l~-h~n-Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~ 225 (297)
.|+.|. |-. +++.+ +.+..++|||++.|-.|.+.-+-. +... +...+..-+.-|. ..|+||+
T Consensus 163 fmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~-------d~~~---ly~~lm~~Iv~la--~~GlIHg 226 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHVE-------DPPT---LYDDLMGLIVRLA--NHGLIHG 226 (465)
T ss_pred HHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeecC-------ChHH---HHHHHHHHHHHHH--HcCceec
Confidence 888886 332 33433 345779999999998876543221 1122 2223333334455 5899999
Q ss_pred cCCCCcEEEcCCCceEEccccc
Q 022413 226 DFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 226 Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
|++-=||++++++.++++||-=
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred ccchheeEEecCCCEEEeechH
Confidence 9999999999999999999964
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=4.9e-06 Score=83.36 Aligned_cols=169 Identities=12% Similarity=-0.003 Sum_probs=117.7
Q ss_pred EEEEecCCcchhhH-----HHHHHHHHHhcCCCCCCcccEEeEEEc--CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCH
Q 022413 126 VAIKKLNPESMQGF-----EEWQSEVNFLGRLSHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSW 198 (297)
Q Consensus 126 vaiK~~~~~~~~~~-----~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 198 (297)
+.+|+.+..+.+.. +....|..-++...|+++...+.-... ....|..++|+.+|.+.+.|-+.-.....++.
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45565554433322 333455555566789888776554432 34678999999999999999765544455555
Q ss_pred HHHHHHHHHHHHHhcchhcC---CCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCccee
Q 022413 199 DIRLKIAIGAARGLGFLHTS---EKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV 275 (297)
Q Consensus 199 ~~~~~i~~~i~~al~yLH~~---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 275 (297)
..+.....+...+..-+|+. ..-.+|++||+-|.+|..+..+|+.++|+.+..... ........+++.|+.|++.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHH
Confidence 55544444446667777752 234789999999999999999999999999832221 1123345678899999988
Q ss_pred cccCCcccccchhhhhhhhhc
Q 022413 276 ATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 276 ~~~~~~~~sDvwslGv~l~~l 296 (297)
..-+++.++|+|..|+.+|.+
T Consensus 1413 N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred HHHhhhhHHHHHHHHHHHHHH
Confidence 888888889999988888753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00093 Score=57.98 Aligned_cols=149 Identities=21% Similarity=0.209 Sum_probs=82.1
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCC-cccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv 173 (297)
+.|..|--..+|+....+.. ..+..+..+++|+...... ......+|..++..+.... ..+++..+. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 34555666788987654321 1223356788898655432 2234467888888875322 345555443 2 468
Q ss_pred EEecCCCCHHHH--------------H---hhcCCCC--C---CCC--HHHHHH--------------------------
Q 022413 174 YEYMQRGSLENH--------------L---FRRNPSI--Q---PLS--WDIRLK-------------------------- 203 (297)
Q Consensus 174 ~e~~~~~~L~~~--------------l---~~~~~~~--~---~~~--~~~~~~-------------------------- 203 (297)
+||++|..+... + +...... . ..+ +.....
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 999988765331 1 1111000 0 011 111100
Q ss_pred HHHHHHHHhcchhc-------CCCCceeccCCCCcEEEcCC----CceEEccccccccC
Q 022413 204 IAIGAARGLGFLHT-------SEKKVIYRDFKASNILLDGN----YNAKISDFGLAKLG 251 (297)
Q Consensus 204 i~~~i~~al~yLH~-------~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~~ 251 (297)
+..++...+.+|-. ....++|+|+.+.|||++++ +.++|+||..|...
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 11112222333321 24678999999999999985 88999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.001 Score=57.03 Aligned_cols=32 Identities=25% Similarity=0.451 Sum_probs=26.7
Q ss_pred CCceeccCCCCcEEEcCCCc-eEEccccccccC
Q 022413 220 KKVIYRDFKASNILLDGNYN-AKISDFGLAKLG 251 (297)
Q Consensus 220 ~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~a~~~ 251 (297)
..++|+|+.|.|||+++++. .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 46899999999999997555 469999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0042 Score=54.82 Aligned_cols=73 Identities=15% Similarity=0.228 Sum_probs=48.0
Q ss_pred eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-------chhhHHHHHHHHHHhcCCC--CC-CcccEEeEEE
Q 022413 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-------SMQGFEEWQSEVNFLGRLS--HP-NLVKLLGYCW 165 (297)
Q Consensus 96 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~ 165 (297)
.||.|....||++...+. +..++||.-.+. -+-..++...|...|+... -| .++++| +.
T Consensus 2 EigdGnlN~VfrV~~~~g---------~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~ 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEG---------DRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HF 70 (370)
T ss_pred cCCCCceEEEEEEEcCCC---------CeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EE
Confidence 578999999999875421 256899875421 1223456667888887664 34 456665 35
Q ss_pred cCCeeEEEEEecCC
Q 022413 166 EDKELLLVYEYMQR 179 (297)
Q Consensus 166 ~~~~~~lv~e~~~~ 179 (297)
++....+|||+++.
T Consensus 71 D~e~~~~vMEdL~~ 84 (370)
T TIGR01767 71 DTEMAVTVMEDLSH 84 (370)
T ss_pred ccccceehHhhCcc
Confidence 56677899999954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0053 Score=55.13 Aligned_cols=73 Identities=16% Similarity=0.108 Sum_probs=48.1
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-------hhHHHHHHHHHHhcCCC---CCCcccEEeE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-------QGFEEWQSEVNFLGRLS---HPNLVKLLGY 163 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~nIv~~~~~ 163 (297)
.+.||.|....||+.... +..++||.-.+... -...+-..|...|+.+. ...+++++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 467899999999996542 33488887652111 12344455666666554 3578888877
Q ss_pred EEcCCeeEEEEEecCC
Q 022413 164 CWEDKELLLVYEYMQR 179 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~ 179 (297)
.. +..+++|||+++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 66 456889999976
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0032 Score=54.65 Aligned_cols=32 Identities=25% Similarity=0.529 Sum_probs=28.7
Q ss_pred CCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 220 KKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 220 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
..++|+|+.+.||+|+..+-+=|.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 46899999999999999888999999998754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0007 Score=66.89 Aligned_cols=147 Identities=20% Similarity=0.131 Sum_probs=103.5
Q ss_pred HHHHHHHHHhcCCCCCCcccEEeEEEcCCe----eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcch
Q 022413 140 EEWQSEVNFLGRLSHPNLVKLLGYCWEDKE----LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215 (297)
Q Consensus 140 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yL 215 (297)
.....|...+.++.|+|++.++.|..+... ..+..+++...++...+..- ...+....+.+..++..||.|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHH
Confidence 344567778888999999999998776532 34556788888888888765 5578889999999999999999
Q ss_pred hcCCCCceeccCCCC---cEEEcCCCceEEc--cccccccCCCCCCcceeeccCCcccccCcceecccCCcc--cccchh
Q 022413 216 HTSEKKVIYRDFKAS---NILLDGNYNAKIS--DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYL--LSAKFG 288 (297)
Q Consensus 216 H~~~~~ivH~Dlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvws 288 (297)
|+ ....|.-|..+ +--.+.++.+.+. ||+..+.+...... .....+..|.+||......+.. ..|+|.
T Consensus 303 h~--~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HS--LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HH--hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence 95 44444444333 3334556666666 88887766544322 2233466788999887655544 479999
Q ss_pred hhhhhhh
Q 022413 289 NVINVCM 295 (297)
Q Consensus 289 lGv~l~~ 295 (297)
+|....-
T Consensus 378 lgll~~~ 384 (1351)
T KOG1035|consen 378 LGLLLLQ 384 (1351)
T ss_pred HHHHHhh
Confidence 9987654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0064 Score=53.88 Aligned_cols=148 Identities=20% Similarity=0.199 Sum_probs=81.3
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCC-cccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv 173 (297)
+.|-.|-.-.+|+..+.... ...+..+++|.........+++ .+|..+++.+..-+ -.++++.+.. . .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~-----~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKE-----GNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCC-----CCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eE
Confidence 34444677789987643210 1124578889876553332233 67888888886333 3455555432 2 58
Q ss_pred EEecCCCCHHHH-----------------HhhcCCCCC--CCCHHHHHHHHHHH-----------------HHHhcc---
Q 022413 174 YEYMQRGSLENH-----------------LFRRNPSIQ--PLSWDIRLKIAIGA-----------------ARGLGF--- 214 (297)
Q Consensus 174 ~e~~~~~~L~~~-----------------l~~~~~~~~--~~~~~~~~~i~~~i-----------------~~al~y--- 214 (297)
++|+++.+|... ++....... ...+..+..+..++ ...+..
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987665311 111111101 11122222222111 111111
Q ss_pred -hh--cCCCCceeccCCCCcEEEcC-CCceEEccccccccCC
Q 022413 215 -LH--TSEKKVIYRDFKASNILLDG-NYNAKISDFGLAKLGP 252 (297)
Q Consensus 215 -LH--~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~ 252 (297)
+. .....++|+|+++.|||+++ ++.+.|+||..+....
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 11 11357899999999999986 4789999999987543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.007 Score=52.65 Aligned_cols=31 Identities=23% Similarity=0.373 Sum_probs=26.8
Q ss_pred CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 368999999999999987 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0065 Score=53.49 Aligned_cols=147 Identities=16% Similarity=0.224 Sum_probs=78.2
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCc-ccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv 173 (297)
+.|..|-...+|+....+.. ..+..|++|+........++ -.+|..+++.+..-++ +++++++ ..+ +|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~-~~G---~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVF-GNG---MI 88 (330)
T ss_pred EEeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEe-CCc---Ee
Confidence 34444666778887554321 01236888877654322222 2678888888864444 4555554 222 58
Q ss_pred EEecCCCCHHH--------------HH---hhcCCC-CCCC-CHHHHHHHHHHH----------------------HHHh
Q 022413 174 YEYMQRGSLEN--------------HL---FRRNPS-IQPL-SWDIRLKIAIGA----------------------ARGL 212 (297)
Q Consensus 174 ~e~~~~~~L~~--------------~l---~~~~~~-~~~~-~~~~~~~i~~~i----------------------~~al 212 (297)
.+|++|..|.. .+ +..... .... .+..+..+..++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 99998765421 11 111100 0101 122222222111 1111
Q ss_pred ----cchhc--CCCCceeccCCCCcEEEcC-CCceEEccccccccCC
Q 022413 213 ----GFLHT--SEKKVIYRDFKASNILLDG-NYNAKISDFGLAKLGP 252 (297)
Q Consensus 213 ----~yLH~--~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~ 252 (297)
.++.. ...-++|+|+.+.|||+++ ++.++++||..|....
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 11211 1234799999999999975 5789999999987543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0023 Score=55.94 Aligned_cols=72 Identities=21% Similarity=0.209 Sum_probs=56.1
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
...|++|++- |+.+.-. ..-.++++..|+++.+.-++-+.. +...=|||+...||||+ +|.+.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeee
Confidence 3567778775 6555322 224567888898887777776765 67889999999999999 99999999999
Q ss_pred ccc
Q 022413 248 AKL 250 (297)
Q Consensus 248 a~~ 250 (297)
+|.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 985
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0099 Score=51.14 Aligned_cols=73 Identities=18% Similarity=0.247 Sum_probs=45.2
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC---CCCcccEEeEEEcCCee
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~ 170 (297)
.+.++-|....+|+.... +..+.+|.-.... ...|..|.+-|+.|. --.+++++++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~~~-----------~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTD-----------GGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEETT-----------S-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEECC-----------CccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 456887888999986522 5678888765222 245677888777773 45688999998888888
Q ss_pred EEEEEecCCC
Q 022413 171 LLVYEYMQRG 180 (297)
Q Consensus 171 ~lv~e~~~~~ 180 (297)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0063 Score=53.49 Aligned_cols=139 Identities=19% Similarity=0.157 Sum_probs=87.1
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc------------------------h-hhH-HHHHHHHH
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES------------------------M-QGF-EEWQSEVN 147 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------------------------~-~~~-~~~~~E~~ 147 (297)
...|..|.-+-||.|.-.+ |..+|||+.+... + +.+ -....|+.
T Consensus 149 nGCiSTGKEANVYHat~~d----------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~R 218 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEED----------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMR 218 (520)
T ss_pred ccccccCccceeEeeecCC----------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHH
Confidence 3456778888899975544 7779999864210 0 111 12346888
Q ss_pred HhcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccC
Q 022413 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF 227 (297)
Q Consensus 148 ~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dl 227 (297)
-|++++...|...--+.. ....|||+++.......-..+ ...++...+..+-.+++.-+.-|-. ..++||.||
T Consensus 219 NLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK----d~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADL 291 (520)
T KOG2270|consen 219 NLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK----DASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADL 291 (520)
T ss_pred HHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccc----cccCChHHHHHHHHHHHHHHHHHHH-Hhceeccch
Confidence 888887666544333222 245899999943211111111 1335555566666666666666654 688999999
Q ss_pred CCCcEEEcCCCceEEcccccccc
Q 022413 228 KASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 228 kp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
.-=|+|+. +|.+.|+|-+=+..
T Consensus 292 SEfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 292 SEFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred hhhhheEE-CCEEEEEEcccccc
Confidence 99999986 67899999876543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0098 Score=53.17 Aligned_cols=75 Identities=17% Similarity=0.252 Sum_probs=50.4
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc------chhhHHHHHHHHHHhcCCC--CC-CcccEEeEE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE------SMQGFEEWQSEVNFLGRLS--HP-NLVKLLGYC 164 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~ 164 (297)
.+.||.|.-.-||++..... +..|+||.-.+. -+-..++...|.+.|+.+. -| .++++| +
T Consensus 34 ~~eigdGnlN~VfrV~~~~~---------~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~ 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQK---------NISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--L 102 (409)
T ss_pred eeEcCCCceEEEEEEeeCCC---------CceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--E
Confidence 46789999999999876321 345888864321 1223466777888888764 34 566665 4
Q ss_pred EcCCeeEEEEEecCC
Q 022413 165 WEDKELLLVYEYMQR 179 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~ 179 (297)
.++....+|||+++.
T Consensus 103 ~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 103 FDSVMNCCVMEDLSD 117 (409)
T ss_pred ECcHHhhHHHHhCcc
Confidence 566677899999964
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.02 Score=49.89 Aligned_cols=32 Identities=16% Similarity=0.228 Sum_probs=29.0
Q ss_pred CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
..+++|+|+.+.|+|+++++.+-++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0046 Score=50.49 Aligned_cols=100 Identities=13% Similarity=0.116 Sum_probs=63.8
Q ss_pred EEEecCCcchh-hHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 022413 127 AIKKLNPESMQ-GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205 (297)
Q Consensus 127 aiK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 205 (297)
.+|++...... ...-+..+.+++.+++ .|+++..- ..-.+-+++|+|-.... .. ..++
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~----~N~i 147 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF----SNFI 147 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch----hHHH
Confidence 44554433222 2244567777877764 46666521 23357788898843111 11 1122
Q ss_pred HHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 206 ~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
.-=+.+|.-.|+...+.+|+|..|+|||-|..|.+||.|-+.
T Consensus 148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 222466778897678999999999999999999999999764
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0055 Score=54.52 Aligned_cols=61 Identities=18% Similarity=0.172 Sum_probs=43.2
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
...++-+|.+|.++..++.... .+++....++.-.++|+--+-- -.+++|.|+.|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEE
Confidence 4577788888999998886532 4455666666655566544332 25799999999999994
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.082 Score=43.64 Aligned_cols=56 Identities=21% Similarity=0.226 Sum_probs=40.2
Q ss_pred cEEEEEecCCcchhhHHHHHHHHHHhcCCC---CCCcccEEeEEEcCCeeEEEEEecCCCCH
Q 022413 124 MVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCWEDKELLLVYEYMQRGSL 182 (297)
Q Consensus 124 ~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~~~L 182 (297)
..+.+|.-... ....|..|+.-|+.|. --.+.+++.+..+.+..|+||||++-+.+
T Consensus 40 ~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 40 DPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred cceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 45777764332 2355667776666654 46688899999999999999999987554
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.042 Score=55.66 Aligned_cols=32 Identities=34% Similarity=0.407 Sum_probs=27.1
Q ss_pred CCCceeccCCCCcEEEcCCC--ceE-Ecccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNY--NAK-ISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~--~~k-l~Dfg~a~~ 250 (297)
..++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 46899999999999999875 565 999998754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.051 Score=48.81 Aligned_cols=31 Identities=23% Similarity=0.132 Sum_probs=25.8
Q ss_pred CCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 220 KKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 220 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
...+|.|+-+.|||.++ ..+.++||..|...
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~n 257 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGFN 257 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccCC
Confidence 56899999999998754 56999999988653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.046 Score=47.96 Aligned_cols=29 Identities=28% Similarity=0.466 Sum_probs=26.1
Q ss_pred ceeccCCCCcEEEcCCCc-eEEcccccccc
Q 022413 222 VIYRDFKASNILLDGNYN-AKISDFGLAKL 250 (297)
Q Consensus 222 ivH~Dlkp~Nill~~~~~-~kl~Dfg~a~~ 250 (297)
+||+|+.|.||+++.+.. .-++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999998875 89999998763
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.19 Score=44.10 Aligned_cols=30 Identities=20% Similarity=0.268 Sum_probs=25.6
Q ss_pred CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
..++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 46799999999999995 4 578999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.026 Score=48.15 Aligned_cols=52 Identities=19% Similarity=0.151 Sum_probs=39.8
Q ss_pred HHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 200 ~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
.....+..+-.++.-.+....-++|+|+.|+|+|+++.+.++|+||..|...
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 3344555666666666641146999999999999999999999999988753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 297 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-41 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-33 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-127
Identities = 88/233 (37%), Positives = 129/233 (55%), Gaps = 33/233 (14%)
Query: 71 LETPDLKVFSFLDLKSATKNFKP------DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
+ FSF +LK+ T NF + +GEGGFG VYKG+V++
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT----------- 55
Query: 125 VVAIKKL----NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRG 180
VA+KKL + + + +++ E+ + + H NLV+LLG+ + +L LVY YM G
Sbjct: 56 TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115
Query: 181 SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240
SL + L + + PLSW +R KIA GAA G+ FLH E I+RD K++NILLD + A
Sbjct: 116 SLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTA 172
Query: 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAK-----FG 288
KISDFGLA+ ++ +T+R++GT Y APE + G ++ K FG
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGE---ITPKSDIYSFG 221
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 361 bits (930), Expect = e-126
Identities = 90/226 (39%), Positives = 133/226 (58%), Gaps = 12/226 (5%)
Query: 53 SQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDD 112
S+ + + L + +DL+ AT NF L+G G FG+VYKG + D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 113 KTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLL 172
G VA+K+ PES QG EE+++E+ L HP+LV L+G+C E E++L
Sbjct: 63 ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112
Query: 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232
+Y+YM+ G+L+ HL+ + +SW+ RL+I IGAARGL +LH + +I+RD K+ NI
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINI 170
Query: 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG 278
LLD N+ KI+DFG++K G ++H++T V GT GY PEY G
Sbjct: 171 LLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG 216
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-109
Identities = 95/205 (46%), Positives = 129/205 (62%), Gaps = 13/205 (6%)
Query: 76 LKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
LK FS +L+ A+ NF ++LG GGFG+VYKG + D G +VA+K+L E
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD----------GTLVAVKRLKEER 66
Query: 136 MQGFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
QG E ++Q+EV + H NL++L G+C E LLVY YM GS+ + L R S
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 195 PLSWDIRLKIAIGAARGLGFLH-TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253
PL W R +IA+G+ARGL +LH + K+I+RD KA+NILLD + A + DFGLAKL
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 254 GGESHVTTRVMGTYGYAAPEYVATG 278
++HVTT V GT G+ APEY++TG
Sbjct: 187 -KDTHVTTAVRGTIGHIAPEYLSTG 210
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 5e-67
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 79 FSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG 138
+L + + + G FG V+K + ++ VA+K + Q
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-----------VAVKIFPIQDKQS 62
Query: 139 FEEWQSEVNFLGRLSHPNLVKLLGYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQ 194
++ + EV L + H N+++ +G +L L+ + ++GSL + L
Sbjct: 63 WQN-EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----N 116
Query: 195 PLSWDIRLKIAIGAARGLGFLHT--------SEKKVIYRDFKASNILLDGNYNAKISDFG 246
+SW+ IA ARGL +LH + + +RD K+ N+LL N A I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 247 LAKLGPAGGESHVTTRVMGTYGYAAPEY 274
LA AG + T +GT Y APE
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEV 204
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 9e-57
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 35/214 (16%)
Query: 79 FSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG 138
+ + N K L+G G +G VYKG +D++ VA+K + + Q
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-----------VAVKVFSFANRQN 51
Query: 139 FEEWQSEVNFLGRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSI 193
F + + + + H N+ + + E LLV EY GSL +L
Sbjct: 52 FIN-EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----- 105
Query: 194 QPLSWDIRLKIAIGAARGLGFLHT-------SEKKVIYRDFKASNILLDGNYNAKISDFG 246
W ++A RGL +LHT + + +RD + N+L+ + ISDFG
Sbjct: 106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 247 LAK------LGPAGGESHVTTRVMGTYGYAAPEY 274
L+ L G E + +GT Y APE
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV 199
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-55
Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
+G G FG V++ W G VA+K L + E+ EV + RL
Sbjct: 45 IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
HPN+V +G + L +V EY+ RGSL L ++ + + L RL +A A+G+
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+LH +++R+ K+ N+L+D Y K+ DFGL++L + S + GT + APE
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPE 209
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-52
Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 33/190 (17%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG-------FEEWQSEVNF 148
+G+GGFG V+KG V D VVAIK L +G F+E+Q EV
Sbjct: 27 IGKGGFGLVHKGRLVKD----------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ L+HPN+VKL G +V E++ G L + L + P+ W ++L++ +
Sbjct: 77 MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDI 131
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD-----GNYNAKISDFGLAKLGPAGGESHVTTRV 263
A G+ ++ +++RD ++ NI L AK++DFGL++ H + +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGL 186
Query: 264 MGTYGYAAPE 273
+G + + APE
Sbjct: 187 LGNFQWMAPE 196
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-52
Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 26/182 (14%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
L E G ++KG W G + +K L ++ E L S
Sbjct: 18 LNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 154 HPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
HPN++ +LG C L+ +M GSL N L + + +K A+ ARG
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARG 123
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
+ FLHT E + + ++++D + A+IS + S + M + A
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVA 176
Query: 272 PE 273
PE
Sbjct: 177 PE 178
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-50
Identities = 56/180 (31%), Positives = 82/180 (45%), Gaps = 25/180 (13%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+G G FG V K W VAIK++ ES + + + E+ L R++HP
Sbjct: 16 VGRGAFGVVCKAKW------------RAKDVAIKQIESESER--KAFIVELRQLSRVNHP 61
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+VKL G C + LV EY + GSL N L P + + + ++G+ +L
Sbjct: 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYL 118
Query: 216 HTSE-KKVIYRDFKASNILLDGNYN-AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
H+ + K +I+RD K N+LL KI DFG A T G+ + APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-50
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 22/180 (12%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
+G G FG VYKG W D VA+K LN + + +++EV L +
Sbjct: 32 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
H N++ +GY + L +V ++ + SL +HL + IA ARG+
Sbjct: 79 HVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMD 134
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+LH K +I+RD K++NI L + KI DFGLA SH ++ G+ + APE
Sbjct: 135 YLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-50
Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 29/198 (14%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LG+G FG+ K G V+ +K+L + + EV + L HP
Sbjct: 18 LGKGCFGQAIKVTH----------RETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N++K +G ++DK L + EY++ G+L + + W R+ A A G+ +L
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYL 124
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL------------GPAGGESHVTTRV 263
H +I+RD + N L+ N N ++DFGLA+L + V
Sbjct: 125 H--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 264 MGTYGYAAPEYVATGNFY 281
+G + APE + G Y
Sbjct: 183 VGNPYWMAPE-MINGRSY 199
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-48
Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 25/183 (13%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLS 153
+G+G FG+VY G W + VAI+ ++ E + ++ EV +
Sbjct: 41 IGKGRFGQVYHGRWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
H N+V +G C L ++ + +L + + L + +IA +G+G
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMG 144
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL---GPAGGESHVTTRVMGTYGYA 270
+LH K ++++D K+ N+ D N I+DFGL + AG G +
Sbjct: 145 YLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 271 APE 273
APE
Sbjct: 202 APE 204
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-47
Identities = 57/191 (29%), Positives = 84/191 (43%), Gaps = 35/191 (18%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQ----GFEEWQSEVNFLGR 151
+G GGFG+VY+ W +G VA+K + + E + E
Sbjct: 15 IGIGGFGKVYRAFW------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
L HPN++ L G C ++ L LV E+ + G L L + + DI + A+ ARG
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARG 117
Query: 212 LGFLHTS-EKKVIYRDFKASNILLD--------GNYNAKISDFGLAKLGPAGGESHVTTR 262
+ +LH +I+RD K+SNIL+ N KI+DFGLA+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMS 173
Query: 263 VMGTYGYAAPE 273
G Y + APE
Sbjct: 174 AAGAYAWMAPE 184
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-45
Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 33/192 (17%)
Query: 96 LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH 154
+G+G +G V++G W G VA+K + + + ++E+ L H
Sbjct: 15 CVGKGRYGEVWRGSW------------QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRH 61
Query: 155 PNLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
N++ + + +L L+ Y + GSL ++L L L+I + A
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIAS 116
Query: 211 GLGFLHTSEK------KVIYRDFKASNILLDGNYNAKISDFGLAKL---GPAGGESHVTT 261
GL LH + +RD K+ NIL+ N I+D GLA + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 262 RVMGTYGYAAPE 273
RV GT Y APE
Sbjct: 177 RV-GTKRYMAPE 187
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-45
Identities = 47/193 (24%), Positives = 73/193 (37%), Gaps = 35/193 (18%)
Query: 96 LLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSE--VNFLGRL 152
+G+G +G V+ G W G VA+K W E + +
Sbjct: 44 QIGKGRYGEVWMGKW------------RGEKVAVKVFFT---TEEASWFRETEIYQTVLM 88
Query: 153 SHPNLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
H N++ + + +L L+ +Y + GSL ++L L LK+A +
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSS 143
Query: 209 ARGLGFLHTSEK------KVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH--VT 260
GL LHT + +RD K+ NIL+ N I+D GLA +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 261 TRVMGTYGYAAPE 273
+GT Y PE
Sbjct: 204 NTRVGTKRYMPPE 216
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-44
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 31/191 (16%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+G+G FG V++G + VA+K + + + ++E+ L H
Sbjct: 49 SIGKGRFGEVWRGKWRGEE-----------VAVKIFSSREERSWFR-EAEIYQTVMLRHE 96
Query: 156 NLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
N++ + +D +L LV +Y + GSL ++L R ++ + +K+A+ A G
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASG 151
Query: 212 LGFLHTSEK------KVIYRDFKASNILLDGNYNAKISDFGLAKL---GPAGGESHVTTR 262
L LH + +RD K+ NIL+ N I+D GLA + R
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 263 VMGTYGYAAPE 273
V GT Y APE
Sbjct: 212 V-GTKRYMAPE 221
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-39
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 65 SPNGQILETPDLKVFSFLDLKSATKN---FKPDSL-----LGEGGFGRVYKGWVDDKTLA 116
+ I T +L + ++ F+ L LG+G FG V
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMC-----RYD 63
Query: 117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE--LLLVY 174
P + G VVA+KKL + + +++ E+ L L H N+VK G C+ L L+
Sbjct: 64 PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123
Query: 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234
EY+ GSL ++L + I + L+ +G+ +L K+ I+RD NIL+
Sbjct: 124 EYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYL--GTKRYIHRDLATRNILV 178
Query: 235 DGNYNAKISDFGLAKLGPAGGE 256
+ KI DFGL K+ P E
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKE 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 91 FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSE 145
F+ L LG+G FG V P + G VVA+KKL + + +++ E
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
+ L L H N+VK G C+ L L+ EY+ GSL ++L + I + L+
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQ 118
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+G+ +L K+ I+RD NIL++ KI DFGL K+
Sbjct: 119 YTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 19/194 (9%)
Query: 65 SPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
+ Q+ D +F LK ++ LG+G FG V P G
Sbjct: 6 HHHAQLYACQDPTIFEERHLKYISQ-------LGKGNFGSVELC-----RYDPLGDNTGA 53
Query: 125 VVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE--LLLVYEYMQRGSL 182
+VA+K+L ++Q E+ L L +VK G + L LV EY+ G L
Sbjct: 54 LVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113
Query: 183 ENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242
+ L R + L + +G+ +L ++ ++RD A NIL++ + KI
Sbjct: 114 RDFLQRHRARLDASRL---LLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKI 168
Query: 243 SDFGLAKLGPAGGE 256
+DFGLAKL P +
Sbjct: 169 ADFGLAKLLPLDKD 182
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-37
Identities = 60/174 (34%), Positives = 84/174 (48%), Gaps = 20/174 (11%)
Query: 91 FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQS 144
F L LGEG FG+V P+ G G +VA+K L ++ Q W+
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLY-----CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ 82
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
E++ L L H +++K G C + L LV EY+ GSL ++L R + + L L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----L 137
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
A G+ +LH + I+RD A N+LLD + KI DFGLAK P G E
Sbjct: 138 LFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-37
Identities = 47/156 (30%), Positives = 70/156 (44%), Gaps = 17/156 (10%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH 154
+G G FG V+ G D TL VA+K ++ E L + SH
Sbjct: 122 IGRGNFGEVFSGRLRADNTL----------VAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
PN+V+L+G C + + + +V E +Q G L R L L++ AA G+ +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEG--ARLRVKTLLQMVGDAAAGMEY 228
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
L K I+RD A N L+ KISDFG+++
Sbjct: 229 LE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-37
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 28/198 (14%)
Query: 67 NGQILETPDLKVFSFLDLKSATKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTG 121
G I+E P + + + K + LGEG FG+V+ + K
Sbjct: 20 QGHIIENPQYFSDACV------HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKM- 72
Query: 122 LGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGS 181
+VA+K L S +++Q E L L H ++V+ G C E + LL+V+EYM+ G
Sbjct: 73 ---LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129
Query: 182 LENHLFRRNP-----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230
L L P + PL L +A A G+ +L + ++RD
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATR 187
Query: 231 NILLDGNYNAKISDFGLA 248
N L+ KI DFG++
Sbjct: 188 NCLVGQGLVVKIGDFGMS 205
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LGEG FG+V+ + + K +VA+K L ++ +++Q E L L H +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKM----LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI------------QPLSWDIRLKI 204
+VK G C + L++V+EYM+ G L L P L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
A A G+ +L + + ++RD N L+ N KI DFG++
Sbjct: 139 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 72 ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
E P+ + L K +LG G FG VYKG P + + VAIK+L
Sbjct: 2 EAPNQALLRILKETEFKK----IKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKEL 52
Query: 132 NPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
+ +E E + + +P++ +LLG C + L+ + M G L +++
Sbjct: 53 REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK 111
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+I L + A+G+ +L ++++++RD A N+L+ + KI+DFGLAKL
Sbjct: 112 DNIGSQY---LLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-36
Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 13/163 (7%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
LGEG FG+V P G VA+K L PES + + E+ L L H
Sbjct: 29 LGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 156 NLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
N+VK G C ED + L+ E++ GSL+ +L + I +LK A+ +G+
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGMD 140
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
+L ++ ++RD A N+L++ + KI DFGL K E
Sbjct: 141 YL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-36
Identities = 50/155 (32%), Positives = 83/155 (53%), Gaps = 16/155 (10%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LG G +G VY+G W + VA+K L ++M+ EE+ E + + HP
Sbjct: 21 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHP 69
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
NLV+LLG C + ++ E+M G+L ++L R + Q +S + L +A + + +L
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+K I+RD A N L+ N+ K++DFGL++L
Sbjct: 128 --EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-36
Identities = 54/196 (27%), Positives = 80/196 (40%), Gaps = 22/196 (11%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
K++ LGEGGF V L G A+K++ Q EE Q E +
Sbjct: 29 KHYLFIQKLGEGGFSYVD--------LVEGLHD-GHFYALKRILCHEQQDREEAQREADM 79
Query: 149 LGRLSHPNLVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
+HPN+++L+ YC ++ E L+ + +RG+L N + R L+ D L +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
+G RGL +H K +RD K +NILL + D G E +
Sbjct: 140 LLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 265 -------GTYGYAAPE 273
T Y APE
Sbjct: 198 QDWAAQRCTISYRAPE 213
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
LG+G FG VY+G +T VAIK +N + E+ +E + + +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPET----RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHL------FRRNPSIQPLSWDIRLKIAIGAA 209
++V+LLG + + L++ E M RG L+++L NP + P S +++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
G+ +L + K ++RD A N ++ ++ KI DFG+ +
Sbjct: 149 DGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 6e-35
Identities = 49/155 (31%), Positives = 83/155 (53%), Gaps = 16/155 (10%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LG G +G VY+G W + VA+K L ++M+ EE+ E + + HP
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHP 276
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
NLV+LLG C + ++ E+M G+L ++L R + Q +S + L +A + + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+K I+R+ A N L+ N+ K++DFGL++L
Sbjct: 335 --EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-35
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
LGEG FG+V + K + VA+K L ++ + + SE+ + + H
Sbjct: 89 LGEGCFGQVVMAEAVG--IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
N++ LLG C +D L ++ EY +G+L +L R P S+DI +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
ARG+ +L + +K I+RD A N+L+ N KI+DFGLA+
Sbjct: 207 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-35
Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSH 154
LGEG FG V +G + G + VA+K + ++ + EE+ SE + SH
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 155 PNLVKLLGYCWEDK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR--LKIAIG 207
PN+++LLG C E + +++ +M+ G L +L P ++ LK +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A G+ +L S + ++RD A N +L + ++DFGL+K
Sbjct: 156 IALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-35
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
LGEG FG+V + K + VA+K L ++ + + SE+ + + H
Sbjct: 43 LGEGAFGQVVMAEAVG--IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
N++ LLG C +D L ++ EY +G+L +L R P S+DI +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
ARG+ +L + +K I+RD A N+L+ N KI+DFGLA+
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 17/163 (10%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
LG+G F +++KG + + V +K L+ E + + + +LSH
Sbjct: 16 LGQGTFTKIFKGVR---REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+LV G C E +LV E+++ GSL+ +L ++N + + W +L++A A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 216 HTSEKKVIYRDFKASNILLDG--------NYNAKISDFGLAKL 250
E +I+ + A NILL K+SD G++
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 72 ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
E P+ + L K +LG G FG VYKG P + + VAIK+L
Sbjct: 2 EAPNQALLRILKETEFKK----IKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKEL 52
Query: 132 NPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
+ +E E + + +P++ +LLG C + L+ + M G L +++
Sbjct: 53 REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK 111
Query: 191 PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+I L + A+G+ +L ++++++RD A N+L+ + KI+DFGLAKL
Sbjct: 112 DNIGSQY---LLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 18/154 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+G+G FG V G VA+K + ++ + + +E + + +L H N
Sbjct: 29 IGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATA--QAFLAEASVMTQLRHSN 75
Query: 157 LVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
LV+LLG E+K L +V EYM +GSL ++L R+ L D LK ++ + +L
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
++RD A N+L+ + AK+SDFGL K
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 20/155 (12%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+G+G FG V G + +K VA+K + ++ + + +E + + +L H
Sbjct: 201 IGKGEFGDVMLGDYRGNK------------VAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 156 NLVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
NLV+LLG E+K L +V EYM +GSL ++L R+ L D LK ++ + +
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
L ++RD A N+L+ + AK+SDFGL K
Sbjct: 305 L--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 23/175 (13%)
Query: 91 FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQS 144
F ++L LG G FG+V + + VA+K L + E S
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL----KVAVKMLKSTAHADEKEALMS 98
Query: 145 EVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ--------- 194
E+ + L H N+V LLG C +L++ EY G L N L R++ ++
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 195 -PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
S L + A+G+ FL + K I+RD A N+LL + AKI DFGLA
Sbjct: 159 STASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 51/165 (30%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
LGE FG+VYKG + VAIK L ++ EE++ E RL HP
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQ----AVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------LK 203
N+V LLG +D+ L +++ Y G L L R+P S D +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
+ A G+ +L S V+++D N+L+ N KISD GL
Sbjct: 133 LVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-34
Identities = 56/168 (33%), Positives = 84/168 (50%), Gaps = 23/168 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-S 153
++GEG FG+V K + K GL M AIK++ + + ++ E+ L +L
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------ 201
HPN++ LLG C L L EY G+L + L + ++ I
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
L A ARG+ +L S+K+ I+RD A NIL+ NY AKI+DFGL++
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-34
Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 27/174 (15%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHP 155
LGEG FG+V K T VA+K L + + SE N L +++HP
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYT----TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR--------------------NPSIQP 195
+++KL G C +D LLL+ EY + GSL L +P +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
L+ + A ++G+ +L +E K+++RD A NIL+ KISDFGL++
Sbjct: 147 LTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
LGEG FG+V L K VA+K L ++ + + SE+ + + H
Sbjct: 77 LGEGAFGQVVLAEAIG--LDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------L 202
N++ LLG C +D L ++ EY +G+L +L R P S++ +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A ARG+ +L + KK I+RD A N+L+ + KI+DFGLA+
Sbjct: 195 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
+F+ ++LG+G FG+V K + AIKK+ + SEV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVK--ARNALD-------SRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 148 FLGRLSHPNLVKLLGYCWEDKE--------------LLLVYEYMQRGSLENHLFRRNPSI 193
L L+H +V+ W ++ L + EY + G+L + + N +
Sbjct: 55 LLASLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 194 QP-LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL-- 250
Q W + +I L ++H + +I+RD K NI +D + N KI DFGLAK
Sbjct: 114 QRDEYWRLFRQIL----EALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 251 -----------GPAGGESHVTTRVMGTYGYAAPE 273
G ++T+ + GT Y A E
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE 200
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 83 DLKSATKNFKPD---------SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNP 133
+L A ++ ++G G FG VY G G + A+K LN
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNR 63
Query: 134 E-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHL--FRR 189
+ ++ +E + SHPN++ LLG C + L+V YM+ G L N +
Sbjct: 64 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 123
Query: 190 NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
NP+++ L + + A+G+ +L + KK ++RD A N +LD + K++DFGLA+
Sbjct: 124 NPTVKDL-----IGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 48/160 (30%), Positives = 69/160 (43%), Gaps = 13/160 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
LG G FG VY+G V PS VA+K L Q ++ E + + +H
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPL----QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI---QPLSWDIRLKIAIGAARGL 212
N+V+ +G + ++ E M G L++ L P L+ L +A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 213 GFLHTSEKKVIYRDFKASNILLDG---NYNAKISDFGLAK 249
+L E I+RD A N LL AKI DFG+A+
Sbjct: 154 QYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-33
Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 16/154 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V G + VA+K + SM +E+ E + +LSHP
Sbjct: 16 LGSGQFGVVKLGKWKGQYD----------VAVKMIKEGSMSE-DEFFQEAQTMMKLSHPK 64
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LVK G C ++ + +V EY+ G L N+L L L++ G+ FL
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL- 120
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+ I+RD A N L+D + K+SDFG+ +
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 84 LKSATKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-Q 137
+K + FK L LG G FG V+KG P + + V IK + +S Q
Sbjct: 3 MKVLARIFKETELRKLKVLGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQ 57
Query: 138 GFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
F+ + +G L H ++V+LLG C L LV +Y+ GSL +H+ + ++ P
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL 116
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
L + A+G+ +L E +++R+ A N+LL +++DFG+A L
Sbjct: 117 ---LLNWGVQIAKGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 38/163 (23%), Positives = 71/163 (43%), Gaps = 18/163 (11%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSH 154
LG+G FG V + + G + VA+K L + + EE+ E + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 155 PNLVKLLGYCWED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR--LKIAI 206
P++ KL+G +++ +M+ G L L P + ++ ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A G+ +L S + I+RD A N +L + ++DFGL++
Sbjct: 145 DIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-33
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 16/179 (8%)
Query: 72 ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
P + + K+ LG G FG V G + VAIK +
Sbjct: 7 NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD----------VAIKMI 56
Query: 132 NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP 191
SM +E+ E + LSH LV+L G C + + + ++ EYM G L N+L
Sbjct: 57 KEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH 115
Query: 192 SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
Q L++ + +L K+ ++RD A N L++ K+SDFGL++
Sbjct: 116 RFQT---QQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 49/160 (30%), Positives = 70/160 (43%), Gaps = 13/160 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
LG G FG VY+G V PS VA+K L S Q ++ E + + +H
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPL----QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI---QPLSWDIRLKIAIGAARGL 212
N+V+ +G + ++ E M G L++ L P L+ L +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 213 GFLHTSEKKVIYRDFKASNILLDG---NYNAKISDFGLAK 249
+L E I+RD A N LL AKI DFG+A+
Sbjct: 195 QYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-33
Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 16/154 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+G G FG V+ G+ +K VAIK + +M E++ E + +LSHP
Sbjct: 16 IGSGQFGLVHLGYWLNKDK----------VAIKTIREGAMSE-EDFIEEAEVMMKLSHPK 64
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LV+L G C E + LV E+M+ G L ++L R + + L + + G+ +L
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRG--LFAAETLLGMCLDVCEGMAYL- 120
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
E VI+RD A N L+ N K+SDFG+ +
Sbjct: 121 -EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 39/213 (18%), Positives = 81/213 (38%), Gaps = 37/213 (17%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
+++ L +G F ++ L A+KK ++ ++
Sbjct: 32 DYRIIRTLNQGKFNKII--------LCEKD---NKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 145 ------------EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS 192
E+ + + + + G E+ ++YEYM+ S+
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 193 IQPLSWDIRLKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
+ + I +++ + ++H +EK + +RD K SNIL+D N K+SDFG +
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
+ + + GTY + PE+ + + Y
Sbjct: 200 EYMV---DKKIKG-SRGTYEFMPPEFFSNESSY 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 46 SAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRV 105
+ + SE ++ PN P L L L+ N + +GEG FGRV
Sbjct: 4 ESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRV 63
Query: 106 YKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164
++ T +VA+K L E+ ++Q E + +PN+VKLLG C
Sbjct: 64 FQARAPGLLPYEPFT----MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119
Query: 165 WEDKELLLVYEYMQRGSLENHLFRRNP--------------------SIQPLSWDIRLKI 204
K + L++EYM G L L +P PLS +L I
Sbjct: 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
A A G+ +L SE+K ++RD N L+ N KI+DFGL++
Sbjct: 180 ARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 41/217 (18%)
Query: 94 DSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLG 150
D LG G FG V KG + K + VA+K L E+ +E +E N +
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKT--------VAVKILKNEANDPALKDELLAEANVMQ 73
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
+L +P +V+++G C E + +LV E + G L +L ++N ++ + +++ +
Sbjct: 74 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKN---IIELVHQVSM 128
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG----- 265
G+ +L E ++RD A N+LL + AKISDFGL+K A E++ + G
Sbjct: 129 GMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVK 185
Query: 266 -TYGYAAPEYVATGNFYLLSAK-----FGNVINVCMY 296
APE + F S+K FG V M+
Sbjct: 186 WY----APECINYYKF---SSKSDVWSFG----VLMW 211
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 52/154 (33%), Positives = 83/154 (53%), Gaps = 16/154 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V+ G+ + T VA+K L SM + + +E N + +L H
Sbjct: 21 LGAGQFGEVWMGYYNGHT----------KVAVKSLKQGSMSP-DAFLAEANLMKQLQHQR 69
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LV+L ++ + ++ EYM+ GSL + L + PS L+ + L +A A G+ F+
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI- 125
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
E+ I+RD +A+NIL+ + KI+DFGLA+L
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 21/168 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRL-SH 154
LG G FG+V + KT VA+K L + SE+ L + H
Sbjct: 35 LGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 155 PNLVKLLGYC-WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------------ 201
N+V LLG C L+++ E+ + G+L +L + P
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ + A+G+ FL + +K I+RD A NILL KI DFGLA+
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 38/202 (18%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
+FK L+G GGFG+V+K + G IK++ + + + EV
Sbjct: 11 MDFKEIELIGSGGFGQVFK--AKHRID-------GKTYVIKRVKYNNEKA----EREVKA 57
Query: 149 LGRLSHPNLVKLLGYCWEDKE-----------------LLLVYEYMQRGSLENHLFRRNP 191
L +L H N+V G CW+ + L + E+ +G+LE + +R
Sbjct: 58 LAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 192 SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251
+ L + L++ +G+ ++H KK+I RD K SNI L KI DFGL
Sbjct: 117 --EKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS- 171
Query: 252 PAGGESHVTTRVMGTYGYAAPE 273
+ T GT Y +PE
Sbjct: 172 -LKNDGKRTRSK-GTLRYMSPE 191
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 53/189 (28%), Positives = 77/189 (40%), Gaps = 23/189 (12%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEE-WQSEVNFLGRL 152
LG+G FG VY LA K ++A+K L ++ G E + EV L
Sbjct: 16 PLGKGKFGNVY--------LAREKQS-KFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
HPN+++L GY + + L+ EY G++ L + A L
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANAL 122
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
+ H K+VI+RD K N+LL KI+DFG + P GT Y P
Sbjct: 123 SYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPP 176
Query: 273 EYVATGNFY 281
E + G +
Sbjct: 177 E-MIEGRMH 184
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
+G G FG VYKG L S + VAIK L + ++ E +G+ SH
Sbjct: 52 IGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+++L G + K ++++ EYM+ G+L+ L R S + + G A G+ +L
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDG--EFSVLQLVGMLRGIAAGMKYL 163
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+ ++RD A NIL++ N K+SDFGL+++
Sbjct: 164 --ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 56/179 (31%), Positives = 75/179 (41%), Gaps = 27/179 (15%)
Query: 91 FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQS 144
F + L LG G FG+V + + + VA+K L P + E S
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM----TVAVKMLKPSAHLTEREALMS 75
Query: 145 EVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI---------- 193
E+ L L +H N+V LLG C L++ EY G L N L R+ S
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 194 ----QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
L + L + A+G+ FL + K I+RD A NILL KI DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
LGEG FG VY+G + + G + VA+K + E++ SE + L HP
Sbjct: 20 LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
++VKL+G E++ ++ E G L ++L R S++ L+ + ++ + + +L
Sbjct: 74 HIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYL 129
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
++RD NIL+ K+ DFGL++
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 37/209 (17%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVN 147
+F+P LG GGFG V++ +K AIK++ + + E+ EV
Sbjct: 5 TDFEPIQCLGRGGFGVVFE--AKNKVD-------DCNYAIKRIRLPNRELAREKVMREVK 55
Query: 148 FLGRLSHPNLVKLLGYCWEDKE-------------LLLVYEYMQRGSLENHLFRRNPSIQ 194
L +L HP +V+ W +K L + + ++ +L++ + R +I+
Sbjct: 56 ALAKLEHPGIVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIE 113
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL---- 250
+ L I + A + FLH K +++RD K SNI + K+ DFGL
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 251 ------GPAGGESHVTTRVMGTYGYAAPE 273
T +GT Y +PE
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPE 200
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 13/155 (8%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
+GEG FG V++G + S + VAIK + E++ E + + HP
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
++VKL+G + + ++ E G L + L R S+ S + A + L +L
Sbjct: 77 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALAYL 132
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
K+ ++RD A N+L+ N K+ DFGL++
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 55/232 (23%), Positives = 102/232 (43%), Gaps = 26/232 (11%)
Query: 24 SSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPD--LKVFSF 81
S + S + ++ + Q + ++ ++ N ++++ + S
Sbjct: 29 RGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSS 88
Query: 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFE 140
L + + ++G G FG VY G G + A+K LN +
Sbjct: 89 LIVHF-------NEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVS 135
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHL--FRRNPSIQPLS 197
++ +E + SHPN++ LLG C + L+V YM+ G L N + NP+++ L
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL- 194
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ + A+G+ FL + KK ++RD A N +LD + K++DFGLA+
Sbjct: 195 ----IGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 50/184 (27%), Positives = 73/184 (39%), Gaps = 32/184 (17%)
Query: 91 FKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQS 144
F ++L LG G FG+V + VA+K L ++ E S
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI----QVAVKMLKEKADSSEREALMS 97
Query: 145 EVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR-- 201
E+ + +L SH N+V LLG C + L++EY G L N+L + +
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 202 -----------------LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244
L A A+G+ FL K ++RD A N+L+ KI D
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 245 FGLA 248
FGLA
Sbjct: 216 FGLA 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 54/228 (23%), Positives = 88/228 (38%), Gaps = 21/228 (9%)
Query: 57 SEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLA 116
A+P P ++ L + + + LG+GGF + ++ D T
Sbjct: 9 KAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI-SDADT-- 65
Query: 117 PSKTGLGMVVAIKKLNPESMQGF---EEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173
V A K + + E+ E++ L+H ++V G+ ++ + +V
Sbjct: 66 ------KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119
Query: 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233
E +R SL RR + L+ G +LH +VI+RD K N+
Sbjct: 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLF 173
Query: 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
L+ + KI DFGLA GE GT Y APE V + +
Sbjct: 174 LNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPE-VLSKKGH 218
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 17/187 (9%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
+ + +GEG FG+ V G IK++N M + EE + EV
Sbjct: 24 EKYVRLQKIGEGSFGKAIL--VKSTED-------GRQYVIKEINISRMSSKEREESRREV 74
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L + HPN+V+ E+ L +V +Y + G L + + D L +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFV 132
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
L +H ++K+++RD K+ NI L + ++ DFG+A++ + +GT
Sbjct: 133 QICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGT 188
Query: 267 YGYAAPE 273
Y +PE
Sbjct: 189 PYYLSPE 195
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHP 155
+G G G V G + VAIK L + ++ SE + +G+ HP
Sbjct: 57 IGSGDSGEVCYG------RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+++L G + ++V EYM+ GSL+ L R + + + + G G+ +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHD--GQFTIMQLVGMLRGVGAGMRYL 167
Query: 216 HTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
S+ ++RD A N+L+D N K+SDFGL+++
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-32
Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHP 155
+G+G FG VY G + + AIK L+ MQ E + E + L+HP
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 156 NLVKLLGYCWEDKE-LLLVYEYMQRGSLENHL--FRRNPSIQPLSWDIRLKIAIGAARGL 212
N++ L+G + ++ YM G L + +RNP+++ L + + ARG+
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGM 137
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+L +E+K ++RD A N +LD ++ K++DFGLA+
Sbjct: 138 EYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-32
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEE-WQSE 145
++FK +LLG+G F VY+ T G+ VAIK ++ ++M G + Q+E
Sbjct: 11 EDFKVGNLLGKGSFAGVYRA-ESIHT--------GLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
V +L HP++++L Y + + LV E G + +L R +P S +
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFM 118
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
G+ +LH +++RD SN+LL N N KI+DFGLA E H T G
Sbjct: 119 HQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CG 174
Query: 266 TYGYAAPEYVATGNFY 281
T Y +PE +AT + +
Sbjct: 175 TPNYISPE-IATRSAH 189
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-32
Identities = 50/196 (25%), Positives = 79/196 (40%), Gaps = 21/196 (10%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEE-WQSE 145
+ + LG+GGF + ++ D T V A K + + E E
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI-SDADT--------KEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
++ L+H ++V G+ ++ + +V E +R SL RR + L+
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYL 121
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
G +LH +VI+RD K N+ L+ + KI DFGLA GE G
Sbjct: 122 RQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CG 177
Query: 266 TYGYAAPEYVATGNFY 281
T Y APE V + +
Sbjct: 178 TPNYIAPE-VLSKKGH 192
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-32
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRL 152
LG+G FG V +G W + +G + VA+K L P+ + + +++ EVN + L
Sbjct: 26 LGDGSFGVVRRGEW-------DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
H NL++L G + +V E GSL + L + + A+ A G+
Sbjct: 79 DHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGM 134
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
G+L K+ I+RD A N+LL KI DFGL +
Sbjct: 135 GYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-32
Identities = 36/192 (18%), Positives = 78/192 (40%), Gaps = 28/192 (14%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQ 143
+ + +G GG +V++ V ++ + AIK + + +++ + +
Sbjct: 28 RIYSILKQIGSGGSSKVFQ--VLNEK--------KQIYAIKYVNLEEADNQTLDSY---R 74
Query: 144 SEVNFLGRLSHPNL--VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
+E+ +L +L + ++L Y D+ + +V E L + L ++ + + R
Sbjct: 75 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK----KSIDPWER 129
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
+ +H + +++ D K +N L+ K+ DFG+A S V
Sbjct: 130 KSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186
Query: 262 RVMGTYGYAAPE 273
+GT Y PE
Sbjct: 187 SQVGTVNYMPPE 198
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 9e-32
Identities = 39/223 (17%), Positives = 74/223 (33%), Gaps = 18/223 (8%)
Query: 63 EASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGL 122
+ PN + + + + +K LLGEG F +VY+ L +K
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYE--ATQGDLNDAKNK- 95
Query: 123 GMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL 182
+K P + F + L +K +LV E G+L
Sbjct: 96 -QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 183 ENHL-FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL------- 234
N + +N + + + + A+ + +H + ++I+ D K N +L
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQ 212
Query: 235 ----DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
D + + D G + + + T T G+ E
Sbjct: 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 24/210 (11%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQ 143
++ + +LG+G V++ KT G + AIK N S +
Sbjct: 5 STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55
Query: 144 SEVNFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
E L +L+H N+VKL E+ + +L+ E+ GSL L + + L
Sbjct: 56 REFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESE 113
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGNYNAKISDFGLAKLGPAGGE 256
L + G+ L E +++R+ K NI+ DG K++DFG A+ +
Sbjct: 114 FLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDD 169
Query: 257 SHVTTRVMGTYGYAAPEYVATGNFYLLSAK 286
+ GT Y P+ K
Sbjct: 170 EQFVSLY-GTEEYLHPDMYERAVLRKDHQK 198
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 57/196 (29%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVNF 148
K D +G G F VYKG +D +T + VA + + + ++ E
Sbjct: 28 LKFDIEIGRGSFKTVYKG-LDTET--------TVEVAWCELQDRKLTKSERQRFKEEAEM 78
Query: 149 LGRLSHPNLVKLLGYCWED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
L L HPN+V+ WE K ++LV E M G+L+ +L R + + +
Sbjct: 79 LKGLQHPNIVRFYD-SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRS 133
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKISDFGLAKLGPAGGESHVTTR 262
+GL FLHT +I+RD K NI + G + KI D GLA L +
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKA 189
Query: 263 VMGTYGYAAPEYVATG 278
V+GT + APE
Sbjct: 190 VIGTPEFMAPEMYEEK 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVN 147
N D ++G G FG V G + + VAIK L + ++ E +
Sbjct: 45 TNISIDKVVGAGEFGEVCSG------RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
+G+ HPN+++L G + K +++V EYM+ GSL++ L + + + + + G
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRG 155
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
A G+ +L S+ ++RD A NIL++ N K+SDFGL ++
Sbjct: 156 IASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 17/184 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG+G FG V+ G + T VAIK L P +M E + E + +L H
Sbjct: 192 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 240
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LV+L E+ + +V EYM +GSL + L + + + L + +A A G+ ++
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV- 296
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA 276
++RD +A+NIL+ N K++DFGLA+L E + APE
Sbjct: 297 -ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 277 TGNF 280
G F
Sbjct: 355 YGRF 358
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 24/210 (11%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQ 143
++ + +LG+G V++ KT G + AIK N S +
Sbjct: 5 STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55
Query: 144 SEVNFLGRLSHPNLVKLLGYCWED---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
E L +L+H N+VKL E+ + +L+ E+ GSL L + + L
Sbjct: 56 REFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESE 113
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGNYNAKISDFGLAKLGPAGGE 256
L + G+ L E +++R+ K NI+ DG K++DFG A+ +
Sbjct: 114 FLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDD 169
Query: 257 SHVTTRVMGTYGYAAPEYVATGNFYLLSAK 286
+ GT Y P+ K
Sbjct: 170 EQFVSLY-GTEEYLHPDMYERAVLRKDHQK 198
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 35/192 (18%), Positives = 77/192 (40%), Gaps = 28/192 (14%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQ 143
+ + +G GG +V++ ++ + AIK + + +++ + +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVL--NEK--------KQIYAIKYVNLEEADNQTLDSY---R 55
Query: 144 SEVNFLGRLSHPNL--VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
+E+ +L +L + ++L Y D+ + +V E L + L ++ + + R
Sbjct: 56 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK----KSIDPWER 110
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
+ +H + +++ D K +N L+ K+ DFG+A S V
Sbjct: 111 KSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 167
Query: 262 RVMGTYGYAAPE 273
+GT Y PE
Sbjct: 168 SQVGTVNYMPPE 179
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-31
Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 16/154 (10%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V+ + T VA+K + P SM E + +E N + L H
Sbjct: 196 LGAGQFGEVWMATYNKHTK----------VAVKTMKPGSMSV-EAFLAEANVMKTLQHDK 244
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LVKL ++ + ++ E+M +GSL + L ++ + + A G+ F+
Sbjct: 245 LVKLHAVVTKEP-IYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFI- 300
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
++ I+RD +A+NIL+ + KI+DFGLA++
Sbjct: 301 -EQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 53/189 (28%), Positives = 80/189 (42%), Gaps = 23/189 (12%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEE-WQSEVNFLGRL 152
LG+G FG VY LA K ++A+K L ++ G E + E+ L
Sbjct: 21 PLGKGKFGNVY--------LAREKQN-KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
HPN++++ Y + K + L+ E+ RG L L + A L
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADAL 127
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
+ H E+KVI+RD K N+L+ KI+DFG + P S + GT Y P
Sbjct: 128 HYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMCGTLDYLPP 181
Query: 273 EYVATGNFY 281
E + G +
Sbjct: 182 E-MIEGKTH 189
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 13/163 (7%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVN 147
+ + +GEG FG V++G + S M VAIK + E++ E
Sbjct: 390 ERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
+ + HP++VKL+G + + ++ E G L + L R S+ S + A
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQ 499
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+ L +L K+ ++RD A N+L+ N K+ DFGL++
Sbjct: 500 LSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 18/197 (9%)
Query: 84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEE 141
+ S ++++ +G G +GR K + K+ G ++ K+L+ SM +
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQK--IRRKSD-------GKILVWKELDYGSMTEAEKQM 51
Query: 142 WQSEVNFLGRLSHPNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
SEVN L L HPN+V+ + L +V EY + G L + + + Q L +
Sbjct: 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 200 IRLKIAIGAARGLGFLH---TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
L++ L H V++RD K +N+ LDG N K+ DFGLA++ +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHD 169
Query: 257 SHVTTRVMGTYGYAAPE 273
+ +GT Y +PE
Sbjct: 170 TSFAKTFVGTPYYMSPE 186
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 17/184 (9%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG+G FG V+ G + T VAIK L P +M E + E + +L H
Sbjct: 275 LGQGCFGEVWMGTWNGTTR----------VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 323
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLH 216
LV+L E+ + +V EYM +GSL + L + + + L + +A A G+ ++
Sbjct: 324 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV- 379
Query: 217 TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA 276
++RD +A+NIL+ N K++DFGLA+L E + APE
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 277 TGNF 280
G F
Sbjct: 438 YGRF 441
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 39/245 (15%), Positives = 89/245 (36%), Gaps = 29/245 (11%)
Query: 36 HTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDS 95
H +G + + A E ++ G + + + + +
Sbjct: 4 HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS-ANECISVKGRIYSILK 62
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLG 150
+G GG +V++ ++ + AIK + + +++ + ++E+ +L
Sbjct: 63 QIGSGGSSKVFQVL--NEK--------KQIYAIKYVNLEEADNQTLDSY---RNEIAYLN 109
Query: 151 RLSHPNL--VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+L + ++L Y D+ + +V E L + L ++ + + R
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK----KSIDPWERKSYWKNM 164
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
+ +H + +++ D K +N L+ K+ DFG+A S V +G
Sbjct: 165 LEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 269 YAAPE 273
Y PE
Sbjct: 222 YMPPE 226
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 39/213 (18%)
Query: 97 LGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSH 154
LG G FG V +G + K VAIK L + EE E + +L +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQID--------VAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGF 214
P +V+L+G C + + L+LV E G L L + I + ++ + G+ +
Sbjct: 70 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMGMKY 125
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG------TYG 268
L EK ++RD A N+LL + AKISDFGL+K A +S+ T R G
Sbjct: 126 L--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWY-- 180
Query: 269 YAAPEYVATGNFYLLSAK-----FGNVINVCMY 296
APE + F S++ +G V M+
Sbjct: 181 --APECINFRKF---SSRSDVWSYG----VTMW 204
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 3e-30
Identities = 57/194 (29%), Positives = 79/194 (40%), Gaps = 25/194 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNF 148
++ LG GGFG V + W+ T G VAIK+ E E W E+
Sbjct: 15 PWEMKERLGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 149 LGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
+ +L+HPN+V + LL EY + G L +L + + L
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIR 124
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA---KISDFGLAKLGPAGGESHV 259
+ + L +LH E ++I+RD K NI+L KI D G AK G
Sbjct: 125 TLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELC 180
Query: 260 TTRVMGTYGYAAPE 273
T V GT Y APE
Sbjct: 181 TEFV-GTLQYLAPE 193
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-30
Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 27/195 (13%)
Query: 94 DSLLGEGGFGRVYKG-WVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGR 151
D LG G FG V +G + K VAIK L + EE E + +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQID--------VAIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
L +P +V+L+G C + + L+LV E G L L + I + ++ + G
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMG 448
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG------ 265
+ +L EK ++R+ A N+LL + AKISDFGL+K A +S+ T R G
Sbjct: 449 MKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKW 505
Query: 266 TYGYAAPEYVATGNF 280
APE + F
Sbjct: 506 Y----APECINFRKF 516
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 20/190 (10%)
Query: 89 KNFKPDSLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ--- 143
NF+ + +G G F VY+ +D G+ VA+KK+ + +
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLD-----------GVPVALKKVQIFDLMDAKARADCI 80
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
E++ L +L+HPN++K ED EL +V E G L + + + K
Sbjct: 81 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRV 263
+ L +H ++V++RD K +N+ + K+ D GL + + + + V
Sbjct: 141 YFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV 197
Query: 264 MGTYGYAAPE 273
GT Y +PE
Sbjct: 198 -GTPYYMSPE 206
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 55/245 (22%), Positives = 87/245 (35%), Gaps = 28/245 (11%)
Query: 36 HTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSAT-KNFKPD 94
H S+ ++ + Q++ + S G+ ET + +S ++F+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL 62
Query: 95 SLLGEGGFGRVYKG--WVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--EVNFLG 150
S LG G +G V+K D G + A+K+ + + EV
Sbjct: 63 SRLGHGSYGEVFKVRSKED-----------GRLYAVKRSMSPFRGPKDRARKLAEVGSHE 111
Query: 151 RL-SHPNLVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
++ HP V+L WE+ +L L E SL+ H L
Sbjct: 112 KVGQHPCCVRLEQ-AWEEGGILYLQTELCG-PSLQQHCEAWG---ASLPEAQVWGYLRDT 166
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
L LH + +++ D K +NI L K+ DFGL G V G
Sbjct: 167 LLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPR 221
Query: 269 YAAPE 273
Y APE
Sbjct: 222 YMAPE 226
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 30/242 (12%)
Query: 36 HTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDS 95
H++ A + S+G ++ + E E + L+ D + +
Sbjct: 11 HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY------EYREEVHWMTHQP 64
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+G G FG V++ D +T G A+KK+ E + E+ LS P
Sbjct: 65 RVGRGSFGEVHRM-KDKQT--------GFQCAVKKVRLEVFR-----VEELVACAGLSSP 110
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
+V L G E + + E ++ GSL + + L D L A GL +L
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYL 166
Query: 216 HTSEKKVIYRDFKASNILLDGN-YNAKISDFGLAK-LGPAGGESHVTTR--VMGTYGYAA 271
H +++++ D KA N+LL + A + DFG A L P G + T + GT + A
Sbjct: 167 H--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 272 PE 273
PE
Sbjct: 225 PE 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 20/164 (12%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
+ ++ LG+G FG+VYK + +T G + A K + +S + E++ E+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIE 68
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI- 206
L HP +VKLLG + D +L ++ E+ G+++ + + + L+ +I +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEP---QIQVV 122
Query: 207 --GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
L FLH K++I+RD KA N+L+ + +++DFG++
Sbjct: 123 CRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+LG+G +G VY G D + +AIK++ + + E+ L H
Sbjct: 29 VLGKGTYGIVYAG-RDLSN--------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+V+ LG E+ + + E + GSL L + ++ I GL +L
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYL 138
Query: 216 HTSEKKVIYRDFKASNILLD-GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
H + ++++RD K N+L++ + KISDFG +K T GT Y APE
Sbjct: 139 H--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 193
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 54/196 (27%), Positives = 77/196 (39%), Gaps = 28/196 (14%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H 154
+L EGGF VY+ D + G A+K+L + EV F+ +LS H
Sbjct: 35 VLAEGGFAFVYEA-QDVGS--------GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85
Query: 155 PNLVKLLGYCWEDKE-------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
PN+V+ KE L+ + +G L L + PLS D LKI
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQ 144
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA---KLGPAGGESHVTTRVM 264
R + +H + +I+RD K N+LL K+ DFG A P S ++
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 265 -------GTYGYAAPE 273
T Y PE
Sbjct: 205 EEEITRNTTPMYRTPE 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
K + +G+G G VY +D T G VAI+++N + E +E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEIL 69
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI- 206
+ +PN+V L EL +V EY+ GSL + + + +IA
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEG-------QIAAV 121
Query: 207 --GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHVTTRV 263
+ L FLH +VI+RD K+ NILL + + K++DFG A++ P +S +T V
Sbjct: 122 CRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV 177
Query: 264 MGTYGYAAPEYVATGNFY 281
GT + APE V T Y
Sbjct: 178 -GTPYWMAPE-VVTRKAY 193
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 56/187 (29%), Positives = 81/187 (43%), Gaps = 27/187 (14%)
Query: 72 ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
L L+ F+ L+G G +G+VYKG KT G + AIK +
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVM 57
Query: 132 NPESMQGFEEWQSEVNFLGRLS-HPNLVKLLG------YCWEDKELLLVYEYMQRGSLEN 184
+ EE + E+N L + S H N+ G D +L LV E+ GS+ +
Sbjct: 58 DVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 185 HLFRRNPSIQPLSWDIRLKIAI---GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241
+ +N L + IA RGL LH + KVI+RD K N+LL N K
Sbjct: 117 LI--KNTKGNTLKEE---WIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVK 169
Query: 242 ISDFGLA 248
+ DFG++
Sbjct: 170 LVDFGVS 176
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 27/198 (13%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
+GEG G V + + G VA+K ++ Q E +EV
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI- 206
+ H N+V++ +EL ++ E++Q G+L + + + + +IA
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEE-------QIATV 146
Query: 207 --GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHVTTRV 263
+ L +LH + VI+RD K+ +ILL + K+SDFG A++ + V
Sbjct: 147 CEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLV 202
Query: 264 MGTYGYAAPEYVATGNFY 281
GT + APE V + + Y
Sbjct: 203 -GTPYWMAPE-VISRSLY 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 52/201 (25%), Positives = 83/201 (41%), Gaps = 19/201 (9%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVN 147
+++ ++G G V VAIK++N E Q +E E+
Sbjct: 15 DDYELQEVIGSGATAVVQAA-YCAPK--------KEKVAIKRINLEKCQTSMDELLKEIQ 65
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR-LKIAI 206
+ + HPN+V EL LV + + GS+ + + + S + IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 207 ---GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHVTTR 262
GL +LH + I+RD KA NILL + + +I+DFG+ A L G + R
Sbjct: 126 ILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 263 --VMGTYGYAAPEYVATGNFY 281
+GT + APE + Y
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGY 204
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 41/192 (21%), Positives = 69/192 (35%), Gaps = 32/192 (16%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEVNFLGRL 152
+ GG G +Y D+ + G V +K L + +E FL +
Sbjct: 85 KGCIAHGGLGWIYLAL--DRNVN------GRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 153 SHPNLVKLLGY-----CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
HP++V++ + D +V EY+ SL+ + L + +
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLE 190
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGESHVTTRVMGT 266
L +LH ++Y D K NI+L K+ D G + G + GT
Sbjct: 191 ILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YLYGT 240
Query: 267 YGYAAPEYVATG 278
G+ APE +
Sbjct: 241 PGFQAPE-IVRT 251
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 68/271 (25%), Positives = 107/271 (39%), Gaps = 27/271 (9%)
Query: 14 SSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVE-EASPNGQILE 72
+ + A A + + ++ + AG F + +P + L+
Sbjct: 105 QKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLD 164
Query: 73 TPDLKVF---SFLDLKSATKN-FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
+ F +L+ + ++ F +LG GGFG V+ K G + A
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF--------ACQMK-ATGKLYAC 215
Query: 129 KKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLEN 184
KKLN + +G++ E L ++ +V L Y +E K L LV M G +
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRY 274
Query: 185 HLFRRNPSIQPLSWD-IRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242
H++ + A I GL LH ++ +IYRD K N+LLD + N +I
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRI 330
Query: 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
SD GLA AG GT G+ APE
Sbjct: 331 SDLGLAVELKAGQTK-TKGYA-GTPGFMAPE 359
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 23/165 (13%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEV 146
+ F +G+G FG V+KG +D++T VVAIK ++ E + E+ Q E+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEI 71
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L + P + K G +D +L ++ EY+ GS L P + +IA
Sbjct: 72 TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDET-------QIAT 123
Query: 207 ---GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
+GL +LH +K I+RD KA+N+LL + K++DFG+A
Sbjct: 124 ILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 27/198 (13%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
+ F LGEG +G VYK + +T G +VAIK++ E +E E++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA-IHKET--------GQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI- 206
+ + P++VK G +++ +L +V EY GS+ + + RN + L+ D +IA
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN---KTLTED---EIATI 130
Query: 207 --GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHVTTRV 263
+GL +LH + I+RD KA NILL+ +AK++DFG+ +L + + V
Sbjct: 131 LQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---V 185
Query: 264 MGTYGYAAPEYVATGNFY 281
+GT + APE V Y
Sbjct: 186 IGTPFWMAPE-VIQEIGY 202
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 23/185 (12%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEE-WQSEVNFLG 150
LG GG VY D T L + VAIK + + + ++ EV+
Sbjct: 16 VDKLGGGGMSTVYLA-ED--------TILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
+LSH N+V ++ ED LV EY++ +L ++ PLS D +
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILD 122
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT--RVMGTYG 268
G+ H + ++++RD K NIL+D N KI DFG+AK A E+ +T V+GT
Sbjct: 123 GIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK---ALSETSLTQTNHVLGTVQ 177
Query: 269 YAAPE 273
Y +PE
Sbjct: 178 YFSPE 182
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 50/185 (27%), Positives = 74/185 (40%), Gaps = 23/185 (12%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEE-WQSEVNFLG 150
L+G GG G VY+ D T +VA+K ++ S F Q E G
Sbjct: 39 RRLVGRGGMGDVYEA-ED--------TVRERIVALKLMSETLSSDPVFRTRMQREARTAG 89
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
RL P++V + + D +L + + L L R+ PL+ + I
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGS 145
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT--RVMGTYG 268
L H +RD K NIL+ + A + DFG+A A + +T +GT
Sbjct: 146 ALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLY 200
Query: 269 YAAPE 273
Y APE
Sbjct: 201 YMAPE 205
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 51/195 (26%), Positives = 77/195 (39%), Gaps = 33/195 (16%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW-QSEVNFLGRLSH 154
LGEG +G V V+ T VA+K ++ + E + E+ L+H
Sbjct: 14 TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR---- 210
N+VK G+ E L EY G L + + + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEP--DAQRFFH 112
Query: 211 ----GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
G+ +LH + +RD K N+LLD N KISDFGLA + + ++ GT
Sbjct: 113 QLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 267 YGYAAPEYVATGNFY 281
Y APE + +
Sbjct: 171 LPYVAPE-LLKRREF 184
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 63 EASPNGQILETPDLKVFSFLDLKSATKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAP 117
+ ++ E ++ +FL K K D LG G G V+K +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKV-SHKPS--- 57
Query: 118 SKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
G+V+A K ++ E + E+ L + P +V G + D E+ + E+
Sbjct: 58 -----GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112
Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236
M GSL+ L + + I K++I +GL +L + K+++RD K SNIL++
Sbjct: 113 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNS 167
Query: 237 NYNAKISDFGLAKLGPAGGE---SHVTTRVMGTYGYAAPEYVATGNFY 281
K+ DFG++ G+ S + V GT Y +PE G Y
Sbjct: 168 RGEIKLCDFGVS------GQLIDSMANSFV-GTRSYMSPE-RLQGTHY 207
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 62/203 (30%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 53 SQAISEAGVEEASPNGQILET-PDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVD 111
++ + G + P G + D V K F +G G FG VY D
Sbjct: 17 TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-RD 75
Query: 112 DKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGRLSHPNLVKLLGYCWEDK 168
+ VVAIKK++ Q E+W EV FL +L HPN ++ G +
Sbjct: 76 VRN--------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI---GAARGLGFLHTSEKKVIYR 225
LV EY GS + L +Q ++IA GA +GL +LH +I+R
Sbjct: 128 TAWLVMEYCL-GSASDLLEVHKKPLQ------EVEIAAVTHGALQGLAYLH--SHNMIHR 178
Query: 226 DFKASNILLDGNYNAKISDFGLA 248
D KA NILL K+ DFG A
Sbjct: 179 DVKAGNILLSEPGLVKLGDFGSA 201
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 47/191 (24%), Positives = 77/191 (40%), Gaps = 26/191 (13%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
+F P +LG G G + + D VA+K++ PE + EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD----------NRDVAVKRILPECFSFAD---REVQLL 71
Query: 150 GRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
HPN+++ + + + E +L+ ++ +++ + + +
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA---HLGLEPITLLQQT 127
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILL-----DGNYNAKISDFGLAK-LGPAGGESHVTTR 262
GL LH +++RD K NIL+ G A ISDFGL K L +
Sbjct: 128 TSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 263 VMGTYGYAAPE 273
V GT G+ APE
Sbjct: 186 VPGTEGWIAPE 196
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-25
Identities = 27/212 (12%), Positives = 63/212 (29%), Gaps = 31/212 (14%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGW--VDDKTLA---PSKTGLGMVVAIKKL----------- 131
+ ++LG+ + ++ P T AIK++
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 132 ---NPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC--WEDKELLLVYEYMQ--RGSLEN 184
N + + + + + ++++ +Y MQ +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 185 HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244
L + + + L RL++ + R L LH +++ + +I+LD ++
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA 276
F + G+ PE A
Sbjct: 250 FEHLV------RDGARVVSSVSRGFEPPELEA 275
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 23/194 (11%)
Query: 88 TKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEE 141
+ K D L LG G +G V K + G ++A+K++ Q +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKM-RHVPS--------GQIMAVKRIRATVNSQEQKR 51
Query: 142 WQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
+++ R P V G + + ++ + E M SL+ + Q + DI
Sbjct: 52 LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDI 110
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHV 259
KIA+ + L LH S+ VI+RD K SN+L++ K+ DFG+ L +
Sbjct: 111 LGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVA 165
Query: 260 TTRVMGTYGYAAPE 273
G Y APE
Sbjct: 166 KDIDAGCKPYMAPE 179
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 30/254 (11%), Positives = 53/254 (20%), Gaps = 54/254 (21%)
Query: 53 SQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDD 112
A+ EA P + V S L + K L G V+ D
Sbjct: 33 PAAMVEAVTATVWPQNA-----ETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLV-RDV 84
Query: 113 KTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLSHPNLVKLLGYC----- 164
+ A+K + E + RL + +
Sbjct: 85 ER--------LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 165 ---------------------WEDKELLLVYEYMQ--RGSLENHLFRRNPSIQPLSWDIR 201
+ LL+ L + L
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
+ R L K +++ F N+ + + + D
Sbjct: 197 HILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK-----VGTRGP 249
Query: 262 RVMGTYGYAAPEYV 275
YA E++
Sbjct: 250 ASSVPVTYAPREFL 263
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNF 148
+ K +G G +G V K V + G ++A+K++ + ++ +++
Sbjct: 23 DLKDLGEIGRGAYGSVNKM-VHKPS--------GQIMAVKRIRSTVDEKEQKQLLMDLDV 73
Query: 149 LGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
+ R S P +V+ G + + + + E M + + + + + +I KI +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL-AKLGPAGGESHVTTRVMGT 266
+ L L K+I+RD K SNILLD + N K+ DFG+ +L +S TR G
Sbjct: 134 TVKALNHLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGC 188
Query: 267 YGYAAPE 273
Y APE
Sbjct: 189 RPYMAPE 195
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-25
Identities = 46/200 (23%), Positives = 82/200 (41%), Gaps = 36/200 (18%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----EVNFLGR 151
LLGEG +G+V + +D +T A+K L + ++ ++ E+ L R
Sbjct: 12 LLGEGSYGKVKEV-LDSET--------LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 152 LSHPNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
L H N+++L+ Y E +++ +V EY G E + P + R + A
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP-------EKRFPVC--QA 111
Query: 210 R--------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
GL +LH + ++++D K N+LL KIS G+A+
Sbjct: 112 HGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 262 RVMGTYGYAAPEYVATGNFY 281
G+ + PE + +
Sbjct: 170 TSQGSPAFQPPEIANGLDTF 189
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 52/195 (26%), Positives = 78/195 (40%), Gaps = 33/195 (16%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW-QSEVNFLGRLSH 154
LGEG +G V V+ T VA+K ++ + E + E+ L+H
Sbjct: 14 TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR---- 210
N+VK G+ E L EY G L + + I + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEP--DAQRFFH 112
Query: 211 ----GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
G+ +LH + +RD K N+LLD N KISDFGLA + + ++ GT
Sbjct: 113 QLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 267 YGYAAPEYVATGNFY 281
Y APE + +
Sbjct: 171 LPYVAPE-LLKRREF 184
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 46/220 (20%), Positives = 71/220 (32%), Gaps = 39/220 (17%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--E 145
T F +G G FG V+K V G + AIK+ +E + E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC-VKRLD--------GCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 146 VNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
V L H ++V+ ED +L+ EY GSL + + + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-------------------YNAKISDF 245
+ RGL ++H +++ D K SNI + KI D
Sbjct: 121 LLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSA 285
G S G + A E + +L A
Sbjct: 179 GHVTRI-----SSPQVEE-GDSRFLANEVLQENYTHLPKA 212
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-24
Identities = 54/192 (28%), Positives = 82/192 (42%), Gaps = 31/192 (16%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
++ +GEG +G V+K + T G +VAIKK +
Sbjct: 4 KYEKIGKIGEGSYGVVFKC-RNRDT--------GQIVAIKKFL---ESEDDPVIKKIALR 51
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
E+ L +L HPNLV LL + L LV+EY ++ + L R + + + I
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVKSI 107
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL--GPAGGESH-VTT 261
+ + F H + I+RD K NIL+ + K+ DFG A+L GP+ V T
Sbjct: 108 TWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
Query: 262 RVMGTYGYAAPE 273
R Y +PE
Sbjct: 166 R-----WYRSPE 172
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 71 LETPDLKVFSFLDLKSATKNFKPDSL---------LGEGGFGRVYKGWVDDKTLAPSKTG 121
L KVF F DL ++ P +L LG G G V + KT
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA-FERKT------- 159
Query: 122 LGMVVAIKKLNPESMQGFEEW--------QSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173
VAI+ ++ ++E+ L +L+HP ++K+ + + ++ +V
Sbjct: 160 -CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIV 217
Query: 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233
E M+ G E LF + + L + +LH E +I+RD K N+L
Sbjct: 218 LELMEGG--E--LFDKVVGNKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVL 271
Query: 234 L---DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
L + + KI+DFG +K+ GE+ + + GT Y APE
Sbjct: 272 LSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 311
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-24
Identities = 32/156 (20%), Positives = 58/156 (37%), Gaps = 21/156 (13%)
Query: 98 GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ--GFEEWQSEVNFLGRLSHP 155
G V T G V ++++N E+ Q E++ +HP
Sbjct: 36 GFEDLMTVNLA-RYKPT--------GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI---GAARGL 212
N+V D EL +V +M GS ++ + + ++ IA G + L
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELA---IAYILQGVLKAL 141
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
++H ++R KAS+IL+ + +S
Sbjct: 142 DYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-24
Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS- 144
S++ FK LG G + VYKG + T G+ VA+K++ +S +G S
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGL-NKTT--------GVYVALKEVKLDSEEGTP---ST 49
Query: 145 ---EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPSIQPLSW 198
E++ + L H N+V+L + +L LV+E+M + +++ P + L
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLEL 107
Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
++ +GL F H E K+++RD K N+L++ K+ DFGLA
Sbjct: 108 NLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 6e-24
Identities = 52/208 (25%), Positives = 77/208 (37%), Gaps = 35/208 (16%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
+S + +LG G G V S G VA+K++ +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVV--------FQGSFQG--RPVAVKRMLIDFCDIA---LM 57
Query: 145 EVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
E+ L HPN+++ D+ L + E +L++ + +N S + L
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116
Query: 204 IAI---GAARGLGFLHTSEKKVIYRDFKASNILLD-------------GNYNAKISDFGL 247
A G+ LH K+I+RD K NIL+ N ISDFGL
Sbjct: 117 PISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 248 AKLGPAGGESHVTTR--VMGTYGYAAPE 273
K +G S T GT G+ APE
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 65/292 (22%), Positives = 99/292 (33%), Gaps = 54/292 (18%)
Query: 16 SNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEA------SPNGQ 69
S I A + I K Q + + +EE +
Sbjct: 105 SREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQK 164
Query: 70 ILETPDLKVFSFLDLKSATKNFKPDS-----LLGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
+E+ F + + ++G GGFG VY G
Sbjct: 165 FIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY--------GCRKA-DTGK 215
Query: 125 VVAIKKLNPE---SMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCWEDKE-LLLVYEYM 177
+ A+K L+ + QG +E L +S P +V + Y + + L + + M
Sbjct: 216 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC-MSYAFHTPDKLSFILDLM 274
Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR--------GLGFLHTSEKKVIYRDFKA 229
G L HL + + R GL +H + V+YRD K
Sbjct: 275 NGGDLHYHLSQHG------------VFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKP 320
Query: 230 SNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
+NILLD + + +ISD GLA V GT+GY APE + G Y
Sbjct: 321 ANILLDEHGHVRISDLGLACDFSKKK---PHASV-GTHGYMAPEVLQKGVAY 368
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 1e-23
Identities = 33/213 (15%), Positives = 64/213 (30%), Gaps = 49/213 (23%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK---KLNPESMQGFEEWQSEVNFLGRL 152
+LG+ + D+ G + ++ + EV L L
Sbjct: 85 VLGQEDPYAYLEAT--DQET-------GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 153 S----------------------HPNLVKLLGYCWEDK-----ELLLVYEYMQR--GSLE 183
P K++ +++ +Y MQ +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 184 NHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243
L + + + L RL++ + R L LH +++ + +I+LD ++
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA 276
F G S V+ G+A PE A
Sbjct: 254 GFEHLV---RDGASAVS---PIGRGFAPPETTA 280
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 22/190 (11%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SE 145
++FK +LGEG F V LA AIK L + + E
Sbjct: 30 EDFKFGKILGEGSFSTVV--------LARELAT-SREYAIKILEKRHIIKENKVPYVTRE 80
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
+ + RL HP VKL + ++D E L Y + G L ++ + + + R
Sbjct: 81 RDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT---RFYT 136
Query: 205 A-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRV 263
A I +A L +LH K +I+RD K NILL+ + + +I+DFG AK+ +
Sbjct: 137 AEIVSA--LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 264 MGTYGYAAPE 273
+GT Y +PE
Sbjct: 193 VGTAQYVSPE 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 56/189 (29%), Positives = 83/189 (43%), Gaps = 25/189 (13%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----- 144
++ L+GEG +G V K + T G +VAIKK ++
Sbjct: 26 KYENLGLVGEGSYGMVMKC-RNKDT--------GRIVAIKKFLESD---DDKMVKKIAMR 73
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
E+ L +L H NLV LL C + K LV+E++ ++ + L L + + K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP---NGLDYQVVQKY 129
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
G+GF H +I+RD K NIL+ + K+ DFG A+ A GE + V
Sbjct: 130 LFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-DDEVA 186
Query: 265 GTYGYAAPE 273
T Y APE
Sbjct: 187 -TRWYRAPE 194
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 38/208 (18%)
Query: 79 FSFLDLKSATKN-FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--- 134
+ +L+ + TKN F+ +LG+GGFG V + G + A KKL +
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVC--------ACQVR-ATGKMYACKKLEKKRIK 223
Query: 135 SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSI 193
+G +E L +++ +V L Y +E K+ L LV M G L+ H++
Sbjct: 224 KRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMG--- 279
Query: 194 QPLSWDIRLKIAIGAAR--------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245
+ A GL LH ++++YRD K NILLD + + +ISD
Sbjct: 280 -------QAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDL 330
Query: 246 GLAKLGPAGGESHVTTRVMGTYGYAAPE 273
GLA P G RV GT GY APE
Sbjct: 331 GLAVHVPEGQTIK--GRV-GTVGYMAPE 355
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 37/195 (18%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR-- 151
+LG GG V+ D VA+K L + + +F R
Sbjct: 17 GEILGFGGMSEVHLA-RD--------LRDHRDVAVKVLRAD-------LARDPSFYLRFR 60
Query: 152 --------LSHPNLVKLLGYCWEDKELL----LVYEYMQRGSLENHLFRRNPSIQPLSWD 199
L+HP +V + + +V EY+ +L + + P++
Sbjct: 61 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPK 116
Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGESH 258
+++ A + L F H + +I+RD K +NI++ K+ DFG+A+ + +G
Sbjct: 117 RAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 259 VTTRVMGTYGYAAPE 273
T V+GT Y +PE
Sbjct: 175 QTAAVIGTAQYLSPE 189
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 5e-23
Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 56/231 (24%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEW 142
K + +G+G +G V ++++T + AIK K+ + + E
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVA-IENQT--------RAIRAIKIMNKNKIRQINPKDVERI 75
Query: 143 QSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
++EV + +L HPN+ +L +++ + LV E G L + L +
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 203 KIAIG-----------------------------AAR-------GLGFLHTSEKKVIYRD 226
K I + L +LH + + +RD
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRD 193
Query: 227 FKASNILL--DGNYNAKISDFGLAKL--GPAGGESHVTTRVMGTYGYAAPE 273
K N L + ++ K+ DFGL+K GE + T GT + APE
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-23
Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 34/218 (15%)
Query: 80 SFLDLKSATKNFK----PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----K 130
LD+ F+ ++G+G F V + ++ +T G A+K K
Sbjct: 11 GILDMADDDVLFEDVYELCEVIGKGPFSVVRRC-INRET--------GQQFAVKIVDVAK 61
Query: 131 LNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRN 190
E+ + E + L HP++V+LL D L +V+E+M L + +R
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 191 PSIQPLSWDIRLKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILL---DGNYNAKIS 243
+ S +A R L + H + +I+RD K +LL + + K+
Sbjct: 122 DAGFVYSE----AVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLG 175
Query: 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
FG+A G RV GT + APE V Y
Sbjct: 176 GFGVAIQLGESGLV-AGGRV-GTPHFMAPE-VVKREPY 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-23
Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 20/173 (11%)
Query: 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE 141
LD+KS K ++ LGEG F VYK D T +VAIKK+ ++
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKAR-DKNT--------NQIVAIKKIKLGHRSEAKD 53
Query: 142 WQS-----EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
+ E+ L LSHPN++ LL + LV+++M+ LE + ++ S+
Sbjct: 54 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT 110
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
I+ + +GL +LH + +++RD K +N+LLD N K++DFGLAK
Sbjct: 111 PSHIK-AYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-23
Identities = 48/207 (23%), Positives = 86/207 (41%), Gaps = 26/207 (12%)
Query: 75 DLKVFSFLDLKSATKNFKPDSL-----LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK 129
K +L + + + L +G G G+V+K KT G V+A+K
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM-RFRKT--------GHVIAVK 56
Query: 130 KLNPES-MQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187
++ + + +++ + + P +V+ G + ++ + E M + + L
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LK 114
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247
+R P+ I K+ + + L +L + VI+RD K SNILLD K+ DFG+
Sbjct: 115 KRMQ--GPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 248 -AKLGPAGGESHVTTRVMGTYGYAAPE 273
+L + R G Y APE
Sbjct: 172 SGRL----VDDKAKDRSAGCAAYMAPE 194
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-23
Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 36/291 (12%)
Query: 1 MGNCFGSLFVASNSSSNNINANASSSSAGAYNKYGHTMEISATSSSAGKSQFSQAISEAG 60
MG+ + + N+ + +S ++ GH + + ++ +
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGH----NEAKEVWSNADLTERMPVKS 56
Query: 61 VEEASPNGQILETPDLKVFSFLDLKSATKN----FKPDSLLGEGGFGRVYKGWVDDKTLA 116
++ I P + K N +LG G FG+V+K + T
Sbjct: 57 KRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC-EETAT-- 113
Query: 117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY 176
G+ +A K + M+ EE ++E++ + +L H NL++L +++LV EY
Sbjct: 114 ------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167
Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----GLGFLHTSEKKVIYRDFKASNI 232
+ G E LF R I S+++ I + G+ +H + +++ D K NI
Sbjct: 168 VDGG--E--LFDR---IIDESYNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENI 218
Query: 233 LL--DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
L KI DFGLA+ GT + APE V +F
Sbjct: 219 LCVNRDAKQIKIIDFGLARR---YKPREKLKVNFGTPEFLAPE-VVNYDFV 265
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-22
Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 34/194 (17%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---- 144
+ + LGEG + VYKG T +VA+K++ E +G
Sbjct: 2 ETYIKLDKLGEGTYATVYKGK-SKLT--------DNLVALKEIRLEHEEGAP---CTAIR 49
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPS-IQPLSWDI 200
EV+ L L H N+V L +K L LV+EY+ + L++ N ++ + +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV- 259
RGL + H +KV++RD K N+L++ K++DFGLA+ +
Sbjct: 110 --------LRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTY 157
Query: 260 TTRVMGTYGYAAPE 273
V+ T Y P+
Sbjct: 158 DNEVV-TLWYRPPD 170
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 50/214 (23%), Positives = 82/214 (38%), Gaps = 58/214 (27%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW-- 142
K+ + LG G G V + KT VAIK ++
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLA-FERKT--------CKKVAIKIISKRKFAIGSAREA 56
Query: 143 ------QSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYM----------QRGSL-EN- 184
++E+ L +L+HP ++K+ + ++ ++ +V E M L E
Sbjct: 57 DPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEAT 115
Query: 185 --HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYN 239
F Q L + +LH E +I+RD K N+LL + +
Sbjct: 116 CKLYFY-----QMLL-------------AVQYLH--ENGIIHRDLKPENVLLSSQEEDCL 155
Query: 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
KI+DFG +K+ GE+ + + GT Y APE
Sbjct: 156 IKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 55/256 (21%), Positives = 98/256 (38%), Gaps = 55/256 (21%)
Query: 41 SATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEG 100
S SA ++ +++A + P+ ++ + K + + P ++G G
Sbjct: 46 DDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRG 105
Query: 101 GFGRVYKGWVDDKTLAPSKTGLGMVVAIK-------KLNPESMQGFEE-WQSEVNFLGRL 152
V + V T G A+K +L+PE ++ E + E + L ++
Sbjct: 106 VSSVVRRC-VHRAT--------GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 153 S-HPNLVKLLGYCWEDKELLLVYEYMQRGSL-----------EN---HLFRRNPSIQPLS 197
+ HP+++ L+ + LV++ M++G L E + R L
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-----SLLE 211
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES 257
+ FLH +++RD K NILLD N ++SDFG +
Sbjct: 212 -------------AVSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGE 254
Query: 258 HVTTRVMGTYGYAAPE 273
+ GT GY APE
Sbjct: 255 KLRELC-GTPGYLAPE 269
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 24/189 (12%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+G G +G VYK D A+K++ + E+ L L HPN
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGIS--MSACREIALLRELKHPN 79
Query: 157 LVKLLGYCWE--DKELLLVYEYMQ---RGSLENHLFR-RNPSIQPLSWDIRLKIAIGAAR 210
++ L D+++ L+++Y + ++ H N L + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNA----KISDFGLAKL--GPAGGESHVTTRVM 264
G+ +LH V++RD K +NIL+ G KI+D G A+L P + + V+
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 265 GTYGYAAPE 273
T+ Y APE
Sbjct: 198 -TFWYRAPE 205
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-22
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLG 150
LG G FG+V G T G VA+K K+ + + + E+ L
Sbjct: 18 TLGVGTFGKVKIG-EHQLT--------GHKVAVKILNRQKIRSLDVV--GKIKREIQNLK 66
Query: 151 RLSHPNLVKLLGY-CWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
HP+++KL Y + +V EY+ G L +++ + R++
Sbjct: 67 LFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEM--E 112
Query: 209 AR--------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
AR + + H V++RD K N+LLD + NAKI+DFGL+ + G +
Sbjct: 113 ARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170
Query: 261 TRVMGTYGYAAPEYVATGNFY 281
G+ YAAPE V +G Y
Sbjct: 171 C---GSPNYAAPE-VISGRLY 187
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-22
Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 56/216 (25%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESM---QGFE 140
+ + S LG G FG V+ VD + V +K K+ +
Sbjct: 24 QKYSTMSPLGSGAFGFVWTA-VDKEK--------NKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEY-----------MQRGSLE----NH 185
+ E+ L R+ H N++K+L LV E + L+ ++
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245
+FR Q +S +G+L K +I+RD K NI++ ++ K+ DF
Sbjct: 135 IFR-----QLVS-------------AVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
G A G + GT Y APE V GN Y
Sbjct: 175 GSAAYLERGKLFYTFC---GTIEYCAPE-VLMGNPY 206
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 50/261 (19%), Positives = 90/261 (34%), Gaps = 45/261 (17%)
Query: 42 ATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGG 101
A ++ S +S + E P + ++ L+G G
Sbjct: 6 AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGS 65
Query: 102 FGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS------EVNFLGRLSHP 155
+G V + D VVAIKK+ FE+ E+ L RL+H
Sbjct: 66 YGHVCEA-YDKLE--------KRVVAIKKILRV----FEDLIDCKRILREIAILNRLNHD 112
Query: 156 NLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
++VK+L + EL +V E LFR + L+ +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DF-KKLFR---TPVYLTELHIKTLLYNLLV 167
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
G+ ++H++ +++RD K +N L++ + + K+ DFGLA+ + +
Sbjct: 168 GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 271 AP--------------EYVAT 277
+V T
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVT 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-22
Identities = 41/189 (21%), Positives = 75/189 (39%), Gaps = 21/189 (11%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
+ + ++ +G G +G V V T + A KK+ ++ + ++ E+
Sbjct: 8 NQYYTLENTIGRGSWGEVKIA-VQKGT--------RIRRAAKKIPKYFVEDVDRFKQEIE 58
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
+ L HPN+++L ++ ++ LV E G E LF R + +I
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG--E--LFERVVHKRVFRESDAARIMKD 114
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
+ + H + V +RD K N L + K+ DFGLA + +
Sbjct: 115 VLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKV 169
Query: 265 GTYGYAAPE 273
GT Y +P+
Sbjct: 170 GTPYYVSPQ 178
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 1e-21
Identities = 44/174 (25%), Positives = 84/174 (48%), Gaps = 32/174 (18%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQ 143
+ + ++ +GEG +G VYK D G +VA+K++ ++ G
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAK--DSQ--------GRIVALKRIRLDAEDEGIP--- 63
Query: 144 S----EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPS-IQP 195
S E++ L L HPN+V L+ ++ L LV+E+M+ + L+ + S I+
Sbjct: 64 STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI 123
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ + RG+ H + ++++RD K N+L++ + K++DFGLA+
Sbjct: 124 YLYQL--------LRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 25/207 (12%)
Query: 72 ETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL 131
+ + F + + + +LG+G FG V K D T A+K +
Sbjct: 7 HSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKC-KDRIT--------QQEYAVKVI 55
Query: 132 NPESMQG--FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR 189
N S + EV L +L HPN++KL + +V E G E LF
Sbjct: 56 NKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG--E--LFDE 111
Query: 190 NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFG 246
+ S +I G+ ++H + +++RD K NILL + + + KI DFG
Sbjct: 112 IIKRKRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 247 LAKLGPAGGESHVTTRVMGTYGYAAPE 273
L+ ++ +GT Y APE
Sbjct: 170 LSTC---FQQNTKMKDRIGTAYYIAPE 193
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLGR 151
+G+G F +V T G VAIK +LNP S+ ++ EV +
Sbjct: 23 IGKGNFAKVKLA-RHILT--------GREVAIKIIDKTQLNPTSL---QKLFREVRIMKI 70
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
L+HPN+VKL +K L L+ EY G + ++L +
Sbjct: 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSA 126
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA 271
+ + H +K++++RD KA N+LLD + N KI+DFG + GG+ G YAA
Sbjct: 127 VQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD--AFC-GAPPYAA 181
Query: 272 PEYVATGNFY 281
PE + G Y
Sbjct: 182 PE-LFQGKKY 190
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 42/199 (21%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLG 150
LG G FG+V G + T G VA+K K+ + + + E+ L
Sbjct: 23 TLGVGTFGKVKVG-KHELT--------GHKVAVKILNRQKIRSLDVV--GKIRREIQNLK 71
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
HP+++KL ++ +V EY+ G L +++ + RL +R
Sbjct: 72 LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEK--ESR 119
Query: 211 --------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTR 262
G+ + H V++RD K N+LLD + NAKI+DFGL+ + G T+
Sbjct: 120 RLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TS- 175
Query: 263 VMGTYGYAAPEYVATGNFY 281
G+ YAAPE V +G Y
Sbjct: 176 -CGSPNYAAPE-VISGRLY 192
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 2e-21
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQS--- 144
+ + +GEG +G VYK + G A+KK+ E G S
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ--NNY--------GETFALKKIRLEKEDEGIP---STTI 48
Query: 145 -EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
E++ L L H N+VKL K L+LV+E++ + L+ L ++ + +
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV--TAK-S 104
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ G+ + H +++V++RD K N+L++ KI+DFGLA+
Sbjct: 105 FLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 28/196 (14%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--------KLNPESMQGF 139
+N++P +LG G V + + T A+K + E +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC-IHKPT--------CKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 140 EE-WQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
E EV+ L ++S HPN+++L + LV++ M++G E LF LS
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--E--LFDYLTEKVTLS 122
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES 257
KI + LH + +++RD K NILLD + N K++DFG +
Sbjct: 123 EKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGE 178
Query: 258 HVTTRVMGTYGYAAPE 273
+ GT Y APE
Sbjct: 179 KLREVC-GTPSYLAPE 193
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-21
Identities = 49/202 (24%), Positives = 78/202 (38%), Gaps = 48/202 (23%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
K F +LG G F V+ T G + A+K + ++E+
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLV-KQRLT--------GKLFALKCIKKSPAFRDSSLENEIA 58
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L ++ H N+V L LV + + G E LF R I + G
Sbjct: 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG--E--LFDR---I----------LERG 101
Query: 208 ------AAR-------GLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKLG 251
A+ + +LH E +++RD K N+L + N I+DFGL+K+
Sbjct: 102 VYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM- 158
Query: 252 PAGGESHVTTRVMGTYGYAAPE 273
++ + + GT GY APE
Sbjct: 159 ---EQNGIMSTACGTPGYVAPE 177
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 29/219 (13%)
Query: 62 EEASPNGQILETPDLKVFSFLDLKSA--TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSK 119
E G + TP F+ K ++ ++ LG G +G V D T
Sbjct: 12 ENLYFQGDLQATPG----MFITSKKGHLSEMYQRVKKLGSGAYGEVLLC-RDKVT----- 61
Query: 120 TGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYM 177
+ AIK + S+ + EV L L HPN++KL + + + LV E
Sbjct: 62 ---HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118
Query: 178 QRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--- 234
+ G LF + I G+ +LH + +++RD K N+LL
Sbjct: 119 KGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESK 172
Query: 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+ + KI DFGL+ + +GT Y APE
Sbjct: 173 EKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPE 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 4e-21
Identities = 53/215 (24%), Positives = 80/215 (37%), Gaps = 56/215 (26%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEW 142
+ N+ LG+G F V + V T G+ A K KL+ Q E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC-VHKTT--------GLEFAAKIINTKKLSARDFQKLE-- 53
Query: 143 QSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
E +L HPN+V+L E+ LV++ + G E LF I
Sbjct: 54 -REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFED---I--------- 96
Query: 203 KIAIG------AAR-------GLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFG 246
+A A+ + + H +++R+ K N+LL K++DFG
Sbjct: 97 -VAREFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFG 153
Query: 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
LA +S GT GY +PE V + Y
Sbjct: 154 LAIE---VNDSEAWHGFAGTPGYLSPE-VLKKDPY 184
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 64 ASPNGQILETPDLKVFSFLDLKSA--TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTG 121
S + TP F+ +A + +K +LG+G FG V D T
Sbjct: 3 GSMMDHLHATPG----MFVQHSTAIFSDRYKGQRVLGKGSFGEVILC-KDKIT------- 50
Query: 122 LGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ 178
G A+K ++ ++ + +S EV L +L HPN++KL + + LV E
Sbjct: 51 -GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109
Query: 179 RGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---D 235
G LF S + S +I G+ ++H + K+++RD K N+LL
Sbjct: 110 GGE----LFDEIISRKRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKS 163
Query: 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+ N +I DFGL+ S +GT Y APE
Sbjct: 164 KDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPE 198
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 46/206 (22%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
+ +F+ SLLGEG +G V T G +VAIKK+ P F++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKPT--------GEIVAIKKIEP-----FDKPLFALR 55
Query: 145 ---EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
E+ L H N++ + E+ ++ E MQ L + S Q L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-----STQML 109
Query: 197 SWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA----KLG 251
S D ++ R + LH S VI+RD K SN+L++ N + K+ DFGLA +
Sbjct: 110 S-DDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 252 PAGGESHVTTRVMGTYGYAAPEYVAT 277
E M E+VAT
Sbjct: 167 ADNSEPTGQQSGM-V------EFVAT 185
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-21
Identities = 44/218 (20%), Positives = 78/218 (35%), Gaps = 24/218 (11%)
Query: 80 SFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF 139
L + + K + L G R + W++ + + + + +
Sbjct: 44 RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPS 103
Query: 140 EEWQS--EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP-- 195
++ + S N V L L + + ++ +L++ + RR
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 196 -LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK----- 249
+ I ++IA + FLH K +++RD K SNI + K+ DFGL
Sbjct: 164 GVCLHIFIQIA----EAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 250 ------LGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
L P + T +V GT Y +PE GN Y
Sbjct: 218 EEEQTVLTPMPAYATHTGQV-GTKLYMSPE-QIHGNNY 253
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 28/119 (23%), Positives = 44/119 (36%), Gaps = 11/119 (9%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-PESMQGFEEWQSEVN 147
+F+P +G GGFG V++ +K AIK++ P E+ EV
Sbjct: 6 TDFEPIQCMGRGGFGVVFE--AKNKV-------DDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L +L HP +V+ W + E M L++ S +KI
Sbjct: 57 ALAKLEHPGIVRYFN-AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 6e-21
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---- 144
+NF+ +GEG +G VYK + T G VVA+KK+ + E
Sbjct: 3 ENFQKVEKIGEGTYGVVYKAR-NKLT--------GEVVALKKIR---LDTETEGVPSTAI 50
Query: 145 -EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
E++ L L+HPN+VKLL + +L LV+E++ + L+ + ++ + +
Sbjct: 51 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKS 107
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+GL F H +V++RD K N+L++ K++DFGLA+
Sbjct: 108 YLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 75/251 (29%), Positives = 104/251 (41%), Gaps = 30/251 (11%)
Query: 37 TMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSL 96
T I + K ++ +G + + +E K + + F+ L
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN----EFEYLKL 155
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNFLGRLS 153
LG+G FG+V L K G A+K L E + +E E L
Sbjct: 156 LGKGTFGKVI--------LVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 154 HPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARG 211
HP L L Y ++ + L V EY G L HL R + + R A I +A
Sbjct: 207 HPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA---RFYGAEIVSA-- 260
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTYGYA 270
L +LH SEK V+YRD K N++LD + + KI+DFGL K G G T + GT Y
Sbjct: 261 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYL 316
Query: 271 APEYVATGNFY 281
APE V N Y
Sbjct: 317 APE-VLEDNDY 326
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 7e-21
Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 35/195 (17%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQS--- 144
+ ++ +GEG +G V+K + +T +VA+K++ + G S
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAK-NRET--------HEIVALKRVRLDDDDEGVP---SSAL 49
Query: 145 -EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPS-IQPLSWD 199
E+ L L H N+V+L DK+L LV+E+ + ++ +P ++ +
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259
+ +GLGF H + V++RD K N+L++ N K+++FGLA+ G
Sbjct: 110 L--------LKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRC 157
Query: 260 -TTRVMGTYGYAAPE 273
+ V+ T Y P+
Sbjct: 158 YSAEVV-TLWYRPPD 171
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-21
Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 42 ATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFS-FLDLKSATKNFKPDSLLGEG 100
T+S A + Q S G + S + + + + ++ ++G G
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65
Query: 101 GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKL 160
FG VY+ + G +VAIKK+ +Q E+ + +L H N+V+L
Sbjct: 66 SFGVVYQA-KLCDS--------GELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 161 LGY------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI-GAARGLG 213
+ ++ L LV +Y+ ++ + + Q L I +K+ + R L
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLA 170
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNA-KISDFGLAKLGPAGGE--SHVTTRVMGTYGYA 270
++H+ + +RD K N+LLD + K+ DFG AK G S++ +R Y Y
Sbjct: 171 YIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YR 223
Query: 271 APE 273
APE
Sbjct: 224 APE 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 33/187 (17%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRL 152
+G+G FG+V + + A+K +N + E+ + L
Sbjct: 22 AIGKGSFGKVC--------IVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 153 SHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRR----NPSIQPLSWDIRLKIA-I 206
HP LV L Y ++D+E + +V + + G L HL + ++L I +
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-------TVKLFICEL 124
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
A L +L +++I+RD K NILLD + + I+DF +A + P + T + GT
Sbjct: 125 VMA--LDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 267 YGYAAPE 273
Y APE
Sbjct: 178 KPYMAPE 184
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 26/188 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H 154
+LGEG RV ++ T A+K + + EV L + H
Sbjct: 20 VLGEGAHARVQTC-INLIT--------SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 155 PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLG 213
N+++L+ + E+ LV+E M+ GS+ +H+ +R + S ++ + A L
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALD 125
Query: 214 FLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAK-LGPAGGESHVTTRVM----G 265
FLH K + +RD K NIL + KI DF L + G S ++T + G
Sbjct: 126 FLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 266 TYGYAAPE 273
+ Y APE
Sbjct: 184 SAEYMAPE 191
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 30/192 (15%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V++ V+ T G V K +N ++E++ + +L HP
Sbjct: 59 LGSGAFGVVHRC-VEKAT--------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----GL 212
L+ L + E++L+ E++ G E LF R I + + I R GL
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGG--E--LFDR---IAAEDYKMSEAEVINYMRQACEGL 162
Query: 213 GFLHTSEKKVIYRDFKASNILL--DGNYNAKISDFGLA-KLGPAGGESHVTTRVMGTYGY 269
+H E +++ D K NI+ + KI DFGLA KL P + T +
Sbjct: 163 KHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP----DEIVKVTTATAEF 216
Query: 270 AAPEYVATGNFY 281
AAPE +
Sbjct: 217 AAPE-IVDREPV 227
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 61/266 (22%), Positives = 96/266 (36%), Gaps = 45/266 (16%)
Query: 30 AYNKYG--HTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSA 87
A NK+G E +A G + + + + G+ + + + F K
Sbjct: 84 AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQY 143
Query: 88 TK---NFKPDSL---------LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES 135
K D + LG G FG V++ + T G A K +
Sbjct: 144 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV-TERAT--------GNNFAAKFVMTPH 194
Query: 136 MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
E + E+ + L HP LV L +D E++++YE+M G E LF +
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKV----- 245
Query: 196 LSWDIRL--KIAIGAAR----GLGFLHTSEKKVIYRDFKASNILL--DGNYNAKISDFGL 247
++ A+ R GL +H E ++ D K NI+ + K+ DFGL
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 248 AKLGPAGGESHVTTRVMGTYGYAAPE 273
V GT +AAPE
Sbjct: 304 TAHLDPKQSVKV---TTGTAEFAAPE 326
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 22/196 (11%)
Query: 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE- 141
++ ++F+ ++G G FG V + K V A+K LN M E
Sbjct: 68 QMRLHREDFEILKVIGRGAFGEVA--------VVKLK-NADKVFAMKILNKWEMLKRAET 118
Query: 142 --WQSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
++ E + L + L Y ++D L LV +Y G L L + P
Sbjct: 119 ACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM 176
Query: 199 DIRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES 257
R +A + A + +H + ++RD K NIL+D N + +++DFG G
Sbjct: 177 -ARFYLAEMVIA--IDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 258 HVTTRVMGTYGYAAPE 273
+ V GT Y +PE
Sbjct: 232 QSSVAV-GTPDYISPE 246
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-20
Identities = 50/196 (25%), Positives = 70/196 (35%), Gaps = 38/196 (19%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP 155
+G G FG D T +VA+K + + E Q E+ L HP
Sbjct: 27 DIGSGNFGVARLM-RDKLT--------KELVAVKYIERGAAID-ENVQREIINHRSLRHP 76
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----- 210
N+V+ L ++ EY G L + R AR
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----------RFSED--EARFFFQQ 124
Query: 211 ---GLGFLHTSEKKVIYRDFKASNILLDGNY--NAKISDFGLAKLGPAGGESHVTTRVMG 265
G+ + H ++ +RD K N LLDG+ KI DFG +K + + V G
Sbjct: 125 LLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-G 179
Query: 266 TYGYAAPEYVATGNFY 281
T Y APE V Y
Sbjct: 180 TPAYIAPE-VLLRQEY 194
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 47/201 (23%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLG 150
LGEG FG+V KT VA+K L M + E+++L
Sbjct: 16 TLGEGSFGKVKLA-THYKT--------QQKVALKFISRQLLKKSDMH--MRVEREISYLK 64
Query: 151 RLSHPNLVKLLGY-CWEDK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
L HP+++KL Y ++++V EY G L +++ + R+
Sbjct: 65 LLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK----------RMTED--E 109
Query: 209 AR--------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
R + + H K+++RD K N+LLD N N KI+DFGL+ + G T
Sbjct: 110 GRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-T 166
Query: 261 TRVMGTYGYAAPEYVATGNFY 281
+ G+ YAAPE V G Y
Sbjct: 167 S--CGSPNYAAPE-VINGKLY 184
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 54/244 (22%), Positives = 91/244 (37%), Gaps = 30/244 (12%)
Query: 48 GKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYK 107
G S S V S + K+ + + ++ LLG GGFG VY
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61
Query: 108 GWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS------EVNFLGRLSH--PNLVK 159
G + + VAIK + + + + E + EV L ++S +++
Sbjct: 62 G-IRVSD--------NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 160 LLGYCWEDKELLLVYEYMQ-RGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS 218
LL + +L+ E + L + + R L ++ + H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN- 167
Query: 219 EKKVIYRDFKASNILLDGNY-NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT 277
V++RD K NIL+D N K+ DFG L ++ T GT Y+ PE++
Sbjct: 168 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYSPPEWIR- 221
Query: 278 GNFY 281
+ Y
Sbjct: 222 YHRY 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 44/212 (20%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
N+ L+G G +G VY D T VAIKK+ FE+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKNT--------EKNVAIKKVNRM-----FEDLIDCK 70
Query: 145 ----EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
E+ L RL +++L + EL +V E L LF+ +
Sbjct: 71 RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL-KKLFK---TPIF 125
Query: 196 LSWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
L+ + +K I G F+H S +I+RD K +N LL+ + + K+ DFGLA+ +
Sbjct: 126 LT-EEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 255 GESHVTTRVMGTYGYAAP---------EYVAT 277
++++ + +V T
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 50/191 (26%), Positives = 78/191 (40%), Gaps = 23/191 (12%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSE 145
+ + +LG+G FG V K D T A+K +N S + E
Sbjct: 21 AERYNIVCMLGKGSFGEVLKC-KDRIT--------QQEYAVKVINKASAKNKDTSTILRE 71
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
V L +L HPN++KL + +V E G LF + S +I
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARII 127
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKLGPAGGESHVTTR 262
G+ ++H + +++RD K NILL + + + KI DFGL+ ++
Sbjct: 128 KQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKD 182
Query: 263 VMGTYGYAAPE 273
+GT Y APE
Sbjct: 183 RIGTAYYIAPE 193
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 57/218 (26%), Positives = 86/218 (39%), Gaps = 32/218 (14%)
Query: 61 VEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKT 120
++ A P L+ L+ F LK ++G G F V + K
Sbjct: 43 LQWAEPIVVRLKEVRLQRDDFEILK----------VIGRGAFSEVA--------VVKMK- 83
Query: 121 GLGMVVAIKKLNPESMQGFEE---WQSEVNFLGRLSHPNLVKLLGYCWEDKELL-LVYEY 176
G V A+K +N M E ++ E + L + +L + ++D+ L LV EY
Sbjct: 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEY 142
Query: 177 MQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLD 235
G L L + I P R +A I A + +H ++RD K NILLD
Sbjct: 143 YVGGDLLTLLSKFGERI-PAEM-ARFYLAEIVMA--IDSVH--RLGYVHRDIKPDNILLD 196
Query: 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+ +++DFG A G V GT Y +PE
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPE 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 37/221 (16%)
Query: 72 ETPDLKVFSFLDLKSA--TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK 129
+ L S T ++ +G G + + + T M A+K
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRC-IHKAT--------NMEFAVK 53
Query: 130 KLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
++ EE + L R HPN++ L + K + +V E M+ G L + + R
Sbjct: 54 IIDKSKRDPTEE----IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR 109
Query: 189 RNPSIQPLS----WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGNYNA 240
+ + S + I + + +LH + V++RD K SNIL +
Sbjct: 110 Q----KFFSEREASAVLFTIT----KTVEYLH--AQGVVHRDLKPSNILYVDESGNPESI 159
Query: 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
+I DFG AK A + T T + APE V Y
Sbjct: 160 RICDFGFAKQLRAENGL-LMTPC-YTANFVAPE-VLERQGY 197
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 57/204 (27%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS-------EVNFL 149
+G+G FG V+K KT G VA+KK+ E+ E + E+ L
Sbjct: 25 IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMEN-----EKEGFPITALREIKIL 70
Query: 150 GRLSHPNLVKLLGYCWEDKE--------LLLVYEYMQ---RGSLENHLFRRNPS------ 192
L H N+V L+ C + LV+++ + G L N L + S
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 193 IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL-- 250
L GL ++H K+++RD KA+N+L+ + K++DFGLA+
Sbjct: 131 QMLL-------------NGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 251 GPAGGESHV-TTRVMGTYGYAAPE 273
+ + T RV+ T Y PE
Sbjct: 176 LAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 38/205 (18%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
+ F+ + + G+G FG V G + T GM VAIKK+ + E Q
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLG-KEKST--------GMSVAIKKVIQDPRFRNRELQ- 68
Query: 145 EVNFLGRLSHPNLVKLLGY-------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
+ L L HPN+V+L Y D L +V EY+ +L
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP 127
Query: 198 WD-IRL---KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDFGLAK-LG 251
I++ ++ R +G LH V +RD K N+L++ + K+ DFG AK L
Sbjct: 128 PILIKVFLFQLI----RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 252 PAGGE---SHVTTRVMGTYGYAAPE 273
P E +++ +R Y Y APE
Sbjct: 184 P--SEPNVAYICSR----Y-YRAPE 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-20
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 66/216 (30%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS----------- 144
+G+G +G V ++ A+K L+ + + +
Sbjct: 20 EIGKGSYGVVKLA-YNEND--------NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 145 ---------------EVNFLGRLSHPNLVKLLGYC-WED---KELLLVYEYMQRGSLENH 185
E+ L +L HPN+VKL +D L +V+E + +G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV--- 125
Query: 186 LFRRNPSIQPLSWDIRLKIAIGAAR--------GLGFLHTSEKKVIYRDFKASNILLDGN 237
P+++PLS D AR G+ +LH +K+I+RD K SN+L+ +
Sbjct: 126 -MEV-PTLKPLSED--------QARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGED 173
Query: 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+ KI+DFG++ G ++ ++ V GT + APE
Sbjct: 174 GHIKIADFGVSNE-FKGSDALLSNTV-GTPAFMAPE 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-20
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 35/166 (21%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQS----EVNFLGR 151
LGEG +G VYK D T VAIK++ E +G EV+ L
Sbjct: 42 LGEGTYGEVYKAI-DTVT--------NETVAIKRIRLEHEEEGVP---GTAIREVSLLKE 89
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQ---RGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
L H N+++L + L L++EY + + ++ + I+ + +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL-------- 141
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNA-----KISDFGLAK 249
G+ F H ++ ++RD K N+LL + + KI DFGLA+
Sbjct: 142 INGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 52/213 (24%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSE 145
+ N+ LG+G F V + V T G+ A K +N + + F++ + E
Sbjct: 28 SDNYDVKEELGKGAFSVVRRC-VHKTT--------GLEFAAKIINTKKLSARDFQKLERE 78
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSL-----------EN---HLFRRNP 191
+L HPN+V+L E+ LV++ + G L E H +
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ--- 135
Query: 192 SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLA 248
Q L + + H +++R+ K N+LL K++DFGLA
Sbjct: 136 --QILE-------------SIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
+S GT GY +PE V + Y
Sbjct: 179 IE---VNDSEAWHGFAGTPGYLSPE-VLKKDPY 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-20
Identities = 49/190 (25%), Positives = 77/190 (40%), Gaps = 18/190 (9%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW-QSEV 146
F LG G FG V+ + + G+ IK +N + Q E ++E+
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLV-EERSS--------GLERVIKTINKDRSQVPMEQIEAEI 71
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L L HPN++K+ + + +V E + G L + + LS ++
Sbjct: 72 EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKLGPAGGESHVTTRV 263
L + H + V+++D K NIL + KI DFGLA+L +T
Sbjct: 132 QMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNA 186
Query: 264 MGTYGYAAPE 273
GT Y APE
Sbjct: 187 AGTALYMAPE 196
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 8e-20
Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 25/248 (10%)
Query: 32 NKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNF 91
+Y + S + + ++ G +P + T + + +F
Sbjct: 284 GEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDF 343
Query: 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EVNF 148
+LG+G FG+V L+ K G + A+K L + + ++ + E
Sbjct: 344 NFLMVLGKGSFGKVM--------LSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRV 394
Query: 149 LGR-LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L P L +L C++ + L V EY+ G L H+ + +P + +IAI
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-G 265
G L FL K +IYRD K N++LD + KI+DFG+ K G TT+ G
Sbjct: 454 G----LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCG 504
Query: 266 TYGYAAPE 273
T Y APE
Sbjct: 505 TPDYIAPE 512
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-20
Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 25/189 (13%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HP 155
LGEG F K V K+ A+K ++ ++ E+ L HP
Sbjct: 19 LGEGSFSICRKC-VHKKS--------NQAFAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 156 NLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFL 215
N+VKL + LV E + G L + ++ + + I K+ + +
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV----SAVSHM 122
Query: 216 HTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAP 272
H + V++RD K N+L + N KI DFG A+L P + + T T YAAP
Sbjct: 123 H--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAP 178
Query: 273 EYVATGNFY 281
E + N Y
Sbjct: 179 E-LLNQNGY 186
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 61/234 (26%), Positives = 93/234 (39%), Gaps = 32/234 (13%)
Query: 44 SSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFG 103
+++A K +++ E + + ETP F LG G FG
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFG 55
Query: 104 RVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKL 160
RV L K G A+K L+ + ++ E +E L ++ P LVKL
Sbjct: 56 RVM--------LVKHKES-GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARGLGFLHTSE 219
++ L +V EY+ G + +HL R +P + R A I +LH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAAQIVLT--FEYLH--S 159
Query: 220 KKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
+IYRD K N+L+D +++DFG AK T + GT APE
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPEALAPE 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 47/212 (22%), Positives = 77/212 (36%), Gaps = 49/212 (23%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE--WQSE 145
T+ ++ LG+G F V + V G A +N + + + + E
Sbjct: 10 TEEYQLFEELGKGAFSVVRRC-VKVLA--------GQEYAAMIINTKKLSARDHQKLERE 60
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L HPN+V+L E+ L+++ + G E LF I +A
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG--E--LFED---I----------VA 103
Query: 206 IG------AAR-------GLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAK 249
A+ + H + V++R+ K N+LL K++DFGLA
Sbjct: 104 REYYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161
Query: 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFY 281
+ GT GY +PE V + Y
Sbjct: 162 EVEGEQQ--AWFGFAGTPGYLSPE-VLRKDPY 190
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 52/191 (27%), Positives = 88/191 (46%), Gaps = 26/191 (13%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGL--GMVVAIKKLNPESMQGFEEWQ--SE 145
F+ +LG+G FG+V+ L +G + A+K L +++ + + E
Sbjct: 25 QFELLKVLGQGSFGKVF--------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
+ L ++HP +VKL Y ++ + L L+ ++++ G L L + + + +
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV---KFYL 132
Query: 205 A-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRV 263
A + A L LH +IYRD K NILLD + K++DFGL+K +
Sbjct: 133 AELALA--LDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYS 185
Query: 264 M-GTYGYAAPE 273
GT Y APE
Sbjct: 186 FCGTVEYMAPE 196
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 66/198 (33%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS---EV 146
+F LLG+G FG+V L K G A+K L E + +E E
Sbjct: 6 DFDYLKLLGKGTFGKVI--------LVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 147 NFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L HP L L Y ++ + L V EY G L HL R + + R A
Sbjct: 57 RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA---RFYGA 112
Query: 206 -IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM 264
I +A L +LH + V+YRD K N++LD + + KI+DFGL K G + G T +
Sbjct: 113 EIVSA--LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTF 165
Query: 265 -GTYGYAAPEYVATGNFY 281
GT Y APE V N Y
Sbjct: 166 CGTPEYLAPE-VLEDNDY 182
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 46/200 (23%), Positives = 76/200 (38%), Gaps = 31/200 (15%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN------PESMQGFEEW 142
++ LLG+GGFG V+ G + VAIK + +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAG-HRLTD--------RLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 143 QSEVNFLGRLS----HPNLVKLLGYCWEDKELLLVYEYMQRGS-LENHLFRRNPSIQPLS 197
EV L ++ HP +++LL + + +LV E L +++ + PL
Sbjct: 82 PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK----GPLG 137
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA-KISDFGLAKLGPAGGE 256
+ H+ + V++RD K NIL+D K+ DFG L
Sbjct: 138 EGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-- 193
Query: 257 SHVTTRVMGTYGYAAPEYVA 276
T GT Y+ PE+++
Sbjct: 194 -PYTDFD-GTRVYSPPEWIS 211
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 46/204 (22%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
+ S +GEG +G V D+ + VAIKK++P FE
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNLN--------KVRVAIKKISP-----FEHQTYCQR 71
Query: 145 ---EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
E+ L R H N++ + + K++ +V + M+ L L + Q L
Sbjct: 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDL-YKLLK----TQHL 125
Query: 197 SWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG 255
S + + RGL ++H++ V++RD K SN+LL+ + KI DFGLA++
Sbjct: 126 S-NDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 256 ES------HVTTRVMGTYGYAAPE 273
+ +V TR Y APE
Sbjct: 183 DHTGFLTEYVATR-----WYRAPE 201
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 51/232 (21%), Positives = 82/232 (35%), Gaps = 38/232 (16%)
Query: 62 EEASPNGQILETPDLKVFSFLDLKSATKNFKPD----SLLGEGGFGRVYKGWVDDKTLAP 117
S + L + + + ++ LG G +G V +
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC-KEKNG--- 60
Query: 118 SKTGLGMVVAIKKLN-------------PESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164
AIK + + EE +E++ L L HPN++KL
Sbjct: 61 -----HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115
Query: 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY 224
+ K LV E+ + G LF + + I G+ +LH + +++
Sbjct: 116 EDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQILSGICYLH--KHNIVH 169
Query: 225 RDFKASNILL---DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
RD K NILL + N KI DFGL+ + + +GT Y APE
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAYYIAPE 218
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 46/210 (21%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
AT ++P + +G G +G VYK D + G VA+K + +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKA-RDPHS--------GHFVALKSVR---VPNGGGGGG 52
Query: 145 --------EVNFLGRLS---HPNLVKLL-----GYCWEDKELLLVYEYMQ---RGSLENH 185
EV L RL HPN+V+L+ + ++ LV+E++ R L+
Sbjct: 53 GLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA 112
Query: 186 LFRRNPS--IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243
P+ I+ L RGL FLH +++RD K NIL+ K++
Sbjct: 113 PPPGLPAETIKDLMRQF--------LRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLA 162
Query: 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
DFGLA+ + +T V+ T Y APE
Sbjct: 163 DFGLAR--IYSYQMALTPVVV-TLWYRAPE 189
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 49/208 (23%), Positives = 78/208 (37%), Gaps = 37/208 (17%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN------PESMQGFEE 141
+ LG G F V K + T G+ A K + EE
Sbjct: 11 EDFYDIGEELGSGQFAIVKKC-REKST--------GLEYAAKFIKKRQSRASRRGVCREE 61
Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
+ EV+ L ++ HPN++ L +++L+ E + G E LF + LS
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGG--E--LFDFLAQKESLSE--- 114
Query: 202 LKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILL----DGNYNAKISDFGLAKLGPA 253
+ A + G+ +LH KK+ + D K NI+L + K+ DFGLA
Sbjct: 115 -EEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--- 168
Query: 254 GGESHVTTRVMGTYGYAAPEYVATGNFY 281
+ + GT + APE +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPE-IVNYEPL 195
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 38/203 (18%)
Query: 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE- 141
DL+ ++++ ++G G FG V L K+ V A+K L+ M +
Sbjct: 63 DLRMKAEDYEVVKVIGRGAFGEVQ--------LVRHKST-RKVYAMKLLSKFEMIKRSDS 113
Query: 142 --WQSEVNFLGRLSHPNLVKLLGYCWEDKELL-LVYEYMQRGSLENHLFRRNPSIQPLSW 198
+ E + + + P +V+L Y ++D L +V EYM G L N +
Sbjct: 114 AFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY--------- 163
Query: 199 DIRLKIAIGAAR--------GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250
+ AR L +H I+RD K N+LLD + + K++DFG
Sbjct: 164 ----DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 251 GPAGGESHVTTRVMGTYGYAAPE 273
G T V GT Y +PE
Sbjct: 218 MNKEGMVRCDTAV-GTPDYISPE 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-19
Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 30/194 (15%)
Query: 90 NFKPDSLLGEGGFGRVY---KGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEW--- 142
F+ +LG+GG+G+V+ K + G + A+K L ++ ++
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANT---------GKIFAMKVLKKAMIVRNAKDTAHT 68
Query: 143 QSEVNFLGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
++E N L + HP +V L+ Y ++ L L+ EY+ G L L R ++ +
Sbjct: 69 KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA---C 124
Query: 202 LKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+A I A LG LH +K +IYRD K NI+L+ + K++DFGL K G
Sbjct: 125 FYLAEISMA--LGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---V 177
Query: 261 TRVM-GTYGYAAPE 273
T GT Y APE
Sbjct: 178 THTFCGTIEYMAPE 191
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 48/208 (23%), Positives = 76/208 (36%), Gaps = 37/208 (17%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK------KLNPESMQGFEE 141
+ LG G F V K + T G+ A K EE
Sbjct: 11 EDFYDIGEELGSGQFAIVKKC-REKST--------GLEYAAKFIKKRQSRASRRGVSREE 61
Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
+ EV+ L ++ H N++ L +++L+ E + G E LF + LS
Sbjct: 62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--E--LFDFLAQKESLSE--- 114
Query: 202 LKIAIGAAR----GLGFLHTSEKKVIYRDFKASNILL----DGNYNAKISDFGLAKLGPA 253
+ A + G+ +LH KK+ + D K NI+L + K+ DFGLA
Sbjct: 115 -EEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--- 168
Query: 254 GGESHVTTRVMGTYGYAAPEYVATGNFY 281
+ + GT + APE +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPE-IVNYEPL 195
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 39/230 (16%)
Query: 57 SEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLA 116
+ + +P + + + + ++G G FG V++ +
Sbjct: 8 APLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL------ 61
Query: 117 PSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLL------GYCWEDKEL 170
++ VAIKK+ + E+ + + HPN+V L G ++ L
Sbjct: 62 -VESD---EVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWD-IRL---KIAIGAARGLGFLHTSEKKVIYRD 226
LV EY+ ++ Q + I+L ++ R L ++H+ + +RD
Sbjct: 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLAYIHS--IGICHRD 166
Query: 227 FKASNILLDGNYNA-KISDFGLAKLGPAGGE--SHVTTRVMGTYGYAAPE 273
K N+LLD K+ DFG AK+ AG S++ +R Y Y APE
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPE 211
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-18
Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 27/183 (14%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRL 152
LG G FGRV+ L S+ G A+K L E ++ E E L +
Sbjct: 13 TLGTGSFGRVH--------LIRSRHN-GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAARG 211
+HP ++++ G + +++ ++ +Y++ G L + L + P++ + A + A
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA---KFYAAEVCLA-- 118
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTYGYA 270
L +LH K +IYRD K NILLD N + KI+DFG AK T + GT Y
Sbjct: 119 LEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAK------YVPDVTYTLCGTPDYI 170
Query: 271 APE 273
APE
Sbjct: 171 APE 173
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 64/253 (25%), Positives = 106/253 (41%), Gaps = 33/253 (13%)
Query: 30 AYNKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATK 89
A++ + H E ++ +AG S E + T + K +
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAE-------KVGIE 54
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTG--LGMVVAIKKLNPESMQGFEEW----Q 143
NF+ +LG G +G+V+ L +G G + A+K L ++ + +
Sbjct: 55 NFELLKVLGTGAYGKVF--------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 144 SEVNFLGRLSH-PNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
+E L + P LV L Y ++ + L L+ +Y+ G L HL +R + +
Sbjct: 107 TERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV---Q 162
Query: 202 LKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ + I A L LH + +IYRD K NILLD N + ++DFGL+K E+
Sbjct: 163 IYVGEIVLA--LEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERA 217
Query: 261 TRVMGTYGYAAPE 273
GT Y AP+
Sbjct: 218 YDFCGTIEYMAPD 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 47/202 (23%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
K + + +G G +G V +D ++ G VAIKKL P F+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKRS--------GEKVAIKKLSRP-----FQSEIFAK 68
Query: 145 ----EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPS-- 192
E+ L + H N++ LL + LV +MQ L + S
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DL-QKIMGLKFSEE 126
Query: 193 -IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251
IQ L + + +GL ++H++ V++RD K N+ ++ + KI DFGLA+
Sbjct: 127 KIQYLVYQM--------LKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHA 176
Query: 252 PAGGESHVTTRVMGTYGYAAPE 273
A +V TR + Y APE
Sbjct: 177 DAEMTGYVVTR----W-YRAPE 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 46/199 (23%), Positives = 74/199 (37%), Gaps = 37/199 (18%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK------KLNPESMQGFEEWQSEVNFLG 150
LG G F V K + T G+ A K + E+ + EV+ L
Sbjct: 19 LGSGQFAVVKKC-REKST--------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
+ HPN++ L +++L+ E + G E LF + L+ + A +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLTE----EEATEFLK 121
Query: 211 ----GLGFLHTSEKKVIYRDFKASNILL----DGNYNAKISDFGLAKLGPAGGESHVTTR 262
G+ +LH ++ + D K NI+L KI DFGLA +
Sbjct: 122 QILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKN 176
Query: 263 VMGTYGYAAPEYVATGNFY 281
+ GT + APE +
Sbjct: 177 IFGTPEFVAPE-IVNYEPL 194
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 51/215 (23%), Positives = 73/215 (33%), Gaps = 61/215 (28%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN-----PESMQGFEEW 142
+ + G +G V D G+ VAIK++ ++ +
Sbjct: 21 QSPYTVQRFISSGSYGAVCA--GVDSE--------GIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 143 QS------EVNFLGRLSHPNLVKLL-----GYCWEDKELLLVYEYM----------QRGS 181
E+ L HPN++ L +L LV E M QR
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV 130
Query: 182 LEN-HLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240
+ H IQ + I GL LH + V++RD NILL N +
Sbjct: 131 ISPQH-------IQYFMYHI--------LLGLHVLHEAG--VVHRDLHPGNILLADNNDI 173
Query: 241 KISDFGLAKLGPAGGES--HVTTRVMGTYGYAAPE 273
I DF LA+ A +VT R + Y APE
Sbjct: 174 TICDFNLAREDTADANKTHYVTHR----W-YRAPE 203
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-18
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 42/207 (20%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQ 143
A + ++ + +GEG +G+V+K G VA+K++ ++ +G
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMP--- 55
Query: 144 S----EVNFLGRLS---HPNLVKLL-----GYCWEDKELLLVYEYMQ---RGSLENH--L 186
EV L L HPN+V+L + +L LV+E++ L+
Sbjct: 56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP 115
Query: 187 FRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246
+I+ + + + RGL FLH +V++RD K NIL+ + K++DFG
Sbjct: 116 GVPTETIKDMMFQL--------LRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFG 165
Query: 247 LAKLGPAGGESHVTTRVMGTYGYAAPE 273
LA+ + +T+ V+ T Y APE
Sbjct: 166 LAR--IYSFQMALTSVVV-TLWYRAPE 189
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 60/261 (22%)
Query: 31 YNKYGHTMEISATSSSAGKSQFS--QAISEAGVEEASPNGQILETPDLKVFSFLDLKSAT 88
++ + H+ + + + S A + G P+ I + + +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL---------S 52
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
F+ +S LG G VY+ T A+K L + + ++E+
Sbjct: 53 DFFEVESELGRGATSIVYRC-KQKGT--------QKPYALKVLKKTVDK--KIVRTEIGV 101
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG- 207
L RLSHPN++KL E+ LV E + G LF R I + G
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFDR---I----------VEKGY 144
Query: 208 -----AAR-------GLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKLGP 252
AA + +LH E +++RD K N+L + KI+DFGL+K+
Sbjct: 145 YSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-- 200
Query: 253 AGGESHVTTRVMGTYGYAAPE 273
+ V GT GY APE
Sbjct: 201 -VEHQVLMKTVCGTPGYCAPE 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 49/200 (24%), Positives = 78/200 (39%), Gaps = 41/200 (20%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
K ++ +G G G V D VAIKKL + F+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA-YDAVL--------DRNVAIKKL----SRPFQNQTHAKR 107
Query: 145 ---EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
E+ + ++H N++ LL E +++ LV E M + + +
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQ-----ME 160
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG 255
L + + G+ LH++ +I+RD K SNI++ + KI DFGLA+
Sbjct: 161 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 256 ES--HVTTRVMGTYGYAAPE 273
+V TR Y Y APE
Sbjct: 219 MMTPYVVTR----Y-YRAPE 233
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-18
Identities = 48/199 (24%), Positives = 73/199 (36%), Gaps = 37/199 (18%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK------KLNPESMQGFEEWQSEVNFLG 150
LG G F V K T G A K + EE + EVN L
Sbjct: 13 LGSGQFAIVRKC-RQKGT--------GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
+ HPN++ L +++L+ E + G E LF + L+ A +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGG--E--LFDFLAEKESLTE----DEATQFLK 115
Query: 211 ----GLGFLHTSEKKVIYRDFKASNILL----DGNYNAKISDFGLAKLGPAGGESHVTTR 262
G+ +LH K++ + D K NI+L N K+ DFG+A +
Sbjct: 116 QILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKN 170
Query: 263 VMGTYGYAAPEYVATGNFY 281
+ GT + APE +
Sbjct: 171 IFGTPEFVAPE-IVNYEPL 188
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-18
Identities = 36/191 (18%), Positives = 72/191 (37%), Gaps = 29/191 (15%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
LG G FG V++ V+ + K + + + E++ L H N
Sbjct: 13 LGRGEFGIVHRC-VETSS--------KKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62
Query: 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR----GL 212
++ L +EL++++E++ + +F R I ++++ + + L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGL--D--IFER---INTSAFELNEREIVSYVHQVCEAL 115
Query: 213 GFLHTSEKKVIYRDFKASNILLDGNYNA--KISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
FLH + + D + NI+ ++ KI +FG A+ + Y
Sbjct: 116 QFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYY 170
Query: 271 APEYVATGNFY 281
APE V +
Sbjct: 171 APE-VHQHDVV 180
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-18
Identities = 57/184 (30%), Positives = 80/184 (43%), Gaps = 25/184 (13%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
+LG+G FG+V+ LA K AIK L + + ++ E L
Sbjct: 24 MLGKGSFGKVF--------LAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
HP L + ++ KE L V EY+ G L H+ + + +I +
Sbjct: 75 WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL---- 129
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTYGY 269
GL FLH K ++YRD K NILLD + + KI+DFG+ K G T GT Y
Sbjct: 130 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGTPDY 184
Query: 270 AAPE 273
APE
Sbjct: 185 IAPE 188
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-18
Identities = 42/200 (21%), Positives = 70/200 (35%), Gaps = 41/200 (20%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK-----KLNPESMQGFEEWQSEVNFLGR 151
LG G F V + + T G A K + + E E+ L
Sbjct: 37 LGRGKFAVVRQC-ISKST--------GQEYAAKFLKKRRRGQDCR---AEILHEIAVLEL 84
Query: 152 LSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL--KIAIGA 208
P ++ L E++L+ EY G + + + I
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--------MVSENDVIRL 136
Query: 209 AR----GLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKLGPAGGESHVTT 261
+ G+ +LH + +++ D K NILL + KI DFG+++ G +
Sbjct: 137 IKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELR 191
Query: 262 RVMGTYGYAAPEYVATGNFY 281
+MGT Y APE + +
Sbjct: 192 EIMGTPEYLAPE-ILNYDPI 210
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 32/201 (15%)
Query: 85 KSATKNFKPD-----SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF 139
S+ + KP ++G+G FG+V LA K + A+K L +++
Sbjct: 29 PSSNPHAKPSDFHFLKVIGKGSFGKVL--------LARHK-AEEVFYAVKVLQKKAILKK 79
Query: 140 EEW---QSEVNFLGR-LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQ 194
+E SE N L + + HP LV L + ++ + L V +Y+ G L HL R ++
Sbjct: 80 KEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLE 138
Query: 195 PLSWDIRLKIA-IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253
P + R A I +A LG+LH ++YRD K NILLD + ++DFGL K
Sbjct: 139 PRA---RFYAAEIASA--LGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191
Query: 254 GGESHVTTRVM-GTYGYAAPE 273
TT GT Y APE
Sbjct: 192 HNS---TTSTFCGTPEYLAPE 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 42/209 (20%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
+ ++ LG+G +G V+K +D +T G VVA+KK+ + F+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRRT--------GEVVAVKKIFDA-----FQNSTDAQ 53
Query: 145 ----EVNFLGRLS-HPNLVKLLG--YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
E+ L LS H N+V LL D+++ LV++YM+ L + + R L
Sbjct: 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDL-HAVIRA----NILE 107
Query: 198 WDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
+ + + + + +LH+ +++RD K SNILL+ + K++DFGL++
Sbjct: 108 -PVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 257 SHVTTRVMGTYGYAAP--------EYVAT 277
+ +YVAT
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVAT 193
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 58/185 (31%), Positives = 84/185 (45%), Gaps = 27/185 (14%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
+LG+G FG+V L+ K G + A+K L + + ++ E L
Sbjct: 27 VLGKGSFGKVM--------LSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 152 LSHPNLVKLLGYCW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
P L +L C+ D+ L V EY+ G L H+ + +P + +IAIG
Sbjct: 78 GKPPFLTQLH-SCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG-- 133
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTYG 268
L FL K +IYRD K N++LD + KI+DFG+ K G TT+ GT
Sbjct: 134 --LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPD 186
Query: 269 YAAPE 273
Y APE
Sbjct: 187 YIAPE 191
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 40/199 (20%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
++ +G G +G V VD +T G VAIKKL P F+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRP-----FQSELFAK 69
Query: 145 ----EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
E+ L + H N++ LL + + LV +M L + +
Sbjct: 70 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-----KHE 123
Query: 195 PLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
L D + +GL ++H + +I+RD K N+ ++ + KI DFGLA+ +
Sbjct: 124 KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 255 GESHVTTRVMGTYGYAAPE 273
+V TR Y APE
Sbjct: 182 MTGYVVTRW-----YRAPE 195
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 50/202 (24%), Positives = 79/202 (39%), Gaps = 45/202 (22%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQS-- 144
K ++ +G G G V D VAIKKL P F+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAIL--------ERNVAIKKLSRP-----FQNQTHAK 69
Query: 145 ----EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQ 194
E+ + ++H N++ LL E +++ +V E M +L + +
Sbjct: 70 RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQ-----M 122
Query: 195 PLSWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253
L R+ + G+ LH++ +I+RD K SNI++ + KI DFGLA+
Sbjct: 123 ELD-HERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 254 GGES--HVTTRVMGTYGYAAPE 273
+V TR Y APE
Sbjct: 180 SFMMTPYVVTRY-----YRAPE 196
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 56/185 (30%), Positives = 87/185 (47%), Gaps = 27/185 (14%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
++G G + +V L K + A+K + E + E+ Q+E + +
Sbjct: 16 VIGRGSYAKVL--------LVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 152 LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGAA 209
+HP LV L C++ + L V EY+ G L H+ R+ + + R A I A
Sbjct: 67 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA 122
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTYG 268
L +LH E+ +IYRD K N+LLD + K++D+G+ K G G+ TT GT
Sbjct: 123 --LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPN 175
Query: 269 YAAPE 273
Y APE
Sbjct: 176 YIAPE 180
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 60/186 (32%), Positives = 88/186 (47%), Gaps = 29/186 (15%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLGR- 151
+LG+G FG+V LA K G + A+K L + + ++ +E L
Sbjct: 30 VLGKGSFGKVM--------LARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 152 LSHPNLVKLLGYCW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IGA 208
+HP L +L C+ D+ L V E++ G L H+ + + + R A I +
Sbjct: 81 RNHPFLTQLF-CCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARA---RFYAAEIIS 135
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GTY 267
A L FLH +K +IYRD K N+LLD + K++DFG+ K G G TT GT
Sbjct: 136 A--LMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCGTP 188
Query: 268 GYAAPE 273
Y APE
Sbjct: 189 DYIAPE 194
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 64/247 (25%), Positives = 103/247 (41%), Gaps = 33/247 (13%)
Query: 34 YGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKP 93
Y H ++ + Q +G+EE E+ L +F
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ------DFDL 56
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEW---QSEVNFLG 150
++G G + +V L K + A++ + E + E+ Q+E +
Sbjct: 57 LRVIGRGSYAKVL--------LVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE 107
Query: 151 R-LSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA-IG 207
+ +HP LV L C++ + L V EY+ G L H+ R+ + + R A I
Sbjct: 108 QASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEIS 163
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVM-GT 266
A L +LH E+ +IYRD K N+LLD + K++D+G+ K G G+ TT GT
Sbjct: 164 LA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 216
Query: 267 YGYAAPE 273
Y APE
Sbjct: 217 PNYIAPE 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 40/199 (20%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
+ ++ S +G G +G V + D KT G+ VA+KKL + F+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAF-DTKT--------GLRVAVKKL----SRPFQSIIHAKR 74
Query: 145 ---EVNFLGRLSHPNLVKLL------GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
E+ L + H N++ LL E ++ LV M L N + Q
Sbjct: 75 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV-----KCQK 128
Query: 196 LSWDIRLK-IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
L+ D ++ + RGL ++H+++ +I+RD K SN+ ++ + KI DFGLA+
Sbjct: 129 LT-DDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 255 GESHVTTRVMGTYGYAAPE 273
+V TR Y APE
Sbjct: 186 MTGYVATRW-----YRAPE 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-17
Identities = 55/263 (20%), Positives = 95/263 (36%), Gaps = 54/263 (20%)
Query: 32 NKYGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNF 91
N G + + + + + A+ + P Q +K + + ++
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY 63
Query: 92 KPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
K S +LG G G+V + + +T A+K +Q + + EV
Sbjct: 64 KVTSQVLGLGINGKVLQI-FNKRT--------QEKFALK-----MLQDCPKARREVELHW 109
Query: 151 RLS-HPNLVKLLGYC----WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
R S P++V+++ K LL+V E + G L F R I+ +
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSR----------IQDRGD 155
Query: 206 IG-----AAR-------GLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKL 250
A+ + +LH + +RD K N+L N K++DFG AK
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 251 GPAGGESHVTTRVMGTYGYAAPE 273
+ +TT T Y APE
Sbjct: 214 TTSHNS--LTTPC-YTPYYVAPE 233
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 52/229 (22%), Positives = 84/229 (36%), Gaps = 59/229 (25%)
Query: 65 SPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGM 124
S + + P+ K ++ D +K +LG G G+V + +T G
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQ-----VLGLGVNGKVLEC-FHRRT--------GQ 55
Query: 125 VVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYC----WEDKELLLVYEYMQR 179
A+K L + EV+ + S P++V +L + LL++ E M+
Sbjct: 56 KCALKLLYDSPKA-----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110
Query: 180 GSLENHLFRRNPSIQPLSWDIRLKIAIG-----AAR-------GLGFLHTSEKKVIYRDF 227
G L F R I+ + AA + FLH + +RD
Sbjct: 111 GEL----FSR----------IQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDV 154
Query: 228 KASNILL---DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPE 273
K N+L + + K++DFG AK + T T Y APE
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPC-YTPYYVAPE 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 64/228 (28%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
+K + LG G FG V + D ++ G A+KK+ + E ++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEV-FDIES--------GKRFALKKVLQDPRYKNRE----LD 52
Query: 148 FLGRLSHPNLVKLLGY--------------------------------------CWEDKE 169
+ L H N++KL+ Y ++K
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI-GAARGLGFLHTSEKKVIYRDFK 228
L ++ EY+ +L L S + + + I I R +GF+H+ + +RD K
Sbjct: 113 LNVIMEYVP-DTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHS--LGICHRDIK 168
Query: 229 ASNILLDGNYNA-KISDFGLAKLGPAGGE--SHVTTRVMGTYGYAAPE 273
N+L++ N K+ DFG AK +++ +R + Y APE
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE 211
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 45/208 (21%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS--- 144
+ LG GG G V+ VD+ VAIKK+ + QS
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSA-VDNDC--------DKRVAIKKIV------LTDPQSVKH 54
Query: 145 ---EVNFLGRLSHPNLVKLL--------------GYCWEDKELLLVYEYMQRGSLENHLF 187
E+ + RL H N+VK+ G E + +V EYM+ + ++
Sbjct: 55 ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVL 112
Query: 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-GNYNAKISDFG 246
+ PL + RGL ++H++ V++RD K +N+ ++ + KI DFG
Sbjct: 113 EQ----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFG 166
Query: 247 LAK-LGPAGGESHVTTRVMGTYGYAAPE 273
LA+ + P + + T Y +P
Sbjct: 167 LARIMDPHYSHKGHLSEGLVTKWYRSPR 194
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 42/199 (21%), Positives = 80/199 (40%), Gaps = 46/199 (23%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVN 147
+++ LG G + V++ + V +K L P + + + E+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAI-NITN--------NEKVVVKILKPVKKK---KIKREIK 82
Query: 148 FLGRLS-HPNLVKLLGYCW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLS-WDIR-- 201
L L PN++ L + LV+E+ + N F++ Q L+ +DIR
Sbjct: 83 ILENLRGGPNIITLADIVKDPVSRTPALVFEH-----VNNTDFKQ--LYQTLTDYDIRFY 135
Query: 202 ----LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDFGLAKLGPAGGE 256
L + L + H+ +++RD K N+++D + ++ D+GLA+ G E
Sbjct: 136 MYEIL-------KALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 257 --SHVTTRVMGTYGYAAPE 273
V +R + PE
Sbjct: 187 YNVRVASRY-----FKGPE 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 25/167 (14%), Positives = 54/167 (32%), Gaps = 22/167 (13%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLG 150
G + ++ +D T L VA+ ++P+ + +E S L
Sbjct: 36 LIFHGGVPPLQFWQA-LD--------TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
R+ P + ++L L+V E+++ GSL+ S ++ A
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAA 140
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES 257
H V S + + + + ++ + A +
Sbjct: 141 AADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPAT--MPDANPQD 183
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 29/110 (26%), Positives = 44/110 (40%), Gaps = 7/110 (6%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNF 148
K LG G FG+V + KT VA+K L + SE+
Sbjct: 23 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 149 LGRL-SHPNLVKLLGYC-WEDKELLLVYEYMQRGSLENHLFRRNPSIQPL 196
L + H N+V LLG C L+++ E+ + G+L +L + P
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 47/234 (20%), Positives = 80/234 (34%), Gaps = 44/234 (18%)
Query: 34 YGHTMEISATSSSAGKSQFSQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKP 93
+ H S F + EA P G +L + + +K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMTTSL---EALPTGTVLT------------DKSGRQWKL 46
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS 153
S G +Y+ TL ++ KL+ + + F +E NF R +
Sbjct: 47 KSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSL-KLDAKDGRLF----NEQNFFQRAA 100
Query: 154 HPNLV---------------KLLGY-CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLS 197
P V +G+ +DK LV + R SL+ +P LS
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPK-HVLS 157
Query: 198 WDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI--SDFGLAK 249
L++A L FLH E + ++ + A NI +D +++ + +G A
Sbjct: 158 ERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 41/173 (23%), Positives = 65/173 (37%), Gaps = 50/173 (28%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HP 155
LG G G+V + + +T A+K L + + EV R S P
Sbjct: 26 LGLGINGKVLQI-FNKRT--------QEKFALKMLQDC-----PKARREVELHWRASQCP 71
Query: 156 NLVKLLGYC----WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG---- 207
++V+++ K LL+V E + G E LF R I+ +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGG--E--LFSR----------IQDRGDQAFTER 117
Query: 208 -AAR-------GLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAK 249
A+ + +LH + +RD K N+L N K++DFG AK
Sbjct: 118 EASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 8e-12
Identities = 35/215 (16%), Positives = 56/215 (26%), Gaps = 55/215 (25%)
Query: 77 KVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL----- 131
F T+ + +GEG FG V++ D VAIK +
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADHTP-----------VAIKIIAIEGP 56
Query: 132 ---NPESMQGFEEWQSEVNFLGRL---------SHPNLVKLLG-YCWEDK---ELLLVYE 175
N + FEE E+ L + L +C + LL ++
Sbjct: 57 DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116
Query: 176 YMQ--RGSLENHLFRRNPS-------------------IQPLSWDIRLKIAIGAARGLGF 214
+ +GS + + S I L
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176
Query: 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ +RD N+LL K+ K
Sbjct: 177 AEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-11
Identities = 46/244 (18%), Positives = 85/244 (34%), Gaps = 42/244 (17%)
Query: 53 SQAISEAGVEEASPNGQILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDD 112
S + A S + L V + +A +K +G+GGFG +Y ++
Sbjct: 1 SMRVKAAQAGRQSSAKRHLAEQ-FAVGEIITDMAAAA-WKVGLPIGQGGFGCIYLADMNS 58
Query: 113 KTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLV-------------- 158
G +K ++ F +E+ F R + P +
Sbjct: 59 SE----SVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQKWIRTRKLKYLGV 110
Query: 159 -KLLGYCWEDKELL----LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG 213
K G DK ++ + L+ ++ N + S L++++ L
Sbjct: 111 PKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANA--KRFSRKTVLQLSLRILDILE 166
Query: 214 FLHTSEKKVIYRDFKASNILLDGNYNAKI--SDFGLAKL-GPAGGESHVTTR----VMGT 266
++H E + ++ D KASN+LL+ ++ D+GLA P G GT
Sbjct: 167 YIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224
Query: 267 YGYA 270
+
Sbjct: 225 IEFT 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 44/167 (26%), Positives = 65/167 (38%), Gaps = 25/167 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVN 147
NF+ +G G FG + G + T VAIK + + Q E++
Sbjct: 10 NFRVGKKIGCGNFGELRLG-KNLYT--------NEYVAIKLEPMKSRAPQLHLEYRFYKQ 60
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
+ ++ + K +V E + SLE LF + S L IAI
Sbjct: 61 LGS---GDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCD--RTFSLKTVLMIAIQ 113
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILL--DGNYNAK---ISDFGLAK 249
+ ++H K +IYRD K N L+ GN + I DF LAK
Sbjct: 114 LISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 47/192 (24%), Positives = 69/192 (35%), Gaps = 30/192 (15%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVN 147
++ +G G FG +Y G D G VAIK + + Q E +
Sbjct: 10 RYRLGRKIGSGSFGDIYLG-TDIAA--------GEEVAIKLECVKTKHPQLHIESK---- 56
Query: 148 FLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
+ + + E ++V E + SLE LF + S L +A
Sbjct: 57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCS--RKFSLKTVLLLAD 112
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK---ISDFGLAKL-GPAGGESHVTTR 262
+ ++H K I+RD K N L+ I DFGLAK A H+ R
Sbjct: 113 QMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170
Query: 263 ----VMGTYGYA 270
+ GT YA
Sbjct: 171 ENKNLTGTARYA 182
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 49/192 (25%), Positives = 72/192 (37%), Gaps = 30/192 (15%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVN 147
F+ +G G FG +Y G + +T VAIK + + Q E +
Sbjct: 8 KFRLGRKIGSGSFGEIYLG-TNIQT--------NEEVAIKLENVKTKHPQLLYESK---- 54
Query: 148 FLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L + + + E +LV + + SLE LF + LS L +A
Sbjct: 55 IYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCS--RKLSLKTVLMLAD 110
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK---ISDFGLAKL-GPAGGESHVTTR 262
+ F+H K ++RD K N L+ A I DFGLAK H+ R
Sbjct: 111 QMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Query: 263 ----VMGTYGYA 270
+ GT YA
Sbjct: 169 ENKNLTGTARYA 180
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 40/204 (19%), Positives = 74/204 (36%), Gaps = 48/204 (23%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLS 153
LG G F V+ D VA+K + + E + E+ L R++
Sbjct: 25 RKLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDKVY--TEAAEDEIKLLQRVN 73
Query: 154 -----------HPNLVKLLGY----CWEDKELLLVYEYMQRGSLENHLF---RRNPSIQP 195
+++KLL + +++V+E L +L ++ +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEH-RG 127
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD------GNYNAKISDFGLAK 249
+ +I+ GL ++H +I+ D K N+L++ KI+D G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA- 185
Query: 250 LGPAGGESHVTTRVMGTYGYAAPE 273
+ H T + T Y +PE
Sbjct: 186 ---CWYDEHYTNSIQ-TREYRSPE 205
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 42/194 (21%), Positives = 73/194 (37%), Gaps = 32/194 (16%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK--KLNPESMQGFEEWQSEVN 147
++K +GEG FG +++G + VAIK ++ Q +E+++
Sbjct: 11 HYKVGRRIGEGSFGVIFEG-TNLLN--------NQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
G + + + E +LV + + SLE L + S A
Sbjct: 62 LAGC---TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCG--RKFSVKTVAMAAKQ 114
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK-----ISDFGLAK--LGPAGGESHVT 260
+ +H EK ++YRD K N L+ + + DFG+ K P + H+
Sbjct: 115 MLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ-HIP 171
Query: 261 TR----VMGTYGYA 270
R + GT Y
Sbjct: 172 YREKKNLSGTARYM 185
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 9e-08
Identities = 33/182 (18%), Positives = 64/182 (35%), Gaps = 38/182 (20%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
+ +G GGFG +Y +K E+ F SE+ F
Sbjct: 37 NQWVLGKKIGSGGFGLIYLA-FPTNK-----PEKDARHVVKVEYQENGPLF----SELKF 86
Query: 149 LGRLSHPNLVKLLGYCWEDKEL-------------------LLVYEYMQRGSLENHLFRR 189
R++ + +K + L +V E + L+ + +
Sbjct: 87 YQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ-KISGQ 144
Query: 190 NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI--SDFGL 247
N + L++ I L ++H E + ++ D KA+N+LL ++ +D+GL
Sbjct: 145 NGT---FKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199
Query: 248 AK 249
+
Sbjct: 200 SY 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 47/166 (28%), Positives = 70/166 (42%), Gaps = 29/166 (17%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLS 153
SL+G+G FG+V K + D VAIK + N ++ + Q EV L ++
Sbjct: 60 SLIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAF--LNQAQIEVRLLELMN 108
Query: 154 HP------NLVKLLGYCWEDKELLLVYEYMQRGSLENHLF---RRNPSIQPLSWDIRLKI 204
+V L + L LV+E L +L+ R + + +S ++ K
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNT-NFRGVSLNLTRKF 162
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILL--DGNYNAKISDFGLA 248
A L FL T E +I+ D K NILL KI DFG +
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 40/171 (23%), Positives = 68/171 (39%), Gaps = 39/171 (22%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRL 152
++G+G FG+V K + D K VA+K + N + + E+ L L
Sbjct: 102 LKVIGKGSFGQVVKAY-DHKV--------HQHVALKMVRNEKRF--HRQAAEEIRILEHL 150
Query: 153 SH------PNLVKLLGY-------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
N++ +L C + +E + +L + ++N Q S
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHIC-------MTFELL-SMNLYELI-KKN-KFQGFSLP 200
Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGNYNAKISDFGLA 248
+ K A + L LH + ++I+ D K NILL G K+ DFG +
Sbjct: 201 LVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 36/185 (19%), Positives = 60/185 (32%), Gaps = 44/185 (23%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLS 153
+G+G FGRV A+K + N + + E + L ++
Sbjct: 41 RKMGDGTFGRVLLCQ-HIDN--------KKYYAVKVVRNIKKY--TRSAKIEADILKKIQ 89
Query: 154 H-----PNLVKLLGY-------CWEDKELLLVYEYMQRGSLENHLF---RRNPSIQPLSW 198
+ N+VK G C L++E L L+ RN +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRN-NYNGFHI 136
Query: 199 D-IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES 257
+ I+ I + L +L + + + D K NILLD Y K +
Sbjct: 137 EDIK-LYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 258 HVTTR 262
+ T
Sbjct: 194 YRTKS 198
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 40/187 (21%), Positives = 62/187 (33%), Gaps = 40/187 (21%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-- 152
LG G F V+ W D + VA+K + E E+ L +
Sbjct: 43 RKLGWGHFSTVWLSW-DIQG--------KKFVAMKVVKSAEHYT-ETALDEIRLLKSVRN 92
Query: 153 ---SHPN---LVKLLGY-----------CWEDKELLLVYEYMQRGSLENHLFRRNPSIQP 195
+ PN +V+LL C +V+E + L ++ Q
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLL-KWIIKSNY-QG 142
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG 255
L KI +GL +LH ++ ++I+ D K NILL N A G
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201
Query: 256 ESHVTTR 262
+
Sbjct: 202 APPPSGS 208
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 35/176 (19%), Positives = 63/176 (35%), Gaps = 30/176 (17%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKL-NPESMQGFEEWQSEVNFLGRLS 153
LGEG FG+V + D VA+K + N E + E+N L ++
Sbjct: 25 GNLGEGTFGKVVECL-DHAR-------GKSQVALKIIRNVGKY--REAARLEINVLKKIK 74
Query: 154 HP------NLVKLLGYCWEDKELLLVYEYMQRGSLENHLF---RRNPSIQPLSWD-IRLK 203
V + + + + +E L + F + N + QP +R
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKEN-NFQPYPLPHVR-H 127
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259
+A L FLH E ++ + D K NIL + + + + + + +
Sbjct: 128 MAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.58 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.37 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.05 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.91 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.82 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.81 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.73 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.58 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.99 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.9 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.79 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.68 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.56 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.6 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.23 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 94.1 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.93 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.21 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=386.29 Aligned_cols=194 Identities=25% Similarity=0.319 Sum_probs=175.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|+++++||+|+||+||+|++..+ ++.||+|++.+.. ....+.+.+|+++|++++|||||+++++++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~---------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELAT---------SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCC---------CCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4799999999999999999987764 8899999997542 234577899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+++.+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++.+||+||
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEc
Confidence 999999999999999999999876 569999999999999999999995 99999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+.+..........+++||+.|||||++.+..|+.++|||||||++|+||
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 228 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999876544444456789999999999999999999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-56 Score=387.67 Aligned_cols=192 Identities=24% Similarity=0.305 Sum_probs=173.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
...|++.+.||+|+||+||+|.+..+ |+.||||+++.......+.+.+|+.+|++++|||||++++++.++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~t---------g~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSS---------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCC---------CCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35699999999999999999987764 889999999766555557788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+|||||||+||+|.+++.. ..+++..+..++.||+.||+|||+ +|||||||||+||||+.++.+||+|||+
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGl 216 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGF 216 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcC
Confidence 999999999999999999975 348999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+.+.... ......+||+.|||||++.+..|+.++|||||||++|+||
T Consensus 217 a~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 264 (346)
T 4fih_A 217 CAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 264 (346)
T ss_dssp CEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 98764432 2345678999999999999999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-56 Score=386.66 Aligned_cols=195 Identities=24% Similarity=0.327 Sum_probs=166.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++++.||+|+||+||+|++..+ ++.||+|++... .....+++.+|+.+|++|+|||||++++++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~ 93 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTED---------GRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTT---------CCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCC---------CCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE
Confidence 35899999999999999999987754 889999998754 3344578899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+++.+|||||||+||+|.++|..+.. ..+++..++.|+.||+.||+|||+ +|||||||||+||||+.++.+||+||
T Consensus 94 ~~~~~yiVmEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DF 169 (350)
T 4b9d_A 94 ENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDF 169 (350)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECST
T ss_pred ECCEEEEEEeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEccc
Confidence 99999999999999999999976532 457899999999999999999994 99999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+.+... .......+||+.|||||++.+..|+.++|||||||++|+||
T Consensus 170 Gla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml 219 (350)
T 4b9d_A 170 GIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219 (350)
T ss_dssp TEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 999865321 12234568999999999999999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=391.12 Aligned_cols=192 Identities=24% Similarity=0.305 Sum_probs=173.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+.|++.+.||+|+||+||+|.+..+ |+.||||++........+.+.+|+.+|+.++|||||++++++.++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~t---------g~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSS---------GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCC---------CCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 35799999999999999999987764 889999999776555567789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+|||||||+||+|.+++... .+++..+..|+.||+.||+|||+ +|||||||||+||||+.+|.+||+|||+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGl 293 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGF 293 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCcc
Confidence 9999999999999999999753 48999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+.+.... ......+||+.|||||++.+..|+.++|||||||++|+||
T Consensus 294 a~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 341 (423)
T 4fie_A 294 CAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 341 (423)
T ss_dssp CEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 98764432 2345678999999999999999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=378.38 Aligned_cols=204 Identities=26% Similarity=0.380 Sum_probs=173.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|.+.+.||+|+||+||+|.+... ....++..||||.++.......++|.+|+.+|++++|||||++++++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 45788999999999999999987642 12234788999999877666678899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcC---------CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 168 KELLLVYEYMQRGSLENHLFRRN---------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
+.+|+|||||++|+|.++|.... .....+++..++.|+.||+.||+|||+ ++||||||||+||||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCC
Confidence 99999999999999999997642 223569999999999999999999995 8999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||+|+
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999998654332222233456899999999999999999999999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=377.58 Aligned_cols=204 Identities=27% Similarity=0.401 Sum_probs=167.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|.+.++||+|+||+||+|.+... ....+++.||||.++.......++|.+|+++|++++|||||++++++.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35678889999999999999987642 12234788999999877766678899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNP-----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
+.+|||||||++|+|.+++..... ...++++..++.|+.||+.||+|||+ .+||||||||+||||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEET
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECC
Confidence 999999999999999999976532 12468999999999999999999995 89999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++..............+||+.|||||++.+..|+.++|||||||+||+||
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ell 254 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHH
Confidence 9999999999998765443333345568999999999999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=368.18 Aligned_cols=192 Identities=29% Similarity=0.452 Sum_probs=160.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.+++++.+.||+|+||+||+|.+.. .||||.++.. ..+..+.|.+|+.+|++++|||||++++++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4578889999999999999997653 3899988754 3345678999999999999999999999875
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+ +.+|||||||+||+|.++|.... ..+++..++.|+.||+.||+|||+ .+||||||||+||||++++.+||+||
T Consensus 103 ~-~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 103 K-DNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp S-SSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCC
T ss_pred C-CeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeec
Confidence 4 67899999999999999997653 469999999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc---cCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT---GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+..............+||+.|||||++.+ +.|+.++|||||||+||+|+
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ell 231 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHH
Confidence 99987654333334456789999999999964 45899999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=373.55 Aligned_cols=190 Identities=26% Similarity=0.293 Sum_probs=164.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+.|++.++||+|+||+||+|++..+ |+.||||+++..... .+|+.+|++++|||||++++++.++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~---------g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQT---------GFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEET
T ss_pred hhheEeCcEeccCCCeEEEEEEECCC---------CCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34688889999999999999987754 889999999754322 4699999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-ceEEcccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKISDFG 246 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg 246 (297)
+.+|||||||+||+|.++|.+. ..+++..++.++.||+.||+||| +++||||||||+||||+.++ ++||+|||
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFG 196 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFG 196 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred CEEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCC
Confidence 9999999999999999999876 56999999999999999999999 59999999999999999987 69999999
Q ss_pred ccccCCCCCCcc---eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESH---VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|+.+....... ....++||+.|||||++.+..|+.++|||||||++|+||
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml 250 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 998765432211 223468999999999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=373.17 Aligned_cols=195 Identities=26% Similarity=0.317 Sum_probs=164.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++++.||+|+||+||+|+.... ..+++.||+|.+++.. .....++.+|+.+|++++|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISG------SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSS------TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccC------CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 5799999999999999999976432 1237889999987643 2233567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++.+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||+ +|||||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 99999999999999999999876 569999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|+...... ......+||+.|||||++.+..|+.++|||||||++|+||
T Consensus 172 la~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml 220 (304)
T 3ubd_A 172 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220 (304)
T ss_dssp EEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred cceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHH
Confidence 998654322 2334578999999999999999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=361.96 Aligned_cols=191 Identities=27% Similarity=0.426 Sum_probs=155.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|.+++.. ....+++.+|+.+|++++||||+++++++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 82 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTT---------GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI 82 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTT---------CCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCC---------CCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 46899999999999999999976654 8899999987542 23346789999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+++.+|+||||+ +|+|.+++.++ ..+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|
T Consensus 83 ~~~~~~~ivmEy~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~D 155 (275)
T 3hyh_A 83 KSKDEIIMVIEYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIAD 155 (275)
T ss_dssp ECSSEEEEEEECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECC
T ss_pred EECCEEEEEEeCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEee
Confidence 9999999999999 77999999876 569999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCc-ccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY-LLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~~ll 297 (297)
||+|+..... ......+||+.|||||++.+..|+ .++|||||||++|+||
T Consensus 156 FGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~ll 206 (275)
T 3hyh_A 156 FGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 206 (275)
T ss_dssp SSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHH
T ss_pred cCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHH
Confidence 9999865432 223457899999999999988764 6899999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=362.56 Aligned_cols=187 Identities=29% Similarity=0.420 Sum_probs=162.4
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc--
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-- 166 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-- 166 (297)
|++.++||+|+||+||+|.+..+ ++.||+|.+... .....++|.+|+.+|++|+|||||++++++.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTET---------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCC---------CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 36677899999999999987764 788999998654 23345789999999999999999999999875
Q ss_pred --CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC--ceeccCCCCcEEEcC-CCceE
Q 022413 167 --DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDG-NYNAK 241 (297)
Q Consensus 167 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~--ivH~Dlkp~Nill~~-~~~~k 241 (297)
++.+|||||||+||+|.+++.+. ..+++..++.++.||+.||+|||+ ++ ||||||||+||||+. ++.+|
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~--~~~~IiHRDlKp~NILl~~~~g~vK 172 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCEEecccChhheeEECCCCCEE
Confidence 35689999999999999999876 568999999999999999999995 66 999999999999984 79999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+|+.... ......+|||.|||||++. ++|+.++|||||||++|+||
T Consensus 173 l~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyell 223 (290)
T 3fpq_A 173 IGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMA 223 (290)
T ss_dssp ECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHH
T ss_pred EEeCcCCEeCCC----CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHH
Confidence 999999986432 2345678999999999886 57999999999999999985
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=370.36 Aligned_cols=203 Identities=28% Similarity=0.383 Sum_probs=169.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++++.+.||+|+||+||+|.+... .....++.||||.++... ....++|.+|+.+|++++|||||++++++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 3567788999999999999987532 122337889999997543 33457899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
+.+++|||||++|+|.++|..+.+. ...+++..++.|+.||+.||+|||+ .+||||||||+||||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccceEEC
Confidence 9999999999999999999754321 2458999999999999999999995 8999999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 236 GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++.+||+|||+++..............+||+.|||||++.++.|+.++|||||||+||||+
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~ 241 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH
Confidence 99999999999998654333223344567999999999999999999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=368.17 Aligned_cols=198 Identities=26% Similarity=0.364 Sum_probs=159.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++++.||+|+||+||+|++..+ ++.||+|++.... ....+++.+|+.+|++|+|||||++++++.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 74 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVD---------DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 74 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTT---------CCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred chhCEEeeEEecCCCeEEEEEEECCC---------CCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 45699999999999999999987754 7889999986543 3344678999999999999999999999976
Q ss_pred CC------------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 167 DK------------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 167 ~~------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
.+ .+|+|||||+||+|.+++..+... ...++..++.|+.||+.||+|||+ +|||||||||+||||
T Consensus 75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl 151 (299)
T 4g31_A 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFF 151 (299)
T ss_dssp EC----------CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE
T ss_pred cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEE
Confidence 54 379999999999999999865322 335677789999999999999995 899999999999999
Q ss_pred cCCCceEEccccccccCCCCCCc----------ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGES----------HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.++.+||+|||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|+||
T Consensus 152 ~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell 224 (299)
T 4g31_A 152 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224 (299)
T ss_dssp CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHc
Confidence 99999999999999876443211 1123467999999999999999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=365.56 Aligned_cols=209 Identities=25% Similarity=0.313 Sum_probs=176.2
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCC-CCcccE
Q 022413 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSH-PNLVKL 160 (297)
Q Consensus 83 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h-~nIv~~ 160 (297)
.+....++|++.+.||+|+||+||+|.+... .+...++.||+|.+.... ....+.|.+|+.+|+++.| ||||++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444567899999999999999999987653 223346789999997653 3345779999999999975 999999
Q ss_pred EeEEEcC-CeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccC
Q 022413 161 LGYCWED-KELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF 227 (297)
Q Consensus 161 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dl 227 (297)
++++.+. +.+++|||||++|+|.++|..... ....+++..++.++.||+.||+|||+ ++||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCcc
Confidence 9998765 578999999999999999975421 12458999999999999999999995 89999999
Q ss_pred CCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 228 KASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 228 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||+|+
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~ 281 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHH
Confidence 9999999999999999999999765444333445567999999999999999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=353.30 Aligned_cols=192 Identities=26% Similarity=0.358 Sum_probs=156.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|.+.+.||+|+||+||+|.++ |+.||||+++...... ..+..|+..+.+++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 46788899999999999999874 6789999997654322 22345666777899999999999998754
Q ss_pred ----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC------CCCceeccCCCCcEEEcCCC
Q 022413 169 ----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 169 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------~~~ivH~Dlkp~Nill~~~~ 238 (297)
.+||||||+++|+|.+++... .+++..+..++.|++.||+|||+. +.+||||||||+||||+.++
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~ 145 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence 589999999999999999764 489999999999999999999952 23899999999999999999
Q ss_pred ceEEccccccccCCCCCCc--ceeeccCCcccccCcceeccc------CCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGES--HVTTRVMGTYGYAAPEYVATG------NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++........ ......+||+.|||||++.+. .++.++|||||||+||+|+
T Consensus 146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 9999999999865433221 122346799999999999754 4678999999999999984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=356.09 Aligned_cols=194 Identities=24% Similarity=0.318 Sum_probs=165.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++++.||+|+||+||+|++..+ |+.||||++.... ....+++.+|+.+|+.++|||||++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t---------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLT---------GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCC---------CCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 35799999999999999999987754 8899999997542 334567889999999999999999999876
Q ss_pred c------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 E------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
. .+.+|||||||+ |+|.+++... ..+++..+..++.||+.||+|||+ .|||||||||+|||++.++.
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~ 196 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCE 196 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCC
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCC
Confidence 4 367999999995 6899999765 569999999999999999999995 99999999999999999999
Q ss_pred eEEccccccccCCCCC--CcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGG--ESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+|+.+.... ........+||+.|||||++.+.. |+.++|||||||++|+||
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence 9999999998764321 122344678999999999988754 678999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=368.47 Aligned_cols=191 Identities=28% Similarity=0.352 Sum_probs=166.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHH---HHHHHHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEW---QSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~---~~E~~~l~~l~h~nIv~~~ 161 (297)
.++|+++++||+|+||+||+|+...+ |+.||+|++.+... .....+ ..++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~t---------g~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADT---------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCC---------CCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 46899999999999999999987754 88999999875421 111222 3457788889999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
++|.+.+.+|||||||+||+|.++|.+. ..+++..++.++.||+.||+||| ++|||||||||+||||+.+|.+|
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEE
Confidence 9999999999999999999999999876 56999999999999999999999 59999999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+|+.+... ...+.+||+.|||||++.. ..|+.++|+|||||+||+||
T Consensus 333 L~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmL 385 (689)
T 3v5w_A 333 ISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385 (689)
T ss_dssp ECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999876432 2345789999999999975 57899999999999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=348.54 Aligned_cols=194 Identities=22% Similarity=0.270 Sum_probs=163.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||+||+|.++.+ ..+++.||+|.+.+... ..++.+|+++|+.+ +||||+++++++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 457899999999999999999976421 23378899999876543 35678999999998 5999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC-CceEEcc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKISD 244 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~-~~~kl~D 244 (297)
+.+.+|+||||++||+|.+++. .+++..++.++.||+.||+|||+ .|||||||||+||||+.+ +.+||+|
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred ECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECc
Confidence 9999999999999999999983 38899999999999999999995 999999999999999876 8999999
Q ss_pred ccccccCCCCCC--------------------------cceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGE--------------------------SHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
||+|+....... .......+||+.|||||++.+. .|+.++||||+||++|+||
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 999976543211 0112345799999999999875 4788999999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=364.10 Aligned_cols=193 Identities=23% Similarity=0.320 Sum_probs=173.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++++.||+|+||+||+|.+..+ |+.||+|.+........+.+.+|+.+|+.|+||||+++++++.+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~t---------g~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERAT---------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCC---------CCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 46899999999999999999987754 889999999776655667889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC--CceEEccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN--YNAKISDF 245 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~--~~~kl~Df 245 (297)
+.+|+|||||+||+|.++|.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+||
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeec
Confidence 99999999999999999996543 458999999999999999999994 999999999999999854 89999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+.+... ......+||+.|||||++.+..|+.++|||||||++|+||
T Consensus 302 G~a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 302 GLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp SSCEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred cceeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999976543 2345568999999999999999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=318.47 Aligned_cols=193 Identities=28% Similarity=0.377 Sum_probs=170.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||+||+|....+ ++.||+|.+.+.. ......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKAT---------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCC---------CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 46799999999999999999987654 7889999987542 23456788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEee
Confidence 9999999999999999999999876 458999999999999999999994 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 149 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 199 (337)
T 1o6l_A 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred ccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHh
Confidence 99998643322 2234568999999999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=310.53 Aligned_cols=193 Identities=25% Similarity=0.328 Sum_probs=171.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||+||+|.+..+ ++.||+|.+........+.+.+|+.++++++||||+++++++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVAT---------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTT---------CCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCC---------CcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 356899999999999999999976554 78899999876655555778999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++... .+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 161 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFG 161 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999999999764 48899999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 162 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 210 (297)
T 3fxz_A 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210 (297)
T ss_dssp TCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHH
T ss_pred CceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 9986544322 234567999999999999999999999999999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=322.47 Aligned_cols=207 Identities=26% Similarity=0.358 Sum_probs=173.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+.... ......+..||+|.+.... ....+.+.+|+.+|+.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3568999999999999999999875321 1122346789999997653 34457889999999999 899999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
.+.+.+|+||||+++|+|.+++...... ...+++..++.++.||+.||+|||+ .||+||||||+||
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NI 234 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNV 234 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhE
Confidence 9999999999999999999999865421 2357899999999999999999994 8999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ell 299 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999998654433222233456789999999999999999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=320.88 Aligned_cols=194 Identities=29% Similarity=0.394 Sum_probs=166.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEe
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLG 162 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 162 (297)
..++|++.++||+|+||+||+|.+..+ ++.||+|++.+.. ....+.+.+|..+++.+ +||||+++++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~---------~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 91 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKET---------GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCC---------CCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence 356899999999999999999987754 7889999987542 23446678999999988 6999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
++.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||
T Consensus 92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 92 CFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEE
Confidence 999999999999999999999999876 558999999999999999999995 89999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+||
T Consensus 166 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 218 (353)
T 3txo_A 166 ADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218 (353)
T ss_dssp CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHH
T ss_pred ccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHH
Confidence 9999998543322 2344578999999999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=310.39 Aligned_cols=196 Identities=27% Similarity=0.452 Sum_probs=171.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.++||+|+||+||+|.+..+ +..||+|.+........+.+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~---------~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRET---------GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTT---------CCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEEECCC---------CcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 46799999999999999999987764 788999998776666678899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 154 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGL 154 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred CeeEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeeccc
Confidence 99999999999999999998743 558999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCcc------------eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESH------------VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++......... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 216 (310)
T 3s95_A 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216 (310)
T ss_dssp CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh
Confidence 98654322111 111457999999999999999999999999999999984
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.87 Aligned_cols=193 Identities=26% Similarity=0.358 Sum_probs=170.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|++... .....+++.+|+.+|+.++||||+++++++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 83 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILT---------GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCC---------CCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456899999999999999999987654 788999998654 334457788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
...+..|+||||+++++|.+++... ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~D 157 (328)
T 3fe3_A 84 ETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIAD 157 (328)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECS
T ss_pred EECCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEee
Confidence 9999999999999999999999876 458999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCc-ccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY-LLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~~ll 297 (297)
||+++...... .....+||+.|+|||++.+..++ .++|||||||++|+|+
T Consensus 158 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 208 (328)
T 3fe3_A 158 FGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208 (328)
T ss_dssp TTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH
T ss_pred ccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHH
Confidence 99998654322 23456899999999999988876 7899999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.09 Aligned_cols=193 Identities=24% Similarity=0.395 Sum_probs=169.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 163 (297)
.++|++.++||+|+||+||+|+...+ ++.||+|++.+.. ....+.+.+|..++.++ +||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~---------~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKT---------DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 56899999999999999999987754 7889999987542 22335678899999887 79999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999876 568999999999999999999995 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+||
T Consensus 196 DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell 247 (396)
T 4dc2_A 196 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 247 (396)
T ss_dssp CCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 999998633222 2345578999999999999999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=315.11 Aligned_cols=202 Identities=45% Similarity=0.781 Sum_probs=176.4
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 84 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
+....++|++.+.||+|+||.||+|.+.. +..||+|.+........+.+.+|+.+++.++||||++++++
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTT----------CCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECC----------CCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34457899999999999999999997543 67899999887766667889999999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+..++||||+++++|.+++.........+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEEC
T ss_pred EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999999999999997655444568999999999999999999995 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...............||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 235 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHH
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHH
Confidence 999998654332222334456899999999999999999999999999999984
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=311.99 Aligned_cols=190 Identities=32% Similarity=0.452 Sum_probs=169.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||+||+|....+ ++.||+|.+.+.. ....+.+.+|..+++.++||||+++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHN---------GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 46799999999999999999987654 7889999987542 23456778999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+...+|+||||++|++|.+++... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEee
Confidence 9999999999999999999999875 45899999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++.... .....+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 150 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 197 (318)
T 1fot_A 150 FGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197 (318)
T ss_dssp CSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred cCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHH
Confidence 999986432 233468999999999999999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.91 Aligned_cols=198 Identities=22% Similarity=0.259 Sum_probs=170.6
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEE
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
....++|++.++||+|+||+||+|.+... ++.||+|++.+... .....+.+|..++..++||||++++
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 140 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNA---------DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCC---------CcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 33467899999999999999999987754 78899999875321 2224478899999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+++.+.+.+|+||||++||+|.+++.... ..+++..++.++.||+.||+|||+ .+||||||||+||||+.++.+|
T Consensus 141 ~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEE
T ss_pred EEEeeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEE
Confidence 99999999999999999999999997642 458999999999999999999994 8999999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|+|+
T Consensus 216 L~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell 275 (437)
T 4aw2_A 216 LADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275 (437)
T ss_dssp ECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred EcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence 999999986544322 2234468999999999997 467899999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=315.63 Aligned_cols=195 Identities=28% Similarity=0.395 Sum_probs=170.3
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLL 161 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~ 161 (297)
...++|++.+.||+|+||+||+|.+..+ ++.||+|.+.... ....+.+..|..++..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKT---------NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTT---------TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 3467899999999999999999987654 7899999987542 23446678899999876 899999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+++.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEE
Confidence 9999999999999999999999999875 458999999999999999999995 8999999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 159 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 212 (345)
T 1xjd_A 159 IADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212 (345)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred EeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHh
Confidence 99999998643322 2244578999999999999999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=314.34 Aligned_cols=193 Identities=25% Similarity=0.396 Sum_probs=170.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 163 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++.+.. ....+.+.+|..+++++ +||||++++++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKT---------DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCC---------CCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 45799999999999999999987654 7889999987542 23446788999999988 79999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+.+|+||||++|++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999876 458999999999999999999995 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 153 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 204 (345)
T 3a8x_A 153 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204 (345)
T ss_dssp CGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred eccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHH
Confidence 999998643222 2344568999999999999999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=314.77 Aligned_cols=194 Identities=28% Similarity=0.323 Sum_probs=170.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEe
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLG 162 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 162 (297)
..++|++.++||+|+||+||+|....+ ++.||+|.+.+.. ....+.+..|..++..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~---------~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGT---------DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTE---------EEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCC---------CCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 356899999999999999999987654 7889999987542 23446778999999988 7999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
++.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEE
Confidence 999999999999999999999999876 458999999999999999999995 89999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 163 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 215 (353)
T 2i0e_A 163 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215 (353)
T ss_dssp CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred EeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHH
Confidence 9999998643322 2344578999999999999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=323.81 Aligned_cols=196 Identities=22% Similarity=0.257 Sum_probs=169.2
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEE
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
....++|++.++||+|+||+||+|.+..+ ++.||+|++.+.. ....+.+.+|+.+++.++||||++++
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~---------~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKST---------RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCC---------CcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 33457899999999999999999987754 7889999986532 12234578899999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+++.+.+.+|+||||++||+|.+++... .+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+|
T Consensus 136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEE
Confidence 9999999999999999999999999753 48999999999999999999995 8999999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccC----CcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN----FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++...... .......+||+.|+|||++.+.. ++.++|||||||++|+||
T Consensus 209 L~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell 267 (410)
T 3v8s_A 209 LADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267 (410)
T ss_dssp ECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH
T ss_pred EeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH
Confidence 99999998754332 11234578999999999998655 788999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.74 Aligned_cols=193 Identities=26% Similarity=0.343 Sum_probs=170.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh------hHHHHHHHHHHhcCCCCCCcccE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ------GFEEWQSEVNFLGRLSHPNLVKL 160 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~ 160 (297)
..++|++.+.||+|+||+||+|....+ +..||+|.+...... ..+.+.+|+.+|++++||||+++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---------~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l 80 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKST---------GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCC---------CCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence 356899999999999999999987654 788999998754321 34678999999999999999999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC--
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-- 238 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-- 238 (297)
++++.+.+.+|+||||++|++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 81 HDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSS
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCC
Confidence 99999999999999999999999999764 568999999999999999999995 8999999999999998776
Q ss_pred --ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 --NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 155 ~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll 212 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212 (361)
T ss_dssp SCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHH
Confidence 79999999998764432 234467999999999999889999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=317.65 Aligned_cols=202 Identities=19% Similarity=0.214 Sum_probs=167.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC---CCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~ 163 (297)
..++|.+.+.||+|+||+||+|.+... .....++.||+|.+..... ..+..|+.+++.++ |+||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 356799999999999999999965331 1223478899999976643 45566777777776 9999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC------
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNP-SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG------ 236 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~------ 236 (297)
+...+..|+||||+++|+|.+++..... ....+++..++.|+.||+.||+||| +.|||||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGGTCC-
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999975322 2356999999999999999999999 589999999999999988
Q ss_pred -----CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 -----NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|+||
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 279 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH
Confidence 8999999999997543322333455678999999999999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.89 Aligned_cols=194 Identities=28% Similarity=0.357 Sum_probs=165.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+... +..||+|.+... .....+++.+|+.++++++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTIL---------NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTT---------CSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCC---------CCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 46899999999999999999987654 788999987543 234457889999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..|+||||++|++|.+++... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~D 154 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFD 154 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999999876 468999999999999999999994 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++....... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 206 (294)
T 4eqm_A 155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH
T ss_pred CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 999986543221 1233457999999999999999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=316.61 Aligned_cols=192 Identities=24% Similarity=0.365 Sum_probs=169.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.+|+.++||||+++++++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~---------~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDT---------KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 46799999999999999999987754 7889999986542 23456788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+.+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEec
Confidence 9999999999999999999999865 558999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecc---cCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT---GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+||
T Consensus 159 FG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ell 211 (384)
T 4fr4_A 159 FNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211 (384)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHH
T ss_pred cceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHH
Confidence 99998754322 3345789999999999974 45889999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=321.99 Aligned_cols=198 Identities=21% Similarity=0.233 Sum_probs=170.7
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEE
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
....++|++.++||+|+||+||+|....+ ++.||+|++.+.. ....+.+.+|..++..++||||++++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~---------~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQT---------GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 33467899999999999999999987654 7899999987532 22335578899999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+++.+.+.+|+||||++||+|.+++.+.. ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+|
T Consensus 128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEE
T ss_pred EEEeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEE
Confidence 99999999999999999999999998653 358999999999999999999994 8999999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceec-------ccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-------TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++....... ......+||+.|+|||++. +..++.++|+|||||++|+|+
T Consensus 203 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell 264 (412)
T 2vd5_A 203 LADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264 (412)
T ss_dssp ECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred EeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence 999999987644322 1233468999999999997 356889999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=325.10 Aligned_cols=194 Identities=23% Similarity=0.309 Sum_probs=153.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.++||+|+||+||+|.+..+ ++.||+|++... .....+++.+|+.+|++++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLE---------KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCC---------CcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 46899999999999999999987654 788999998653 3344578899999999999999999999985
Q ss_pred cC-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 166 ED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 166 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
.. ..+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+ .|||||||||+||||+.++.+
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEECCCCCE
Confidence 43 5799999998 57999998765 558999999999999999999995 899999999999999999999
Q ss_pred EEccccccccCCCCCCc-------------------------ceeeccCCcccccCcceec-ccCCcccccchhhhhhhh
Q 022413 241 KISDFGLAKLGPAGGES-------------------------HVTTRVMGTYGYAAPEYVA-TGNFYLLSAKFGNVINVC 294 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGv~l~ 294 (297)
||+|||+++........ ......+||+.|+|||++. +..|+.++|||||||++|
T Consensus 196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ 275 (458)
T 3rp9_A 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275 (458)
T ss_dssp EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence 99999999875432110 1234467899999999864 566999999999999999
Q ss_pred hcC
Q 022413 295 MYL 297 (297)
Q Consensus 295 ~ll 297 (297)
+||
T Consensus 276 ell 278 (458)
T 3rp9_A 276 ELL 278 (458)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=313.60 Aligned_cols=190 Identities=27% Similarity=0.324 Sum_probs=170.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKES---------GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCC---------CCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 46799999999999999999987654 7889999987542 23456788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+...+|+||||++|++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECC
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcc
Confidence 9999999999999999999999876 458999999999999999999994 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 185 Fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 232 (350)
T 1rdq_E 185 FGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp CTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred cccceeccC-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHh
Confidence 999986532 223467999999999999999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=314.33 Aligned_cols=197 Identities=23% Similarity=0.318 Sum_probs=169.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-----hhHHHHHHHHHHhcCCCCCCcccEEe
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-----QGFEEWQSEVNFLGRLSHPNLVKLLG 162 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~ 162 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRET---------GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCC---------CCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 45799999999999999999987654 78899999864321 13467899999999999999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc---
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN--- 239 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~--- 239 (297)
++.+.+.+|+||||++|++|.+++.........+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCc
Confidence 9999999999999999999998887653333558999999999999999999995 89999999999999976554
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 172 vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 227 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227 (351)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred EEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHH
Confidence 9999999998764422 1234467999999999999989999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=317.42 Aligned_cols=193 Identities=28% Similarity=0.363 Sum_probs=161.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHH-hcCCCCCCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNF-LGRLSHPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~~~~~ 163 (297)
.++|++.+.||+|+||+||+|++..+ ++.||+|++.+... .....+..|..+ ++.++||||++++++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~---------~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAE---------EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTT---------CCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCC---------CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 46899999999999999999987654 78899999875432 233456677776 577899999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999875 458899999999999999999994 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 182 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 233 (373)
T 2r5t_A 182 DFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233 (373)
T ss_dssp CCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred eCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 999998532221 2344578999999999999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=309.16 Aligned_cols=211 Identities=45% Similarity=0.730 Sum_probs=181.4
Q ss_pred CCCcccCHHHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCC
Q 022413 74 PDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL 152 (297)
Q Consensus 74 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l 152 (297)
.....++..++....++|++.+.||+|+||.||+|.+.+ +..||+|.+..... .....+.+|+.+++.+
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 84 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD----------GTLVAVKRLKEERTQGGELQFQTEVEMISMA 84 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS----------SCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC----------CCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence 344567788888889999999999999999999996432 67899999876532 2224688999999999
Q ss_pred CCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCC---CceeccCCC
Q 022413 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK---KVIYRDFKA 229 (297)
Q Consensus 153 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~---~ivH~Dlkp 229 (297)
+||||+++++++.+.+..++||||+++++|.+++.........+++..+..++.|++.||+|||+ . ||+||||||
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~ivH~Dlkp 162 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD--HCDPKIIHRDVKA 162 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH--SSSSCEECCCCSG
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCCch
Confidence 99999999999999999999999999999999998776555679999999999999999999995 6 999999999
Q ss_pred CcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 230 SNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 230 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 229 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 229 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHH
T ss_pred hhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHH
Confidence 999999999999999999987643322 2334456999999999999999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=307.82 Aligned_cols=199 Identities=27% Similarity=0.373 Sum_probs=165.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 74 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVD---------DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 74 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTT---------CCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCC---------CcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 346799999999999999999987754 7889999986543 334577899999999999999999999986
Q ss_pred cCC---------------------------------------------------------eeEEEEEecCCCCHHHHHhh
Q 022413 166 EDK---------------------------------------------------------ELLLVYEYMQRGSLENHLFR 188 (297)
Q Consensus 166 ~~~---------------------------------------------------------~~~lv~e~~~~~~L~~~l~~ 188 (297)
+.. ..++||||+++++|.+++..
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 154 (332)
T 3qd2_B 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154 (332)
T ss_dssp ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence 643 38999999999999999986
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCc----------c
Q 022413 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGES----------H 258 (297)
Q Consensus 189 ~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~ 258 (297)
.... ...++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++........ .
T Consensus 155 ~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~ 231 (332)
T 3qd2_B 155 RCSL-EDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231 (332)
T ss_dssp CCSG-GGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------
T ss_pred ccCc-cchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccc
Confidence 5432 345677889999999999999994 89999999999999999999999999999876543211 1
Q ss_pred eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 259 VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 259 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (332)
T 3qd2_B 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270 (332)
T ss_dssp CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHH
T ss_pred cccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence 123457999999999999999999999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=306.92 Aligned_cols=192 Identities=18% Similarity=0.191 Sum_probs=169.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+..+ +..+|+|.+..... ....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---------~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSS---------KKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECCC---------CcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 46899999999999999999987654 78899999875533 336688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC--CCceEEccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG--NYNAKISDF 245 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~--~~~~kl~Df 245 (297)
+.+++||||++|++|.+++.... ..+++..+..++.||+.||+|||+ .||+||||||+|||++. ++.+||+||
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Df 148 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence 99999999999999999997542 458999999999999999999994 89999999999999987 789999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 149 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred CCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 9998764322 234467999999999999888899999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=311.92 Aligned_cols=193 Identities=23% Similarity=0.349 Sum_probs=169.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTT---------GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCC---------CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 356799999999999999999987654 788999998654 234456788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC---CceE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN---YNAK 241 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~---~~~k 241 (297)
.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.+ +.+|
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~k 171 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVK 171 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEE
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEE
Confidence 9999999999999999999999765 458999999999999999999995 899999999999999765 4599
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 172 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 224 (362)
T 2bdw_A 172 LADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224 (362)
T ss_dssp ECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred EeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999998764322 233467999999999999889999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=311.32 Aligned_cols=195 Identities=26% Similarity=0.312 Sum_probs=167.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVT---------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEECCC---------CcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 56899999999999999999987754 78899999865432 223567899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEee
Confidence 99999999999999999998755 458999999999999999999994 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
+++...............||+.|+|||++.+..+ +.++|||||||++|+|+
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 202 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHH
Confidence 9986543332223345689999999999988776 67899999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=319.26 Aligned_cols=194 Identities=22% Similarity=0.255 Sum_probs=169.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||+||+|.+..+ +..+|+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~---------~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLA---------GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTT---------TEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCC---------CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 467899999999999999999987654 7889999987543 33456788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc---CCCceE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GNYNAK 241 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~---~~~~~k 241 (297)
.+.+..|+||||++||+|.+.+... ..+++..+..++.||+.||+|||+ .||+||||||+|||++ .++.+|
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vk 153 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVK 153 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEE
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEE
Confidence 9999999999999999999999876 558999999999999999999995 8999999999999998 468899
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 L~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell 207 (444)
T 3soa_A 154 LADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207 (444)
T ss_dssp ECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred EccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHH
Confidence 99999998654322 2234568999999999999889999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=304.04 Aligned_cols=189 Identities=24% Similarity=0.296 Sum_probs=168.0
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCee
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 170 (297)
|...+.||+|+||.||+|....+ |+.||+|.+........+.+.+|+.++++++||||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHS---------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEECCC---------CcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 66678999999999999987654 788999998766655667889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 171 LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 171 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
++||||+++++|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++.
T Consensus 118 ~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 190 (321)
T ss_dssp EEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCcEEEeeeeeeee
Confidence 999999999999999864 348999999999999999999995 8999999999999999999999999999986
Q ss_pred CCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 251 GPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 251 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 191 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 235 (321)
T 2c30_A 191 ISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235 (321)
T ss_dssp CCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred cccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 543221 234467999999999999999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=324.02 Aligned_cols=197 Identities=28% Similarity=0.404 Sum_probs=172.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.++||+|+||+||+|.+..+ ++.||+|++.+.. ....+.+.+|+.++++++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~t---------g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKAT---------GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCC---------CcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 36789999999999999999987654 7899999987542 23346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+...+|+||||++||+|.+++.........+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEee
Confidence 99999999999999999999998754444569999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++....... .....+||+.|+|||++.+..++.++|+|||||++|+||
T Consensus 333 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyell 383 (543)
T 3c4z_A 333 LGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383 (543)
T ss_dssp CTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred cceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHH
Confidence 999987543321 234468999999999999999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=310.87 Aligned_cols=211 Identities=25% Similarity=0.305 Sum_probs=175.2
Q ss_pred HHHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcc
Q 022413 81 FLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLV 158 (297)
Q Consensus 81 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv 158 (297)
...+....++|++.+.||+|+||.||+|.+... .....++.||+|.+.... ....+.+.+|+.+++++ +||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 344455678999999999999999999986532 123347899999997653 33446789999999999 699999
Q ss_pred cEEeEEEcCC-eeEEEEEecCCCCHHHHHhhcCCC---------------------------------------------
Q 022413 159 KLLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPS--------------------------------------------- 192 (297)
Q Consensus 159 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------- 192 (297)
++++++.+.+ ..++||||+++|+|.+++......
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999998765 499999999999999999865321
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCC
Q 022413 193 -----------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG 255 (297)
Q Consensus 193 -----------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 255 (297)
...+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1228899999999999999999995 899999999999999999999999999998664433
Q ss_pred CcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 256 ESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 256 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.........||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 289 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHH
Confidence 333344567899999999999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=310.28 Aligned_cols=207 Identities=27% Similarity=0.384 Sum_probs=172.3
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
....++|++.+.||+|+||.||+|.+... .....+..||+|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 33567899999999999999999987642 111236789999998653 3345678999999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCce
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPS--------------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVI 223 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~iv 223 (297)
+.+.+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+ .||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~iv 196 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFV 196 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCee
Confidence 99999999999999999999999864321 1568999999999999999999995 8999
Q ss_pred eccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 224 YRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 224 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 99999999999999999999999997543222222233456899999999999999999999999999999984
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=310.89 Aligned_cols=193 Identities=23% Similarity=0.301 Sum_probs=170.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|....+ ++.+|+|.+..........+.+|+.+|+.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~---------~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKAT---------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCC---------CCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 46899999999999999999987654 788999998776555556789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC--CCceEEccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG--NYNAKISDF 245 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~--~~~~kl~Df 245 (297)
...++||||+++++|.+++.... ..+++..+..++.||+.||+|||+ .||+||||||+|||++. .+.+||+||
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEec
Confidence 99999999999999999987542 458999999999999999999994 89999999999999974 578999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 196 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 196 GLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp TTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred ccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 9998764322 233457999999999999989999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=306.19 Aligned_cols=196 Identities=29% Similarity=0.386 Sum_probs=160.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc----hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
.++|++.+.||+|+||.||+|..... ...+..||+|++.... ......+.+|+.+++.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTG------ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSS------TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEecc------CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 46799999999999999999986421 1237899999987642 2234567889999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEEC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEE
Confidence 99999999999999999999999876 458899999999999999999994 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...... ......+||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 164 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (327)
T 3a62_A 164 DFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred eCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHH
Confidence 999997543221 1234567999999999999989999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=304.78 Aligned_cols=192 Identities=24% Similarity=0.336 Sum_probs=168.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch------hhHHHHHHHHHHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
.++|++.+.||+|+||.||+|....+ +..||+|.+..... ...+.+.+|+.++++++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKST---------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTT---------CCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCC---------CcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 45799999999999999999987654 78899998865422 1346789999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY--- 238 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~--- 238 (297)
+++.+....++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCC
Confidence 9999999999999999999999999764 558999999999999999999994 8999999999999998877
Q ss_pred -ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 -NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 155 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 211 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211 (326)
T ss_dssp CCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence 89999999998764322 223457999999999999889999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=298.74 Aligned_cols=192 Identities=24% Similarity=0.347 Sum_probs=165.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|+||+||+|.+..+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRET---------HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCC---------CceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 5799999999999999999987754 7889999986542 2334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++ +|.+.+.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999965 6766665543 558999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
+++...... .......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 147 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 196 (292)
T 3o0g_A 147 LARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp TCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred cceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHH
Confidence 998654322 1233457899999999998766 789999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=307.03 Aligned_cols=191 Identities=26% Similarity=0.382 Sum_probs=167.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKT---------QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCC---------CCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 46899999999999999999987654 7889999986542 12235788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
...+..++||||+ +|+|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECC
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEE
Confidence 9999999999999 78999999876 458999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
||+++...... .....+||+.|+|||++.+..+ +.++|||||||++|+|+
T Consensus 152 FG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 202 (336)
T 3h4j_B 152 FGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML 202 (336)
T ss_dssp SSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHH
T ss_pred eccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHH
Confidence 99998654322 2344679999999999988776 57899999999999984
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=304.67 Aligned_cols=199 Identities=26% Similarity=0.386 Sum_probs=167.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+. ..+..||+|.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPG------QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTT------SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCC------CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 467999999999999999999886431 12567999999765 33445778999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCC
Confidence 999999999999999999997543 458999999999999999999994 899999999999999999999999999
Q ss_pred ccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++........ .......+|+.|+|||++.+..++.++||||||+++|+||
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 248 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 99876443221 1222345678899999999899999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=320.55 Aligned_cols=194 Identities=30% Similarity=0.385 Sum_probs=160.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.++||+|+||.||+|....+ ++.||+|.+... .......+.+|+.+++.++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKAT---------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCC---------CCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 46799999999999999999987654 788999998754 223345678899999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+.+++||||+++++|.+++... ..+++..+..++.||+.||+|||+ +.||+||||||+||||+.++.+||+|
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEcc
Confidence 9999999999999999999999876 468999999999999999999994 38999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|+||
T Consensus 293 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 343 (446)
T 4ejn_A 293 FGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343 (446)
T ss_dssp CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHh
Confidence 99998643322 2234578999999999999999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=302.54 Aligned_cols=194 Identities=28% Similarity=0.441 Sum_probs=159.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..+|++.+.||+|+||+||+|.+. +..||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 567999999999999999999764 6679999987653 344567899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC--ceeccCCCCcEEEcCCCceEEc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~--ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+||| +.| |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 99999999999999999999976421 123889999999999999999999 478 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 233 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 999997543321 1233467999999999999999999999999999999984
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=306.29 Aligned_cols=192 Identities=29% Similarity=0.383 Sum_probs=163.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.++||+|+||+||+|.+. ++.||+|++...... ......|+.++++++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 4568999999999999999999765 567999999765433 2455679999999999999999999987
Q ss_pred CC----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCC----------CceeccCCCCcE
Q 022413 167 DK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK----------KVIYRDFKASNI 232 (297)
Q Consensus 167 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~----------~ivH~Dlkp~Ni 232 (297)
.. .+++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Ni 162 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNV 162 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGE
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhE
Confidence 54 479999999999999999763 4899999999999999999999 47 999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~ 232 (322)
T 3soc_A 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232 (322)
T ss_dssp EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH
Confidence 999999999999999976544333223344679999999999986 45667899999999999984
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=305.22 Aligned_cols=195 Identities=23% Similarity=0.329 Sum_probs=161.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .....++.+|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRD---------HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCC---------CceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 56899999999999999999987654 7889999997652 23346788999999999999999999998
Q ss_pred EcCCe----eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 165 WEDKE----LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 165 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
..... .|+||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCE
Confidence 76543 49999999999999999876 458999999999999999999994 899999999999999999999
Q ss_pred EEccccccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 213 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence 99999999865433211 1233457999999999999999999999999999999985
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=313.10 Aligned_cols=204 Identities=26% Similarity=0.313 Sum_probs=168.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|.+... .....+..||+|.+... .......+.+|+.++++++||||+++++++.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 46799999999999999999986542 12234788999999754 33444678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---ce
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNP---SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY---NA 240 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~---~~ 240 (297)
....++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+ .||+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999986542 22458899999999999999999995 8999999999999998554 59
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|+||
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ell 280 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999997532222222233456899999999999999999999999999999984
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=303.27 Aligned_cols=205 Identities=27% Similarity=0.328 Sum_probs=172.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+... .....+..||+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred chhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 456899999999999999999987432 112236789999997653 345578899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceec
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNP--------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~ 225 (297)
+.+..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+ .||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~ 174 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHR 174 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCccc
Confidence 99999999999999999999986532 12348899999999999999999995 899999
Q ss_pred cCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 226 DFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 226 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 246 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH
Confidence 999999999999999999999998654433222233345788999999999989999999999999999984
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=300.78 Aligned_cols=200 Identities=29% Similarity=0.450 Sum_probs=166.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||+||+|.+.. ....++..||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 5689999999999999999998642 12234889999999877666667899999999999999999999998654
Q ss_pred --CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 168 --KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 168 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccC
Confidence 56899999999999999998653 458999999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++........ .......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 211 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 999865433211 1223345788899999999999999999999999999984
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=313.21 Aligned_cols=197 Identities=25% Similarity=0.366 Sum_probs=167.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.+|++++||||+++++++.
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRAD---------NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecC---------CeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 356789999999999999999988754 7789999987653 233457889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcC
Confidence 9999999999999999999998653 358899999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...............+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 309 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence 9998643221111111123577899999999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.04 Aligned_cols=194 Identities=29% Similarity=0.392 Sum_probs=170.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.++||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+|+.++||||+++++++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~t---------g~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRAT---------GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCC---------CCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 46799999999999999999987654 7899999986542 22346678999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+.+|+||||++||+|.+++..... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999976432 348999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 330 FGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLl 379 (576)
T 2acx_A 330 LGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379 (576)
T ss_dssp CTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHH
T ss_pred cccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHH
Confidence 99998764332 234468999999999999989999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=308.30 Aligned_cols=187 Identities=26% Similarity=0.352 Sum_probs=160.2
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEEE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 173 (297)
.++||+|+||.||+|....+ +..||+|++........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETAT---------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEETTT---------CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEcCC---------CcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 56899999999999987654 788999999876655667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE--cCCCceEEccccccccC
Q 022413 174 YEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL--DGNYNAKISDFGLAKLG 251 (297)
Q Consensus 174 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill--~~~~~~kl~Dfg~a~~~ 251 (297)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 165 ~E~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EECCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999987543 458899999999999999999995 899999999999999 56789999999999876
Q ss_pred CCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 252 PAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 252 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 240 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 282 (373)
T 2x4f_A 240 KPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282 (373)
T ss_dssp CTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH
T ss_pred CCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH
Confidence 4332 223456999999999999888999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=307.52 Aligned_cols=207 Identities=28% Similarity=0.344 Sum_probs=174.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+.... ......+..||+|++.... ....+++.+|+++++++ +||||+++++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 3568999999999999999999875421 1122335689999987653 34457789999999999 899999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
.+.+..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+ .+|+||||||+||
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNV 222 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceE
Confidence 9999999999999999999999875421 2458999999999999999999995 8999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 99999999999999998664433223334456789999999999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=299.90 Aligned_cols=192 Identities=24% Similarity=0.343 Sum_probs=162.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||+||+|.+.. ++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ----------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT----------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC----------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 5689999999999999999998743 67899999875432 23467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+++..++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 90 SERCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp CSSCEEEEEECCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEcCCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccC
Confidence 99999999999975 8888887653 458999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 164 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 214 (311)
T 3niz_A 164 GLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214 (311)
T ss_dssp TTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred cCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHH
Confidence 9998654322 12334578999999999876 56889999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=305.77 Aligned_cols=191 Identities=27% Similarity=0.332 Sum_probs=153.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+... ++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGT---------QKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCC---------CcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 356799999999999999999987754 7789999987543 23567889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CCceEEc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NYNAKIS 243 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~~~kl~ 243 (297)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~ 193 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIA 193 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEc
Confidence 99999999999999999999765 458999999999999999999994 89999999999999975 8999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 194 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 244 (349)
T 2w4o_A 194 DFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244 (349)
T ss_dssp CCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHH
Confidence 99999865332 1233467999999999999989999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=299.26 Aligned_cols=196 Identities=24% Similarity=0.371 Sum_probs=152.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTT---------GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECSSS---------CCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEECCC---------CcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 45899999999999999999976654 78899999865432 233678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
++..++||||++ ++|.+++.... .....+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECc
Confidence 999999999997 59999987542 222458899999999999999999994 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 203 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999986543221 22345789999999999764 5889999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=313.29 Aligned_cols=194 Identities=26% Similarity=0.351 Sum_probs=163.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++... .....+++.+|+.+|++++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNT---------EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTT---------TEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCC---------CcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 56899999999999999999987654 788999999754 3344578899999999999999999999997
Q ss_pred cC-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 166 ED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 166 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
.. ..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEECCCCCE
Confidence 76 57999999995 5999999765 558999999999999999999995 899999999999999999999
Q ss_pred EEccccccccCCCCCCc--------------------ceeeccCCcccccCccee-cccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGES--------------------HVTTRVMGTYGYAAPEYV-ATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++........ ......+||+.|+|||++ ....++.++|||||||++|+||
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell 246 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence 99999999875432211 123556899999999986 4566899999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=306.74 Aligned_cols=199 Identities=27% Similarity=0.425 Sum_probs=158.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+... ...+..||+|.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLP------SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCT------TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecC------CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 45899999999999999999976521 122677999999765 33445688999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCc
Confidence 999999999999999999997653 458999999999999999999994 899999999999999999999999999
Q ss_pred ccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++........ .......+++.|+|||++.+..++.++||||||+++|+||
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ell 244 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHH
Confidence 99865432211 1112234578899999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.98 Aligned_cols=194 Identities=28% Similarity=0.323 Sum_probs=170.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCC-CCCCcccEEe
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRL-SHPNLVKLLG 162 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 162 (297)
..++|+++++||+|+||+||+|.+..+ ++.||+|++.+.. ....+.+..|..++..+ +||+|+++++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~---------~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGT---------DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSS---------CCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCC---------CcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 456899999999999999999987754 7889999987542 23446778899999988 6999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
++.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+ .|||||||||+||||+.++.+||
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL 483 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKI 483 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEE
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEE
Confidence 999999999999999999999999876 458999999999999999999995 89999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|+||
T Consensus 484 ~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyell 536 (674)
T 3pfq_A 484 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536 (674)
T ss_dssp CCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHH
T ss_pred eecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHH
Confidence 9999998643322 2345578999999999999999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=305.95 Aligned_cols=191 Identities=24% Similarity=0.292 Sum_probs=158.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||+||++....+ ++.||+|.+...... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLT---------KELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTT---------CCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCC---------CcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 56899999999999999999987754 788999998754332 25678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc--eEEccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN--AKISDF 245 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~--~kl~Df 245 (297)
+.+++||||+++++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++. +||+||
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Df 162 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDF 162 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeec
Confidence 9999999999999999999775 458999999999999999999994 89999999999999987665 999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCccc-ccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLL-SAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslGv~l~~ll 297 (297)
|+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|+
T Consensus 163 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 212 (361)
T 3uc3_A 163 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML 212 (361)
T ss_dssp CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHH
T ss_pred Ccccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHH
Confidence 999743222 12334579999999999988887665 89999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=297.72 Aligned_cols=192 Identities=24% Similarity=0.389 Sum_probs=160.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------------------------hhHHH
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------------------------QGFEE 141 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~ 141 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... ...+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEND---------NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTT---------TEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCC---------CcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 46899999999999999999987654 78899999865421 12356
Q ss_pred HHHHHHHhcCCCCCCcccEEeEEEc--CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCC
Q 022413 142 WQSEVNFLGRLSHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE 219 (297)
Q Consensus 142 ~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~ 219 (297)
+.+|+.++++++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||+.||+|||+
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-- 155 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY-- 155 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 8899999999999999999999987 5689999999999999876532 458999999999999999999995
Q ss_pred CCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccC---Ccccccchhhhhhhhhc
Q 022413 220 KKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN---FYLLSAKFGNVINVCMY 296 (297)
Q Consensus 220 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~~l 296 (297)
.||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++||||||+++|+|
T Consensus 156 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred CCeeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 899999999999999999999999999998654322 2234567999999999998655 36789999999999998
Q ss_pred C
Q 022413 297 L 297 (297)
Q Consensus 297 l 297 (297)
+
T Consensus 234 ~ 234 (298)
T 2zv2_A 234 V 234 (298)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=298.67 Aligned_cols=195 Identities=23% Similarity=0.302 Sum_probs=167.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.++||+|+||+||+|.+..+ ++.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKT---------GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCC---------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 46799999999999999999987754 7889999987643 2345677899999999999999999999987
Q ss_pred CC--eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE----cCCCce
Q 022413 167 DK--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGNYNA 240 (297)
Q Consensus 167 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill----~~~~~~ 240 (297)
.. ..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceE
Confidence 65 789999999999999999865322 338999999999999999999995 899999999999999 778889
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceec--------ccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA--------TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...... ......||+.|+|||++. +..++.++|||||||++|+|+
T Consensus 156 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~ 217 (319)
T 4euu_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (319)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred EEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence 999999998764432 233457999999999986 477889999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.04 Aligned_cols=193 Identities=24% Similarity=0.212 Sum_probs=166.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|....+ ++.||+|.+...... +.+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYT---------NEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTT---------TEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCC---------CcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 46899999999999999999987654 789999998654322 4578899999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc-----eE
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN-----AK 241 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~-----~k 241 (297)
.+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++. +|
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEE
Confidence 99999999999 999999998652 468999999999999999999995 89999999999999998887 99
Q ss_pred EccccccccCCCCCCcc-----eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESH-----VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 211 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL 211 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHh
Confidence 99999998654332211 124567999999999999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=314.12 Aligned_cols=192 Identities=27% Similarity=0.407 Sum_probs=169.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~---------g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELT---------GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTT---------CCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 46899999999999999999987654 78899999875432 2346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
...+.+|+||||+++++|.+++... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~D 159 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIAD 159 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEEe
Confidence 9999999999999999999999764 56899999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
||+++...... .....+||+.|+|||++.+..+ +.++|||||||++|+|+
T Consensus 160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 210 (476)
T 2y94_A 160 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL 210 (476)
T ss_dssp CSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHH
T ss_pred ccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHh
Confidence 99998754322 2344679999999999988766 57899999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=306.96 Aligned_cols=197 Identities=19% Similarity=0.237 Sum_probs=169.0
Q ss_pred hcCCCCCceeccc--CceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 88 TKNFKPDSLLGEG--GFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
.++|++.++||+| +||.||+|.+..+ ++.||+|.+.... ....+.+.+|+.+++.++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPT---------GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTT---------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCC---------CCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 5689999999999 9999999987754 7889999987543 3445678899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+.+|+||||+++++|.+++..... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEEC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEc
Confidence 9999999999999999999999976532 448999999999999999999995 899999999999999999999999
Q ss_pred cccccccCCCCCC-----cceeeccCCcccccCcceecc--cCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGE-----SHVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~ll 297 (297)
|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 231 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence 9999865422111 111223478999999999987 57899999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=311.16 Aligned_cols=189 Identities=23% Similarity=0.289 Sum_probs=154.2
Q ss_pred hcCCCCC-ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhc-CCCCCCcccEEeEEE
Q 022413 88 TKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG-RLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~ 165 (297)
.++|.+. ++||+|+||+||+|.+..+ ++.||+|++... ..+.+|+.++. ..+||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~---------~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRT---------QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCC---------CCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 4567776 6899999999999987654 788999998533 34567888874 457999999999987
Q ss_pred c----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CC
Q 022413 166 E----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NY 238 (297)
Q Consensus 166 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~ 238 (297)
. ...+|+||||++||+|.+++..... ..+++..++.|+.||+.||+|||+ .||+||||||+|||++. ++
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTC
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCc
Confidence 5 5679999999999999999976421 458999999999999999999994 89999999999999987 78
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 202 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 257 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_dssp CEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH
T ss_pred cEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH
Confidence 99999999998654321 234567999999999999999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=291.37 Aligned_cols=192 Identities=20% Similarity=0.331 Sum_probs=169.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+... +..+|+|++........+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGT---------RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCC---------CcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456799999999999999999987754 67899999877655566789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE---cCCCceEEc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKIS 243 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill---~~~~~~kl~ 243 (297)
.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+ .||+||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~ 151 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLI 151 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCeEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEE
Confidence 99999999999999999999876 458999999999999999999994 899999999999999 788999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 152 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~ 201 (277)
T 3f3z_A 152 DFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLL 201 (277)
T ss_dssp CCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHH
T ss_pred ecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHH
Confidence 999998654322 2334579999999998864 5899999999999999984
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=302.68 Aligned_cols=205 Identities=30% Similarity=0.413 Sum_probs=169.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+... .+...+..||+|.+.... ....+.+.+|+.+++++ .||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 457899999999999999999987432 122347789999987542 33447789999999999 899999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceec
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPS-------------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~ 225 (297)
...+..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+ .||+||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~ 196 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHR 196 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEET
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccC
Confidence 9999999999999999999999765321 1347899999999999999999995 899999
Q ss_pred cCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 226 DFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 226 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence 999999999999999999999998654333322333456788999999999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=293.12 Aligned_cols=193 Identities=27% Similarity=0.401 Sum_probs=167.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4679999999999999999998764 567999999765432 36789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred CceEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEeccccc
Confidence 99999999999999999997643 45899999999999999999999 48999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... ........+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 201 (269)
T 4hcu_A 153 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 201 (269)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHh
Confidence 98643221 11122345678899999999999999999999999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=302.49 Aligned_cols=199 Identities=25% Similarity=0.379 Sum_probs=161.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|.+..+. ......||+|.+.... ....+++.+|+.++++++||||+++++++.+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCC-----ceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 457999999999999999999876531 1113457899886542 3445788999999999999999999999987
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.. .++|+||+.+|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg 162 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCc
Confidence 54 789999999999999998754 558999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...............+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 213 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHH
Confidence 998654433333334456788999999999999999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=306.31 Aligned_cols=194 Identities=26% Similarity=0.346 Sum_probs=155.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCC-CCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS-HPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~ 163 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|++... .....+++.+|+.+++.+. ||||++++++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~ 77 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRT---------GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV 77 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTT---------CCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCC---------CCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence 467899999999999999999987654 788999998653 3344567889999999998 9999999999
Q ss_pred EEcCC--eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 164 CWEDK--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 164 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+...+ .+|+||||++ ++|.+++... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+|
T Consensus 78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~k 149 (388)
T 3oz6_A 78 LRADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVK 149 (388)
T ss_dssp EECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred EecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEE
Confidence 98654 7899999996 5899998763 48899999999999999999995 8999999999999999999999
Q ss_pred EccccccccCCCCC-------------------CcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGG-------------------ESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|+||
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 225 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence 99999998653211 1112344689999999999986 67899999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=303.70 Aligned_cols=193 Identities=22% Similarity=0.251 Sum_probs=167.5
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-----CCCccc
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-----HPNLVK 159 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~ 159 (297)
....++|++.+.||+|+||+||+|.+..+ ++.||+|++.... ...+.+..|+.+++.+. ||||++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDN---------KKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCC---------CeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34567899999999999999999987654 7889999987543 23356678999999886 999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG--- 236 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~--- 236 (297)
+++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccc
Confidence 999999999999999999 9999999986532 348899999999999999999994 89999999999999975
Q ss_pred ----------------------CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhh
Q 022413 237 ----------------------NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVC 294 (297)
Q Consensus 237 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~ 294 (297)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 78999999999986432 223457999999999999999999999999999999
Q ss_pred hcC
Q 022413 295 MYL 297 (297)
Q Consensus 295 ~ll 297 (297)
+|+
T Consensus 251 ell 253 (360)
T 3llt_A 251 ELY 253 (360)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=296.82 Aligned_cols=197 Identities=23% Similarity=0.284 Sum_probs=168.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+....- .....+..||+|.+........+.+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4679999999999999999998765310 00001357999999877666668899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc--------
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN-------- 239 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~-------- 239 (297)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999998653 348999999999999999999994 89999999999999998887
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 212 (289)
T 4fvq_A 160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212 (289)
T ss_dssp EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence 99999999875321 223458999999999987 67899999999999999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=299.66 Aligned_cols=184 Identities=26% Similarity=0.322 Sum_probs=144.5
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLL 172 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~l 172 (297)
.++||+|+||.||+|.+..+ ++.||+|++.... ...+.+|+.+++.+. ||||+++++++.+....|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKS---------NQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETTT---------CCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEECCC---------CCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 47899999999999987754 7889999986542 356778999999997 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---ceEEccccccc
Q 022413 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY---NAKISDFGLAK 249 (297)
Q Consensus 173 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~ 249 (297)
||||+++++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++ .+||+|||+++
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999999999999875 568999999999999999999994 8999999999999997765 89999999998
Q ss_pred cCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 250 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...... ......+||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 158 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 203 (325)
T 3kn6_A 158 LKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML 203 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred ecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 654322 2234457899999999999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=294.96 Aligned_cols=191 Identities=25% Similarity=0.323 Sum_probs=160.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|+||+||+|.... ++.||+|++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~----------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNY----------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT----------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCC----------CCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 478999999999999999997632 67899999875432 233678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++ +|.+++.... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCeEEEEEEecCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECc
Confidence 9999999999975 9999987643 458899999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+++...... .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 146 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 195 (288)
T 1ob3_A 146 LARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195 (288)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred cccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHH
Confidence 997643221 122345789999999999764 5889999999999999984
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=290.42 Aligned_cols=193 Identities=27% Similarity=0.353 Sum_probs=167.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 5679999999999999999997764 567999998765432 36788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred CceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCcc
Confidence 99999999999999999998653 458999999999999999999994 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 199 (268)
T 3sxs_A 151 TRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199 (268)
T ss_dssp EEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHH
T ss_pred ceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHH
Confidence 986544321 1223345678899999999889999999999999999974
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=291.74 Aligned_cols=208 Identities=41% Similarity=0.672 Sum_probs=175.5
Q ss_pred CCcccCHHHHHHhhcCCCCC------ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc----chhhHHHHHH
Q 022413 75 DLKVFSFLDLKSATKNFKPD------SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE----SMQGFEEWQS 144 (297)
Q Consensus 75 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~ 144 (297)
+...+++.++...+++|... +.||+|+||.||+|.+. +..||+|.+... .....+.+.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~ 79 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQ 79 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHH
Confidence 44567778888888777766 89999999999999753 567999988653 2234577899
Q ss_pred HHHHhcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCcee
Q 022413 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY 224 (297)
Q Consensus 145 E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH 224 (297)
|+.++++++||||+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+ .||+|
T Consensus 80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H 156 (307)
T 2nru_A 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE--NHHIH 156 (307)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH--TTEEC
T ss_pred HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc--CCeec
Confidence 99999999999999999999999999999999999999999975322 2458999999999999999999994 89999
Q ss_pred ccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 225 RDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 225 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||||+|||++.++.+||+|||+++...............||+.|+|||++. +.++.++||||||+++|+|+
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~ 228 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEII 228 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHH
Confidence 9999999999999999999999998654433322334467999999999886 46889999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=302.34 Aligned_cols=199 Identities=26% Similarity=0.415 Sum_probs=164.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|.+..+. ......|++|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEG-----ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTT-----CSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCC-----ceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 457999999999999999999876541 1123458888875432 233356678999999999999999999886
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCC
Confidence 467899999999999999997642 458888999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...............||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 211 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHH
Confidence 998765544333344567888999999999999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=299.32 Aligned_cols=203 Identities=21% Similarity=0.361 Sum_probs=153.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+.... .....||+|.+... .....+++.+|+.++++++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQED------GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccC------CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3568999999999999999999876531 11237999998765 334457889999999999999999999999
Q ss_pred EcCCee------EEEEEecCCCCHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 165 WEDKEL------LLVYEYMQRGSLENHLFRRNP--SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 165 ~~~~~~------~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
...... ++||||+++++|.+++..... ....+++..++.++.|++.||+|||+ .||+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAE 172 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECT
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcC
Confidence 887655 999999999999999975421 12358999999999999999999995 89999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 233 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHH
Confidence 9999999999998654433222233445788999999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.92 Aligned_cols=191 Identities=24% Similarity=0.248 Sum_probs=159.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
.++|++.++||+|+||+||+|.+..+ ++.||+|++.... .........|+..+.++ +||||+++++++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKED---------GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTT---------SCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCC---------CeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 46799999999999999999988754 7889999876532 23334455666666555 899999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+.+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECC
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999 779999988764 458999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 201 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~ 249 (311)
T 3p1a_A 201 FGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVA 249 (311)
T ss_dssp CTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHH
T ss_pred ceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHH
Confidence 99998654322 2334569999999998875 7999999999999999984
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=305.14 Aligned_cols=190 Identities=23% Similarity=0.306 Sum_probs=163.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||+||+|.+..+ ++.||+|.+...... ..+|++++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKAT---------NMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCC---------CCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 356799999999999999999987654 788999998765422 35688888887 6999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC----CceE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN----YNAK 241 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~----~~~k 241 (297)
+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||+..+ +.+|
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~k 160 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIR 160 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEE
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEE
Confidence 999999999999999999999765 458999999999999999999995 899999999999998543 3599
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 214 (342)
T 2qr7_A 161 ICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214 (342)
T ss_dssp ECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHh
Confidence 99999998654322 1234567999999999999888999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=313.66 Aligned_cols=189 Identities=24% Similarity=0.271 Sum_probs=158.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|++... .....+++.+|+.+|+.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~---------~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVL---------DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTT---------TEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCC---------CCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 56899999999999999999987654 788999998754 3344577889999999999999999999997
Q ss_pred cC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 ED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
.. ..+|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+ .||+||||||+||||+.++.
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSC
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCCC
Confidence 55 357999999965 57777643 38899999999999999999995 89999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 203 ~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 257 (464)
T 3ttj_A 203 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257 (464)
T ss_dssp EEECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred EEEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence 999999999865432 2234568999999999999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=296.31 Aligned_cols=205 Identities=30% Similarity=0.371 Sum_probs=173.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+... .+...+..||+|.+..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 356899999999999999999986431 1223478899999976533 3457789999999999 899999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCC
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPS--------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~ 230 (297)
.+.+..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+ .||+||||||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~ 174 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAAR 174 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccc
Confidence 9999999999999999999999865321 2358999999999999999999995 89999999999
Q ss_pred cEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 231 NILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 231 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 241 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 9999999999999999998765443322333455788999999999999999999999999999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.66 Aligned_cols=195 Identities=25% Similarity=0.312 Sum_probs=161.7
Q ss_pred hcCCCCC-ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 88 TKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
.+.|++. ++||+|+||.||+|.+..+ ++.||+|++........+.+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLIT---------SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSS---------CCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCC---------CcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4578885 7899999999999976543 788999999766555567889999999985 6999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc---eEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN---AKI 242 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~---~kl 242 (297)
+.+.+|+||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl 155 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKI 155 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEE
Confidence 999999999999999999999876 458999999999999999999995 89999999999999988766 999
Q ss_pred ccccccccCCCCCC-----cceeeccCCcccccCcceecc-----cCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGE-----SHVTTRVMGTYGYAAPEYVAT-----GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 99999876532211 111223569999999999975 56889999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=301.80 Aligned_cols=193 Identities=24% Similarity=0.339 Sum_probs=167.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------hhHHHHHHHHHHhcCCCCCCcc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLV 158 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv 158 (297)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.++++++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEK---------NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTT---------TEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCC---------CcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 457899999999999999999987654 78899999875421 1234567899999999999999
Q ss_pred cEEeEEEcCCeeEEEEEecCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 159 KLLGYCWEDKELLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 159 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
++++++.+.+..++||||+.+| +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAED 166 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTT
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCC
Confidence 9999999999999999999766 999999765 458999999999999999999995 899999999999999999
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||||+++|+|+
T Consensus 167 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 224 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224 (335)
T ss_dssp SCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHH
T ss_pred CcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHH
Confidence 999999999998764432 2334579999999999988777 77899999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=296.84 Aligned_cols=194 Identities=25% Similarity=0.331 Sum_probs=170.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
..++|.+.+.||+|+||.||++.+... +..+|+|.+... .....+.+.+|+.+++.++||||++++++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 109 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADT---------KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 356899999999999999999987754 778999998654 22345678899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 110 FEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEEC
T ss_pred EecCCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEe
Confidence 99999999999999999999998775 458999999999999999999995 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 184 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 235 (335)
T 2owb_A 184 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235 (335)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHH
T ss_pred eccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 9999986543222 233457999999999999888999999999999999984
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=291.56 Aligned_cols=197 Identities=23% Similarity=0.316 Sum_probs=156.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+.... ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++ .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCC------CCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 568999999999999999999876431 126679999987643 33456789999999999999999999987 4
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECccc
Confidence 567899999999999999997653 458999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 211 (281)
T 1mp8_A 162 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred cccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHH
Confidence 9986543221 1122345788999999999899999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=289.15 Aligned_cols=191 Identities=26% Similarity=0.410 Sum_probs=165.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQS---------KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccC---------CcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 56899999999999999999987764 77899999865422 2346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..++||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEECS
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEEe
Confidence 9999999999999999999999876 45899999999999999999999 59999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||++...... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 153 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (279)
T 3fdn_A 153 FGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHH
Confidence 9998654322 223457899999999999989999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.35 Aligned_cols=207 Identities=26% Similarity=0.362 Sum_probs=171.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+.... ......+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 3568999999999999999999876421 1122347789999997653 34457789999999999 899999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
.+.+..++||||+++++|.+++...... ...+++..++.++.||+.||+|||+ .||+||||||+||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNV 188 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceE
Confidence 9999999999999999999999865421 1348899999999999999999995 8999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 253 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHH
Confidence 99999999999999998654433222233345788999999999889999999999999999974
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=294.27 Aligned_cols=194 Identities=25% Similarity=0.336 Sum_probs=164.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.++++++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETT----------TEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcC----------CCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 35689999999999999999997764 567999999865433 3678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred CCCeEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEcccc
Confidence 999999999999999999997643 458999999999999999999994 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...... ........+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 166 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~ 215 (283)
T 3gen_A 166 LSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215 (283)
T ss_dssp GGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred ccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 998643221 11122345678899999999999999999999999999984
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.95 Aligned_cols=192 Identities=26% Similarity=0.332 Sum_probs=168.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh------hHHHHHHHHHHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ------GFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ..+.+.+|+.++++++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKST---------GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCC---------CeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 45799999999999999999987654 788999998654221 346789999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY--- 238 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~--- 238 (297)
+++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~ 155 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPI 155 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCc
Confidence 9999999999999999999999999764 458999999999999999999995 8999999999999999887
Q ss_pred -ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 -NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 156 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 212 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212 (321)
T ss_dssp CCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHH
Confidence 79999999998654422 223457999999999999899999999999999999984
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=292.45 Aligned_cols=200 Identities=30% Similarity=0.463 Sum_probs=167.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+... ....++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTT-----SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccc-----cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 35689999999999999999986431 22348899999987553 3345778999999999999999999999987
Q ss_pred C--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 167 D--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 167 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
. ..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECc
Confidence 7 67899999999999999996653 458999999999999999999994 8999999999999999999999999
Q ss_pred ccccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++........ .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 223 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHH
Confidence 9999876543221 1223456888999999999999999999999999999984
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=288.90 Aligned_cols=193 Identities=23% Similarity=0.347 Sum_probs=169.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTT---------GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCC---------CceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 356899999999999999999987754 7889999986543 33456788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc---eE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN---AK 241 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~---~k 241 (297)
.+.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++. +|
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~k 148 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVK 148 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEE
T ss_pred EcCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEE
Confidence 9999999999999999999998876 558999999999999999999994 89999999999999976655 99
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 149 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 201 (284)
T 3kk8_A 149 LADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201 (284)
T ss_dssp ECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred EeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHH
Confidence 99999997654322 223467999999999999999999999999999999984
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=289.47 Aligned_cols=195 Identities=30% Similarity=0.416 Sum_probs=149.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
..++|++.+.||+|+||.||+|....+ ++.||+|.+..... ...+++.+|+.++++++||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 79 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHT---------GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccC---------CceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEE
Confidence 356799999999999999999987654 78899999865422 234678899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~ 154 (278)
T 3cok_A 80 FEDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIA 154 (278)
T ss_dssp EECSSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEEC
T ss_pred EccCCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999999999997643 458999999999999999999994 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++........ ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 155 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 206 (278)
T 3cok_A 155 DFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206 (278)
T ss_dssp CCTTCEECC------------------------------CTHHHHHHHHHHHHH
T ss_pred eecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999986543221 223457899999999999888999999999999999984
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=300.34 Aligned_cols=192 Identities=20% Similarity=0.295 Sum_probs=158.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCC--CCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSH--PNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~ 163 (297)
.++|++.+.||+|+||.||++.... +..||+|.+... .....+.+.+|+.++++++| |||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEK----------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTT----------SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCC----------CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 4579999999999999999997643 678999988654 33445778999999999986 999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+.+++|||+ .+++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+||||+ ++.+||+
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~ 149 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLI 149 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEEC
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEe
Confidence 9999999999995 588999999875 568999999999999999999994 8999999999999997 6789999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecc-----------cCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell 214 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH
Confidence 9999987654333223345679999999999875 67888999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=298.57 Aligned_cols=189 Identities=31% Similarity=0.418 Sum_probs=164.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.+.|++.+.||+|+||.||+|....+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 123 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRN---------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 123 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccC---------CeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34588999999999999999987654 7889999986432 23446788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..++||||+. |+|.+++.... ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 124 ~~~~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~D 197 (348)
T 1u5q_A 124 LREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGD 197 (348)
T ss_dssp EETTEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECC
T ss_pred EECCeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEee
Confidence 99999999999996 58888886543 568999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++.... .....||+.|+|||++. +..++.++|||||||++|+|+
T Consensus 198 fG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 198 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp CTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred ccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence 999986432 23457999999999985 567889999999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=289.21 Aligned_cols=194 Identities=25% Similarity=0.328 Sum_probs=170.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
..++|.+.+.||+|+||.||+|.+... +..+|+|.+.... ....+.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADT---------KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCC---------CceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence 356899999999999999999987654 7789999986542 2345678899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~ 157 (294)
T 2rku_A 84 FEDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIG 157 (294)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred eccCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEE
Confidence 99999999999999999999998775 458999999999999999999994 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 158 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 209 (294)
T 2rku_A 158 DFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209 (294)
T ss_dssp CCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHH
T ss_pred eccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHH
Confidence 9999986543222 233457899999999999888999999999999999984
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=298.38 Aligned_cols=193 Identities=25% Similarity=0.328 Sum_probs=157.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||+||+|.+..+ ++.||+|.+..... ...+.+.+|+.++++++||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVT---------NETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI 102 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTT---------TEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCC---------CceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence 356899999999999999999987654 78999999975532 2235677999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc-----CCCc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-----GNYN 239 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~-----~~~~ 239 (297)
.+.+..++||||+++ +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++ ..+.
T Consensus 103 ~~~~~~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 103 HHNHRLHLIFEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp EETTEEEEEEECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCE
T ss_pred ecCCEEEEEEecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccce
Confidence 999999999999975 999999876 458999999999999999999995 8999999999999994 5556
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 176 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 232 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232 (329)
T ss_dssp EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred EEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999997653221 123345689999999999874 4899999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=314.21 Aligned_cols=196 Identities=28% Similarity=0.420 Sum_probs=169.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
...+|++.+.||+|+||.||+|.+... +..||+|.+..... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~---------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGG---------TEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCC---------CeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 356788899999999999999988754 67899999976543 34788999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+.+++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecc
Confidence 9999999999999999999986432 458899999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...... ........+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 364 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~ 413 (495)
T 1opk_A 364 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413 (495)
T ss_dssp CEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred cceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHH
Confidence 998754321 11122345678999999999999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=291.14 Aligned_cols=194 Identities=29% Similarity=0.403 Sum_probs=161.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-----hhhHHHHHHHHHHhcCCC---CCCcc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-----MQGFEEWQSEVNFLGRLS---HPNLV 158 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~nIv 158 (297)
..++|++.+.||+|+||+||+|.+..+ ++.||+|.+.... ......+.+|+.+++++. ||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHS---------GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTT---------CCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCC---------CcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 357899999999999999999976543 7889999986332 111245667777777664 99999
Q ss_pred cEEeEEEcCC-----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 159 KLLGYCWEDK-----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 159 ~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
++++++.... ..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil 152 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENIL 152 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEE
Confidence 9999998765 5899999996 599999976532 348999999999999999999995 89999999999999
Q ss_pred EcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 213 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTT
T ss_pred EcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHH
Confidence 9999999999999998654322 234467999999999999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=302.14 Aligned_cols=202 Identities=24% Similarity=0.288 Sum_probs=163.5
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-----chhhHHHHHHHHHHhcCCCCCCccc
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-----SMQGFEEWQSEVNFLGRLSHPNLVK 159 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~ 159 (297)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+... .....+.+.+|+.++++++||||++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 92 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQT---------RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCC---------CceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 34567899999999999999999987654 788999998654 2344578899999999999999999
Q ss_pred EEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCC------------------------------------CCCCCHHHHHH
Q 022413 160 LLGYCWEDKELLLVYEYMQRGSLENHLFRRNPS------------------------------------IQPLSWDIRLK 203 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------~~~~~~~~~~~ 203 (297)
+++++.+.+..++||||+++++|.+++...... ...+++..++.
T Consensus 93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 999999999999999999999999998521100 12245778889
Q ss_pred HHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC--ceEEccccccccCCCCC--CcceeeccCCcccccCcceecc--
Q 022413 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY--NAKISDFGLAKLGPAGG--ESHVTTRVMGTYGYAAPEYVAT-- 277 (297)
Q Consensus 204 i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-- 277 (297)
++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++...... .........||+.|+|||++.+
T Consensus 173 i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 173 IMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 99999999999995 8999999999999998766 89999999997543211 1112345679999999999975
Q ss_pred cCCcccccchhhhhhhhhcC
Q 022413 278 GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 278 ~~~~~~sDvwslGv~l~~ll 297 (297)
..++.++||||||+++|+|+
T Consensus 251 ~~~~~~~DiwslG~il~el~ 270 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLL 270 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHH
Confidence 67889999999999999984
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.48 Aligned_cols=192 Identities=20% Similarity=0.292 Sum_probs=159.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCC--CCCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS--HPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~~~~~ 163 (297)
.++|++.+.||+|+||+||+|.... ++.||+|++... .....+.+.+|+.+|+++. ||||++++++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK----------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT----------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC----------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 3569999999999999999997543 678999998654 3345578899999999996 5999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+...+.+|+||| +.+++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||||+ ++.+||+
T Consensus 125 ~~~~~~~~lv~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 125 EITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp EECSSEEEEEEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred EecCCEEEEEEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEE
Confidence 999999999999 5588999999875 46888999999999999999999 58999999999999995 5899999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecc-----------cCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++..............+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell 261 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence 9999987644332223345679999999999875 36888999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=291.51 Aligned_cols=196 Identities=25% Similarity=0.355 Sum_probs=163.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|.+.+.||+|+||.||+|..... +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 90 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSS---------GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccC---------CceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence 346799999999999999999987654 7789999987653 234577899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE---cCCCceEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKI 242 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill---~~~~~~kl 242 (297)
+....++||||+++++|.+++.........+++..++.++.|++.||+|||+ .||+||||||+|||+ +.++.+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEE
Confidence 9999999999999999999986543223568999999999999999999994 899999999999999 45688999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... ......||+.|+|||++. ..++.++||||||+++|+|+
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 169 IDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHH
T ss_pred EeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHH
Confidence 9999997654321 234457999999999875 67889999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=292.86 Aligned_cols=193 Identities=26% Similarity=0.334 Sum_probs=161.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||+||+|.+..+ +..||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDT---------GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR 72 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCC---------CcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence 35799999999999999999987654 78899998865432 33467789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Df 146 (311)
T 4agu_A 73 RKRRLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDF 146 (311)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCeEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeC
Confidence 999999999999999998887654 458999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... .......||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 147 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 197 (311)
T 4agu_A 147 GFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197 (311)
T ss_dssp TTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence 9998654322 12334578999999999976 56889999999999999984
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=288.95 Aligned_cols=196 Identities=26% Similarity=0.310 Sum_probs=169.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVT---------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCC---------CcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence 356799999999999999999987654 7789999986543 234467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeC
Confidence 999999999999999999998654 458999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
|++................||+.|+|||++.+..+ +.++||||||+++|+|+
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 202 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHH
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHH
Confidence 99976543222222345679999999999987765 67899999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=295.02 Aligned_cols=200 Identities=28% Similarity=0.382 Sum_probs=171.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEE--
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW-- 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-- 165 (297)
.++|++.+.||+|+||.||+|.+.. .....+..||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 4679999999999999999998642 122348899999998776666678999999999999999999999987
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEccc
Confidence 4567999999999999999998643 358999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++......... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 224 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHH
Confidence 9998764432211 123346888999999999999999999999999999984
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=295.75 Aligned_cols=199 Identities=26% Similarity=0.380 Sum_probs=159.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.++||+|+||.||+|.+..+. ......|++|.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTT-----CSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCC-----ceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 467999999999999999999876541 111335788887644 33445788999999999999999999999987
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.. .++++||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG 162 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCc
Confidence 64 889999999999999998754 458999999999999999999994 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...............+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 213 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHH
Confidence 998764433333333455788999999999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=306.77 Aligned_cols=189 Identities=30% Similarity=0.413 Sum_probs=163.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+. +..||+|.++... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 3467889999999999999999765 5679999997654 34778999999999999999999999877
Q ss_pred CC-eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 167 DK-ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 167 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.+ .+++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCC
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeC
Confidence 65 79999999999999999987532 347899999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++..... .....+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 334 G~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~ 380 (450)
T 1k9a_A 334 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380 (450)
T ss_dssp TTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred CCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999854321 12235788999999999999999999999999999984
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=290.48 Aligned_cols=195 Identities=23% Similarity=0.267 Sum_probs=159.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... ...+.+.+|+.++++++||||++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 102 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVR---------ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDF 102 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTT---------TEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCC---------CeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence 356899999999999999999987654 78899999875432 234678899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+.+..|+||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 103 GEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp EEETTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred EeeCCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEe
Confidence 99999999999999999999999876 458999999999999999999994 899999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++........ .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 229 (309)
T 2h34_A 177 DFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229 (309)
T ss_dssp SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHH
T ss_pred cCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHH
Confidence 9999876543221 1223456899999999999999999999999999999984
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=289.51 Aligned_cols=194 Identities=22% Similarity=0.273 Sum_probs=165.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCC-CCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRL-SHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 163 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.++..+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLD---------GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCC---------CceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 356799999999999999999987654 788999998754 223446788999999999 89999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-------
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG------- 236 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~------- 236 (297)
+.+.+..++||||+++++|.+++.........+++..++.++.||+.||+|||+ .||+||||||+|||++.
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC--------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCccc
Confidence 999999999999999999999998653333558999999999999999999995 89999999999999984
Q ss_pred ------------CCceEEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 237 ------------NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
...+||+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh
Confidence 447999999999865432 223589999999999865 5667999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.21 Aligned_cols=210 Identities=25% Similarity=0.310 Sum_probs=173.6
Q ss_pred HHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCccc
Q 022413 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVK 159 (297)
Q Consensus 82 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~ 159 (297)
..+....++|++.+.||+|+||.||+|.+... .+...++.||+|.+.... ....+.+.+|+.+++++ +||||++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 34444567899999999999999999986431 123347889999987653 33446788999999999 6999999
Q ss_pred EEeEEEcCC-eeEEEEEecCCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHhcchhcCCCCceecc
Q 022413 160 LLGYCWEDK-ELLLVYEYMQRGSLENHLFRRNPS------------IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRD 226 (297)
Q Consensus 160 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~D 226 (297)
+++++...+ .+++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ .||+|||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~d 173 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRD 173 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCccccc
Confidence 999988764 599999999999999999865421 1237899999999999999999995 8999999
Q ss_pred CCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 227 FKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 227 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 244 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHH
Confidence 99999999999999999999998664433333334456789999999999999999999999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=289.05 Aligned_cols=193 Identities=21% Similarity=0.182 Sum_probs=166.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... .+.+.+|+.+++.+ +|+||+++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLN---------NQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTT---------TEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCC---------CcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 46799999999999999999987554 78899998864432 24577899999999 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc-----eE
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN-----AK 241 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~-----~k 241 (297)
....++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++. +|
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CceeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeEE
Confidence 99999999999 999999998653 45899999999999999999999 589999999999999987766 99
Q ss_pred EccccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 212 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 212 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 9999999865443221 1234467999999999999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.11 Aligned_cols=205 Identities=29% Similarity=0.351 Sum_probs=171.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+.... .......||+|.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLG----KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCS----SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCC----cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4578999999999999999999876531 11224579999987653 33456789999999999 899999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNP----------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
.+.+..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+ .||+||||||+|||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLL 197 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEE
Confidence 999999999999999999999975421 12457899999999999999999995 899999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 260 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHH
Confidence 999999999999998653332222233445788999999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=292.18 Aligned_cols=192 Identities=25% Similarity=0.370 Sum_probs=157.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcC--CCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR--LSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||+||+|.+. +..||+|++..... ..+..|.+++.. ++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 3568999999999999999999764 67799999876533 344556666555 7899999999987
Q ss_pred EcC----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC------CCCceeccCCCCcEEE
Q 022413 165 WED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASNILL 234 (297)
Q Consensus 165 ~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------~~~ivH~Dlkp~Nill 234 (297)
.+. ...++||||+++++|.+++.. ..+++..++.++.|++.||+|||.. +.+|+||||||+|||+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE
Confidence 643 468999999999999999954 3589999999999999999999921 3899999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcc--eeeccCCcccccCcceeccc------CCcccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGESH--VTTRVMGTYGYAAPEYVATG------NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~~ll 297 (297)
+.++.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~ 217 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH
Confidence 999999999999997543322211 12234799999999999876 5667999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=286.93 Aligned_cols=191 Identities=25% Similarity=0.390 Sum_probs=168.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|....+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQN---------KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCC---------CcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 56899999999999999999987654 7789999986542 22246788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~D 157 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIAD 157 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEec
Confidence 9999999999999999999999876 45899999999999999999999 58999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||++...... ......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 158 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 206 (284)
T 2vgo_A 158 FGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206 (284)
T ss_dssp CTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred ccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHH
Confidence 9998754322 223457999999999999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=297.73 Aligned_cols=195 Identities=29% Similarity=0.360 Sum_probs=159.3
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-----hHHHHHHHHHHhcCCCCCCcccE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-----GFEEWQSEVNFLGRLSHPNLVKL 160 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~ 160 (297)
...++|++.+.||+|+||.||+|.+..+ ++.||+|.+...... ..+.+.+|+.++++++||||+++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNT---------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSC---------CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCC---------CcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 3467899999999999999999977653 788999998753221 12467899999999999999999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
++++.+.+..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCE
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCE
Confidence 9999999999999999976 8988887643 457888999999999999999995 899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 152 kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 207 (346)
T 1ua2_A 152 KLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207 (346)
T ss_dssp EECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH
T ss_pred EEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHH
Confidence 999999998654322 123446789999999999764 4788999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=291.81 Aligned_cols=192 Identities=23% Similarity=0.348 Sum_probs=166.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|.+.+.||+|+||.||+|....+ ++.||+|.+........+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLT---------GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCC---------CCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 356799999999999999999987654 78899999876544444678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE---cCCCceEEc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKIS 243 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill---~~~~~~kl~ 243 (297)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .||+||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred CCEEEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEc
Confidence 99999999999999999999776 458999999999999999999994 899999999999999 788999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++..... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 152 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 152 DFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp SCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH
T ss_pred cCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99998754321 123356899999999999999999999999999999984
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.78 Aligned_cols=206 Identities=25% Similarity=0.362 Sum_probs=169.9
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
...++|++.+.||+|+||.||+|.+... .+...+..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred chhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 3467899999999999999999976531 111226789999997653 33446788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRN------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
.+.+..++||||+++++|.+++.... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTC
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCCC
Confidence 99999999999999999999997532 122457899999999999999999995 8999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 234 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999997543222111122345688999999999999999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=292.42 Aligned_cols=196 Identities=28% Similarity=0.424 Sum_probs=170.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+... +..||+|.+..... ..+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGG---------TEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeEEeecCCCCceeEEEeEecCC---------CEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 467899999999999999999987754 78899999876543 34778899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCc
Confidence 9999999999999999999976432 458999999999999999999994 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...... ........+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 206 (288)
T 3kfa_A 157 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206 (288)
T ss_dssp GGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 998654322 12233345788999999999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=292.58 Aligned_cols=203 Identities=25% Similarity=0.390 Sum_probs=159.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|.+.+.||+|+||.||+|.+... ..++..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQE------DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECT------TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEecc------CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 456899999999999999999977543 123668999998754 334457789999999999999999999999
Q ss_pred EcCC-----eeEEEEEecCCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 165 WEDK-----ELLLVYEYMQRGSLENHLFRRN--PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 165 ~~~~-----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
.+.. ..++||||+++++|.+++.... .....+++..++.++.||+.||.||| +.||+||||||+|||++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEECTT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCC
Confidence 8765 3599999999999999985432 22356899999999999999999999 5899999999999999999
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 999999999998654332222233445788999999999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=309.33 Aligned_cols=192 Identities=26% Similarity=0.372 Sum_probs=165.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||+||+|.+..+ ++.||+|++.... ......+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 90 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRIT---------QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTT---------CCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCC---------CCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 456799999999999999999987654 7889999986432 23446788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc---CCCceE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GNYNAK 241 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~---~~~~~k 241 (297)
.+...+|+||||+++++|.+.+... ..+++..+..++.||+.||.|||+ .||+||||||+|||++ .++.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 91 EDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEE
T ss_pred EcCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEE
Confidence 9999999999999999999999876 458999999999999999999995 8999999999999995 466899
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++...... ......||+.|+|||++.+ .|+.++|||||||++|+|+
T Consensus 165 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 165 IIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp ECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH
T ss_pred EEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH
Confidence 99999998654322 2334579999999999874 6899999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.60 Aligned_cols=189 Identities=28% Similarity=0.564 Sum_probs=160.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-------hHHHHHHHHHHhcCCCCCCcccE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-------GFEEWQSEVNFLGRLSHPNLVKL 160 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~~ 160 (297)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ..+.+.+|+.++++++||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKD---------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTT---------CCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hccceehhccccCCceeEEEEEEcCC---------ceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 46799999999999999999987654 788999998654321 12678899999999999999999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC--ceeccCCCCcEEEcCCC
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDGNY 238 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~--ivH~Dlkp~Nill~~~~ 238 (297)
++++.+.. ++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEEESCCC
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEEEeccC
Confidence 99987655 79999999999999887653 46899999999999999999999 478 99999999999998877
Q ss_pred c-----eEEccccccccCCCCCCcceeeccCCcccccCcceec--ccCCcccccchhhhhhhhhcC
Q 022413 239 N-----AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA--TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~-----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslGv~l~~ll 297 (297)
. +||+|||+++.... ......||+.|+|||++. ...++.++||||||+++|+|+
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~ 222 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred CCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence 6 99999999975322 234567999999999984 456788999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=296.52 Aligned_cols=192 Identities=26% Similarity=0.350 Sum_probs=157.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh-HHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++|++.+.||+|+||+||+|.+..+ +..||+|.+....... ...+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLT---------DNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECCC---------CcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 4789999999999999999987654 7889999987543221 12445799999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred CEEEEEecccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcc
Confidence 99999999996 59999987653 458899999999999999999994 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
++...... .......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 147 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 195 (324)
T 3mtl_A 147 ARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA 195 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred cccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 98643322 12334578999999999876 56889999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=299.92 Aligned_cols=192 Identities=26% Similarity=0.372 Sum_probs=167.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPS---------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCC---------CcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 45799999999999999999987754 788999998765 33445678999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+ ..||+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCCCEEEEECC
Confidence 99999999999999999999876 458999999999999999999995 2489999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++.... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 178 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 224 (360)
T 3eqc_A 178 VSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224 (360)
T ss_dssp CCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHH
T ss_pred CCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9864321 1223457999999999999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=300.02 Aligned_cols=200 Identities=17% Similarity=0.148 Sum_probs=162.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh-----------HHHHHHHHHHhcCCCCCC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-----------FEEWQSEVNFLGRLSHPN 156 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~n 156 (297)
.++|++.+.||+|+||.||+|.+.... ....++.||+|.+....... ...+..|+..++.++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSS----CCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCcc----ccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 458999999999999999999886541 12235779999986543211 123446777888899999
Q ss_pred cccEEeEEEcC----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 157 LVKLLGYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 157 Iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
|+++++++... ...|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Ni 183 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNL 183 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHE
Confidence 99999998775 4589999999 999999998653 458999999999999999999995 8999999999999
Q ss_pred EEc--CCCceEEccccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLD--GNYNAKISDFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~--~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+ .++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 999 8899999999999765432111 1113356999999999999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=289.48 Aligned_cols=192 Identities=30% Similarity=0.473 Sum_probs=152.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+.. .+|+|.+... .....+.+.+|+.++++++||||++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 4679999999999999999997543 3899988654 334457789999999999999999999954
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
..+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred cCCccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccc
Confidence 5667899999999999999996543 558999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...............||+.|+|||++. +..++.++||||||+++|+|+
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 219 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHH
Confidence 9997654322222334467999999999986 567888999999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=308.71 Aligned_cols=191 Identities=25% Similarity=0.341 Sum_probs=162.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||+||+|.+... +..||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVT---------HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTT---------CCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCC---------CcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45799999999999999999987654 7889999987542 233467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CCceEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NYNAKI 242 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~~~kl 242 (297)
+...+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++. ++.+||
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl 180 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKI 180 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEE
Confidence 999999999999999999999876 458999999999999999999995 89999999999999976 455999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... .....+||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 181 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll 231 (494)
T 3lij_A 181 VDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL 231 (494)
T ss_dssp CCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH
T ss_pred EECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHH
Confidence 9999998654321 234467999999999876 67999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=315.04 Aligned_cols=195 Identities=27% Similarity=0.360 Sum_probs=159.5
Q ss_pred CCCCCc-eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 90 NFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
++.+.+ .||+|+||.||+|.+... ..+..||+|.++... ....+.+.+|+.+|++++||||+++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 344444 799999999999987542 126679999998653 3355789999999999999999999999876
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 56999999999999999997543 558999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++........ .......+|+.|+|||++.+..++.++|||||||++|+||
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 9875432211 1112234568999999999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=309.66 Aligned_cols=192 Identities=27% Similarity=0.378 Sum_probs=167.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
..++|++.++||+|+||.||+|.+..+ +..||+|++.... ....+.+.+|+.++++++||||++++++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 94 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKIT---------GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCC---------CCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 346799999999999999999987654 7889999986432 2345778999999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE---cCCCce
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNA 240 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill---~~~~~~ 240 (297)
+.+.+..|+||||+.+++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcE
Confidence 99999999999999999999999765 458999999999999999999995 899999999999999 567899
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 169 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 169 RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL 221 (484)
T ss_dssp EECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHH
T ss_pred EEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHH
Confidence 999999998654332 2334579999999999865 7999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=304.68 Aligned_cols=193 Identities=22% Similarity=0.331 Sum_probs=156.1
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------hhHHHHHHHHHHhcCCCCCCc
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNL 157 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nI 157 (297)
...++|.+.+.||+|+||+||+|.+..+ +..||+|++..... .....+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKT---------CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCC---------CcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 3467899999999999999999987764 78899999865321 122357899999999999999
Q ss_pred ccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 158 VKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 158 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
+++++++. .+..|+||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQ 275 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecC
Confidence 99999875 45689999999999999988765 568999999999999999999994 899999999999999654
Q ss_pred ---CceEEccccccccCCCCCCcceeeccCCcccccCcceecc---cCCcccccchhhhhhhhhcC
Q 022413 238 ---YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT---GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll 338 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338 (419)
T ss_dssp SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH
T ss_pred CCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH
Confidence 45999999999875432 22345679999999999863 66888999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=298.43 Aligned_cols=188 Identities=24% Similarity=0.315 Sum_probs=157.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++... .....+++.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRT---------GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTT---------CCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCC---------CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 46799999999999999999987654 788999998653 2334567889999999999999999999998
Q ss_pred cCC------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
... .+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~ 166 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCE 166 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCC
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCC
Confidence 763 469999999 8899999876 348899999999999999999995 89999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 167 ~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 220 (367)
T 1cm8_A 167 LKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220 (367)
T ss_dssp EEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred EEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence 99999999986432 1334578999999999987 67899999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.45 Aligned_cols=192 Identities=26% Similarity=0.367 Sum_probs=165.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch------hhHHHHHHHHHHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
.++|++.+.||+|+||.||+|....+ ++.||+|.+..... ...+.+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGT---------GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCC---------CCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 35799999999999999999987754 78899998865421 1357789999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY--- 238 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~--- 238 (297)
+++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSS
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCC
Confidence 9999999999999999999999999765 458999999999999999999994 8999999999999998877
Q ss_pred -ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 -NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 149 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHH
Confidence 89999999998654322 223456899999999999889999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.23 Aligned_cols=192 Identities=26% Similarity=0.365 Sum_probs=164.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-------------hhHHHHHHHHHHhcCCC
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-------------QGFEEWQSEVNFLGRLS 153 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~ 153 (297)
..++|++.+.||+|+||+||+|.+... +..||+|.+..... ...+.+.+|+.++++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNG---------HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTT---------CCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEECCC---------CcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 457899999999999999999987654 78899999865321 23467889999999999
Q ss_pred CCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 154 h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
||||+++++++.+...+|+||||+++++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENIL 178 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEE
Confidence 999999999999999999999999999999999876 458999999999999999999995 89999999999999
Q ss_pred EcCCC---ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 234 LDGNY---NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.++ .+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|+|+
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll 241 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL 241 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH
T ss_pred EecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHH
Confidence 98765 69999999998764322 234457999999999886 57999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.70 Aligned_cols=195 Identities=27% Similarity=0.407 Sum_probs=165.6
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
...++|++.+.||+|+||+||+|.+.. +..||+|.+..... ..+.+.+|+.+|++++||||+++++++.
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 253 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 253 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 345689999999999999999998764 56799999986543 3578999999999999999999999886
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+||
T Consensus 254 -~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DF 328 (454)
T 1qcf_A 254 -KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADF 328 (454)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECST
T ss_pred -CCccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeC
Confidence 5679999999999999999975421 247888999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... ........+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 329 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~ 379 (454)
T 1qcf_A 329 GLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379 (454)
T ss_dssp TGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHH
Confidence 9998653211 11112334678999999999999999999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=289.77 Aligned_cols=197 Identities=23% Similarity=0.351 Sum_probs=159.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|....+ +..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 101 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLD---------GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTT---------CCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCC---------CceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 45799999999999999999987654 788999998753 234457788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEe
Confidence 99999999999999999999997543333568999999999999999999994 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... .......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 180 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 230 (310)
T 2wqm_A 180 LGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 99987654321 1223456899999999999999999999999999999984
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.48 Aligned_cols=197 Identities=24% Similarity=0.361 Sum_probs=169.2
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------hhHHHHHHHHHHhcCC-C
Q 022413 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRL-S 153 (297)
Q Consensus 83 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l-~ 153 (297)
......++|++.+.||+|+||.||+|.+..+ |+.||||++..... ...+.+.+|+.+++++ +
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 158 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT---------GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCC---------CcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3344567899999999999999999987654 78899998865421 1235678999999999 7
Q ss_pred CCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 154 h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
||||+++++++......|+||||++|++|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus 159 hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENIL 232 (365)
T ss_dssp CTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred CCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence 999999999999999999999999999999999865 458999999999999999999995 89999999999999
Q ss_pred EcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc------cCCcccccchhhhhhhhhcC
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~~ll 297 (297)
++.++.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell 299 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH
T ss_pred ECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH
Confidence 9999999999999998764332 2344679999999999864 35888999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=299.64 Aligned_cols=197 Identities=27% Similarity=0.330 Sum_probs=165.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc----hhhHHHHHHHHHHhcCC-CCCCcccEEe
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRL-SHPNLVKLLG 162 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 162 (297)
.++|++.+.||+|+||.||+|..... ..+++.||+|++.... ....+.+.+|+.+++++ +||||+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSS------TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEccc------CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 46799999999999999999987431 1237899999987542 22335667899999999 6999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
++...+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEE
Confidence 999999999999999999999999876 458999999999999999999995 89999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecc--cCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... .......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 201 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell 256 (355)
T 1vzo_A 201 TDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256 (355)
T ss_dssp SCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred eeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 9999998653321 122334679999999999986 34778999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=288.88 Aligned_cols=199 Identities=27% Similarity=0.404 Sum_probs=164.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEE-
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW- 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~- 165 (297)
..+|++.+.||+|+||.||+|.+.... .....+|+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecCC------CceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 457899999999999999999875431 12457899998764 3344577899999999999999999999865
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Df 172 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADF 172 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcc
Confidence 4568899999999999999997543 457899999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCC--cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGE--SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++....... ........||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 226 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 99986543221 11223456788999999999999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=305.11 Aligned_cols=192 Identities=13% Similarity=0.150 Sum_probs=157.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHH---HHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEV---NFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~~~ 161 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|++... .....+.+.+|+ .++++++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQET---------GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CC---------CCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECCC---------CcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 46799999999999999999987543 788999998643 334457788999 556666899999998
Q ss_pred -------eEEEcCC-----------------eeEEEEEecCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHhcc
Q 022413 162 -------GYCWEDK-----------------ELLLVYEYMQRGSLENHLFRRNPS---IQPLSWDIRLKIAIGAARGLGF 214 (297)
Q Consensus 162 -------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~al~y 214 (297)
+++.+.+ ..|+||||+ +|+|.+++...... ...+++..++.|+.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 7766553 289999999 67999999864211 1123458888999999999999
Q ss_pred hhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceeccc-----------CCccc
Q 022413 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-----------NFYLL 283 (297)
Q Consensus 215 LH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 283 (297)
||+ .||+||||||+||||+.++.+||+|||+++... .......| +.|+|||++.+. .++.+
T Consensus 222 LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHh--CCeecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 995 899999999999999999999999999998532 23445678 999999999987 89999
Q ss_pred ccchhhhhhhhhcC
Q 022413 284 SAKFGNVINVCMYL 297 (297)
Q Consensus 284 sDvwslGv~l~~ll 297 (297)
+|||||||++|+|+
T Consensus 294 ~DvwSlG~il~ell 307 (377)
T 3byv_A 294 FDAWALGLVIYWIW 307 (377)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHH
Confidence 99999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=302.98 Aligned_cols=195 Identities=23% Similarity=0.302 Sum_probs=166.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.++||+|+||+||+|.+..+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKT---------GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCC---------CcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 45799999999999999999987754 7889999997643 2345677899999999999999999999987
Q ss_pred CC--eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE----cCCCce
Q 022413 167 DK--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DGNYNA 240 (297)
Q Consensus 167 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill----~~~~~~ 240 (297)
.+ ..++||||+++++|.+++...... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeE
Confidence 65 789999999999999999764322 338999999999999999999995 899999999999999 778889
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecc--------cCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT--------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~ 217 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHH
Confidence 999999998754322 2334679999999999875 56888999999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=299.78 Aligned_cols=198 Identities=27% Similarity=0.408 Sum_probs=156.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc-
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE- 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 166 (297)
..|.+.+.||+|+||+||+|.+.... .....||+|.+... .....+++.+|+.++++++||||+++++++.+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETT------TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCC------CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 35777899999999999999875321 11457899998754 33455788999999999999999999998765
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCCeEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecc
Confidence 468899999999999999997543 457889999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCc--ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGES--HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++........ .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ell 290 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 99865332211 1123345788999999999999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=300.01 Aligned_cols=192 Identities=23% Similarity=0.317 Sum_probs=159.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||+||+|.+..+ +..||+|++..... ...+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~---------~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIES---------GKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTT---------CCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCC---------CCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeee
Confidence 456899999999999999999987654 78899998865432 22469999999999999999999854
Q ss_pred --------------------------------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHH
Q 022413 167 --------------------------------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208 (297)
Q Consensus 167 --------------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i 208 (297)
...+++||||++ ++|.+.+.........+++..++.++.||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 334899999997 58888876533333668999999999999
Q ss_pred HHHhcchhcCCCCceeccCCCCcEEEc-CCCceEEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccc
Q 022413 209 ARGLGFLHTSEKKVIYRDFKASNILLD-GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAK 286 (297)
Q Consensus 209 ~~al~yLH~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv 286 (297)
+.||+||| +.||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||
T Consensus 151 ~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 151 FRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 99999999 59999999999999998 68999999999998654332 23345789999999998875 48999999
Q ss_pred hhhhhhhhhcC
Q 022413 287 FGNVINVCMYL 297 (297)
Q Consensus 287 wslGv~l~~ll 297 (297)
|||||++|+|+
T Consensus 226 wslG~il~ell 236 (383)
T 3eb0_A 226 WSIGCVFGELI 236 (383)
T ss_dssp HHHHHHHHHHH
T ss_pred hhHHHHHHHHH
Confidence 99999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=289.35 Aligned_cols=195 Identities=34% Similarity=0.490 Sum_probs=165.4
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC--
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED-- 167 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 167 (297)
|++.+.||+|+||+||++.+.. ....+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 4899999999999999987653 223358899999998653 34457789999999999999999999999874
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
..+++||||+++++|.+++... .+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCccc
Confidence 6799999999999999999764 38999999999999999999994 8999999999999999999999999999
Q ss_pred cccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++........ .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 231 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 9876543221 1223456888999999999989999999999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=292.83 Aligned_cols=193 Identities=29% Similarity=0.414 Sum_probs=161.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDT---------GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTT---------CCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCC---------CceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 45799999999999999999987754 7889999875442 233456789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Df 168 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDF 168 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeC
Confidence 999999999999998888876654 458999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... .......||+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 169 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 219 (331)
T 4aaa_A 169 GFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219 (331)
T ss_dssp TTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred CCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHH
Confidence 9997654322 123345789999999999875 6889999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.79 Aligned_cols=195 Identities=24% Similarity=0.325 Sum_probs=163.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKT---------GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTT---------CCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeEEEEEecCCCcEEEEEEECCC---------CCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 46899999999999999999987654 78899999865432 22356789999999999999999999998
Q ss_pred c--------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 166 E--------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 166 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
. .+.+++||||+++ +|.+.+.... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRD 160 (351)
T ss_dssp EC--------CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTT
T ss_pred ccccccccCCceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCC
Confidence 7 3468999999965 8888776543 458999999999999999999995 899999999999999999
Q ss_pred CceEEccccccccCCCCCC--cceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGE--SHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 223 (351)
T 3mi9_A 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223 (351)
T ss_dssp SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH
Confidence 9999999999986543221 122344578999999999876 45789999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.21 Aligned_cols=196 Identities=27% Similarity=0.358 Sum_probs=160.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALD---------SRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEcCC---------CeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence 356799999999999999999987654 788999998643 3344778899999999999999999998865
Q ss_pred -------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 167 -------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 167 -------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
....|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil 148 (303)
T 1zy4_A 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIF 148 (303)
T ss_dssp CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEE
T ss_pred hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEE
Confidence 357899999999999999998643 457888999999999999999995 89999999999999
Q ss_pred EcCCCceEEccccccccCCCCCC------------cceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGE------------SHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
++.++.+||+|||+++....... ........||+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH
T ss_pred EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH
Confidence 99999999999999986542210 1122345689999999999864 6889999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=283.01 Aligned_cols=190 Identities=28% Similarity=0.398 Sum_probs=163.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.+.|++.+.||+|+||.||+|.+... +..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---------~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTET---------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCC---------ceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 34588889999999999999987654 778999988654 2344577899999999999999999999987
Q ss_pred c----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC--ceeccCCCCcEEEc-CCC
Q 022413 166 E----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLD-GNY 238 (297)
Q Consensus 166 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~--ivH~Dlkp~Nill~-~~~ 238 (297)
. ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+ |+||||||+|||++ .++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTS
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHc--CCCCEEECCCCHHHEEEECCCC
Confidence 5 35689999999999999999875 458999999999999999999994 67 99999999999997 789
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||++...... ......||+.|+|||++. +.++.++||||||+++|+|+
T Consensus 170 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~ 223 (290)
T 1t4h_A 170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMA 223 (290)
T ss_dssp CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHH
T ss_pred CEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHH
Confidence 9999999999754322 233457999999999876 56899999999999999984
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=287.06 Aligned_cols=191 Identities=30% Similarity=0.460 Sum_probs=165.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
...+|++.+.||+|+||.||+|.+..+ ++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRID---------GKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTT---------CCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcCC---------CeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 456799999999999999999987654 7889999987554 345789999999999999999998864
Q ss_pred ----------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCC
Q 022413 167 ----------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230 (297)
Q Consensus 167 ----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~ 230 (297)
...+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~ 151 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPS 151 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHH
Confidence 3458999999999999999975422 458899999999999999999995 89999999999
Q ss_pred cEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 231 NILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 231 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 152 Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 152 NIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp GEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH
T ss_pred HEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH
Confidence 9999999999999999998654332 223456999999999999989999999999999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.06 Aligned_cols=200 Identities=27% Similarity=0.406 Sum_probs=161.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..+|++.+.||+|+||.||+|.+.... ...+..||+|.+.... ......+.+|+.++++++||||+++++++.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSS-----GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCC-----CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 457888999999999999999876431 1124569999987653 3344678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999997653 458999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++........ .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 244 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHH
Confidence 99865432211 1122234688999999999899999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=284.35 Aligned_cols=193 Identities=26% Similarity=0.382 Sum_probs=166.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4579999999999999999998764 567999999865432 36788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEccccc
Confidence 99999999999999999997653 458899999999999999999994 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... ........+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 199 (267)
T 3t9t_A 151 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199 (267)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHh
Confidence 98643211 11122345788999999999889999999999999999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=288.30 Aligned_cols=192 Identities=24% Similarity=0.329 Sum_probs=157.8
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC--CCCCcccEEe
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL--SHPNLVKLLG 162 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~~~~ 162 (297)
....++|++.+.||+|+||.||+|.+. +..||+|.+..... ..+..|.+++..+ +||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEE
Confidence 345678999999999999999999765 67799999864432 3445566666554 8999999999
Q ss_pred EEEcC----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCC--------CceeccCCCC
Q 022413 163 YCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK--------KVIYRDFKAS 230 (297)
Q Consensus 163 ~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~--------~ivH~Dlkp~ 230 (297)
++.+. ...++||||+++++|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~~~~ivH~Dikp~ 171 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHT--EIFSTQGKPAIAHRDLKSK 171 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHS--CBCSTTCBCCEECSCCCGG
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH--hhhhhccCCCEEecccchH
Confidence 99887 7899999999999999999753 48999999999999999999995 5 9999999999
Q ss_pred cEEEcCCCceEEccccccccCCCCCCcc--eeeccCCcccccCcceecccCCccc------ccchhhhhhhhhcC
Q 022413 231 NILLDGNYNAKISDFGLAKLGPAGGESH--VTTRVMGTYGYAAPEYVATGNFYLL------SAKFGNVINVCMYL 297 (297)
Q Consensus 231 Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslGv~l~~ll 297 (297)
|||++.++.+||+|||+++......... ......||+.|+|||++.+..+... +|||||||++|+|+
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 246 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH
Confidence 9999999999999999997654332211 1224579999999999987766655 99999999999984
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=290.31 Aligned_cols=200 Identities=29% Similarity=0.441 Sum_probs=169.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+.. .....++.||+|.+........+.+.+|+.++++++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 4579999999999999999998642 12234889999999877666667899999999999999999999998765
Q ss_pred C--eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 168 K--ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 168 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+ ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecC
Confidence 4 7899999999999999998753 458999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++......... ......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 242 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9998764432211 122345778899999999888999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=291.99 Aligned_cols=199 Identities=27% Similarity=0.313 Sum_probs=165.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc-
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE- 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 166 (297)
.++|++.+.||+|+||.||++....+ ++.||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHD---------GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTT---------CCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCC---------CcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 46799999999999999999987654 78899999876655666788999999999999999999999873
Q ss_pred ---CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEc
Q 022413 167 ---DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 167 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
....++||||+++++|.+++.........+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEEC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEE
Confidence 357899999999999999998754334678999999999999999999995 899999999999999999999999
Q ss_pred cccccccCCCCCCcc-------eeeccCCcccccCcceecccC---CcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESH-------VTTRVMGTYGYAAPEYVATGN---FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGv~l~~ll 297 (297)
|||+++......... ......||+.|+|||++.+.. ++.++||||||+++|+|+
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 999987543211000 012345799999999987543 688999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=286.41 Aligned_cols=197 Identities=26% Similarity=0.354 Sum_probs=165.4
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
.|.+.++||+|+||+||+|.+..+. ..+..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA------QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS------SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecCC------CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 5667799999999999999875431 124579999987643 345578899999999999999999999998766
Q ss_pred ee-EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 169 EL-LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 169 ~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
.. ++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 55 99999999999999997643 558899999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCC--CcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGG--ESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... .........+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 222 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHh
Confidence 98653321 111223456889999999999999999999999999999984
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=287.10 Aligned_cols=193 Identities=31% Similarity=0.441 Sum_probs=163.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ..+.+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKET---------GQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTT---------CCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCC---------CCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 356899999999999999999987654 7889999987543 23678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg 170 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFG 170 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecc
Confidence 999999999999999999997543 558999999999999999999994 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 171 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 219 (314)
T 3com_A 171 VAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219 (314)
T ss_dssp TCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHH
T ss_pred cchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHH
Confidence 997654321 1233457899999999999989999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.63 Aligned_cols=189 Identities=24% Similarity=0.269 Sum_probs=154.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+... ++.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAIL---------ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCC---------CceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 46899999999999999999987654 788999998653 2334567889999999999999999999998
Q ss_pred cCC------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
..+ ..|+||||+++ +|.+++.. .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSC
T ss_pred cccccccccceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCC
Confidence 765 78999999965 78888853 38899999999999999999995 89999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 166 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 220 (371)
T 2xrw_A 166 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220 (371)
T ss_dssp EEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred EEEEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence 999999999865322 1233467999999999999999999999999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=303.25 Aligned_cols=191 Identities=25% Similarity=0.322 Sum_probs=156.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.++||+|+||+||+|.+..+ ++.||+|++..... ...+|+++|+.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---------~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDS---------GELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCC---------CcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEecc
Confidence 34699999999999999999988654 78899999865432 234699999999999999999988542
Q ss_pred ------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC-Cce
Q 022413 168 ------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNA 240 (297)
Q Consensus 168 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~-~~~ 240 (297)
..+++||||+++ +|.+.+.........+++..++.++.||+.||+||| +.||+||||||+||||+.+ +.+
T Consensus 120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEE
T ss_pred CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeE
Confidence 247799999965 777766543222356899999999999999999999 5999999999999999965 678
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+||
T Consensus 197 kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 251 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251 (420)
T ss_dssp EECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred EeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHH
Confidence 999999998754332 22345789999999999765 6899999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=284.48 Aligned_cols=198 Identities=24% Similarity=0.354 Sum_probs=164.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+.... ..+..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTT------CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCC------CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3568999999999999999999876431 22567999998865 3344578899999999999999999999876
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+ +..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred C-CCCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCcc
Confidence 5 46799999999999999997653 458899999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++....... .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 158 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 208 (281)
T 3cc6_A 158 GLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHH
Confidence 99986543221 1223345788999999999899999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=285.27 Aligned_cols=192 Identities=29% Similarity=0.394 Sum_probs=168.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.+.|++.+.||+|+||.||+|.+... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRT---------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCC---------CcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 45699999999999999999987654 7889999986543 3345788999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecc
Confidence 9999999999999999999864 358999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 213 (303)
T 3a7i_A 165 VAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 213 (303)
T ss_dssp TCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred cceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHc
Confidence 997654322 1233457899999999999999999999999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=292.57 Aligned_cols=204 Identities=26% Similarity=0.308 Sum_probs=163.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+... .....+..||+|.+... ......++.+|+.++++++||||+++++++.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 46799999999999999999985431 12234778999999754 33445678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CCce
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPS---IQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NYNA 240 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~~~ 240 (297)
....|+||||+++++|.+++...... ...+++..++.++.||+.||.|||+ .||+||||||+|||++. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999865422 2348899999999999999999995 89999999999999984 4569
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 239 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 999999987543222222233456899999999999999999999999999999984
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=306.32 Aligned_cols=194 Identities=28% Similarity=0.410 Sum_probs=160.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45678999999999999999998764 45699999986543 34678999999999999999999998876
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred -CceEEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCc
Confidence 678999999999999999975321 348899999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... .......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 326 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~ 375 (452)
T 1fmk_A 326 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHH
Confidence 9986543211 1222345788999999999999999999999999999984
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=282.94 Aligned_cols=188 Identities=32% Similarity=0.506 Sum_probs=153.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch----hhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
.++|++.+.||+|+||.||+|.+. +..||+|.+..... ...+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 457999999999999999999865 56799999875422 234678899999999999999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC---ceeccCCCCcEEEcC----
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK---VIYRDFKASNILLDG---- 236 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~---ivH~Dlkp~Nill~~---- 236 (297)
+.+.+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+ .+ |+||||||+|||++.
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSS
T ss_pred EecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEeccccc
Confidence 9999999999999999999999854 458999999999999999999995 66 999999999999986
Q ss_pred ----CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 ----NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 208 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208 (271)
T ss_dssp SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred ccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 7789999999997653321 22457899999999999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=282.53 Aligned_cols=195 Identities=24% Similarity=0.289 Sum_probs=163.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|....+||+|+||.||+|.+..+ +..||+|.+........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSN---------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTT---------CCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEeecCcEEEEEEEECCC---------CeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 3456667999999999999987654 7789999987765555678899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-CCceEEccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDFGL 247 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~ 247 (297)
..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+ .||+||||||+|||++. ++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred cEEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 99999999999999999976532 2346788999999999999999994 89999999999999987 89999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccC--CcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGN--FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~~ll 297 (297)
++...... .......||+.|+|||++.+.. ++.++||||||+++|+|+
T Consensus 170 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~ 219 (295)
T 2clq_A 170 SKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 219 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHH
T ss_pred ccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHH
Confidence 98654321 1233457899999999997654 788999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=289.53 Aligned_cols=195 Identities=25% Similarity=0.420 Sum_probs=162.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+........+.+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~---------~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKET---------GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTT---------CCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEcCC---------CcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 356899999999999999999987754 77899999987666666888999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999999999987643 458999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... ........||+.|+|||++. +..++.++||||||+++|+|+
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 216 (302)
T 2j7t_A 163 VSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216 (302)
T ss_dssp HHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH
T ss_pred CCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh
Confidence 87532110 01123356899999999984 567888999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=288.15 Aligned_cols=197 Identities=25% Similarity=0.368 Sum_probs=166.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSD---------GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCC---------CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 46899999999999999999987654 788999998654 2344567899999999999999999999885
Q ss_pred c--CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC-----ceeccCCCCcEEEcCCC
Q 022413 166 E--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK-----VIYRDFKASNILLDGNY 238 (297)
Q Consensus 166 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-----ivH~Dlkp~Nill~~~~ 238 (297)
+ ....++||||+++++|.+++.........+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSS
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCC
Confidence 4 578999999999999999998654333568999999999999999999995 66 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 154 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 210 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 210 (279)
T ss_dssp CEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHH
T ss_pred CEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999998654321 1123456899999999999889999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=281.53 Aligned_cols=192 Identities=26% Similarity=0.375 Sum_probs=160.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLT---------GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCC---------CceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 46899999999999999999987654 7889999986542 23346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d 154 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIAD 154 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEee
Confidence 9999999999999999999999876 458999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|+
T Consensus 155 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 205 (276)
T 2h6d_A 155 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205 (276)
T ss_dssp CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 99998654322 2234568999999999987765 57999999999999984
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.50 Aligned_cols=189 Identities=31% Similarity=0.441 Sum_probs=155.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||+||+|.+. +..||+|.+.... ..+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 71 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL-- 71 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence 457889999999999999999765 5679999987543 3467899999999999999999999876
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCC-CCceeccCCCCcEEEcCCCc-eEEccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE-KKVIYRDFKASNILLDGNYN-AKISDF 245 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~~ivH~Dlkp~Nill~~~~~-~kl~Df 245 (297)
+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.. .||+||||||+|||++.++. +||+||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 72 NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp TTTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred CCcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 458999999999999999976532 134788899999999999999999411 78999999999999998886 799999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++...... .....||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 151 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 197 (307)
T 2eva_A 151 GTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 197 (307)
T ss_dssp CC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999754321 22346899999999999989999999999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=299.32 Aligned_cols=191 Identities=21% Similarity=0.257 Sum_probs=163.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC------CCCCcccE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL------SHPNLVKL 160 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~ 160 (297)
...+|++.++||+|+||+||+|.+... ++.||+|++..... ..+.+.+|+.+++.+ .|+||+++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~---------~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKV---------HQHVALKMVRNEKR-FHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTT---------TEEEEEEEECSCHH-HHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCC---------CcEEEEEEECCccc-hHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 346799999999999999999987654 78899999976532 235567788877766 57899999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc-
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN- 239 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~- 239 (297)
++++...+.+++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~ 239 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRS 239 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSC
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCc
Confidence 999999999999999995 699999976532 348999999999999999999995 89999999999999999887
Q ss_pred -eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 -AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 240 ~vkL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 293 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293 (429)
T ss_dssp CEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHH
T ss_pred ceEEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHH
Confidence 99999999975432 223457999999999999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=283.10 Aligned_cols=196 Identities=21% Similarity=0.291 Sum_probs=162.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc----hhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~---------~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSET---------LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTT---------CCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCC---------CcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 46899999999999999999977654 7889999987643 2334678999999999999999999999
Q ss_pred EE--cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 164 CW--EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 164 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+. +....++||||++++ |.+++..... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEE
Confidence 85 445899999999876 7777765432 458999999999999999999995 8999999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccC--CcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN--FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGv~l~~ll 297 (297)
|+|||++................||+.|+|||++.+.. ++.++||||||+++|+|+
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~ 207 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT 207 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHH
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHH
Confidence 99999998765433333344567999999999987644 367899999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.39 Aligned_cols=197 Identities=22% Similarity=0.266 Sum_probs=165.6
Q ss_pred HHhhcCCCCC-ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCC-CCCcccE
Q 022413 85 KSATKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLS-HPNLVKL 160 (297)
Q Consensus 85 ~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~ 160 (297)
....++|.+. +.||+|+||.||+|.+..+ ++.||+|.+..... .....+.+|+.+++.+. ||||+++
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKST---------GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCC---------CCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3445678877 8999999999999987754 78899999875432 33467889999999995 7999999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---C
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---N 237 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~ 237 (297)
++++.+.+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||+ .||+||||||+|||++. +
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTB
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCC
Confidence 999999999999999999999999986432 2458999999999999999999994 89999999999999987 7
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 171 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 227 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227 (327)
T ss_dssp CCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHH
Confidence 899999999998654322 223457999999999999999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.77 Aligned_cols=196 Identities=30% Similarity=0.433 Sum_probs=162.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCc--EEEEEecCCc-chhhHHHHHHHHHHhcCC-CCCCcccEEeE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGM--VVAIKKLNPE-SMQGFEEWQSEVNFLGRL-SHPNLVKLLGY 163 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 163 (297)
.++|++.+.||+|+||.||+|.+..+ +. .+++|.+... .....+.+.+|+.+++++ +||||++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKD---------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEET---------TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccC---------CcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 35799999999999999999987653 44 3588987653 233446788999999999 89999999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCc
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRN------------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN 231 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~N 231 (297)
+.+.+..++||||+++++|.+++.... .....+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~N 172 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARN 172 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccce
Confidence 999999999999999999999997653 223468999999999999999999994 899999999999
Q ss_pred EEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 232 ILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 232 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||++.++.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 235 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHH
Confidence 99999999999999998743221 1122345788999999999888999999999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=292.61 Aligned_cols=189 Identities=28% Similarity=0.392 Sum_probs=153.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHH--hcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF--LGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... ..+..|.++ +..++||||+++++.+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC-----------CeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheeccc
Confidence 568999999999999999999663 67899999865433 333444444 55689999999998654
Q ss_pred c-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCC---------CceeccCCCCc
Q 022413 166 E-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK---------KVIYRDFKASN 231 (297)
Q Consensus 166 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~---------~ivH~Dlkp~N 231 (297)
. ...+++||||+++|+|.+++... ..++..+..++.||+.||+|||+ . +|+||||||+|
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~--~~~~~~~~~~~ivH~Dikp~N 150 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHT--ELPRGDHYKPAISHRDLNSRN 150 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHC--CBCCGGGCBCCEECSSCSGGG
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHh--hhccccccccceeecccccce
Confidence 2 23679999999999999999764 35888999999999999999994 6 99999999999
Q ss_pred EEEcCCCceEEccccccccCCCCCC------cceeeccCCcccccCcceecc-------cCCcccccchhhhhhhhhcC
Q 022413 232 ILLDGNYNAKISDFGLAKLGPAGGE------SHVTTRVMGTYGYAAPEYVAT-------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 232 ill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~~ll 297 (297)
|||+.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell 229 (336)
T 3g2f_A 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229 (336)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence 9999999999999999986543211 112234579999999999986 46678899999999999984
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=295.31 Aligned_cols=197 Identities=16% Similarity=0.143 Sum_probs=158.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-----------hHHHHHHHHHHhcCCCCCC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-----------GFEEWQSEVNFLGRLSHPN 156 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n 156 (297)
.++|++.+.||+|+||.||+|.+.... ..+..+|+|.+...... ....+.+|+.+++.++|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSC------GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCC------CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 457999999999999999999887521 12677999988654321 1134668899999999999
Q ss_pred cccEEeEEEc----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 157 LVKLLGYCWE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 157 Iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
|+++++++.. ....|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NI 182 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANL 182 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHE
Confidence 9999999988 67899999999 99999999765 368999999999999999999995 8999999999999
Q ss_pred EEcCCC--ceEEccccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNY--NAKISDFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 254 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 999877 9999999999765432111 1113457999999999999988999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=283.07 Aligned_cols=193 Identities=26% Similarity=0.345 Sum_probs=167.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---------hhhHHHHHHHHHHhcCCC-CCC
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---------MQGFEEWQSEVNFLGRLS-HPN 156 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~n 156 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+.+.+|+.+++++. |||
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPT---------CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhccceeeeecCCCceEEEEEEEcCc---------CceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 456899999999999999999987654 7889999986432 123456789999999996 999
Q ss_pred cccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 157 LVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 157 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
|+++++++...+..++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDD 159 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECT
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcC
Confidence 999999999999999999999999999999875 458999999999999999999994 89999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceec------ccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA------TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~ 223 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223 (298)
T ss_dssp TCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred CCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHH
Confidence 9999999999998654322 233457899999999985 356788999999999999984
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=279.19 Aligned_cols=188 Identities=22% Similarity=0.284 Sum_probs=161.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+. +..||+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 467999999999999999999875 5679999987653 344567899999999999999999999998
Q ss_pred cC--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC--ceeccCCCCcEEEcCCCceE
Q 022413 166 ED--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 166 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~--ivH~Dlkp~Nill~~~~~~k 241 (297)
+. +..++||||+++++|.+++..... ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.++
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCccee
Confidence 87 789999999999999999976432 35899999999999999999999 477 99999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcc---cccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYL---LSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslGv~l~~ll 297 (297)
|+|||++.... .....||+.|+|||++.+..++. ++||||||+++|+|+
T Consensus 154 l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 205 (271)
T 3kmu_A 154 ISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205 (271)
T ss_dssp EEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH
T ss_pred EEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence 99988875322 12346899999999998765554 799999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=288.35 Aligned_cols=201 Identities=25% Similarity=0.355 Sum_probs=150.3
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+++.+|+.++++++||||+++++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPK---------KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCC---------CcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 3467899999999999999999976543 7789999987543 23346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhc----CCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRR----NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
...+..++||||+++++|.+++... ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCE
Confidence 9999999999999999999998742 1122558999999999999999999995 899999999999999999999
Q ss_pred EEccccccccCCCCCC---cceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGE---SHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 221 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence 9999999876543221 111234579999999999876 56889999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=295.66 Aligned_cols=188 Identities=27% Similarity=0.361 Sum_probs=146.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++... .....+++.+|+.+++.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKT---------GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTT---------TEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCC---------CCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 46899999999999999999987654 889999998754 2334567889999999999999999999987
Q ss_pred cC------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 ED------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
.. ...|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCC
Confidence 54 5689999999 7899988865 348999999999999999999995 89999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 171 ~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 224 (367)
T 2fst_X 171 LKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224 (367)
T ss_dssp EEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH
T ss_pred EEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH
Confidence 99999999986432 2334579999999999987 67889999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=286.74 Aligned_cols=186 Identities=17% Similarity=0.261 Sum_probs=162.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .+.+.+|+.+++++. ||||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITN---------NEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCC---------CcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 46799999999999999999987654 7889999987544 356789999999997 9999999999998
Q ss_pred --CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-ceEEc
Q 022413 167 --DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKIS 243 (297)
Q Consensus 167 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-~~kl~ 243 (297)
....++||||+++++|.+++.. +++..++.++.||+.||+|||+ .||+||||||+|||++.++ .+||+
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEE
Confidence 5679999999999999998842 7889999999999999999994 8999999999999999776 89999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 174 Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 225 (330)
T 3nsz_A 174 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225 (330)
T ss_dssp CCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred eCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH
Confidence 999998654332 2334578999999999987 66889999999999999984
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=312.63 Aligned_cols=189 Identities=28% Similarity=0.358 Sum_probs=156.9
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLL 172 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 172 (297)
+.||+|+||+||+|.+... ..+..||+|++.... ....+++.+|+.+|++++||||+++++++.. +..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 4799999999999976532 226789999997643 2345789999999999999999999998865 56899
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC
Q 022413 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 173 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
||||+++|+|.+++... ..+++..++.|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++.+.
T Consensus 447 v~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 99999999999999765 558999999999999999999994 899999999999999999999999999998764
Q ss_pred CCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 253 AGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 253 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
..... .......+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 566 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 566 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 33211 1223345688999999999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.48 Aligned_cols=195 Identities=29% Similarity=0.394 Sum_probs=159.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKT---------GQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCC---------CCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 467899999999999999999987654 78899999865432 236788999999999 7999999999998
Q ss_pred c------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 E------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
. .+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCC
Confidence 7 4689999999999999999976421 458899999999999999999995 89999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||++....... .......||+.|+|||++. +..++.++||||||+++|+|+
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 228 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH
Confidence 9999999987653321 1223457999999999987 567889999999999999984
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=282.96 Aligned_cols=197 Identities=27% Similarity=0.368 Sum_probs=164.5
Q ss_pred hcCCCCCc-eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|.+.+ .||+|+||.||+|.+... ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 34666666 999999999999976532 127789999998753 34557889999999999999999999998
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
..+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCC
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcc
Confidence 4567999999999999999997543 458999999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++........ .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 207 (287)
T 1u59_A 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207 (287)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 999876433221 1122345689999999999888999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=292.38 Aligned_cols=193 Identities=26% Similarity=0.361 Sum_probs=163.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ +..||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLN---------KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCC---------CeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 45899999999999999999987654 7889999987543 3344678899999999999999999999976
Q ss_pred C-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 167 D-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 167 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
. ...|+||||+. ++|.+++... .+++..+..++.||+.||+|||+ .||+||||||+||||+.++.+|
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEE
Confidence 5 36899999996 5999998753 48999999999999999999994 8999999999999999999999
Q ss_pred EccccccccCCCCCCc-ceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHH
Confidence 9999999865432111 112345799999999987654 4889999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.90 Aligned_cols=195 Identities=24% Similarity=0.289 Sum_probs=151.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|.+..... ...+.+..+...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPS---------GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCC---------CeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 56899999999999999999987654 78899999876522 22234445555688899999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCC-CceeccCCCCcEEEcCCCceEEcc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK-KVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~-~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
+++..++||||++ ++|.+++.........+++..++.++.|++.||+|||+ . ||+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEee
Confidence 9999999999996 48888876533333669999999999999999999995 6 999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCccee----cccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYV----ATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... ......||+.|+|||++ .+..++.++||||||+++|+|+
T Consensus 154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 207 (290)
T 3fme_A 154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH
T ss_pred cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH
Confidence 99997654322 22334699999999996 5567889999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=290.02 Aligned_cols=200 Identities=24% Similarity=0.277 Sum_probs=153.1
Q ss_pred HHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeE
Q 022413 84 LKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGY 163 (297)
Q Consensus 84 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 163 (297)
.....++|++.+.||+|+||.||+|.+..+ +..||+|++..... ...+..+|+..++.++||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~ 87 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKST---------GMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSY 87 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTT---------CCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCC---------CCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHh
Confidence 345578999999999999999999987654 78899998854432 22456778888899999999999999
Q ss_pred EEcCCe-------eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 164 CWEDKE-------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 164 ~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
+..... +++||||+++ +|...+.........+++..+..++.|++.||.|||.++.||+||||||+||||+.
T Consensus 88 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE 166 (360)
T ss_dssp EEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET
T ss_pred hhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC
Confidence 976433 8999999976 66655554323336688999999999999999999955599999999999999997
Q ss_pred -CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 237 -NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell 226 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence 8999999999998764332 233457899999999987654 899999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.01 Aligned_cols=192 Identities=23% Similarity=0.336 Sum_probs=160.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------hhHHHHHHHHHHhcCCCCCCcc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLV 158 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv 158 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... .....+.+|+.++++++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKT---------CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCC---------CcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 456899999999999999999987654 78899999875421 1224578999999999999999
Q ss_pred cEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 159 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
++++++..+. .|+||||+++++|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSS
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCC
Confidence 9999987655 89999999999999998764 568999999999999999999994 8999999999999998765
Q ss_pred c---eEEccccccccCCCCCCcceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 239 N---AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
. +||+|||+++..... .......||+.|+|||++. +..++.++||||||+++|+|+
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp SSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred CCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence 4 999999999865322 1223456899999999974 467888999999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.77 Aligned_cols=193 Identities=28% Similarity=0.413 Sum_probs=163.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4567788899999999999998765 45699999986543 34678999999999999999999998876
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred ccceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 679999999999999999975321 348899999999999999999994 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...... ........++..|+|||++.+..++.++|||||||+||+|+
T Consensus 410 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~ 458 (535)
T 2h8h_A 410 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458 (535)
T ss_dssp TTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred ceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 98654211 11122345678999999999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=283.02 Aligned_cols=194 Identities=29% Similarity=0.443 Sum_probs=164.3
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 78 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcC----------CcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence 35689999999999999999998654 56799999876543 3467899999999999999999999876
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCc
Confidence 4568999999999999999975311 258899999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... .......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 204 (279)
T 1qpc_A 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204 (279)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred ccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence 9986543221 1122345688999999999888999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=288.56 Aligned_cols=197 Identities=27% Similarity=0.326 Sum_probs=151.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEE-
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCW- 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~- 165 (297)
..+|++.++||+|+||.||+|.+..+ ++.||+|.+........+.+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGS---------GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTT---------CCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CceEEEEEEEccCCceEEEEEEECCC---------CcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 45799999999999999999987654 7889999987666556678899999999996 999999999984
Q ss_pred -------cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC--ceeccCCCCcEEEcC
Q 022413 166 -------EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLDG 236 (297)
Q Consensus 166 -------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~--ivH~Dlkp~Nill~~ 236 (297)
....++++|||+. |+|.+++...... ..+++..++.++.||+.||+|||+ .+ |+||||||+||||+.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT-CSCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCCCCCGGGCEECT
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCCCEEEccCCcccEEECC
Confidence 3345899999995 6999988753221 458999999999999999999994 77 999999999999999
Q ss_pred CCceEEccccccccCCCCCCcc----------eeeccCCcccccCccee---cccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESH----------VTTRVMGTYGYAAPEYV---ATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++......... ......||+.|+|||++ .+..++.++||||||+++|+|+
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~ 247 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence 9999999999998654322110 11235689999999998 5677889999999999999984
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=282.67 Aligned_cols=196 Identities=28% Similarity=0.358 Sum_probs=163.0
Q ss_pred hcCCCCCc-eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+ .||+|+||.||+|.+... ..+..||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45788888 999999999999965432 126789999987653 23357789999999999999999999998
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
..+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECC
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEcc
Confidence 567889999999999999999875 458999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++......... ......+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 214 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHH
Confidence 99998764432211 122234678999999999888999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=290.83 Aligned_cols=198 Identities=25% Similarity=0.323 Sum_probs=158.7
Q ss_pred HHHHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-----------hhHHHHHHHHHHh
Q 022413 81 FLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-----------QGFEEWQSEVNFL 149 (297)
Q Consensus 81 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~E~~~l 149 (297)
..++....++|++.+.||+|+||.||+|.+.. +..||+|++..... ...+.+.+|+.++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE----------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT----------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCC----------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence 33556677899999999999999999997543 77899998864321 1236789999999
Q ss_pred cCCCCCCcccEEeEEEc-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCcee
Q 022413 150 GRLSHPNLVKLLGYCWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY 224 (297)
Q Consensus 150 ~~l~h~nIv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH 224 (297)
++++||||+++++++.. ...+|+||||++ ++|.+++.... ..+++..+..++.||+.||.|||+ .||+|
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH 157 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE--AGVVH 157 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH--CcCEe
Confidence 99999999999999854 346899999997 58888887543 468999999999999999999995 89999
Q ss_pred ccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 225 RDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 225 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 158 RDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp CCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred cCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence 9999999999999999999999997543221 2334578999999999987 67889999999999999984
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.28 Aligned_cols=194 Identities=26% Similarity=0.401 Sum_probs=162.4
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcC--CCCCCcccEEe
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR--LSHPNLVKLLG 162 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~ 162 (297)
....++|++.+.||+|+||.||+|.+. ++.||+|.+.... ...+.+|.+++.. ++||||+++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 445678999999999999999999764 6789999987543 2556778888877 78999999999
Q ss_pred EEEcCC----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC------CCCceeccCCCCcE
Q 022413 163 YCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASNI 232 (297)
Q Consensus 163 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------~~~ivH~Dlkp~Ni 232 (297)
++.... ..++||||+++++|.+++... .+++..++.++.|++.||.|||.. +.+|+||||||+||
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI 178 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence 998876 899999999999999999763 489999999999999999999931 37999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcc--eeeccCCcccccCcceeccc------CCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESH--VTTRVMGTYGYAAPEYVATG------NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~~ll 297 (297)
||+.++.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|+|+
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 99999999999999997654332111 12345799999999999765 3446899999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=294.34 Aligned_cols=190 Identities=24% Similarity=0.280 Sum_probs=162.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC--------CCCccc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS--------HPNLVK 159 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~ 159 (297)
.++|++.+.||+|+||+||+|++..+ ++.||+|++.... ...+.+.+|+.+++.++ ||||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQG---------KKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCC---------CeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 46899999999999999999987654 7889999997543 23467889999999985 788999
Q ss_pred EEeEEE----cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCC-CceeccCCCCcEEE
Q 022413 160 LLGYCW----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK-KVIYRDFKASNILL 234 (297)
Q Consensus 160 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~-~ivH~Dlkp~Nill 234 (297)
+++++. ....+++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ . ||+||||||+||||
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIll 180 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEEE
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHeeE
Confidence 999988 556899999999 6677777765422 458999999999999999999995 6 99999999999999
Q ss_pred cCCC-------------------------------------------------ceEEccccccccCCCCCCcceeeccCC
Q 022413 235 DGNY-------------------------------------------------NAKISDFGLAKLGPAGGESHVTTRVMG 265 (297)
Q Consensus 235 ~~~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g 265 (297)
+.++ .+||+|||+++.... ......|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCC
Confidence 8775 799999999986532 1234579
Q ss_pred cccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 266 TYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 266 t~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.90 Aligned_cols=198 Identities=24% Similarity=0.310 Sum_probs=164.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||.||+|.+.... ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPE------NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSS------SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCC------CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4567999999999999999999876431 126789999987643 334467899999999999999999999884
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
++..|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEec
Confidence 467899999999999999998653 458899999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++....... .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 536 G~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 586 (656)
T 2j0j_A 536 GLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 99987543321 1223345788999999999899999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=281.11 Aligned_cols=188 Identities=30% Similarity=0.408 Sum_probs=156.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+. +..||+|.+.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 467999999999999999999764 6679999987654 346788999999999999999999997655
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 168 -KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 168 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeecc
Confidence 479999999999999999976421 237889999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++..... .....+++.|+|||++.+..++.++||||||+++|+|+
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 208 (278)
T 1byg_A 163 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHH
Confidence 98754321 22335789999999999999999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=290.16 Aligned_cols=193 Identities=26% Similarity=0.265 Sum_probs=164.4
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CC-----CcccE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HP-----NLVKL 160 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~~ 160 (297)
..++|++.+.||+|+||+||+|.+..+ ++.||+|++.... .....+..|+.+++.+. |+ +|+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVE---------QEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTT---------TEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCC---------CcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 457899999999999999999987654 7889999997543 23356778888888875 54 49999
Q ss_pred EeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc--CCC
Q 022413 161 LGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GNY 238 (297)
Q Consensus 161 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~--~~~ 238 (297)
++++...+..++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+++.||+||||||+||||+ .++
T Consensus 122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred eeeeccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 999999999999999995 599999986532 348899999999999999999997568999999999999994 578
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 199 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 252 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252 (382)
T ss_dssp CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 8999999999865321 23457999999999999999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=296.75 Aligned_cols=197 Identities=23% Similarity=0.306 Sum_probs=147.9
Q ss_pred cCCCC-CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc-
Q 022413 89 KNFKP-DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE- 166 (297)
Q Consensus 89 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~- 166 (297)
+.|.+ +++||+|+||+||+|.+.+. ..+..||+|.+...... ..+.+|+.+|++++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 44666 56899999999999987632 12678999999765432 567899999999999999999999964
Q ss_pred -CCeeEEEEEecCCCCHHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE----cC
Q 022413 167 -DKELLLVYEYMQRGSLENHLFRRN-----PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL----DG 236 (297)
Q Consensus 167 -~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill----~~ 236 (297)
...+|+||||+. ++|.+++.... .....+++..++.++.||+.||+|||+ .||+||||||+|||| +.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCC
Confidence 678999999996 58888876321 112348999999999999999999995 899999999999999 67
Q ss_pred CCceEEccccccccCCCCCC-cceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGE-SHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 230 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH
Confidence 89999999999986543211 1223446799999999999874 4889999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.43 Aligned_cols=193 Identities=26% Similarity=0.337 Sum_probs=157.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEE--
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW-- 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~-- 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDC---------DKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTT---------TEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECCC---------CeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 56899999999999999999987754 7889999987766666688899999999999999999999874
Q ss_pred ------------cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 166 ------------EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 166 ------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
+....++||||++ ++|.+++.. ..+++..++.++.|++.||+|||+ .||+||||||+|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil 152 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLF 152 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEE
Confidence 3468899999997 599999864 358899999999999999999994 89999999999999
Q ss_pred Ec-CCCceEEccccccccCCCCCC-cceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 234 LD-GNYNAKISDFGLAKLGPAGGE-SHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 234 l~-~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
++ +++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 219 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219 (320)
T ss_dssp EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence 97 567999999999986543211 112233467999999998876 67889999999999999984
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=280.96 Aligned_cols=194 Identities=21% Similarity=0.214 Sum_probs=159.1
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEE-E
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC-W 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~ 165 (297)
..++|++.+.||+|+||.||+|.+... ++.||+|.+...... ..+.+|+.+++.++|++++..+..+ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA---------GEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTT---------TEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCC---------CceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 457899999999999999999987654 788999986544322 4577899999999988766666655 6
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE---cCCCceEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKI 242 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill---~~~~~~kl 242 (297)
..+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL 149 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEE
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEE
Confidence 677899999999 999999997543 458999999999999999999995 899999999999999 78999999
Q ss_pred ccccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 4hgt_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHh
Confidence 999999865443221 1223467999999999999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=295.74 Aligned_cols=190 Identities=24% Similarity=0.308 Sum_probs=153.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
..+|++.++||+|+||+||+|.+... ..+|+|++..... ...+|+.+++.++||||+++++++...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~----------~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVES----------DEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTT----------EEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCC----------CeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 45799999999999999999987653 3478887754332 123699999999999999999999654
Q ss_pred C------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc-CCCce
Q 022413 168 K------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-GNYNA 240 (297)
Q Consensus 168 ~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~-~~~~~ 240 (297)
. .+++||||+++ ++...+.........+++..++.++.||+.||+|||+ .||+||||||+||||+ .++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEE
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcE
Confidence 3 38899999976 4544443322222568999999999999999999995 8999999999999999 79999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 182 kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 236 (394)
T 4e7w_A 182 KLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236 (394)
T ss_dssp EECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred EEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999998764332 22345789999999999765 5899999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.60 Aligned_cols=193 Identities=21% Similarity=0.215 Sum_probs=162.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEE-Ec
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYC-WE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+...... +.+.+|+.+++.++|++++..+..+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAA---------GEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT---------TEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCC---------CcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 56899999999999999999987654 788999987654332 4678999999999988766665554 56
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE---cCCCceEEc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKIS 243 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill---~~~~~~kl~ 243 (297)
.+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||+ +.++.+||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEe
Confidence 67899999999 999999997543 458999999999999999999994 899999999999999 488999999
Q ss_pred cccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence 99999865443221 1123457999999999999999999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.80 Aligned_cols=187 Identities=26% Similarity=0.319 Sum_probs=159.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|.+.+.||+|+||.||+|.+..+ ++.||+|++.... ....+++.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRS---------GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCC---------CCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 46899999999999999999987654 8899999987642 233467889999999999999999999998
Q ss_pred cCCee------EEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDKEL------LLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
..+.. ++||||+. ++|.+++. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCC
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCC
Confidence 87654 99999996 58888774 338999999999999999999995 89999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 183 ~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 183 LKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp EEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred EEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH
Confidence 99999999985432 2334678999999999987 67899999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=293.31 Aligned_cols=189 Identities=12% Similarity=0.029 Sum_probs=144.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHH---HHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEV---NFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~---~~l~~l~h~nIv~~~ 161 (297)
..+|++.+.||+|+||+||+|.+..+ ++.||+|++..... ...+.+.+|+ .+|+. +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~ 130 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVER---------LEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDR 130 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCC---------CceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhc
Confidence 44689999999999999999987654 78899999876532 3345667774 55555 799988755
Q ss_pred -------eEEEcC-----------------CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHH------HHHHHHHHHH
Q 022413 162 -------GYCWED-----------------KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR------LKIAIGAARG 211 (297)
Q Consensus 162 -------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~i~~~i~~a 211 (297)
+++... ..+|+||||++ ++|.+++.... ..+.+..+ +.++.||+.|
T Consensus 131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~a 206 (371)
T 3q60_A 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRL 206 (371)
T ss_dssp -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHH
Confidence 455433 33899999998 89999998642 22344445 6778999999
Q ss_pred hcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc--cCCcccccchhh
Q 022413 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGN 289 (297)
Q Consensus 212 l~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwsl 289 (297)
|+|||+ .||+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||
T Consensus 207 L~~LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 207 AANLQS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp HHHHHH--TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred HHHHHH--CCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 999994 8999999999999999999999999999986432 2224567799999999987 679999999999
Q ss_pred hhhhhhcC
Q 022413 290 VINVCMYL 297 (297)
Q Consensus 290 Gv~l~~ll 297 (297)
||++|+|+
T Consensus 280 G~il~ell 287 (371)
T 3q60_A 280 GLSIYRVW 287 (371)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.71 Aligned_cols=193 Identities=23% Similarity=0.226 Sum_probs=163.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCC-CCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH-PNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~ 166 (297)
.++|++.++||+|+||.||+|.+..+ +..||||++...... ..+..|+.+++.+.| ++|..+..++.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---------~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---------NEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTT---------CCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCC---------CcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 56899999999999999999987654 788999987654322 357889999999986 566677777778
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE---cCCCceEEc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKIS 243 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill---~~~~~~kl~ 243 (297)
.+..++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+ .+||||||||+|||| +.++.+||+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEE
Confidence 88999999999 999999997543 458999999999999999999994 899999999999999 688999999
Q ss_pred cccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||+||
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell 207 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL 207 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 99999876543221 1123567999999999999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.32 Aligned_cols=191 Identities=24% Similarity=0.318 Sum_probs=163.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCC------CcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP------NLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~~~ 161 (297)
.++|++.+.||+|+||.||+|.+... .++.||+|++.... ...+.+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKA--------GGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCC--------CCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 46899999999999999999987432 27889999987543 2346778899999888665 499999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-----
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG----- 236 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~----- 236 (297)
+++.+.+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEecccccc
Confidence 9999999999999999 8899999976532 358899999999999999999995 89999999999999987
Q ss_pred --------------CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 --------------NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 228 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH
Confidence 67899999999986432 123457999999999999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=286.29 Aligned_cols=193 Identities=28% Similarity=0.375 Sum_probs=162.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .....++.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPT---------GEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCC---------CcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 56899999999999999999987654 7889999987543 3344678899999999999999999998775
Q ss_pred C-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 167 D-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 167 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
. ...++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+|
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEE
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEE
Confidence 4 67999999996 599999876 348999999999999999999995 8999999999999999999999
Q ss_pred EccccccccCCCCCCcc--------eeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESH--------VTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 217 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHH
Confidence 99999998654321110 1223578999999998765 67889999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=281.46 Aligned_cols=198 Identities=28% Similarity=0.435 Sum_probs=157.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||+||+|.+.... ..+..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 457999999999999999999865321 11446899998754 234457889999999999999999999998
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.... .++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECC
T ss_pred ccCC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEcc
Confidence 8765 899999999999999998653 458899999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++......... ......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 99998764432211 122345788999999999888999999999999999984
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.21 Aligned_cols=199 Identities=19% Similarity=0.172 Sum_probs=160.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCccc--------
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVK-------- 159 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-------- 159 (297)
.++|++.+.||+|+||.||+|.+..+... .....++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 46899999999999999999987752100 00012678999998644 35678999999999999988
Q ss_pred -------EEeEEEc-CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCc
Q 022413 160 -------LLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN 231 (297)
Q Consensus 160 -------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~N 231 (297)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHH
Confidence 6777766 67899999999 999999998642 1458999999999999999999995 899999999999
Q ss_pred EEEcCCC--ceEEccccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 232 ILLDGNY--NAKISDFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 232 ill~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 262 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 9999998 9999999999865432111 1123457999999999999989999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.02 Aligned_cols=192 Identities=21% Similarity=0.343 Sum_probs=165.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhh-----------------HHHHHHHHHHhc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-----------------FEEWQSEVNFLG 150 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~E~~~l~ 150 (297)
.++|++.+.||+|+||.||+|.+ . +..||+|.+....... .+.+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-D----------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-T----------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-C----------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999987 2 7889999986542211 177899999999
Q ss_pred CCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHH------HhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCcee
Q 022413 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENH------LFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIY 224 (297)
Q Consensus 151 ~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH 224 (297)
+++||||+++++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||+|||+ +.||+|
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H 175 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICH 175 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEEC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhc-cCCEee
Confidence 99999999999999999999999999999999998 4432 12568999999999999999999994 389999
Q ss_pred ccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcc-cccchhhhhhhhhcC
Q 022413 225 RDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYL-LSAKFGNVINVCMYL 297 (297)
Q Consensus 225 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslGv~l~~ll 297 (297)
|||||+|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|+
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~ 246 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence 999999999999999999999999865332 33456799999999999877 5666 899999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=276.75 Aligned_cols=194 Identities=25% Similarity=0.374 Sum_probs=165.8
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEe
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLG 162 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~ 162 (297)
....++|++.+.||+|+||.||+|....+ ++.||+|.+.... ....+.+.+|+.++++++||||+++++
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRIT---------QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCC---------CcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEE
Confidence 33567899999999999999999987654 7789999986542 234577899999999999999999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC---Cc
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN---YN 239 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~---~~ 239 (297)
++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.+ +.
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~ 162 (287)
T 2wei_A 89 ILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCD 162 (287)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCC
T ss_pred EEeCCCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCccc
Confidence 999999999999999999999998765 458999999999999999999995 899999999999999754 47
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++....... .....||+.|+|||++.+ .++.++||||||+++|+|+
T Consensus 163 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 163 IKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (287)
T ss_dssp EEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHH
T ss_pred EEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHH
Confidence 99999999986543221 223458999999998864 5889999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.59 Aligned_cols=180 Identities=21% Similarity=0.215 Sum_probs=149.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--------hhhHHHHHHHHHHhcCCC------
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--------MQGFEEWQSEVNFLGRLS------ 153 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~------ 153 (297)
.++|++.+.||+|+||+||+|++. ++.||+|.+.... ....+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIAD-----------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEET-----------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEeC-----------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 467999999999999999999763 6789999987542 223467888999988885
Q ss_pred ---CCCcccEEeEEE-----------------c-------------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHH
Q 022413 154 ---HPNLVKLLGYCW-----------------E-------------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200 (297)
Q Consensus 154 ---h~nIv~~~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 200 (297)
||||+++.+++. + .+.+|+||||+++|++.+.+.+ ..+++..
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~ 162 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLAT 162 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHH
Confidence 777777766643 2 6789999999999987777643 3479999
Q ss_pred HHHHHHHHHHHhcchh-cCCCCceeccCCCCcEEEcCCC--------------------ceEEccccccccCCCCCCcce
Q 022413 201 RLKIAIGAARGLGFLH-TSEKKVIYRDFKASNILLDGNY--------------------NAKISDFGLAKLGPAGGESHV 259 (297)
Q Consensus 201 ~~~i~~~i~~al~yLH-~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~ 259 (297)
++.++.||+.||+||| + .+|+||||||+||||+.++ .+||+|||+++....
T Consensus 163 ~~~i~~qi~~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------ 234 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------ 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------
T ss_pred HHHHHHHHHHHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------
Confidence 9999999999999999 6 8999999999999999887 899999999986432
Q ss_pred eeccCCcccccCcceecccCCcccccchhhhhhh
Q 022413 260 TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINV 293 (297)
Q Consensus 260 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l 293 (297)
...+||+.|+|||++.+.. +.++|||||++++
T Consensus 235 -~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~ 266 (336)
T 2vuw_A 235 -GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKE 266 (336)
T ss_dssp -TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHH
T ss_pred -CcEEEeecccChhhhcCCC-ccceehhhhhCCC
Confidence 1247999999999998665 8899999987773
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.20 Aligned_cols=194 Identities=20% Similarity=0.283 Sum_probs=158.2
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCC--CCCcccEE
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLS--HPNLVKLL 161 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~~~ 161 (297)
...++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++ ||||++++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK----------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC----------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 345689999999999999999997643 678999998644 3345578899999999997 59999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+++...+..++||| +.+++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||+++ +.+|
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEE
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEE
Confidence 99999999999999 5588999999875 468999999999999999999995 89999999999999974 8999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecc-----------cCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-----------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++...............||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 233 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH
Confidence 999999986544322222334579999999999875 46888999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=281.93 Aligned_cols=191 Identities=22% Similarity=0.283 Sum_probs=162.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCC------cccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN------LVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~ 161 (297)
.++|++.+.||+|+||+||+|.+.... +..||+|.+.... ...+.+.+|+.+++.+.|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARG--------KSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT--------TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCC--------ceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 468999999999999999999876541 4689999997543 23467788999999987665 99999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE-------
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL------- 234 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill------- 234 (297)
+++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+||| +.||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCCEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecccccc
Confidence 9999999999999999 6788887765432 45899999999999999999999 5899999999999999
Q ss_pred ------------cCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 235 ------------DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 233 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence 6788999999999986432 223457999999999999999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=284.28 Aligned_cols=187 Identities=25% Similarity=0.313 Sum_probs=158.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+++.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRS---------GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCC---------CCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 45799999999999999999987654 7899999987542 233467889999999999999999999998
Q ss_pred cCCe------eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDKE------LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
.... .|+||||+. ++|.+++.. .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCC
T ss_pred cccccccceeEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCc
Confidence 7654 499999996 588877642 38999999999999999999995 89999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++.... ......||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 165 ~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 218 (353)
T 3coi_A 165 LKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218 (353)
T ss_dssp EEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred EEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHH
Confidence 99999999986432 1234578999999999887 67889999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=280.24 Aligned_cols=195 Identities=27% Similarity=0.382 Sum_probs=162.0
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCC---CCCCcccEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLL 161 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~ 161 (297)
..++|++.+.||+|+||.||+|.+... .++.||+|.+..... .....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecCC--------CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 356899999999999999999987532 178899998864322 1223456777777766 899999999
Q ss_pred eEEE-----cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC
Q 022413 162 GYCW-----EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG 236 (297)
Q Consensus 162 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~ 236 (297)
+++. .....++||||++ ++|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTS 155 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcC
Confidence 9987 5568999999997 599999976532 348999999999999999999994 89999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++..... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 156 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 213 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213 (326)
T ss_dssp TCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 999999999999865321 1233457899999999999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.65 Aligned_cols=195 Identities=23% Similarity=0.329 Sum_probs=143.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHH-HhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVN-FLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ......+..|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPS---------GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTT---------TEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCC---------CCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 46899999999999999999987654 7889999987542 233345556665 778889999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHhcchhcCCC-CceeccCCCCcEEEcCCCceEEc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRN-PSIQPLSWDIRLKIAIGAARGLGFLHTSEK-KVIYRDFKASNILLDGNYNAKIS 243 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~~-~ivH~Dlkp~Nill~~~~~~kl~ 243 (297)
+.+..++||||+++ +|.+++.... .....+++..+..++.|++.||.|||+ . ||+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEEc
Confidence 99999999999975 8888776311 112568999999999999999999995 6 99999999999999999999999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCccee----cccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV----ATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+++...... ......||+.|+|||++ .+..++.++||||||+++|+|+
T Consensus 169 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (327)
T 3aln_A 169 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHH
T ss_pred cCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH
Confidence 999998654321 22334689999999998 4567889999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.33 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=156.5
Q ss_pred HhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch------hhHHHHHHHHHHhcCC----CCC
Q 022413 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRL----SHP 155 (297)
Q Consensus 86 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l----~h~ 155 (297)
...++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... .....+.+|+.+++++ +||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTD---------RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTT---------CCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccC---------CeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence 3467899999999999999999976554 78899999875432 1223455788888888 899
Q ss_pred CcccEEeEEEcCCeeEEEEEe-cCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 156 NLVKLLGYCWEDKELLLVYEY-MQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 156 nIv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
||+++++++...+..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILI 172 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEE
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEE
Confidence 999999999999999999999 7899999999876 458999999999999999999995 899999999999999
Q ss_pred c-CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCc-ccccchhhhhhhhhcC
Q 022413 235 D-GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFY-LLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGv~l~~ll 297 (297)
+ .++.+||+|||+++..... ......||+.|+|||++.+..+. .++||||||+++|+|+
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 233 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred eCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence 9 8899999999999875432 22345689999999999877764 4899999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=283.63 Aligned_cols=192 Identities=25% Similarity=0.348 Sum_probs=164.6
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh------hHHHHHHHHHHhcCCC--CCCcc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ------GFEEWQSEVNFLGRLS--HPNLV 158 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~--h~nIv 158 (297)
..++|++.+.||+|+||.||+|.+..+ ++.||+|.+...... ..+++.+|+.+++++. ||||+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSD---------NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTT---------TEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCC---------CcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 456899999999999999999987654 788999998654321 2245667999999996 59999
Q ss_pred cEEeEEEcCCeeEEEEEecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc-C
Q 022413 159 KLLGYCWEDKELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD-G 236 (297)
Q Consensus 159 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~-~ 236 (297)
++++++...+..++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++ +
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLN 185 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCC
Confidence 999999999999999999976 8999999875 568999999999999999999994 8999999999999999 7
Q ss_pred CCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 237 NYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 237 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
++.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|+|+
T Consensus 186 ~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~ 243 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243 (320)
T ss_dssp TTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH
Confidence 899999999999865432 2234579999999999987776 67889999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=307.11 Aligned_cols=186 Identities=22% Similarity=0.333 Sum_probs=157.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|.+... .++.||+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 46899999999999999999987642 1788999998654 33445678899999999999999999999987
Q ss_pred CCe-----eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 167 DKE-----LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 167 ~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
.+. .|+||||++|++|.+++.. .+++..++.++.||+.||.|||+ .|||||||||+||||+.+ .+|
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEE
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEE
Confidence 665 7999999999999887643 48999999999999999999995 899999999999999875 899
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|+
T Consensus 222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~ 270 (681)
T 2pzi_A 222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALT 270 (681)
T ss_dssp ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHH
T ss_pred EEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHH
Confidence 9999999865432 345799999999998754 588999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=280.95 Aligned_cols=190 Identities=23% Similarity=0.300 Sum_probs=139.9
Q ss_pred hhcCCCCCc-eecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDS-LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|.+.+ +||+|+||+||+|.+..+ ++.||+|++..... ........++.+.||||+++++++.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRT---------GQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCC---------CCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHh
Confidence 356888854 699999999999987754 78899999865421 1122233456678999999999987
Q ss_pred c----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CC
Q 022413 166 E----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NY 238 (297)
Q Consensus 166 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~ 238 (297)
. ...+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||++. ++
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTC
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCc
Confidence 6 4568999999999999999986532 458999999999999999999994 89999999999999976 45
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++..... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 169 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 223 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 223 (336)
T ss_dssp CEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHH
Confidence 6999999999864322 223457899999999999889999999999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.89 Aligned_cols=193 Identities=24% Similarity=0.330 Sum_probs=157.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
..++|++.+.||+|+||.||+|.+.. .+|+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 35689999999999999999998753 28999887542 22335677899999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||++ ++.+||+|
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEee
Confidence 99999999999999999999997643 458889999999999999999994 8999999999999998 68999999
Q ss_pred ccccccCCCCC---CcceeeccCCcccccCcceecc---------cCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGG---ESHVTTRVMGTYGYAAPEYVAT---------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... .........||+.|+|||++.+ ..++.++||||||+++|+|+
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 237 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence 99987543211 1112233468999999999874 34788999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=285.49 Aligned_cols=190 Identities=19% Similarity=0.239 Sum_probs=161.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-----------CCC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-----------HPN 156 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 156 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|.+..... ..+.+.+|+.+++++. |||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVN---------NTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCC---------CcEEEEEEecCCcc-chhhhhHHHHHHHHhhcccccchhccccch
Confidence 45899999999999999999987654 78899999975432 3366788999999886 899
Q ss_pred cccEEeEEEcCC----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCC-CceeccCCCCc
Q 022413 157 LVKLLGYCWEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEK-KVIYRDFKASN 231 (297)
Q Consensus 157 Iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~-~ivH~Dlkp~N 231 (297)
|+++++++...+ .+++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+ . ||+||||||+|
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~N 162 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPEN 162 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGG
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChHH
Confidence 999999998654 799999999 8899999986432 448899999999999999999995 6 99999999999
Q ss_pred EEEc------CCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 232 ILLD------GNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 232 ill~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+ ..+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 229 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH
T ss_pred eEEeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHH
Confidence 9994 445899999999986532 123357899999999999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=297.76 Aligned_cols=195 Identities=28% Similarity=0.368 Sum_probs=164.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+... .....+++.+|+.++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~t---------g~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~ 83 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDT---------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTT---------TCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCC---------CcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence 46899999999999999999866543 788999998765 34445778999999999999999999998765
Q ss_pred ------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc-
Q 022413 167 ------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN- 239 (297)
Q Consensus 167 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~- 239 (297)
.+..++||||++|++|.+++...... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~-~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC-CGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT-TCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSS
T ss_pred cccccCCCeEEEEEEeCCCCCHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCc
Confidence 67789999999999999999864321 358888999999999999999995 89999999999999997665
Q ss_pred --eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 --AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 161 ~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLl 217 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI 217 (676)
T ss_dssp CEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHH
T ss_pred eeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHH
Confidence 9999999998754332 234467999999999999999999999999999999974
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.92 Aligned_cols=193 Identities=25% Similarity=0.273 Sum_probs=146.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 167 (297)
+.|.+.++||+|+||+||.+.... |+.||+|.+.... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~----------g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQ----------GRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESS----------SSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEEEC----------CeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 345667889999999998653322 7889999886543 24568899999876 799999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCC---CCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC-------
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQP---LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN------- 237 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~------- 237 (297)
+.+|+||||+. |+|.+++......... ..+..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCccccccc
Confidence 99999999995 6999999765322111 1233457899999999999995 899999999999999754
Q ss_pred ------CceEEccccccccCCCCCCcc--eeeccCCcccccCcceecc-------cCCcccccchhhhhhhhhcC
Q 022413 238 ------YNAKISDFGLAKLGPAGGESH--VTTRVMGTYGYAAPEYVAT-------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ------~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ell 233 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHH
Confidence 489999999998765432211 1234579999999999975 56889999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.76 Aligned_cols=191 Identities=26% Similarity=0.329 Sum_probs=148.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCC-CCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 166 (297)
..+|.+.++||+|+||+||...... ++.||||++...... .+.+|+.+|+.+ +||||+++++++.+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~----------~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFD----------NRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESS----------SSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeC----------CeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 3468889999999999965432222 678999998765332 346799999999 79999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-----CCceE
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-----NYNAK 241 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-----~~~~k 241 (297)
....|+||||+. ++|.+++.... ..+.+..+..++.||+.||+|||+ .||+||||||+||||+. ...+|
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~k 163 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAM 163 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred CCEEEEEEECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEE
Confidence 999999999995 59999997654 223444567899999999999995 89999999999999943 34688
Q ss_pred EccccccccCCCCCCc-ceeeccCCcccccCcceec---ccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVA---TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++........ .......||+.|+|||++. ...++.++|||||||++|+||
T Consensus 164 L~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 164 ISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp ECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred EecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence 9999999876433211 2234467999999999997 456778999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=272.97 Aligned_cols=193 Identities=23% Similarity=0.317 Sum_probs=144.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... ...+.+..+..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKT---------GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTT---------CCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecC---------CeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 46799999999999999999987654 78899999875432 22234445556788889999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+.+..++||||+ ++.+..+..... ..+++..++.++.|++.||.|||+ ..||+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999999 556666655432 458999999999999999999994 139999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... ......||+.|+|||++. ...++.++||||||+++|+|+
T Consensus 170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (318)
T 2dyl_A 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHH
T ss_pred CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHH
Confidence 9997653321 223456899999999984 466888999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=258.76 Aligned_cols=164 Identities=14% Similarity=0.052 Sum_probs=142.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTAL---------DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTT---------TEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCC---------CceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 45799999999999999999987654 7889999998653 23447789999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+..|+||||++|++|.+++... .....+..++.||+.||+|||+ .||+||||||+||||+.++.+||++
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECS
T ss_pred EECCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEe
Confidence 9999999999999999999998542 3555788899999999999994 8999999999999999999999974
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+| |++| ++.++|||||||++|+|+
T Consensus 173 ~~----------------------~~~~-------~~~~~Di~slG~il~ell 196 (286)
T 3uqc_A 173 PA----------------------TMPD-------ANPQDDIRGIGASLYALL 196 (286)
T ss_dssp CC----------------------CCTT-------CCHHHHHHHHHHHHHHHH
T ss_pred cc----------------------ccCC-------CCchhHHHHHHHHHHHHH
Confidence 43 3333 678899999999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=287.66 Aligned_cols=167 Identities=17% Similarity=0.122 Sum_probs=124.8
Q ss_pred cCCCCcEEEEEecCCcc----------hhhHHHHHHHHHHhcCC-CCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHh
Q 022413 119 KTGLGMVVAIKKLNPES----------MQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLF 187 (297)
Q Consensus 119 ~~~~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 187 (297)
+..+|..+++|.+.... ....++|.+|+++|+++ .|+||++++++++++..+||||||++|++|.++|.
T Consensus 255 r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~ 334 (569)
T 4azs_A 255 RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA 334 (569)
T ss_dssp EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH
T ss_pred cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH
Confidence 33457789999886431 23346789999999999 59999999999999999999999999999999998
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcc
Q 022413 188 RRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267 (297)
Q Consensus 188 ~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 267 (297)
.. .++++. .|+.||+.||+||| ++|||||||||+||||+.+|.+||+|||+|+...... ......+||+
T Consensus 335 ~~----~~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp 403 (569)
T 4azs_A 335 AG----EEIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSF 403 (569)
T ss_dssp TT----CCCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHH
T ss_pred hC----CCCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceech
Confidence 76 446654 58899999999999 4999999999999999999999999999998764432 2334568999
Q ss_pred cccCcceecccCCcccccchhhhhhhhhcC
Q 022413 268 GYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 268 ~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||||++.+ .+...+|+||+|++++.|+
T Consensus 404 ~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~ 432 (569)
T 4azs_A 404 FVFVNELFAE-NKSWNGFWRSAPVHPFNLP 432 (569)
T ss_dssp HHHHHHHC------------------CCCC
T ss_pred hhccHHHhCC-CCCCcccccccccchhhhc
Confidence 9999999874 5677899999999988763
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=274.54 Aligned_cols=192 Identities=15% Similarity=0.158 Sum_probs=147.1
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHHHHHHHHHHhcCCCC-CCcc-----
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEVNFLGRLSH-PNLV----- 158 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h-~nIv----- 158 (297)
...|...++||+|+||+||+|.+..+ ++.||||++..... ...+.+.+|+.+++.+.| +|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~ 147 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQET---------GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred ceeEEEecccccCCCEEEEEEEecCC---------CCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence 34577889999999999999987754 78899999874322 235778999999999987 2211
Q ss_pred ----------------cEEeEEEc-----CCeeEEEEEecCCCCHHHHHhhc---CCCCCCCCHHHHHHHHHHHHHHhcc
Q 022413 159 ----------------KLLGYCWE-----DKELLLVYEYMQRGSLENHLFRR---NPSIQPLSWDIRLKIAIGAARGLGF 214 (297)
Q Consensus 159 ----------------~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~i~~al~y 214 (297)
.+..++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||+|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 226 (413)
T 3dzo_A 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226 (413)
T ss_dssp TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 11111111 12467777766 77999988521 2222457788999999999999999
Q ss_pred hhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCccee----------cccCCcccc
Q 022413 215 LHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYV----------ATGNFYLLS 284 (297)
Q Consensus 215 LH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~s 284 (297)
||+ .||+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++ .+..++.++
T Consensus 227 LH~--~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 227 LHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HHh--CCcccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 994 8999999999999999999999999999886422 2445678 999999999 556688899
Q ss_pred cchhhhhhhhhcC
Q 022413 285 AKFGNVINVCMYL 297 (297)
Q Consensus 285 DvwslGv~l~~ll 297 (297)
|||||||++|+|+
T Consensus 299 DvwSlGvil~ell 311 (413)
T 3dzo_A 299 DTWTLGLAIYWIW 311 (413)
T ss_dssp HHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHH
Confidence 9999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=252.36 Aligned_cols=169 Identities=22% Similarity=0.302 Sum_probs=144.0
Q ss_pred hhcCCCCC-ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHh-cCCCCCCcccEEeEE
Q 022413 87 ATKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL-GRLSHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~ 164 (297)
..++|.+. ++||+|+||.||+|.+..+ ++.||+|.+... ..+.+|+.++ +.++||||+++++++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~---------~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRT---------QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCC---------CcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhh
Confidence 34577777 7899999999999987654 788999998542 4567788887 556899999999998
Q ss_pred Ec----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---C
Q 022413 165 WE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---N 237 (297)
Q Consensus 165 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~ 237 (297)
.. ....++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ .||+||||||+|||++. +
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~ 156 (299)
T 3m2w_A 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPN 156 (299)
T ss_dssp EEEETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTT
T ss_pred hhhcCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCC
Confidence 87 6789999999999999999987532 458999999999999999999995 89999999999999998 7
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||++.... +..++.++|||||||++|+|+
T Consensus 157 ~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~ 192 (299)
T 3m2w_A 157 AILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILL 192 (299)
T ss_dssp CCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHH
T ss_pred CcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHH
Confidence 899999999986421 245778899999999999984
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=255.47 Aligned_cols=177 Identities=18% Similarity=0.215 Sum_probs=133.3
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------hhHHHHHHHHHHhcCCCCCCcccEEe
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------QGFEEWQSEVNFLGRLSHPNLVKLLG 162 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~ 162 (297)
+...++||+|+||+||+|... +..+++|....... ...+++.+|++++++++||||+++..
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 406 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYI 406 (540)
T ss_dssp ----------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCE
T ss_pred CCCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEE
Confidence 345678999999999999443 55688887543211 12356899999999999999996555
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
++...+..|+||||++|++|.+++.. ++.++.|++.||+|||+ .+|+||||||+|||++. .+||
T Consensus 407 ~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL 470 (540)
T 3en9_A 407 FDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYI 470 (540)
T ss_dssp EEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEE
T ss_pred EEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEE
Confidence 55677788999999999999999864 45789999999999994 89999999999999998 9999
Q ss_pred ccccccccCCCCCCcc-----eeeccCCcccccCcceecc--cCCcccccchhhhhhhh
Q 022413 243 SDFGLAKLGPAGGESH-----VTTRVMGTYGYAAPEYVAT--GNFYLLSAKFGNVINVC 294 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGv~l~ 294 (297)
+|||+++......... ......||+.|||||++.. ..|+...|+|+..+-.+
T Consensus 471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l 529 (540)
T 3en9_A 471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELM 529 (540)
T ss_dssp CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHH
T ss_pred EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHH
Confidence 9999998764321111 1235689999999999987 56778899999765443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=210.59 Aligned_cols=160 Identities=13% Similarity=0.037 Sum_probs=124.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch------------------hhHHHHHHHHHH
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------------------QGFEEWQSEVNF 148 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~ 148 (297)
....|.+.+.||+|+||.||+|.+ .+ ++.||+|.+..... .....+.+|+.+
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~---------g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~ 157 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-EK---------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-TT---------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred CCeEEEecCEeccCCCceEEEEEe-CC---------CCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence 344566779999999999999987 32 78899999864321 124568899999
Q ss_pred hcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCC
Q 022413 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFK 228 (297)
Q Consensus 149 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlk 228 (297)
|++++| +++.+++. .+..|+||||++|++|.+ +.. .....++.|++.||.||| +.||+|||||
T Consensus 158 l~~l~~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH--~~giiHrDlk 220 (282)
T 1zar_A 158 LQKLQG---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFY--HRGIVHGDLS 220 (282)
T ss_dssp HHHTTT---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHH--HTTEECSCCS
T ss_pred HHhccC---CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHH--HCCCEeCCCC
Confidence 999984 55555443 356799999999999988 421 123469999999999999 4999999999
Q ss_pred CCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecc----------cCCcccccchhh
Q 022413 229 ASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT----------GNFYLLSAKFGN 289 (297)
Q Consensus 229 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvwsl 289 (297)
|+|||++ ++.+||+|||+++. +..|+|||++.. .+|...+|+|.+
T Consensus 221 p~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 221 QYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp TTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred HHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9999999 99999999999862 455789998864 456667788764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=177.27 Aligned_cols=138 Identities=17% Similarity=0.089 Sum_probs=104.9
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcE--EEEEecCCcchh------------------------hHHHHHH
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMV--VAIKKLNPESMQ------------------------GFEEWQS 144 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~~ 144 (297)
|.+.+.||+|+||.||+|.+..+ |.. ||+|++...... ....+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~---------g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFD---------GKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEET---------TEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCC---------CcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 66789999999999999987322 777 999986543111 1136789
Q ss_pred HHHHhcCCCCCCc--ccEEeEEEcCCeeEEEEEecCC-C----CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhc
Q 022413 145 EVNFLGRLSHPNL--VKLLGYCWEDKELLLVYEYMQR-G----SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT 217 (297)
Q Consensus 145 E~~~l~~l~h~nI--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~ 217 (297)
|+.+|.++.|++| +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.||.|||.
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH
Confidence 9999999988754 444442 357899999942 3 66665432 2234567899999999999993
Q ss_pred CCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 218 SEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 218 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+.||+||||||+|||++. .++|+|||+|...
T Consensus 189 -~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 -EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp -TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred -HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 289999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=6.9e-20 Score=161.16 Aligned_cols=136 Identities=13% Similarity=0.032 Sum_probs=97.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--------------hhH--------HHHHHHHH
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--------------QGF--------EEWQSEVN 147 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------~~~--------~~~~~E~~ 147 (297)
-|.+...||+|++|.||+|.... |+.||+|+++.... ... ....+|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~----------G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK----------GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT----------CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCC----------CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 38999999999999999997643 78899998753210 000 11235777
Q ss_pred HhcCCCCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccC
Q 022413 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDF 227 (297)
Q Consensus 148 ~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dl 227 (297)
.|.++.+.++....-+.. ...+|||||++|++|.++... .....++.||+.+|.||| +.|||||||
T Consensus 166 nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH--~~gIVHrDL 231 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLA--KHGLIHGDF 231 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHH--HTTEECSCC
T ss_pred HHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHH--HCCCcCCCC
Confidence 777776544432221212 234799999999888654321 123567899999999999 489999999
Q ss_pred CCCcEEEcCCC----------ceEEccccccc
Q 022413 228 KASNILLDGNY----------NAKISDFGLAK 249 (297)
Q Consensus 228 kp~Nill~~~~----------~~kl~Dfg~a~ 249 (297)
||.|||+++++ .+.|+||+=+.
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 99999998776 38999998664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=3.7e-15 Score=125.45 Aligned_cols=146 Identities=15% Similarity=0.034 Sum_probs=111.9
Q ss_pred HHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeE
Q 022413 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGY 163 (297)
Q Consensus 85 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~ 163 (297)
......|++...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..+++++++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~ 78 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF 78 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 344567888888888999999997532 4579999987532222245788999999885 7788999999
Q ss_pred EEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC-------------------------
Q 022413 164 CWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------------------------- 218 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------------------------- 218 (297)
+.+.+..|+||||++|.+|.+.+.. ......++.+++.+|+.||+.
T Consensus 79 ~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T 3tm0_A 79 ERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp EEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred EecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence 9988999999999999998775311 112236778888889999951
Q ss_pred --------------------------------CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 --------------------------------EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 --------------------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 04589999999999998766667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.8e-13 Score=114.58 Aligned_cols=136 Identities=17% Similarity=0.068 Sum_probs=95.5
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCC--cccEEeEEEcC
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN--LVKLLGYCWED 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~ 167 (297)
+|.+..+.+.|..+.||++...+ |..+++|...... ...+..|+.+++.+.+.+ +++++++....
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~----------g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQG----------RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTT----------SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecCC----------CCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 34443333456679999975432 5568999876542 245678999998886444 56789888888
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCC----------------------------
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE---------------------------- 219 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~---------------------------- 219 (297)
+..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred CCCEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 8899999999998873 111 11 1245566667777777421
Q ss_pred ----------------------------CCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 220 ----------------------------KKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 220 ----------------------------~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
.+++|+|++|.|||+++++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 2399999999999998776677999999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.5e-12 Score=114.51 Aligned_cols=141 Identities=14% Similarity=0.217 Sum_probs=103.7
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecC--Ccc-hhhHHHHHHHHHHhcCCC--CCCcccEEeEEEcC
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN--PES-MQGFEEWQSEVNFLGRLS--HPNLVKLLGYCWED 167 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~ 167 (297)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.|. +..+++++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3567889999999997543 3457888776 332 122346778999999887 45688899888766
Q ss_pred ---CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC--------------------------
Q 022413 168 ---KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS-------------------------- 218 (297)
Q Consensus 168 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-------------------------- 218 (297)
+..|+||||++|..+.+... ..++......++.+++..|+.||+.
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK 184 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence 45899999999987744211 3367778888999999999999962
Q ss_pred ------------------------------CCCceeccCCCCcEEEcCCCc--eEEcccccccc
Q 022413 219 ------------------------------EKKVIYRDFKASNILLDGNYN--AKISDFGLAKL 250 (297)
Q Consensus 219 ------------------------------~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~ 250 (297)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.3e-11 Score=105.98 Aligned_cols=136 Identities=24% Similarity=0.206 Sum_probs=94.5
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCC--cccEEeEEEcCC--
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPN--LVKLLGYCWEDK-- 168 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~~~~~~~~~~-- 168 (297)
.+.++.|....||+. +..+++|..... .....+.+|..+|+.+. +.. +.+++.......
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 456889999999984 234888886543 23467889999998874 332 455555443332
Q ss_pred -eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC-----------------------------
Q 022413 169 -ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS----------------------------- 218 (297)
Q Consensus 169 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~----------------------------- 218 (297)
..|+||++++|.+|.+.... .++......++.+++..|+.||+.
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS 162 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEcccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence 35899999999888654322 255566666677777776666631
Q ss_pred ---------------------------CCCceeccCCCCcEEEcC--CCceEEccccccccC
Q 022413 219 ---------------------------EKKVIYRDFKASNILLDG--NYNAKISDFGLAKLG 251 (297)
Q Consensus 219 ---------------------------~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~ 251 (297)
...++|+|++|.||++++ ...+.|+||+.+...
T Consensus 163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 135799999999999998 556889999988653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=8.6e-09 Score=88.51 Aligned_cols=135 Identities=21% Similarity=0.154 Sum_probs=89.1
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCC---CcccEEeEEE-cCCe
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP---NLVKLLGYCW-EDKE 169 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~-~~~~ 169 (297)
.+.++.|....||+. +..+++|+... ......+.+|..+|+.|.+. .+.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 356788888899986 33478887432 22346788999999998742 3667777764 4456
Q ss_pred eEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhc--------------------------------
Q 022413 170 LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT-------------------------------- 217 (297)
Q Consensus 170 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-------------------------------- 217 (297)
.++||||++|..|...... .++......++.++...|+.||+
T Consensus 88 ~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~ 161 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVF 161 (306)
T ss_dssp EEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTG
T ss_pred eEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcc
Confidence 7899999999887653211 12233333333333333333332
Q ss_pred --------------------------CCCCceeccCCCCcEEEcC---CCc-eEEcccccccc
Q 022413 218 --------------------------SEKKVIYRDFKASNILLDG---NYN-AKISDFGLAKL 250 (297)
Q Consensus 218 --------------------------~~~~ivH~Dlkp~Nill~~---~~~-~kl~Dfg~a~~ 250 (297)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 162 ~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 162 PLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1346799999999999987 455 48999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=2.8e-08 Score=83.50 Aligned_cols=134 Identities=17% Similarity=0.118 Sum_probs=89.2
Q ss_pred ecccCce-EEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEEEE
Q 022413 97 LGEGGFG-RVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVY 174 (297)
Q Consensus 97 lg~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~ 174 (297)
+..|..+ .||+...... +..+++|.-.... ...+.+|..+|+.+. +--+.+++.++.+.+..|+||
T Consensus 32 ~~~G~S~~~v~rl~~~~~---------~~~~~lk~~~~~~---~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPN---------APELFLKHGKGSV---ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EECSSSSCEEEEEECCTT---------CCCEEEEEEETHH---HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCCcCCeEEEEEecCC---------CeEEEEEECCCCC---HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 4445444 6888654332 4568888755432 356778999988875 445788899999999999999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC------------------------------------
Q 022413 175 EYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------------------------------------ 218 (297)
Q Consensus 175 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------------------------------------ 218 (297)
|+++|.++.+...... .....+..++...|.-||+.
T Consensus 100 e~l~G~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp ECCCSEEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EeeCCccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 9999988766543210 11122333333334434320
Q ss_pred --------------------CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 --------------------EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 --------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=9.7e-08 Score=83.54 Aligned_cols=86 Identities=3% Similarity=-0.085 Sum_probs=53.5
Q ss_pred cee-cccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCC-C--CCcccEEeEEEcC
Q 022413 95 SLL-GEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLS-H--PNLVKLLGYCWED 167 (297)
Q Consensus 95 ~~l-g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~ 167 (297)
+.| +.|....+|+....... .....+..+++|...... ......+.+|..+++.|. + ..+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~---~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQ---DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEE---TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EECCCCCccceEEEEEEeccc---CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 567 78888999987543000 000003468888765432 101145677888888875 3 3577888877655
Q ss_pred ---CeeEEEEEecCCCCHH
Q 022413 168 ---KELLLVYEYMQRGSLE 183 (297)
Q Consensus 168 ---~~~~lv~e~~~~~~L~ 183 (297)
+..|+||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3578999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=3.8e-07 Score=81.00 Aligned_cols=76 Identities=16% Similarity=0.199 Sum_probs=49.3
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-------hhHHHHHHHHHHhcCCCC--C-CcccEEeE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-------QGFEEWQSEVNFLGRLSH--P-NLVKLLGY 163 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~~~~~ 163 (297)
.+.||.|..+.||++..... ++.+++|...+... ....++..|.++++.+.. | .+++++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~---------~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEH---------DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECCC---------CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 46789999999999865432 56789997653211 123456778888887642 3 44566643
Q ss_pred EEcCCeeEEEEEecCCC
Q 022413 164 CWEDKELLLVYEYMQRG 180 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~ 180 (297)
+.+..++||||+++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.46 E-value=1.4e-06 Score=75.40 Aligned_cols=32 Identities=19% Similarity=0.284 Sum_probs=29.0
Q ss_pred CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
..+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 47899999999999998888999999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.8e-05 Score=70.71 Aligned_cols=31 Identities=10% Similarity=0.251 Sum_probs=27.8
Q ss_pred CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 57899999999999998776 99999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.01 E-value=6.5e-05 Score=64.30 Aligned_cols=75 Identities=15% Similarity=0.100 Sum_probs=57.7
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC---CCCcccEEeEEEcCCee
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS---HPNLVKLLGYCWEDKEL 170 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~ 170 (297)
.+.|+.|....+|+.... +..+++|..... ....+..|...|+.|. ...+++++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~~-----------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-----------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEESS-----------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEEC-----------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 356888999999987532 456788876543 2356788988888874 36788999988888899
Q ss_pred EEEEEecCCCCH
Q 022413 171 LLVYEYMQRGSL 182 (297)
Q Consensus 171 ~lv~e~~~~~~L 182 (297)
++||||++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.99 E-value=4.4e-05 Score=64.50 Aligned_cols=77 Identities=16% Similarity=0.156 Sum_probs=54.2
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCC---CCcccEEeEEEcC
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH---PNLVKLLGYCWED 167 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~ 167 (297)
..-.+.+|.|..+.||+....+ |+.+++|+...........+..|...|+.|.- --+++++++.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~D----------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--- 83 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELAD----------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--- 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT----------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---
T ss_pred eEEEEecCCCCCeEEEEEEECC----------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---
Confidence 3345678999999999987654 77899998765544333567789998887742 2355666542
Q ss_pred CeeEEEEEecCCCC
Q 022413 168 KELLLVYEYMQRGS 181 (297)
Q Consensus 168 ~~~~lv~e~~~~~~ 181 (297)
.-++||||++++.
T Consensus 84 -~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 -DRTLAMEWVDERP 96 (288)
T ss_dssp -TTEEEEECCCCCC
T ss_pred -CceEEEEeecccC
Confidence 3478999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.90 E-value=5.3e-05 Score=64.44 Aligned_cols=137 Identities=11% Similarity=0.046 Sum_probs=74.4
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCc-ccEEeEEEcCCeeEE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLL 172 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~l 172 (297)
.+.|+.|....+|+. . .+++|+........ ....+|..+++.+....+ .+++.. +.+.-++
T Consensus 23 i~~l~gG~tN~~~~~---~------------~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---G------------DLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---T------------TEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee---e------------eEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 678888999999987 1 27888776532211 122457777777652222 456543 3444688
Q ss_pred EEEec-CCCCHHH---------------HH---hhcCCC-CCCCCH-HH---------------------HHHHHHHHHH
Q 022413 173 VYEYM-QRGSLEN---------------HL---FRRNPS-IQPLSW-DI---------------------RLKIAIGAAR 210 (297)
Q Consensus 173 v~e~~-~~~~L~~---------------~l---~~~~~~-~~~~~~-~~---------------------~~~i~~~i~~ 210 (297)
++||+ +|.++.. .+ +..... ...... .. ....+..+..
T Consensus 85 v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 85 VTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp EEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred EEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 99999 6654421 01 111110 000111 11 1111111111
Q ss_pred HhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 211 al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
.+.-.. ....++|+|+.+.||| ..++.+.|+||..+..
T Consensus 165 ~l~~~~-~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHP-LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSC-CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcC-CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 111111 1356899999999999 5667889999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00026 Score=60.57 Aligned_cols=143 Identities=12% Similarity=0.080 Sum_probs=74.2
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCC--cccEEeE------EEc
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN--LVKLLGY------CWE 166 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~~ 166 (297)
+.|+.|....+|+....+ + .+++|....... ...+..|+.+++.|.... +.+++.. ...
T Consensus 28 ~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTK----------D-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp EEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred eccCCCcccceEEEEeCC----------c-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 346667778899875442 2 478888765311 134455777776654111 2333321 123
Q ss_pred CCeeEEEEEecCCCCHHH-----------H---HhhcC-C--CCC--CCC---HHHHHH------------HHHHHHHHh
Q 022413 167 DKELLLVYEYMQRGSLEN-----------H---LFRRN-P--SIQ--PLS---WDIRLK------------IAIGAARGL 212 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~-----------~---l~~~~-~--~~~--~~~---~~~~~~------------i~~~i~~al 212 (297)
.+..+++|+|++|..+.. . ++... . ... ... |..... +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 456799999998865311 1 11110 0 000 011 111000 000122333
Q ss_pred cchhc-----CCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 213 GFLHT-----SEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 213 ~yLH~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
+++.. ...+++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 33331 135799999999999999876668999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00031 Score=60.46 Aligned_cols=33 Identities=36% Similarity=0.473 Sum_probs=28.4
Q ss_pred CCCceeccCCCCcEEEcCC----CceEEccccccccC
Q 022413 219 EKKVIYRDFKASNILLDGN----YNAKISDFGLAKLG 251 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~~ 251 (297)
...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4689999999999999874 68999999988653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00033 Score=60.10 Aligned_cols=142 Identities=15% Similarity=0.098 Sum_probs=76.8
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCC--CcccEEeE-----EEcC
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHP--NLVKLLGY-----CWED 167 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~-----~~~~ 167 (297)
..++ |....||+....+ |..+++|...+... ....+..|..+++.|... .+++++.. ....
T Consensus 32 ~~l~-g~~n~~y~v~~~~----------g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDED----------RRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCTT----------CCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEcCC----------CCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 4566 7778899864322 44689998864321 224556677777766421 23444432 1224
Q ss_pred CeeEEEEEecCCCCHH-----------HH---Hhhc---CCC--CCCCCHHHH----------------------HHHHH
Q 022413 168 KELLLVYEYMQRGSLE-----------NH---LFRR---NPS--IQPLSWDIR----------------------LKIAI 206 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~-----------~~---l~~~---~~~--~~~~~~~~~----------------------~~i~~ 206 (297)
+..+++|+|++|..+. .. ++.. ... ...++.... ...+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 5678899999875431 11 1110 000 011221111 11111
Q ss_pred HHHHHhcchh--cCCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 207 GAARGLGFLH--TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 207 ~i~~al~yLH--~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
+++..+.-+- .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1222221111 0146789999999999999 4 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00041 Score=60.98 Aligned_cols=149 Identities=16% Similarity=0.137 Sum_probs=81.6
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 173 (297)
+.|..|-...+|+....+... .....+..+++|+.... ........+|..+++.|. +.-..++++.+.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 456567778899986542100 00112467888886432 223355568999988875 3334667665543 399
Q ss_pred EEecCCCCHHH--------------HH---hhcC-CCCCCCC--HHHHHHHHHHHHH-------------------Hhcc
Q 022413 174 YEYMQRGSLEN--------------HL---FRRN-PSIQPLS--WDIRLKIAIGAAR-------------------GLGF 214 (297)
Q Consensus 174 ~e~~~~~~L~~--------------~l---~~~~-~~~~~~~--~~~~~~i~~~i~~-------------------al~y 214 (297)
|||++|..|.. .| +... +...... +..+..+..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99999865421 11 1111 1111122 3344444433322 1222
Q ss_pred hh----c--CCCCceeccCCCCcEEEcCC----CceEEcccccccc
Q 022413 215 LH----T--SEKKVIYRDFKASNILLDGN----YNAKISDFGLAKL 250 (297)
Q Consensus 215 LH----~--~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~ 250 (297)
|. . ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 1 13579999999999999876 7899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0012 Score=59.43 Aligned_cols=74 Identities=16% Similarity=0.097 Sum_probs=45.0
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCc-ccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-VKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv 173 (297)
+.|+.|-...+|+....+. +..+++|+.......... ..+|..+++.|...++ +++++.+. + .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~---------~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSK---------QAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETTT---------TEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEE
T ss_pred EEcCCCeEeEEEEEEECCC---------CceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEE
Confidence 4577777889999865431 356888886543221111 2578888888864444 56776652 2 359
Q ss_pred EEecCCCCH
Q 022413 174 YEYMQRGSL 182 (297)
Q Consensus 174 ~e~~~~~~L 182 (297)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00051 Score=60.05 Aligned_cols=81 Identities=11% Similarity=0.063 Sum_probs=43.2
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCC-cccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv 173 (297)
+.|+.|....+|+....+... ......+..+++|+....... ......|..+++.+...+ ++++++.. . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 456777778899876542100 000001256888886543221 112356888888775223 45676544 2 3789
Q ss_pred EEecCCCC
Q 022413 174 YEYMQRGS 181 (297)
Q Consensus 174 ~e~~~~~~ 181 (297)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0011 Score=59.23 Aligned_cols=80 Identities=14% Similarity=-0.026 Sum_probs=48.2
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLL 172 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~l 172 (297)
.+.|+.|-...+|++...+.... ....+..+++|+...... ...+..|..+++.|. +.-.+++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~--~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCccc--cCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 35677788899999876431100 011245788888744211 134457888888875 333466776543 2 38
Q ss_pred EEEecCCCC
Q 022413 173 VYEYMQRGS 181 (297)
Q Consensus 173 v~e~~~~~~ 181 (297)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998744
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00093 Score=57.78 Aligned_cols=32 Identities=22% Similarity=0.261 Sum_probs=28.4
Q ss_pred CCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 36799999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0069 Score=53.94 Aligned_cols=81 Identities=7% Similarity=-0.005 Sum_probs=46.6
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 173 (297)
+.+..|-...+|+......... ....+..+++|+........ -...+|..+++.+. +.-..++++.+ . -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 4566677788999876531100 00114568888865432211 12256888888775 33355666533 2 3789
Q ss_pred EEecCCCCH
Q 022413 174 YEYMQRGSL 182 (297)
Q Consensus 174 ~e~~~~~~L 182 (297)
|||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0064 Score=48.68 Aligned_cols=97 Identities=14% Similarity=-0.022 Sum_probs=62.0
Q ss_pred CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCCCCCCcce
Q 022413 180 GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259 (297)
Q Consensus 180 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 259 (297)
-+|.++|.... .++++.+++.++.|.+.+|.-+-. +..-..+=+-|..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 37999998776 789999999999999998776611 11111233457899999999988763 1110
Q ss_pred eeccCCcccccCcceecccCCcccccchhhhhhhhhc
Q 022413 260 TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMY 296 (297)
Q Consensus 260 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~l 296 (297)
.....+.+||... ...+.+.=|||||+++|.-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~A 129 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKA 129 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHH
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHH
Confidence 1233567888763 3344566899999999963
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=94.10 E-value=0.43 Score=38.08 Aligned_cols=84 Identities=10% Similarity=0.028 Sum_probs=62.1
Q ss_pred CCCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhc-chhcCCCCceeccCCCCc
Q 022413 153 SHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLG-FLHTSEKKVIYRDFKASN 231 (297)
Q Consensus 153 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~-yLH~~~~~ivH~Dlkp~N 231 (297)
.||++ --.+-.+++.+.+.++.-+++.=...+. .++....++++..|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCce
Confidence 58888 3344467777777777654443333342 2678899999999988877 6663 5778899999
Q ss_pred EEEcCCCceEEccccccc
Q 022413 232 ILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 232 ill~~~~~~kl~Dfg~a~ 249 (297)
|+++.++.+++.-.|+-.
T Consensus 115 L~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EEECTTCCEEESCCEETT
T ss_pred EEEeCCCcEEEEEcCCcc
Confidence 999999999999888744
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.93 E-value=0.28 Score=39.03 Aligned_cols=85 Identities=8% Similarity=0.107 Sum_probs=62.8
Q ss_pred CCCCcccEEeEEEcCCeeEEEEEecCCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCc
Q 022413 153 SHPNLVKLLGYCWEDKELLLVYEYMQRG-SLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN 231 (297)
Q Consensus 153 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~N 231 (297)
.||+++.. .+-.+++.+.+.++.-+.+ ++.. + ...+....+.++..|+....++++ =+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecce
Confidence 58988877 5666677776666654322 2322 3 337788899999999888876663 4678899999
Q ss_pred EEEcCCCceEEcccccccc
Q 022413 232 ILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 232 ill~~~~~~kl~Dfg~a~~ 250 (297)
|+++.++.+++.--|+-..
T Consensus 110 L~f~~~~~p~i~~RGik~~ 128 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV 128 (215)
T ss_dssp EEECTTSCEEESCCEETTT
T ss_pred EEEcCCCCEEEEEccCccC
Confidence 9999999999998887543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.03 E-value=0.026 Score=50.84 Aligned_cols=62 Identities=10% Similarity=0.067 Sum_probs=17.0
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEE------EecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI------KKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vai------K~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
+.+.|| ||.||+|.+... ...||+ |...... .+....+.+|..+++.++|||+++.+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 446666 999999987642 234666 5544322 22335678899999999999999998876
Q ss_pred Ec
Q 022413 165 WE 166 (297)
Q Consensus 165 ~~ 166 (297)
..
T Consensus 214 ~~ 215 (463)
T 3cxl_A 214 VH 215 (463)
T ss_dssp EE
T ss_pred Ee
Confidence 53
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.21 E-value=0.13 Score=45.19 Aligned_cols=30 Identities=23% Similarity=0.303 Sum_probs=25.6
Q ss_pred CceeccCCCCcEEE------cCCCceEEcccccccc
Q 022413 221 KVIYRDFKASNILL------DGNYNAKISDFGLAKL 250 (297)
Q Consensus 221 ~ivH~Dlkp~Nill------~~~~~~kl~Dfg~a~~ 250 (297)
.++|+|+.+.|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 297 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-56
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVN 147
+G G FG VYKG VA+K LN + Q + +++EV
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD------------VAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L + H N++ +GY + L +V ++ + SL +HL + IA
Sbjct: 57 VLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQ 112
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
A+G+ +LH K +I+RD K++NI L + KI DFGLA + SH ++ G+
Sbjct: 113 TAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 268 GYAAPEYVATGNFYLLSAK 286
+ APE + + S +
Sbjct: 171 LWMAPEVIRMQDKNPYSFQ 189
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-54
Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-E 140
++LK +F+ S LG G G V+K G+V+A K ++ E
Sbjct: 1 MELK--DDDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRN 49
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
+ E+ L + P +V G + D E+ + E+M GSL+ L + + I
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQI 105
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
K++I +GL +L + K+++RD K SNIL++ K+ DFG++ +
Sbjct: 106 LGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMA 160
Query: 261 TRVMGTYGYAAPEYVATGNF 280
+GT Y +PE + ++
Sbjct: 161 NSFVGTRSYMSPERLQGTHY 180
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (438), Expect = 6e-53
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 79 FSFLDLKSATKNF---------KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIK 129
F+F D A + F K + ++G G FG V G + + VAIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 130 KLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
L + + ++ SE + +G+ HPN++ L G + ++++ E+M+ GSL++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
+ + + + G A G+ +L ++RD A NIL++ N K+SDFGL+
Sbjct: 121 NDG---QFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 249 KLGPAGGESHVTTRV---MGTYGYAAPEYVATGNFY 281
+ T + APE + F
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-53
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 85 KSATKNFKPD------SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG 138
+ T++ P+ LG+G FG+VYK ++ A K ++ +S +
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQ---------NKETSVLAAAKVIDTKSEEE 52
Query: 139 FEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
E++ E++ L HPN+VKLL + + L ++ E+ G+++ + +PL+
Sbjct: 53 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTE 109
Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH 258
+ L +LH + K+I+RD KA NIL + + K++DFG++ +
Sbjct: 110 SQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 166
Query: 259 VTTRVMGTYGYAAPEYVATGN 279
+GT + APE V
Sbjct: 167 -RDSFIGTPYWMAPEVVMCET 186
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 8e-53
Identities = 64/243 (26%), Positives = 102/243 (41%), Gaps = 30/243 (12%)
Query: 61 VEEASPNGQILETPDLKVFSFLDLKS--ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPS 118
V+ + D + + + DLK +N + +LG G FG+V S
Sbjct: 8 VQVTGSSDNEYFYVDFREYEY-DLKWEFPRENLEFGKVLGSGAFGKVMNA----TAYGIS 62
Query: 119 KTGLGMVVAIKKLNPESMQGF-EEWQSEVNFLGRL-SHPNLVKLLGYCWEDKELLLVYEY 176
KTG+ + VA+K L ++ E SE+ + +L SH N+V LLG C + L++EY
Sbjct: 63 KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 122
Query: 177 MQRGSLENHLFRRNP-------------------SIQPLSWDIRLKIAIGAARGLGFLHT 217
G L N+L + + L+++ L A A+G+ FL
Sbjct: 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE- 181
Query: 218 SEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT 277
K ++RD A N+L+ KI DFGLA+ + V + APE +
Sbjct: 182 -FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240
Query: 278 GNF 280
G +
Sbjct: 241 GIY 243
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-52
Identities = 49/192 (25%), Positives = 78/192 (40%), Gaps = 17/192 (8%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
K+ LG G FG V G VAIK + SM +E+ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSMSE-DEFIEEAKV 52
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ LSH LV+L G C + + + ++ EYM G L N+L L++
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDV 109
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
+ +L + K+ ++RD A N L++ K+SDFGL++ E +
Sbjct: 110 CEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVR 166
Query: 269 YAAPEYVATGNF 280
++ PE + F
Sbjct: 167 WSPPEVLMYSKF 178
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-52
Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 16/194 (8%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVN 147
+++ LGEG +G V VA+K ++ + E + E+
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEIC 55
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L+H N+VK G+ E L EY G L + + + +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQ 111
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
G+ +LH + +RD K N+LLD N KISDFGLA + + ++ GT
Sbjct: 112 LMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 268 GYAAPEYVATGNFY 281
Y APE + F+
Sbjct: 170 PYVAPELLKRREFH 183
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 6e-52
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 32/229 (13%)
Query: 73 TPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
P L + N + +GEG FGRV++ L P + +VA+K L
Sbjct: 2 NPKLLSLEY-----PRNNIEYVRDIGEGAFGRVFQAR--APGLLPYEPF--TMVAVKMLK 52
Query: 133 PESMQGFE-EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNP 191
E+ + ++Q E + +PN+VKLLG C K + L++EYM G L L +P
Sbjct: 53 EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSP 112
Query: 192 SI--------------------QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN 231
PLS +L IA A G+ +L E+K ++RD N
Sbjct: 113 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRN 170
Query: 232 ILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF 280
L+ N KI+DFGL++ + + PE + +
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 6e-52
Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 17/192 (8%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
+ K LG G FG V+ G+ + VA+K L SM + + +E N
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSMSP-DAFLAEANL 61
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ +L H LV+L + + ++ EYM+ GSL + L + L+ + L +A
Sbjct: 62 MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQI 118
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
A G+ F+ E+ I+RD +A+NIL+ + KI+DFGLA+L E
Sbjct: 119 AEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIK 175
Query: 269 YAAPEYVATGNF 280
+ APE + G F
Sbjct: 176 WTAPEAINYGTF 187
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 2e-51
Identities = 63/217 (29%), Positives = 90/217 (41%), Gaps = 28/217 (12%)
Query: 74 PDL-KVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLN 132
PD+ ++F D + K F +G G FG VY VVAIKK++
Sbjct: 2 PDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMS 49
Query: 133 PESMQGFEEWQ---SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR 189
Q E+WQ EV FL +L HPN ++ G + LV EY + + +
Sbjct: 50 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK 109
Query: 190 NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+PL + GA +GL +LH +I+RD KA NILL K+ DFG A
Sbjct: 110 ----KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163
Query: 250 LGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAK 286
+ +GT + APE + + K
Sbjct: 164 I------MAPANSFVGTPYWMAPEVILAMDEGQYDGK 194
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-51
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 86 SATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQ 143
S ++++ +G G +GR K + G ++ K+L+ SM +
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIR---------RKSDGKILVWKELDYGSMTEAEKQMLV 51
Query: 144 SEVNFLGRLSHPNLVKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
SEVN L L HPN+V+ + + L +V EY + G L + + + Q L +
Sbjct: 52 SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 111
Query: 202 LKIAIGAARGLGFLH---TSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESH 258
L++ L H V++RD K +N+ LDG N K+ DFGLA++ ++
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTS 169
Query: 259 VTTRVMGTYGYAAPEYVATGNF 280
+GT Y +PE + ++
Sbjct: 170 FAKAFVGTPYYMSPEQMNRMSY 191
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 9e-51
Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 16/202 (7%)
Query: 83 DLKSATKNFKPDSL-LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-E 140
L N + LG G FG V +G + VAIK L + + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTE 54
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
E E + +L +P +V+L+G C + + L+LV E G L L + + +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSN 110
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGESHV 259
++ + G+ +L K ++RD A N+LL + AKISDFGL+K LG
Sbjct: 111 VAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168
Query: 260 TTRVMGTYGYAAPEYVATGNFY 281
+ + APE + F
Sbjct: 169 RSAGKWPLKWYAPECINFRKFS 190
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 2e-50
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 15/192 (7%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
+ LG G +G VY+G V K + VA+K L ++M+ EE+ E
Sbjct: 17 TDITMKHKLGGGQYGEVYEG-VWKKY--------SLTVAVKTLKEDTMEV-EEFLKEAAV 66
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ + HPNLV+LLG C + ++ E+M G+L ++L N Q +S + L +A
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQI 124
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
+ + +L +K I+RD A N L+ N+ K++DFGL++L G
Sbjct: 125 SSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 181
Query: 269 YAAPEYVATGNF 280
+ APE +A F
Sbjct: 182 WTAPESLAYNKF 193
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 6e-50
Identities = 57/193 (29%), Positives = 87/193 (45%), Gaps = 23/193 (11%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
K K +G+G FG V G G VA+K + ++ + + +E +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAEASV 53
Query: 149 LGRLSHPNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
+ +L H NLV+LLG E+K L +V EYM +GSL ++L R S L D LK ++
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLD 111
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
+ +L ++RD A N+L+ + AK+SDFGL K S
Sbjct: 112 VCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPV 164
Query: 268 GYAAPEYVATGNF 280
+ APE + F
Sbjct: 165 KWTAPEALREKKF 177
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 9e-50
Identities = 60/205 (29%), Positives = 78/205 (38%), Gaps = 22/205 (10%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNF 148
LG G FG+V + K+ M VA+K L P + E SE+
Sbjct: 24 RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 149 LGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI-------------- 193
L L H N+V LLG C L++ EY G L N L R+ S
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 194 QPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPA 253
L + L + A+G+ FL K I+RD A NILL KI DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 254 GGESHVTTRVMGTYGYAAPEYVATG 278
V + APE +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNC 222
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-49
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSE 145
K+ + LG+G FG V +G D + +G + VA+K L P+ + + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWD------APSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
VN + L H NL++L G + +V E GSL + L + + A
Sbjct: 62 VNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYA 117
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV-TTRVM 264
+ A G+G+L K+ I+RD A N+LL KI DFGL + P + +V
Sbjct: 118 VQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 265 GTYGYAAPEYVATGNF 280
+ + APE + T F
Sbjct: 176 VPFAWCAPESLKTRTF 191
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-49
Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 17/191 (8%)
Query: 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVNFLGR 151
D LG G FG V KG+ K + VA+K L E+ +E +E N + +
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 152 LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARG 211
L +P +V+++G C + +LV E + G L +L + + + +++ + G
Sbjct: 65 LDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMG 119
Query: 212 LGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT-TRVMGTYGYA 270
+ +L ++RD A N+LL + AKISDFGL+K A + T +
Sbjct: 120 MKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 271 APEYVATGNFY 281
APE + F
Sbjct: 178 APECINYYKFS 188
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-49
Identities = 55/194 (28%), Positives = 81/194 (41%), Gaps = 24/194 (12%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
+ K D +G G F VYKG T + VA +L + + ++ E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 147 NFLGRLSHPNLVKLLGYCWE----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
L L HPN+V+ K ++LV E M G+L+ +L R + + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLR 115
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDFGLAKLGPAGGESHVTT 261
+GL FLHT +I+RD K NI + G + KI D GLA L +
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 171
Query: 262 RVMGTYGYAAPEYV 275
V+GT + APE
Sbjct: 172 AVIGTPEFMAPEMY 185
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-48
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 12/194 (6%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNF 148
++G G FG VYKG + S + VAIK L + ++ E
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+G+ SH N+++L G + K ++++ EYM+ G+L+ L ++ S + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGI 119
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE-SHVTTRVMGTY 267
A G+ +L ++RD A NIL++ N K+SDFGL+++ E ++ T+
Sbjct: 120 AAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 268 GYAAPEYVATGNFY 281
+ APE ++ F
Sbjct: 178 RWTAPEAISYRKFT 191
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-48
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
+G G FG V+ G+ + VAIK + +M E++ E
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAMSE-EDFIEEAEV 53
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ +LSHP LV+L G C E + LV+E+M+ G L ++L + + + L + +
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDV 110
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
G+ +L E VI+RD A N L+ N K+SDFG+ + + +T
Sbjct: 111 CEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVK 167
Query: 269 YAAPEYVATGNF 280
+A+PE + +
Sbjct: 168 WASPEVFSFSRY 179
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-48
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 29/197 (14%)
Query: 97 LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN 156
+G+G FG V++G G VA+K + + + ++E+ L H N
Sbjct: 11 IGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHEN 58
Query: 157 LVKLLGYCWED----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGL 212
++ + +D +L LV +Y + GSL ++L R ++ + +K+A+ A GL
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGL 113
Query: 213 GFLHT------SEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE--SHVTTRVM 264
LH + + +RD K+ NIL+ N I+D GLA + + +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 265 GTYGYAAPEYVATGNFY 281
GT Y APE +
Sbjct: 174 GTKRYMAPEVLDDSINM 190
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-48
Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 12/191 (6%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFL 149
FK +LG G FG VYKG P + + VAIK+L S + +E E +
Sbjct: 11 FKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
+ +P++ +LLG C + L+ + M G L +++ + L + A
Sbjct: 66 ASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIA 121
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGY 269
+G+ +L +++++RD A N+L+ + KI+DFGLAKL A + + +
Sbjct: 122 KGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 270 AAPEYVATGNF 280
A E + +
Sbjct: 180 MALESILHRIY 190
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-47
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 78 VFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SM 136
++ LD + K ++GEG FG+V K + K GL M AIK++ S
Sbjct: 3 IYPVLDWN----DIKFQDVIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASK 51
Query: 137 QGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR------ 189
++ E+ L +L HPN++ LLG C L L EY G+L + L +
Sbjct: 52 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 190 ------NPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKIS 243
N + LS L A ARG+ +L +K+ I+RD A NIL+ NY AKI+
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIA 169
Query: 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG 278
DFGL++ T + A E +
Sbjct: 170 DFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYS 201
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-47
Identities = 50/195 (25%), Positives = 79/195 (40%), Gaps = 22/195 (11%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSE 145
++F+ LG+G FG VY + ++A+K L + + + E
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAR---------EKQSKFILALKVLFKAQLEKAGVEHQLRRE 56
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
V L HPN+++L GY + + L+ EY G++ L + +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYI 112
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
A L + H K+VI+RD K N+LL KI+DFG + P S T + G
Sbjct: 113 TELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCG 166
Query: 266 TYGYAAPEYVATGNF 280
T Y PE +
Sbjct: 167 TLDYLPPEMIEGRMH 181
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 4e-47
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 82 LDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-E 140
+ S +F + ++G G FG VY G + D G + A+K LN + G
Sbjct: 22 IGPSSLIVHF--NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVS 73
Query: 141 EWQSEVNFLGRLSHPNLVKLLGYCWE-DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
++ +E + SHPN++ LLG C + L+V YM+ G L N + +
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVK 130
Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKL--GPAGGES 257
+ + A+G+ FL + KK ++RD A N +LD + K++DFGLA+
Sbjct: 131 DLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188
Query: 258 HVTTRVMGTYGYAAPEYVATGNFY 281
H T + A E + T F
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFT 212
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-46
Identities = 49/199 (24%), Positives = 77/199 (38%), Gaps = 18/199 (9%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEE 141
K ++FK +LGEG F V + AIK L +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPY 54
Query: 142 WQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIR 201
E + + RL HP VKL +D++L Y + G L ++ +
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCT 110
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
L +LH K +I+RD K NILL+ + + +I+DFG AK+ +
Sbjct: 111 RFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 262 RVMGTYGYAAPEYVATGNF 280
+GT Y +PE + +
Sbjct: 169 SFVGTAQYVSPELLTEKSA 187
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-46
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 69 QILETPDLKVFSFLDLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAI 128
+ILE K+ S + + K + +G+G G VY G VAI
Sbjct: 4 EILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAI 50
Query: 129 KKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFR 188
+++N + E +E+ + +PN+V L EL +V EY+ GSL + +
Sbjct: 51 RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 189 RNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248
+ + + L FLH +VI+RD K+ NILL + + K++DFG
Sbjct: 111 T-----CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNF 280
E + ++GT + APE V +
Sbjct: 164 AQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-46
Identities = 54/192 (28%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
++ + + LG+G FG V+ G + VAIK L P +M E + E
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTMSP-EAFLQEAQV 65
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ +L H LV+L E+ + +V EYM +GSL + L + L + +A
Sbjct: 66 MKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQI 122
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
A G+ ++ ++RD +A+NIL+ N K++DFGLA+L E
Sbjct: 123 ASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIK 179
Query: 269 YAAPEYVATGNF 280
+ APE G F
Sbjct: 180 WTAPEAALYGRF 191
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-46
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVN 147
+ LG+G FG VY+G K + + VAIK +N SM+ E+ +E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGV--AKGVVKDEPE--TRVAIKTVNEAASMRERIEFLNEAS 75
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRR------NPSIQPLSWDIR 201
+ + ++V+LLG + + L++ E M RG L+++L NP + P S
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 202 LKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTT 261
+++A A G+ +L+ K ++RD A N ++ ++ KI DFG+ +
Sbjct: 136 IQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 262 RVMGTYGYAAPEYVATGNF 280
+ + + +PE + G F
Sbjct: 194 KGLLPVRWMSPESLKDGVF 212
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-46
Identities = 46/193 (23%), Positives = 80/193 (41%), Gaps = 14/193 (7%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEVNF 148
+ +GEG FG V++G S + VAIK + E++ E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIY------MSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
+ + HP++VKL+G E+ + ++ E G L + L R L + A
Sbjct: 62 MRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQL 117
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYG 268
+ L +L K+ ++RD A N+L+ N K+ DFGL++ + ++
Sbjct: 118 STALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIK 174
Query: 269 YAAPEYVATGNFY 281
+ APE + F
Sbjct: 175 WMAPESINFRRFT 187
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (386), Expect = 1e-44
Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 19/193 (9%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
++ LG G FG V++ + G A K + E + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
L HP LV L +D E++++YE+M G L + + +S D ++
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVC 134
Query: 210 RGLGFLHTSEKKVIYRDFKASNILL--DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
+GL +H E ++ D K NI+ + K+ DFGL GT
Sbjct: 135 KGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTA 189
Query: 268 GYAAPEYVATGNF 280
+AAPE
Sbjct: 190 EFAAPEVAEGKPV 202
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (383), Expect = 3e-44
Identities = 44/193 (22%), Positives = 76/193 (39%), Gaps = 19/193 (9%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
+ LG G FG V++ + G V K +N ++E++ +
Sbjct: 30 YYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
+L HP L+ L + E++L+ E++ G L + + + +S + A
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQAC 137
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLDGNYNA--KISDFGLAKLGPAGGESHVTTRVMGTY 267
GL +H E +++ D K NI+ + + KI DFGLA + T
Sbjct: 138 EGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATA 192
Query: 268 GYAAPEYVATGNF 280
+AAPE V
Sbjct: 193 EFAAPEIVDREPV 205
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-43
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-GFEEWQSEVNF 148
LGEG FG+V L K VA+K L ++ + + SE+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 149 LGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSI------------QP 195
+ + H N++ LLG C +D L ++ EY +G+L +L R P +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 196 LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGG 255
LS + A ARG+ +L KK I+RD A N+L+ + KI+DFGLA+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 256 ESHVTTRVMGTYGYAAPEYVATGNF 280
TT + APE + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIY 214
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-43
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 21/206 (10%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG-FEEWQSEVNF 148
K LG G FG+V + KT VA+K L + SE+
Sbjct: 14 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 149 LGRLSH-PNLVKLLGYCWEDKE-LLLVYEYMQRGSLENHLFRRNPSIQP----------- 195
L + H N+V LLG C + L+++ E+ + G+L +L + P
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 196 -LSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAG 254
L+ + + + A+G+ FL +K I+RD A NILL KI DFGLA+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 255 GESHVTTRVMGTYGYAAPEYVATGNF 280
+ + APE + +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVY 213
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-42
Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 14/196 (7%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF-EEWQSEV 146
+ S +GEG +G V + + VAIKK++P Q + + E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L R H N++ + + Y+ + L++ + Q LS D
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLY 116
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGESHVTTRVMG 265
RGL ++H V++RD K SN+LL+ + KI DFGLA+ P + T +
Sbjct: 117 QILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 266 TYGYAAPEYVATGNFY 281
T Y APE + Y
Sbjct: 175 TRWYRAPEIMLNSKGY 190
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (356), Expect = 5e-41
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 28/199 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF---------E 140
N++P +LG G V + A+K ++ F E
Sbjct: 4 NYEPKEILGRGVSSVVRRCI---------HKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 141 EWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
EV+ L ++S HPN+++L + LV++ M++G L ++L + LS
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEK 110
Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259
KI + LH + +++RD K NILLD + N K++DFG +
Sbjct: 111 ETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEK 165
Query: 260 TTRVMGTYGYAAPEYVATG 278
V GT Y APE +
Sbjct: 166 LREVCGTPSYLAPEIIECS 184
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (360), Expect = 1e-40
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 25/198 (12%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG------FEEWQ 143
+F ++G GGFG VY K G + A+K L+ + ++ +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 144 SEVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
++ + P +V + +L + + M G L HL + + +
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRV 263
I GL +H + V+YRD K +NILLD + + +ISD GLA
Sbjct: 116 I----ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHAS 165
Query: 264 MGTYGYAAPEYVATGNFY 281
+GT+GY APE + G Y
Sbjct: 166 VGTHGYMAPEVLQKGVAY 183
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (346), Expect = 2e-39
Identities = 43/201 (21%), Positives = 83/201 (41%), Gaps = 23/201 (11%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG---FEEWQS 144
+ ++ +LG GG V+ L VA+K L + + + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRR 56
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKE----LLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
E L+HP +V + + +V EY+ +L + + P++
Sbjct: 57 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKR 112
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK-LGPAGGESHV 259
+++ A + L F H + +I+RD K +NI++ K+ DFG+A+ + +G
Sbjct: 113 AIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 260 TTRVMGTYGYAAPEYVATGNF 280
T V+GT Y +PE +
Sbjct: 171 TAAVIGTAQYLSPEQARGDSV 191
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 3e-39
Identities = 53/195 (27%), Positives = 72/195 (36%), Gaps = 21/195 (10%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSEV 146
+F +LG+G FG+V+ AIK L + + E E
Sbjct: 3 DFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 147 NFLGR-LSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L HP L + + L V EY+ G L H+ A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYA 109
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
GL FLH K ++YRD K NILLD + + KI+DFG+ K G G
Sbjct: 110 AEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCG 165
Query: 266 TYGYAAPEYVATGNF 280
T Y APE + +
Sbjct: 166 TPDYIAPEILLGQKY 180
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 4e-39
Identities = 46/197 (23%), Positives = 82/197 (41%), Gaps = 22/197 (11%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-WQSEV 146
+ +LG G F V +VAIK + ++++G E ++E+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAE---------DKRTQKLVAIKCIAKKALEGKEGSMENEI 58
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L ++ HPN+V L L L+ + + G L + + + + ++
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIF 114
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILL---DGNYNAKISDFGLAKLGPAGGESHVTTRV 263
+ +LH + +++RD K N+L D + ISDFGL+K+ V +
Sbjct: 115 QVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTA 169
Query: 264 MGTYGYAAPEYVATGNF 280
GT GY APE +A +
Sbjct: 170 CGTPGYVAPEVLAQKPY 186
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (339), Expect = 4e-38
Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSE 145
++F+ LG G FGRV+ G A+K L E + + E E
Sbjct: 4 QDFQILRTLGTGSFGRVHLIR---------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L ++HP ++++ G + +++ ++ +Y++ LF Q + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYA 110
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
L +LH K +IYRD K NILLD N + KI+DFG AK P VT + G
Sbjct: 111 AEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCG 163
Query: 266 TYGYAAPEYVATGNF 280
T Y APE V+T +
Sbjct: 164 TPDYIAPEVVSTKPY 178
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 5e-38
Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 27/204 (13%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE------WQS 144
++ LLG GGFG VY G + + VAIK + + + + E
Sbjct: 6 YQVGPLLGSGGFGSVYSGI---------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 145 EVNFLGRLS--HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRL 202
EV L ++S +++LL + +L+ E + L ++
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELAR 113
Query: 203 KIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKISDFGLAKLGPAGGESHVTT 261
+ H V++RD K NIL+D N K+ DFG L + V T
Sbjct: 114 SFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 167
Query: 262 RVMGTYGYAAPEYVATGNFYLLSA 285
GT Y+ PE++ ++ SA
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSA 191
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-38
Identities = 53/191 (27%), Positives = 80/191 (41%), Gaps = 22/191 (11%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEE-----WQSEVNFLG 150
LGEG F VYK +VAIKK+ ++ E+ L
Sbjct: 5 FLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
LSHPN++ LL + LV+++M+ L+ + +
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQ 111
Query: 211 GLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYA 270
GL +LH + +++RD K +N+LLD N K++DFGLAK G + T + T Y
Sbjct: 112 GLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYR 167
Query: 271 APEYVATGNFY 281
APE + Y
Sbjct: 168 APELLFGARMY 178
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-36
Identities = 34/193 (17%), Positives = 64/193 (33%), Gaps = 20/193 (10%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
+ LG G FG V++ +T K + + + E++ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKGTDQ-VLVKKEISIL 55
Query: 150 GRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAA 209
H N++ L +EL++++E++ + + L+ +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVC 112
Query: 210 RGLGFLHTSEKKVIYRDFKASNILLD--GNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
L FLH + + D + NI+ + KI +FG A+ G +
Sbjct: 113 EALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAP 167
Query: 268 GYAAPEYVATGNF 280
Y APE
Sbjct: 168 EYYAPEVHQHDVV 180
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-36
Identities = 46/200 (23%), Positives = 76/200 (38%), Gaps = 28/200 (14%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGF------EEWQS 144
+ LG G F V K + G+ A K + + E+ +
Sbjct: 12 YDTGEELGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
EV+ L + HPN++ L +++L+ E + G L + L + + L+ + +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEF 118
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLD----GNYNAKISDFGLAKLGPAGGESHVT 260
G+ +LH ++ + D K NI+L KI DFGLA G E
Sbjct: 119 LKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 173
Query: 261 TRVMGTYGYAAPEYVATGNF 280
+ GT + APE V
Sbjct: 174 KNIFGTPEFVAPEIVNYEPL 193
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 4e-35
Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 17/193 (8%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVN 147
NF+ +GEG +G VYK G VVA+KK+ ++ E++
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---------NKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L L+HPN+VKLL + +L LV+E++ + + F ++ + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQ 110
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
+GL F H +V++RD K N+L++ K++DFGLA+ T V+ +
Sbjct: 111 LLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLW 167
Query: 268 GYAAPEYVATGNF 280
A + +
Sbjct: 168 YRAPEILLGCKYY 180
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 126 bits (316), Expect = 5e-35
Identities = 46/194 (23%), Positives = 78/194 (40%), Gaps = 20/194 (10%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVN 147
+ +GEG +G VYK + G A+KK+ E E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQ--NNY--------GETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 148 FLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIG 207
L L H N+VKL K L+LV+E++ + + L +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQ 108
Query: 208 AARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
G+ + H +++V++RD K N+L++ KI+DFGLA+ + + T
Sbjct: 109 LLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTL 164
Query: 268 GYAAPEYVATGNFY 281
Y AP+ + Y
Sbjct: 165 WYRAPDVLMGSKKY 178
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-34
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQS 144
A + ++ + +GEG +G+V+K D K G VA+K++ ++ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKA-RDLKNG-------GRFVALKRVRVQTGEEGMPLSTIR 56
Query: 145 EVNFLGRLS---HPNLVKLLGYCWEDKE-----LLLVYEYMQRGSLENHLFRRNPSIQPL 196
EV L L HPN+V+L C + L LV+E++ + P +
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GV 113
Query: 197 SWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGE 256
+ + RGL FLH +V++RD K NIL+ + K++DFGLA++
Sbjct: 114 PTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---F 168
Query: 257 SHVTTRVMGTYGYAAPEYVATGNF 280
T V+ T Y APE + ++
Sbjct: 169 QMALTSVVVTLWYRAPEVLLQSSY 192
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-34
Identities = 48/204 (23%), Positives = 76/204 (37%), Gaps = 26/204 (12%)
Query: 85 KSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQS 144
+ ++ ++G G FG VY+ G +VAIKK+ +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAK---------LCDSGELVAIKKVLQDK----RFKNR 62
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKE------LLLVYEYMQRGSLENHLFRRNPSIQPLSW 198
E+ + +L H N+V+L + + E L LV +Y+ Q L
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPV 121
Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKISDFGLAKLGPAGGES 257
R L ++H + +RD K N+LLD + K+ DFG AK G
Sbjct: 122 IYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--E 177
Query: 258 HVTTRVMGTYGYAAPEYVATGNFY 281
+ + Y Y APE + Y
Sbjct: 178 PNVSYICSRY-YRAPELIFGATDY 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-34
Identities = 54/195 (27%), Positives = 77/195 (39%), Gaps = 20/195 (10%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFEEWQSE 145
+F LLG+G FG+V + G A+K L E + +E
Sbjct: 5 NDFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
L HP L L L V EY G L HL R + + +
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYG 111
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
L +LH + V+YRD K N++LD + + KI+DFGL K G + G + G
Sbjct: 112 AEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 167
Query: 266 TYGYAAPEYVATGNF 280
T Y APE + ++
Sbjct: 168 TPEYLAPEVLEDNDY 182
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-34
Identities = 43/193 (22%), Positives = 71/193 (36%), Gaps = 29/193 (15%)
Query: 96 LLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-H 154
+LG G G+V + + A+K L + + EV R S
Sbjct: 19 VLGLGINGKVLQIF---------NKRTQEKFALKMLQDC-----PKARREVELHWRASQC 64
Query: 155 PNLVKLLGYC----WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
P++V+++ K LL+V E + G L + + R Q + +I
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGE 122
Query: 211 GLGFLHTSEKKVIYRDFKASNILLD---GNYNAKISDFGLAKLGPAGGESHVTTRVMGTY 267
+ +LH + +RD K N+L N K++DFG AK + T
Sbjct: 123 AIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTP 177
Query: 268 GYAAPEYVATGNF 280
Y APE + +
Sbjct: 178 YYVAPEVLGPEKY 190
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-34
Identities = 45/204 (22%), Positives = 80/204 (39%), Gaps = 27/204 (13%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQG--FEEWQSEVN 147
++ + +G+G FG V+K G VA+KK+ E+ + E+
Sbjct: 11 KYEKLAKIGQGTFGEVFKAR---------HRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 148 FLGRLSHPNLVKLLGYCWEDKE--------LLLVYEYMQRGSLENHLFRRNPSIQPLSWD 199
L L H N+V L+ C + LV+++ + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLS 117
Query: 200 IRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHV 259
++ GL ++H K+++RD KA+N+L+ + K++DFGLA+ S
Sbjct: 118 EIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 260 T--TRVMGTYGYAAPEYVATGNFY 281
T + T Y PE + Y
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDY 199
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 8e-33
Identities = 47/200 (23%), Positives = 80/200 (40%), Gaps = 29/200 (14%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
++ +G G +G V VD +T G VAIKKL + E+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 147 NFLGRLSHPNLVKLLGYCWEDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
L + H N++ LL D+ + LV +M G+ L + + L D
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH----EKLGEDR 122
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ +GL ++H +I+RD K N+ ++ + KI DFGLA+ +S +T
Sbjct: 123 IQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMT 176
Query: 261 TRVMGTYGYAAPEYVATGNF 280
V+ + A + +
Sbjct: 177 GYVVTRWYRAPEVILNWMRY 196
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (301), Expect = 3e-32
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 23/194 (11%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQ---SEV 146
F LG G FGRV ++ G A+K L+ + + ++ + +E
Sbjct: 42 QFDRIKTLGTGSFGRVMLV-KHKES--------GNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L ++ P LVKL ++ L +V EY+ G + +HL R S A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAA 148
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
+LH +IYRD K N+L+D +++DFG AK T + GT
Sbjct: 149 QIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGT 201
Query: 267 YGYAAPEYVATGNF 280
APE + + +
Sbjct: 202 PEALAPEIILSKGY 215
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 4e-32
Identities = 38/198 (19%), Positives = 64/198 (32%), Gaps = 24/198 (12%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
++ +G G FG +Y G G VAIK ++ + E
Sbjct: 9 YRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVKTKH--PQLHIESKIYK 57
Query: 151 RLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAAR 210
+ + + +C + + ++ + SLE+ + + S L +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114
Query: 211 GLGFLHTSEKKVIYRDFKASNIL---LDGNYNAKISDFGLAKLGPAGGES-----HVTTR 262
+ ++H K I+RD K N L I DFGLAK
Sbjct: 115 RIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 263 VMGTYGYAAPEYVATGNF 280
+ GT YA+
Sbjct: 173 LTGTARYASINTHLGIEQ 190
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (296), Expect = 9e-32
Identities = 35/196 (17%), Positives = 71/196 (36%), Gaps = 28/196 (14%)
Query: 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFL 149
+++ LG G + V++ V +K L P ++ + E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVKK---KKIKREIKIL 83
Query: 150 GRLS-HPNLVKLLGYCWEDKE--LLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L PN++ L + LV+E++ + Q L+
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMY 136
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDG-NYNAKISDFGLAKLGPAGGESHVTTRVMG 265
+ L + H +++RD K N+++D + ++ D+GLA+ G E +
Sbjct: 137 EILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVA 191
Query: 266 TYGYAAPEYVATGNFY 281
+ + PE + Y
Sbjct: 192 SRYFKGPELLVDYQMY 207
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-31
Identities = 44/195 (22%), Positives = 81/195 (41%), Gaps = 19/195 (9%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
+ ++ +GEG +G V+K +VA+K++ + E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREI 52
Query: 147 NFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAI 206
L L H N+V+L DK+L LV+E+ + + +I
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLF 108
Query: 207 GAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGT 266
+GLGF H+ + V++RD K N+L++ N K+++FGLA+ + + + T
Sbjct: 109 QLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVT 164
Query: 267 YGYAAPEYVATGNFY 281
Y P+ + Y
Sbjct: 165 LWYRPPDVLFGAKLY 179
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (291), Expect = 3e-31
Identities = 37/196 (18%), Positives = 63/196 (32%), Gaps = 26/196 (13%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNF 148
++K +GEG FG +++G VAIK S + + E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDA--PQLRDEYRT 53
Query: 149 LGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGA 208
L+ + + Y ++ ++ + SLE+ L S A
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQM 110
Query: 209 ARGLGFLHTSEKKVIYRDFKASNILLD-----GNYNAKISDFGLAKLGPAGGES-----H 258
+ +H EK ++YRD K N L+ + DFG+ K
Sbjct: 111 LARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 168
Query: 259 VTTRVMGTYGYAAPEY 274
+ GT Y +
Sbjct: 169 EKKNLSGTARYMSINT 184
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 8e-30
Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 18/198 (9%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM----QGFEEWQS 144
+NF+ +LG G +G+V+ S G + A+K L ++ + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 145 EVNFLGRLSH-PNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLK 203
E L + P LV L + +L L+ +Y+ G L HL +R + +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQI 133
Query: 204 IAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRV 263
L LH + +IYRD K NILLD N + ++DFGL+K A E+
Sbjct: 134 YVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDF 190
Query: 264 MGTYGYAAPEYVATGNFY 281
GT Y AP+ V G+
Sbjct: 191 CGTIEYMAPDIVRGGDSG 208
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-28
Identities = 47/195 (24%), Positives = 75/195 (38%), Gaps = 29/195 (14%)
Query: 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEV 146
K ++ +G G G V + L VAIKKL+ + E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 147 NFLGRLSHPNLVKLLGYCW------EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDI 200
+ ++H N++ LL E +++ LV E M + +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHER 120
Query: 201 RLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVT 260
+ G+ LH +I+RD K SNI++ + KI DFGLA+ G S +
Sbjct: 121 MSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 261 TRVMGTYGYAAPEYV 275
T + T Y APE +
Sbjct: 176 TPYVVTRYYRAPEVI 190
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 9e-27
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 21/214 (9%)
Query: 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSE 145
+ ++ S +G G +G V + T G+ VA+KKL+ S+ + E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 146 VNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIA 205
+ L + H N++ LL + L + L Q L+ D +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 206 IGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMG 265
RGL ++H +I+RD K SN+ ++ + KI DFGLA+ T +
Sbjct: 128 YQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVA 180
Query: 266 TYGYAAPEYVATGNFYLLSA---KFGNVINVCMY 296
T Y APE + Y + G ++ +
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.9 bits (224), Expect = 2e-21
Identities = 36/203 (17%), Positives = 69/203 (33%), Gaps = 24/203 (11%)
Query: 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLG 150
+ LG G F V+ VA+K + + + E + E+ L
Sbjct: 15 YILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQ 64
Query: 151 RLSHPNL-----------VKLLGYCWEDKELLLVYEYMQRGSLENHL-FRRNPSIQPLSW 198
R++ + +KLL + + + EN L + + +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 199 DIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN-YNAKISDFGLAKLGPAGGES 257
+I+ GL ++H +I+ D K N+L++ + +A LG A
Sbjct: 125 IYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 258 HVTTRVMGTYGYAAPEYVATGNF 280
T + T Y +PE + +
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPW 206
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.4 bits (182), Expect = 9e-17
Identities = 20/165 (12%), Positives = 40/165 (24%), Gaps = 30/165 (18%)
Query: 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----------MQGFEEWQS 144
L+GEG V+ + + +K G +
Sbjct: 6 KLMGEGKESAVFNCYSEK----------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 55
Query: 145 EVNFLGRLSHPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKI 204
R L KL G Y + L + + + +
Sbjct: 56 LAIRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--V 108
Query: 205 AIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAK 249
+ + + +++ D N+L+ I DF +
Sbjct: 109 LDMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 297 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.26 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.46 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.42 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.3 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=365.67 Aligned_cols=195 Identities=26% Similarity=0.315 Sum_probs=169.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|.+.... .+..+++.+|+.+|++++||||+++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVT---------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCC---------CCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 46799999999999999999987754 7889999986543 2334678899999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+||||++++.+||+|||
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG 148 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFG 148 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred CceeEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccch
Confidence 99999999999999999999754 569999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
+|+..............+||+.|||||++.+..+ +.++|||||||++|+|+
T Consensus 149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml 200 (271)
T d1nvra_ 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200 (271)
T ss_dssp TCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred hheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHH
Confidence 9987654433333456789999999999988776 46799999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=360.41 Aligned_cols=192 Identities=26% Similarity=0.328 Sum_probs=172.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||+||+|.+..+ |+.||+|++........+.+.+|+.+|++++||||+++++++.++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 89 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVAT---------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTT---------CCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccccEEEEEEecCcCcEEEEEEECCC---------CCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence 34799999999999999999986654 889999998766555567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+|+||||++||+|.+++... .+++..++.++.||+.||+|||+ +|||||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~ 162 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchh
Confidence 9999999999999999988653 48999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+.+.... ......+||+.|+|||++.+..|+.++|||||||++|+||
T Consensus 163 a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyeml 210 (293)
T d1yhwa1 163 CAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210 (293)
T ss_dssp CEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHH
T ss_pred heeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHh
Confidence 98764432 2344568999999999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-53 Score=354.72 Aligned_cols=191 Identities=26% Similarity=0.407 Sum_probs=170.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++++.||+|+||+||+|.+..+ ++.||+|++.+.. ....+.+.+|+.+|++++||||+++++++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 75 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQS---------KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 75 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCC---------CcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 45799999999999999999987754 7889999987542 23346788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+++.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .|||||||||+||||+.++.+||+|
T Consensus 76 ~~~~~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~D 149 (263)
T d2j4za1 76 HDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIAD 149 (263)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred EECCEEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecc
Confidence 9999999999999999999999876 568999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|+..... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 150 FG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell 198 (263)
T d2j4za1 150 FGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198 (263)
T ss_dssp CCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHh
Confidence 9999865432 234568999999999999999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=360.49 Aligned_cols=194 Identities=25% Similarity=0.319 Sum_probs=169.2
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++++.||+|+||+||+|.+..+ ++.||+|++.+.. ....+.+.+|+++|++++||||+++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELAT---------SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 5799999999999999999987654 7889999987542 234567899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+++.+|+||||++||+|.+++... ..+++..++.++.|++.||+|||+ .+||||||||+|||+++++.+||+||
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEeccc
Confidence 999999999999999999999876 569999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+.+............+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell 204 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHh
Confidence 9998765443333445578999999999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=366.41 Aligned_cols=192 Identities=26% Similarity=0.372 Sum_probs=169.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++++.||+|+||+||+|++..+ ++.||+|+++.. .....+++.+|+.+|++++|||||++++++.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPS---------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTT---------TEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCC---------CcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 46899999999999999999987654 889999998754 33344678999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++.+|+||||++||+|.+++.+. ..+++..++.++.|++.||+|||+ ..||+||||||+||||+.++.+||+|||
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~-~~~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH-hCCEEccccCHHHeeECCCCCEEEeeCC
Confidence 99999999999999999999876 458999999999999999999995 2589999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|+.... ......+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 151 la~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell 197 (322)
T d1s9ja_ 151 VSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197 (322)
T ss_dssp CCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH
T ss_pred CccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9985422 1234568999999999999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=355.19 Aligned_cols=198 Identities=26% Similarity=0.362 Sum_probs=158.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++.+.||+|+||+||+|++..+ |+.||+|.+.... ....+.+.+|+++|++++||||+++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSD---------GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECCC---------CCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 5799999999999999999987754 7889999987653 3345678899999999999999999999875
Q ss_pred --CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCC---CCceeccCCCCcEEEcCCCceE
Q 022413 167 --DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSE---KKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 167 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~---~~ivH~Dlkp~Nill~~~~~~k 241 (297)
.+.+|+|||||++|+|.+++.........+++..++.++.||+.||+|||+.. .+||||||||+||||+.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 35689999999999999999754333366999999999999999999999511 2499999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++.+.... .......||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 155 l~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~ 208 (269)
T d2java1 155 LGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred EeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHh
Confidence 99999998764322 2234578999999999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=357.07 Aligned_cols=193 Identities=25% Similarity=0.427 Sum_probs=169.9
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
+.|++++.||+|+||+||+|.+..+ ++.||+|+++.......+.+.+|+++|++++||||+++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~---------~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKET---------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCC---------CeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4689999999999999999987754 7889999998766666678899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
.+|+||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhh
Confidence 9999999999999999987653 458999999999999999999994 89999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccCCcccccCcceec-----ccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVA-----TGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGv~l~~ll 297 (297)
+..... ........||+.|+|||++. +..|+.++|||||||++|+|+
T Consensus 158 ~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyeml 209 (288)
T d2jfla1 158 AKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209 (288)
T ss_dssp EECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHH
T ss_pred hccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHh
Confidence 754221 11233467999999999984 456789999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=358.11 Aligned_cols=193 Identities=28% Similarity=0.377 Sum_probs=172.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++++.||+|+||+||+|+...+ ++.||+|++++.. ....+.+.+|+.+|++++||||+++++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~---------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 74 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKAT---------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCC---------CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence 46799999999999999999987654 8899999997542 23457788999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||+|||+ +|||||||||+||||+++|.+||+|
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~D 148 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred ccccccccceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEee
Confidence 9999999999999999999999876 568999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|+...... ......+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 149 FG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml 199 (337)
T d1o6la_ 149 FGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp CTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred cccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHH
Confidence 99998654322 2344578999999999999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-52 Score=354.82 Aligned_cols=196 Identities=28% Similarity=0.424 Sum_probs=171.9
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..++|++.+.||+|+||+||+|.+..+ ++.||+|+++.... ..+++.+|+.+|++++||||+++++++.+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~---------~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGG---------TEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCC---------CeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 356799999999999999999988754 78899999876543 34779999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++.+++||||+++|+|.+++..... ..+++..++.|+.||+.||+|||+ .+|+||||||+||||++++.+||+|||
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCeeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEcccc
Confidence 9999999999999999999976432 568999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++...... ........||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 161 ~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell 210 (287)
T d1opja_ 161 LSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210 (287)
T ss_dssp CTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred ceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHH
Confidence 998764432 22233446899999999999999999999999999999984
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=347.93 Aligned_cols=192 Identities=29% Similarity=0.454 Sum_probs=160.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++.+.||+|+||+||+|.+.. .||||+++.. ..+..+.|.+|+.+|++++||||+++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 4689999999999999999996542 3899998754 3445678999999999999999999999765
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
.+.+++||||+++|+|.+++.... ..+++..++.|+.||+.||+|||+ .+||||||||+||||+.++.+||+||
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred -ccEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccc
Confidence 467899999999999999997653 458999999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc---cCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT---GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+...............||+.|||||++.+ ..|+.++|||||||++|+|+
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~ 203 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHH
Confidence 99987654333334456789999999999864 34788999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-51 Score=352.08 Aligned_cols=190 Identities=32% Similarity=0.452 Sum_probs=170.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++++.||+|+||+||+|.+..+ |+.||+|++.+.. ....+.+.+|+.+|++++||||+++++++
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~---------g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 73 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHN---------GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 73 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCC---------CCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE
Confidence 35799999999999999999987654 8899999987542 23457889999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+++.+|+||||++||+|..++... ..+++..++.++.||+.||+||| ++|||||||||+||||+.++.+||+|
T Consensus 74 ~~~~~~~ivmE~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~D 147 (316)
T d1fota_ 74 QDAQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITD 147 (316)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECC
T ss_pred eeCCeeeeEeeecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEec
Confidence 9999999999999999999998876 55788999999999999999999 59999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|+.... .....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 148 FG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyeml 195 (316)
T d1fota_ 148 FGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195 (316)
T ss_dssp CSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred CccceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHH
Confidence 999987543 234568999999999999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-51 Score=356.09 Aligned_cols=193 Identities=23% Similarity=0.317 Sum_probs=172.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||+||+|.+..+ |+.||+|++........+.+.+|+.+|++++||||+++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~---------g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERAT---------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT---------TEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCC---------CCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 45899999999999999999987654 889999999877666667889999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc--CCCceEEccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GNYNAKISDF 245 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~--~~~~~kl~Df 245 (297)
+.+|+|||||+||+|.+++.... ..+++..++.|+.||+.||+|||+ .|||||||||+||||+ .++.+||+||
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred CEEEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeec
Confidence 99999999999999999996543 469999999999999999999994 9999999999999995 4688999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++...... ......||+.|||||++.+..++.++|||||||++|+||
T Consensus 171 G~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 171 GLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp TTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred chheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 9998764322 344568999999999999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-51 Score=352.66 Aligned_cols=193 Identities=23% Similarity=0.350 Sum_probs=154.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..+.|++.++||+|+||+||+|.+..+ ++.||+|.+..... .....+.+|+.+|++++||||+++++++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRT---------QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTT---------CCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCC---------CCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 346799999999999999999987654 78899999875532 23356789999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc---CCCceEE
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD---GNYNAKI 242 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~---~~~~~kl 242 (297)
+++.+|+|||||+||+|.+++... ..+++..+..++.||+.||+||| +.||+||||||+|||+. +++.+||
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vkl 151 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMI 151 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred ECCEEEEEEeccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEEE
Confidence 999999999999999999999765 56999999999999999999999 48999999999999994 5789999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... .....+||+.|||||++.+..|+.++|||||||++|+|+
T Consensus 152 ~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 152 SDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp CCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred eccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH
Confidence 9999998654322 234567999999999999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.7e-51 Score=355.51 Aligned_cols=193 Identities=23% Similarity=0.308 Sum_probs=172.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++++.||+|+||+||+|.+..+ |+.||+|++........+.+.+|+.+|++++||||+++++++.++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~---------~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKAT---------GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCeEEEEEEECCC---------CCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35799999999999999999987654 889999999876655567788999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc--CCCceEEccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD--GNYNAKISDF 245 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~--~~~~~kl~Df 245 (297)
+.+|+|||||+||+|.+++.... ..+++..++.|+.||+.||+||| +.|||||||||+||||+ .++.+||+||
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred CEEEEEEEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeec
Confidence 99999999999999999876543 46999999999999999999999 59999999999999997 6789999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+.+.... ......||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 174 Gla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 222 (352)
T d1koba_ 174 GLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222 (352)
T ss_dssp TTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred ccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH
Confidence 9998765432 344567999999999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=340.90 Aligned_cols=187 Identities=29% Similarity=0.407 Sum_probs=161.3
Q ss_pred CCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc--
Q 022413 91 FKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-- 166 (297)
Q Consensus 91 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-- 166 (297)
|++.+.||+|+||+||+|.+..+ ++.||+|.+... .....+.+.+|+++|++++||||+++++++.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~---------~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTET---------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEECCC---------CeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 36677899999999999987754 788999998654 23345678999999999999999999999875
Q ss_pred --CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCC--ceeccCCCCcEEEc-CCCceE
Q 022413 167 --DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKK--VIYRDFKASNILLD-GNYNAK 241 (297)
Q Consensus 167 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~--ivH~Dlkp~Nill~-~~~~~k 241 (297)
...+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+ ++ |+||||||+||||+ +++.+|
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~--~~~~IiHrDiKp~NILl~~~~~~~K 155 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGSVK 155 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHH--CCCCEEeCCcChhhceeeCCCCCEE
Confidence 35689999999999999999876 568999999999999999999995 66 99999999999996 578999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+++..... .....+||+.|||||++. ++++.++|||||||++|+|+
T Consensus 156 l~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~ 206 (270)
T d1t4ha_ 156 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMA 206 (270)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHH
T ss_pred EeecCcceeccCC----ccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHH
Confidence 9999999864322 234568999999999886 46999999999999999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=344.52 Aligned_cols=192 Identities=27% Similarity=0.395 Sum_probs=159.7
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|++.+.||+|+||+||+|.+.+ +..||||++..... ..+++.+|+.++++++||||+++++++.+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 578899999999999999998764 56799999976543 3367899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||||++++.+||+|||++
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred ceEEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchh
Confidence 9999999999999999987653 558899999999999999999994 89999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 149 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 149 RFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred eeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHH
Confidence 87644322 1223457899999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-50 Score=348.95 Aligned_cols=188 Identities=30% Similarity=0.403 Sum_probs=165.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..|++++.||+|+||+||+|++..+ ++.||+|.+.... ....+.+.+|+.+|++++||||+++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRN---------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTT---------TEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCC---------CcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 3589999999999999999987654 7889999986543 234467889999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+++.+|+|||||++|+|..++... ..+++..++.++.||+.||.|||+ .|||||||||+||||+.++.+||+||
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCEEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeec
Confidence 999999999999999987776654 568999999999999999999995 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecc---cCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT---GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGv~l~~ll 297 (297)
|+++.... .....||+.|||||++.+ +.|+.++|||||||++|+|+
T Consensus 160 G~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~ 208 (309)
T d1u5ra_ 160 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208 (309)
T ss_dssp TTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred ccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHH
Confidence 99986432 234679999999999864 45888999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-50 Score=346.17 Aligned_cols=199 Identities=25% Similarity=0.391 Sum_probs=159.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.++||+|+||+||+|.+..+. .....||+|.+... .....++|.+|+.+|++++|||||++++++.+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 356888899999999999999876531 11446899998764 33455789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++.+++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcc
Confidence 999999999999999999887653 458999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcce---eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHV---TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++.......... .....||+.|||||++.+..++.++|||||||++|+|+
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~ 227 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHH
Confidence 9987644322111 12245799999999999999999999999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=351.08 Aligned_cols=204 Identities=30% Similarity=0.414 Sum_probs=170.0
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCC-CCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 165 (297)
.++|++.++||+|+||+||+|.+... .+......||+|.+... .......+.+|+.+|+++ +|||||++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 46799999999999999999987653 12223457999998654 333446789999999998 7999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceecc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNP-------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRD 226 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~D 226 (297)
+.+.+|+|||||++|+|.++|..+.. ....+++..++.++.||+.||+|||+ .+|||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRD 189 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRD 189 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETT
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecc
Confidence 99999999999999999999976532 12358899999999999999999995 8999999
Q ss_pred CCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 227 FKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 227 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|+||
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence 99999999999999999999998655443333344567899999999999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=342.39 Aligned_cols=192 Identities=24% Similarity=0.334 Sum_probs=169.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch------hhHHHHHHHHHHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~ 161 (297)
.++|++++.||+|+||+||+|++..+ |+.||+|++.+... ...+.+.+|+.+|++++||||++++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~---------~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKST---------GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTT---------CCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCC---------CCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 45799999999999999999987654 88999999864321 2347789999999999999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC---
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY--- 238 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~--- 238 (297)
+++.+++.+|+|||||+||+|.+++... ..+++..++.++.|++.||+||| +.+||||||||+|||++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSSS
T ss_pred EEEEECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCcc
Confidence 9999999999999999999999999876 46999999999999999999999 48999999999999998776
Q ss_pred -ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 -NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp CCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred cceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH
Confidence 59999999998764432 234467999999999999999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-50 Score=351.59 Aligned_cols=189 Identities=27% Similarity=0.328 Sum_probs=170.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
++|++++.||+|+||+||+|.+..+ |+.||+|++.+.. ....+.+.+|+.+|+.++||||+++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~---------g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKES---------GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCC---------CCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 5799999999999999999987654 8899999987542 234567899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccc
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDF 245 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 245 (297)
+...+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+ .+||||||||+||||+.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred cccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeec
Confidence 999999999999999999999876 458999999999999999999994 89999999999999999999999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|+.... ......||+.|||||++.+..|+.++|||||||++|+|+
T Consensus 186 G~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 186 GFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp TTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred eeeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHH
Confidence 99987542 233467999999999999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=341.92 Aligned_cols=193 Identities=29% Similarity=0.447 Sum_probs=166.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||+||+|.++. +..||||+++.... ..+.+.+|+.+|++++||||+++++++. +
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC----------CCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 4678999999999999999998764 56799999976543 3467999999999999999999999775 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++|+|.+++..... ..+++..++.|+.||+.||+|||+ .+|+||||||+||||++++.+||+|||+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccc
Confidence 568999999999999998764421 348999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+...... ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 156 a~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ell 204 (272)
T d1qpca_ 156 ARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204 (272)
T ss_dssp CEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred eEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHH
Confidence 98765432 12233457899999999999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=332.25 Aligned_cols=192 Identities=26% Similarity=0.338 Sum_probs=169.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|+++++||+|+||+||+|++++ +..||||.++..... .+.+.+|+.++++++||||+++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETT----------TEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEECC----------CCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 589999999999999999998764 678999998765433 367899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccccc
Q 022413 169 ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLA 248 (297)
Q Consensus 169 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 248 (297)
.+++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||+++++.+||+|||++
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred ceEEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhh
Confidence 9999999999999999976553 458899999999999999999994 89999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 249 KLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 249 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+....... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 148 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~ 195 (258)
T d1k2pa_ 148 RYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195 (258)
T ss_dssp CBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred eeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHH
Confidence 86544322 2233467899999999999999999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=338.14 Aligned_cols=196 Identities=28% Similarity=0.373 Sum_probs=165.2
Q ss_pred cCCCCCce-ecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSL-LGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~-lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|.+.+. ||+|+||+||+|.++.. ..+..||||.++... ....++|.+|+++|++++|||||++++++.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecC-------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45666674 99999999999987542 125679999997653 3455789999999999999999999999865
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+.+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccch
Confidence 56899999999999999986543 568999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCc-ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGES-HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++........ .......||+.|+|||++.+..++.++|||||||++|+||
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~l 206 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHH
Confidence 99876543221 1223456899999999999999999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=336.49 Aligned_cols=189 Identities=28% Similarity=0.352 Sum_probs=159.5
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCCeeEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDKELLL 172 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 172 (297)
++||+|+||+||+|.+... .+++.||+|.+... +....+++.+|+.+|++++||||+++++++.. +..++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 5799999999999987543 23678999998754 23345789999999999999999999999865 46789
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccCC
Q 022413 173 VYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLGP 252 (297)
Q Consensus 173 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 252 (297)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++.+.
T Consensus 85 vmE~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence 99999999999999876 568999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCcc-eeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 253 AGGESH-VTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 253 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...... ......||+.|+|||++.+..++.++|||||||++|+||
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 433221 223457899999999999999999999999999999974
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=337.83 Aligned_cols=199 Identities=27% Similarity=0.409 Sum_probs=162.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
+.|++.++||+|+||+||+|.++... ......||||.+.... .....+|.+|+.+|++++|||||++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSS-----GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCC-----CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 46888899999999999999876531 1113579999987643 33446789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+.++++.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999887654 558999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCC-cceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGE-SHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~ 207 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 207 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHH
Confidence 987644322 12233456899999999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-49 Score=346.71 Aligned_cols=191 Identities=28% Similarity=0.357 Sum_probs=164.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---hhHH---HHHHHHHHhcCCCCCCcccEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---QGFE---EWQSEVNFLGRLSHPNLVKLL 161 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~---~~~~E~~~l~~l~h~nIv~~~ 161 (297)
.++|++.++||+|+||+||+|++..+ |+.||+|.+.+... .... +...|+.+++.++||||++++
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t---------~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~ 73 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADT---------GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCC---------CCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence 46899999999999999999987654 88999999864321 1112 233457888899999999999
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceE
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAK 241 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~k 241 (297)
+++.+.+.+|+||||++||+|.++|... ..+++..++.++.||+.||+||| +.|||||||||+||||+.++.+|
T Consensus 74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iK 147 (364)
T d1omwa3 74 YAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVR 147 (364)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEE
T ss_pred EEEEECCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEE
Confidence 9999999999999999999999999876 56889999999999999999999 49999999999999999999999
Q ss_pred EccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+|+..... .....+||+.|+|||++.+ ..|+.++|||||||++|+||
T Consensus 148 l~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyeml 200 (364)
T d1omwa3 148 ISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200 (364)
T ss_dssp ECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred EeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHH
Confidence 9999999865432 2344679999999999975 46889999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=340.30 Aligned_cols=192 Identities=29% Similarity=0.410 Sum_probs=168.6
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhc-CCCCCCcccEEeEE
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLG-RLSHPNLVKLLGYC 164 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~ 164 (297)
++|++++.||+|+||+||+|.+..+ ++.||+|++++.. ....+.+..|..++. .++||||+++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t---------~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKT---------NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTT---------TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCC---------CCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 5799999999999999999987754 8899999997542 233456677777765 68999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+++.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred ccCCceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccc
Confidence 9999999999999999999999876 568999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 147 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyeml 197 (320)
T d1xjda_ 147 FGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197 (320)
T ss_dssp CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred cchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHH
Confidence 99998654332 2334568999999999999999999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=338.77 Aligned_cols=192 Identities=18% Similarity=0.193 Sum_probs=169.4
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
-++|++++.||+|+||+||+|.+..+ ++.||+|.++..... ...+.+|+.+|+.++||||+++++++.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~---------~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSS---------KKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECCC---------CcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 45799999999999999999987764 788999999876433 35678999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC--CCceEEccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG--NYNAKISDF 245 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~--~~~~kl~Df 245 (297)
+.+|+|||||+||+|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||++. ...+||+||
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEccc
Confidence 99999999999999999997653 458999999999999999999994 89999999999999985 458999999
Q ss_pred cccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 246 GLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 246 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+++..... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 149 G~~~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll 197 (321)
T d1tkia_ 149 GQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp TTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred chhhccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHH
Confidence 999875432 2344567999999999999999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-48 Score=332.47 Aligned_cols=195 Identities=23% Similarity=0.317 Sum_probs=162.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc---hhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES---MQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||+||+|.+..+ ++.||+|.+.... ....+++.+|+.+|+.++||||+++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRL---------HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCC---------CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 46799999999999999999987654 8899999997643 33456789999999999999999999999
Q ss_pred EcCC----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 165 WEDK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 165 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
...+ .+|+||||++|++|.+++... ..+++..++.++.||+.||+||| +.|||||||||+||||+.++..
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccc
Confidence 8654 489999999999999999876 56899999999999999999999 4999999999999999999999
Q ss_pred EEccccccccCCCCC-CcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGG-ESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|+|||+++...... ........+||+.|+|||++.+..++.++|||||||++|+||
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHH
Confidence 999999987543322 122334567999999999999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-49 Score=337.30 Aligned_cols=205 Identities=27% Similarity=0.388 Sum_probs=172.5
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
..++|++.+.||+|+||+||+|.+... .....+..||||+++.... +..+++.+|+.+|++++||||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 467899999999999999999987542 1223367899999976533 34567999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceec
Q 022413 166 EDKELLLVYEYMQRGSLENHLFRRNP--------------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYR 225 (297)
Q Consensus 166 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~ 225 (297)
+.+..+++|||+++|+|.+++..... ....+++..++.|+.|++.||+|||+ .+||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivHr 164 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR 164 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEee
Confidence 99999999999999999999975321 12348899999999999999999994 899999
Q ss_pred cCCCCcEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 226 DFKASNILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 226 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||||+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|+||
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell 236 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHH
Confidence 999999999999999999999998654433333344567899999999999999999999999999999974
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=336.32 Aligned_cols=205 Identities=26% Similarity=0.321 Sum_probs=162.8
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.++||+|+||+||+|.+... .+..+++.||+|.+.... ....+.+.+|..++.++ +|+||+.+++++
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 457899999999999999999987643 233447789999987543 33446778888888777 589999999988
Q ss_pred EcC-CeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCc
Q 022413 165 WED-KELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASN 231 (297)
Q Consensus 165 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~N 231 (297)
.+. ..+++|||||++|+|.+++..... ....+++..++.++.||+.||+|||+ .+||||||||+|
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDlKp~N 164 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARN 164 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcCCccc
Confidence 765 468999999999999999975421 12458899999999999999999995 899999999999
Q ss_pred EEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 232 ILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 232 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHH
Confidence 999999999999999998765443333344567999999999999999999999999999999984
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=337.22 Aligned_cols=198 Identities=26% Similarity=0.382 Sum_probs=163.4
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+|+++++||+|+||+||+|.+..+. ......||+|.+... ..+..+++.+|+.+|++++|||||++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCC-----CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46999999999999999999876531 112346899988754 334557899999999999999999999999875
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
..+++|||+.+++|.+++.... ..+++..++.++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred -CeeEEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeecccc
Confidence 5678889999999999887654 568999999999999999999995 8999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++...............||+.|+|||++.++.|+.++|||||||++|+|+
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~ 207 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHH
Confidence 98765544433344557899999999999999999999999999999984
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.3e-48 Score=328.16 Aligned_cols=191 Identities=27% Similarity=0.353 Sum_probs=167.5
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch---------hhHHHHHHHHHHhcCCC-CCCcc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM---------QGFEEWQSEVNFLGRLS-HPNLV 158 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv 158 (297)
++|++.+.||+|+||+||+|++..+ ++.||+|+++.... ...+.+.+|+.+|++++ ||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~---------~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPT---------CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEECCC---------CCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 5899999999999999999987654 88999999865421 12346889999999997 99999
Q ss_pred cEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC
Q 022413 159 KLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 159 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~ 238 (297)
++++++.+++.+|+||||+++|+|.++|..+ ..+++..++.++.||+.||+||| +.||+||||||+|||++.++
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDM 147 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTC
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCCC
Confidence 9999999999999999999999999999876 56999999999999999999999 58999999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecc------cCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT------GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|+|+
T Consensus 148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml 209 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209 (277)
T ss_dssp CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc
Confidence 99999999998765432 2344679999999999874 34677899999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=333.92 Aligned_cols=193 Identities=28% Similarity=0.411 Sum_probs=160.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||+||+|+++. +..||||++..... ..+.|.+|+.+|++++|||||++++++. +
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 3579999999999999999998765 45699999976543 3477999999999999999999999885 4
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+..++||||+++|+|..++..... ..+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred CCeEEEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccch
Confidence 678999999999999999875422 45899999999999999999999 48999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......||+.|+|||++.++.++.++|||||||++|+|+
T Consensus 160 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~ 208 (285)
T d1fmka3 160 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred hhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHH
Confidence 986543322 2233457899999999999999999999999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=331.36 Aligned_cols=197 Identities=23% Similarity=0.311 Sum_probs=157.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++++.||+|+||+||+|.+.... ..+..||+|.++... ....+.+.+|+.+|++++||||+++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCC------ceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 467999999999999999999876432 225679999987543 334567899999999999999999999885
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++.+|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCeEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccch
Confidence 568999999999999999887653 568999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++....... .......||+.|+|||++.+..++.++|||||||++|+||
T Consensus 154 ~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~l 203 (273)
T d1mp8a_ 154 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred hheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHH
Confidence 9986543322 2234456899999999999999999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=335.49 Aligned_cols=189 Identities=24% Similarity=0.296 Sum_probs=161.8
Q ss_pred hcCCCCC-ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcC-CCCCCcccEEeEEE
Q 022413 88 TKNFKPD-SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGR-LSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~ 165 (297)
.++|.+. ++||+|+||+||+|.+..+ ++.||+|+++.. ..+.+|+.++.+ ++||||++++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~---------~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRT---------QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTT---------CCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCC---------CCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 4689876 4699999999999987654 788999998543 456789998765 47999999999987
Q ss_pred c----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CC
Q 022413 166 E----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NY 238 (297)
Q Consensus 166 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~ 238 (297)
+ ...+|+|||||+||+|.++|..+.. ..+++..++.|+.||+.||+||| +.||+||||||+|||++. .+
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTTC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHH--HcCCccccccccccccccccccc
Confidence 5 3679999999999999999976432 46999999999999999999999 499999999999999975 56
Q ss_pred ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+|+...... .....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 152 ~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll 207 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207 (335)
T ss_dssp CEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT
T ss_pred cccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh
Confidence 79999999998764432 234568999999999999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=331.19 Aligned_cols=188 Identities=28% Similarity=0.312 Sum_probs=156.8
Q ss_pred CCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchh-----hHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 93 PDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQ-----GFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 93 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.+++||+|+||+||+|.+..+ ++.||+|+++..... ..+.+.+|+.+|++++||||+++++++.++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNT---------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSC---------CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cceEeccCcCeEEEEEEECCC---------CcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 357899999999999977654 889999998754321 125688999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccc
Q 022413 168 KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGL 247 (297)
Q Consensus 168 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 247 (297)
+.+|+||||+.++++..++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~ 146 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGL 146 (299)
T ss_dssp TCCEEEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred CceeehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCcc
Confidence 9999999999887766555433 558889999999999999999994 9999999999999999999999999999
Q ss_pred cccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 248 AKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 248 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
++...... ......+||+.|+|||++.+. .|+.++|||||||++|+|+
T Consensus 147 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~ 195 (299)
T d1ua2a_ 147 AKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 195 (299)
T ss_dssp GSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH
T ss_pred ccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHH
Confidence 98654432 223446799999999998755 5788999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=326.30 Aligned_cols=193 Identities=27% Similarity=0.385 Sum_probs=162.0
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++++.||+|+||+||+|.+..+ ++.||+|++..... ...+.+.+|+.+|++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLT---------GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCC---------CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 5799999999999999999988764 78899999965432 234778999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
.+.+|+||||+.+ .+.+++..... ..+++..++.++.||+.||+||| +.|||||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ccceeEEEeecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCC
Confidence 9999999999965 55555544322 45899999999999999999999 5999999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
+|+...... .......||+.|+|||++.... ++.++|+|||||++|+|+
T Consensus 148 ~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~ 197 (298)
T d1gz8a_ 148 LARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197 (298)
T ss_dssp HHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred cceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHh
Confidence 997654322 2233457999999999987766 467899999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=327.51 Aligned_cols=205 Identities=30% Similarity=0.375 Sum_probs=175.7
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++.++||+|+||.||+|.+... .+...++.||||+++... ......+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 356899999999999999999987532 223447899999997653 34456788999999999 699999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCC--------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCC
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNP--------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKAS 230 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~ 230 (297)
.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+ .+||||||||+
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAAR 174 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccccc
Confidence 999999999999999999999976532 22458899999999999999999995 89999999999
Q ss_pred cEEEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 231 NILLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 231 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|+||
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHH
Confidence 9999999999999999998765544444445578999999999999999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=325.73 Aligned_cols=191 Identities=25% Similarity=0.343 Sum_probs=162.9
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch------hhHHHHHHHHHHhcCCC--CCCccc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------QGFEEWQSEVNFLGRLS--HPNLVK 159 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~ 159 (297)
.++|++.++||+|+||+||+|++..+ ++.||+|.+..... ....++.+|+.+|++++ ||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSD---------NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCC---------CCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 45799999999999999999987654 78899999865321 12234678999999987 899999
Q ss_pred EEeEEEcCCeeEEEEEecCC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-C
Q 022413 160 LLGYCWEDKELLLVYEYMQR-GSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-N 237 (297)
Q Consensus 160 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-~ 237 (297)
+++++.+++..|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++. +
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNR 147 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTT
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCC
Confidence 99999999999999999976 5788888766 568999999999999999999994 99999999999999985 4
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceecccCC-cccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNF-YLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|+|+
T Consensus 148 ~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell 204 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204 (273)
T ss_dssp TEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred CeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh
Confidence 79999999999865332 2345689999999999988776 46789999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=322.57 Aligned_cols=188 Identities=30% Similarity=0.410 Sum_probs=157.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED 167 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 167 (297)
.++|++.+.||+|+||.||+|.+. +..||+|.++... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 457888999999999999999875 5679999997653 336789999999999999999999998654
Q ss_pred -CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 168 -KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 168 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
+.+|+||||+++|+|.+++..+.. ..+++..++.|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccc
Confidence 578999999999999999975421 348999999999999999999995 899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+++.... ......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 149 ~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~ 194 (262)
T d1byga_ 149 LTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 194 (262)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHH
Confidence 9986432 223356899999999999999999999999999999984
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=325.55 Aligned_cols=207 Identities=28% Similarity=0.346 Sum_probs=169.2
Q ss_pred hhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch-hhHHHHHHHHHHhcCC-CCCCcccEEeEE
Q 022413 87 ATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM-QGFEEWQSEVNFLGRL-SHPNLVKLLGYC 164 (297)
Q Consensus 87 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 164 (297)
..++|++++.||+|+||.||+|+..... ......+..||+|+++.... .....+.+|...+.++ +||||+++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCC--cccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3568999999999999999999865431 11223356899999976543 4457788999999888 799999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcE
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNP------------SIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNI 232 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Ni 232 (297)
.+++..++||||+++|+|.++|..+.. ....+++..++.++.||+.||+|||+ .+||||||||+||
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNV 166 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeecccce
Confidence 999999999999999999999976532 12458999999999999999999994 8999999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 233 LLDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 233 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|+||
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell 231 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhc
Confidence 99999999999999998665443333345567999999999999999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=326.88 Aligned_cols=197 Identities=30% Similarity=0.429 Sum_probs=164.1
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCC-CCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRL-SHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 166 (297)
++|++.++||+|+||+||+|.+..+. ....||||.+... .....+.+.+|+.+|+++ +||||+++++++.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT-------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCC-------eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 57999999999999999999886531 1235788887543 333456899999999999 69999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEE
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRN------------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILL 234 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill 234 (297)
++.+++||||+++|+|.++|.... .....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV 160 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEE
Confidence 999999999999999999997542 233668999999999999999999995 899999999999999
Q ss_pred cCCCceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 235 DGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 235 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|+||
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell 220 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 220 (309)
T ss_dssp CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred cCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHH
Confidence 999999999999998643221 223456899999999999999999999999999999984
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=321.79 Aligned_cols=198 Identities=29% Similarity=0.439 Sum_probs=158.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc---chhhHHHHHHHHHHhcCCCCCCcccEEeEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE---SMQGFEEWQSEVNFLGRLSHPNLVKLLGYC 164 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 164 (297)
.++|++.+.||+|+||.||+|.+.... .....||+|.+.+. ..+..++|.+|+.+|++++||||+++++++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~------~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCC------CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 357999999999999999999876432 22457999998754 233457899999999999999999999999
Q ss_pred EcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcc
Q 022413 165 WEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISD 244 (297)
Q Consensus 165 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~D 244 (297)
.+ +..++||||+++++|.+++..+. ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECC
T ss_pred ee-cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeecc
Confidence 65 57799999999999999887653 458999999999999999999995 8999999999999999999999999
Q ss_pred ccccccCCCCCCcce-eeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 245 FGLAKLGPAGGESHV-TTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 245 fg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+++.......... .....|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml 208 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence 999987654433222 23346788999999999999999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=321.97 Aligned_cols=192 Identities=26% Similarity=0.358 Sum_probs=156.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcCC
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWEDK 168 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 168 (297)
++|.+.+.||+|+||.||+|+++ |+.||||.++...... .....|+..+.+++||||+++++++.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~~~~~-~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchhH-HHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence 46778899999999999999864 6789999987553321 22334555667889999999999998654
Q ss_pred ----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcC------CCCceeccCCCCcEEEcCCC
Q 022413 169 ----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTS------EKKVIYRDFKASNILLDGNY 238 (297)
Q Consensus 169 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------~~~ivH~Dlkp~Nill~~~~ 238 (297)
.+|+||||+++|+|.+++.+. .+++..++.++.|++.||+|||+. +.+||||||||+||||+.++
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred CcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 689999999999999999763 489999999999999999999952 36999999999999999999
Q ss_pred ceEEccccccccCCCCCCc--ceeeccCCcccccCcceeccc------CCcccccchhhhhhhhhcC
Q 022413 239 NAKISDFGLAKLGPAGGES--HVTTRVMGTYGYAAPEYVATG------NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 239 ~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGv~l~~ll 297 (297)
.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||+||+|+
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~ 212 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence 9999999999865443221 123356799999999998754 3677899999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=324.80 Aligned_cols=204 Identities=25% Similarity=0.365 Sum_probs=171.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|.+... .+...+..||||+++.. ..+....+.+|+.++++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 46889999999999999999987531 11112567999999764 33444678999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRN------PSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
++..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+ .+|+||||||+||||+.++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceE
Confidence 999999999999999999986432 223457899999999999999999994 899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
||+|||+++...............||+.|+|||.+.+..++.++||||||+++|+|+
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~ 229 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHH
Confidence 999999998654433322334456899999999999999999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=317.66 Aligned_cols=193 Identities=28% Similarity=0.432 Sum_probs=163.1
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc-chhhHHHHHHHHHHhcCCCCCCcccEEeEEEc-CCeeE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE-SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE-DKELL 171 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~ 171 (297)
.++||+|+||+||+|.+.... .+...||||.++.. .....++|.+|+++|++++||||+++++++.+ ++..+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 578999999999999876531 12457899998754 44556789999999999999999999999875 46899
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEccccccccC
Q 022413 172 LVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFGLAKLG 251 (297)
Q Consensus 172 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 251 (297)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++..
T Consensus 106 lv~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEEEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 9999999999999987653 457788999999999999999995 89999999999999999999999999999876
Q ss_pred CCCCCc--ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 252 PAGGES--HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 252 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
...... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~ 228 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHH
Confidence 543221 1223356899999999999999999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=320.71 Aligned_cols=194 Identities=26% Similarity=0.358 Sum_probs=159.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCC---CCCCcccEEe
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRL---SHPNLVKLLG 162 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~~~~ 162 (297)
.++|++++.||+|+||+||+|.+..+. ++.||+|++..... .....+.+|+.+|+.| +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT--------TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCC--------CEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 468999999999999999999875432 67799999864322 2223456777777665 7999999999
Q ss_pred EEEc-----CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 163 YCWE-----DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 163 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
++.. ...++++|||+.++.+........ ..+++..++.++.|++.||+|||+ .+||||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSS 152 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTT
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCC
Confidence 9863 347899999998876654444332 558999999999999999999994 899999999999999999
Q ss_pred CceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++.... ........||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 153 ~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell 209 (305)
T d1blxa_ 153 GQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209 (305)
T ss_dssp CCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCeeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHH
Confidence 9999999999875432 22344568999999999999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.1e-46 Score=316.23 Aligned_cols=191 Identities=24% Similarity=0.303 Sum_probs=160.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch--hhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM--QGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|+++++||+|+||+||+|.+.. ++.||+|++..... ...+++.+|+.+|++++||||+++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNY----------GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT----------SCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCC----------CCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 579999999999999999998753 67899999876532 334788999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
++..+++|||+.++.+..+.... ..+++..++.++.||+.||+||| +.+||||||||+||||+.++.+||+|||
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccc
Confidence 99999999999776666655443 56999999999999999999999 4899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
++....... .......|++.|+|||++.+. .++.++|||||||++|+|+
T Consensus 146 ~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~ 195 (286)
T d1ob3a_ 146 LARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195 (286)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred cceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHH
Confidence 997653322 223345689999999999764 4688999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8e-45 Score=310.87 Aligned_cols=193 Identities=21% Similarity=0.179 Sum_probs=164.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCC-CCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSH-PNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~ 166 (297)
.++|+++++||+|+||+||+|++..+ ++.||+|++..... ...+.+|+++++.+.| +||+.+++++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~---------~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLN---------NQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTT---------TEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCC---------CCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 45799999999999999999987754 78899998755432 1346778889998875 899999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC-----CCceE
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG-----NYNAK 241 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~-----~~~~k 241 (297)
....++||||+ +++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||||+. ++.+|
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CCccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceE
Confidence 99999999999 789999987654 45899999999999999999999 599999999999999964 57899
Q ss_pred EccccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 242 ISDFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 242 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|+|||+|+........ .......||+.|||||++.+..++.++|||||||++|+|+
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell 207 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 207 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHH
Confidence 9999999876432211 1234568999999999999999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=318.21 Aligned_cols=194 Identities=25% Similarity=0.320 Sum_probs=159.3
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
..+|++++.||+|+||+||+|.+..+ ++.||||++.+.. ....+++.+|+.+|++++||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVN---------KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTT---------CSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCC---------CcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 45799999999999999999987654 8899999997653 3445688999999999999999999999876
Q ss_pred CC----eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 167 DK----ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 167 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
.. ..+++++|+.+++|.+++..+ .+++..++.++.||+.||+||| +.|||||||||+||||+.++.+||
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEE
T ss_pred ccccccceEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEEE
Confidence 53 345556667799999999753 4899999999999999999999 489999999999999999999999
Q ss_pred ccccccccCCCCCCc-ceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGES-HVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++........ ......+||+.|+|||++.. ..++.++||||+||++|+|+
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 207 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHH
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHh
Confidence 999999865432211 12344679999999999855 45678899999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=318.23 Aligned_cols=188 Identities=24% Similarity=0.314 Sum_probs=156.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++++.||+|+||+||+|.+..+ |+.||+|+++.. .....+.+.+|+.+|++++||||+++++++.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRT---------GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTT---------CCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCC---------CCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 46899999999999999999987654 889999999754 2334567889999999999999999999998
Q ss_pred cCC------eeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 EDK------ELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
..+ .+|+||||+ +.+|..++.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccc
Confidence 654 579999999 6678877754 359999999999999999999994 99999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 160 ~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 213 (346)
T d1cm8a_ 160 LKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213 (346)
T ss_dssp EEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred cccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHH
Confidence 99999999986532 23446799999999999864 4678999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=319.45 Aligned_cols=189 Identities=25% Similarity=0.322 Sum_probs=155.3
Q ss_pred CCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCcccEEeEEEcC--
Q 022413 90 NFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNLVKLLGYCWED-- 167 (297)
Q Consensus 90 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 167 (297)
+|+..++||+|+||+||+|++..+ ++.||||++..... ...+|+.+|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~---------~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDS---------GELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTT---------CCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECCC---------CCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 688899999999999999987754 88999999876532 224699999999999999999998643
Q ss_pred ----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-ceEE
Q 022413 168 ----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKI 242 (297)
Q Consensus 168 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-~~kl 242 (297)
..+|+||||++++ +.+.+.........+++..++.++.||+.||+||| ++||+||||||+||||+.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCceeE
Confidence 3589999999765 44444322222256999999999999999999999 59999999999999999775 8999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceecc-cCCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVAT-GNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 165 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~ 217 (350)
T d1q5ka_ 165 CDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217 (350)
T ss_dssp CCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred ecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehh
Confidence 9999998654322 2344679999999999875 46889999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=306.50 Aligned_cols=192 Identities=23% Similarity=0.316 Sum_probs=166.8
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEEc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCWE 166 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 166 (297)
++|++++.||+|+||+||+|++..+ ++.||+|+++... ....+++.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRET---------HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECCC---------CcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 5799999999999999999987654 7889999986442 3345788999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEEcccc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKISDFG 246 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 246 (297)
....++++|++.+++|..++... ..+++..++.++.|++.||+||| +++||||||||+||||+.++.+||+|||
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecc
Confidence 99999999999998888877655 56889999999999999999999 5899999999999999999999999999
Q ss_pred ccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 247 LAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 247 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
.++....... ......+++.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 147 ~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell 196 (292)
T d1unla_ 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred hhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHh
Confidence 9987644322 223345788999999988665 688999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=312.99 Aligned_cols=195 Identities=23% Similarity=0.298 Sum_probs=158.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++++.||+|+||+||+|++..+ |+.||||++.... ....+++.+|+.+|++++||||+++++++.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~---------~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKT---------GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT---------CCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCC---------CCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 57899999999999999999987754 7899999986542 233467889999999999999999999986
Q ss_pred c--------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCC
Q 022413 166 E--------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGN 237 (297)
Q Consensus 166 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~ 237 (297)
. ++.+|+||||+.++.+..+.... ..+++..++.++.||+.||+|||+ .||+||||||+||||+.+
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~ 153 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRD 153 (318)
T ss_dssp C----------CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTT
T ss_pred cccccccccCceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCC
Confidence 5 34689999999776555443332 558899999999999999999994 899999999999999999
Q ss_pred CceEEccccccccCCCCCCc--ceeeccCCcccccCcceeccc-CCcccccchhhhhhhhhcC
Q 022413 238 YNAKISDFGLAKLGPAGGES--HVTTRVMGTYGYAAPEYVATG-NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 238 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGv~l~~ll 297 (297)
+.+||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|+|+
T Consensus 154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~ 216 (318)
T d3blha1 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216 (318)
T ss_dssp SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh
Confidence 99999999999765432211 122335799999999999865 5889999999999999984
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-44 Score=312.78 Aligned_cols=186 Identities=18% Similarity=0.269 Sum_probs=159.7
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 166 (297)
.++|+++++||+|+||+||+|++..+ ++.||+|+++... .+++.+|+.+|+++. ||||+++++++..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~---------~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITN---------NEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCC---------CCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 35799999999999999999987654 8899999997654 356789999999996 9999999999985
Q ss_pred C--CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCC-ceEEc
Q 022413 167 D--KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNY-NAKIS 243 (297)
Q Consensus 167 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~-~~kl~ 243 (297)
. ..+++||||+.+++|..+. ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++ .+||+
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeec
Confidence 4 5699999999999987653 358999999999999999999994 9999999999999998655 69999
Q ss_pred cccccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
|||+|+...... ......||+.|+|||++.+.. ++.++|+|||||++|+|+
T Consensus 173 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~ 224 (328)
T d3bqca1 173 DWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224 (328)
T ss_dssp CGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhc
Confidence 999998764432 234567999999999988754 788999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=314.73 Aligned_cols=197 Identities=27% Similarity=0.344 Sum_probs=166.8
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc----hhhHHHHHHHHHHhcCCCC-CCcccEEe
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES----MQGFEEWQSEVNFLGRLSH-PNLVKLLG 162 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h-~nIv~~~~ 162 (297)
.++|++++.||+|+||+||+|+.... ..+|+.||+|.+++.. ....+.+.+|+.+|++++| |||+++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSS------TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECcc------CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence 36799999999999999999976432 2348899999987542 2234667899999999976 89999999
Q ss_pred EEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCceEE
Q 022413 163 YCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNAKI 242 (297)
Q Consensus 163 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~kl 242 (297)
++.+....+++|||+.+++|.+++... ..+.+..++.++.||+.||+||| +.+||||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 97 AFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred eeccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEE
Confidence 999999999999999999999999877 45788899999999999999999 489999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeccCCcccccCcceeccc--CCcccccchhhhhhhhhcC
Q 022413 243 SDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATG--NFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 243 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGv~l~~ll 297 (297)
+|||+++.+.... ........|++.|+|||.+.+. .++.++|||||||+||+|+
T Consensus 171 ~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyell 226 (322)
T d1vzoa_ 171 TDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226 (322)
T ss_dssp SCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred eeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHH
Confidence 9999998654332 2233456799999999999764 4677899999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-44 Score=305.90 Aligned_cols=193 Identities=21% Similarity=0.176 Sum_probs=159.6
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCC-cccEEeEEEc
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPN-LVKLLGYCWE 166 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~ 166 (297)
.++|++.+.||+|+||+||+|++..+ ++.||||++...... .++..|+++++.++|+| |+.+..++.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~---------~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAA---------GEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTT---------TEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCC---------CCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 45799999999999999999987654 788999987654322 45788999999998665 5555666678
Q ss_pred CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcC---CCceEEc
Q 022413 167 DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDG---NYNAKIS 243 (297)
Q Consensus 167 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~---~~~~kl~ 243 (297)
.+..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||+ +|||||||||+|||++. +..+||+
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeee
Confidence 88999999999 667777766543 568999999999999999999995 89999999999999853 5679999
Q ss_pred cccccccCCCCCCc-----ceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 244 DFGLAKLGPAGGES-----HVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 244 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
|||+|+........ .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHH
Confidence 99999876543221 1234567999999999999999999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=309.35 Aligned_cols=189 Identities=24% Similarity=0.306 Sum_probs=158.2
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc--hhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES--MQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|++++.||+|+||+||+|++..+ |+.||||++.... ....+++.+|+.+|++++||||+++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~---------~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKT---------GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTT---------TEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCC---------CCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45799999999999999999987654 8899999997653 334467889999999999999999999986
Q ss_pred cC-----CeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCce
Q 022413 166 ED-----KELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYNA 240 (297)
Q Consensus 166 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~~ 240 (297)
.. ...+++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCE
T ss_pred eccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccc
Confidence 43 345677788889999999864 349999999999999999999994 899999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeccCCcccccCcceecccC-CcccccchhhhhhhhhcC
Q 022413 241 KISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGN-FYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 241 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGv~l~~ll 297 (297)
|++|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 161 kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll 213 (348)
T d2gfsa1 161 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213 (348)
T ss_dssp EECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH
T ss_pred cccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHH
Confidence 9999999875422 234467999999999987755 578999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=308.63 Aligned_cols=189 Identities=24% Similarity=0.263 Sum_probs=152.5
Q ss_pred hcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCc--chhhHHHHHHHHHHhcCCCCCCcccEEeEEE
Q 022413 88 TKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPE--SMQGFEEWQSEVNFLGRLSHPNLVKLLGYCW 165 (297)
Q Consensus 88 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 165 (297)
.++|+++++||+|+||+||+|++..+ |+.||||++... .....+++.+|+.+|++++||||+++++++.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t---------~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~ 86 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVL---------DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTT---------TEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCC---------CCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence 36799999999999999999987654 889999998754 2344567899999999999999999999996
Q ss_pred c------CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEcCCCc
Q 022413 166 E------DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLDGNYN 239 (297)
Q Consensus 166 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~~~~~ 239 (297)
. .+.+|+||||+.+ ++.+.+. ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~ 157 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT 157 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCC
T ss_pred cccccccCceeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccc
Confidence 4 3689999999965 5555553 348999999999999999999995 89999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 240 AKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 240 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
+|++|||+++..... ......+||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 158 ~kl~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell 212 (355)
T d2b1pa1 158 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212 (355)
T ss_dssp EEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred eeeechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHh
Confidence 999999998764432 2334567999999999999999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-38 Score=275.78 Aligned_cols=192 Identities=19% Similarity=0.200 Sum_probs=154.3
Q ss_pred cCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-----------CCCc
Q 022413 89 KNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-----------HPNL 157 (297)
Q Consensus 89 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nI 157 (297)
.+|+++++||+|+||+||+|++..+ |+.||||+++..... .+.+.+|+.+++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~---------g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVN---------NTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTT---------TEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCC---------CCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 3599999999999999999987654 889999999865432 356788999888775 5789
Q ss_pred ccEEeEEEc--CCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEEEc
Q 022413 158 VKLLGYCWE--DKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNILLD 235 (297)
Q Consensus 158 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nill~ 235 (297)
+++++++.. ....+++|+++..+.......... ....+++..+..++.||+.||+|||+ ..||+||||||+||||+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLME 160 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeee
Confidence 999988764 356777777776554433333222 22568899999999999999999995 58999999999999997
Q ss_pred CCC------ceEEccccccccCCCCCCcceeeccCCcccccCcceecccCCcccccchhhhhhhhhcC
Q 022413 236 GNY------NAKISDFGLAKLGPAGGESHVTTRVMGTYGYAAPEYVATGNFYLLSAKFGNVINVCMYL 297 (297)
Q Consensus 236 ~~~------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGv~l~~ll 297 (297)
.++ .+||+|||.+..... .....+||+.|+|||++.+..++.++|+||+||++++|+
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 223 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 223 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHH
Confidence 654 399999999976432 234467999999999999999999999999999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5.8e-28 Score=192.92 Aligned_cols=163 Identities=12% Similarity=0.090 Sum_probs=118.1
Q ss_pred CCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcch------------------hhHHHHHHHHHHhcCCC
Q 022413 92 KPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESM------------------QGFEEWQSEVNFLGRLS 153 (297)
Q Consensus 92 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 153 (297)
.++++||+|+||+||+|.+.+ |+.||+|+++.... ........|...+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~----------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEK----------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETT----------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECCC----------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 467899999999999997653 77899998653211 01133457889999999
Q ss_pred CCCcccEEeEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhcCCCCceeccCCCCcEE
Q 022413 154 HPNLVKLLGYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHTSEKKVIYRDFKASNIL 233 (297)
Q Consensus 154 h~nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~ivH~Dlkp~Nil 233 (297)
|++++..+++. ..+++|||+++..+.+ +....+..++.|++.+|+|||+ .||+||||||+|||
T Consensus 73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NIL 135 (191)
T d1zara2 73 GLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVL 135 (191)
T ss_dssp TSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEE
T ss_pred CCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhhee
Confidence 99999988653 2379999998765432 2333456789999999999994 89999999999999
Q ss_pred EcCCCceEEccccccccCCCCCCcceeeccCCcccccC------cceecccCCcccccchhhhhhh
Q 022413 234 LDGNYNAKISDFGLAKLGPAGGESHVTTRVMGTYGYAA------PEYVATGNFYLLSAKFGNVINV 293 (297)
Q Consensus 234 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwslGv~l 293 (297)
++++ .++|+|||+|+....... ..|.. .|.+ ..+|..++|+||+.--+
T Consensus 136 v~~~-~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETT-EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred eeCC-CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9965 589999999875432111 11111 1112 36788899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.96 E-value=1.5e-09 Score=88.90 Aligned_cols=148 Identities=16% Similarity=0.067 Sum_probs=95.9
Q ss_pred HHHHhhcCCCCCceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEE
Q 022413 83 DLKSATKNFKPDSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLL 161 (297)
Q Consensus 83 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~ 161 (297)
++......|++.+..+-++...||+.... +..+++|+...........+.+|...+..+. +--+.+++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-----------~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-----------CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 34445566776666554555789986433 4557888877654444445677888877764 44478888
Q ss_pred eEEEcCCeeEEEEEecCCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHhcchhc------------------------
Q 022413 162 GYCWEDKELLLVYEYMQRGSLENHLFRRNPSIQPLSWDIRLKIAIGAARGLGFLHT------------------------ 217 (297)
Q Consensus 162 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~------------------------ 217 (297)
.+..+++..++||++++|.++.+..... .. ...++.++...++.||+
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred EEEecCCceEEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence 8888889999999999998775443211 01 11122222233333331
Q ss_pred ---------------------------------CCCCceeccCCCCcEEEcCCCceEEcccccccc
Q 022413 218 ---------------------------------SEKKVIYRDFKASNILLDGNYNAKISDFGLAKL 250 (297)
Q Consensus 218 ---------------------------------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 250 (297)
....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012479999999999999876677999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.28 E-value=1.6e-06 Score=74.77 Aligned_cols=77 Identities=14% Similarity=0.149 Sum_probs=48.9
Q ss_pred CceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcc-------hhhHHHHHHHHHHhcCCC---CCCcccEEeE
Q 022413 94 DSLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPES-------MQGFEEWQSEVNFLGRLS---HPNLVKLLGY 163 (297)
Q Consensus 94 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~nIv~~~~~ 163 (297)
.+.||.|....||+....+. ++.+++|.-.+.. .....+...|.+.|+.+. ...+++++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~---------~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEH---------DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEEEeCCC---------CeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 35689999999999865432 5678888654321 112345567888777653 2456666653
Q ss_pred EEcCCeeEEEEEecCCCC
Q 022413 164 CWEDKELLLVYEYMQRGS 181 (297)
Q Consensus 164 ~~~~~~~~lv~e~~~~~~ 181 (297)
++...++|||++++..
T Consensus 102 --d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLK 117 (392)
T ss_dssp --ETTTTEEEECCCTTSE
T ss_pred --cCCCCEEEEeccCCcc
Confidence 5566789999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.26 E-value=2e-06 Score=69.32 Aligned_cols=73 Identities=18% Similarity=0.076 Sum_probs=49.8
Q ss_pred ecccC-ceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC--CCCcccEEeEEEcCCeeEEE
Q 022413 97 LGEGG-FGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS--HPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 97 lg~G~-~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv 173 (297)
+..|. .+.||+..... +..+++|....... ..+..|...++.+. .-.+.+++.+..+++..++|
T Consensus 18 ~~~G~s~~~v~r~~~~~----------~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG----------RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEECTT----------SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEeCC----------CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 33444 36789875443 55678888665543 23566777777664 33467788888888899999
Q ss_pred EEecCCCCH
Q 022413 174 YEYMQRGSL 182 (297)
Q Consensus 174 ~e~~~~~~L 182 (297)
|++++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999988654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.46 E-value=0.00016 Score=60.25 Aligned_cols=68 Identities=18% Similarity=0.157 Sum_probs=41.8
Q ss_pred eEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCCCCCc-----ccE--EeEEEcCCeeEEEEE
Q 022413 103 GRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLSHPNL-----VKL--LGYCWEDKELLLVYE 175 (297)
Q Consensus 103 g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~--~~~~~~~~~~~lv~e 175 (297)
-.||++...+ |..+++|+..+... ..+.+..|...+..|....| +.. -..+...+..+.+++
T Consensus 36 N~vy~v~~~d----------g~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQDED----------RRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEECCTT----------CCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEEcCC----------CCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 4799876544 67799999876532 22556678877776642211 111 112234567889999
Q ss_pred ecCCCC
Q 022413 176 YMQRGS 181 (297)
Q Consensus 176 ~~~~~~ 181 (297)
+++|..
T Consensus 105 ~~~G~~ 110 (325)
T d1zyla1 105 SVGGRQ 110 (325)
T ss_dssp CCCCEE
T ss_pred ecCCcC
Confidence 997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.42 E-value=0.00035 Score=59.67 Aligned_cols=80 Identities=15% Similarity=0.005 Sum_probs=50.3
Q ss_pred ceecccCceEEEEEEECCCCCccccCCCCcEEEEEecCCcchhhHHHHHHHHHHhcCCC-CCCcccEEeEEEcCCeeEEE
Q 022413 95 SLLGEGGFGRVYKGWVDDKTLAPSKTGLGMVVAIKKLNPESMQGFEEWQSEVNFLGRLS-HPNLVKLLGYCWEDKELLLV 173 (297)
Q Consensus 95 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 173 (297)
+.|+.|---.+|++...+.... .......|.+++..... ......+|..+++.+. +.-.+++++++.. .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~--~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCcc--ccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 5677677889999877654221 11224567777765322 2234467888888886 4445677776632 689
Q ss_pred EEecCCCCH
Q 022413 174 YEYMQRGSL 182 (297)
Q Consensus 174 ~e~~~~~~L 182 (297)
+||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.30 E-value=0.00083 Score=55.23 Aligned_cols=31 Identities=26% Similarity=0.287 Sum_probs=28.0
Q ss_pred CCCceeccCCCCcEEEcCCCceEEccccccc
Q 022413 219 EKKVIYRDFKASNILLDGNYNAKISDFGLAK 249 (297)
Q Consensus 219 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 249 (297)
..|+||+|+.++||+++++...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4789999999999999988877899999875
|